<SEC-DOCUMENT>0000859737-18-000002.txt : 20180208
<SEC-HEADER>0000859737-18-000002.hdr.sgml : 20180208
<ACCEPTANCE-DATETIME>20180208162300
ACCESSION NUMBER:		0000859737-18-000002
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20171230
FILED AS OF DATE:		20180208
DATE AS OF CHANGE:		20180208

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		18586061

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>holx_q1-2018.htm
<DESCRIPTION>10-Q
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s88EE5E23B200E9CC1E1D03E9029B8269"></a></div><div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.46588693957115%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:120%;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">__________________________________________________________&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 10-Q</font></div><div style="line-height:120%;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;__________________________________________________________&#160;</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Mark One)</font></div><div style="line-height:120%;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">&#253;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the quarterly period ended </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">or</font><font style="font-family:inherit;font-size:12pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:Wingdings;font-size:12pt;">&#168;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the transition period from </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">to</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commission File Number: 1-36214</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">__________________________________________________________&#160;</font></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">Hologic, Inc.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">__________________________________________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:49%;"></td><td style="width:3%;"></td><td style="width:48%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">04-2902449</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State of incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(I.R.S. Employer Identification No.)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">250 Campus Drive,</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Marlborough, Massachusetts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">01752</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of principal executive offices)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(508) 263-2900</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">__________________________________________________________</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#253;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#253;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check One):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:21%;"></td><td style="width:3%;"></td><td style="width:43%;"></td><td style="width:3%;"></td><td style="width:24%;"></td><td style="width:3%;"></td><td style="width:3%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Large&#160;accelerated&#160;filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#253;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accelerated&#160;filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-accelerated filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168; </font><font style="font-family:inherit;font-size:10pt;">(Do not check if a smaller reporting company)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smaller&#160;reporting&#160;company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)&#160;&#160;&#160;&#160;Yes&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;No&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#253;</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">February&#160;5, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">276,529,054</font><font style="font-family:inherit;font-size:10pt;">&#32;shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.46588693957115%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:1px solid #000000;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s23F14C22A3782A51388303E9332CA9DE"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">HOLOGIC, INC.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INDEX</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:9%;"></td><td style="width:87%;"></td><td style="width:4%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Page</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s5ED1054C4043CF5944AE03E93352CADE"><font style="font-family:inherit;font-size:10pt;">PART I &#8211; FINANCIAL INFORMATION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item 1.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8F42B83CFF3FF060CD5803E933577667"><font style="font-family:inherit;font-size:10pt;">Financial Statements (unaudited)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC3315F6A911DCB4B4C9903E90089104D"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Income for the Three Months Ended December 30, 2017 and December 31, 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC3315F6A911DCB4B4C9903E90089104D">3</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE38A241CB2B029F63C5703E901060D6B"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Comprehensive Income for the Three Months Ended December 30, 2017 and December 31, 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sE38A241CB2B029F63C5703E901060D6B">4</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s24FAC3219051976EA14E03E8FFEDE574"><font style="font-family:inherit;font-size:10pt;">Consolidated Balance Sheets as of December 30, 2017 and September 30, 2017</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s24FAC3219051976EA14E03E8FFEDE574">5</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8A8AF6BAE85FB402D76703E900A83B6C"><font style="font-family:inherit;font-size:10pt;">Consolidated Statements of Cash Flows for the Three Months Ended December 30, 2017 and December 31, 2016</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8A8AF6BAE85FB402D76703E900A83B6C">6</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s6A60894DE3B50B699AAD03E9348C071C"><font style="font-family:inherit;font-size:10pt;">Notes to Consolidated Financial Statements</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s6A60894DE3B50B699AAD03E9348C071C">7</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item 2.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sDE2EDBA165D4C2E7075803E937EA40CF"><font style="font-family:inherit;font-size:10pt;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sDE2EDBA165D4C2E7075803E937EA40CF">32</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item 3.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4AE671952BAC67212E5A03E9391BD609"><font style="font-family:inherit;font-size:10pt;">Quantitative and Qualitative Disclosures About Market Risk</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s4AE671952BAC67212E5A03E9391BD609">49</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item 4.</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8FA7AE097CB8C92EAA9203E939425639"><font style="font-family:inherit;font-size:10pt;">Controls and Procedures</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s8FA7AE097CB8C92EAA9203E939425639">50</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s6E35DE419729BD1D6E9603E9394285DF"><font style="font-family:inherit;font-size:10pt;">PART II &#8211; OTHER INFORMATION</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;1.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC7E9BD9F7F2F1F429CB003E939430288"><font style="font-family:inherit;font-size:10pt;">Legal Proceedings</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sC7E9BD9F7F2F1F429CB003E939430288">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;1A.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s675C5950A35A4703F86D03E93967EAB3"><font style="font-family:inherit;font-size:10pt;">Risk Factors</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s675C5950A35A4703F86D03E93967EAB3">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;2.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s57D41AB998E1FF098D3103E90C94129C"><font style="font-family:inherit;font-size:10pt;">Unregistered Sales of Equity Securities and Use of Proceeds</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s57D41AB998E1FF098D3103E90C94129C">52</a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Item&#160;6.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s12CD25D3A2FCD9C9303503E939B883CC"><font style="font-family:inherit;font-size:10pt;">Exhibits</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#s12CD25D3A2FCD9C9303503E939B883CC">53</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAD518252665B5049562603E939FEFEF9"><font style="font-family:inherit;font-size:10pt;">SIGNATURES</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="#sAD518252665B5049562603E939FEFEF9">55</a></div></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">EXHIBITS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></div><hr style="page-break-after:always"><div><a name="s5ED1054C4043CF5944AE03E93352CADE"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART I &#8211; FINANCIAL INFORMATION</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div><a name="s8F42B83CFF3FF060CD5803E933577667"></a></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Financial Statements (unaudited)</font></div></td></tr></table><div><a name="sC3315F6A911DCB4B4C9903E90089104D"></a></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">HOLOGIC, INC.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions, except number of shares, which are reflected in thousands, and per share data)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">650.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">613.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Costs of revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">213.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of acquired intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service and other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Profit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">404.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and marketing</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">139.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">110.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">69.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of acquired intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">290.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">258.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest income</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt extinguishment loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Benefit) provision for income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(310.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income per common share:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.31</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.45</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average number of shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">276,856</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278,663</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280,802</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284,224</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></div><hr style="page-break-after:always"><div><a name="sE38A241CB2B029F63C5703E901060D6B"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#32;HOLOGIC, INC.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.609375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">86.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in foreign currency translation adjustment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in unrealized holding gains and losses on available-for-sale securities, net of tax of $0.2 and $1.5 for the three months December 30, 2017 and December 31, 2016:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain recognized in other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss reclassified from accumulated other comprehensive loss to the statements of income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in pension plans, net of taxes of $0.6 for the three months ended December 30, 2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in value of hedged interest rate caps, net of tax of $(4.9) and $0.5 for the three  months ended December 30, 2017 and December 31, 2016:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Loss) gain recognized in other comprehensive income (loss), net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Loss reclassified from accumulated other comprehensive loss to the statements of income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other comprehensive income (loss)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">411.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes.</font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></div><hr style="page-break-after:always"><div><a name="s24FAC3219051976EA14E03E8FFEDE574"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">HOLOGIC, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONSOLIDATED BALANCE SHEETS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions, except number of shares, which are reflected in thousands, and par value)</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASSETS</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">664.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">540.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable, less reserves of $11.5 and $9.8, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">548.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">533.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">331.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,638.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,478.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment, net</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">467.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,681.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,772.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,176.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,171.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,048.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,979.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of long-term debt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,150.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">166.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">412.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">375.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current portion of capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,309.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,865.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt, net of current portion</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,757.7</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,172.1</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligations, net of current portion</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">586.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">973.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long-term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">159.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commitments and contingencies (Note 7)</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders&#8217; equity:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 288,750 and 287,853 shares issued, respectively</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional paid-in-capital</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,628.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,630.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated deficit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,976.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,382.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury stock, at cost &#8211; 12,560 shares</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(450.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(16.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholders&#8217; equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,194.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,784.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders&#8217; equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,048.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,979.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See accompanying notes.</font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></div><hr style="page-break-after:always"><div><a name="s8A8AF6BAE85FB402D76703E900A83B6C"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">HOLOGIC, INC.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">CONSOLIDATED STATEMENTS OF CASH FLOWS</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(Unaudited) </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions</font><font style="font-family:inherit;font-size:10pt;">)</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">OPERATING ACTIVITIES</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net income </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">406.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">86.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">27.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">20.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of acquired intangibles</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">94.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">94.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Non-cash interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Stock-based compensation expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(390.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(24.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Debt extinguishment loss</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other adjustments and non-cash items</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Changes in operating assets and liabilities, excluding the effect of acquisitions:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Inventories</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(23.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(20.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Prepaid expenses and other assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accounts payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(17.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accrued expenses and other liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">48.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(14.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash provided by operating activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">169.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">169.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">INVESTING ACTIVITIES</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Acquisition of businesses, net of cash acquired</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Capital expenditures</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(10.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Increase in equipment under customer usage agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(13.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from sale of available-for-sale marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Other activity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(26.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(25.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">FINANCING ACTIVITIES</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1,331.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(18.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from long-term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,500.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayment of amounts borrowed under accounts receivable securitization program</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from senior notes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">350.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payments to extinguish convertible notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(296.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from amounts borrowed under revolving credit line</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">495.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Repayments of amounts borrowed under revolving credit line</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(720.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payment of debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Proceeds from issuance of common stock pursuant to employee stock plans</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payments under capital lease obligations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Payment of minimum tax withholdings on net share settlements of equity awards</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(14.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(16.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net cash used in financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(20.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(40.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Effect of exchange rate changes on cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Net increase in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">123.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">97.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents, beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">540.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">548.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Cash and cash equivalents, end of period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">664.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-bottom:3px double #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">646.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">See accompanying notes.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></div><hr style="page-break-after:always"><div><a name="s6A60894DE3B50B699AAD03E9348C071C"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">HOLOGIC, INC.</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Unaudited)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">(all tabular amounts in millions, except number of shares, which are reflected in thousands, and per share data)</font></div><div><a name="sB2CEDDD57FDFFC55186C03E9006A8BE2"></a></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(1) Basis of Presentation</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). These financial statements should be read in conjunction with the consolidated financial statements and related notes for the year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;21, 2017. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 22, 2017, the Company completed the acquisition of Cynosure, Inc. ("Cynosure"), which resulted in the Company expanding into the medical aesthetics market. Cynosure develops, manufactures and markets aesthetic treatment systems that enable medical practitioners to perform non-invasive and minimally invasive procedures. Cynosure's results of operations are reported within the Company's Medical Aesthetics reportable segment. The Company's acquisition of Cynosure is more fully described in Note 3.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2016, the FASB issued Accounting Standards Update No. 2016-19, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Technical Corrections and Improvements</font><font style="font-family:inherit;font-size:10pt;">&#32;(ASU 2016-19). This guidance changes how companies classify internal-use software from classification within property, plant, and equipment to intangible assets. The amendments in the update are effective for annual periods beginning after December 15, 2016, and were applicable to the Company in fiscal 2018. The Company adopted ASU 2016-19 in the first quarter of fiscal 2018. As a result of the adoption, the Company has reclassified </font><font style="font-family:inherit;font-size:10pt;">$17.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$18.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of internal-use software from property, plant, and equipment to intangible assets as of December 30, 2017 and September 30, 2017, respectively. Additionally, the Company reclassified </font><font style="font-family:inherit;font-size:10pt;">$12.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$12.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of capitalized software embedded in its products from other assets to intangible assets as of December 30, 2017 and September 30, 2017, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Subsequent Events Consideration</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events recorded in the unaudited consolidated financial statements as of and for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. On  January 19, 2018, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal amount of senior notes, allocated between (i) </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of its </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2025 (the &#8220;New 2025 Senior Notes&#8221;) at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount of the 2025 Senior Notes, plus accrued and unpaid interest from October 10, 2017, and (ii) </font><font style="font-family:inherit;font-size:10pt;">$400 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of its new </font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2028 (the "2028 Senior Notes," and together with the New 2025 Senior Notes, the "New Notes") at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount of the 2028 Senior Notes. In connection with the offering of the New Notes, the Company has called all of its outstanding </font><font style="font-family:inherit;font-size:10pt;">5.250%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2022 (the "2022 Senior Notes"), in aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, on January 29, 2018, the Company announced that pursuant to the terms of the indenture for the </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;">&#32;Convertible Senior Notes due 2042 (the &#8220;2042 Notes&#8221;), holders of the 2042 Notes had the option of requiring the Company to repurchase their 2042 Notes on March 1, 2018 at a repurchase price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the put date. The Company also announced on January 29, 2018 that it had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the redemption date. Holders also have a right to convert their 2042 Notes. In connection with holders&#8217; right to convert the 2042 Notes, the Company announced that it would settle all conversions of 2042 Notes entirely in cash. </font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></div><hr style="page-break-after:always"><div><a name="s667B77E7D7F0947ABF2B03E9006A4FEC"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(2) Fair Value Measurements</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has investments in derivative instruments consisting of interest rate caps and forward foreign currency contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of the Company's interest rate caps and forward foreign currency contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 6 for further discussion and information on the interest rate caps and forward foreign currency contracts. </font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a payment obligation to the participants under its Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;). This liability is recorded at fair value based on the underlying value of certain hypothetical investments under the DCP as designated by each participant for their benefit. Since the value of the DCP obligation is based on market prices, the liability is classified within Level 1. </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:38%;"></td><td style="width:1%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value at Reporting Date Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance as of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;Prices&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active&#160;Market&#160;for</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical&#160;Assets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs&#160;(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs&#160;(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap - derivative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets consist of cost-method equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements for the three months ended December 30, 2017 and December 31, 2016.</font></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Disclosure of Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, interest rate caps, forward foreign currency contracts, insurance contracts, DCP liability, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate caps and forward foreign currency contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value, and the related DCP liability is recorded at fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under the Company&#8217;s Amended and Restated Credit Agreement and Securitization Program of </font><font style="font-family:inherit;font-size:10pt;">$1.6 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal, respectively, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2022 Senior Notes and 2025 Senior Notes had a fair value of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$358.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;based on their trading prices, representing a Level 1 measurement. The fair values of the Company&#8217;s Convertible Notes were based on the trading prices of the respective notes and represents a Level 1 measurement. Refer to Note 5 for the carrying amounts of the various components of the Company&#8217;s debt.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated fair values of the Company&#8217;s Convertible Notes at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;were as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:83%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2042 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2043 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s49558E97BE1C074DD15E03E8FFBE7687"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(3) Business Combinations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cynosure Inc.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On March 22, 2017, the Company completed the acquisition of Cynosure and acquired all of the outstanding shares of Cynosure. Each share of common stock of Cynosure outstanding immediately prior to the effective time of the acquisition was canceled and converted into the right to receive </font><font style="font-family:inherit;font-size:10pt;">$66.00</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash. In addition, all outstanding restricted stock units, performance stock units, and stock options were canceled and converted into the right to receive </font><font style="font-family:inherit;font-size:10pt;">$66.00</font><font style="font-family:inherit;font-size:10pt;">&#32;per share in cash less the applicable exercise price, as applicable. The acquisition was funded through available cash, and the total purchase price was </font><font style="font-family:inherit;font-size:10pt;">$1.66 billion</font><font style="font-family:inherit;font-size:10pt;">. The Company incurred </font><font style="font-family:inherit;font-size:10pt;">$18.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of transaction costs, which were recorded within general and administrative expenses. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cynosure, headquartered in Westford, Massachusetts, develops, manufactures, and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women&#8217;s health. Cynosure also markets radiofrequency (RF) energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure's results of operations are reported in the Company's Medical Aesthetics reportable segment from the date of acquisition and the goodwill within this reportable segment is solely related to Cynosure.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total purchase price was allocated to Cynosure&#8217;s preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of March 22, 2017, as set forth below. The preliminary purchase price allocation is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.5390625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:75%;"></td><td style="width:1%;"></td><td style="width:23%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets and liabilities, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">736.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Distribution agreement</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(315.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">683.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase Price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,657.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Cynosure&#8217;s </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">business. The Company has not yet obtained all of the information related to the fair value of the acquired assets and liabilities, primarily taxes, to finalize the purchase price allocation.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the preliminary purchase price allocation, the Company has determined the identifiable intangible assets are developed technology, in-process research and development ("IPR&amp;D"), a distribution agreement, customer relationships, and trade names. The preliminary fair value of the intangible assets has been estimated using the income approach, and the cash flow projections were discounted using rates ranging from </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;">, except for the IPR&amp;D assets in which the Company used a range of </font><font style="font-family:inherit;font-size:10pt;">14%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;">. The cash flows are based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The developed technology assets are comprised of know-how, patents and technologies embedded in Cynosure's products and relate to currently marketed products. The developed technology assets primarily comprise the significant product families of Cynosure, primarily SculpSure, Icon, and PicoSure.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&amp;D projects relate to in-process projects that have not reached technological feasibility as of the acquisition date and have no alternative future use. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying project or expected commercial release depending on the project. The Company recorded, on a preliminary basis, </font><font style="font-family:inherit;font-size:10pt;">$107.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of IPR&amp;D related to </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;projects, which were expected to be completed during fiscal 2018 and 2019 with a preliminary cost to complete of approximately </font><font style="font-family:inherit;font-size:10pt;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;">. During the fourth quarter of fiscal 2017, the Company obtained regulatory approval for </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;projects with an aggregate fair value of </font><font style="font-family:inherit;font-size:10pt;">$61.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and these assets were reclassified to developed technology. The remaining project is expected to be completed during fiscal 2019 with an estimated cost to complete of approximately </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">. Given the uncertainties inherent with product development and introduction, there can be no assurance that any of the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. All of the IPR&amp;D assets were valued using the multiple-period excess earnings method approach.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The distribution agreement intangible asset relates to Cynosure's exclusive distribution rights for the MonaLisa Touch device in certain geographic regions. The customer relationships intangible asset pertains to Cynosure's relationships with its end customers and related service arrangements and distributors throughout the world. Trade names relate to the Cynosure corporate name and primary product names, and the Company used the Relief-from-Royalty Method to estimate the fair value of this asset.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology, distribution agreement, customer relationships and trade names are being amortized on a straight-line basis over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">11.8</font><font style="font-family:inherit;font-size:10pt;">&#32;years, </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;">&#32;years, </font><font style="font-family:inherit;font-size:10pt;">7.7</font><font style="font-family:inherit;font-size:10pt;">&#32;years and </font><font style="font-family:inherit;font-size:10pt;">8.9</font><font style="font-family:inherit;font-size:10pt;">&#32;years, respectively. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on several strategic and synergistic benefits that are expected to be realized from the Cynosure acquisition. These benefits include the expectation that the Company's entry into the aesthetics market will significantly broaden the Company's offering in women's health. The combined company is expected to benefit from a broader global presence, synergistic utilization of Hologic's direct sales force, primarily its GYN Surgical sales force, with certain Cynosure products, and the Company's entry into an adjacent cash-pay segment. None of the goodwill is expected to be deductible for income tax purposes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal 2017, Cynosure's revenue and pre-tax loss, which excludes acquisition expenses incurred by the Company, for the period from the acquisition date to September 30, 2017 were </font><font style="font-family:inherit;font-size:10pt;">$207.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$96.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The pre-tax loss includes amortization expense, the impact of the step-up in inventory, retention and integration expenses including legal and consulting fees, and restructuring charges. The following unaudited pro forma information presents the combined financial results for the Company and Cynosure as if the acquisition of Cynosure had been completed at the beginning of the prior fiscal year, September 26, 2015 (fiscal 2016):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.34375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:81%;"></td><td style="width:1%;"></td><td style="width:17%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.26</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited pro forma information for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;">&#32;December 31, 2016 (the first quarter of fiscal 2017) was calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. The pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments to reflect pro forma results of operations as if the acquisition occurred on September 27, 2015 (the beginning of fiscal 2016), such as increased amortization for the fair value of acquired intangible assets. The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of the period presented, or of future results of the consolidated entities. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Medicor Medical Supply</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On April 7, 2017, the Company completed the acquisition of MMS Medicor Medical Supplies GmbH ("Medicor") for a purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$19.0 million</font><font style="font-family:inherit;font-size:10pt;">, which includes a working capital adjustment of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;that was paid in the fourth quarter of fiscal 2017, and a holdback of </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;that is payable </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;years from the date of acquisition. Medicor was a long-standing distributor of the Company's Breast and Skeletal Health products in Germany, Austria and Switzerland. Based on the Company's preliminary valuation, it has allocated </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the purchase price to the preliminary value of intangible assets, which have a weighted average life of </font><font style="font-family:inherit;font-size:10pt;">7.7</font><font style="font-family:inherit;font-size:10pt;">&#32;years, and </font><font style="font-family:inherit;font-size:10pt;">$8.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to goodwill. The remaining </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of purchase price has been allocated to the acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Emsor, S.A.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On December 11, 2017, the Company completed the acquisition of Emsor S.A. ("Emsor") for a purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;">, which includes a holdback of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;that is payable </font><font style="font-family:inherit;font-size:10pt;">eighteen</font><font style="font-family:inherit;font-size:10pt;">&#32;months from the date of acquisition, and contingent consideration which the Company has estimated at </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">. The contingent consideration is payable upon Emsor achieving predefined amounts of cumulative revenue over a </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;year period from the date of acquisition. Emsor was a distributor of the Company's Breast and Skeletal Health products in Spain and Portugal. Based on the Company's preliminary valuation, it has allocated </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the purchase price to the preliminary value of intangible assets and </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to goodwill. The remaining </font><font style="font-family:inherit;font-size:10pt;">$6.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of purchase price has been allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s0CA3E81BBA7F54E941E503E8FFAEFF42"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(4) Restructuring Charges</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. In addition, the Company continually assesses its management and organizational structure. As a result of these assessments, the Company has undertaken various restructuring actions, which are described below. The following table displays charges related to these actions recorded in the fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;year to date period (</font><font style="font-family:inherit;font-size:10pt;">three months ended December 30, 2017</font><font style="font-family:inherit;font-size:10pt;">) and fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">&#32;(the year ended September 30, 2017) and a rollforward of the accrued balances from </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2018 Actions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2017 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2016 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Restructuring Charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2017 charges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workforce reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Facility closure costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2017 restructuring charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 charges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workforce reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 restructuring charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.5703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="21"></td></tr><tr><td style="width:35%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2018 Actions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2017 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2016 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Rollforward of Accrued Restructuring</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of September 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Severance payments and adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal 2018 Actions</font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">During the first quarter of fiscal 2018, the Company decided to terminate certain employees across the organization, including a corporate executive and sales and marketing personnel in its Diagnostics and Medical Aesthetics reportable segments. The charges were recorded pursuant to ASC 712, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Nonretirement Postemployment Benefits </font><font style="font-family:inherit;font-size:10pt;">(ASC 712) or ASC 420, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Exit or Disposal Cost Obligations </font><font style="font-family:inherit;font-size:10pt;">(ASC 420) depending on the employee. As such, the Company recorded severance and benefits charges of </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the first quarter. Included within this charge is </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to the modification of equity awards.</font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal 2017 Actions</font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In connection with its acquisition of Cynosure, the Company decided to terminate certain Cynosure executives in the second quarter of fiscal 2017 and recorded </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in severance and benefits charges. During the third and fourth quarters of fiscal 2017, the Company terminated additional executives and employees and recorded </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in severance and benefits charges. </font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal 2016 Actions</font></div><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;"></font><font style="font-family:inherit;font-size:10pt;">In connection with the closure of the Bedford, Massachusetts facility, during the first quarter of fiscal 2017 the Company recorded </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for lease obligation charges related to a section of the facility that the Company had determined met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it can obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it will take to obtain a subtenant at the Bedford location and as a result recorded an additional </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;lease obligation charge. These estimates may vary from the actual sublease agreements executed, if at all, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></div><hr style="page-break-after:always"><div><a name="sEA80987BE6B0374EB80103E900D74297"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(5) Borrowings and Credit Arrangements</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s borrowings consisted of the following:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:74%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current debt obligations, net of debt discount and deferred issuance costs:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolver</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securitization Program</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current debt obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,150.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt obligations, net of debt discount and deferred issuance costs:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,430.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022 Senior Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">982.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">981.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2025 Senior Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,757.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,172.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt obligations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,329.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,322.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amended and Restated Credit Agreement</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 3, 2017, the Company and certain of its domestic subsidiaries entered into an Amended and Restated Credit and Guaranty Agreement (the "Amended and Restated Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto. The Amended and Restated Credit Agreement amends and restates the Company's prior credit and guaranty agreement, originally dated as of May 29, 2015 (the "Prior Credit Agreement"). The proceeds under the Amended and Restated Credit Agreement of </font><font style="font-family:inherit;font-size:10pt;">$1.8 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;were used, among other things, to pay off the Term Loan of </font><font style="font-family:inherit;font-size:10pt;">$1.32 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;and the Revolver then outstanding under the Company's Prior Credit Agreement. Borrowings under the Amended and Restated Credit Agreement are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company's U.S. subsidiaries, with certain exceptions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The credit facilities (the &#8220;Amended and Restated Credit Facilities&#8221;) under the Amended and Restated Credit Agreement consist of:</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A </font><font style="font-family:inherit;font-size:10pt;">$1.5 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;secured term loan to the Company ("Amended Term Loan") with a maturity date of October 3, 2022; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A secured revolving credit facility (the "Amended Revolver") under which the the Company may borrow up to </font><font style="font-family:inherit;font-size:10pt;">$1.5 billion</font><font style="font-family:inherit;font-size:10pt;">, subject to certain sublimits, with a maturity date of October 3, 2022.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the closing, the Company borrowed </font><font style="font-family:inherit;font-size:10pt;">$345 million</font><font style="font-family:inherit;font-size:10pt;">&#32;under the Amended Revolver, which was fully repaid during October 2017. As of December 30, 2017, the Company had </font><font style="font-family:inherit;font-size:10pt;">$120.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;outstanding under the Amended Revolver. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Amended and Restated Credit Facilities bear interest, at the Company's option and in each case plus an applicable margin as follows: </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amended Term Loan</font><font style="font-family:inherit;font-size:10pt;">: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate (as defined in the Amended and Restated Credit Agreement),&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amended Revolver</font><font style="font-family:inherit;font-size:10pt;">: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate is subject to specified changes depending on the total net leverage ratio as defined in the Amended and Restated Credit Agreement. The borrowings of the Amended Term Loan initially bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to </font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;">. The borrowings of the Amended Revolver initially bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to </font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;">. The Company is also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the Amended Revolver.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to make scheduled principal payments under the Amended Term Loan in increasing amounts ranging from </font><font style="font-family:inherit;font-size:10pt;">$9.375 million</font><font style="font-family:inherit;font-size:10pt;">&#32;per </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-month period commencing with the three-month period ending on December&#160;29, 2017 to </font><font style="font-family:inherit;font-size:10pt;">$37.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;per three-month period commencing with the three-month period ending on December&#160;23, 2021. The remaining balance of the Amended Term Loan and any amounts outstanding under the Amended Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the Amended and Restated Credit Agreement, the Company is required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by the Company,&#160;first, to the Amended Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans (as defined in the Amended and Restated Credit Agreement),&#160;third,&#160;to the Amended Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit (as defined in the Amended and Restated Credit Agreement) and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the Amended and Restated Credit Facilities without premium or penalty.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings outstanding under the Amended and Restated Credit Agreement and the Prior Credit Agreement for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;had weighted-average interest rates of </font><font style="font-family:inherit;font-size:10pt;">2.75%</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2.05%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The interest rate on the outstanding Amended Term Loan borrowing at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">3.07%</font><font style="font-family:inherit;font-size:10pt;">. Interest expense under the Amended and Restated Credit Agreement aggregated </font><font style="font-family:inherit;font-size:10pt;">$12.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, which includes non-cash interest expense of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to the amortization of the deferred issuance costs and accretion of the debt discount. Interest expense under the Prior Credit Agreement aggregated </font><font style="font-family:inherit;font-size:10pt;">$9.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, which includes </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the Amended and Restated Credit Agreement requires the the Company to maintain certain financial ratios. The Amended and Restated Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company, with certain exceptions. For example, borrowings under the Amended and Restated Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program. The Amended and Restated Credit Agreement contains total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter and an excess cash flow prepayment requirement measured as of the end of each fiscal year. The total net leverage ratio was </font><font style="font-family:inherit;font-size:10pt;">5.00</font><font style="font-family:inherit;font-size:10pt;">:1.00 beginning on the Company's fiscal quarter ended December 30, 2017, and then decreases over time to </font><font style="font-family:inherit;font-size:10pt;">4.50</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the quarter ending March 27, 2021. The interest coverage ratio was </font><font style="font-family:inherit;font-size:10pt;">3.75</font><font style="font-family:inherit;font-size:10pt;">:1.00 beginning on the Company's fiscal quarter ended December 30, 2017, and remains as such for each quarter thereafter. The total net leverage ratio is defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the Amended and Restated Credit Agreement) for the </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">-fiscal quarter period ending on the measurement date. The interest coverage ratio is defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the Amended and Restated Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of December 30, 2017.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluated the Amended and Restated Credit Agreement for derivatives pursuant to ASC 815, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;">, and identified embedded derivatives that required bifurcation as the features are not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of December 30, 2017.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to ASC 470, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt </font><font style="font-family:inherit;font-size:10pt;">(ASC 470), the accounting for the Amended and Restated Credit Agreement was evaluated on a creditor-by-creditor basis with regard to the Amended and Restated Credit Agreement to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the Amended and Restated Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the first quarter of fiscal 2018 to write-off the pro-rata amount </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">. Pursuant to ASC 470, subtopic 50-40, third-party costs of </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to this transaction were recorded as interest expense and </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2025 Senior Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October&#160;10, 2017, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$350 million</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal amount of its </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2025 (the &#8220;2025 Senior Notes&#8221;) at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount of the 2025 Senior Notes. The 2025 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &#8220; 2025 Domestic Guarantors&#8221;).</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2025 Senior Notes mature on October&#160;15, 2025 and bear interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year, payable semi-annually on April&#160;15 and October&#160;15 of each year, commencing on April&#160;15, 2018. The Company recorded interest expense of </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended December 30, 2017 which includes non-cash interest expense of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to the amortization of the deferred issuance costs and accretion of the debt discount.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company may redeem the 2025 Senior Notes at any time prior to October 15, 2020 at a price equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount of the 2025 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before October&#160;15, 2020, at a redemption price equal to </font><font style="font-family:inherit;font-size:10pt;">104.375%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2025 Senior Notes on or after: October&#160;15, 2020 through October 14, 2021 at </font><font style="font-family:inherit;font-size:10pt;">102.188%</font><font style="font-family:inherit;font-size:10pt;">&#32;of par; October 15, 2021 through October 14, 2022 at </font><font style="font-family:inherit;font-size:10pt;">101.094%</font><font style="font-family:inherit;font-size:10pt;">&#32;of par; and October 15, 2022 and thereafter at </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the 2025 Indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2025 Senior Notes at a price equal to </font><font style="font-family:inherit;font-size:10pt;">101%</font><font style="font-family:inherit;font-size:10pt;">&#32;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 19, 2018, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal amount of senior notes, which included </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of additional </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2025 (the &#8220;New 2025 Senior Notes&#8221;), issued under a supplement to the 2025 Indenture. See &#8220;Subsequent Events&#8221; below.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2022 Senior Notes</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's </font><font style="font-family:inherit;font-size:10pt;">5.250%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2022 (the &#8220;2022 Senior Notes&#8221;) mature on July 15, 2022 and bear interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">5.250%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year, payable semi-annually on January 15 and July 15 of each year, commencing on January 15, 2016. The Company recorded interest expense of </font><font style="font-family:inherit;font-size:10pt;">$14.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$15.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and December 31, 2016, respectively, which includes non-cash interest expense of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the amortization of the deferred issuance costs and accretion of the debt discount.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the offering of the New 2025 Senior Notes and the Company&#8217;s </font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2028, the Company has called all of its outstanding 2022 Senior Notes, in the aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. See &#8220;Subsequent Events&#8221; below. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On various dates during the first quarter of fiscal 2018, the Company entered into privately negotiated repurchase transactions and extinguished </font><font style="font-family:inherit;font-size:10pt;">$39.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;principal amount of its </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;">&#32;Convertible Senior Notes due 2042 (the "2042 Notes") for total payments of </font><font style="font-family:inherit;font-size:10pt;">$52.8 million</font><font style="font-family:inherit;font-size:10pt;">. This amount includes the conversion premium resulting from the Company's stock price on the date of the transactions being in excess of the conversion prices of </font><font style="font-family:inherit;font-size:10pt;">$31.175</font><font style="font-family:inherit;font-size:10pt;">. As a result, on a gross basis, </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the consideration paid was allocated to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;within additional paid-in-capital.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;On December 15, 2017, pursuant to the provisions of the indenture governing the Company's </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;">&#32;Convertible Senior Notes due December 15, 2043 (the "2043 Notes"),  the Company redeemed or repurchased an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$201.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in original principal amount of the 2043 Notes then outstanding for an aggregate repurchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$244.1 </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">million</font><font style="font-family:inherit;font-size:10pt;">, representing the then accreted principal amount of the 2043 Notes. The remaining </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in original principal amount of the 2043 Notes were converted, and the Company elected to settle these conversions, which will occur in the second quarter of fiscal 2018.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The term "Convertible Notes" refers to the 2042 Notes and the 2043 Notes.</font></div><div style="line-height:120%;padding-top:24px;text-indent:36px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense under the Convertible Notes was as follows:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.859375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of deferred financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal accretion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00% accrued interest (cash)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">2025 Senior Notes and 2028 Senior Notes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">On January 19, 2018, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal amount of senior notes, allocated between (i) an additional </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal amounts of its 2025 Senior Notes pursuant to a supplement to the indenture governing the Company's existing 2025 Senior Notes, at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount of the 2025 Senior Notes, plus accrued and unpaid interest from October 10, 2017 and (ii)  </font><font style="font-family:inherit;font-size:10pt;">$400 million</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal amounts of its </font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;">&#32;Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the aggregate principal amount of the 2028 Senior Notes. The new 2025 Senior Notes have the same terms as the existing 2025 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &#8220;2028 Domestic Guarantors&#8221;).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2028 Senior Notes were issued pursuant to an indenture (the &#8220;2028 Indenture&#8221;), dated as of January 19, 2018 among the Company, the 2028 Domestic Guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;</font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. The 2028 Indenture contains covenants which limit, among other things, the ability of the Company and the Guarantors to create liens and engage in certain sale and leaseback transactions. These covenants are subject to a number exceptions and qualifications.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to&#160;</font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;</font><font style="font-family:inherit;font-size:10pt;">104.625%</font><font style="font-family:inherit;font-size:10pt;">&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;</font><font style="font-family:inherit;font-size:10pt;">102.312%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par; February 1, 2024 through February 1, 2025 at&#160;</font><font style="font-family:inherit;font-size:10pt;">101.541%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par; February 1, 2025 through February 1, 2026 at&#160;</font><font style="font-family:inherit;font-size:10pt;">100.770%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par; and February 1, 2026 and thereafter at&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the 2028 Indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;</font><font style="font-family:inherit;font-size:10pt;">101%</font><font style="font-family:inherit;font-size:10pt;">&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2042 Notes </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 29, 2018, the Company announced that pursuant to the terms of the indenture for the </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;">&#32;Convertible Senior Notes due 2042 (the &#8220;2042 Notes&#8221;), holders of the 2042 Notes had the option of requiring the Company to repurchase their 2042 Notes on March 1, 2018 at a repurchase price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the put date. The accreted principal amount of the 2042 notes will be </font><font style="font-family:inherit;font-size:10pt;">$206.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;as of the repurchase date. The Company also announced on January 29, 2018 that, it had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the redemption date. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders also have a right to convert their 2042 Notes. Based on a closing price of the Company&#8217;s common stock of </font><font style="font-family:inherit;font-size:10pt;">$42.75</font><font style="font-family:inherit;font-size:10pt;">&#32;per share (the closing price for the Company&#8217;s common stock on December&#160;29, 2017), the conversion value for the outstanding 2042 notes would be </font><font style="font-family:inherit;font-size:10pt;">$1,371</font><font style="font-family:inherit;font-size:10pt;">&#32;per </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;">&#32;of original principal amount of the notes, or </font><font style="font-family:inherit;font-size:10pt;">$282.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in the aggregate. The conversion value of the notes would increase or decrease to the extent that the trading price of the Company&#8217;s common stock increases or decreases. The Company has elected to settle any conversion of the 2042 Notes entirely in cash. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s4364B88DC41066B3C19B03E901638AAD"></a></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(6) Derivatives</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Rate Cap - Cash Flow Hedge</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense) in the Consolidated Statements of Income.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2015, the Company entered into separate interest rate cap agreements with multiple counter-parties to help mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 6). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for the interest rate cap agreements was </font><font style="font-family:inherit;font-size:10pt;">$13.2 million</font><font style="font-family:inherit;font-size:10pt;">, which was the initial fair value of the instruments recorded in the Company's financial statements. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2017, the Company entered into new separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for the interest rate cap agreements was </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">, which was the initial fair value of the instruments recorded in the Company's financial statements. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Prior Credit Agreement and Amended and Restated Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;of principal, which ended on December 29, 2017 and which will end on December 30, 2018 for the interest rate cap agreements entered into in fiscal 2015 and fiscal 2017, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial, and all changes in the fair value of the interest rate caps were recorded in the Consolidated Statements of Comprehensive Income as a component of AOCI.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, was reclassified from AOCI to the Company&#8217;s Consolidated Statements of Income related to the interest rate cap agreements. The Company expects to similarly reclassify a loss of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from AOCI to the Consolidated Statements of Income in the next twelve months.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair value of these interest rate caps was </font><font style="font-family:inherit;font-size:10pt;">$5.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, and is included in Prepaid expenses and other current assets on the Company&#8217;s Consolidated Balance Sheet. Refer to Note 2 &#8220;Fair Value Measurements&#8221; above for related fair value disclosures.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Forward Foreign Currency Contracts</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company enters into forward foreign currency exchange contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company has not elected hedge accounting for any of the forward foreign currency contracts it has executed; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded net realized loss of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and a net realized gain of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, from settling forward foreign currency contracts and unrealized gains of </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$8.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, on the mark-to-market for its outstanding forward foreign currency contracts. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro, </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">UK Pound, Australian dollar, Canadian Dollar and Japanese Yen with an aggregate notional amount of </font><font style="font-family:inherit;font-size:10pt;">$157.4 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instrument Presentation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:49%;"></td><td style="width:19%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative instruments designated as a cash flow hedge:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the unrealized gain recognized in AOCI related to the interest rate caps for the following reporting periods:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.8125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:67%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.53125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:36%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:30%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives not classified as hedging instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss) Recognized in Income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain (Loss) Recognized in Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s6B6281F2B6DA7039003603E901D012BD"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(7) Commitments and Contingencies</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Litigation and Related Matters</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June&#160;9, 2010, Smith&#160;&amp; Nephew, Inc. ("Smith &amp; Nephew") filed suit against Interlace Medical, Inc. ("Interlace"), which the Company acquired on January&#160;6, 2011, in the United States District Court for the District of Massachusetts. The complaint alleged that the Interlace MyoSure hysteroscopic tissue removal device infringed U.S. patent 7,226,459 (the '459 patent). On November&#160;22, 2011, Smith&#160;&amp; Nephew filed suit against the Company in the United States District Court for the District of Massachusetts. The complaint alleged that use of the MyoSure tissue removal system infringed U.S. patent 8,061,359 (the '359 patent). Both complaints sought preliminary and permanent injunctive relief and unspecified damages. On </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">September&#160;4, 2012, following a two week trial, the jury returned a verdict of infringement of both the '459 and '359 patents and assessed damages of  </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">.&#160;A two-day bench trial regarding the Company&#8217;s assertion of inequitable conduct on the part of Smith&#160;&amp; Nephew with regard to the '359 patent began on December&#160;10, 2012 and oral arguments on the issue of inequitable conduct were presented on February&#160;27, 2013. On June&#160;27, 2013, the Court denied the Company&#8217;s motions related to inequitable conduct and allowed Smith&#160;&amp; Nephew&#8217;s request for injunction, but ordered that enforcement of the injunction be stayed until final resolution, including appeal, of the current re-examinations of both patents at the United States Patent and Trademark Office (&#8220;USPTO&#8221;). The Court also rejected the jury&#8217;s damage award and ordered the parties to identify a mechanism for resolving the damages issue. The USPTO issued final decisions that the claims of the '459 and the '359 patents asserted as part of the litigation are not patentable, which decisions Smith &amp; Nephew appealed to the U.S. Patent Trial and Appeal Board ("PTAB"). In 2016, the PTAB (i) affirmed the USPTO decision with respect to the '459 patent, holding that the claims at issue are invalid, and (ii) reversed the USPTO decision with respect to the '359 patent, holding that the claims at issue are not invalid. The Company and Smith &amp; Nephew have appealed the decisions by the Patent Trial and Appeal Board on the '359 patent and the '459 patent, respectively, to the U.S. Court of Appeals for the Federal Circuit ("Court of Appeals"). Briefing on both appeals is completed. Oral arguments were held in the '459 patent appeal on October 24, 2017 and in the '359 patent appeal on December 7, 2017. On January 30, 2018, the Court of Appeals issued a decision in the '459 patent appeal that affirmed-in-part and reversed-in-part the PTAB ruling and remanded the matter to the PTAB for further proceedings. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 11, 2017, Minerva Surgical, Inc. (&#8220;Minerva&#8221;) filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including in lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2012, Enzo Life Sciences, Inc. ("Enzo") filed suit against the Company's subsidiary, Gen-Probe Incorporated ("Gen-Probe"), in the United States District Court for the District of Delaware, alleging that certain of Gen-Probe&#8217;s diagnostics products, including products that incorporate Gen-Probe&#8217;s hybridization protection assay technology (HPA), which include the Aptima line of products, infringe Enzo&#8217;s U.S. patent 6,992,180 (the '180 patent). On March&#160;6, 2012, Enzo filed suit against the Company in the United States District Court for the District of Delaware, alleging that products based on the Company's Invader chemistry platform, such as Cervista HPV HR and Cervista HPV 16/18, infringe the '180 patent. On July 16, 2012, Enzo amended its complaint to include additional products that include HPA or TaqMan reagent chemistry, including the Progensa, AccuProbe and Prodesse product lines. The Company counter-claimed for non-infringement, invalidity and unenforceability of the '180 patent. On September&#160;30, 2013, Enzo filed its infringement contentions which added products including "Torch" probes (e.g., MilliPROBE Real-Time Detection System for Mycoplasma), PACE and certain Procleix assays. Both complaints sought preliminary and permanent injunctive relief and unspecified damages. Summary judgment and Daubert motions were filed by the parties on December 15, 2016. A hearing on the summary judgment motions was held on April 4, 2017, and on June 28, 2017, the Court ruled that the '180 patent is invalid for nonenablement. Final judgment was entered on July 19, 2017, and on August 18, 2017, Enzo filed a notice of appeal with the Court of Appeals for the Federal Circuit. Enzo&#8217;s opening appeal brief was filed on November 28, 2017, and the Company&#8217;s responsive brief is due March 8, 2018. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 27, 2015, Enzo filed an additional suit against the Company in the United States District Court for the District of Delaware. The complaint alleges that certain additional Company molecular diagnostic products, including, inter alia, the Procleix Parvo/HAV assays and coagulation products, including the Invader Factor II test and the Invader Factor V test, also infringe the '180 patent. The complaint further alleged that certain of the Company&#8217;s molecular diagnostic products, including the Company&#8217;s Progensa PCA3, Aptima and Procleix products using target capture technology infringe Enzo&#8217;s U. S. Patent 7,064,197 (the '197 patent). On June 11, 2015, this matter was stayed pending the resolution of summary judgment motions in the other related suits involving the '197 patent. The litigation remains stayed. On March 30, 2016, Hologic filed two requests for inter partes review of the &#8216;197 patent at the USPTO. The USPTO instituted the two inter partes reviews on all challenged claims on October 4, 2016. Combined oral arguments for the two inter partes reviews were held on June 1, 2017. On September 28 and October 2, 2017, the PTAB issued final written decisions in the two inter partes reviews finding that all of the challenged claims of the &#8216;197 patent are unpatentable. In response to the final written decisions, Enzo filed notices of appeal on November 29, 2017, and the United States Court of Appeals for the Federal Circuit consolidated Enzo&#8217;s appeals on December 14, 2017. Enzo&#8217;s opening brief is due March 12, 2018. At this time, based on available information regarding this </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">litigation and the related inter partes reviews, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 3, 2016, Enzo filed an additional suit against the Company in the United States District Court for the District of Delaware. The complaint alleges that all of the Company's Progensa PCA3, Aptima and Procleix products infringe U.S. Patent 6,221,581 (the '581 patent). On November 28, 2016, the Company filed an answer and counterclaims of non-infringement, invalidity and unenforceability. On June 30, 2017, Hologic filed its initial invalidity contentions, which provide support for finding that the asserted claims of the '581 patent are invalid based on anticipation, obviousness, lack of adequate written description and enablement, and indefiniteness. On August 31, 2017, the Company and Enzo filed supplemental invalidity charts and supplemental infringement charts, respectively. The parties filed their proposed claim constructions on September 28, 2017. The parties&#8217; claim construction briefs are due in April 2018. On October 4, 2017, the Company filed for inter partes review of the &#8216;581 patent with the USPTO based on Enzo&#8217;s asserted claims. Enzo filed its preliminary response on January 19, 2018. A decision on whether to institute inter partes review is expected in April 2018. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 3, 2017, bioM&#233;rieux, S.A. and bioM&#233;rieux, Inc. (collectively &#8220;bioM&#233;rieux&#8221;) filed suit against the Company in the United States District Court for the Middle District of North Carolina. The complaint alleged that the Company&#8217;s Aptima HIV-1 RNA Qualitative assay and Aptima HIV-1 Quant Dx assay, as well as products manufactured by the Company and sold to Grifols, S.A. and Grifols Diagnostic Solutions Inc. (&#8220;Grifols USA&#8221;) for resale under the names Procleix HIV-1/HCV assay, Procleix Ultrio assay, and Procleix Ultrio Plus assay, infringe U.S. Patent Nos. 8,697,352 and 9,074,262. On April 3, 2017, the Company and Grifols USA filed a Motion to dismiss asking the Court to dismiss the complaint in its entirety for bioM&#233;rieux&#8217;s failure to state a claim upon which relief can be granted. On June 9, 2017, Hologic and Grifols USA filed a supplemental motion to dismiss for improper venue. bioM&#233;rieux filed a response to the venue motion on June 30, 2017, and Hologic and Grifols USA responded by filing a brief in further support of their motion to dismiss for improper venue on July 14, 2017. On January 3, 2018, the district court judge for the Middle District of North Carolina granted the parties&#8217; consent motion to transfer the case to Delaware. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 27, 2016, plaintiff ARcare, Inc., individually and as putative representative of a purported nationwide class, filed a complaint against Cynosure.&#160; The plaintiff alleges that Cynosure violated the Telephone Consumer Protection Act by: (i) sending fax advertisements that did not comply with statutory and Federal Communications Commission requirements that senders provide recipients with certain information about how to opt out from receiving faxed advertisements in the future; and (ii) sending unsolicited fax advertisements.&#160;The complaint sought damages, declaratory and injunctive relief, and attorneys&#8217; fees on behalf of a purported class of all recipients of purported fax advertisements that the plaintiff alleges did not receive an adequate opt-out notice. On September 30, 2016, Cynosure answered the complaint and denied liability. On September 7, 2016, the plaintiff sent a demand letter seeking a class settlement for statutory damages under Massachusetts General Laws, Chapter 93A &#167; 9 (&#8220;Chapter 93A&#8221;). On October 7, 2016, Cynosure responded denying any liability under Chapter 93A, but offering the plaintiff statutory damages of $25 on an individual basis.&#160;In March 2017, Cynosure and ARcare entered into a settlement agreement, subject to court approval, which requires Cynosure to pay settlement compensation of </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;notwithstanding the number of claims filed.&#160;If approved, Cynosure would receive a full release from the settlement class concerning the conduct alleged in the complaint.&#160;As a result of the settlement agreement, Cynosure recorded a charge of </font><font style="font-family:inherit;font-size:10pt;">$9.2 million</font><font style="font-family:inherit;font-size:10pt;">, in the period ended December 31, 2016, which is still accrued on the Company's balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March&#160;17, 2017, a purported shareholder of Cynosure, Michael Guido, filed an action against Cynosure in the Court of Chancery of the State of Delaware pursuant to Section&#160;220 of the Delaware General Corporation Law seeking the production of certain books and records, including books and records related to the acquisition of Cynosure by Hologic. The action follows Cynosure&#8217;s rejection of Mr.&#160;Guido&#8217;s demand for these books and records on the ground that he had not met the requirements of the statute. In addition to books and records, the complaint seeks reasonable attorneys&#8217; fees. The Company filed an answer to the complaint on April 10, 2017. At this time, based on available information regarding this matter, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal costs are expensed as incurred.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s9CB81640E43128E8B85C03E901A2FD44"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(8) Net Income Per Share</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of basic and diluted share amounts is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:71%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">276,856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278,663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common stock equivalents from assumed exercise of stock options and stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,212</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,143</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incremental shares from Convertible Notes premium</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280,802</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284,224</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average anti-dilutive shares related to:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,272</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,442</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has outstanding Convertible Notes, and the principal balance and any conversion premium may be satisfied, at the Company&#8217;s option, by issuing shares of common stock, cash or a combination of shares and cash. The Company's current policy is that it will settle the principal balance of the Convertible Notes in cash. As such, the Company applies the treasury stock method to these securities and the dilution related to the conversion premium of the 2042 and 2043 Notes is included in the calculation of diluted weighted-average shares outstanding to the extent each issuance is dilutive based on the average stock price during each reporting period being greater than the conversion price of the respective Notes.</font></div><div><a name="s176CD6E55DFED98AD9C203E8FF8FE41D"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(9) Stock-Based Compensation</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and marketing</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company granted </font><font style="font-family:inherit;font-size:10pt;">1.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">0.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;stock options during the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, with weighted-average exercise prices of </font><font style="font-family:inherit;font-size:10pt;">$40.82</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$37.62</font><font style="font-family:inherit;font-size:10pt;">, respectively. There were </font><font style="font-family:inherit;font-size:10pt;">6.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;options outstanding at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;with a weighted-average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$31.20</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.2421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value of options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company granted </font><font style="font-family:inherit;font-size:10pt;">0.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">0.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;restricted stock units (RSUs) during each of the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, with weighted-average grant date fair values of </font><font style="font-family:inherit;font-size:10pt;">$40.79</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$37.58</font><font style="font-family:inherit;font-size:10pt;">&#32;per unit, respectively. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">2.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;unvested RSUs outstanding with a weighted-average grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$37.72</font><font style="font-family:inherit;font-size:10pt;">&#32;per unit. In addition, the Company granted </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">0.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;performance stock units (PSUs) during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, to members of its senior management team, which have a weighted-average grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$40.86</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$37.64</font><font style="font-family:inherit;font-size:10pt;">&#32;per unit, respectively. Each recipient of PSUs is eligible to receive between </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the target number of shares of the Company&#8217;s common stock at the end of </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;">&#32;provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company is recognizing compensation expense ratably over the required service period based on its estimate of the number of shares that will vest. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted </font><font style="font-family:inherit;font-size:10pt;">0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">0.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;market based awards (MSUs) to its senior management team during the three months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Each recipient of MSUs is eligible to receive between </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;">&#32;of the target number of shares of the Company&#8217;s common stock at the end of </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;">&#32;based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at </font><font style="font-family:inherit;font-size:10pt;">$49.45</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$48.90</font><font style="font-family:inherit;font-size:10pt;">&#32;per share using the Monte Carlo simulation model. The Company is recognizing compensation expense for the MSUs ratably over the service period.</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$37.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$98.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of unrecognized compensation expense related to stock options and stock units (comprised of RSUs and PSUs), respectively, to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">3.1</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">2.1</font><font style="font-family:inherit;font-size:10pt;">&#32;years, respectively.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></div><hr style="page-break-after:always"><div><a name="s93D7AA0D2484B294B96303E90115D161"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(10) Disposition</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Blood Screening Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On December 14, 2016, the Company entered into a definitive agreement to sell the assets of its blood screening business to its long-time commercial partner, Grifols for a sales price of </font><font style="font-family:inherit;font-size:10pt;">$1.85 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash, subject to adjustment based on an estimated closing amount of inventory. The divestiture was completed on January 31, 2017, and the Company received </font><font style="font-family:inherit;font-size:10pt;">$1.865 billion</font><font style="font-family:inherit;font-size:10pt;">. The sale resulted in a gain of </font><font style="font-family:inherit;font-size:10pt;">$899.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;recorded in the second quarter of fiscal 2017 within operations in the Consolidated Statements of Income. As a result of this disposition and proceeds received, the Company recorded a tax obligation of </font><font style="font-family:inherit;font-size:10pt;">$649.5 million</font><font style="font-family:inherit;font-size:10pt;">, which was paid in fiscal 2017. Upon the closing of the transaction, the Company's existing collaboration agreement with Grifols terminated, and a new collaboration agreement was executed as part of this transaction pursuant to which the Company provides certain research and development services to Grifols. In addition, the Company agreed to provide transition services to Grifols over the next </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;years depending on the nature of the respective service, including the manufacture of inventory. The Company also agreed to sell Panther instrumentation and certain supplies to Grifols as part of a long term supply agreement. In determining the accounting for the multiple elements of the overall arrangement, the Company allocated </font><font style="font-family:inherit;font-size:10pt;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the proceeds to these elements based on their estimated fair values. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determined this disposal did not qualify to be reported as a discontinued operation as the blood screening business was deemed not to be strategic to the Company and has not had and will not have a major effect on the Company's operations and financial results. Under the previous collaboration agreement, the Company performed research and development activities and manufacturing, while Grifols performed the commercial and distribution activities. The blood screening business was embedded within the Company's molecular diagnostics business, and the Company retains ownership and will continue to use the intellectual property for the underlying technology of its molecular diagnostics assays and instrumentation.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations of the disposed business presented below represents the pretax profit of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business and are now incurred by Grifols. As noted above, the Company is performing a number of transition services and the financial impact from these services are not included in income from operations presented below. The Company is in effect serving as a contract manufacturer of assays for Grifols for a two to three year period from the date of disposal. Revenue and income from operations of the disposed business for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;month period ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">$65.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$28.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Under the long term supply agreement, transition services agreement to manufacture assays and research and development services, the Company recorded revenue of </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for the three months ended December 30, 2017.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></div><hr style="page-break-after:always"><div><a name="s5E6D07D2FF1AF09D0B5B03E8FF8F6330"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(11) Other Balance Sheet Information</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">331.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:73%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, plant and equipment</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment under customer usage agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and improvements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less &#8211; accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(576.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(553.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">467.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><a name="s006A5A9942B2D4C2764A03E8FFAE0A16"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(12) Business Segments and Geographic Information</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">&#32;reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, acquisition related fair value adjustments and integration expenses, restructuring, divestiture and facility consolidation charges and other one-time or unusual items.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets for the </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">&#32;principal operating segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;">&#32;reportable segments. The Company has presented all other identifiable assets as corporate assets. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;inter-segment revenues during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Segment information is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:69%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">288.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from operations:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:65%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,583.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,621.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">824.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,751.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,477.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,494.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,396.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,262.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,048.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,979.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;customers that represented greater than 10% of consolidated revenues during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;">&#32;single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, Germany and the United Kingdom. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of World&#8221; designation includes Canada, Latin America and the Middle East.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues by geography as a percentage of total revenues were as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:24px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:65%;"></td><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:16%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia-Pacific</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of World</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div><div><a name="s4ADB1CA4275A1C7F8E3503E8FFAED295"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(13) Income Taxes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC 740, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;">&#32;(ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">(324.5)%</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;">25.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;&#32;for the corresponding period in the prior year. The benefit recorded in the current quarter is primarily due to the impact of the Tax Cuts and Jobs Act (the "Act") enacted on December 22, 2017. As a result of this law, US corporations are subject to lower income tax rates, and the Company is required to remeasure its US net deferred tax liabilities at a lower rate, resulting in a net benefit of </font><font style="font-family:inherit;font-size:10pt;">$355.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;recorded in the provision for income taxes. Partially offsetting this benefit, the Company recorded a charge of </font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for transition taxes related to the deemed repatriation of foreign earnings. For the current quarter, in addition to the items noted, the effective tax rate was lower than the statutory tax rate primarily due to the impact of earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit. For the three months ended December 31, 2016, the effective tax rate was lower than the statutory tax rate primarily due to the tax benefit from restricted stock units upon vesting, earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">US Tax Reform</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Act reduces the US federal corporate income tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred, and creates new taxes on certain foreign sourced earnings.</font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 30, 2017, the Company has not completed its accounting for the tax effects of enactment of the Act; however, as described below, the Company has made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax, and recognized a provisional net benefit of </font><font style="font-family:inherit;font-size:10pt;">$329.2 million</font><font style="font-family:inherit;font-size:10pt;">, which is included in income tax expense. </font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (&#8220;SAB 118&#8221;) directing SEC registrants to consider the impact of the US legislation as &#8220;provisional&#8221; when it does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. In accordance with SAB 118, the additional estimated net income tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$329.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;represents the Company&#8217;s best estimate based on its interpretation of the US legislation as the Company is still accumulating data to finalize the underlying calculations, or in certain cases, the US Treasury is expected to issue further guidance on the application of certain provisions of the US legislation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the three months ended December 30, 2017, the Company revised its estimated annual effective rate to reflect a change in the federal statutory income tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">. The rate change is administratively effective at the beginning of the Company&#8217;s fiscal year, using a blended rate for the annual period. The Company's blended statutory income tax rate for fiscal 2018 is </font><font style="font-family:inherit;font-size:10pt;">24.5%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred tax assets and liabilities</font><font style="font-family:inherit;font-size:10pt;">: The Company re-measured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is </font><font style="font-family:inherit;font-size:10pt;">24.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;for fiscal 2018 reversals and </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">&#32;for post-fiscal 2018 reversals. However, the Company is still analyzing certain aspects of the Act and refining its calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts. The provisional net benefit amount recorded related to the re-measurement of the Company&#8217;s deferred tax balance was </font><font style="font-family:inherit;font-size:10pt;">$355.2 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign tax effects</font><font style="font-family:inherit;font-size:10pt;">:  The one-time transition tax is based on the Company&#8217;s total post-1986 earnings and profits (E&amp;P) which were previously deferred from US income taxes. The Company recorded a provisional amount for its one-time transition tax liability related to the deemed repatriation of the earnings of its foreign subsidiaries, resulting in an increase in income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;">. The Company has not yet finalized its calculation of the total post-1986 foreign E&amp;P for these foreign subsidiaries. Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets. This amount may change when the Company finalizes the calculation of its post-1986 foreign E&amp;P previously deferred from US federal taxation and finalizes the amounts held in cash or other specified assets. No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax and any additional outside basis difference inherent in these entities as these amounts continue to be indefinitely reinvested in foreign operations. The Company continues to evaluate this assertion in its ongoing analysis of the effects of tax reform on the Company's strategic initiatives. The Company believes that determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings not subject to the transition tax and additional outside basis difference in these entities (i.e., basis difference in excess of that subject to the one time transition tax) is not practicable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Further, starting in fiscal 2019, the Act subjects a US shareholder of a controlled foreign corporation to current tax on &#8220;global intangible low-taxed income&#8221; (GILTI) and establishes a tax on certain payments from corporations subject to US tax to related foreign persons, also referred to as base erosion and anti-abuse tax (BEAT). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because of the complexity of the new international tax provisions not applicable to the Company until fiscal 2019, the Company is continuing to evaluate these provisions of the Act and the application of ASC 740. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Income Tax Matters</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to tax examinations for value added, sales-based, payroll and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2018, the Company settled an ongoing state tax audit for approximately </font><font style="font-family:inherit;font-size:10pt;">$11.0 million</font><font style="font-family:inherit;font-size:10pt;">, resulting in a reversal of </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;recorded to general and administrative expenses in the first quarter of fiscal 2018.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></div><hr style="page-break-after:always"><div><a name="sEA5DC1D510B77B2B709D03E8FF9FF282"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(14) Intangible Assets and Goodwill</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets consisted of the following:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:45%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Description</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of September 30, 2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed&#160;technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,528.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,266.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,528.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,186.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">556.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">402.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">552.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution agreement</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-competition agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business licenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total acquired intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,487.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,837.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,483.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,742.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal-use software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized software embedded in products</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,569.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,887.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,562.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,790.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated remaining amortization expense of the Company's acquired intangible assets as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;for each of the five succeeding fiscal years is as follows:</font></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:87%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of Fiscal 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company conducted its fiscal 2017 impairment test on the first day of the fourth quarter, and used a discounted cash flow method (DCF) to estimate the fair value of its reporting units as of July 2, 2017. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing Step 1, all of the Company's reporting units had fair values exceeding their carrying values, and as such, Step 2 of the impairment test was not required. However, </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">&#32;of its reporting units, Medical Aesthetics, had a fair value as of the measurement date that exceeded its carrying value by </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-family:inherit;font-size:10pt;">&#32;with goodwill of </font><font style="font-family:inherit;font-size:10pt;">$683.5 million</font><font style="font-family:inherit;font-size:10pt;">. The Medical Aesthetics reporting unit is solely comprised of the Cynosure, Inc. business, which the Company acquired on March 22, 2017. In connection with the Company's annual strategic planning process and annual goodwill impairment test, it lowered its estimated financial projections for this business as a result of its then current operating performance being below expectations, which the Company primarily attributed to the significant turnover in the U.S. sales force in 2017 following the date of acquisition. The Company is continuing its efforts to rebuild the U.S. sales force and this continues to affect short term performance. The Company&#8217;s long-term outlook for the Medical Aesthetics business has not materially changed. The Company is continuing to monitor the operating performance of this reporting unit compared to the projections used in the annual impairment test, as well as current market and business conditions, to determine if an event has occurred or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. The Company has evaluated these factors and determined that no significant events occurred or circumstances changed during the period ended December 30, 2017 that would suggest it is more likely than not that the fair value of the reporting unit has declined below its carrying value. In the event the Company is unsuccessful in its efforts to rebuild the U.S. sales force or its efforts take significantly longer than expected, or other adverse conditions are identified, future operating performance may be below forecasted projections. If this occurs, the Company may need to revise its long-term growth rates or increase discount rates, and these factors could result in a decline in the fair value of the reporting unit and the Company may be required to record a goodwill impairment charge.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sDA33400BD355530CD7E403E901347D24"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(15) Product Warranties</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product warranty activity was as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.9453125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Beginning&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Provisions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Settlements/</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">End&#160;of&#160;Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.2</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><a name="sF2672DE13F2497137E0503E901259BF1"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(16) Accumulated Other Comprehensive Loss</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended December 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hedged Interest Rate Caps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Beginning Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.6</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Amounts reclassified to statement of income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ending Balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"></td></tr><tr><td style="width:46%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hedged Interest Rate Caps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Beginning Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(26.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(32.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Amounts reclassified to statement of income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ending Balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(41.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(42.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal 2017, one of the Company's cost-method equity investments became a marketable security, and the Company recorded the increase in value on a gross basis of </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to other comprehensive income.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s663F502B98471E2F65F203E8FFED961B"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(17) New Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350)</font><font style="font-family:inherit;font-size:10pt;">. This guidance simplifies how companies calculate goodwill impairments by eliminating Step 2 of the impairment test. The guidance requires companies to compare the fair value of a reporting unit to its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value. The guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2020. Early adoption is permitted. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU No. 2016-16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740).</font><font style="font-family:inherit;font-size:10pt;">&#32;The guidance requires companies to recognize the income tax effects of intercompany sales and transfers of assets, other than inventory, in the income statement as income tax expense (or benefit) in the period in which the transfer occurs. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of the adoption of ASU 2016-16 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flow (Topic 230)</font><font style="font-family:inherit;font-size:10pt;">. The guidance reduces diversity in how certain cash receipts and cash payments are presented and classified in the Statements of Cash Flows. Certain of ASU </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016-15 requirements are as follows: 1) cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities, 2) contingent consideration payments made soon after a business combination should be classified as cash outflows for investing activities and cash payment made thereafter should be classified as cash outflows for financing up to the amount of the contingent consideration liability recognized at the acquisition date with any excess classified as operating activities, 3) cash proceeds from the settlement of insurance claims should be classified on the basis of the nature of the loss, 4) cash proceeds from the settlement of Corporate-Owned Life Insurance (COLI) Policies should be classified as cash inflows from investing activities and cash payments for premiums on COLI policies may be classified as cash outflows for investing activities, operating activities, or a combination of investing and operating activities, and 5) cash paid to a tax authority by an employer when withholding shares from an employee's award for tax-withholding purposes should be classified as cash outflows for financing activities. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted. The adoption of ASU 2016-15 is not expected to have a material effect on the Company's consolidated financial statements. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:10pt;">. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842).</font><font style="font-family:inherit;font-size:10pt;">&#32;The guidance requires an entity to recognize a right-of-use asset and a lease liability for virtually all of its leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as a finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The guidance is effective for annual periods beginning after December&#160;15, 2018, and is applicable to the Company in fiscal 2020. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-02 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;">. This guidance changes how </font><font style="font-family:inherit;font-size:10pt;color:#333333;">entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. A practicability exception will be available for equity investments that do not have readily determinable fair values, </font><font style="font-family:inherit;font-size:10pt;">however; the exception requires the Company to consider relevant transactions that can be&#160;reasonably known to identify any observable price changes that would impact the fair value</font><font style="font-family:inherit;font-size:10pt;color:#333333;">. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019</font><font style="font-family:inherit;font-size:10pt;">. Early adoption is permitted. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-01 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">, which provides guidance for revenue recognition. This ASU is applicable to any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets. ASU 2014-09 will supersede the revenue recognition requirements in Topic 605,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;">, and most industry-specific guidance. The standard&#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to receive in exchange for those goods or services. In doing so, companies will need to use more judgment and make more estimates than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December&#160;15, 2017, which is fiscal 2019 for the Company. The Company will adopt Topic 606 effective September 30, 2018 and has established a cross-functional team to evaluate and implement the new revenue recognition rules. The Company will adopt Topic 606 using the modified retrospective method but has not finalized evaluating the anticipated impact of the adoption of ASU 2014-09 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></div><hr style="page-break-after:always"><div><a name="sDE2EDBA165D4C2E7075803E937EA40CF"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 2.</font><font style="font-family:inherit;font-size:10pt;">&#32;&#160;&#160;&#160;&#160;</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CAUTIONARY STATEMENT</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Some of the statements contained in this report are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</font></div><div style="line-height:120%;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the effect of the continuing worldwide macroeconomic uncertainty, including the UK's decision to leave the European Union, on our business and results of operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the coverage and reimbursement decisions of third-party payors and the guidelines, recommendations, and studies published by various organizations relating to the use of our products and treatments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact to our results of operations from the disposal of our blood screening business to Grifols, and the operational challenges of separating this business unit from our molecular diagnostics business;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact and anticipated benefits of completed acquisitions, including our acquisition of Cynosure, Inc. in the second quarter of fiscal 2017, and acquisitions we may complete in the future;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our goal of expanding our market positions;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the development of new competitive technologies and products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">regulatory approvals and clearances for our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">production schedules for our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the anticipated development of markets we sell our products into and the success of our products in these markets;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the anticipated performance and benefits of our products;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">business strategies;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">estimated asset and liability values;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the impact and costs and expenses of any litigation we may be subject to now or in the future;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our compliance with covenants contained in our debt agreements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">our capital resources and the adequacy thereof.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; &#8220;potential&#8221; and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the Securities and Exchange Commission, including those set forth under "Risk Factors" set forth in Part II, Item 1A of this Quarterly Report, if any, as well as those described in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. We qualify all of our forward-looking statements by these cautionary statements.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></div><hr style="page-break-after:always"><div><a name="s9E10DB6EBF31BC5040EC03E937ED198E"></a></div><div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">OVERVIEW</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. On March 22, 2017, we acquired Cynosure, Inc., or Cynosure. Cynosure is a developer, manufacturer and supplier of a broad array of light-based aesthetic and medical treatment systems. The products are used to provide a diverse range of treatment applications such as non-invasive body contouring, hair removal, skin revitalization and scar reduction, as well as the treatment of vascular lesions. The Cynosure business is referred to as Medical Aesthetics and operates as a separate business segment. As a result of our acquisition of Cynosure, we operate in five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We offer a wide range of diagnostic products which are used primarily to aid in the diagnosis of human diseases and through January 31, 2017, we offered products that screened donated human blood and plasma. Our primary diagnostics products include our Aptima family of assays, which run on our advanced instrumentation systems (Panther and Tigris), our ThinPrep system, the Rapid Fetal Fibronectin Test and, through January 31, 2017, our Procleix blood screening assays. The Aptima family of assays is used to detect, among other things, the infectious microorganisms that cause the common sexually transmitted diseases, or STDs, chlamydia and gonorrhea, certain high-risk strains of human papillomavirus, or HPV, and</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#32;Trichomonas vaginalis</font><font style="font-family:inherit;font-size:10pt;">, the parasite that causes trichomoniasis. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. In blood screening, we developed and manufactured the Procleix family of assays, which are used to detect various infectious diseases. These blood screening products were marketed worldwide by our former blood screening collaborator, Grifols S.A., or Grifols, to whom we sold the blood screening business. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal 2017, we entered into a definitive agreement to sell our blood screening business to Grifols for a sales price of </font><font style="font-family:inherit;font-size:10pt;">$1.85 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;in cash, subject to adjustment based on the closing amount of inventory. The transaction closed on January 31, 2017 and we received $1.865 billion. The sales price was subject to adjustment based on a finalization of inventory provided to Grifols. The sale resulted in a gain of </font><font style="font-family:inherit;font-size:10pt;">$899.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;recorded in the second quarter of fiscal 2017. As a result of this disposition and proceeds received, we recorded a tax obligation of $649.5 million, which was paid in fiscal 2017. Upon the closing of the transaction, our existing collaboration agreement with Grifols terminated, and a new collaboration agreement was executed as part of this transaction for us to provide certain research and development services to Grifols. In addition, we agreed to provide transition services to Grifols over a two to three year period depending on the nature of the respective service, including the manufacture of inventory, and we are in effect serving as a contract manufacturer of assays for Grifols for a two to three year period from the disposal date. We also agreed to sell Panther instrumentation and certain supplies to Grifols as part of a long term supply agreement. Following the closing of this disposition, we no longer operate our blood screening business, except to the limited extent we have agreed to support Grifols. Under the long term supply agreement, transition services agreement to manufacture assays, and research and development services, we recognized revenues of $12.6 million in the first quarter of fiscal 2018. For the disposed blood screening business, in the first quarter of fiscal 2017, revenue was $65.2 million, gross profit was $43.6 million, and operating income was $28.6 million. Revenue, gross profit and operating income of the disposed business represents the financial impact of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business and are now incurred by Grifols. See Note 10 to our consolidated financial statements included herein.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Breast Health products include a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, or CAD, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. Our most advanced breast imaging platform, Dimensions, utilizes a technology called tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam, as well as conventional 2D full field digital mammography images. Our clinical results for FDA approval demonstrated that conventional 2D digital mammography with the addition of 3D tomosynthesis is superior to 2D digital mammography alone for both screening and diagnostics.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Medical Aesthetics segment offers a portfolio of aesthetic treatment systems, including SculpSure, PicoSure and MonaLisa Touch that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve gynecologic health. This segment also markets radio frequency, or RF, energy sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, back and thigh procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, and our MyoSure </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hysteroscopic Tissue Removal System, or MyoSure. The NovaSure endometrial ablation is a one-time procedure for the treatment of abnormal uterine bleeding. MyoSure tissue removal is a minimally invasive procedure that targets and removes fibroids, polyps, and other pathology within the uterus.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems that assist in performing minimally invasive surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Trademark Notice</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 2D Dimensions, 3Dimensions 3D Mammography, AccuProbe, Affirm Prone, Aptima, ATEC, Brevera, C-View, Cervista, Cynosure, Dimensions, Discovery, Eviva, Fluoroscan, Gen-Probe, Genius, Genius 3D, Genius 3D Mammography, Horizon, Icon, Invader, Medicor, MedLite, MultiCare, MyoSure, NovaSure, PACE, Panther, PicoSure, Procleix, Prodesse, Progensa, Rapid Fibronectin Test, SculpSure, ThinPrep, and Tigris.</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Procleix, Ultrio, and Ultrio Plus are trademarks of Grifols Worldwide Operations Limited. MonaLisa Touch is a registered trademark of DEKA M.E.L.A. Srl-Calenzano-Italy. </font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></div><hr style="page-break-after:always"><div><a name="s15A5DA990A9ABD5188FF03E9383ACB1F"></a></div><div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ACQUISITIONS</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cynosure, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 22, 2017, we completed the acquisition of Cynosure and acquired all of the outstanding shares of Cynosure. The acquisition was funded through available cash, and the total purchase price was </font><font style="font-family:inherit;font-size:10pt;">$1.66 billion</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary allocation of the purchase price is based on estimates of the fair value of assets acquired and liabilities assumed as of March 22, 2017. The Company has not yet obtained all of the information related to the fair value of the acquired assets and liabilities, primarily taxes, to finalize the purchase price allocation. The purchase price has been allocated to the acquired assets and assumed liabilities based on management&#8217;s estimate of their fair values.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the preliminary purchase price allocation, the Company has determined the identifiable intangible assets are developed technology of </font><font style="font-family:inherit;font-size:10pt;">$736.0 million</font><font style="font-family:inherit;font-size:10pt;">, in-process research and development of </font><font style="font-family:inherit;font-size:10pt;">$107.0 million</font><font style="font-family:inherit;font-size:10pt;">, trade names of </font><font style="font-family:inherit;font-size:10pt;">$74.0 million</font><font style="font-family:inherit;font-size:10pt;">, a distribution agreement of </font><font style="font-family:inherit;font-size:10pt;">$42.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and customer relationships of </font><font style="font-family:inherit;font-size:10pt;">$35.0 million</font><font style="font-family:inherit;font-size:10pt;">.&#160;The preliminary fair value of the intangible assets has been estimated using the income approach, specifically the excess earning method and relief from royalty method, and the cash flow projections were discounted using rates ranging from </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;">. The cash flows are based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The developed technology assets comprise know-how, patents and technologies embedded in Cynosure&#8217;s products and relate to currently marketed products. In-process research and development projects relate to in-process projects that have not reached technological feasibility as of the acquisition date and have no alternative future use. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying product or expected commercial release depending on the project. We recorded </font><font style="font-family:inherit;font-size:10pt;">$107.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of in-process research and development assets related to three projects, which were expected to be completed during fiscal 2018 and 2019 with a preliminary cost to complete of approximately </font><font style="font-family:inherit;font-size:10pt;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;">. During the fourth quarter of fiscal 2017, we obtained regulatory approval for two projects with an aggregate fair value of $61.0 million and these assets were reclassified to developed technology. The remaining project is expected to be completed during fiscal 2019 with an estimated cost to complete of approximately $4.0 million. Given the uncertainties inherent with product development and introduction, we cannot assure that any of our product development efforts will be successful, completed on a timely basis or within budget, if at all. All of the in-process research and development assets were valued using the multiple-period excess earnings method approach using discount rates ranging from </font><font style="font-family:inherit;font-size:10pt;">14%</font><font style="font-family:inherit;font-size:10pt;">&#32;to </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The excess of the purchase price over the preliminary estimated fair value of the tangible net assets and intangible assets acquired of </font><font style="font-family:inherit;font-size:10pt;">$683.5 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was recorded to goodwill. The factors contributing to the recognition of the amount of goodwill are based on several strategic and synergistic benefits that are expected to be realized from the Cynosure acquisition. These benefits include the expectation that the Company's entry into the aesthetics market will significantly broaden our offering in women's health. The Company is expected to benefit from a broader global presence, synergistic utilization of Hologic's direct sales force, primarily its GYN Surgical sales force, with certain Cynosure products and entry into an adjacent, cash-pay segment.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Medicor Medical Supply</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 7, 2017, we completed the acquisition of MMS Medicor Medical Supplies GmbH, or Medicor, for a purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$19.0 million</font><font style="font-family:inherit;font-size:10pt;">. Medicor was a long-standing distributor of our Breast and Skeletal Health products in Germany, Austria and Switzerland. Based on the preliminary valuation, we have allocated </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of the purchase price to the preliminary value of intangible assets and </font><font style="font-family:inherit;font-size:10pt;">$8.9 million</font><font style="font-family:inherit;font-size:10pt;">&#32;to goodwill. The allocation of the purchase price is preliminary as we are continuing to gather information supporting the acquired assets and liabilities.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Emsor, S.A.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 11, 2017, we completed the acquisition of Emsor S.A. ("Emsor") for a purchase price of approximately $13.1 million, which includes contingent consideration which the Company has estimated at $2.0 million. The contingent consideration is payable upon Emsor achieving predefined amounts of cumulative revenue over a two year period from the date of acquisition. Emsor was a distributor of the Company's Breast and Skeletal Health products in Spain and Portugal. Based on the Company's preliminary valuation, it has allocated $2.8 million of the purchase price to the preliminary value of intangible assets and $3.5 million to goodwill. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="sE1BB69363E2243FD3E1303E90A6863F7"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RESULTS OF OPERATIONS</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All dollar amounts in tables are presented in millions.</font></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Revenues</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.58878504672897%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">% of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Product Revenues</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">279.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">319.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">43.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(40.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">175.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">165.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">22.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#8212;</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">76.7</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">100.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">107.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">13.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">114.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(6.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Skeletal&#160;Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(12.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">650.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">82.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">613.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">83.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">37.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We generated an increase in product revenues of 6.1% in the current quarter compared to the corresponding period in the prior year primarily due to our acquisition of Cynosure on March 22, 2017 and an increase in Breast Health sales. Cynosure's results (after the date of acquisition) are reported in our Medical Aesthetics segment and is the sole business in this segment. Partially offsetting the increase, our Diagnostics business product revenues declined as a result of the sale of our blood screening business effective January 31, 2017, and we had lower revenues in GYN Surgical and Skeletal Health. Excluding blood screening, Diagnostics revenues increased $13.2 million in the current quarter compared to the corresponding period in the prior year. In addition, the first quarter of fiscal 2017 was a 14-week quarter as fiscal 2017 was a 53-week fiscal period, and we estimate that the four extra selling days in the prior year period contributed approximately $20 million to revenue, primarily in the U.S.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics product revenues </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">12.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to the corresponding period in the prior year primarily due to the decrease in blood screening revenues of $53.2 million as a result of the divestiture of the business during the second quarter of FY17, and we had four fewer selling days in the first quarter of fiscal 2018. In connection with the divestiture agreement, we have committed to providing Grifols manufacturing support through the defined transition services period and long term access to Panther instrumentation and certain supplies. As such, we will continue to generate a level of revenues, but much lower than historical trends. For the current three month period, product revenue under the new long term supply agreement and transition services agreement to manufacture assays for Grifols was $10.2 million. Excluding the divestiture of the blood screening business, diagnostic product revenues grew driven by increases in Molecular Diagnostics of $10.3 million and Cytology and Perinatal of $2.9 million.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Molecular Diagnostics product revenue of $146.3 million, and in particular revenue related to our Aptima family of assays, increased $10.3 million in the current quarter on a worldwide basis due to our increased installed base of Panther instruments, which is driving higher volumes of assay testing and an increase in international sales of our virology products as we have recently received regulatory approval for certain of these products. These increases were partially offset by lower instrument sales and the loss of one week in the current three month period compared to the corresponding period in the prior year. Cytology and Perinatal product revenue increased $2.9 million due to higher international ThinPrep volumes, partially offset by slightly lower domestic volumes as average selling prices remained relatively consistent. In addition, we experienced an increase in Perinatal revenue as domestic volumes increased primarily due to a change in certain customers ordering patterns.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health product revenues </font><font style="font-family:inherit;font-size:10pt;">increased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">5.9%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to the corresponding period in the prior year primarily due to increased unit volumes of our 2D and 3D Dimensions systems internationally, increased sales volume of our Affirm Prone table and Brevera breast biopsy system, which was recently commercially released in the US, and an increase in Eviva and ATEC volumes internationally. In addition, the acquisition of Medicor and Emsor, former distributors of our products, resulted in </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">higher revenues. These increases were partially offset by lower sales volume of our 2D and 3D Dimensions systems and related components in the U.S. due to market and competitive dynamics, as well as a shift to lower priced systems. In addition, we experienced lower sales of our C-View software product and 3D upgrades in the US.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our Medical Aesthetics business was formed in fiscal 2017 by the acquisition of Cynosure effective March 22, 2017. Accordingly, we did not have any revenues in the prior year period.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical product revenues </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">6.4%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in volume of NovaSure system sales of $9.9 million in the US, which we primarily attribute to increased competition and a stagnant market for endometrial ablation, partially offset by a slight increase in average selling prices from a mix shift to the higher priced NovaSure ADVANCED device and an increase in MyoSure system sales on a worldwide basis. In addition, we had four fewer selling days in the first quarter of fiscal 2018.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health product revenues </font><font style="font-family:inherit;font-size:10pt;">decreased</font><font style="font-family:inherit;font-size:10pt;">&#32;</font><font style="font-family:inherit;font-size:10pt;">12.4%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to the corresponding period in the prior year, primarily due to a decrease in our mini C-arm sales in the U.S. due to competitive pressures, which was partially offset by increases in Horizon osteoporosis assessment product revenues, primarily attributable to higher sales volume in the current three month period. </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product revenues by geography as a percentage of total product revenues were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.90654205607477%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:66%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:15%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">76.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia-Pacific</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of World</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the current quarter compared to the corresponding period in the prior year, the percentage of product revenue from Europe, Asia-Pacific and Rest of World increased and the percentage of product revenue from the U.S. decreased, primarily as a result of the Cynosure acquisition, and to a lesser extent an increase in digital mammography systems in Europe. A higher percentage of Cynosure's revenues are internationally based compared to legacy Hologic's. In addition, the percentage of product revenue from regions other than the U.S., Europe and Asia-Pacific increased as we expanded our international infrastructure and sales efforts in these regions.</font></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Service and Other Revenues</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:79.43925233644859%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:44%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Service and Other Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">140.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">121.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">19.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">16.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service and other revenues consist primarily of revenue generated from our field service organization to provide ongoing service, installation and repair of our products. The majority of these revenues are generated within our Breast Health segment, and to a lesser extent, our Medical Aesthetics business. The Breast Health business continues to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period. Our Medical Aesthetics business represented approximately 10% of service revenues in the first quarter of fiscal 2018. Service and other revenues increased </font><font style="font-family:inherit;font-size:10pt;">16.0%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to the corresponding period in the prior year primarily due to $14.6 million contributed by Cynosure, which was acquired in the second quarter of fiscal 2017, and higher service contract conversion and renewal rates. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cost of Product Revenues</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.71028037383178%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Product</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Product</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Cost of Product Revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">213.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">198.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">32.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Amortization of Intangible Assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">79.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.5</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.0</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.3</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">293.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">45.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">271.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">44.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cost of Product Revenues.</font><font style="font-family:inherit;font-size:10pt;">&#32;The cost of product revenues as a percentage of product revenues was </font><font style="font-family:inherit;font-size:10pt;">32.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to </font><font style="font-family:inherit;font-size:10pt;">32.3%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the corresponding period in the prior year. Cost of product revenues as a percentage of product revenues in the current quarter were relatively consistent within the legacy Hologic segments. However, the cost of product revenues was higher due to the inclusion of Cynosure results as Cynosure products have a lower gross margin than our legacy products.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics' product costs as a percentage of revenue decreased slightly in the current quarter compared to the corresponding period in the prior year primarily due to increased Aptima assay volumes, increased sales volume of Perinatal products that have high margins, favorable manufacturing variances and lower instrument sales, which have low margins. These improvements were primarily offset by the divestiture of the blood screening business that occurred during the second quarter of fiscal 2017. The products that we supply to Grifols under the new supply and collaboration agreements are at lower gross margins than we earned in the disposed business, and we expect this to continue. </font></div><div style="line-height:120%;padding-top:16px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health&#8217;s product costs as a percentage of revenue was relatively consistent in the current quarter compared to the corresponding period in the prior year. Higher gross margins from sales volume increases in the Affirm Prone table, the Brevera breast biopsy system,and Eviva and ATEC devices, and favorable manufacturing variances were offset by a reduction in 3D Dimensions systems, a mix shift to lower priced 3D systems and a decrease in 3D upgrades and C-View software sales, which have higher gross margins than capital equipment sales. </font></div><div style="line-height:120%;padding-top:16px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical&#8217;s product costs as a percentage of revenue was relatively consistent in the current quarter compared to the corresponding period in the prior year.</font></div><div style="line-height:120%;padding-top:16px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health&#8217;s product costs as a percentage of revenue decreased in the current quarter compared to the corresponding period in the prior year primarily due to higher obsolescence charges recorded in the prior year.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Amortization of Intangible Assets.</font><font style="font-family:inherit;font-size:10pt;">&#32;Amortization of intangible assets relates to acquired developed technology, which is generally amortized over its estimated useful life of between 8 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense has increased in the current three month period primarily due to $17.4 million related to intangible assets acquired in the Cynosure acquisition, partially offset by a decrease in amortization expense related to divestiture of the blood screening business of $5.4 million, lower amortization expense related to the Cytyc acquisition intangibles, which are being amortized based on the pattern of economic benefits, and having one less week of expense in the current quarter as compared to the corresponding period in the prior year.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:24px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cost of Service and Other Revenues</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.33644859813084%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Service</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Service</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Cost of Service and Other Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">73.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">52.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">57.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">47.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service and other revenues gross margin decreased to 47.9% in the current three month period compared to 52.2% in the corresponding period in the prior year primarily due to Cynosure's service gross margin, which is lower than that generated by the Breast Health business. </font></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Operating Expenses</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:92.71028037383178%;border-collapse:collapse;text-align:left;"><tr><td colspan="22"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="20" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">Operating Expenses</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Research and development</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">54.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">6.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">54.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">7.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Selling and marketing</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">139.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">17.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">110.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">15.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">29.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">26.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">77.9</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">69.8</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">9.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">8.1</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">11.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Amortization of intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">14.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">21.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(7.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(32.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Restructuring and divestiture charges</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">0.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">18.8</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">290.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">36.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">258.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">35.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">31.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">12.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development Expenses.</font><font style="font-family:inherit;font-size:10pt;">&#32;Research and development expenses increased </font><font style="font-family:inherit;font-size:10pt;">0.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to the corresponding period in the prior year primarily due to the inclusion of Cynosure research and development expenses of $6.5 million, partially offset by the divestiture of the blood screening business, lower project spend, a reduction in headcount primarily in Diagnostics, and one less week of expenses compared to the prior year first quarter, which had 14 weeks. At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Selling and Marketing Expenses.</font><font style="font-family:inherit;font-size:10pt;">&#32;Selling and marketing expenses increased </font><font style="font-family:inherit;font-size:10pt;">26.8%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current period compared to the corresponding period in the prior year. The increase in the current quarter was primarily due to the inclusion of Cynosure, which contributed $33.1 million. Excluding Cynosure, expenses related to Hologic's legacy business decreased in the current quarter compared to the corresponding prior year period primarily due to lower commissions, lower spend on travel and meeting expenses, a decline in sales personnel headcount in GYN Surgical and Diagnostics and one less week of expenses, partially offset by higher salary compensation from increased headcount in Breast Health and increased spending on marketing initiatives in Diagnostics.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">General and Administrative Expenses.</font><font style="font-family:inherit;font-size:10pt;">&#32;General and administrative expenses increased </font><font style="font-family:inherit;font-size:10pt;">11.6%</font><font style="font-family:inherit;font-size:10pt;">&#32;in the current quarter compared to the corresponding period in the prior year. The current three month period includes expenses related to Cynosure of $13.7 million which includes accelerated depreciation of Cynosure's SAP ERP system. Excluding Cynosure, expenses related to Hologic's legacy business decreased in the current quarter compared to the corresponding period in the prior year primarily due to resolution of a non-income tax matter which resulted in a $4.0 million reduction in the Company's expected tax liability, lower compensation from stock compensation as a result terminating certain executives and lower measurement on performance stock units, a decrease in transaction related expenses and one less week of expenses, partially offset by an increase in litigation fees.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Amortization of Intangible Assets.</font><font style="font-family:inherit;font-size:10pt;">&#32;Amortization of intangible assets results from customer relationships, trade names, distributor relationships and business licenses related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 2 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense decreased in the current quarter compared to the corresponding period in the prior year primarily due to lower amortization expense from intangible assets related to the blood screening business of $10.4 million that was disposed of during the second quarter of fiscal 2017 and one less week of expenses. This decrease was partially offset by intangible asset amortization expense of $4.7 million as a result of the Cynosure acquisition.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restructuring and Divestiture Charges.</font><font style="font-family:inherit;font-size:10pt;">&#32;In fiscal 2015, we decided to shut down our Bedford, Massachusetts facility and transfer production of our Skeletal Health products to a third-party contract manufacturer and other activities to our Marlborough, Massachusetts and Danbury, Connecticut facilities. We also implemented additional organizational changes to our international operations in fiscal 2016. In addition, in connection with our acquisition of Cynosure, we implemented certain organizational changes. Pursuant to U.S. generally accepted accounting principles, the related severance and benefit charges are recognized either ratably over the respective required employee service periods or up-front for contractual benefits, and other charges are being recognized as incurred. In the current quarter, we recorded charges of $3.8 million for severance benefits primarily related to the departure of an executive officer and employees within our Diagnostics and Medical Aesthetics segments. In the prior year period, we recorded a charge of $3.5 million related to the closure of the Bedford facility, partially offset by small adjustments to actions noted above for severance and benefits. For additional information pertaining to restructuring actions and charges, please refer to Note 4 to the consolidated financial statements contained in Part I, Item 1 of this Quarterly Report. </font></div><div style="line-height:120%;padding-top:24px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest Expense</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(41.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(40.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our Convertible Notes, 2022 Senior Notes, 2025 Senior Notes, and amounts borrowed under our Amended and Restated Credit Agreement and Accounts Receivable Securitization Program. Interest expense in the current quarter has increased from the prior year primarily due to an increase in interest rates under our credit facilities and issuance costs expensed from the refinancing of our credit facilities in the quarter partially offset by lower interest from Convertible Note repurchases in fiscal 2017 and fiscal 2018, and the prior year quarter had an additional week of expense.</font></div><div style="line-height:120%;padding-top:24px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Debt Extinguishment Loss</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt Extinguishment Loss</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal 2018, we entered into an Amended and Restated Credit Agreement with Bank of America, N.A. The proceeds under the Amended and Restated Credit Agreement of $1.8 billion were used, among other things, to pay off the Term Loan and Revolver outstanding under the Prior Credit Agreement. In connection with this transaction, we recorded a debt extinguishment loss of $1.0 million.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:24px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Income, net</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Income, net</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(71.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the current three month period, this account primarily consisted of a gain of $1.6 million of net foreign currency exchange gains primarily from the mark-to market of outstanding forward foreign currency exchange contracts, a gain of $1.4 million on the cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains and a $0.7 million insurance recovery, partially offset by a realized loss of $0.6 million on the sale of a marketable security. For the first quarter of fiscal 2017, this account primarily consisted of gains of $8.4 million on the mark-to-market of outstanding forward foreign currency contracts due to the strengthening US dollar, $0.8 million on net foreign currency exchange gains and $0.8 million on the cash surrender value of life insurance contracts related to our deferred compensation plan.</font></div><div style="line-height:120%;padding-top:24px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Provision for Income Taxes</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="13" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Provision for Income Taxes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(310.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(340.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">** Percentage not meaningful</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;was </font><font style="font-family:inherit;font-size:10pt;">(324.5)%</font><font style="font-family:inherit;font-size:10pt;">&#32;compared to </font><font style="font-family:inherit;font-size:10pt;">25.5%</font><font style="font-family:inherit;font-size:10pt;">&#32;for the corresponding period in the prior year. The benefit recorded in the current quarter is due primarily to the impact of the Tax Cuts and Jobs Act (the "Act") enacted on December 22, 2017. We have made reasonable estimates of the effects of the Act and these estimates could change in future periods as we complete our analysis of the effects of the Act (refer to Note 13 of the accompanying notes to the consolidating financial statements for additional discussion). As a result of this law, US corporations are subject to lower income tax rates, and we were required to remeasure our U.S. net deferred tax liabilities at a lower rate, resulting in a net benefit of $355.2 million recorded in the provision for income taxes. Partially offsetting this benefit, we recorded a charge of $26.0 million for transition taxes related to the deemed repatriation of foreign earnings. For the current quarter, in addition to the items noted, the effective tax rate was lower than the statutory tax rate primarily due to the impact of earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit. For the three months ended December 31, 2016, the effective tax rate was lower than the statutory tax rate primarily due to the tax benefit from restricted stock units upon vesting, earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit.</font></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Segment Results of Operations</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We report our business as five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. The accounting policies of the segments are the same as those described in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. We measure segment performance based on total revenues and operating income or loss. Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Diagnostics</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">284.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">325.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(40.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">36.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">41.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(11.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income as a % of Segment Revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">12.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics revenues decreased in the current quarter compared to the corresponding period in the prior year primarily due to the fluctuations in product revenues discussed above. The primary driver of the reduction in revenues was the divestiture of the blood screening business in the second quarter of fiscal 2017.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income for this business segment decreased in the current quarter compared to the corresponding period in the prior year primarily due to the decrease in gross profit from lower revenues partially offset by lower operating expenses. Gross margin was 48.0% in the current quarter, compared with 48.8% in the corresponding prior year period. The decrease in gross margin was primarily due to lower revenues as a result of the disposition of the higher-margin blood screening business and lower margins generated under the new supply and collaboration arrangement. These gross margin decreases were partially offset by the impact of the increase in Aptima assay volumes, increased sales volume of Perinatal products that have high margins, favorable manufacturing variances, lower instrument sales, which have lower margins, and lower amortization expense. </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses decreased in the current period compared to the corresponding period in the prior year primarily due to lower amortization expense as a result of the blood screening divestiture, lower research and development expenses related to a reduction in project spending as well as the divestiture of blood screening, lower headcount, no transaction fees in the current quarter, and one less week of expenses in the current quarter, partially offset by increased spending on marketing initiatives and restructuring charges. </font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Breast Health</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">288.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">273.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">14.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">89.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income as a % of Segment Revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">31.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health revenues increased in the current quarter compared to the corresponding period in the prior year primarily due to the $9.7 million increase in product revenue in the current quarter discussed above and increases of $5.0 million in service revenue.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income for this business segment increased in the current quarter primarily due to the increase in gross profit from higher revenues as gross margins were consistent year over year. The overall gross margin decreased to 60.3% in the current quarter compared to 60.6% in the corresponding period in the prior year primarily due to the increase in service revenue. Higher gross margins from sales volume increases in the Affirm Prone table, the Brevera breast biopsy system,and Eviva and ATEC devices, and favorable manufacturing variances were offset by a reduction in 3D Dimensions systems, a mix shift to lower priced 3D systems and a decrease in 3D upgrades and C-View software sales, which have higher gross margins than capital equipment sales.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses increased in the current quarter compared to the corresponding period in the prior year primarily due to increase in salary compensation from increased headcount in the Breast Health sales organization primarily due to the Medicor </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">acquisition in the third quarter of fiscal 2017, increased commissions and litigation expenses, partially offset by one less week of expenses.</font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Medical Aesthetics</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-align:center;text-indent:32px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.28971962616822%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:56%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">91.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Loss</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(23.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Loss as a % of Segment Revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(25.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics revenue increased in the current period related to the acquisition of Cynosure.</font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The operating loss of $23.0 million in the current period was primarily due to amortization of intangible assets of $22.1 million, and accelerated depreciation expense for Cynosure's SAP ERP system. </font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">GYN Surgical</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">107.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">114.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(7.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(6.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">30.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">25.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">18.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income as a % of Segment Revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">28.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">22.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical revenues decreased in the current quarter compared to the corresponding period in the prior year primarily due to the increase in product revenues discussed above.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income for this business segment increased in the current quarter compared to the corresponding period in the prior year primarily due to lower operating expenses partially offset by lower gross profit driven by lower revenues. Gross margin increased to 64.9% in the current quarter from 63.9% in the corresponding period in the prior year primarily due to a decrease in amortization expense.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating expenses decreased in the current quarter due to a decrease in headcount in the GYN Surgical sales organization and lower commissions, lower research and development project spend, the resolution of a tax matter which resulted in a $4.0 million reduction in the Company's expected tax liability in the current quarter of which $3.2 million was related to GYN Surgical and one less week of expenses, partially offset by an increase in litigation fees.</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">43</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Skeletal Health</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.97196261682242%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:52%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="14" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Change</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Total Revenues</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">19.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">20.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income (Loss)</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(5.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(111.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Operating Income (Loss) as a % of Segment Revenue</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">3.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(27.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health revenues decreased in the current quarter compared to the corresponding period in the prior year primarily due to the decrease in product revenues discussed above</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income increased in the current quarter compared to the corresponding period in the prior year primarily due to a $2.0 million increase in gross profit due to higher obsolescence charges in the prior year period. Gross margin increased to 46.4% in the current quarter as compared to 34.3% in the corresponding period in the prior year. This business also had lower operating expenses due to the prior year period including facility closure costs incurred for the Bedford facility of $3.5 million and we had one less week of expenses.</font></div><div><a name="s67D32EAD8A3B6E786A1303E938F9BC95"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LIQUIDITY AND CAPITAL RESOURCES</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, we had $328.5 million of working capital and our cash and cash equivalents totaled </font><font style="font-family:inherit;font-size:10pt;">$664.4 million</font><font style="font-family:inherit;font-size:10pt;">. Our cash and cash equivalents balance increased by $123.8 million during the first </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months of fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily due to cash generated through cash flow from our core operating activities, partially offset by net repurchases and repayments of debt, and capital expenditures.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months of fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, our operating activities provided cash of </font><font style="font-family:inherit;font-size:10pt;">$169.1 million</font><font style="font-family:inherit;font-size:10pt;">, primarily due to net income of </font><font style="font-family:inherit;font-size:10pt;">$406.7 million</font><font style="font-family:inherit;font-size:10pt;">, non-cash charges for depreciation and amortization aggregating </font><font style="font-family:inherit;font-size:10pt;">$121.2 million</font><font style="font-family:inherit;font-size:10pt;">, stock-based compensation expense of </font><font style="font-family:inherit;font-size:10pt;">$16.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and non-cash interest expense of </font><font style="font-family:inherit;font-size:10pt;">$8.7 million</font><font style="font-family:inherit;font-size:10pt;">&#32;related to our outstanding debt. These adjustments to net income were partially offset by a decrease in net deferred tax liabilities of $390.7 million, primarily from the change in tax rate due to tax reform, and to a lesser extent, the amortization of intangible assets. Cash provided by operations also included a net cash </font><font style="font-family:inherit;font-size:10pt;">inflow</font><font style="font-family:inherit;font-size:10pt;">&#32;of </font><font style="font-family:inherit;font-size:10pt;">$4.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;from changes in our operating assets and liabilities. Changes in our operating assets and liabilities were driven primarily by an increase in accrued expenses of $48.9 million primarily related to an increase in accrued federal income taxes and interest on debt based on timing of payments, partially offset by lower compensation accruals, principally bonus (paid annually), and a reduction of prepaid income taxes of $8.1 million. These cash flow increases were partially offset by an increase in inventory of $23.3 million as inventory levels were built up to meet anticipated demand and launch newer products, a decrease of deferred revenue of $10.6 million primarily due to meeting the required revenue recognition criteria on certain transactions and timing of invoicing of support and maintenance contracts, an increase in accounts receivable of $6.4 million due to a slight increase in days sales outstanding, and a decrease in accounts payable of $7.1 million based on timing of payments. </font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months of fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, our investing activities used cash of </font><font style="font-family:inherit;font-size:10pt;">$26.2 million</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily related to </font><font style="font-family:inherit;font-size:10pt;">$21.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;for capital expenditures, which primarily consisted of the placement of equipment under customer usage agreements and purchases of manufacturing equipment and computer hardware, and $4.1 million to acquire Emsor.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">&#32;months of fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, our financing activities </font><font style="font-family:inherit;font-size:10pt;">used</font><font style="font-family:inherit;font-size:10pt;">&#32;cash of </font><font style="font-family:inherit;font-size:10pt;">$20.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;primarily for payments of $1.3 billion to pay off the Term Loan outstanding under the Prior Credit Agreement, $296.9 million to repurchase our 2042 and 2043 Notes including accreted principal on the 2043 Notes and conversion premium on the 2042 Notes, $225.0 million of net repayments on amounts borrowed under our revolving credit facilities, and payments of $14.3 million for employee-related taxes withheld for the net share settlement of vested restricted stock units. Partially offsetting these uses of cash were proceeds of $1.5 billion from the Amended and Restated Credit Agreement, proceeds of $350 million from issuance of the 2025 Senior Notes and $9.5 million from our equity plans, primarily from the exercise of stock options.</font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Debt</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We had total recorded debt outstanding of </font><font style="font-family:inherit;font-size:10pt;">$3.3 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, which is comprised of amounts outstanding under our Amended and Restated Credit Agreement and Amended Revolver of </font><font style="font-family:inherit;font-size:10pt;">$1.60 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;(principal of </font><font style="font-family:inherit;font-size:10pt;">$1.61 billion</font><font style="font-family:inherit;font-size:10pt;">), 2022 </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior Notes of </font><font style="font-family:inherit;font-size:10pt;">$982.6 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(principal of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">), 2025 Senior Notes of </font><font style="font-family:inherit;font-size:10pt;">$345.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(principal of $350.0 million) Convertible Notes of </font><font style="font-family:inherit;font-size:10pt;">$205.4 million</font><font style="font-family:inherit;font-size:10pt;">&#32;(principal of </font><font style="font-family:inherit;font-size:10pt;">$206.3 million</font><font style="font-family:inherit;font-size:10pt;">) and amounts outstanding under the accounts receivable securitization program of $200.0 million.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amended and Restated Credit Agreement</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 3, 2017, we entered into an Amended and Restated Credit and Guaranty Agreement (the "Amended and Restated Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto. The Amended and Restated Credit Agreement amends and restates the Company's prior credit and guaranty agreement, originally dated as of May 29, 2015 (the "Prior Credit Agreement"). The proceeds under the Amended and Restated Credit Agreement of $1.8 billion were used, among other things, to pay off the Term Loan of $1.32 billion and the Revolver then outstanding under the Prior Credit Agreement. Borrowings under the Amended and Restated Credit Agreement are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company's U.S. subsidiaries, with certain exceptions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The credit facilities (the &#8220;Amended and Restated Credit Facilities&#8221;) under the Amended and Restated Credit Agreement consist of:</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A $1.5 billion secured term loan to the Company ("Amended Term Loan") with a maturity date of October 3, 2022; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A secured revolving credit facility (the "Amended Revolver") under which the we may borrow up to $1.5 billion, subject to certain sublimits, with a maturity date of October 3, 2022.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the closing, we borrowed $345 million under the Amended Revolver, which was fully repaid during October 2017. As of December 30, 2017, the Company had $120.0 million outstanding under the Amended Revolver. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are required to make scheduled principal payments under the Amended Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;29, 2017 to $37.5 million per three-month period commencing with the three-month period ending on December&#160;23, 2021. The remaining balance of the Amended Term Loan and any amounts outstanding under the Amended Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the Amended and Restated Credit Agreement, we are required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by us,&#160;first, to the Amended Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans (as defined in the Amended and Restated Credit Agreement),&#160;third,&#160;to the Amended Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit (as defined in the Amended and Restated Credit Agreement) and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, we may voluntarily prepay any of the Amended and Restated Credit Facilities without premium or penalty.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company, with certain exceptions. For example, borrowings under the Prior Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the Amended and Restated Credit Agreement requires the the Company to maintain certain financial ratios. The Amended and Restated Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement contains two financial covenants (a total net leverage ratio and an interest coverage ratio) measured as of the last day of each fiscal quarter and an excess cash flow prepayment requirement measured as of the end of each fiscal year. As of December&#160;30, 2017, we were in compliance with these covenants.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2025 Senior Notes</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October&#160;10, 2017, we completed a private placement of $350 million aggregate principal amount of  4.375% Senior Notes due 2025 (the &#8220;2025 Senior Notes&#8221;) at an offering price of 100% of the aggregate principal amount of the 2025 Senior Notes. The 2025 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &#8220; 2025 Domestic Guarantors&#8221;).</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2025 Senior Notes were issued pursuant to an indenture (the &#8220;2025 Indenture&#8221;), dated as of October&#160;10, 2017, among the Company, the 2025 Domestic Guarantors and Wells Fargo Bank, National Association, as trustee. The 2025 Senior Notes mature on October&#160;15, 2025 and bear interest at the rate of 4.375%&#160;per year, payable semi-annually on April&#160;15 and October&#160;15 of each year, commencing on April&#160;15, 2018.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may redeem the 2025 Senior Notes at any time prior to October 15, 2020 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to 35% of the aggregate principal amount of the 2025 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before October&#160;15, 2020, at a redemption price equal to 104.375% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We also have the option to redeem the 2025 Senior Notes on or after: October&#160;15, 2020 through October 14, 2021 at 102.188% of par; October 15, 2021 through October 14, 2022 at 101.094% of par; and October 15, 2022 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the 2025 Indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2025 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 19, 2018, the Company completed a private placement of $1.0 billion aggregate principal amount of senior notes, which included $600 million of additional 4.375% Senior Notes due 2025, issued under a supplement to the 2025 Indenture. See &#8220;Subsequent Events&#8221; below.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2022 Senior Notes</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 2, 2015, we issued $1.0 billion aggregate principal amount of our 2022 Senior Notes. The 2022 Senior Notes are our general senior unsecured obligations and are guaranteed on a senior unsecured basis by certain of our domestic subsidiaries. The 2022 Senior Notes mature on July 15, 2022 and bear interest at the rate of 5.250%&#160;per year, payable semi-annually on January 15 and July 15 of each year, commencing on January 15, 2016. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the offering of the New 2025 Senior Notes and our 4.625% Senior Notes due 2028, we called all of our outstanding 2022 Senior Notes, in the aggregate principal amount of $1.0 billion, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, our Convertible Notes, in the aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$206.3 million</font><font style="font-family:inherit;font-size:10pt;">, are recorded at </font><font style="font-family:inherit;font-size:10pt;">$205.4 million</font><font style="font-family:inherit;font-size:10pt;">. These notes consist of:</font></div><div style="line-height:120%;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$206.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of our 2.00% Convertible Senior Notes due 2042 issued in March 2012 ("2042 Notes"); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:60px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:36px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;of our 2.00% Convertible Senior Notes due 2043 issued in February 2013 ("2043 Notes").</font></div></td></tr></table><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2042 Notes have conversion price of $31.175 and is subject in each case to adjustment. Holders of the 2042 Notes may convert their Convertible Notes at the applicable conversion price under certain circumstances, including without limitation (x) if the last reported sale price of our common stock exceeds 130% of the applicable conversion price for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter and (y) if the applicable series of Convertible Notes has been called for redemption. It is our current intent and policy to settle any conversion of the Convertible Notes as if we had elected to make either a net share settlement or all cash election, such that upon conversion, we intend to pay the holders in cash for the principal amount of the Convertible Notes and, if applicable shares of our common stock or cash to satisfy the premium based on a calculated daily conversion value.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Holders may require us to repurchase the 2042 Notes on each of March&#160;1, 2018, 2022, 2027 and 2032,&#160;and on March&#160;2, 2037, or upon a fundamental change, as provided in the indenture for the 2012 Notes, at a repurchase price equal to 100% of their accreted principal amount, plus accrued and unpaid interest.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may redeem any of the 2042 Notes beginning March&#160;6, 2018. We may redeem all or a portion of the 2042 Notes (i.e., in cash or a combination of cash and shares of our common stock) at a redemption price equal to 100% of their principal amount, plus accrued and unpaid interest to, but excluding, the applicable redemption date.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We have recorded deferred tax liabilities related to our Convertible Notes original issuance discount, representing the spread between the stated cash coupon rate and the higher interest rate that is deductible for tax purposes based on the type of security. When our Convertible Notes are extinguished, we are required to recapture the original issuance discount previously deducted for tax purposes. The tax recapture, however, decreases as the fair market value of the Convertible Notes and the amount paid on settlement increases. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 29, 2018, we announced that, pursuant to the terms of the indenture governing the 2042 Notes, we had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to 100% of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest, including contingent interest, if any, to, but not including the redemption date. See &#8220;Subsequent Events&#8221; below.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Accounts Receivable Securitization Program</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 25, 2016, we entered into a one-year $200.0 million accounts receivable securitization program (the "Securitization Program") with several of our wholly owned subsidiaries and certain financial institutions. Under the terms of the Securitization Program, we and certain of our wholly-owned subsidiaries sell our customer receivables to a bankruptcy remote special purpose entity, which is wholly-owned by us. The special purpose entity, as borrower, and we, as servicer, have entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity may borrow from the lenders up to $200.0 million, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. On April 21, 2017, we entered into an amendment to extend the Securitization Program an additional year to April 20, 2018. The amendment allows us to continue to borrow up to $200.0 million and due to structural changes to the terms, the borrowing base has fewer limitations. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;was outstanding under the Securitization Program. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay our other debts or liabilities.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Credit and Security Agreement contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, and an event of default upon a change of control. In addition, it contains financial covenants consistent with that of the Prior Credit Agreement. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, we were in compliance with these covenants.</font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">2025 Senior Notes and 2028 Senior Notes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">On January 19, 2018, we completed a private placement of $1.0 billion aggregate principal amount of senior notes, allocated between (i) an additional $600 million aggregate principal amounts of our 2025 Senior Notes (the "New 2025 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2025 Senior Notes, plus accrued and unpaid interest from October 10, 2017 and (ii) $400 million aggregate principal amounts of our 4.625% Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2028 Senior Notes. The New 2025 Senior Notes have the same terms as the existing 2025 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &#8220;2028 Domestic Guarantors&#8221;). In connection with the offering of the New Notes, we called all of our outstanding 2022 Senior Notes, in aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2028 Senior Notes were issued pursuant to an indenture (the &#8220;2028 Indenture&#8221;), dated as of January 19, 2018 among the Company, the 2028 Domestic Guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. The 2028 Indenture contains covenants which limit, among other things, the ability of the Company and the Guarantors to create liens and engage in certain sale and leaseback transactions. These covenants are subject to a number exceptions and qualifications.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to&#160;35%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;104.625%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if we undergo a change of control coupled with a decline in ratings, as provided in the 2028 Indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</font></div><div style="line-height:174%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2042 Notes</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 29, 2018, we announced that pursuant to the terms of the indenture governing the 2042 Notes, holders of the 2042 Notes had the option of requiring us to repurchase their 2042 Notes on March 1, 2018 at a repurchase price payable in cash equal to 100% of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the put date. The accreted principal amount of the 2042 notes will be $206.0&#160;million as of the repurchase date. We also announced on January 29, 2018 that, pursuant to the terms of the indenture governing the 2042 Notes, we had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to 100% of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest, including contingent interest, if any, to, but not including the redemption date. Holders also have a right to convert their 2042 Notes in accordance with the terms of the indenture. If the closing price of our common stock exceeds the conversion price of the 2042 notes, which is $31.175 per share, holders of the 2042 Notes will likely exercise their conversion rights prior to the redemption date as they would receive more value upon conversion compared to redemption. Based on a closing price of our common stock of $42.75 per share (the closing price for our common stock on December&#160;29, 2017), the conversion value for the outstanding 2042 notes would be $1,371 per $1,000 of original principal amount of the notes, or $282.6&#160;million in the aggregate. The conversion value of the notes would increase or decrease to the extent that the trading price of our common stock increases or decreases. We have elected to settle any conversion of the 2042 Notes entirely in cash.</font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock Repurchase Program</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 21, 2016, the Board of Directors authorized the repurchase of up to $500.0 million of the Company's outstanding common stock over the next five years of which $300.0 million remains available for repurchase under this authorization as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. There were no repurchases of common stock made under this authorization during the quarter ended December&#160;30, 2017.</font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Legal Contingencies</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are currently involved in several legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are developed, as applicable in consultation with outside counsel, and are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</font><font style="font-family:inherit;font-size:10pt;">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such financial outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings. Information with respect to this disclosure may be found in Note 7 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</font></div><div style="line-height:120%;padding-top:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Future Liquidity Considerations</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We intend to use the net proceeds from the sale of our New 2025 Senior Notes and our 2028 Senior Notes and available cash, which may include borrowings under our Amended Revolver, to redeem our outstanding 2022 Senior Notes on February 15, 2018. Additionally, we intend to use the net proceeds from the sale of our 2025 Senior Notes, our Amended and Restated Credit Agreement and available cash, which may include borrowings under our Amended Revolver, to redeem or repurchase all of our outstanding Convertible Notes in the second quarter of fiscal 2018. We also expect to continue to review and evaluate potential strategic transactions and alliances that we believe will complement our current or future business. Subject to the </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48</font></div></div><hr style="page-break-after:always"><div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;30, 2017, and the general disclaimers set forth in our Special Note Regarding Forward-Looking Statements at the outset of this Quarterly Report, we believe that our cash and cash equivalents, cash flows from operations, the cash available under our Amended Revolver and our Securitization Program will provide us with sufficient funds in order to fund our expected normal operations and debt payments, including interest and potential payouts for any Convertible Notes, and the costs of redeeming our outstanding 2022 Senior Notes, including payment of any premium, over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt and related deferred tax liabilities, as applicable, acquisitions, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our Amended and Restated Credit Agreement, 2022 Senior Notes, 2025 Senior Notes, 2028 Senior Notes, Convertible Notes and the Securitization Program. These capital requirements could be substantial. For a description of risks to our operating performance and our indebtedness, see &#8220;Risk Factors&#8221; in Part I, Item&#160;1A in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div><a name="sDACE60506CD8658A1A3503E9391AA802"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The discussion and analysis of our financial condition and results of operations are based upon our interim consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations. For a discussion of how these and other factors may affect our business, see the &#8220;Cautionary Statement&#8221; above and &#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report as well as those described in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The critical accounting estimates that we believe affect our more significant judgments and estimates used in the preparation of our consolidated financial statements presented in this report are described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. There have been no material changes to our critical accounting policies or estimates from those set forth in our Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div><a name="s4AE671952BAC67212E5A03E9391BD609"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</font><font style="font-family:inherit;font-size:10pt;">. Financial instruments consist of cash equivalents, accounts receivable, cost-method equity investments, insurance contracts and related deferred compensation plan liabilities, interest rate cap agreements, forward foreign currency contracts, accounts payable and debt obligations. Except for our outstanding Convertible Notes, 2022 Senior Notes and 2025 Senior Notes, the fair value of these financial instruments approximates their carrying amount. </font><font style="font-family:inherit;font-size:10pt;">As of December 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, we have </font><font style="font-family:inherit;font-size:10pt;">$206.3 million</font><font style="font-family:inherit;font-size:10pt;">&#32;in principal amount of Convertible Notes outstanding. The fair value of our 2042 Notes and 2043 Notes as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;was approximately </font><font style="font-family:inherit;font-size:10pt;">$284.8 million</font><font style="font-family:inherit;font-size:10pt;">&#32;and $</font><font style="font-family:inherit;font-size:10pt;">0.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The fair value of our 2022 Senior Notes and 2025 Senior Notes as of December 30, 2017 was approximately </font><font style="font-family:inherit;font-size:10pt;">$1.10 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;and $358.6 million, respectively. Amounts outstanding under our Amended and Restated Credit Agreement and Securitization Program of </font><font style="font-family:inherit;font-size:10pt;">$1.61 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;and </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value. </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Primary Market Risk Exposures</font><font style="font-family:inherit;font-size:10pt;">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our Convertible Notes, 2022 Senior Notes, 2025 Senior Notes and Amended and Restated Credit Agreement, as well as under our accounts receivable securitization program. The Convertible Notes, 2022 Senior Notes, and 2025 Senior Notes have fixed interest rates. Borrowings under our Amended and Restated Credit Agreement currently bear interest at the Eurocurrency Rate (i.e., Libor) plus the applicable margin of 1.50% per annum. Borrowings under our accounts receivable securitization program currently bear interest at Libor plus the applicable margin of 0.7%.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$1.61 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;of aggregate principal outstanding under the Amended and Restated Credit Agreement, including amounts borrowed under the Amended Revolver, and </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;">&#32;aggregate principal outstanding under the securitization program. Since these debt obligations are variable rate instruments, our interest expense associated with these instruments is subject to change. A 10% adverse movement (increase in LIBOR rate) would increase annual interest expense by approximately $2.4 million. We entered into multiple interest rate cap agreements to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding. The critical terms of the interest rate caps were designed to mirror the terms of our LIBOR-based borrowings under the Prior Credit Agreement, and therefore the interest rate caps are highly effective at offsetting the cash flows being hedged. We designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">&#32;of principal which ends on December 28, 2018.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase or decrease in interest rates, however, would not have a material adverse effect on our business, financial condition or results of operations.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign Currency Exchange Risk.</font><font style="font-family:inherit;font-size:10pt;">&#32;Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conduct business worldwide and maintain sales and service offices outside the United States as well as manufacturing facilities in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Renminbi. The majority of our foreign subsidiaries' functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Our revenues denominated in foreign currencies are positively affected when the U.S. dollar weakens against them and adversely effected when the U.S. dollar strengthens. Fluctuations in foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen and Canadian dollar. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Income due to (i) the impact of unrealized gains and losses reported in other income, net on the mark-to-market of outstanding contracts and (ii) realized gains and losses recognized in other income, net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </font></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar strengthens against them and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. A hypothetical 10% increase or decrease in foreign currencies in which we transact would not have a material adverse impact on our business, financial condition or results of operations.</font></div><div><a name="s8FA7AE097CB8C92EAA9203E939425639"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of December 30, 2017</font><font style="font-family:inherit;font-size:10pt;">, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">An evaluation was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></div><hr style="page-break-after:always"><div><a name="s6E35DE419729BD1D6E9603E9394285DF"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">PART II &#8211; OTHER INFORMATION</font></div><div><a name="sC7E9BD9F7F2F1F429CB003E939430288"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Information with respect to this Item may be found in Note 7 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional information on our commitments and contingencies can be found in our Annual Report on Form 10-K for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div><a name="s675C5950A35A4703F86D03E93967EAB3"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;1A. Risk Factors.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">There are no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for our fiscal year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, except as noted below.</font></div><div style="line-height:174%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">The impact of recently enacted U.S. tax laws is not yet clear. </font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Congress recently enacted legislation commonly known as &#8220; The Tax Cuts and Jobs Act&#8221; (the &#8220;Act&#8221;). The Act made significant changes to U.S. federal income tax laws. Certain provisions of the Act could have an adverse effect on the financial condition of the Company or its affiliates.&#160;The interpretations of many provisions of the Act are still unclear. We cannot predict when or to what extent any U.S. federal tax laws, regulations, interpretations, or rulings clarifying the Act will be issued or the impact of any such guidance on the Company.&#160;Certain key provisions of the Act that could impact us include, but are not limited to international tax provisions that affect the overall tax rate applicable to income earned from non-U.S. operations, limitations on the deductibility of executive compensation and limitations on a taxpayer&#8217;s net interest expense deduction. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><a name="s57D41AB998E1FF098D3103E90C94129C"></a></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds.</font></div><div style="line-height:120%;padding-top:8px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Issuer's Purchases of Equity Securities</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"></td></tr><tr><td style="width:34%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Period of Repurchase</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;Number&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares&#160;Purchased</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(#)&#160;(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average&#160;Price</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Paid&#160;Per&#160;Share</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">($)&#160;(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;Number&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Shares Purchased As Part of Publicly</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Announced Plans or Programs&#160;</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(#)&#160;(2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Average Price Paid Per Share As Part of Publicly Announced Plans or Programs($)&#160;(2)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Maximum</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Programs   </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(in millions)      ($) (2)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 1, 2017 &#8211; October 28, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">610</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">October 29, 2017 &#8211; November 25, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">251,463</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.61</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300.0</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">November 26, 2017 &#8211; December 30, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106,078</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358,151</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39.99</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;___________________________________</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June 21, 2016, the Board of Directors authorized the repurchase of up to an additional $500.0 million of our outstanding common stock over the next five years. There were no repurchases of common stock made under this authorization during the quarter ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;padding-left:4px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52</font></div></div><hr style="page-break-after:always"><div><a name="s12CD25D3A2FCD9C9303503E939B883CC"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 6.&#160;&#160;&#160;&#160;Exhibits.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">(a) Exhibits </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.875%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:68%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:12%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Incorporated by</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reference</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Number</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Exhibit Description</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Form</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Filing&#160;Date/</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Period End</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Date</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517307090/d466217dex41.htm"><font style="font-family:inherit;font-size:10pt;">Indenture dated October&#160;10, 2017, by and among Hologic, the Guarantors party thereto and Wells Fargo Bank, National Association, as Trustee.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10/10/2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517307090/d466217dex41.htm"><font style="font-family:inherit;font-size:10pt;">Form of 4.375% Senior Note due 2025 (included in Exhibit 4.1).</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10/10/2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex43.htm"><font style="font-family:inherit;font-size:10pt;">First Supplemental Indenture dated January 19, 2018, by and among Hologic, the Guarantors party thereto and Wells Fargo Bank, National Association, as Trustee</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1/19/2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex44.htm"><font style="font-family:inherit;font-size:10pt;">Indenture dated January 19, 2018, by and among Hologic, the guarantors party thereto and Wells Fargo Bank, National Association, as Trustee.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1/19/2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312518014748/d515657dex44.htm"><font style="font-family:inherit;font-size:10pt;">Form of 4.625% Senior Note due 2028 (included in Exhibit 4.4).</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1/19/2018</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517302740/d417723dex101.htm"><font style="font-family:inherit;font-size:10pt;">Amended and Restated Credit and Guaranty Agreement, originally dated as of May&#160;29, 2015 and amended and restated as of October&#160; 3, 2017, among Hologic, Hologic GGO 4 Ltd, Hologic UK Finance LTD and each other Designated Borrower from time to time party thereto, the Guarantors from time to time party thereto, each Lender from time to time party thereto and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10/4/2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517338964/d469571dex102.htm"><font style="font-family:inherit;font-size:10pt;">Form of Performance Stock Unit Award Agreement (ROIC) (adopted fiscal 2018)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11/9/2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517338964/d469571dex101.htm"><font style="font-family:inherit;font-size:10pt;">Form of Performance Stock Unit Award Agreement (relative TSR) (adopted fiscal 2018)</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11/9/2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="http://www.sec.gov/Archives/edgar/data/859737/000119312517358082/d499384dex101.htm"><font style="font-family:inherit;font-size:10pt;">Transition Agreement by and between Eric B. Compton and Hologic, Inc., dated November&#160;30, 2017.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8-K</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12/1/2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.5*&#8224;</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="holx_q1-2018xex105.htm"><font style="font-family:inherit;font-size:10pt;">Addendum No. 3 to Current Lease by and Between BCR Fondo de Inversion Inmobiliario and Hologic Surgical Products Costa Rica S.R.L.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.1*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="holx_q1-2018xex311.htm"><font style="font-family:inherit;font-size:10pt;">Certification of Hologic&#8217;s CEO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.2*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="holx_q1-2018xex312.htm"><font style="font-family:inherit;font-size:10pt;">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.1**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="holx_q1-2018xex321.htm"><font style="font-family:inherit;font-size:10pt;">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.2**</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="holx_q1-2018xex322.htm"><font style="font-family:inherit;font-size:10pt;">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</font></a></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.INS*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Instance Document</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.SCH*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Schema Document</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.CAL*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Calculation Linkbase Document</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.LAB*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Label Linkbase Document</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.PRE*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Presentation Linkbase Document</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101.DEF*</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">XBRL Taxonomy Extension Definition</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">_______________</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">*&#160;&#160;&#160;&#160;Filed herewith.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">**&#160;&#160;&#160;&#160;Furnished herewith.</font></div><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8224;&#160;&#160;&#160;&#160;Confidential treatment has been requested as to portions of the exhibit. Confidential materials omitted and filed separately with the Securities and Exchange Commission. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:22px;padding-top:22px;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">54</font></div></div><hr style="page-break-after:always"><div><a name="sAD518252665B5049562603E939FEFEF9"></a></div><div><div style="line-height:120%;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;font-weight:bold;" href="#s23F14C22A3782A51388303E9332CA9DE"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Table of Contents</font></a></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:5%;"></td><td style="width:51%;"></td><td style="width:3%;"></td><td style="width:41%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hologic, Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Registrant)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;8, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stephen P. MacMillan</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Chairman, President and Chief Executive Officer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Principal Executive Officer)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date:</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February&#160;8, 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Robert W. McMahon&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Robert W. McMahon</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Chief Financial Officer</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Principal Financial Officer)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55</font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>2
<FILENAME>holx_q1-2018xex105.htm
<DESCRIPTION>EXHIBIT 10.5
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sD5318D65E1645A72289370BC7CB6A6C8"></a></div><div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CONFIDENTIAL TREATMENT REQUESTED:</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (&#8220;[***]&#8221;) to denote where omissions have been made. The confidential material has been filed separately with the Securities and Exchange Commission.</font></div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ADDENDUM TO CURRENT LEASE BY AND BETWEEN</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BCR FONDO DE INVERSI&#211;N INMOBILIARIO AND HOLOGIC SURGICAL PRODUCTS COSTA RICA S.R.L</font></div><div style="line-height:138%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">No. 3</font></div><div style="line-height:138%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:138%;padding-bottom:6px;padding-top:6px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">We, </font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BCR FONDO DE INVERSI&#211;N INMOBILIARIO</font><font style="font-family:inherit;font-size:12pt;">, a real estate investment fund with legal entity identification number three &#8211; one hundred and ten &#8211; two hundred and seventy-seven thousand four hundred and eight, duly registered with the National Register of Securities and Intermediaries of the Superintendence General of Securities, by means of resolution number </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SGV-R-ONE HUNDRED AND FORTY-FOUR</font><font style="font-family:inherit;font-size:12pt;">, issued at ten hours on the eleventh day of September, two thousand, which fund, in accordance with the provisions of Article 62 of the Stock Market Regulatory Law, is managed and represented by </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BCR SOCIEDAD ADMINISTRADORA DE FONDOS DE INVERSI&#211;N, SOCIEDAD AN&#211;NIMA</font><font style="font-family:inherit;font-size:12pt;">, with legal entity identification number three &#8211; one hundred and one &#8211; two hundred and forty-nine thousand and fifty-one, company that is in turn represented by </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#193;LVARO CAMACHO DE LA O</font><font style="font-family:inherit;font-size:12pt;">, of age, a Costa Rican national, divorced, a Licentiate in economics, bearer of identity card number four &#8211; one hundred forty seven  &#8211; four hundred fifty-seven, domiciled in Oficentro Torre Cordillera, Rohrmoser, 13</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;floor, 300 meters South of &#8220;Plaza Mayor&#8221;, in my capacity as </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LEGAL REPRESENTATIVE</font><font style="font-family:inherit;font-size:12pt;">, with </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FULL POWER OF ATTORNEY AND NO RESTRICTIONS AS TO THE AMOUNTS INVOLVED</font><font style="font-family:inherit;font-size:12pt;">, hereinafter and collectively referred to as the </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;OWNER&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;or </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;LESSOR&#8221;</font><font style="font-family:inherit;font-size:12pt;">&#32;or the </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;FUND&#8221;</font><font style="font-family:inherit;font-size:12pt;">, and</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">NILO CARAVACA GARC&#201;S,</font><font style="font-family:inherit;font-size:12pt;">&#32;of age, a Costa Rican national, married, an electrical engineer, resident of Cartago, San Ram&#243;n of Tres R&#237;os, bearer of identity card number </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">1-0783-0984</font><font style="font-family:inherit;font-size:12pt;">, in his capacity as duly authorized representative with </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FULL POWER OF ATTORNEY AND NO RESTRICTIONS AS TO THE AMOUNTS INVOLVED</font><font style="font-family:inherit;font-size:12pt;">, of the company </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">HOLOGIC SURGICAL PRODUCTS COSTA RICA S.R.L</font><font style="font-family:inherit;font-size:12pt;">, with legal entity identification number 3-102-348759, hereinafter referred to as </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;LESSEE&#8221; </font><font style="font-family:inherit;font-size:12pt;">or </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#8220;TENANT&#8221;.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">PREAMBLE:</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">FIRST</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WHEREAS, LESSEE</font><font style="font-family:inherit;font-size:12pt;">, formerly </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CYTYC SURGICAL PRODUCTS COSTA RICA S.A., </font><font style="font-family:inherit;font-size:12pt;">executed a Lease with ZONA FRANCA COYOL S.A. on the twenty third day of April, 2007, to lease a property duly registered with the Real Estate Register of the National Registry, under Real Estate registration number 2-68515-F-000, located in district 13, La Garita, of Canton 1, Alajuela, of the Province of Alajuela.</font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CONFIDENTIAL TREATMENT REQUESTED:</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (&#8220;[***]&#8221;) to denote where omissions have been made. The confidential material has been filed separately with the Securities and Exchange Commission.</font></div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">SECOND</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WHEREAS, </font><font style="font-family:inherit;font-size:12pt;">by means of instrument executed in the city of San Jos&#233;, at ten hours and thirty minutes on September 29</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">, 2016, before Notary Karla Villalobos Alp&#237;zar, by means of which </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BCR FONDO DE INVERSI&#211;N INMOBILIARIO</font><font style="font-family:inherit;font-size:12pt;">&#32;acquired from </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ZONA FRANCA COYOL S.A.</font><font style="font-family:inherit;font-size:12pt;">&#32;the property subject matter of the Lease, and in view of such purchase and sale, the aforesaid REAL ESTATE INVESTMENT FUND assumed, in its dual capacity as owner and Lessor, all leases of the properties assigned and delivered to it under such instrument, a situation that was duly communicated by notice to </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LESSEE.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">THIRD</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">WHEREAS, </font><font style="font-family:inherit;font-size:12pt;">in view of the notice of assignment made by </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ZONA FRANCA COYOL S.A.</font><font style="font-family:inherit;font-size:12pt;">, the REAL ESTATE INVESTMENT FUND recognizes and accepts </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">HOLOGIC SURGICAL PRODUCTS COSTA RICA S.R.L</font><font style="font-family:inherit;font-size:12pt;">&#32;as the TENANT or LESSEE of the property described above, and the latter recognizes and accepts the REAL ESTATE INVESTMENT FUND as the OWNER or LESSOR of the property subject matter of the Agreement hereby added.</font></div><div style="line-height:138%;padding-bottom:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Therefore, we do hereby execute this Addendum, which shall be governed by the following clauses, approved by the parties by mutual agreement:</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CLAUSES</font></div><div style="line-height:138%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">1.</font></div></td><td style="vertical-align:top;padding-left:24px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">LESSOR:</font></div></td></tr></table><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">It is agreed to modify the Lease in order that any reference therein made to LESSOR or OWNER shall be hereinafter read as a reference to </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BCR FONDO DE INVERSI&#211;N INMOBILIARIO.</font></div><div style="line-height:138%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">2.</font></div></td><td style="vertical-align:top;padding-left:24px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">STOCK MARKET REGULATORY LAW:</font></div></td></tr></table><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In accordance with Article 95 of the Stock Market Regulatory Law and Article 86 of the General Regulations on Management Companies and Investment Funds in force at the time of execution of this Agreement, </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LESSEE </font><font style="font-family:inherit;font-size:12pt;">represents that it does not have, and undertakes not to acquire, any shares in the Real Estate Investment Fund that is the owner of the property hereunder leased, whether directly, or through any individual or legal entity that is a member of its group of interest, as such term is defined in Article 120 of said Regulations. Failure to comply with the above is grounds for termination of the Agreement, with liability being incurred by </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LESSEE</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">3.</font></div></td><td style="vertical-align:top;padding-left:24px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">TERM:</font></div></td></tr></table><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CONFIDENTIAL TREATMENT REQUESTED:</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (&#8220;[***]&#8221;) to denote where omissions have been made. The confidential material has been filed separately with the Securities and Exchange Commission.</font></div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">By common agreement, the parties state that they hereby extend the term of the Agreement for an additional period of ten (10) years or one hundred and twenty months (120), counted from the 1</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of August, 2018, and to expire on the </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">31</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;day of July, 2028.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The LESEE is hereby granted two (2) additional and consecutive five (5) year options to extend the Lease at the end of the Term.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The LESSEE shall have the right to terminate this lease effective at any time after the 31</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of July 2022, by giving LESSOR written notice of the termination no less than eighteen (18) months in advance of the termination date. Given the case that the LESSEE chooses to terminate this lease effective at any time before the 31</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of July, 2022, in addition to the eighteen (18) months notice, the LESSEE shall also pay the LESSOR, as penalty for early termination, the amount of rent that otherwise would have paid up to the aforementioned date. In any given case, in addition to the prior, LESSEE shall pay the LESSOR any unamortized portion of the LESSOR&#8217;S contribution to the Building Improvement Projects corresponding to finished projects.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">4.</font></div></td><td style="vertical-align:top;padding-left:24px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">RENT:</font></div></td></tr></table><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The rent to be paid by </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LESSEE </font><font style="font-family:inherit;font-size:12pt;">to</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;LESSOR</font><font style="font-family:inherit;font-size:12pt;">, from the 1</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of August, 2018 to the 31</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of July, 2020 shall be the amount of</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;</font><font style="font-family:inherit;font-size:12pt;">[***], legal tender of the United States of America, payable on a monthly basis and in advance. This amount shall be applied an annual increase of [***] on the 1</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of August of the following years, as detailed in &#8220;Exhibit A&#8221; to this document, which, duly signed by both parties hereto, becomes an integral part of the Agreement.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In addition, </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LESSEE </font><font style="font-family:inherit;font-size:12pt;">shall pay to </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">LESSOR</font><font style="font-family:inherit;font-size:12pt;">&#32;the sum required to cover the private services of maintenance of the property under the &#8220;Park Services Provision Agreement&#8221;, which, starting from the 1</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of August, 2018 and until the 31</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of July, 2020, shall be the sum of </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">[***]</font><font style="font-family:inherit;font-size:12pt;">, legal tender of the United States of America, payable on a monthly basis and in advance. This amount shall be applied an annual increase of [***] on the 1</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">st</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of August of the following years, as detailed in &#8220;Exhibit A&#8221; to this document, which, duly signed by both parties hereto, becomes an integral part of the Agreement.</font></div><div style="line-height:120%;text-align:left;font-size:5pt;"><font style="font-family:inherit;font-size:5pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">5.</font></div></td><td style="vertical-align:top;padding-left:24px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">BUILDING IMPROVEMENTS</font></div></td></tr></table><div style="line-height:138%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In addition, LESSEE shall be permitted to construct the Building Improvement Projects listed on &#8220;Exhibit B&#8221; to this document, and LESSOR shall reimburse LESSEE for [***] of the costs of each project, up to an amount of [***] for all projects altogether, which shall be approved in advance by the Parties.  Any Landlord contribution will be amortized on a straight line basis over the remaining </font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CONFIDENTIAL TREATMENT REQUESTED:</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">&#160;Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (&#8220;[***]&#8221;) to denote where omissions have been made. The confidential material has been filed separately with the Securities and Exchange Commission.</font></div><div style="line-height:145%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">months in the Lease term at the time the asset is placed in service and until the 31st day of July, 2028</font></div><div style="line-height:138%;text-align:justify;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">All permits and authorizations required by the improvements shall run by Lessee&#8217;s account.</font></div><div style="line-height:138%;text-align:justify;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">6.</font></div></td><td style="vertical-align:top;padding-left:24px;"><div style="line-height:120%;text-align:justify;font-size:12pt;text-indent:-24px;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">RESPECT TO PREVIOUS PROVISIONS:</font></div></td></tr></table><div style="line-height:138%;text-align:justify;padding-left:24px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Anything not expressly modified by the parties in this Addendum with regard to the Lease executed on April 23, 2007, as amended, shall remain the same, reason for which the parties undertake to respect the rights and comply with the obligations and undertakings that were assumed originally by and between </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">ZONA FRANCA COYOL S.A.</font><font style="font-family:inherit;font-size:12pt;">&#32;and </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">HOLOGIC SURGICAL PRODUCTS COSTA RICA S.R.L</font><font style="font-family:inherit;font-size:12pt;">; and which arise out of and exist and are effective under the executed Lease, as amended.  </font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">In witness whereof, we have hereunto set our hand on two original, prevailing the version in the Spanish language for interpretation purposes, on this the 4</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">th</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;day of January, 2018, in San Jos&#233;, Costa Rica.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.72649572649573%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ &#193;lvaro Camacho De La O</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;text-decoration:underline;">/s/ Nilo Caravaca Garc&#233;s</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">EL ARRENDANTE</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">EL ARRENDATARIO</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#193;LVARO CAMACHO DE LA O</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">NILO CARAVACA GARC&#201;S</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">BCR FONDO DE INVERSI&#211;N INMOBILIARIO</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:46px;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">HOLOGIC SURGICAL PRODUCTS COSTA RICA S.R.L</font></div></td></tr></table></div></div><div style="line-height:138%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><a name="s7126A193F76D479EC76870BC7D23C6AE"></a></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Exhibit A</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Ajustes de Renta de [***]</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Rent Adjustments of [***]</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:17%;"></td><td style="width:16%;"></td><td style="width:22%;"></td><td style="width:23%;"></td><td style="width:22%;"></td></tr><tr><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Period</font></div></td><td rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Monthly   <br>Rent</font></div></td><td rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Monthly   <br>Maintenance</font></div></td><td rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Total Monthly   <br>Payment</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Beginning</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Ending</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-18</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-19</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-19</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-20</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-20</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-21</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-21</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-22</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-22</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-23</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-23</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-24</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-24</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-25</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-25</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-26</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-26</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-27</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">1-Aug-27</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">31-Jul-28</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;"><div style="text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">[***]</font><font style="font-family:inherit;font-size:11pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div><a name="s21BDD9B7F6B19EDCC23570BC7D25A1E0"></a></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">ANEXO B</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:justify;"><img src="hologiccostaricalease_image1.gif" alt="hologiccostaricalease_image1.gif" style="height:282px;width:664px;"></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#1f497d;">[***])</font></div><div style="line-height:138%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:justify;"><img src="hologiccostaricalease_image2.gif" alt="hologiccostaricalease_image2.gif" style="height:274px;width:664px;"></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#1f497d;">[***])</font></div><div style="line-height:138%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:justify;"><img src="hologiccostaricalease_image3.gif" alt="hologiccostaricalease_image3.gif" style="height:293px;width:664px;"></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#1f497d;">[***])</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#1f497d;">[***])</font></div><div style="line-height:138%;text-align:justify;"><img src="hologiccostaricalease_image4.gif" alt="hologiccostaricalease_image4.gif" style="height:274px;width:664px;"></div><div style="line-height:138%;text-align:justify;"><img src="hologiccostaricalease_image5.gif" alt="hologiccostaricalease_image5.gif" style="height:278px;width:664px;"></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#1f497d;">$514,080</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;color:#1f497d;">[***])</font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>holx_q1-2018xex311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s1860F61F23233793555603E91D4ED185"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.1</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Stephen P. MacMillan, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: </font><font style="font-family:inherit;font-size:10pt;">February&#160;8, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stephen P. MacMillan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Chairman, President and Chief Executive Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>holx_q1-2018xex312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sD7B6526EB62C5C963A7C03E92F6A187D"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 31.2</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Robert W. McMahon, certify that:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">3.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">4.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(c)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(d)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">5.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(a)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">(b)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div></td></tr></table><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: </font><font style="font-family:inherit;font-size:10pt;">February&#160;8, 2018</font><font style="font-family:inherit;font-size:10pt;">&#32;</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Robert W. McMahon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Robert W. McMahon</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Chief Financial Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>holx_q1-2018xex321.htm
<DESCRIPTION>EXHIBIT 32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s471D62AA5C0A4C58725903E9301FFBD9"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.1</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Certification</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Quarterly Report on Form 10-Q for the quarter ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;(the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dated: February 8, 2018</font></div></td><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stephen P. MacMillan</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Chairman, President and Chief Executive Officer</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>holx_q1-2018xex322.htm
<DESCRIPTION>EXHIBIT 32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2018 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sE77C9B60D314580C6C5A03E930C487AE"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 32.2</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Certification</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">I, Robert W. McMahon, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Quarterly Report on Form 10-Q for the quarter ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">&#32;(the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:16px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:54px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:30px;"><font style="font-family:inherit;font-size:10pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div></td></tr></table><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dated: February 8, 2018</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">/s/&#160;&#160;&#160;&#160;Robert W. McMahon</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Robert W. McMahon</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Chief Financial Officer</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>7
<FILENAME>holx-20171230.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!--p:baa0caca65b4409b9b5402544b29982d,x:44e706eabd8e476fa63fb82b376ee161-->
<xbrli:xbrl xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2017-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2017-01-31" xmlns:holx="http://www.hologic.com/20171230" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2011-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2017-01-31" xmlns:us-roles="http://fasb.org/us-roles/2017-01-31" xmlns:us-types="http://fasb.org/us-types/2017-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
	<link:schemaRef xlink:href="holx-20171230.xsd" xlink:type="simple" />
	<xbrli:context id="FD2018Q1YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Feb05">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-02-05</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q2Jan29-Jan29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-29</xbrli:startDate>
			<xbrli:endDate>2018-01-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_holx_A2022NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2022NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2022NotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Jan29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_AccountsReceivableSecuritizationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FinancialInstrumentAxis_holx_TwoThousandAndThirteenNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandAndThirteenNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FinancialInstrumentAxis_holx_TwoThousandAndTwelveNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:TwoThousandAndTwelveNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_InterestRateCapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_InterestRateCapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_InterestRateCapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DeferredCompensationShareBasedPaymentsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-11</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q2Apr7-Apr7_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MedicorMedicalSupplyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-04-07</xbrli:startDate>
			<xbrli:endDate>2017-04-07</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-12-11</xbrli:startDate>
			<xbrli:endDate>2017-12-11</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q3_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-21</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q3Apr0717_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MedicorMedicalSupplyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-04-07</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:EmsorMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_CounterpartyNameAxis_holx_CynosureShareholdersMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">holx:CynosureShareholdersMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-03-22</xbrli:startDate>
			<xbrli:endDate>2017-03-22</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-03-22</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD_us-gaap_RestructuringPlanAxis_holx_CynosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:CynosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4QTD_us-gaap_RestructuringPlanAxis_holx_CynosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:CynosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-07-02</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_RestructuringPlanAxis_holx_BedfordMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3QTD_us-gaap_RestructuringPlanAxis_holx_BedfordMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:BedfordMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-04-02</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q3QTD_us-gaap_RestructuringPlanAxis_holx_CynosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:CynosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-04-02</xbrli:startDate>
			<xbrli:endDate>2017-07-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2016ActionsDomain</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2016ActionsDomain</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2016ActionsDomain</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2017ActionsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2016ActionsDomain</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwothousandeighteenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">holx:Fiscal2018ActionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:TwoThousandSeventeenMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_RevolverMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_TermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_AccountsReceivableSecuritizationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_RevolverMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_A2022NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2022NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_AccountsReceivableSecuritizationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_A2022NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2022NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_holx_AmendedTermLoanMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q2Jan19-Jan19_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-19</xbrli:startDate>
			<xbrli:endDate>2018-01-19</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Oct03_us-gaap_DebtInstrumentAxis_holx_AmendedRevolverMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolverMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-03</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-10</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_holx_AmendedTermLoanMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedCreditAgreementMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_A2043NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2043NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2017Q1Dec1617_us-gaap_DebtInstrumentAxis_holx_TwoThousandAndTwelveNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:TwoThousandAndTwelveNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1commonstock_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Oct03_us-gaap_DebtInstrumentAxis_holx_AmendedTermLoanMember_us-gaap_LongtermDebtTypeAxis_holx_SecuredTermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-10-03</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedTermLoanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedRevolverMember_us-gaap_DebtSecurityAxis_holx_PercentageAddedtoEurodollarRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedRevolverMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtSecurityAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2016Q3QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-03-27</xbrli:startDate>
			<xbrli:endDate>2016-06-25</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedTermLoanMember_us-gaap_DebtSecurityAxis_holx_PercentageAddedtoEurodollarRateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DebtSecurityAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-19</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Dec29-Dec29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-12-29</xbrli:startDate>
			<xbrli:endDate>2017-12-29</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1commonstock">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q2Jan19-Jan19_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-19</xbrli:startDate>
			<xbrli:endDate>2018-01-19</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q1Jan29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-29</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2043NotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2043NotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q1Oct10-Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-10</xbrli:startDate>
			<xbrli:endDate>2017-10-10</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_TwoThousandAndTwelveNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:TwoThousandAndTwelveNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2018Q2Jan19-Jan19_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2042NotesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2018-01-19</xbrli:startDate>
			<xbrli:endDate>2018-01-19</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2015Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2014-09-28</xbrli:startDate>
			<xbrli:endDate>2015-09-26</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q4YTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2017-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2012Q4September4th">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2012-09-04</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_StockCompensationPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_StockCompensationPlanMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="D2017Q1Dec1417_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:BloodScreeningBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-12-14</xbrli:startDate>
			<xbrli:endDate>2016-12-14</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD_dei_LegalEntityAxis_holx_GrifolsMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:GrifolsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:BloodScreeningBusinessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD_dei_LegalEntityAxis_holx_GrifolsMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember_us-gaap_RangeAxis_us-gaap_MinimumMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:GrifolsMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:BloodScreeningBusinessMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:BloodScreeningBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q2QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:BloodScreeningBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-01-01</xbrli:startDate>
			<xbrli:endDate>2017-04-01</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:BloodScreeningBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:BloodScreeningBusinessMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_IntersegmentEliminationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_holx_AllOtherCountriesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_AsiaPacificMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:AsiaPacificMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_EuropeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_holx_AllOtherCountriesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_AsiaPacificMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:AsiaPacificMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_EuropeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">us-gaap:EuropeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_country_US">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsDomain</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsDomain</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsDomain</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsDomain</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_IntersegmentEliminationMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q4YTD_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2018-09-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q4_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2018Q2Jan31_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-01-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
				<xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="I2019Q1Oct01_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">us-gaap:ScenarioForecastMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2018-10-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CustomerRelationshipsContractsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_AcquiredintangibleassetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CustomerRelationshipsContractsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_AcquiredintangibleassetsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_InternalusesoftwareMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DevelopedTechnologyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_InternalusesoftwareMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_BusinessLicensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DistributionagreementMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_BusinessLicensesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DevelopedTechnologyMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CapitalizedsoftwareMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CapitalizedsoftwareMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q3_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:CynosureMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-07-01</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2017-10-01</xbrli:startDate>
			<xbrli:endDate>2017-12-30</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-12-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2017-09-30</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-12-31</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:startDate>2016-09-25</xbrli:startDate>
			<xbrli:endDate>2016-12-31</xbrli:endDate>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:context id="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
		<xbrli:entity>
			<xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier>
			<xbrli:segment>
				<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
			</xbrli:segment>
		</xbrli:entity>
		<xbrli:period>
			<xbrli:instant>2016-09-24</xbrli:instant>
		</xbrli:period>
	</xbrli:context>
	<xbrli:unit id="project">
		<xbrli:measure>holx:project</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usdPerShare">
		<xbrli:divide>
			<xbrli:unitNumerator>
				<xbrli:measure>iso4217:USD</xbrli:measure>
			</xbrli:unitNumerator>
			<xbrli:unitDenominator>
				<xbrli:measure>xbrli:shares</xbrli:measure>
			</xbrli:unitDenominator>
		</xbrli:divide>
	</xbrli:unit>
	<xbrli:unit id="number">
		<xbrli:measure>xbrli:pure</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="usd">
		<xbrli:measure>iso4217:USD</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="Segment">
		<xbrli:measure>holx:Segment</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="shares">
		<xbrli:measure>xbrli:shares</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="Customer">
		<xbrli:measure>holx:Customer</xbrli:measure>
	</xbrli:unit>
	<xbrli:unit id="unit">
		<xbrli:measure>holx:unit</xbrli:measure>
	</xbrli:unit>
	<dei:AmendmentFlag contextRef="FD2018Q1YTD" id="Fact-3CCE01585C6BC85D27592012DE025BE0">false</dei:AmendmentFlag>
	<dei:CurrentFiscalYearEndDate contextRef="FD2018Q1YTD" id="Fact-45F2501146DE96941AD72012DE02748F">--09-30</dei:CurrentFiscalYearEndDate>
	<dei:DocumentFiscalPeriodFocus contextRef="FD2018Q1YTD" id="Fact-8DB163D7B101F11DD4002012DE02B30D">Q1</dei:DocumentFiscalPeriodFocus>
	<dei:DocumentFiscalYearFocus contextRef="FD2018Q1YTD" id="Fact-2F0A60C99734B3B0ADE42012DE02F45B">2018</dei:DocumentFiscalYearFocus>
	<dei:DocumentPeriodEndDate contextRef="FD2018Q1YTD" id="Fact-5316C6F478EC89FA0D692012DE021640">2017-12-30</dei:DocumentPeriodEndDate>
	<dei:DocumentType contextRef="FD2018Q1YTD" id="Fact-86CDBCF8BB7A3060E0F72012DE02CA14">10-Q</dei:DocumentType>
	<dei:EntityCentralIndexKey contextRef="FD2018Q1YTD" id="Fact-918A49F034C2BD6BEABC2012DE02E98D">0000859737</dei:EntityCentralIndexKey>
	<dei:EntityCommonStockSharesOutstanding contextRef="I2018Q1Feb05" decimals="INF" id="Fact-5F54C61738129A1A77892012DE021B89" unitRef="shares">276529054</dei:EntityCommonStockSharesOutstanding>
	<dei:EntityFilerCategory contextRef="FD2018Q1YTD" id="Fact-94708BD7DE955BF0FF1A2012DE02738F">Large Accelerated Filer</dei:EntityFilerCategory>
	<dei:EntityRegistrantName contextRef="FD2018Q1YTD" id="Fact-BCD142FE78D53F6489B62012DE026204">HOLOGIC INC</dei:EntityRegistrantName>
	<holx:AccumulatedothercomprehensiveIncomelossHedge contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-0F71E41D368BA486CA972012DE02AF17" unitRef="usd">-3400000</holx:AccumulatedothercomprehensiveIncomelossHedge>
	<holx:AccumulatedothercomprehensiveIncomelossHedge contextRef="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-3CFC183259E43371CCDD2012DE021303" unitRef="usd">-600000</holx:AccumulatedothercomprehensiveIncomelossHedge>
	<holx:AccumulatedothercomprehensiveIncomelossHedge contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-660EB528818AB140BC0F2012DE02D1C1" unitRef="usd">4300000</holx:AccumulatedothercomprehensiveIncomelossHedge>
	<holx:AccumulatedothercomprehensiveIncomelossHedge contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-B5E439E27C66DCB6B4802012DE02F3A6" unitRef="usd">2300000</holx:AccumulatedothercomprehensiveIncomelossHedge>
	<holx:AcquisitionPriceAdjustment contextRef="I2017Q3Apr0717_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" decimals="-5" id="Fact-957CD41DD1029CA7CFC02012DE02F770" unitRef="usd">2000000</holx:AcquisitionPriceAdjustment>
	<holx:AmortizationOfDeferredFinancingCosts contextRef="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-88AB1EE96CD3699E0BF92012DE027579" unitRef="usd">200000</holx:AmortizationOfDeferredFinancingCosts>
	<holx:AmortizationOfDeferredFinancingCosts contextRef="FD2018Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-7E3F9AC6A640CFD7C8A22012DE0276A2" unitRef="usd">100000</holx:AmortizationOfDeferredFinancingCosts>
	<holx:AmountAssessedInDamages contextRef="I2012Q4September4th" decimals="-5" id="Fact-FA618E9BF6488814D3A72012DE0206E1" unitRef="usd">4000000</holx:AmountAssessedInDamages>
	<holx:BasePrincipalAmountForAccretionValue contextRef="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-881A9CFBE784FEA8E7D42012DE02A504" unitRef="usd">-4600000</holx:BasePrincipalAmountForAccretionValue>
	<holx:BasePrincipalAmountForAccretionValue contextRef="FD2018Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-7437F4FFCE16F00E4B692012DE027E66" unitRef="usd">-1600000</holx:BasePrincipalAmountForAccretionValue>
	<holx:BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability contextRef="D2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" id="Fact-BC52CA4C4A03F8F0C053713C6A9C45BE">P2Y</holx:BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability>
	<holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability contextRef="D2017Q2Apr7-Apr7_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" id="Fact-69439457A3E9CEAB08BF713A98CEA636">P2Y</holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability>
	<holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability contextRef="D2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" id="Fact-1F0835D830D718C776BD713BAD528491">P18M</holx:BusinessCombinationPeriodforPaymentofContingentConsiderationLiability>
	<holx:CashPerOriginalPrincipalAmountofExchangeNotes contextRef="I2018Q1commonstock_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-DC010E10555C4B4D9A5E52B82E291B30" unitRef="usd">1371</holx:CashPerOriginalPrincipalAmountofExchangeNotes>
	<holx:CashSeverancePayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-187989C50FC39937A9DA2012DE028C31" unitRef="usd">200000</holx:CashSeverancePayments>
	<holx:CashSeverancePayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-6721F66AE1572A1C6A442012DE0203EC" unitRef="usd">2300000</holx:CashSeverancePayments>
	<holx:CashSeverancePayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-36144775380924878D15488FFC7602BC" unitRef="usd">900000</holx:CashSeverancePayments>
	<holx:CashSeverancePayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-2AF36330C97A237D1B712012DE02D0F6" unitRef="usd">0</holx:CashSeverancePayments>
	<holx:CashSeverancePayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-2B7532150D9158F6CBD62012DE024DBA" unitRef="usd">3400000</holx:CashSeverancePayments>
	<holx:DebtInstrumentCashAccruedInterestPercentage contextRef="FD2017Q1QTD" decimals="INF" id="Fact-E3CB497224A3730EA2D4714E2523A616" unitRef="number">0.02</holx:DebtInstrumentCashAccruedInterestPercentage>
	<holx:DebtInstrumentCashAccruedInterestPercentage contextRef="FD2018Q1YTD" decimals="INF" id="Fact-5E5FFF09CB3262D0A96C714E250AD259" unitRef="number">0.02</holx:DebtInstrumentCashAccruedInterestPercentage>
	<holx:DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="INF" id="Fact-E42BD7ECDBF50ECA91F27147B706DFF1" unitRef="number">4</holx:DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate>
	<holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod contextRef="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-E8E1ADF1CA5BCBF8B9124DF4FC9CBFC1" unitRef="number">1</holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod>
	<holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-36BF92B4CB80EF790C50529E05DD5AE7" unitRef="number">1.0077</holx:DebtInstrumentPercentageOfRedemptionPriceFifthPeriod>
	<holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod contextRef="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-81C2BA406F1FC570AF9A4DF3B4D111C0" unitRef="number">1.01094</holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod>
	<holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-E1916D0BE0C36EE65AAB529C8A7F9EEB" unitRef="number">1.01541</holx:DebtInstrumentPercentageOfRedemptionPriceFourthPeriod>
	<holx:DebtInstrumentPercentageOfRedemptionPriceSecondPeriod contextRef="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-914402F981DC5F599FDB4DEB8ED36627" unitRef="number">1.04375</holx:DebtInstrumentPercentageOfRedemptionPriceSecondPeriod>
	<holx:DebtInstrumentPercentageOfRedemptionPriceSecondPeriod contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-165152F91DEE8D2A29E552942FE6F00D" unitRef="number">1.04625</holx:DebtInstrumentPercentageOfRedemptionPriceSecondPeriod>
	<holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod contextRef="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-8523DDF6471F2E21A52E4DF05E89F9CE" unitRef="number">1.02188</holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod>
	<holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-0E39A5A4DC9264DAE08B529619AB9F1E" unitRef="number">1.02312</holx:DebtInstrumentPercentageOfRedemptionPriceThirdPeriod>
	<holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-40AEFB952D9AE05D496152A614FA56D2" unitRef="number">1</holx:DebtInstrumentPercentageRedemptionPriceSixthPeriod>
	<holx:DebtInstrumentPeriodicPaymentPrincipalPeriod contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_holx_AmendedTermLoanMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-C61B9E4CA37F9569A64671444D4C2F4A">P3M</holx:DebtInstrumentPeriodicPaymentPrincipalPeriod>
	<holx:DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="INF" id="Fact-381E2BE857616E41753A524765914581" unitRef="number">4.50</holx:DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility>
	<holx:DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse contextRef="FI2018Q4_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="3" id="Fact-611B5D6B416A1548608F5717DBC2939D" unitRef="number">0.245</holx:DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse>
	<holx:DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse contextRef="I2019Q1Oct01_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="2" id="Fact-E5E8A7433A852CC1F1045717DBD2F90D" unitRef="number">0.21</holx:DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse>
	<holx:DeferredTaxesReacquisitionofEquityComponent contextRef="FD2018Q1YTD" decimals="-5" id="Fact-B66A7BD6CBEE6D4AB8DD4E05A4C6D6CE" unitRef="usd">3800000</holx:DeferredTaxesReacquisitionofEquityComponent>
	<holx:DirectThirdPartyCostsinterestExpense contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="-5" id="Fact-5BBA35410BBE8D51AFED523B65B829F0" unitRef="usd">1700000</holx:DirectThirdPartyCostsinterestExpense>
	<holx:DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal contextRef="FD2017Q2QTD_dei_LegalEntityAxis_holx_GrifolsMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember_us-gaap_RangeAxis_us-gaap_MaximumMember" id="Fact-15AE65059F39D5842E63715B96A4CB0B">P3Y</holx:DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal>
	<holx:DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal contextRef="FD2017Q2QTD_dei_LegalEntityAxis_holx_GrifolsMember_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember_us-gaap_RangeAxis_us-gaap_MinimumMember" id="Fact-CB9E8E70D5F7D80912EA7156CAF63680">P2Y</holx:DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal>
	<holx:EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount contextRef="FD2018Q1YTD" decimals="-5" id="Fact-27EC8E2BD361F92E0EFF570212D3FA38" unitRef="usd">26000000</holx:EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount>
	<holx:EquipmentUnderCustomerUsageAgreements contextRef="FI2017Q4" decimals="-5" id="Fact-4992B46FBC6E807FD9732012DE023634" unitRef="usd">368700000</holx:EquipmentUnderCustomerUsageAgreements>
	<holx:EquipmentUnderCustomerUsageAgreements contextRef="FI2018Q1" decimals="-5" id="Fact-24B54AFCE8233C33950A2012DE020226" unitRef="usd">379000000</holx:EquipmentUnderCustomerUsageAgreements>
	<holx:FacilityClosureCosts contextRef="FD2017Q1QTD_us-gaap_RestructuringPlanAxis_holx_BedfordMember" decimals="-5" id="Fact-7EEB17AB63288DFF15BF2012DE020520" unitRef="usd">3500000</holx:FacilityClosureCosts>
	<holx:FacilityClosureCosts contextRef="FD2017Q3QTD_us-gaap_RestructuringPlanAxis_holx_BedfordMember" decimals="-5" id="Fact-4E34064300B7F7BF45A12012DE020A67" unitRef="usd">1300000</holx:FacilityClosureCosts>
	<holx:FacilityClosureCosts contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-A5BB7ECAAC18449EDBAF2012DE02F175" unitRef="usd">4800000</holx:FacilityClosureCosts>
	<holx:FacilityClosureCosts contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-80EDF6756936EA15EF48486DED324F8A" unitRef="usd">0</holx:FacilityClosureCosts>
	<holx:FacilityClosureCosts contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-B24F163A6461CD4EAB53486E636795D5" unitRef="usd">0</holx:FacilityClosureCosts>
	<holx:FacilityClosureCosts contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-EB83E6C707C38B0AE7CB2012DE021FD3" unitRef="usd">4800000</holx:FacilityClosureCosts>
	<holx:GrossProceedsonSale contextRef="D2017Q1Dec1417_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-7" id="Fact-1EB18BF438F7BE06DC362012DE024599" unitRef="usd">1850000000</holx:GrossProceedsonSale>
	<holx:IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities contextRef="FD2017Q1QTD" decimals="-3" id="Fact-5D5A7B2C8AAC50420E842012DE02D55F" unitRef="shares">2418000</holx:IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities>
	<holx:IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities contextRef="FD2018Q1YTD" decimals="-3" id="Fact-E27533780F3F24F124FD2012DE021C6D" unitRef="shares">1734000</holx:IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities>
	<holx:InterestCoverageRatio contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="INF" id="Fact-4475999D1B001C30DF7F52496ABBA003" unitRef="number">3.75</holx:InterestCoverageRatio>
	<holx:InterestRateCapAgreementsAggregatePremiumPayable contextRef="FD2015Q4YTD" decimals="-5" id="Fact-251964A86B1EB0B505FB2012DE02FC2A" unitRef="usd">13200000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
	<holx:InterestRateCapAgreementsAggregatePremiumPayable contextRef="FD2017Q4YTD" decimals="-5" id="Fact-9B8F81B29108C7FF115F2DA44B419989" unitRef="usd">1900000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
	<holx:Internalusesoftware contextRef="FI2017Q4" decimals="-5" id="Fact-B9A679A041D57C011AAE4D1B2616E668" unitRef="usd">18400000</holx:Internalusesoftware>
	<holx:Internalusesoftware contextRef="FI2018Q1" decimals="-5" id="Fact-780F932103757E4A8C014D1AD8B38A1B" unitRef="usd">17600000</holx:Internalusesoftware>
	<holx:LeverageRatioMaximum contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="INF" id="Fact-4697C504AAE2E09B9BE852456AE61263" unitRef="number">5.00</holx:LeverageRatioMaximum>
	<holx:LongTermDebtObligationsWithoutConvertibleNotes contextRef="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_A2022NotesMember" decimals="-5" id="Fact-26575562526BABE354972012DE029A05" unitRef="usd">981600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
	<holx:LongTermDebtObligationsWithoutConvertibleNotes contextRef="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember" decimals="-5" id="Fact-A68653793659727CC2DC2012DE02093B" unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
	<holx:LongTermDebtObligationsWithoutConvertibleNotes contextRef="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_TermLoanMember" decimals="-5" id="Fact-ADC6D3AD1901D1B5D2EE2012DE02C751" unitRef="usd">1190500000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
	<holx:LongTermDebtObligationsWithoutConvertibleNotes contextRef="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_A2022NotesMember" decimals="-5" id="Fact-05F6F25D4917751715062012DE02E48D" unitRef="usd">982600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
	<holx:LongTermDebtObligationsWithoutConvertibleNotes contextRef="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember" decimals="-5" id="Fact-B22713D6ED906181467C4D8813B6CEBB" unitRef="usd">345000000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
	<holx:LongTermDebtObligationsWithoutConvertibleNotes contextRef="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_TermLoanMember" decimals="-5" id="Fact-12FDE28DE88BE8FA96982012DE027E2F" unitRef="usd">1430100000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
	<holx:ManufacturingEquipmentAndSoftware contextRef="FI2017Q4" decimals="-5" id="Fact-C22F848BD3884D2A1A162012DE022242" unitRef="usd">357900000</holx:ManufacturingEquipmentAndSoftware>
	<holx:ManufacturingEquipmentAndSoftware contextRef="FI2018Q1" decimals="-5" id="Fact-3DAFDC50DCC92A91BA5C2012DE02CD9B" unitRef="usd">363700000</holx:ManufacturingEquipmentAndSoftware>
	<holx:MaximumRangeofPresentValueofCashFlowPercentage contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="INF" id="Fact-1CA741061A8321C6042052540DFC7A97" unitRef="number">0.1</holx:MaximumRangeofPresentValueofCashFlowPercentage>
	<holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember" decimals="INF" id="Fact-A526575480C8982327842012DE026784" unitRef="number">2.00</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
	<holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember" decimals="INF" id="Fact-258C52BFBC60917DEC6F2012DE02E328" unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
	<holx:NotionalAmount contextRef="FI2018Q1" decimals="-5" id="Fact-BB60F7784C33055017792012DE024106" unitRef="usd">157400000</holx:NotionalAmount>
	<holx:NumberofProjects contextRef="FI2017Q4_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="INF" id="Fact-E6EA6FE444A48B6672EB714145F1E9D8" unitRef="project">2</holx:NumberofProjects>
	<holx:NumberofProjects contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="INF" id="Fact-F5919AF9DC2B6B3184E171403E219445" unitRef="project">3</holx:NumberofProjects>
	<holx:Numberofcountrieswithgreaterthan10ofconsolidatedrevenue contextRef="FI2018Q1" decimals="INF" id="Fact-F6E6D294C31FF89B06AC2012DE02EA17" unitRef="Customer">0</holx:Numberofcountrieswithgreaterthan10ofconsolidatedrevenue>
	<holx:OfferingPriceofPrincipalAmount contextRef="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-32D5387D64A83952A1D84DDE528A5032" unitRef="number">1</holx:OfferingPriceofPrincipalAmount>
	<holx:OfferingPriceofPrincipalAmount contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-6B6900328AFCB80E951A4D5A4EDCF2D1" unitRef="number">1</holx:OfferingPriceofPrincipalAmount>
	<holx:OfferingPriceofPrincipalAmount contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-70A318243A284931B9204D584213EF80" unitRef="number">1</holx:OfferingPriceofPrincipalAmount>
	<holx:OfferingPriceofPrincipalAmount contextRef="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-2F93C510E80E1A0CC37B51E73F1EE0C1" unitRef="number">1</holx:OfferingPriceofPrincipalAmount>
	<holx:OfferingPriceofPrincipalAmount contextRef="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-8282DC157D04ED3D8CCF51E7E4605E56" unitRef="number">1</holx:OfferingPriceofPrincipalAmount>
	<holx:OtherRestructuringPayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-2B050ADA1E7FD0015ED32012DE02614D" unitRef="usd">300000</holx:OtherRestructuringPayments>
	<holx:OtherRestructuringPayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-01AB095B350B1CC4176E2012DE029C16" unitRef="usd">0</holx:OtherRestructuringPayments>
	<holx:OtherRestructuringPayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-FD2CBCC4FAA98B0C11B5488FE3B43843" unitRef="usd">0</holx:OtherRestructuringPayments>
	<holx:OtherRestructuringPayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-3F03BFCD91AA18C59E952012DE0228F8" unitRef="usd">100000</holx:OtherRestructuringPayments>
	<holx:OtherRestructuringPayments contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-396D6E5C2435C47091182012DE027BBB" unitRef="usd">400000</holx:OtherRestructuringPayments>
	<holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits contextRef="FD2017Q1QTD" decimals="-5" id="Fact-A2FEA0BE478DB9192B6A2012DE02C349" unitRef="usd">16400000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
	<holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits contextRef="FD2018Q1YTD" decimals="-5" id="Fact-07B57D02F206D92AB9DC2012DE0287F6" unitRef="usd">14300000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
	<holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements contextRef="FD2017Q1QTD" decimals="-5" id="Fact-6CE5FE409F0919FE12F02012DE02142D" unitRef="usd">13200000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
	<holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements contextRef="FD2018Q1YTD" decimals="-5" id="Fact-0C4B85E83C353EEF7C352012DE024312" unitRef="usd">11600000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
	<holx:PercentageOfRevenues contextRef="FD2017Q1QTD" decimals="INF" id="Fact-CB5EA27D4DB987C3547B2012DE0267C0" unitRef="number">1</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_country_US" decimals="3" id="Fact-DE93B889F7C14FC106C92012DE02F48F" unitRef="number">0.779</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_holx_AllOtherCountriesMember" decimals="3" id="Fact-7ACB8EBC564C34ACF1C52012DE0229E2" unitRef="number">0.030</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_AsiaPacificMember" decimals="3" id="Fact-FE5621EBCA018E18ADB42012DE027F76" unitRef="number">0.084</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2017Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_EuropeMember" decimals="3" id="Fact-D7A9A74B5D1A88735B832012DE02081B" unitRef="number">0.107</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_country_US" decimals="3" id="Fact-74AE12EFBA403C2CE6972012DE02496F" unitRef="number">0.755</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_holx_AllOtherCountriesMember" decimals="3" id="Fact-BEC1C0C92B2325D1E6342012DE02C3C6" unitRef="number">0.043</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_AsiaPacificMember" decimals="3" id="Fact-A7F3DA759CA58173B6FE2012DE02413F" unitRef="number">0.087</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2018Q1QTD_us-gaap_StatementGeographicalAxis_us-gaap_EuropeMember" decimals="3" id="Fact-FC6836C77AC8B452C29D2012DE02ADB8" unitRef="number">0.115</holx:PercentageOfRevenues>
	<holx:PercentageOfRevenues contextRef="FD2018Q1YTD" decimals="INF" id="Fact-64E1A2797AB8072AC3312012DE02E5D9" unitRef="number">1</holx:PercentageOfRevenues>
	<holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes contextRef="D2018Q1Oct10-Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-B9CB768E6DBADF93DC0A4DF65B38DFB7" unitRef="number">1.01</holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes>
	<holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes contextRef="D2018Q2Jan19-Jan19_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-92C3026A277C6E5083EE52A2A74C6B01" unitRef="number">1.01</holx:PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes>
	<holx:PrincipalAmountOfBorrowings contextRef="FI2018Q1" decimals="-8" id="Fact-3F7A24BC2177491944DF2012DE02D2A1" unitRef="usd">1000000000</holx:PrincipalAmountOfBorrowings>
	<holx:PrincipalAmountOfBorrowings contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_AccountsReceivableSecuritizationMember" decimals="-5" id="Fact-183FB54D26A5835DD5E22012DE02C29B" unitRef="usd">200000000</holx:PrincipalAmountOfBorrowings>
	<holx:PrincipalAmountOfBorrowings contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="-8" id="Fact-5AB36BAE812D99CD21052012DE02DD82" unitRef="usd">1600000000</holx:PrincipalAmountOfBorrowings>
	<holx:PrincipalAmountOfBorrowings contextRef="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-6" id="Fact-2FDE066D18386BF906064DFB01771DF7" unitRef="usd">600000000</holx:PrincipalAmountOfBorrowings>
	<holx:PrincipalConvertibleToCommonStock contextRef="I2018Q1commonstock_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-4471CE1FC4F5B8F54DC452B63B4AD064" unitRef="usd">1000</holx:PrincipalConvertibleToCommonStock>
	<holx:ProceedsFromSaleOfBusiness contextRef="FD2017Q2QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-6" id="Fact-F83D3B0053AB1084957E2012DE02B551" unitRef="usd">1865000000</holx:ProceedsFromSaleOfBusiness>
	<holx:Proceedsallocatedtomanufactureofinventory contextRef="FI2017Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-5" id="Fact-DB5F44E008ECC35686CD2012DE020A85" unitRef="usd">13100000</holx:Proceedsallocatedtomanufactureofinventory>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-7DF00492D87F772AD58D2012DE02B747" unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-7D14B907BA8E3A64FEFA2012DE029794" unitRef="usd">8500000</holx:ReductionOfWorkforceExpenses>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-0E8E59FE8ED797A7A31D487320F14F8F" unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-984C378835001C603DCB2012DE029BF3" unitRef="usd">8500000</holx:ReductionOfWorkforceExpenses>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-09F26DA167EBEED62B522012DE02E095" unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-2B1E275CDE3CF649C26F2012DE0250C2" unitRef="usd">0</holx:ReductionOfWorkforceExpenses>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-508E0D9C2E42BFD93E48488484D9FE2F" unitRef="usd">3800000</holx:ReductionOfWorkforceExpenses>
	<holx:ReductionOfWorkforceExpenses contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-08AEF34EC16D6FD5B6D82012DE028CF3" unitRef="usd">3800000</holx:ReductionOfWorkforceExpenses>
	<holx:ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete contextRef="FI2017Q4_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-1628DF0596383E8E821B2EBC406620B4" unitRef="usd">4000000</holx:ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete>
	<holx:ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-30515588339FDF28D7002012DE02F3FF" unitRef="usd">18000000</holx:ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-ECC026692424613CFF4D2012DE02B385" unitRef="usd">4800000</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-A3D174FBA471B6C1DACE2012DE0239E9" unitRef="usd">8500000</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-BEDBE11E65B297E114E64887EA741743" unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2017Q4YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-F3C55D3ABBB088DD586B2012DE026172" unitRef="usd">13300000</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-DD07DDE8E2AC4DE6358F2012DE0217E4" unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-817F90DE514EEB9B1FC42012DE028FF3" unitRef="usd">0</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-D5B330F1DADCE08BE693488B1681734B" unitRef="usd">3800000</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:RestructuringChargesUnderExitOrDisposalPlan contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-886953474A2A5002AB022012DE02C6F7" unitRef="usd">3800000</holx:RestructuringChargesUnderExitOrDisposalPlan>
	<holx:Restructuringchargesgross contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-F638BA997F0646AF090D2012DE0261E6" unitRef="usd">0</holx:Restructuringchargesgross>
	<holx:Restructuringchargesgross contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-04C73E319AC102E032442012DE02F7B7" unitRef="usd">0</holx:Restructuringchargesgross>
	<holx:Restructuringchargesgross contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-E08AD1DF2BE829D503D3489084B029EC" unitRef="usd">3800000</holx:Restructuringchargesgross>
	<holx:Restructuringchargesgross contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-B4BE689E8F17D5F59C802012DE02D86B" unitRef="usd">0</holx:Restructuringchargesgross>
	<holx:Restructuringchargesgross contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-95187B3D80DD3478EA2F2012DE0275BE" unitRef="usd">3800000</holx:Restructuringchargesgross>
	<holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts contextRef="FD2018Q1YTD" decimals="-5" id="Fact-9AFC4A84E0E2FB1B2D7B48906DB5BA1B" unitRef="usd">1300000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
	<holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-BF61970C84BB2FCEC8922012DE021EC3" unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
	<holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-49C0F83DD0D87929042D489015E4515E" unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
	<holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-0E4243B4E9F1D01DF0B548902957D1DA" unitRef="usd">1300000</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
	<holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts contextRef="FD2018Q1YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-78026F452B9C85DDFC9248903C66857B" unitRef="usd">0</holx:ShareBasedCompensationExpenseIncludedOtherRestructuringCosts>
	<holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember" id="Fact-0946C0737F6DF8E49C542012DE0272DA">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
	<holx:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-B2B52F82027584CA30C8571E2FBCBC33" unitRef="usd">-355200000</holx:TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit>
	<holx:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-D8EBF47CEACD340F5500570D3BD06FA1" unitRef="usd">-329200000</holx:TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit>
	<holx:TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-AFB4BA944F95365A02985705733239FD" unitRef="usd">355200000</holx:TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit>
	<us-gaap:AccountsPayableCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-2E0A99966F55080AEB0B2012DE022807" unitRef="usd">166600000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsPayableCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-9F7F447FD3C29D9694972012DE026210" unitRef="usd">160300000</us-gaap:AccountsPayableCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-2790738A619AE19854712012DE02E40A" unitRef="usd">533500000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccountsReceivableNetCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-D53BFCB96D933038F8BE2012DE027592" unitRef="usd">548000000</us-gaap:AccountsReceivableNetCurrent>
	<us-gaap:AccruedIncomeTaxes contextRef="FI2017Q4_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-5" id="Fact-4F482735ABA9CF0A57C72012DE02ECB5" unitRef="usd">649500000</us-gaap:AccruedIncomeTaxes>
	<us-gaap:AccruedLiabilitiesCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-0222730AF02D2488BB2A2012DE027D65" unitRef="usd">375300000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccruedLiabilitiesCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-A719C5DAA7857044024B2012DE02E816" unitRef="usd">412700000</us-gaap:AccruedLiabilitiesCurrent>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2017Q4" decimals="-5" id="Fact-E6762D3CEA4EC9F052A52012DE027B67" unitRef="usd">553500000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="FI2018Q1" decimals="-5" id="Fact-70A37A5D24A98AC573712012DE02A951" unitRef="usd">576800000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-B2B6B3C68804E39B646B2012DE02C311" unitRef="usd">-300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-5395029553B9788A2AD32012DE025F10" unitRef="usd">2100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-900F3F940CBC6C5E174E2012DE024518" unitRef="usd">-400000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-896F934CC25084AD8A322012DE024BDE" unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-A7BE53F86EAD76E0F4112012DE022CBF" unitRef="usd">2500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-B869214358980885752E2012DE02321E" unitRef="usd">2500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-9E697D4112CC97FA65FE2012DE024963" unitRef="usd">1600000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-E677206244DE5623022A2012DE02D4A9" unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-103DA2EA74EC4DEF86922012DE02B33E" unitRef="usd">-26100000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-7D30BF753DACE7DE60842012DE02E4DC" unitRef="usd">-41800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-678B471B7AA9A12A6F142012DE02B8E5" unitRef="usd">-18500000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-4AA39FC355113A81FFC82012DE023A58" unitRef="usd">-13000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-D312F93D55A8DCA051AD2012DE022562" unitRef="usd">-32300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2017Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-65E48AA70E938F67F8BE2012DE02D456" unitRef="usd">-42800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2017Q4" decimals="-5" id="Fact-5920055A8DB7C29DF80B2012DE02DE78" unitRef="usd">-16200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-3A058317FAD76C019CDC2012DE02FFFC" unitRef="usd">-16200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2018Q1" decimals="-5" id="Fact-DCD8ADC0B8DD14636FE52012DE027664" unitRef="usd">-11700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="FI2018Q1_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-4B75FE5BE589729D23652012DE02162E" unitRef="usd">-11700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember" id="Fact-C0158D488C15E9C611CF2012DE02F6AD">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" id="Fact-7FB9F7D365FB604682892012DE02A3F2">P7Y8M12D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" id="Fact-D013A46965E75883088C2012DE024BC6">P11Y9M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" id="Fact-9CC85BD9C2B73D0C5C3C2012DE02ECE3">P8Y10M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="D2017Q2Apr7-Apr7_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" id="Fact-3B5633590F7FA49852782012DE0246CB">P7Y8M12D
</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
	<us-gaap:AdditionalPaidInCapital contextRef="FI2017Q4" decimals="-5" id="Fact-BBB53947344C11387ACE2012DE028DDC" unitRef="usd">5630800000</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdditionalPaidInCapital contextRef="FI2018Q1" decimals="-5" id="Fact-D28667CF2D2AB7D7007C2012DE02C14F" unitRef="usd">5628900000</us-gaap:AdditionalPaidInCapital>
	<us-gaap:AdjustmentForAmortization contextRef="FD2017Q1QTD" decimals="-5" id="Fact-B30C45DA835BE00253EB2012DE02B8EE" unitRef="usd">94900000</us-gaap:AdjustmentForAmortization>
	<us-gaap:AdjustmentForAmortization contextRef="FD2018Q1YTD" decimals="-5" id="Fact-8BB3BE1710253A2067DF2012DE02195F" unitRef="usd">94200000</us-gaap:AdjustmentForAmortization>
	<us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt contextRef="FD2018Q1YTD" decimals="-5" id="Fact-8AF3E20151A2D6DD59154E06CBEFCD27" unitRef="usd">13400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-CD96A9534AEAD25B8E602012DE02D0C6" unitRef="usd">9800000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-202F5590E78A0E12CA832012DE02ADEA" unitRef="usd">11500000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
	<us-gaap:AmortizationOfDebtDiscountPremium contextRef="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-5233FF2904345F9C17672012DE024047" unitRef="usd">5200000</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:AmortizationOfDebtDiscountPremium contextRef="FD2018Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-34C86B13D5092E363D0D2012DE02EAFE" unitRef="usd">2900000</us-gaap:AmortizationOfDebtDiscountPremium>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2016Q3QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="-5" id="Fact-6BA639DB36049634AEFF2012DE02D7FD" unitRef="usd">1100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2017Q1QTD" decimals="-5" id="Fact-5085FAE13AF781E3E79E2012DE02F268" unitRef="usd">14300000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-2F2F19B7396E787F87422012DE02E6F2" unitRef="usd">10000000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember" decimals="-5" id="Fact-A76E66945DE23D95F51E4E323B9286A2" unitRef="usd">100000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="-5" id="Fact-0F6830CD13F1D6E9CF8A2012DE02C1EC" unitRef="usd">700000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2018Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-8C5B4F5DAAB977F902642012DE02ECB5" unitRef="usd">4600000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2018Q1YTD" decimals="-5" id="Fact-8878D9B2F2E8A39CD50B2012DE02C740" unitRef="usd">8700000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_holx_A2022NotesMember" decimals="-5" id="Fact-C2BB25B22B38800E97AB2012DE021F57" unitRef="usd">1000000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2017Q1QTD" decimals="-5" id="Fact-99EBB78360B6B8187BBD2012DE02C14F" unitRef="usd">21400000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AmortizationOfIntangibleAssets contextRef="FD2018Q1YTD" decimals="-5" id="Fact-F6B97DB4B35594E200642012DE02EDFD" unitRef="usd">14400000</us-gaap:AmortizationOfIntangibleAssets>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2017Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-3" id="Fact-C68C76EC672958129D492012DE028876" unitRef="shares">13000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2017Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_StockCompensationPlanMember" decimals="-3" id="Fact-6696321A60E2050ACE812012DE02214A" unitRef="shares">1442000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-3" id="Fact-A834344C5F39123A58022012DE02240E" unitRef="shares">216000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="FD2018Q1QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_StockCompensationPlanMember" decimals="-3" id="Fact-BBEA23B384D97CB20EDA2012DE02DAF7" unitRef="shares">2272000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
	<us-gaap:Assets contextRef="FI2017Q4" decimals="-5" id="Fact-6B711E94C0B5D55B7F5E2012DE02BCCB" unitRef="usd">7979600000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-2B53CF5788F8B425FE192012DE02F01A" unitRef="usd">824000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-C7734BA14941F7950DB12012DE021637" unitRef="usd">2621600000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-7E0AA28F9DF7202817C82012DE02F068" unitRef="usd">1494600000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-3F97A5295D3A11D59C302012DE0237B8" unitRef="usd">1751200000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-BADF0D774E876D4719B32012DE02C4E6" unitRef="usd">25500000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2017Q4_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember" decimals="-5" id="Fact-7E58E011E3E7B580E50B2012DE02B6FB" unitRef="usd">1262700000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1" decimals="-5" id="Fact-A73FB9C1B667A1125DCD2012DE028E72" unitRef="usd">8048300000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-0084749079240ED58D1F2012DE026C59" unitRef="usd">840500000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-57857D4E721E5A3600012012DE02BE32" unitRef="usd">2583000000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-85BFFACD267FEBE3279F2012DE02714C" unitRef="usd">1477800000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-B98A967F6773FB423C8D2012DE02C91E" unitRef="usd">1723900000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-6B108DFBC290A79BCC392012DE02AFEE" unitRef="usd">26800000</us-gaap:Assets>
	<us-gaap:Assets contextRef="FI2018Q1_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember" decimals="-5" id="Fact-33F17010D1FB75A4E5C22012DE021459" unitRef="usd">1396300000</us-gaap:Assets>
	<us-gaap:AssetsCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-E714D7100E282531B8992012DE023236" unitRef="usd">1478600000</us-gaap:AssetsCurrent>
	<us-gaap:AssetsCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-6FED1978B6186CCE94C72012DE02D273" unitRef="usd">1638400000</us-gaap:AssetsCurrent>
	<us-gaap:BuildingsAndImprovementsGross contextRef="FI2017Q4" decimals="-5" id="Fact-3EEECA60D1282296E27F2012DE02FB0A" unitRef="usd">172000000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BuildingsAndImprovementsGross contextRef="FI2018Q1" decimals="-5" id="Fact-64372E36184D2798D54F2012DE0232EE" unitRef="usd">172700000</us-gaap:BuildingsAndImprovementsGross>
	<us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-1FC61BFB7205407054672012DE02C2A3" unitRef="usd">18800000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
	<us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-1" id="Fact-0AF63FB5B8A88FE0B3882012DE020738" unitRef="usdPerShare">270</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
	<us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-1" id="Fact-D89EA8062B8ADB9947E12012DE021B68" unitRef="usdPerShare">260</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
	<us-gaap:BusinessAcquisitionSharePrice contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="2" id="Fact-53367E1F8725301D5EB12012DE027D48" unitRef="usdPerShare">66.00</us-gaap:BusinessAcquisitionSharePrice>
	<us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-D0B8FC0DB76B4C8C67162012DE0273BF" unitRef="usd">74100000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
	<us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="FD2018Q1QTD_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-8BC883755E0048D503F62012DE026523" unitRef="usd">856300000</us-gaap:BusinessAcquisitionsProFormaRevenue>
	<us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="D2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" decimals="-5" id="Fact-6C91C4D87B108A8C98562ECC58431732" unitRef="usd">13100000</us-gaap:BusinessCombinationConsiderationTransferred1>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" decimals="-5" id="Fact-C1D735820EA33B53DC352EBF5CA5AC66" unitRef="usd">2000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2017Q3Apr0717_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" decimals="-5" id="Fact-DE5FB112BD0620673F262012DE0205DE" unitRef="usd">1900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="I2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" decimals="-5" id="Fact-95FD9CF086F2FA2A1D3B2ED541BB6ADF" unitRef="usd">500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-04DECE8841CB644E32C12012DE027455" unitRef="usd">25200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-E9A5F70D6B99FC46FC332012DE023460" unitRef="usd">107200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-1768AA12E55B5795B44B2012DE0298FA" unitRef="usd">82900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-AF63E0FCDBB7065A2B5A2012DE02569F" unitRef="usd">40200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-0C077B84494DD1C299D02012DE0254BD" unitRef="usd">75300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-8A32228FD95BD18968812012DE0224C3" unitRef="usd">11200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-B61717CFEF112381CA912012DE02A277" unitRef="usd">315700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember" decimals="-5" id="Fact-6CDDB956E1A8107A4EE12012DE022B88" unitRef="usd">42000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_CustomerRelationshipsMember" decimals="-5" id="Fact-D897D729EF495AB766EE2012DE028C1B" unitRef="usd">35000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-93120BB037154D98613B2012DE02D2F1" unitRef="usd">736000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-9B750919CFA5F5AEB27F2012DE02B1A7" unitRef="usd">107000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-5178E05619C1B522924A2012DE02C4BF" unitRef="usd">74000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2017Q3Apr0717_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" decimals="-5" id="Fact-0526D826A3D6B27FD6452012DE020297" unitRef="usd">5400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill contextRef="I2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" decimals="-5" id="Fact-D204A162417CFE84EB6D2ED7266C740C" unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-65CEFD0DF6332D49BF9C2012DE02AE3A" unitRef="usd">121100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-5F60120D537BCEF7A6EA2012DE027D3D" unitRef="usd">12200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" decimals="-5" id="Fact-CE82957844B9136F1DD52ED14DA019B6" unitRef="usd">6800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-2A7411C19B08641612B32012DE02E652" unitRef="usd">44100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="I2017Q3Apr0717_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" decimals="-5" id="Fact-AA71B9F42CB561C5D77A2012DE02A3D9" unitRef="usd">4700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
	<us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-302152F345C1B24872502012DE02580C" unitRef="usd">1657800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
	<us-gaap:CapitalLeaseObligationsCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-10DBF558CCBDA17AD62D2012DE02329B" unitRef="usd">1600000</us-gaap:CapitalLeaseObligationsCurrent>
	<us-gaap:CapitalLeaseObligationsCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-AD639CE4731CB837C58C2012DE02F435" unitRef="usd">1600000</us-gaap:CapitalLeaseObligationsCurrent>
	<us-gaap:CapitalLeaseObligationsNoncurrent contextRef="FI2017Q4" decimals="-5" id="Fact-7FFE8A8077999EA8200E2012DE02966B" unitRef="usd">22700000</us-gaap:CapitalLeaseObligationsNoncurrent>
	<us-gaap:CapitalLeaseObligationsNoncurrent contextRef="FI2018Q1" decimals="-5" id="Fact-B4690C0BC4CF941103482012DE027E69" unitRef="usd">22300000</us-gaap:CapitalLeaseObligationsNoncurrent>
	<us-gaap:CapitalizedComputerSoftwareNet contextRef="FI2017Q4" decimals="-5" id="Fact-AA8D27674F9A9EB8A7684D34C148CC5E" unitRef="usd">12300000</us-gaap:CapitalizedComputerSoftwareNet>
	<us-gaap:CapitalizedComputerSoftwareNet contextRef="FI2018Q1" decimals="-5" id="Fact-DF1B5E442824EA80CC1D4D34B065A6F6" unitRef="usd">12900000</us-gaap:CapitalizedComputerSoftwareNet>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2016Q4" decimals="-5" id="Fact-922A5AB6DA2E62161CF62012DE02A647" unitRef="usd">548400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2017Q1" decimals="-5" id="Fact-9F0E2D039A46D875775C2012DE02676A" unitRef="usd">646000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2017Q4" decimals="-5" id="Fact-67ED3AB6458B3BF3B3D12012DE02129E" unitRef="usd">540600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="FI2018Q1" decimals="-5" id="Fact-50C2DB61C822F7EBD3292012DE02F88F" unitRef="usd">664400000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2017Q1QTD" decimals="-5" id="Fact-E34726386732FD73DFB02012DE02CEF0" unitRef="usd">97600000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="FD2018Q1YTD" decimals="-5" id="Fact-9A4784980DCF68DFC9E82012DE028080" unitRef="usd">123800000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-5657695FC06A140A38BC2012DE02C250" unitRef="usd">4000000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-ACD820100F538F13A8452012DE027719" unitRef="usd">1200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-CE433D8C3263F4A4A6352012DE020653" unitRef="usd">400000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2017Q4_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-96D691B6B5D8198E0D802012DE02293B" unitRef="usd">3600000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2017Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-6D059165B69D268A06D82012DE022620" unitRef="usd">4800000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_AccruedLiabilitiesMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-B3D80AD404494E951CD92012DE02FF78" unitRef="usd">2600000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-48513B6B2BAD20FD50452012DE0237D4" unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember" decimals="-5" id="Fact-F001D6530B8023C0C66A2012DE0257C8" unitRef="usd">400000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2018Q1_us-gaap_BalanceSheetLocationAxis_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-6A6F4E6780E3ED5A09432012DE02D5B7" unitRef="usd">5300000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue contextRef="FI2018Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember" decimals="-5" id="Fact-48B344A94BEC08EF95152012DE021DD8" unitRef="usd">5300000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
	<us-gaap:CommitmentsAndContingencies contextRef="FI2017Q4" id="Fact-30992AACD82EC1E654F22012DE021980" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommitmentsAndContingencies contextRef="FI2018Q1" id="Fact-FDB1D75BD563A8FB66762012DE02CF8A" unitRef="usd" xsi:nil="true" />
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2017Q4" decimals="INF" id="Fact-9C673D430CE9E2BC93AE2012DE023F10" unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockParOrStatedValuePerShare contextRef="FI2018Q1" decimals="INF" id="Fact-6CC820502C3D80FCD1BB2012DE022202" unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2017Q4" decimals="INF" id="Fact-8274D49168AB33B6447E2012DE02B134" unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesAuthorized contextRef="FI2018Q1" decimals="INF" id="Fact-B8EC51E3806D5D61EA952012DE020EFE" unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
	<us-gaap:CommonStockSharesIssued contextRef="FI2017Q4" decimals="-3" id="Fact-86E6D3706522D9A5CABB2012DE02CCBB" unitRef="shares">287853000</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockSharesIssued contextRef="FI2018Q1" decimals="-3" id="Fact-6D2F95487F107ACC669B2012DE024818" unitRef="shares">288750000</us-gaap:CommonStockSharesIssued>
	<us-gaap:CommonStockValue contextRef="FI2017Q4" decimals="-5" id="Fact-36E957A69C54C90B5AF32012DE025619" unitRef="usd">2900000</us-gaap:CommonStockValue>
	<us-gaap:CommonStockValue contextRef="FI2018Q1" decimals="-5" id="Fact-6FADBC985C1DAD0558BB2012DE0206E0" unitRef="usd">2900000</us-gaap:CommonStockValue>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2017Q1QTD" decimals="-5" id="Fact-936239F03025C84163B72012DE0203A9" unitRef="usd">76000000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ComprehensiveIncomeNetOfTax contextRef="FD2018Q1YTD" decimals="-5" id="Fact-58C9C5DBC5447B2B737D2012DE026DDD" unitRef="usd">411200000</us-gaap:ComprehensiveIncomeNetOfTax>
	<us-gaap:ConvertibleDebtFairValueDisclosures contextRef="FI2018Q1" decimals="-5" id="Fact-00930C58DA1D46F28B782012DE021BC5" unitRef="usd">285100000</us-gaap:ConvertibleDebtFairValueDisclosures>
	<us-gaap:ConvertibleDebtFairValueDisclosures contextRef="FI2018Q1_us-gaap_FinancialInstrumentAxis_holx_TwoThousandAndThirteenNotesMember" decimals="-5" id="Fact-5A71DF8A4BE057D836AE2012DE025AE0" unitRef="usd">300000</us-gaap:ConvertibleDebtFairValueDisclosures>
	<us-gaap:ConvertibleDebtFairValueDisclosures contextRef="FI2018Q1_us-gaap_FinancialInstrumentAxis_holx_TwoThousandAndTwelveNotesMember" decimals="-5" id="Fact-08924F915FEB7CAA7F822012DE026F4B" unitRef="usd">284800000</us-gaap:ConvertibleDebtFairValueDisclosures>
	<us-gaap:ConvertibleNotesPayableCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-B9BEC45353B52E3D40652012DE025B79" unitRef="usd">484500000</us-gaap:ConvertibleNotesPayableCurrent>
	<us-gaap:ConvertibleNotesPayableCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-B08E12615E124140C4292012DE02AA25" unitRef="usd">205400000</us-gaap:ConvertibleNotesPayableCurrent>
	<us-gaap:CostOfGoodsSold contextRef="FD2017Q1QTD" decimals="-5" id="Fact-BD8A6370228F91FAD0212012DE02F7FD" unitRef="usd">198300000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSold contextRef="FD2018Q1YTD" decimals="-5" id="Fact-75D039336F97BF0BD7CB2012DE0201C8" unitRef="usd">213700000</us-gaap:CostOfGoodsSold>
	<us-gaap:CostOfGoodsSoldAmortization contextRef="FD2017Q1QTD" decimals="-5" id="Fact-44B500244FCED9250DDE2012DE02EE2A" unitRef="usd">73500000</us-gaap:CostOfGoodsSoldAmortization>
	<us-gaap:CostOfGoodsSoldAmortization contextRef="FD2018Q1YTD" decimals="-5" id="Fact-65313F0C57089694092C2012DE02F7BA" unitRef="usd">79800000</us-gaap:CostOfGoodsSoldAmortization>
	<us-gaap:CostOfServices contextRef="FD2017Q1QTD" decimals="-5" id="Fact-96D5A7718315E996CA372012DE02F8DF" unitRef="usd">57800000</us-gaap:CostOfServices>
	<us-gaap:CostOfServices contextRef="FD2018Q1YTD" decimals="-5" id="Fact-159FAC66BAA3BA04CEDA2012DE028B88" unitRef="usd">73100000</us-gaap:CostOfServices>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedRevolverMember_us-gaap_DebtSecurityAxis_holx_PercentageAddedtoEurodollarRateMember" decimals="INF" id="Fact-EE3BB685EC95EEE09D03521F56B7FD3C" unitRef="number">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedTermLoanMember_us-gaap_DebtSecurityAxis_holx_PercentageAddedtoEurodollarRateMember" decimals="INF" id="Fact-6B0854A2122D6E917118521C9B376CAB" unitRef="number">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
	<us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_TwoThousandAndTwelveNotesMember" decimals="INF" id="Fact-2C551B6ECC735B2DFAAC2012DE026AE8" unitRef="usdPerShare">31.175</us-gaap:DebtInstrumentConvertibleConversionPrice1>
	<us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="D2018Q1Dec29-Dec29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-903424BA32E58A2DB11951F6152349D1" unitRef="usd">282600000.0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
	<us-gaap:DebtInstrumentFaceAmount contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember" decimals="-5" id="Fact-7255E2A157285ED478182012DE0252F7" unitRef="usd">39300000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_A2043NotesMember" decimals="-5" id="Fact-009EC8C9D67F7899EA924E0A860A10AF" unitRef="usd">300000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="-6" id="Fact-9F2BD33D94B3CACAC5404DD970E97D9A" unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2022NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-8" id="Fact-B0E153AE02E11456534B4D46091A8F7C" unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-6" id="Fact-9D5AD9E7F9A8FDBA3D6A4D3D664ABF19" unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-6" id="Fact-887B73D269744F10B3F64D4522E03F13" unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2025SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-5" id="Fact-A42D73C0591114DB7F1E4E30072F6179" unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-57ACC9897A65FDDB09EF4E3707485368" unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1SD_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-5" id="Fact-5F37C7D1046EC1C9E02B4E341016127F" unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFaceAmount contextRef="I2018Q1SD_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-8" id="Fact-E86D44F7B16100DA46F04D3B6D265432" unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember" decimals="-5" id="Fact-B0A84C5C2812A3B5C47843B5B2F77C64" unitRef="usd">358600000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentFairValue contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_us-gaap_SeniorNotesMember" decimals="-8" id="Fact-F746655EE1D81140CCAE2012DE02FE18" unitRef="usd">1100000000</us-gaap:DebtInstrumentFairValue>
	<us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember" decimals="5" id="Fact-D349F4186FC246270BCB4D4156185823" unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
	<us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_holx_A2022NotesMember" decimals="INF" id="Fact-440CA8B99B58B565B2B54D59BB3C6317" unitRef="number">0.0525</us-gaap:DebtInstrumentInterestRateDuringPeriod>
	<us-gaap:DebtInstrumentInterestRateDuringPeriod contextRef="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember" decimals="INF" id="Fact-AD84628325B49DF049834E0F141D004B" unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember" decimals="INF" id="Fact-20D5743D1637723A227B51E427775E75" unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2017Q1Dec1617_us-gaap_DebtInstrumentAxis_holx_TwoThousandAndTwelveNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember" decimals="INF" id="Fact-8D4B573EFE1A6162C2392012DE02A87F" unitRef="number">0.02</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2018Q1Jan29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleDebtMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-2B4F1E588FCF3E3A012B51E8CF89D0F5" unitRef="number">0.02</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2018Q1Jan29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-507622B0A8B6FE1397AD4D5F63D67ECB" unitRef="number">0.02</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2018Q1Oct10_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-FF531CD47CA311F21C4E4DDD88AAD433" unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-57C471CB8574941FE6484DF7FB45A2FA" unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="5" id="Fact-F218C4AD6C4C410884394D4CA1FEE5D1" unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="I2018Q1SD_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-7C3A3E2C35C49B50A45E4E352C0AD8B9" unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
	<us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_holx_AmendedTermLoanMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="-5" id="Fact-4D1336C1053030F50F00522DF9BB9716" unitRef="usd">37500000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
	<us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember_us-gaap_LongtermDebtTypeAxis_holx_AmendedTermLoanMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="-3" id="Fact-33F870E18F2A143194E1522B1A839AA1" unitRef="usd">9375000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
	<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="D2018Q2Jan19-Jan19_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-6FE809C3D90951233F8F52B3FD549FB6" unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
	<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="D2018Q2Jan19-Jan19_us-gaap_LongtermDebtTypeAxis_holx_A2028SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-B3517B6073A50C34A62451E5FDD9F886" unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
	<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="D2018Q2Jan29-Jan29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-867C3D720041841618B64D63F07EC51C" unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
	<us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember" decimals="INF" id="Fact-FD2E461D79A2341B1E344DE8C6C8EF76" unitRef="number">0.35</us-gaap:DebtInstrumentRedemptionPricePercentage>
	<us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="D2018Q2Jan19-Jan19_us-gaap_DebtInstrumentAxis_holx_A2028SeniorNotesMember_us-gaap_LongtermDebtTypeAxis_us-gaap_SeniorNotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="INF" id="Fact-09B4DC4F94CCFC9518445298E8DD4932" unitRef="number">0.35</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
	<us-gaap:DebtInstrumentRepurchaseAmount contextRef="FI2018Q1_us-gaap_DebtInstrumentAxis_holx_A2043NotesMember" decimals="-5" id="Fact-E51DFE46F0CE11EF6C984E0DEA31085C" unitRef="usd">201700000</us-gaap:DebtInstrumentRepurchaseAmount>
	<us-gaap:DebtInstrumentRepurchaseAmount contextRef="I2018Q1Jan29_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-5" id="Fact-6E16B6F8F340B971239652AC648EB170" unitRef="usd">206000000</us-gaap:DebtInstrumentRepurchaseAmount>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2017Q1QTD" decimals="-5" id="Fact-7371A983C3EE384060C82012DE021C28" unitRef="usd">-24600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-C01265C44C36A542B8E42012DE02F23F" unitRef="usd">-390700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
	<us-gaap:DeferredRevenueCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-5AC6B8E80F96875A4AA82012DE020DBA" unitRef="usd">171200000</us-gaap:DeferredRevenueCurrent>
	<us-gaap:DeferredRevenueCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-8EA7912CDBE99DA349782012DE02DA05" unitRef="usd">163200000</us-gaap:DeferredRevenueCurrent>
	<us-gaap:DeferredRevenueNoncurrent contextRef="FI2017Q4" decimals="-5" id="Fact-A4C2225FC544411E36792012DE02E59A" unitRef="usd">20800000</us-gaap:DeferredRevenueNoncurrent>
	<us-gaap:DeferredRevenueNoncurrent contextRef="FI2018Q1" decimals="-5" id="Fact-2031E279C7D0DB0108E02012DE02C48A" unitRef="usd">18800000</us-gaap:DeferredRevenueNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2017Q4" decimals="-5" id="Fact-C949735301D97329BE102012DE02303A" unitRef="usd">973600000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:DeferredTaxLiabilitiesNoncurrent contextRef="FI2018Q1" decimals="-5" id="Fact-653DAC03940A7D363A562012DE02452F" unitRef="usd">586400000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
	<us-gaap:Depreciation contextRef="FD2017Q1QTD" decimals="-5" id="Fact-2F377D91E899C80BE6212012DE02965D" unitRef="usd">20400000</us-gaap:Depreciation>
	<us-gaap:Depreciation contextRef="FD2018Q1YTD" decimals="-5" id="Fact-8BEB40742AF9AF45ED2E2012DE022016" unitRef="usd">27000000</us-gaap:Depreciation>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2017Q1QTD" decimals="-5" id="Fact-1146DBC4BD704AC4AB162012DE024F07" unitRef="usd">115300000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-1D4B2C9F93155D6386FD2012DE027F4E" unitRef="usd">5100000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-7EA76DA2E4FBD052B4F42012DE02EAFB" unitRef="usd">84900000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-0604386FC35ED8B78AFE2012DE02E79A" unitRef="usd">25100000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-B935A22E5090C29F87DC2012DE02D65B" unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-40B1362B0022F28BB97E2012DE02C81F" unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-0D6AE43ADE39CBFC010A2012DE0245A7" unitRef="usd">4900000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-BC7D82AD5154112F827D2012DE0260F7" unitRef="usd">64700000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-9317F533CC57389A20D42012DE027F43" unitRef="usd">22900000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-4D4448476231D57450A32012DE026C23" unitRef="usd">28500000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-0F14625CF849620A3C6B2012DE0271D5" unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DepreciationAmortizationAndAccretionNet contextRef="FD2018Q1YTD" decimals="-5" id="Fact-39CB0AB73C6539607EC22012DE0204A9" unitRef="usd">121200000</us-gaap:DepreciationAmortizationAndAccretionNet>
	<us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred contextRef="FD2018Q1YTD" decimals="-5" id="Fact-60623183F1895DD3CF602012DE0200F4" unitRef="usd">1900000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="FD2017Q1QTD" decimals="-5" id="Fact-880279AEB168857CEC4F2012DE02A8AB" unitRef="usd">700000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="FD2017Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateCapMember" decimals="-5" id="Fact-52056724F384286C8B842012DE0239ED" unitRef="usd">700000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-F69333E0F70E9B385D3C2012DE02EA92" unitRef="usd">700000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-228BD03DA90DC999EEF42012DE029C70" unitRef="usd">-4300000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
	<us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet contextRef="FD2018Q1YTD" decimals="-5" id="Fact-A96C42E0DBB29992CCBF2012DE02E417" unitRef="usd">-4300000</us-gaap:DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet>
	<us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-5" id="Fact-DA2DF0102C8513D6C5182E994E45D510" unitRef="usd">28600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
	<us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="FD2017Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-5" id="Fact-25F85926269BCAFE10052E912EE34AD0" unitRef="usd">65200000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
	<us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue contextRef="FD2018Q1QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-5" id="Fact-C59C4721B7C07787638A2E91D869AE69" unitRef="usd">12600000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
	<us-gaap:EarningsPerShareBasic contextRef="FD2017Q1QTD" decimals="2" id="Fact-54BC5F4755EEA55E309E2012DE02F12D" unitRef="usdPerShare">0.31</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareBasic contextRef="FD2018Q1YTD" decimals="2" id="Fact-6A392201E44242D4AB2C2012DE022717" unitRef="usdPerShare">1.47</us-gaap:EarningsPerShareBasic>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2017Q1QTD" decimals="2" id="Fact-EF0ACD3AA5D83328124C2012DE0293E5" unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EarningsPerShareDiluted contextRef="FD2018Q1YTD" decimals="2" id="Fact-EA4505F52F1D6322E58F2012DE027D6F" unitRef="usdPerShare">1.45</us-gaap:EarningsPerShareDiluted>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2017Q1QTD" decimals="-5" id="Fact-1B0F774F822D1BA342412012DE02E929" unitRef="usd">-6400000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents contextRef="FD2018Q1YTD" decimals="-5" id="Fact-2FD154D88EDA8D9938812012DE02B7E6" unitRef="usd">1200000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2017Q1QTD" decimals="3" id="Fact-BD5DA108736D6E353FBE2012DE022D4B" unitRef="number">0.255</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="FD2018Q1YTD" decimals="3" id="Fact-C4D9D54D99570598E52D2012DE023A05" unitRef="number">-3.245</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
	<us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="FD2018Q4YTD_us-gaap_StatementScenarioAxis_us-gaap_ScenarioForecastMember" decimals="3" id="Fact-F57F11289FD15FBA24C757111A929B50" unitRef="number">0.245</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-5" id="Fact-C07027AF4DB1D8347CC32012DE02BFF7" unitRef="usd">37000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-5" id="Fact-3E9F191F681F920746852012DE023099" unitRef="usd">98400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" id="Fact-CC4109E3CB75221D27402012DE026AE4">P3Y1M22D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" id="Fact-4496C8940EDFC9A12E402012DE0232D2">P2Y1M22D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
	<us-gaap:FairValueInputsDiscountRate contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-9C74F918F450CEE58A732012DE0235AC" unitRef="number">0.22</us-gaap:FairValueInputsDiscountRate>
	<us-gaap:FairValueInputsDiscountRate contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="INF" id="Fact-7A2753F52D886E8C6D122012DE02DAA1" unitRef="number">0.14</us-gaap:FairValueInputsDiscountRate>
	<us-gaap:FairValueInputsDiscountRate contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_us-gaap_RangeAxis_us-gaap_MaximumMember" decimals="INF" id="Fact-7B9805D25EB20F410CA82012DE02D808" unitRef="number">0.12</us-gaap:FairValueInputsDiscountRate>
	<us-gaap:FairValueInputsDiscountRate contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember_us-gaap_RangeAxis_us-gaap_MinimumMember" decimals="INF" id="Fact-126C96A58796C8A0A64C2012DE02BB1A" unitRef="number">0.11</us-gaap:FairValueInputsDiscountRate>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1" decimals="-5" id="Fact-4A9DD065EAE33B26CD122012DE02B7AE" unitRef="usd">52300000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" decimals="-5" id="Fact-288A5CC4A938B9C5AC4D2012DE02BEC1" unitRef="usd">49700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember" decimals="-5" id="Fact-F7E1438C262036C1791B2012DE021CCE" unitRef="usd">49700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" decimals="-5" id="Fact-CF15ADA41336ABB27E832012DE0260C2" unitRef="usd">2600000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember" decimals="-5" id="Fact-0C469B554AC287FD94272012DE028BAA" unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="-5" id="Fact-2E9293FD1044648148312012DE0264A7" unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember" decimals="-5" id="Fact-7CD0871415B687E645822012DE02D5D9" unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations contextRef="FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_DeferredCompensationShareBasedPaymentsMember" decimals="-5" id="Fact-5DBE278156A4AA94E1592012DE021306" unitRef="usd">49700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4" decimals="-5" id="Fact-FF87BA1F20C14CCBC7C12012DE02F2B0" unitRef="usd">2790200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_AcquiredintangibleassetsMember" decimals="-5" id="Fact-D52AA191AEEF9FBB1ECD47BA2C842307" unitRef="usd">2742100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_BusinessLicensesMember" decimals="-5" id="Fact-9A0943BCE58D475CAA152012DE0275F2" unitRef="usd">2200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CapitalizedsoftwareMember" decimals="-5" id="Fact-16FEAE09C69A564B528947B75EDAFCDD" unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CustomerRelationshipsContractsMember" decimals="-5" id="Fact-57DEC0F96E498F7573062012DE0289A7" unitRef="usd">393800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DevelopedTechnologyMember" decimals="-5" id="Fact-64EA85717E749689DB972012DE027E80" unitRef="usd">2186800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember" decimals="-5" id="Fact-39B0AEE1BCA11716CEBE2012DE0282F3" unitRef="usd">2800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_InternalusesoftwareMember" decimals="-5" id="Fact-C9ED8E961DFAA943C0E947A42A49FF3D" unitRef="usd">46100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-C382E7F8C4BB4932180E2012DE02B2E4" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-5" id="Fact-F94167CD87A768D253912012DE02D5C2" unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-EC937D6887737717B0EC2012DE026862" unitRef="usd">156400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1" decimals="-5" id="Fact-E77803FD61626ABECB1F2012DE02D966" unitRef="usd">2887800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_AcquiredintangibleassetsMember" decimals="-5" id="Fact-4E2A0AEFA7BB17666D8747B99D98EF53" unitRef="usd">2837000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_BusinessLicensesMember" decimals="-5" id="Fact-F0DDCA6C8FBAD9FC5E292012DE022BC1" unitRef="usd">2200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CapitalizedsoftwareMember" decimals="-5" id="Fact-2B4E72629BA68D6F232E47B75EF70016" unitRef="usd">2600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CustomerRelationshipsContractsMember" decimals="-5" id="Fact-30951B914D63FE10AE542012DE02F200" unitRef="usd">402800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DevelopedTechnologyMember" decimals="-5" id="Fact-7651B1C0AE5E6D2F710C2012DE02DFD8" unitRef="usd">2266700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember" decimals="-5" id="Fact-BC609CF3527662D4AC022012DE0238F5" unitRef="usd">4100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_InternalusesoftwareMember" decimals="-5" id="Fact-FD4206AA8F33A4D1604D47A3F4948B82" unitRef="usd">48200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-4A10A3E4D84CBEBE7D602012DE02542D" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-5" id="Fact-24B604F3808197523FCB2012DE02135C" unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-868254634718E29505D22012DE02140D" unitRef="usd">161100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear contextRef="FI2018Q1" decimals="-5" id="Fact-4AB9545799829718F1B52012DE024407" unitRef="usd">283100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="FI2018Q1" decimals="-5" id="Fact-66890837508F75FBB9B92012DE020619" unitRef="usd">320300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="FI2018Q1" decimals="-5" id="Fact-5CC870DD2B8DFB11B8BF2012DE02F759" unitRef="usd">333200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="FI2018Q1" decimals="-5" id="Fact-4524D932904EA1B93DD72012DE027888" unitRef="usd">354800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
	<us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="FI2018Q1" decimals="-5" id="Fact-E82ADBCA452FFD3CA0332012DE020EFC" unitRef="usd">366000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4" decimals="-5" id="Fact-072B280FD67044C816CB2012DE025852" unitRef="usd">5562500000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_DevelopedTechnologyRightsMember" decimals="-5" id="Fact-8833237B0D7DD867EC392EB9EC1643A1" unitRef="usd">61000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_AcquiredintangibleassetsMember" decimals="-5" id="Fact-5179AB53E878C758981847B9D2A6BFCC" unitRef="usd">5483700000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_BusinessLicensesMember" decimals="-5" id="Fact-4890FCB4548353B692862012DE021A8C" unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CapitalizedsoftwareMember" decimals="-5" id="Fact-109B6EADCD9D825DEDD447B75EE85D2D" unitRef="usd">14300000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CustomerRelationshipsContractsMember" decimals="-5" id="Fact-0AD381061195037992D52012DE02CE5B" unitRef="usd">552800000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DevelopedTechnologyMember" decimals="-5" id="Fact-0A6E65729490D2A7661C2012DE02CDDB" unitRef="usd">4528700000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember" decimals="-5" id="Fact-F5EB6823CB78E1B8201B2012DE020961" unitRef="usd">42000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_InternalusesoftwareMember" decimals="-5" id="Fact-F3A53F590832A12EAF8C47A2DA452A3C" unitRef="usd">64500000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-697789CB5D53714089742012DE020D76" unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-5" id="Fact-0E6BD2FF34BED70FA2F32012DE02767F" unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2017Q4_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-1E8E0816FC87978B2F4E2012DE020CCF" unitRef="usd">310300000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1" decimals="-5" id="Fact-6F0226ED93E7F80DAF832012DE023AA4" unitRef="usd">5569100000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_AcquiredintangibleassetsMember" decimals="-5" id="Fact-2B6824044ABFC5DE316747B85D9F9EED" unitRef="usd">5487800000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_BusinessLicensesMember" decimals="-5" id="Fact-155A7F20BF0E7A58EBE42012DE02C08B" unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CapitalizedsoftwareMember" decimals="-5" id="Fact-BBD5FC9BE3AE30D3BCF947B75EEF8016" unitRef="usd">15500000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_CustomerRelationshipsContractsMember" decimals="-5" id="Fact-F820E219140F1FB392742012DE02D34E" unitRef="usd">556700000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DevelopedTechnologyMember" decimals="-5" id="Fact-C0070DE581B6506BE2702012DE02F2E0" unitRef="usd">4528800000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_DistributionagreementMember" decimals="-5" id="Fact-7FCCACAD1B347272E5592012DE0288F6" unitRef="usd">42000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_holx_InternalusesoftwareMember" decimals="-5" id="Fact-6672EBAA1DAD8CDA6FDE47A225EF1BA6" unitRef="usd">65800000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" decimals="-5" id="Fact-AA33567CFE03BEB5D5B92012DE0212D9" unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_NoncompeteAgreementsMember" decimals="-5" id="Fact-1657F961DBB872C1959E2012DE02F866" unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:FiniteLivedIntangibleAssetsGross contextRef="FI2018Q1_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_TradeNamesMember" decimals="-5" id="Fact-40CDB5B1F4A4948B6F082012DE020CA9" unitRef="usd">310300000</us-gaap:FiniteLivedIntangibleAssetsGross>
	<us-gaap:ForeignCurrencyContractAssetFairValueDisclosure contextRef="FI2018Q1_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember" decimals="-5" id="Fact-33FA1724CC8EB41BAB1A2012DE0250C2" unitRef="usd">400000</us-gaap:ForeignCurrencyContractAssetFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember" decimals="-5" id="Fact-29E5606CD5D499B2923D43BC968F98D8" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember" decimals="-5" id="Fact-095C09C0DD0A0731756C2012DE022B61" unitRef="usd">2600000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForwardContractsMember" decimals="-5" id="Fact-1444DFD7FBEA6A6A0A1B43BD262170BF" unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
	<us-gaap:FurnitureAndFixturesGross contextRef="FI2017Q4" decimals="-5" id="Fact-D934AE5405B21858E7982012DE02B88E" unitRef="usd">20800000</us-gaap:FurnitureAndFixturesGross>
	<us-gaap:FurnitureAndFixturesGross contextRef="FI2018Q1" decimals="-5" id="Fact-61C23055804CA13890542012DE02B2DF" unitRef="usd">21000000</us-gaap:FurnitureAndFixturesGross>
	<us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings contextRef="FD2017Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" decimals="-5" id="Fact-102A561254069907D79F2012DE025817" unitRef="usd">9600000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
	<us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings contextRef="FD2018Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeForwardMember" decimals="-5" id="Fact-FA4BFBB6CA190E2053892012DE02A148" unitRef="usd">1200000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
	<us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="FD2017Q1QTD" decimals="-5" id="Fact-34A4FBB932B492FD14EA2DA65C5C77AD" unitRef="usd">1200000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
	<us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments contextRef="FD2018Q1YTD" decimals="-5" id="Fact-FD7A3B114A2E34A5ABC32012DE0201D4" unitRef="usd">200000</us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments>
	<us-gaap:GainLossOnSaleOfBusiness contextRef="FD2017Q2QTD_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_holx_BloodScreeningBusinessMember" decimals="-5" id="Fact-7AE08DB1B426D915C2472012DE028879" unitRef="usd">899700000</us-gaap:GainLossOnSaleOfBusiness>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2017Q1QTD" decimals="-5" id="Fact-6F4CCE75CCE91744D1862012DE026816" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="-5" id="Fact-213F34442605C6E126794DD4016776A1" unitRef="usd">-1000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="FD2018Q1YTD" decimals="-5" id="Fact-9F20D4C3809CEC143A592012DE02D555" unitRef="usd">-1000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="FD2017Q1QTD" decimals="-5" id="Fact-6CEABA95543C46C8978C2012DE02F248" unitRef="usd">69800000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:GeneralAndAdministrativeExpense contextRef="FD2018Q1YTD" decimals="-5" id="Fact-190D11CC496C8949165C2012DE02723D" unitRef="usd">77900000</us-gaap:GeneralAndAdministrativeExpense>
	<us-gaap:Goodwill contextRef="FI2017Q3_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-003ABAFBC3122ABAEACC47AC4C4301A1" unitRef="usd">683500000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2017Q4" decimals="-5" id="Fact-EDD1999B2A627546206E2012DE02BF23" unitRef="usd">3171200000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q1" decimals="-5" id="Fact-017DDF1C5DBDF4623BDA2012DE02205E" unitRef="usd">3176700000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="FI2018Q1_us-gaap_BusinessAcquisitionAxis_holx_EmsorMember" decimals="-5" id="Fact-BA26BF27E1E049777F1D2ECFCCABE77B" unitRef="usd">3500000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-E945C012E81770C7342C2012DE023670" unitRef="usd">683500000</us-gaap:Goodwill>
	<us-gaap:Goodwill contextRef="I2017Q3Apr0717_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" decimals="-5" id="Fact-A7EE568650301421221A2012DE02F708" unitRef="usd">8900000</us-gaap:Goodwill>
	<us-gaap:GrossProfit contextRef="FD2017Q1QTD" decimals="-5" id="Fact-ED4A063FE55C6EB9B9152012DE0221D3" unitRef="usd">404800000</us-gaap:GrossProfit>
	<us-gaap:GrossProfit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-E4EF6FAA4784CC672ADD2012DE028275" unitRef="usd">424500000</us-gaap:GrossProfit>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2017Q1QTD" decimals="-5" id="Fact-FFDF182188D59B47A96E2012DE02E23E" unitRef="usd">116100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments contextRef="FD2018Q1YTD" decimals="-5" id="Fact-F97809E47FABC710FD612012DE021398" unitRef="usd">95800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
	<us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority contextRef="I2018Q2Jan31_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-5" id="Fact-844C95071D9FCBFD239556EFFA673242" unitRef="usd">11000000</us-gaap:IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2017Q1QTD" decimals="-5" id="Fact-26D68533390577C128DB2012DE023463" unitRef="usd">29600000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncomeTaxExpenseBenefit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-878850233FEC7601134D2012DE029E11" unitRef="usd">-310900000</us-gaap:IncomeTaxExpenseBenefit>
	<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="FD2017Q1QTD" decimals="-5" id="Fact-1E91294B95F4EBB5DC1A2012DE0285D7" unitRef="usd">-17800000</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsPayable contextRef="FD2018Q1YTD" decimals="-5" id="Fact-7179D407B0D0F1E1675B2012DE021D3D" unitRef="usd">-7100000</us-gaap:IncreaseDecreaseInAccountsPayable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2017Q1QTD" decimals="-5" id="Fact-F27B8A585D4F7E723B732012DE0244B9" unitRef="usd">-21500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="FD2018Q1YTD" decimals="-5" id="Fact-43E6D65545E142BC1E7A2012DE0253EF" unitRef="usd">6400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="FD2017Q1QTD" decimals="-5" id="Fact-D182DBD953785C3C97DA2012DE02E797" unitRef="usd">14600000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="FD2018Q1YTD" decimals="-5" id="Fact-E2675AC6BF9694DFE02F2012DE023E14" unitRef="usd">48900000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
	<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="FD2017Q1QTD" decimals="-5" id="Fact-3D1B8AB09F70D56F90A32012DE02B018" unitRef="usd">-14500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
	<us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="FD2018Q1YTD" decimals="-5" id="Fact-F7ADD1B515D02C1933222012DE02DE7E" unitRef="usd">-10600000</us-gaap:IncreaseDecreaseInDeferredRevenue>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2017Q1QTD" decimals="-5" id="Fact-17E8A4DD60FEECD6AFAC2012DE024F8B" unitRef="usd">20700000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInInventories contextRef="FD2018Q1YTD" decimals="-5" id="Fact-07BC77293014EA432E262012DE02C4DA" unitRef="usd">23300000</us-gaap:IncreaseDecreaseInInventories>
	<us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="FD2017Q1QTD" decimals="-5" id="Fact-FB1C5C4A45DDADD851872012DE02B40C" unitRef="usd">900000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
	<us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="FD2018Q1YTD" decimals="-5" id="Fact-6B65064FDD3DB1A079EC2012DE0268A3" unitRef="usd">400000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="FD2017Q1QTD" decimals="-5" id="Fact-E7A10AF9AA61B1E1C24C2012DE027B40" unitRef="usd">17400000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="FD2018Q1YTD" decimals="-5" id="Fact-C255288261618E2DB7CC2012DE023189" unitRef="usd">5000000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
	<us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="FD2017Q1QTD" decimals="-5" id="Fact-BE532D0220D8C1678E812012DE021C31" unitRef="usd">800000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
	<us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="FD2018Q1YTD" decimals="-5" id="Fact-692F383131492D7607772012DE02DE17" unitRef="usd">-8100000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2017Q1QTD" decimals="-3" id="Fact-D617F461FE2B2DED48B62012DE02D6C9" unitRef="shares">3143000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="FD2018Q1YTD" decimals="-3" id="Fact-1A5A119B2827A8EB7B102012DE020A06" unitRef="shares">2212000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2017Q4" decimals="-5" id="Fact-A6A6E6137A1B881FFD812012DE02B212" unitRef="usd">2772300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="FI2018Q1" decimals="-5" id="Fact-147336299E52BF444AAF2012DE02DD6E" unitRef="usd">2681300000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
	<us-gaap:InterestExpense contextRef="FD2017Q1QTD" decimals="-5" id="Fact-EB63BC06638CD743E9F82012DE026036" unitRef="usd">40400000</us-gaap:InterestExpense>
	<us-gaap:InterestExpense contextRef="FD2018Q1YTD" decimals="-5" id="Fact-D57623173A97451796DF2012DE0255F3" unitRef="usd">41000000</us-gaap:InterestExpense>
	<us-gaap:InterestExpenseDebt contextRef="FD2016Q3QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="-5" id="Fact-F6F1C2D372803AA2F58C2012DE02D71A" unitRef="usd">9800000</us-gaap:InterestExpenseDebt>
	<us-gaap:InterestExpenseDebt contextRef="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-AC27803EDB7F650B052D2012DE02B6CE" unitRef="usd">12000000</us-gaap:InterestExpenseDebt>
	<us-gaap:InterestExpenseDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2025SeniorNotesMember" decimals="-5" id="Fact-10D9A3664B1D4B9E20494E119886E1A0" unitRef="usd">3500000</us-gaap:InterestExpenseDebt>
	<us-gaap:InterestExpenseDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="-5" id="Fact-67D69D94FE349D7A4A4A2012DE026025" unitRef="usd">12400000</us-gaap:InterestExpenseDebt>
	<us-gaap:InterestExpenseDebt contextRef="FD2018Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-D908095D0ABB59E006D02012DE02B647" unitRef="usd">5700000</us-gaap:InterestExpenseDebt>
	<us-gaap:InterestExpenseDebt contextRef="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_holx_A2022NotesMember" decimals="-5" id="Fact-235E67F950C5F37358382012DE020345" unitRef="usd">14000000</us-gaap:InterestExpenseDebt>
	<us-gaap:InterestExpenseDebt contextRef="FD2018Q1YTD_us-gaap_DebtInstrumentAxis_us-gaap_SeniorNotesMember" decimals="-5" id="Fact-F0A4CE4BDD541912F2232012DE02DB6A" unitRef="usd">15100000</us-gaap:InterestExpenseDebt>
	<us-gaap:InterestExpenseDebtExcludingAmortization contextRef="FD2017Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-3DBDBE1966FDF979F2502012DE02D5A3" unitRef="usd">2000000</us-gaap:InterestExpenseDebtExcludingAmortization>
	<us-gaap:InterestExpenseDebtExcludingAmortization contextRef="FD2018Q1QTD_us-gaap_LongtermDebtTypeAxis_us-gaap_ConvertibleNotesPayableMember" decimals="-5" id="Fact-5591B6EFBB95F436D45F2012DE02F056" unitRef="usd">1100000</us-gaap:InterestExpenseDebtExcludingAmortization>
	<us-gaap:InterestRateCashFlowHedgeAssetAtFairValue contextRef="FI2017Q4" decimals="-5" id="Fact-90E630CFE83C8308DF352012DE026ACD" unitRef="usd">4800000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
	<us-gaap:InterestRateCashFlowHedgeAssetAtFairValue contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_InterestRateCapMember" decimals="-5" id="Fact-B42F553E5A0577AEE5152012DE02AAA5" unitRef="usd">5300000</us-gaap:InterestRateCashFlowHedgeAssetAtFairValue>
	<us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="FI2017Q4" decimals="-5" id="Fact-137F35D8196A45C81B9C2012DE023CE1" unitRef="usd">190900000</us-gaap:InventoryFinishedGoodsNetOfReserves>
	<us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="FI2018Q1" decimals="-5" id="Fact-DED49BE0BF1F8371F3702012DE02C848" unitRef="usd">199400000</us-gaap:InventoryFinishedGoodsNetOfReserves>
	<us-gaap:InventoryNet contextRef="FI2017Q4" decimals="-5" id="Fact-D193984D5E1CC9C0CFE42012DE02F6E2" unitRef="usd">331600000</us-gaap:InventoryNet>
	<us-gaap:InventoryNet contextRef="FI2018Q1" decimals="-5" id="Fact-D2B9770D92587849D69E2012DE0270AE" unitRef="usd">358200000</us-gaap:InventoryNet>
	<us-gaap:InventoryRawMaterialsNetOfReserves contextRef="FI2017Q4" decimals="-5" id="Fact-6BAFE71E6F005B44C3C62012DE02D70A" unitRef="usd">95700000</us-gaap:InventoryRawMaterialsNetOfReserves>
	<us-gaap:InventoryRawMaterialsNetOfReserves contextRef="FI2018Q1" decimals="-5" id="Fact-640334A036C6C5908BA82012DE02B6D9" unitRef="usd">114200000</us-gaap:InventoryRawMaterialsNetOfReserves>
	<us-gaap:InventoryWorkInProcessNetOfReserves contextRef="FI2017Q4" decimals="-5" id="Fact-8C71EE36157312181DD12012DE02C0D1" unitRef="usd">45000000</us-gaap:InventoryWorkInProcessNetOfReserves>
	<us-gaap:InventoryWorkInProcessNetOfReserves contextRef="FI2018Q1" decimals="-5" id="Fact-37FF43FDCDDEDBC714542012DE0222C2" unitRef="usd">44600000</us-gaap:InventoryWorkInProcessNetOfReserves>
	<us-gaap:InvestmentIncomeInterest contextRef="FD2017Q1QTD" decimals="-5" id="Fact-A1F25D244366B888636A2012DE02377D" unitRef="usd">300000</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentIncomeInterest contextRef="FD2018Q1YTD" decimals="-5" id="Fact-A7613F0B65FBCC2D11812012DE027DBF" unitRef="usd">800000</us-gaap:InvestmentIncomeInterest>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1" decimals="-5" id="Fact-599A5364FFD2227515C52012DE0280DF" unitRef="usd">5700000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member" decimals="-5" id="Fact-62EE4DA2FFB59F4A87832012DE0255BF" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember" decimals="-5" id="Fact-8C9EAB3891978CF51A972012DE020D33" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel1Member_us-gaap_FinancialInstrumentAxis_us-gaap_InterestRateCapMember" decimals="-5" id="Fact-A40EA3F196B592FB87CD2012DE024620" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member" decimals="-5" id="Fact-589A82AACC9A479744392012DE025126" unitRef="usd">5700000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember" decimals="-5" id="Fact-C6ECBE2070FA26D6EF302012DE029B64" unitRef="usd">400000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FinancialInstrumentAxis_us-gaap_InterestRateCapMember" decimals="-5" id="Fact-B429E55E2E78A99332822012DE021E94" unitRef="usd">5300000</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member" decimals="-5" id="Fact-9C1E03CA84DD7FF6A25F2012DE027908" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_ForeignExchangeContractMember" decimals="-5" id="Fact-37A673D71A243B5BEB062012DE02D62E" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:InvestmentsFairValueDisclosure contextRef="FI2018Q1_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FinancialInstrumentAxis_us-gaap_InterestRateCapMember" decimals="-5" id="Fact-C56D5DE95420B8BCE1D02012DE023C0B" unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
	<us-gaap:Land contextRef="FI2017Q4" decimals="-5" id="Fact-4CD74F1A72D0F256E50B2012DE02929B" unitRef="usd">46300000</us-gaap:Land>
	<us-gaap:Land contextRef="FI2018Q1" decimals="-5" id="Fact-961F7F3C1FFF3E69C7E92012DE027258" unitRef="usd">46400000</us-gaap:Land>
	<us-gaap:LeaseholdImprovementsGross contextRef="FI2017Q4" decimals="-5" id="Fact-440D44BFB56A37ECDAC52012DE02D834" unitRef="usd">60600000</us-gaap:LeaseholdImprovementsGross>
	<us-gaap:LeaseholdImprovementsGross contextRef="FI2018Q1" decimals="-5" id="Fact-F74821C098037AE85C2E2012DE02773D" unitRef="usd">61100000</us-gaap:LeaseholdImprovementsGross>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2017Q4" decimals="-5" id="Fact-94B1C91ECE38FF3FD8B72012DE0230CC" unitRef="usd">7979600000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesAndStockholdersEquity contextRef="FI2018Q1" decimals="-5" id="Fact-281F0A61A081D64FA9FE2012DE028595" unitRef="usd">8048300000</us-gaap:LiabilitiesAndStockholdersEquity>
	<us-gaap:LiabilitiesCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-25B75469A05F194574DF2012DE026A43" unitRef="usd">1865500000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LiabilitiesCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-2D6509A83F28505AD6792012DE02BFEE" unitRef="usd">1309900000</us-gaap:LiabilitiesCurrent>
	<us-gaap:LineOfCreditFacilityInterestRateDuringPeriod contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="INF" id="Fact-3B5CA44C24EAE6521E592012DE023E6C" unitRef="number">0.03069</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2018Q1Oct03_us-gaap_DebtInstrumentAxis_holx_AmendedRevolverMember" decimals="-8" id="Fact-EA0D3732EAAD42FC53574E224F2D6794" unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="I2018Q1Oct03_us-gaap_DebtInstrumentAxis_holx_AmendedTermLoanMember_us-gaap_LongtermDebtTypeAxis_holx_SecuredTermLoanMember" decimals="-8" id="Fact-3DD6BCEAF2711F7C3E234E1ED5859E4B" unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
	<us-gaap:LinesOfCreditCurrent contextRef="I2018Q1Oct03_us-gaap_DebtInstrumentAxis_holx_AmendedRevolverMember" decimals="-6" id="Fact-CCDACF808141E5D2C6074E28E287E3B2" unitRef="usd">345000000</us-gaap:LinesOfCreditCurrent>
	<us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="FD2017Q2QTD" decimals="-5" id="Fact-D350924859302BA5F4CE2012DE02DF2F" unitRef="usd">8500000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
	<us-gaap:LitigationSettlementExpense contextRef="FD2017Q1QTD" decimals="-5" id="Fact-43EF4597E7ABC7E53E922012DE02C1D1" unitRef="usd">9200000</us-gaap:LitigationSettlementExpense>
	<us-gaap:LongTermDebt contextRef="FI2017Q4" decimals="-5" id="Fact-B149D8F86FA3A9F8F1812012DE026C2A" unitRef="usd">3322900000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebt contextRef="FI2018Q1" decimals="-5" id="Fact-5DC4A0F0C0B862420B122012DE026C19" unitRef="usd">3329800000</us-gaap:LongTermDebt>
	<us-gaap:LongTermDebtCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-D6B30E41CEA5F525D3A32012DE02CD0D" unitRef="usd">1150800000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_AccountsReceivableSecuritizationMember" decimals="-5" id="Fact-C77E8F6576D9852ACEED2012DE02F48E" unitRef="usd">200000000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_RevolverMember" decimals="-5" id="Fact-6BE5B839739BC8DD79CC2012DE0229A5" unitRef="usd">345000000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2017Q4_us-gaap_LongtermDebtTypeAxis_holx_TermLoanMember" decimals="-5" id="Fact-076DEC280E62113F03A82012DE0227B7" unitRef="usd">121300000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-6BA327D275066B3CFB052012DE024FCE" unitRef="usd">572100000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_AccountsReceivableSecuritizationMember" decimals="-5" id="Fact-4020AA98A7C3FAA479432012DE022D34" unitRef="usd">200000000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_RevolverMember" decimals="-5" id="Fact-DB8BA3BEDDB86ADF8E992012DE02BDCB" unitRef="usd">120000000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtCurrent contextRef="FI2018Q1_us-gaap_LongtermDebtTypeAxis_holx_TermLoanMember" decimals="-5" id="Fact-2FF9FD5F7491F56DEB8F2012DE024E91" unitRef="usd">46700000</us-gaap:LongTermDebtCurrent>
	<us-gaap:LongTermDebtNoncurrent contextRef="FI2017Q4" decimals="-5" id="Fact-6334C6F17BA0013BD8F82012DE021477" unitRef="usd">2172100000</us-gaap:LongTermDebtNoncurrent>
	<us-gaap:LongTermDebtNoncurrent contextRef="FI2018Q1" decimals="-5" id="Fact-DDF5BD781621A626241C2012DE02232B" unitRef="usd">2757700000</us-gaap:LongTermDebtNoncurrent>
	<us-gaap:MarketableSecuritiesUnrealizedGainLoss contextRef="FD2017Q1QTD" decimals="-5" id="Fact-91A23536D87557C33E38485D79B7054A" unitRef="usd">4000000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2017Q1QTD" decimals="-5" id="Fact-CA85D804EBE5097225462012DE02048B" unitRef="usd">-40400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="FD2018Q1YTD" decimals="-5" id="Fact-759745D1C4F9D48BDCC82012DE02E3E6" unitRef="usd">-20300000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2017Q1QTD" decimals="-5" id="Fact-F2D6396F9A302FE03D282012DE028765" unitRef="usd">-25200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="FD2018Q1YTD" decimals="-5" id="Fact-FF0856852620288CE4262012DE029D52" unitRef="usd">-26200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2017Q1QTD" decimals="-5" id="Fact-6A99581E7A46CB6343FA2012DE024DC1" unitRef="usd">169600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="FD2018Q1YTD" decimals="-5" id="Fact-F7E1974B01C6DBA9BD462012DE02A99E" unitRef="usd">169100000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
	<us-gaap:NetIncomeLoss contextRef="FD2017Q1QTD" decimals="-5" id="Fact-C4D48C513D4C9D38F5022012DE02F546" unitRef="usd">86500000</us-gaap:NetIncomeLoss>
	<us-gaap:NetIncomeLoss contextRef="FD2018Q1YTD" decimals="-5" id="Fact-BE67C931051485B391842012DE02F168" unitRef="usd">406700000</us-gaap:NetIncomeLoss>
	<us-gaap:NumberOfOperatingSegments contextRef="FD2018Q1YTD" decimals="INF" id="Fact-5DFC422DD09C671209BC2012DE02C9A1" unitRef="Segment">5</us-gaap:NumberOfOperatingSegments>
	<us-gaap:NumberOfReportableSegments contextRef="FD2018Q1YTD" decimals="INF" id="Fact-549F11789A7590866AF12012DE02420B" unitRef="Segment">5</us-gaap:NumberOfReportableSegments>
	<us-gaap:NumberOfReportingUnits contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="INF" id="Fact-5EB7A61B82449B7127C171616685CD77" unitRef="unit">1</us-gaap:NumberOfReportingUnits>
	<us-gaap:OperatingExpenses contextRef="FD2017Q1QTD" decimals="-5" id="Fact-965F00399E784FF7E42A2012DE0215D6" unitRef="usd">258800000</us-gaap:OperatingExpenses>
	<us-gaap:OperatingExpenses contextRef="FD2018Q1YTD" decimals="-5" id="Fact-01B751B2E38A8C3EF2172012DE023D83" unitRef="usd">290400000</us-gaap:OperatingExpenses>
	<us-gaap:OperatingIncomeLoss contextRef="D2017Q3_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-E744CB999F97BA9E16572012DE0246B1" unitRef="usd">96400000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD" decimals="-5" id="Fact-7FE6814C306105DA87F42012DE0218AB" unitRef="usd">146000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-7846BB73F65AB1C48FE82012DE02ABBE" unitRef="usd">85200000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-09761AAD524F4A9D82292012DE02B1A6" unitRef="usd">41100000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-45162B9C288D97273F292012DE0237B3" unitRef="usd">25500000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-51799316C517517B01182012DE02766D" unitRef="usd">0</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-750E8BA7DEB75C08683A2012DE02EEC5" unitRef="usd">-5800000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-F3B038EEC4BA6865C4E42012DE02351C" unitRef="usd">89700000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-F143B5BD7EB581D5DEEA2012DE02A4B7" unitRef="usd">36500000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-77A24616A002B1CFE8CB2012DE02BD59" unitRef="usd">30200000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-BEDC25D9D00C9300C5112012DE02A82C" unitRef="usd">-23000000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-2C012393514D64DE5DC62012DE02962B" unitRef="usd">700000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OperatingIncomeLoss contextRef="FD2018Q1YTD" decimals="-5" id="Fact-1C33D087E5C35E78A42A2012DE022820" unitRef="usd">134100000</us-gaap:OperatingIncomeLoss>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2017Q4" decimals="-5" id="Fact-880AA578C3DCBD0A00BC2012DE0244AB" unitRef="usd">84700000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherAssetsNoncurrent contextRef="FI2018Q1" decimals="-5" id="Fact-5B6FE638D1452A4FBFAB2012DE024F17" unitRef="usd">84800000</us-gaap:OtherAssetsNoncurrent>
	<us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="FD2017Q1QTD" decimals="-5" id="Fact-0097C3EDA2F44477B71A2012DE026C54" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-AD51FFB3F7A4E3DA2F202012DE0215AC" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent contextRef="FD2018Q1YTD" decimals="-5" id="Fact-B35F2F9FC84514ADED452E43B8088303" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent contextRef="FD2017Q1QTD" decimals="-5" id="Fact-E37063865B889B29E38157447E43C4C7" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent contextRef="FD2018Q1YTD" decimals="-5" id="Fact-E725AC4C925E802BA32257447C3ABF63" unitRef="usd">-600000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="FD2017Q1QTD" decimals="-5" id="Fact-EFC85D4C91507AD6A5932012DE02631F" unitRef="usd">-15700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-4C681C5AB595D44EE1822012DE020E7A" unitRef="usd">-15700000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-24D8B8D185EEE29D85AD2012DE02775E" unitRef="usd">5500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="FD2018Q1YTD" decimals="-5" id="Fact-F41CB69E884B1A1163442012DE0208B4" unitRef="usd">5500000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2017Q1QTD" decimals="-5" id="Fact-0BBF1E0DD5583942AA942012DE0270D9" unitRef="usd">2300000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-8CDCD05D9D025B25B0C72012DE02C887" unitRef="usd">2300000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-E92EC6BEDEA706BA798A2012DE02F1D3" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="FD2018Q1YTD" decimals="-5" id="Fact-F4A23BDF593B262744D22012DE024B10" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-C7D4AA8F5D1390A1FE082012DE02F18C" unitRef="usd">12700000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
	<us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-945017184769BE1067A02012DE02CCE5" unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2017Q1QTD" decimals="-5" id="Fact-642C8AD6E31E1D2BC0602012DE02D004" unitRef="usd">500000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax contextRef="FD2018Q1YTD" decimals="-5" id="Fact-C7830A296D6F384DBE6B2012DE0200EA" unitRef="usd">-4900000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2017Q1QTD" decimals="-5" id="Fact-F36F23112FCD8993A7202012DE02C557" unitRef="usd">-10500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="FD2018Q1YTD" decimals="-5" id="Fact-D58C4903D8918A50C3752012DE028F03" unitRef="usd">4500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="FD2017Q1QTD" decimals="-5" id="Fact-00CB3B31549814C337262012DE023269" unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax contextRef="FD2018Q1YTD" decimals="-5" id="Fact-5C12E15B37AE8A96D6D32012DE02A103" unitRef="usd">-400000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax contextRef="FD2017Q1QTD" decimals="-5" id="Fact-DA9A552BEF411B60536D2012DE02C6BA" unitRef="usd">-2100000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax contextRef="FD2018Q1YTD" decimals="-5" id="Fact-7ACF71BBBDEAA722D0992012DE020445" unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax contextRef="FD2017Q1QTD" decimals="-5" id="Fact-6D5DC9E3A19EE95367812012DE028F86" unitRef="usd">1500000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
	<us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax contextRef="FD2018Q1YTD" decimals="-5" id="Fact-2597CE7A392A06BDDA5A2012DE0285C8" unitRef="usd">200000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2017Q4" decimals="-5" id="Fact-CBFCA04D67A5AF004A6D2012DE02A8F7" unitRef="usd">140200000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherLiabilitiesNoncurrent contextRef="FI2018Q1" decimals="-5" id="Fact-687A14FECE298AF94F692012DE02FF40" unitRef="usd">159200000</us-gaap:OtherLiabilitiesNoncurrent>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2017Q1QTD" decimals="-5" id="Fact-87F6CA1BF40B260CF9632012DE027F65" unitRef="usd">6000000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNoncashIncomeExpense contextRef="FD2018Q1YTD" decimals="-5" id="Fact-AD963B2473FF0BF7D4702012DE02430A" unitRef="usd">-1200000</us-gaap:OtherNoncashIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2017Q1QTD" decimals="-5" id="Fact-9063BE7EC91C61E8C45C2012DE02FD9D" unitRef="usd">10200000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:OtherNonoperatingIncomeExpense contextRef="FD2018Q1YTD" decimals="-5" id="Fact-C7CAEA3377C7A9D377F32012DE0243A5" unitRef="usd">2900000</us-gaap:OtherNonoperatingIncomeExpense>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2017Q1QTD" decimals="-5" id="Fact-9742F9E573A44F33FA102012DE02C704" unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedCreditAgreementMember" decimals="-5" id="Fact-94674529BEEEF06630B65239D7F26FF0" unitRef="usd">4900000</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsOfDebtIssuanceCosts contextRef="FD2018Q1YTD" decimals="-5" id="Fact-325F974F8CE136068DD32012DE02D39C" unitRef="usd">11900000</us-gaap:PaymentsOfDebtIssuanceCosts>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2017Q1Mar2217_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember_us-gaap_CounterpartyNameAxis_holx_CynosureShareholdersMember" decimals="-7" id="Fact-AC4DAAFBBF8C9B8C2A522012DE02B03F" unitRef="usd">1660000000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesGross contextRef="D2017Q2Apr7-Apr7_us-gaap_BusinessAcquisitionAxis_holx_MedicorMedicalSupplyMember" decimals="-5" id="Fact-F98D6101B5EF1037EA9C2012DE022285" unitRef="usd">19000000</us-gaap:PaymentsToAcquireBusinessesGross>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2017Q1QTD" decimals="-5" id="Fact-D7DBE5237C2319A0D3952012DE024DFF" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="FD2018Q1YTD" decimals="-5" id="Fact-23D3B958D6042363A3AC2012DE024AF9" unitRef="usd">4100000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2017Q1QTD" decimals="-5" id="Fact-6D191228DB92FB3851DD2012DE02DF25" unitRef="usd">24700000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-11FD5F891C4F83534A2C2012DE02E253" unitRef="usd">2200000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-5D033BC1F2321531CC962012DE0266DB" unitRef="usd">10300000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-F4BFBE757BFE6896DD742012DE02919A" unitRef="usd">4100000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-717C1E09658B1DA3ECF92012DE0291D4" unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-196E9681CAFE18AD1D482012DE024863" unitRef="usd">300000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember" decimals="-5" id="Fact-CDE857206E48464C64222012DE02EF0E" unitRef="usd">7800000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-1F613C665912DAF786AA2012DE02946E" unitRef="usd">3500000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-9AEB33E7B0C4E561B14B2012DE020059" unitRef="usd">11900000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-B710A62F8BDD16B685C62012DE026C19" unitRef="usd">2400000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-19DFAEB5226C910918F62012DE0219BD" unitRef="usd">1600000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-2335DDEB085A84E127072012DE02B6A6" unitRef="usd">700000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_us-gaap_CorporateMember" decimals="-5" id="Fact-1F532ADAB46981662D6B2012DE02B811" unitRef="usd">1700000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquireProductiveAssets contextRef="FD2018Q1YTD" decimals="-5" id="Fact-4D4D22E7B2678772796B2012DE02378C" unitRef="usd">21800000</us-gaap:PaymentsToAcquireProductiveAssets>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2017Q1QTD" decimals="-5" id="Fact-68A059FD88EB058A77942012DE02F94E" unitRef="usd">11500000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="FD2018Q1YTD" decimals="-5" id="Fact-C0CB2D904BAD52CF13E62012DE0271E2" unitRef="usd">10200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2017Q4" decimals="INF" id="Fact-17B4619945D0CCC1A73A2012DE029944" unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockParOrStatedValuePerShare contextRef="FI2018Q1" decimals="INF" id="Fact-63969BC6B58FF13368942012DE029145" unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2017Q4" decimals="INF" id="Fact-BBFAB9BD8C86A6D209162012DE028DA1" unitRef="shares">1623000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesAuthorized contextRef="FI2018Q1" decimals="INF" id="Fact-406A9C88E19F4BA60A4A2012DE0291CF" unitRef="shares">1623000</us-gaap:PreferredStockSharesAuthorized>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2017Q4" decimals="-3" id="Fact-4D2F2329313132368D0E2012DE02FC9F" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockSharesIssued contextRef="FI2018Q1" decimals="-3" id="Fact-C6D8AD2416D19041BEB22012DE021FBE" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
	<us-gaap:PreferredStockValue contextRef="FI2017Q4" decimals="-5" id="Fact-F0BE0F7BE766B8A537352012DE02A4F5" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:PreferredStockValue contextRef="FI2018Q1" decimals="-5" id="Fact-C5804AA07B43609152EE2012DE028177" unitRef="usd">0</us-gaap:PreferredStockValue>
	<us-gaap:PrepaidExpenseCurrent contextRef="FI2017Q4" decimals="-5" id="Fact-5CE915158ED61413321C2012DE02C39B" unitRef="usd">50500000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidExpenseCurrent contextRef="FI2018Q1" decimals="-5" id="Fact-E6ED369002BC3E51A7CA2012DE02C2BE" unitRef="usd">53500000</us-gaap:PrepaidExpenseCurrent>
	<us-gaap:PrepaidTaxes contextRef="FI2017Q4" decimals="-5" id="Fact-125BF9DDE3AADDEEB8942012DE02C936" unitRef="usd">22400000</us-gaap:PrepaidTaxes>
	<us-gaap:PrepaidTaxes contextRef="FI2018Q1" decimals="-5" id="Fact-178EF7BF57FA315978C12012DE02EADC" unitRef="usd">14300000</us-gaap:PrepaidTaxes>
	<us-gaap:ProceedsFromIssuanceOfDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_AmendedTermLoanMember" decimals="-8" id="Fact-4FBBC87D50BB644652DC5214422F1524" unitRef="usd">1800000000</us-gaap:ProceedsFromIssuanceOfDebt>
	<us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="FD2017Q1QTD" decimals="-5" id="Fact-A2361D4D50EF966A20882012DE028078" unitRef="usd">13200000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
	<us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions contextRef="FD2018Q1YTD" decimals="-5" id="Fact-ABB25A37B16881CABE8A2012DE021058" unitRef="usd">9500000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
	<us-gaap:ProceedsFromLinesOfCredit contextRef="FD2017Q1QTD" decimals="-5" id="Fact-50B58A282A94BB521C132012DE0224D2" unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
	<us-gaap:ProceedsFromLinesOfCredit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-87BD3545C97C3178E1972012DE024B20" unitRef="usd">495000000</us-gaap:ProceedsFromLinesOfCredit>
	<us-gaap:ProceedsFromNotesPayable contextRef="FD2017Q1QTD" decimals="-5" id="Fact-37A6083126EA3883ED452012DE021751" unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
	<us-gaap:ProceedsFromNotesPayable contextRef="FD2018Q1YTD" decimals="-5" id="Fact-E8925EC7C9D480646921296FA6791543" unitRef="usd">350000000</us-gaap:ProceedsFromNotesPayable>
	<us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt contextRef="FD2017Q1QTD" decimals="-5" id="Fact-F34A0C04106CAD445421296DF554AB29" unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
	<us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt contextRef="FD2018Q1YTD" decimals="-5" id="Fact-8211D794456CB02BD9FB296D8E4CAD53" unitRef="usd">1500000000</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
	<us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities contextRef="FD2017Q1QTD" decimals="-5" id="Fact-DD67A93C40574885CC462012DE02C88D" unitRef="usd">400000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
	<us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities contextRef="FD2018Q1YTD" decimals="-5" id="Fact-1F569368A696494CB1542012DE02EC09" unitRef="usd">100000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities>
	<us-gaap:ProductWarrantyAccrual contextRef="FI2016Q4" decimals="-5" id="Fact-9590603DA261BE88B2842012DE02FA6A" unitRef="usd">5000000</us-gaap:ProductWarrantyAccrual>
	<us-gaap:ProductWarrantyAccrual contextRef="FI2017Q1" decimals="-5" id="Fact-E03C88C7F8E5F41213B82012DE02F611" unitRef="usd">5900000</us-gaap:ProductWarrantyAccrual>
	<us-gaap:ProductWarrantyAccrual contextRef="FI2017Q4" decimals="-5" id="Fact-C6975256D84547FA03772012DE02E4FD" unitRef="usd">17000000</us-gaap:ProductWarrantyAccrual>
	<us-gaap:ProductWarrantyAccrual contextRef="FI2018Q1" decimals="-5" id="Fact-05CB4C2E47892D2FD7EB2012DE022445" unitRef="usd">16200000</us-gaap:ProductWarrantyAccrual>
	<us-gaap:ProductWarrantyAccrualPayments contextRef="FD2017Q1QTD" decimals="-5" id="Fact-B39FAB9A13BB56A084F92012DE0260CE" unitRef="usd">1700000</us-gaap:ProductWarrantyAccrualPayments>
	<us-gaap:ProductWarrantyAccrualPayments contextRef="FD2018Q1YTD" decimals="-5" id="Fact-AF7B200764ECE24AED102012DE02D0F0" unitRef="usd">5100000</us-gaap:ProductWarrantyAccrualPayments>
	<us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="FD2017Q1QTD" decimals="-5" id="Fact-2DB67DC5B4B0E4A90F6E2012DE0240B3" unitRef="usd">2600000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
	<us-gaap:ProductWarrantyAccrualWarrantiesIssued contextRef="FD2018Q1YTD" decimals="-5" id="Fact-BB417FA5105F97D051372012DE02F63E" unitRef="usd">4300000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2017Q4" decimals="-5" id="Fact-E71B487A03BFDCA60EC32012DE021647" unitRef="usd">1026300000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentGross contextRef="FI2018Q1" decimals="-5" id="Fact-3B825B451E4FC043D85D2012DE028CDC" unitRef="usd">1043900000</us-gaap:PropertyPlantAndEquipmentGross>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2017Q4" decimals="-5" id="Fact-08D478FF261A4E4D31412012DE020731" unitRef="usd">472800000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:PropertyPlantAndEquipmentNet contextRef="FI2018Q1" decimals="-5" id="Fact-10328A1F7EE4F47BA34A2012DE02CA3C" unitRef="usd">467100000</us-gaap:PropertyPlantAndEquipmentNet>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-86A23F6A151918E7733B2012DE0215FC" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-9FAC906F9CCB905D92A02012DE02BC29" unitRef="usd">-2100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-15A870D0FF4AAD803F752012DE029764" unitRef="usd">-100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-4ED8D209A20E097C81182012DE02D1F4" unitRef="usd">-2200000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2017Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-D892DCF6C063A3A5551C2012DE027EE5" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" decimals="-5" id="Fact-0C934C0399FF4D82CDD42012DE0219F3" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" decimals="-5" id="Fact-EA1153D3DAC2E39595852012DE026EB2" unitRef="usd">-2300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" decimals="-5" id="Fact-E00408D5CB7FED40442F2012DE02F993" unitRef="usd">-400000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" decimals="-5" id="Fact-DBCC69721F15D64012F12012DE023936" unitRef="usd">-2700000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="FD2018Q1QTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" decimals="-5" id="Fact-07119250073163C211372012DE02CD87" unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
	<us-gaap:RepaymentsOfAccountsReceivableSecuritization contextRef="FD2017Q1QTD" decimals="-5" id="Fact-E8F917450865630C805E2012DE0248FD" unitRef="usd">12000000</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
	<us-gaap:RepaymentsOfAccountsReceivableSecuritization contextRef="FD2018Q1YTD" decimals="-5" id="Fact-2F12CF4E49FC844815BC2012DE026239" unitRef="usd">0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
	<us-gaap:RepaymentsOfConvertibleDebt contextRef="FD2017Q1QTD" decimals="-5" id="Fact-EF8BCAFBDE5FEB6A6C542012DE025A88" unitRef="usd">6400000</us-gaap:RepaymentsOfConvertibleDebt>
	<us-gaap:RepaymentsOfConvertibleDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2042NotesMember" decimals="-5" id="Fact-F83404E5AFED050FDCC64E01F73B0042" unitRef="usd">52800000</us-gaap:RepaymentsOfConvertibleDebt>
	<us-gaap:RepaymentsOfConvertibleDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_A2043NotesMember" decimals="-5" id="Fact-6A4F79A84B45AEFA89294E03623F5870" unitRef="usd">244100000</us-gaap:RepaymentsOfConvertibleDebt>
	<us-gaap:RepaymentsOfConvertibleDebt contextRef="FD2018Q1YTD" decimals="-5" id="Fact-957908049D03388213E12012DE02E492" unitRef="usd">296900000</us-gaap:RepaymentsOfConvertibleDebt>
	<us-gaap:RepaymentsOfLinesOfCredit contextRef="FD2017Q1QTD" decimals="-5" id="Fact-12F929879BE4F4862ADB2012DE02DC13" unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
	<us-gaap:RepaymentsOfLinesOfCredit contextRef="FD2018Q1YTD" decimals="-5" id="Fact-DA1441C477B18DAB876A2012DE0229B4" unitRef="usd">720000000</us-gaap:RepaymentsOfLinesOfCredit>
	<us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="FD2017Q1QTD" decimals="-5" id="Fact-BF30771C9E9AA62FABF12012DE02F26F" unitRef="usd">0</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
	<us-gaap:RepaymentsOfLongTermCapitalLeaseObligations contextRef="FD2018Q1YTD" decimals="-5" id="Fact-0029111A8B0F8C27CF682012DE020F6A" unitRef="usd">400000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2017Q1QTD" decimals="-5" id="Fact-1ECFB1EF6363736612752012DE02246A" unitRef="usd">18800000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfLongTermDebt contextRef="FD2018Q1YTD" decimals="-5" id="Fact-807C1398165B00C08DD02012DE02D8DA" unitRef="usd">1331300000</us-gaap:RepaymentsOfLongTermDebt>
	<us-gaap:RepaymentsOfSecuredDebt contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="-7" id="Fact-C1EA1AA6FDDE95C4ECF25215891EC08D" unitRef="usd">1320000000</us-gaap:RepaymentsOfSecuredDebt>
	<us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount contextRef="FI2017Q3_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="INF" id="Fact-C3FDFFBBCF23BD8FAE3147A9C7CBA016" unitRef="number">0.02</us-gaap:ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="FD2017Q1QTD" decimals="-5" id="Fact-AE43B232FE1F88AF95FC2012DE023FD5" unitRef="usd">54400000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:ResearchAndDevelopmentExpense contextRef="FD2018Q1YTD" decimals="-5" id="Fact-5FEB59A4B21B026B2E432012DE021B97" unitRef="usd">54800000</us-gaap:ResearchAndDevelopmentExpense>
	<us-gaap:RestructuringCharges contextRef="FD2017Q1QTD" decimals="-5" id="Fact-0B651A18656108A915292012DE02E15B" unitRef="usd">3200000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringCharges contextRef="FD2018Q1YTD" decimals="-5" id="Fact-2C19BCFDF088585D69AE2012DE025688" unitRef="usd">3800000</us-gaap:RestructuringCharges>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-BE9C8132A0D1B25576352012DE0295D1" unitRef="usd">3700000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-90CA9C67ED2844567E7D2012DE02E3A9" unitRef="usd">7500000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-3061B8AF198F46F37F72488D6835CA08" unitRef="usd">0</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-75EA6670AF6AD0F3D9BE2012DE0205DB" unitRef="usd">300000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2017Q4_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwoThousandSeventeenMember" decimals="-5" id="Fact-5297F97E8CA585A7416C2012DE02905B" unitRef="usd">11500000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2016ActionsDomain_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-92DA757CC2D6B62DD9862012DE028D3F" unitRef="usd">3200000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2017ActionsMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-9B27F8050AE737A87B4B2012DE02C2CA" unitRef="usd">5200000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_holx_Fiscal2018ActionMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-C102B75396DB790DE36D488FB95D081D" unitRef="usd">1600000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringCostAndReserveAxis_us-gaap_OtherRestructuringMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-B417EC50AEB1BB0279682012DE028488" unitRef="usd">200000</us-gaap:RestructuringReserve>
	<us-gaap:RestructuringReserve contextRef="FI2018Q1_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember_us-gaap_RestructuringPlanAxis_holx_TwothousandeighteenMember" decimals="-5" id="Fact-542684289F4A22C4275F2012DE02E2DE" unitRef="usd">10200000</us-gaap:RestructuringReserve>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2017Q4" decimals="-5" id="Fact-5E6D172113E78B2DE0122012DE02024F" unitRef="usd">-2382700000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:RetainedEarningsAccumulatedDeficit contextRef="FI2018Q1" decimals="-5" id="Fact-63A8032F7021B40F8C472012DE0275FC" unitRef="usd">-1976000000</us-gaap:RetainedEarningsAccumulatedDeficit>
	<us-gaap:Revenues contextRef="D2017Q3_us-gaap_BusinessAcquisitionAxis_holx_CynosureMember" decimals="-5" id="Fact-30AF7C0CFC5E5D18B6432012DE02C4E8" unitRef="usd">207500000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD" decimals="-5" id="Fact-608495A3B4C13434F7722012DE0213F4" unitRef="usd">734400000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_IntersegmentEliminationMember" decimals="INF" id="Fact-C7ED98791B5B06B7FCB82012DE023FA1" unitRef="usd">0</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-E08749C4D80582B179652012DE02698F" unitRef="usd">273300000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-8BD126659BD02184F2A32012DE02CBA5" unitRef="usd">325400000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-B5949425BA64F43D8EFA2012DE026549" unitRef="usd">114800000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-FE82CCCC0D48E3486D542012DE0282C9" unitRef="usd">0</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2017Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-3E8D4CA60673DA2431212012DE02ADDB" unitRef="usd">20900000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_ConsolidationItemsAxis_us-gaap_IntersegmentEliminationMember" decimals="INF" id="Fact-5F1B057D1FDC8AF42B9B2012DE026631" unitRef="usd">0</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_BreastHealthMember" decimals="-5" id="Fact-11B55C77C06EC5693AFC2012DE02F55A" unitRef="usd">288000000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_DiagnosticsMember" decimals="-5" id="Fact-650EEA789B9F326D06D92012DE029CA4" unitRef="usd">284600000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_GynSurgicalMember" decimals="-5" id="Fact-C36850B6D30BB5945A112012DE02E19A" unitRef="usd">107500000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_MedicalAestheticsDomain" decimals="-5" id="Fact-6CBFCEE7F4857AA96DED2012DE023DD7" unitRef="usd">91300000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1QTD_us-gaap_StatementBusinessSegmentsAxis_holx_SkeletalHealthMember" decimals="-5" id="Fact-F8507E48C5C72FE8C9912012DE02A00A" unitRef="usd">19700000</us-gaap:Revenues>
	<us-gaap:Revenues contextRef="FD2018Q1YTD" decimals="-5" id="Fact-E4DB974CE7FBC2FA46DA2012DE0289C2" unitRef="usd">791100000</us-gaap:Revenues>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2017Q1QTD" decimals="-5" id="Fact-3349BC215C439EB318622012DE028A41" unitRef="usd">613400000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueGoodsNet contextRef="FD2018Q1YTD" decimals="-5" id="Fact-BD74488898526DD7557F2012DE02F786" unitRef="usd">650700000</us-gaap:SalesRevenueGoodsNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2017Q1QTD" decimals="-5" id="Fact-FA849F8948EF7880BAB82012DE024E95" unitRef="usd">121000000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SalesRevenueServicesNet contextRef="FD2018Q1YTD" decimals="-5" id="Fact-66D99ADB6C8DEEE7B4E12012DE022CF7" unitRef="usd">140400000</us-gaap:SalesRevenueServicesNet>
	<us-gaap:SegmentReportingDisclosureOfMajorCustomers contextRef="FD2017Q1QTD" id="Fact-5D2E092D96C2100163B82012DE02CA03">0</us-gaap:SegmentReportingDisclosureOfMajorCustomers>
	<us-gaap:SegmentReportingDisclosureOfMajorCustomers contextRef="FD2018Q1YTD" id="Fact-339452B475E352B29A112012DE028D35">0</us-gaap:SegmentReportingDisclosureOfMajorCustomers>
	<us-gaap:SellingAndMarketingExpense contextRef="FD2017Q1QTD" decimals="-5" id="Fact-87C78ED5620DC10B56EE2012DE02FFE1" unitRef="usd">110000000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:SellingAndMarketingExpense contextRef="FD2018Q1YTD" decimals="-5" id="Fact-EACA4FF18D9495890FB12012DE027A55" unitRef="usd">139500000</us-gaap:SellingAndMarketingExpense>
	<us-gaap:SeniorNotes contextRef="I2018Q1SD_us-gaap_DebtInstrumentAxis_holx_A2022NotesMember_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-8" id="Fact-2D15AF437EEFEC11F4144E1037CA0019" unitRef="usd">1000000000</us-gaap:SeniorNotes>
	<us-gaap:SeniorNotes contextRef="I2018Q1SD_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember" decimals="-8" id="Fact-2246A647909362C48A354DFD8C676161" unitRef="usd">1000000000</us-gaap:SeniorNotes>
	<us-gaap:SeveranceCosts1 contextRef="FD2017Q2QTD_us-gaap_RestructuringPlanAxis_holx_CynosureMember" decimals="-5" id="Fact-A4F714F732199145D55E2012DE024A46" unitRef="usd">1500000</us-gaap:SeveranceCosts1>
	<us-gaap:SeveranceCosts1 contextRef="FD2017Q3QTD_us-gaap_RestructuringPlanAxis_holx_CynosureMember" decimals="-5" id="Fact-B2702A15FF6FAEED331E2012DE02D54A" unitRef="usd">4300000</us-gaap:SeveranceCosts1>
	<us-gaap:SeveranceCosts1 contextRef="FD2017Q4QTD_us-gaap_RestructuringPlanAxis_holx_CynosureMember" decimals="-5" id="Fact-D8A5E0DA2E25F71E876048972D2A0B58" unitRef="usd">1300000</us-gaap:SeveranceCosts1>
	<us-gaap:SeveranceCosts1 contextRef="FD2018Q1YTD" decimals="-5" id="Fact-3CC28FC669DBD8C37E9C48961099A835" unitRef="usd">3800000</us-gaap:SeveranceCosts1>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1QTD" decimals="-5" id="Fact-F9FCCA08FD20ACB31BA02012DE025A07" unitRef="usd">19200000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" decimals="-5" id="Fact-3D6C9BE2E627834BBBE62012DE0252A9" unitRef="usd">2800000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" decimals="-5" id="Fact-3181E2D27CD5954A1A372012DE025C24" unitRef="usd">10900000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="-5" id="Fact-85B51AEEFB32475D0F512012DE02C3DE" unitRef="usd">2800000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember" decimals="-5" id="Fact-4D140428E78386244EBC29778EB5FA7F" unitRef="usd">0</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2017Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember" decimals="-5" id="Fact-92F68A901F97359D952E2012DE0201EC" unitRef="usd">2700000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_CostOfSalesMember" decimals="-5" id="Fact-776D62288A78EF0F02D12012DE02238E" unitRef="usd">2200000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" decimals="-5" id="Fact-D3ECECD323B92144CAEF2012DE026279" unitRef="usd">7500000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" decimals="-5" id="Fact-1C87EFF3D25B0A39F9872012DE0243C5" unitRef="usd">2500000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_RestructuringChargesMember" decimals="-5" id="Fact-38C389AD746BFD95C2B52976F8CA5B79" unitRef="usd">1300000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember" decimals="-5" id="Fact-0ADCA3CA9D53A740DB702012DE0285EE" unitRef="usd">2900000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensation contextRef="FD2018Q1YTD" decimals="-5" id="Fact-BE6236E1E96C4F3EA9BC2012DE02352A" unitRef="usd">16400000</us-gaap:ShareBasedCompensation>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember" decimals="-5" id="Fact-B503157DB1599901E3022012DE02E81F" unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-BC9C4BC8F09F3B5A10132012DE025BF2" unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-5" id="Fact-A9DADD91A82CB62AD8A52012DE025A51" unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember" decimals="-5" id="Fact-C34B39528DB4F83E17132978F47E4B0D" unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="-5" id="Fact-1E4FDEBCC6DED6A55F512012DE027F46" unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-5" id="Fact-89B76B62D59604F0DFA643570FD018E5" unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember" decimals="2" id="Fact-0B979C31B6643553043D2012DE02F3F7" unitRef="usdPerShare">48.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-5DF5755A5609F881DBA42012DE027C64" unitRef="usdPerShare">37.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-E877EC0BD1332D7D64312012DE023B59" unitRef="usdPerShare">37.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_holx_MarketBasedAwardsMember" decimals="2" id="Fact-273AA7EBAFE1E157DF2F4356810EFB4F" unitRef="usdPerShare">49.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_PerformanceSharesMember" decimals="2" id="Fact-12BDEFA84AB92AF4E5FA2012DE024F1E" unitRef="usdPerShare">40.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-61E3B78817123D96484B2012DE02241C" unitRef="usdPerShare">40.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="-5" id="Fact-D8BBEEA475C234EC47D92012DE0235C9" unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_RestrictedStockUnitsRSUMember" decimals="2" id="Fact-AC3DD64E5FEA539802992012DE023408" unitRef="usdPerShare">37.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="FD2017Q1QTD" decimals="3" id="Fact-8CB3D62AEE3BCD3D084C2012DE028C91" unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="FD2018Q1YTD" decimals="3" id="Fact-FE1A4A6DAF7F5B44B9B72012DE0217C9" unitRef="number">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend contextRef="FD2017Q1QTD" decimals="INF" id="Fact-E01DA37DFDB480C50FE52012DE027BFD" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend contextRef="FD2018Q1YTD" decimals="INF" id="Fact-1B5C43238EB0034478C12012DE02E090" unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="FD2017Q1QTD" decimals="3" id="Fact-8C872EC0D13FB1880B482012DE027C57" unitRef="number">0.366</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="FD2018Q1YTD" decimals="3" id="Fact-F31ECF9C5F4DB53D80802012DE022478" unitRef="number">0.353</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-5" id="Fact-531CAEF275992500D1BE2012DE026E16" unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-5" id="Fact-2E13A879D28FA98AF0732012DE02DC6A" unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2017Q1QTD" decimals="2" id="Fact-F598E5DA63D8810656CF2012DE023171" unitRef="usdPerShare">12.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="FD2018Q1YTD" decimals="2" id="Fact-BEAC30ECFD04174695BE2012DE02A38C" unitRef="usdPerShare">13.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="-5" id="Fact-C5847EAB6348ACD48D4D2012DE02C56B" unitRef="shares">6700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="FI2018Q1_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="2" id="Fact-70F8FD6C08D4935926C02012DE021DF4" unitRef="usdPerShare">31.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost contextRef="FD2018Q1YTD" decimals="-5" id="Fact-3A7600B0114A234F98014899FE748D97" unitRef="usd">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="FD2017Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="2" id="Fact-0612963AF448E2F565002012DE026F46" unitRef="usdPerShare">37.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="FD2018Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember" decimals="2" id="Fact-8B41EC1891EEAF09E9032012DE02E928" unitRef="usdPerShare">40.82</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
	<us-gaap:SharePrice contextRef="I2018Q1commonstock" decimals="INF" id="Fact-B0C49EDB41E1CDA005765205996A2DE2" unitRef="usdPerShare">42.75</us-gaap:SharePrice>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="FD2017Q1QTD" id="Fact-997447706C96836DEC752012DE0264EF">P4Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="FD2018Q1YTD" id="Fact-397794A34FCDF59014C62012DE020225">P4Y8M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
	<us-gaap:StockholdersEquity contextRef="FI2017Q4" decimals="-5" id="Fact-FFD1F0FD6C9323D709BE2012DE02AE47" unitRef="usd">2784700000</us-gaap:StockholdersEquity>
	<us-gaap:StockholdersEquity contextRef="FI2018Q1" decimals="-5" id="Fact-A248067A9D0FD6B0E9622012DE02A82E" unitRef="usd">3194000000</us-gaap:StockholdersEquity>
	<us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions contextRef="FD2018Q1QTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_IncomeTaxAuthorityAxis_us-gaap_StateAndLocalJurisdictionMember" decimals="-5" id="Fact-56993C0FF41466BC9C4656F58F09765A" unitRef="usd">-4000000</us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions>
	<us-gaap:TreasuryStockShares contextRef="FI2017Q4" decimals="-3" id="Fact-331F6B97400F491B08F72012DE023BDB" unitRef="shares">12560000</us-gaap:TreasuryStockShares>
	<us-gaap:TreasuryStockShares contextRef="FI2018Q1" decimals="-3" id="Fact-FC1DDA2AF5AAE5491B1F438CC6455D35" unitRef="shares">12560000</us-gaap:TreasuryStockShares>
	<us-gaap:TreasuryStockValue contextRef="FI2017Q4" decimals="-5" id="Fact-80F3ADADB6F98DBC51A62012DE02AEB8" unitRef="usd">450100000</us-gaap:TreasuryStockValue>
	<us-gaap:TreasuryStockValue contextRef="FI2018Q1" decimals="-5" id="Fact-5F19A299913672D139C32012DE02F9B2" unitRef="usd">450100000</us-gaap:TreasuryStockValue>
	<us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax contextRef="FD2017Q1QTD" decimals="-5" id="Fact-EBB93F810B784D9698D02012DE020D9E" unitRef="usd">8400000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
	<us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax contextRef="FD2018Q1YTD" decimals="-5" id="Fact-84A664BE82D2DDFB70632012DE02124C" unitRef="usd">1500000</us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax>
	<us-gaap:WeightedAverageDiscountRatePercent contextRef="FD2017Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="INF" id="Fact-E279C19E525F3EE1454A2012DE0279BB" unitRef="number">0.0205</us-gaap:WeightedAverageDiscountRatePercent>
	<us-gaap:WeightedAverageDiscountRatePercent contextRef="FD2018Q1QTD_us-gaap_DebtInstrumentAxis_holx_CreditAgreementMember" decimals="INF" id="Fact-AA93203A9B4F024DFEB42012DE024F7E" unitRef="number">0.0275</us-gaap:WeightedAverageDiscountRatePercent>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2017Q1QTD" decimals="-3" id="Fact-2A9EC96BB7CE8BA25AB62012DE02A140" unitRef="shares">284224000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="FD2018Q1YTD" decimals="-3" id="Fact-B2DE89416B8E83F3CBBA2012DE0212EE" unitRef="shares">280802000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2017Q1QTD" decimals="-3" id="Fact-A5E06360C7E2B8BD45D02012DE025846" unitRef="shares">278663000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="FD2018Q1YTD" decimals="-3" id="Fact-B44E231577F7ABF75F842012DE02DAC7" unitRef="shares">276856000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
	<holx:DetailsOfCertainBalanceSheetAccountsTextBlock contextRef="FD2018Q1YTD" id="Fact-F050D45A1F6AF40BC1CA2012DE021D35">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Other Balance Sheet Information&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;114.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;95.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Work-in-process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Finished goods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;199.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;190.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;358.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;331.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Property, plant and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;363.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;357.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Equipment under customer usage agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;379.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;368.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Building and improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;172.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;172.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Leasehold improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;61.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Land&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,043.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,026.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less &amp;#8211; accumulated depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(576.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(553.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;467.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;472.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</holx:DetailsOfCertainBalanceSheetAccountsTextBlock>
	<holx:PurchasePriceAllocationTableTextBlock contextRef="FD2018Q1YTD" id="Fact-C18B1F019EDC0612750B2012DE0251B7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The total purchase price was allocated to Cynosure&amp;#8217;s preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of March 22, 2017, as set forth below. The preliminary purchase price allocation is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.5390625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;107.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property, plant and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other assets and liabilities, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts payable and accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(75.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capital lease obligation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Identifiable intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Developed technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;736.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;107.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Distribution agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;74.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred income taxes, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(315.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;683.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Purchase Price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,657.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</holx:PurchasePriceAllocationTableTextBlock>
	<holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock contextRef="FD2018Q1YTD" id="Fact-27E1FDC21A2902427DE02012DE02C9CB">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:36px;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest expense under the Convertible Notes was as follows:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.859375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amortization of debt discount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amortization of deferred financing costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Principal accretion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-cash interest expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00% accrued interest (cash)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock>
	<holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock contextRef="FD2018Q1YTD" id="Fact-40376842258C874AF0342012DE022F5D">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following presents stock-based compensation expense in the Company&amp;#8217;s Consolidated Statements of Income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cost of revenues&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Selling and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restructuring&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
	<us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="FD2018Q1YTD" id="Fact-51374396957F8F0CCB8A2012DE021DBA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following unaudited pro forma information presents the combined financial results for the Company and Cynosure as if the acquisition of Cynosure had been completed at the beginning of the prior fiscal year, September 26, 2015 (fiscal 2016):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.34375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(unaudited)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;856.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;74.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic earnings per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.27&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted earnings per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.26&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
	<us-gaap:BusinessCombinationDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-A43E05524E16B04C9F7E2012DE02F5E5">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Business Combinations&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Cynosure Inc.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 22, 2017, the Company completed the acquisition of Cynosure and acquired all of the outstanding shares of Cynosure. Each share of common stock of Cynosure outstanding immediately prior to the effective time of the acquisition was canceled and converted into the right to receive &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$66.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in cash. In addition, all outstanding restricted stock units, performance stock units, and stock options were canceled and converted into the right to receive &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$66.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share in cash less the applicable exercise price, as applicable. The acquisition was funded through available cash, and the total purchase price was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.66 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The Company incurred &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$18.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of transaction costs, which were recorded within general and administrative expenses. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cynosure, headquartered in Westford, Massachusetts, develops, manufactures, and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women&amp;#8217;s health. Cynosure also markets radiofrequency (RF) energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure's results of operations are reported in the Company's Medical Aesthetics reportable segment from the date of acquisition and the goodwill within this reportable segment is solely related to Cynosure.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The total purchase price was allocated to Cynosure&amp;#8217;s preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of March 22, 2017, as set forth below. The preliminary purchase price allocation is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.5390625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:75%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:23%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cash&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;107.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Marketable securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;82.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts receivable&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;40.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Property, plant and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other assets and liabilities, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accounts payable and accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(75.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(11.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capital lease obligation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(25.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Identifiable intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Developed technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;736.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;107.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Distribution agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;74.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred income taxes, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(315.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;683.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Purchase Price&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,657.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Cynosure&amp;#8217;s business. The Company has not yet obtained all of the information related to the fair value of the acquired assets and liabilities, primarily taxes, to finalize the purchase price allocation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As part of the preliminary purchase price allocation, the Company has determined the identifiable intangible assets are developed technology, in-process research and development ("IPR&amp;amp;D"), a distribution agreement, customer relationships, and trade names. The preliminary fair value of the intangible assets has been estimated using the income approach, and the cash flow projections were discounted using rates ranging from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, except for the IPR&amp;amp;D assets in which the Company used a range of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The cash flows are based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The developed technology assets are comprised of know-how, patents and technologies embedded in Cynosure's products and relate to currently marketed products. The developed technology assets primarily comprise the significant product families of Cynosure, primarily SculpSure, Icon, and PicoSure.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;IPR&amp;amp;D projects relate to in-process projects that have not reached technological feasibility as of the acquisition date and have no alternative future use. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying project or expected commercial release depending on the project. The Company recorded, on a preliminary basis, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$107.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of IPR&amp;amp;D related to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; projects, which were expected to be completed during fiscal 2018 and 2019 with a preliminary cost to complete of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$18.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. During the fourth quarter of fiscal 2017, the Company obtained regulatory approval for &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; projects with an aggregate fair value of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$61.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and these assets were reclassified to developed technology. The remaining project is expected to be completed during fiscal 2019 with an estimated cost to complete of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Given the uncertainties inherent with product development and introduction, there can be no assurance that any of the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. All of the IPR&amp;amp;D assets were valued using the multiple-period excess earnings method approach.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The distribution agreement intangible asset relates to Cynosure's exclusive distribution rights for the MonaLisa Touch device in certain geographic regions. The customer relationships intangible asset pertains to Cynosure's relationships with its end customers and related service arrangements and distributors throughout the world. Trade names relate to the Cynosure corporate name and primary product names, and the Company used the Relief-from-Royalty Method to estimate the fair value of this asset.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Developed technology, distribution agreement, customer relationships and trade names are being amortized on a straight-line basis over a weighted average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.8&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.7&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.9&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, respectively. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on several strategic and synergistic benefits that are expected to be realized from the Cynosure acquisition. These benefits include the expectation that the Company's entry into the aesthetics market will significantly broaden the Company's offering in women's health. The combined company is expected to benefit from a broader global presence, synergistic utilization of Hologic's direct sales force, primarily its GYN Surgical sales force, with certain Cynosure products, and the Company's entry into an adjacent cash-pay segment. None of the goodwill is expected to be deductible for income tax purposes. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In fiscal 2017, Cynosure's revenue and pre-tax loss, which excludes acquisition expenses incurred by the Company, for the period from the acquisition date to September 30, 2017 were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$207.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$96.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. The pre-tax loss includes amortization expense, the impact of the step-up in inventory, retention and integration expenses including legal and consulting fees, and restructuring charges. The following unaudited pro forma information presents the combined financial results for the Company and Cynosure as if the acquisition of Cynosure had been completed at the beginning of the prior fiscal year, September 26, 2015 (fiscal 2016):&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.34375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:81%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:17%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(unaudited)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenue&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;856.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Net income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;74.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic earnings per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.27&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted earnings per common share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.26&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The unaudited pro forma information for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; December 31, 2016 (the first quarter of fiscal 2017) was calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. The pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments to reflect pro forma results of operations as if the acquisition occurred on September 27, 2015 (the beginning of fiscal 2016), such as increased amortization for the fair value of acquired intangible assets. The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of the period presented, or of future results of the consolidated entities. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Medicor Medical Supply&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On April 7, 2017, the Company completed the acquisition of MMS Medicor Medical Supplies GmbH ("Medicor") for a purchase price of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$19.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes a working capital adjustment of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; that was paid in the fourth quarter of fiscal 2017, and a holdback of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; that is payable &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years from the date of acquisition. Medicor was a long-standing distributor of the Company's Breast and Skeletal Health products in Germany, Austria and Switzerland. Based on the Company's preliminary valuation, it has allocated &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the purchase price to the preliminary value of intangible assets, which have a weighted average life of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.7&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to goodwill. The remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of purchase price has been allocated to the acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Emsor, S.A.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 11, 2017, the Company completed the acquisition of Emsor S.A. ("Emsor") for a purchase price of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$13.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes a holdback of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; that is payable &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;eighteen&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months from the date of acquisition, and contingent consideration which the Company has estimated at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The contingent consideration is payable upon Emsor achieving predefined amounts of cumulative revenue over a &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; year period from the date of acquisition. Emsor was a distributor of the Company's Breast and Skeletal Health products in Spain and Portugal. Based on the Company's preliminary valuation, it has allocated &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the purchase price to the preliminary value of intangible assets and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to goodwill. The remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$6.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of purchase price has been allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
	<us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-41596FDFEF85854E1F282012DE021CDE">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Commitments and Contingencies&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Litigation and Related Matters&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On June&amp;#160;9, 2010, Smith&amp;#160;&amp;amp; Nephew, Inc. ("Smith &amp;amp; Nephew") filed suit against Interlace Medical, Inc. ("Interlace"), which the Company acquired on January&amp;#160;6, 2011, in the United States District Court for the District of Massachusetts. The complaint alleged that the Interlace MyoSure hysteroscopic tissue removal device infringed U.S. patent 7,226,459 (the '459 patent). On November&amp;#160;22, 2011, Smith&amp;#160;&amp;amp; Nephew filed suit against the Company in the United States District Court for the District of Massachusetts. The complaint alleged that use of the MyoSure tissue removal system infringed U.S. patent 8,061,359 (the '359 patent). Both complaints sought preliminary and permanent injunctive relief and unspecified damages. On September&amp;#160;4, 2012, following a two week trial, the jury returned a verdict of infringement of both the '459 and '359 patents and assessed damages of  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&amp;#160;A two-day bench trial regarding the Company&amp;#8217;s assertion of inequitable conduct on the part of Smith&amp;#160;&amp;amp; Nephew with regard to the '359 patent began on December&amp;#160;10, 2012 and oral arguments on the issue of inequitable conduct were presented on February&amp;#160;27, 2013. On June&amp;#160;27, 2013, the Court denied the Company&amp;#8217;s motions related to inequitable conduct and allowed Smith&amp;#160;&amp;amp; Nephew&amp;#8217;s request for injunction, but ordered that enforcement of the injunction be stayed until final resolution, including appeal, of the current re-examinations of both patents at the United States Patent and Trademark Office (&amp;#8220;USPTO&amp;#8221;). The Court also rejected the jury&amp;#8217;s damage award and ordered the parties to identify a mechanism for resolving the damages issue. The USPTO issued final decisions that the claims of the '459 and the '359 patents asserted as part of the litigation are not patentable, which decisions Smith &amp;amp; Nephew appealed to the U.S. Patent Trial and Appeal Board ("PTAB"). In 2016, the PTAB (i) affirmed the USPTO decision with respect to the '459 patent, holding that the claims at issue are invalid, and (ii) reversed the USPTO decision with respect to the '359 patent, holding that the claims at issue are not invalid. The Company and Smith &amp;amp; Nephew have appealed the decisions by the Patent Trial and Appeal Board on the '359 patent and the '459 patent, respectively, to the U.S. Court of Appeals for the Federal Circuit ("Court of Appeals"). Briefing on both appeals is completed. Oral arguments were held in the '459 patent appeal on October 24, 2017 and in the '359 patent appeal on December 7, 2017. On January 30, 2018, the Court of Appeals issued a decision in the '459 patent appeal that affirmed-in-part and reversed-in-part the PTAB ruling and remanded the matter to the PTAB for further proceedings. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On April 11, 2017, Minerva Surgical, Inc. (&amp;#8220;Minerva&amp;#8221;) filed suit against the Company and Cytyc Surgical Products, LLC (&amp;#8220;Cytyc&amp;#8221;) in the United States District Court for the Northern District of California alleging that the Company&amp;#8217;s and Cytyc&amp;#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&amp;#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including in lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2012, Enzo Life Sciences, Inc. ("Enzo") filed suit against the Company's subsidiary, Gen-Probe Incorporated ("Gen-Probe"), in the United States District Court for the District of Delaware, alleging that certain of Gen-Probe&amp;#8217;s diagnostics products, including products that incorporate Gen-Probe&amp;#8217;s hybridization protection assay technology (HPA), which include the Aptima line of products, infringe Enzo&amp;#8217;s U.S. patent 6,992,180 (the '180 patent). On March&amp;#160;6, 2012, Enzo filed suit against the Company in the United States District Court for the District of Delaware, alleging that products based on the Company's Invader chemistry platform, such as Cervista HPV HR and Cervista HPV 16/18, infringe the '180 patent. On July 16, 2012, Enzo amended its complaint to include additional products that include HPA or TaqMan reagent chemistry, including the Progensa, AccuProbe and Prodesse product lines. The Company counter-claimed for non-infringement, invalidity and unenforceability of the '180 patent. On September&amp;#160;30, 2013, Enzo filed its infringement contentions which added products including "Torch" probes (e.g., MilliPROBE Real-Time Detection System for Mycoplasma), PACE and certain Procleix assays. Both complaints sought preliminary and permanent injunctive relief and unspecified damages. Summary judgment and Daubert motions were filed by the parties on December 15, 2016. A hearing on the summary judgment motions was held on April 4, 2017, and on June 28, 2017, the Court ruled that the '180 patent is invalid for nonenablement. Final judgment was entered on July 19, 2017, and on August 18, 2017, Enzo filed a notice of appeal with the Court of Appeals for the Federal Circuit. Enzo&amp;#8217;s opening appeal brief was filed on November 28, 2017, and the Company&amp;#8217;s responsive brief is due March 8, 2018. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 27, 2015, Enzo filed an additional suit against the Company in the United States District Court for the District of Delaware. The complaint alleges that certain additional Company molecular diagnostic products, including, inter alia, the Procleix Parvo/HAV assays and coagulation products, including the Invader Factor II test and the Invader Factor V test, also infringe the '180 patent. The complaint further alleged that certain of the Company&amp;#8217;s molecular diagnostic products, including the Company&amp;#8217;s Progensa PCA3, Aptima and Procleix products using target capture technology infringe Enzo&amp;#8217;s U. S. Patent 7,064,197 (the '197 patent). On June 11, 2015, this matter was stayed pending the resolution of summary judgment motions in the other related suits involving the '197 patent. The litigation remains stayed. On March 30, 2016, Hologic filed two requests for inter partes review of the &amp;#8216;197 patent at the USPTO. The USPTO instituted the two inter partes reviews on all challenged claims on October 4, 2016. Combined oral arguments for the two inter partes reviews were held on June 1, 2017. On September 28 and October 2, 2017, the PTAB issued final written decisions in the two inter partes reviews finding that all of the challenged claims of the &amp;#8216;197 patent are unpatentable. In response to the final written decisions, Enzo filed notices of appeal on November 29, 2017, and the United States Court of Appeals for the Federal Circuit consolidated Enzo&amp;#8217;s appeals on December 14, 2017. Enzo&amp;#8217;s opening brief is due March 12, 2018. At this time, based on available information regarding this litigation and the related inter partes reviews, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October 3, 2016, Enzo filed an additional suit against the Company in the United States District Court for the District of Delaware. The complaint alleges that all of the Company's Progensa PCA3, Aptima and Procleix products infringe U.S. Patent 6,221,581 (the '581 patent). On November 28, 2016, the Company filed an answer and counterclaims of non-infringement, invalidity and unenforceability. On June 30, 2017, Hologic filed its initial invalidity contentions, which provide support for finding that the asserted claims of the '581 patent are invalid based on anticipation, obviousness, lack of adequate written description and enablement, and indefiniteness. On August 31, 2017, the Company and Enzo filed supplemental invalidity charts and supplemental infringement charts, respectively. The parties filed their proposed claim constructions on September 28, 2017. The parties&amp;#8217; claim construction briefs are due in April 2018. On October 4, 2017, the Company filed for inter partes review of the &amp;#8216;581 patent with the USPTO based on Enzo&amp;#8217;s asserted claims. Enzo filed its preliminary response on January 19, 2018. A decision on whether to institute inter partes review is expected in April 2018. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On February 3, 2017, bioM&amp;#233;rieux, S.A. and bioM&amp;#233;rieux, Inc. (collectively &amp;#8220;bioM&amp;#233;rieux&amp;#8221;) filed suit against the Company in the United States District Court for the Middle District of North Carolina. The complaint alleged that the Company&amp;#8217;s Aptima HIV-1 RNA Qualitative assay and Aptima HIV-1 Quant Dx assay, as well as products manufactured by the Company and sold to Grifols, S.A. and Grifols Diagnostic Solutions Inc. (&amp;#8220;Grifols USA&amp;#8221;) for resale under the names Procleix HIV-1/HCV assay, Procleix Ultrio assay, and Procleix Ultrio Plus assay, infringe U.S. Patent Nos. 8,697,352 and 9,074,262. On April 3, 2017, the Company and Grifols USA filed a Motion to dismiss asking the Court to dismiss the complaint in its entirety for bioM&amp;#233;rieux&amp;#8217;s failure to state a claim upon which relief can be granted. On June 9, 2017, Hologic and Grifols USA filed a supplemental motion to dismiss for improper venue. bioM&amp;#233;rieux filed a response to the venue motion on June 30, 2017, and Hologic and Grifols USA responded by filing a brief in further support of their motion to dismiss for improper venue on July 14, 2017. On January 3, 2018, the district court judge for the Middle District of North Carolina granted the parties&amp;#8217; consent motion to transfer the case to Delaware. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On July 27, 2016, plaintiff ARcare, Inc., individually and as putative representative of a purported nationwide class, filed a complaint against Cynosure.&amp;#160; The plaintiff alleges that Cynosure violated the Telephone Consumer Protection Act by: (i) sending fax advertisements that did not comply with statutory and Federal Communications Commission requirements that senders provide recipients with certain information about how to opt out from receiving faxed advertisements in the future; and (ii) sending unsolicited fax advertisements.&amp;#160;The complaint sought damages, declaratory and injunctive relief, and attorneys&amp;#8217; fees on behalf of a purported class of all recipients of purported fax advertisements that the plaintiff alleges did not receive an adequate opt-out notice. On September 30, 2016, Cynosure answered the complaint and denied liability. On September 7, 2016, the plaintiff sent a demand letter seeking a class settlement for statutory damages under Massachusetts General Laws, Chapter 93A &amp;#167; 9 (&amp;#8220;Chapter 93A&amp;#8221;). On October 7, 2016, Cynosure responded denying any liability under Chapter 93A, but offering the plaintiff statutory damages of $25 on an individual basis.&amp;#160;In March 2017, Cynosure and ARcare entered into a settlement agreement, subject to court approval, which requires Cynosure to pay settlement compensation of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; notwithstanding the number of claims filed.&amp;#160;If approved, Cynosure would receive a full release from the settlement class concerning the conduct alleged in the complaint.&amp;#160;As a result of the settlement agreement, Cynosure recorded a charge of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, in the period ended December 31, 2016, which is still accrued on the Company's balance sheet as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March&amp;#160;17, 2017, a purported shareholder of Cynosure, Michael Guido, filed an action against Cynosure in the Court of Chancery of the State of Delaware pursuant to Section&amp;#160;220 of the Delaware General Corporation Law seeking the production of certain books and records, including books and records related to the acquisition of Cynosure by Hologic. The action follows Cynosure&amp;#8217;s rejection of Mr.&amp;#160;Guido&amp;#8217;s demand for these books and records on the ground that he had not met the requirements of the statute. In addition to books and records, the complaint seeks reasonable attorneys&amp;#8217; fees. The Company filed an answer to the complaint on April 10, 2017. At this time, based on available information regarding this matter, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal costs are expensed as incurred.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
	<us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="FD2018Q1YTD" id="Fact-8284452BF294622CCCA12012DE022934">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Accumulated Other Comprehensive Loss&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Three Months Ended December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Pension Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Hedged Interest Rate Caps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Beginning Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(18.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(16.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;5.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Amounts reclassified to statement of income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Ending Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(13.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(11.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Three Months Ended December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Pension Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Hedged Interest Rate Caps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Beginning Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(26.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(3.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(32.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(15.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(12.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Amounts reclassified to statement of income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Ending Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(41.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(42.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the first quarter of fiscal 2017, one of the Company's cost-method equity investments became a marketable security, and the Company recorded the increase in value on a gross basis of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to other comprehensive income.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
	<us-gaap:DebtDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-C172BC476AB47CE773132012DE025CB1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Borrowings and Credit Arrangements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s borrowings consisted of the following:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:74%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revolver&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;120.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Securitization Program&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;205.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;484.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total current debt obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;572.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,150.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term debt obligations, net of debt discount and deferred issuance costs:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,430.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,190.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022 Senior Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;982.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;981.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2025 Senior Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total long-term debt obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,757.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,172.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total debt obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,329.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,322.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Amended and Restated Credit Agreement&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October 3, 2017, the Company and certain of its domestic subsidiaries entered into an Amended and Restated Credit and Guaranty Agreement (the "Amended and Restated Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto. The Amended and Restated Credit Agreement amends and restates the Company's prior credit and guaranty agreement, originally dated as of May 29, 2015 (the "Prior Credit Agreement"). The proceeds under the Amended and Restated Credit Agreement of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.8 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; were used, among other things, to pay off the Term Loan of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.32 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and the Revolver then outstanding under the Company's Prior Credit Agreement. Borrowings under the Amended and Restated Credit Agreement are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company's U.S. subsidiaries, with certain exceptions.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The credit facilities (the &amp;#8220;Amended and Restated Credit Facilities&amp;#8221;) under the Amended and Restated Credit Agreement consist of:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.5 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; secured term loan to the Company ("Amended Term Loan") with a maturity date of October 3, 2022; and &lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A secured revolving credit facility (the "Amended Revolver") under which the the Company may borrow up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.5 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, subject to certain sublimits, with a maturity date of October 3, 2022.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At the closing, the Company borrowed &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$345 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; under the Amended Revolver, which was fully repaid during October 2017. As of December 30, 2017, the Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$120.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; outstanding under the Amended Revolver. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Borrowings under the Amended and Restated Credit Facilities bear interest, at the Company's option and in each case plus an applicable margin as follows: &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Amended Term Loan&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate (as defined in the Amended and Restated Credit Agreement),&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"&gt;&lt;tr&gt;&lt;td style="width:48px;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:top" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;font-size:10pt;padding-left:24px;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8226;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:top;" rowspan="1" colspan="1"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Amended Revolver&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate is subject to specified changes depending on the total net leverage ratio as defined in the Amended and Restated Credit Agreement. The borrowings of the Amended Term Loan initially bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The borrowings of the Amended Revolver initially bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.50%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The Company is also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the Amended Revolver.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is required to make scheduled principal payments under the Amended Term Loan in increasing amounts ranging from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.375 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;-month period commencing with the three-month period ending on December&amp;#160;29, 2017 to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$37.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per three-month period commencing with the three-month period ending on December&amp;#160;23, 2021. The remaining balance of the Amended Term Loan and any amounts outstanding under the Amended Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the Amended and Restated Credit Agreement, the Company is required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by the Company,&amp;#160;first, to the Amended Term Loan,&amp;#160;second, to any outstanding amount under any Swing Line Loans (as defined in the Amended and Restated Credit Agreement),&amp;#160;third,&amp;#160;to the Amended Revolver,&amp;#160;fourth&amp;#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit (as defined in the Amended and Restated Credit Agreement) and&amp;#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the Amended and Restated Credit Facilities without premium or penalty.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Borrowings outstanding under the Amended and Restated Credit Agreement and the Prior Credit Agreement for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; had weighted-average interest rates of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.75%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.05%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. The interest rate on the outstanding Amended Term Loan borrowing at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.07%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Interest expense under the Amended and Restated Credit Agreement aggregated &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes non-cash interest expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to the amortization of the deferred issuance costs and accretion of the debt discount. Interest expense under the Prior Credit Agreement aggregated &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$9.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which includes &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Amended and Restated Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the Amended and Restated Credit Agreement requires the the Company to maintain certain financial ratios. The Amended and Restated Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company, with certain exceptions. For example, borrowings under the Amended and Restated Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program. The Amended and Restated Credit Agreement contains total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter and an excess cash flow prepayment requirement measured as of the end of each fiscal year. The total net leverage ratio was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.00&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 beginning on the Company's fiscal quarter ended December 30, 2017, and then decreases over time to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.50&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 for the quarter ending March 27, 2021. The interest coverage ratio was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.75&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:1.00 beginning on the Company's fiscal quarter ended December 30, 2017, and remains as such for each quarter thereafter. The total net leverage ratio is defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the Amended and Restated Credit Agreement) for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;four&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;-fiscal quarter period ending on the measurement date. The interest coverage ratio is defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the Amended and Restated Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of December 30, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company evaluated the Amended and Restated Credit Agreement for derivatives pursuant to ASC 815, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Derivatives and Hedging&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and identified embedded derivatives that required bifurcation as the features are not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of December 30, 2017.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Pursuant to ASC 470, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Debt &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(ASC 470), the accounting for the Amended and Restated Credit Agreement was evaluated on a creditor-by-creditor basis with regard to the Amended and Restated Credit Agreement to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the Amended and Restated Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in the first quarter of fiscal 2018 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Pursuant to ASC 470, subtopic 50-40, third-party costs of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to this transaction were recorded as interest expense and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2025 Senior Notes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On October&amp;#160;10, 2017, the Company completed a private placement of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$350 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; aggregate principal amount of its &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.375%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2025 (the &amp;#8220;2025 Senior Notes&amp;#8221;) at an offering price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount of the 2025 Senior Notes. The 2025 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &amp;#8220; 2025 Domestic Guarantors&amp;#8221;).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The 2025 Senior Notes mature on October&amp;#160;15, 2025 and bear interest at the rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.375%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;per year, payable semi-annually on April&amp;#160;15 and October&amp;#160;15 of each year, commencing on April&amp;#160;15, 2018. The Company recorded interest expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the three months ended December 30, 2017 which includes non-cash interest expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company may redeem the 2025 Senior Notes at any time prior to October 15, 2020 at a price equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount of the 2025 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before October&amp;#160;15, 2020, at a redemption price equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;104.375%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2025 Senior Notes on or after: October&amp;#160;15, 2020 through October 14, 2021 at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102.188%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of par; October 15, 2021 through October 14, 2022 at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101.094%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of par; and October 15, 2022 and thereafter at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the 2025 Indenture, the Company will be required to make an offer to purchase each holder&amp;#8217;s 2025 Senior Notes at a price equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On January 19, 2018, the Company completed a private placement of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; aggregate principal amount of senior notes, which included &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$600 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.375%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2025 (the &amp;#8220;New 2025 Senior Notes&amp;#8221;), issued under a supplement to the 2025 Indenture. See &amp;#8220;Subsequent Events&amp;#8221; below.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2022 Senior Notes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company's &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.250%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2022 (the &amp;#8220;2022 Senior Notes&amp;#8221;) mature on July 15, 2022 and bear interest at the rate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.250%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;per year, payable semi-annually on January 15 and July 15 of each year, commencing on January 15, 2016. The Company recorded interest expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$14.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$15.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and December 31, 2016, respectively, which includes non-cash interest expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, related to the amortization of the deferred issuance costs and accretion of the debt discount.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In connection with the offering of the New 2025 Senior Notes and the Company&amp;#8217;s &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.625%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2028, the Company has called all of its outstanding 2022 Senior Notes, in the aggregate principal amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. See &amp;#8220;Subsequent Events&amp;#8221; below. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On various dates during the first quarter of fiscal 2018, the Company entered into privately negotiated repurchase transactions and extinguished &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$39.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; principal amount of its &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Convertible Senior Notes due 2042 (the "2042 Notes") for total payments of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$52.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. This amount includes the conversion premium resulting from the Company's stock price on the date of the transactions being in excess of the conversion prices of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$31.175&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. As a result, on a gross basis, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$13.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the consideration paid was allocated to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; within additional paid-in-capital.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; On December 15, 2017, pursuant to the provisions of the indenture governing the Company's &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Convertible Senior Notes due December 15, 2043 (the "2043 Notes"),  the Company redeemed or repurchased an aggregate of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$201.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in original principal amount of the 2043 Notes then outstanding for an aggregate repurchase price of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$244.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, representing the then accreted principal amount of the 2043 Notes. The remaining &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in original principal amount of the 2043 Notes were converted, and the Company elected to settle these conversions, which will occur in the second quarter of fiscal 2018.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:36px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The term "Convertible Notes" refers to the 2042 Notes and the 2043 Notes.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:36px;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest expense under the Convertible Notes was as follows:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.859375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amortization of debt discount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amortization of deferred financing costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Principal accretion&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-cash interest expense&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00% accrued interest (cash)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Subsequent Events&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2025 Senior Notes and 2028 Senior Notes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On January 19, 2018, the Company completed a private placement of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; aggregate principal amount of senior notes, allocated between (i) an additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$600 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; aggregate principal amounts of its 2025 Senior Notes pursuant to a supplement to the indenture governing the Company's existing 2025 Senior Notes, at an offering price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount of the 2025 Senior Notes, plus accrued and unpaid interest from October 10, 2017 and (ii)  &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$400 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; aggregate principal amounts of its &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.625%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount of the 2028 Senior Notes. The new 2025 Senior Notes have the same terms as the existing 2025 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &amp;#8220;2028 Domestic Guarantors&amp;#8221;).&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The 2028 Senior Notes were issued pursuant to an indenture (the &amp;#8220;2028 Indenture&amp;#8221;), dated as of January 19, 2018 among the Company, the 2028 Domestic Guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&amp;#160;1, 2028 and bear interest at the rate of&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.625%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;per year, payable semi-annually on February&amp;#160;1 and August&amp;#160;1 of each year, commencing on August 1, 2018. The 2028 Indenture contains covenants which limit, among other things, the ability of the Company and the Guarantors to create liens and engage in certain sale and leaseback transactions. These covenants are subject to a number exceptions and qualifications.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&amp;#160;1, 2021, at a redemption price equal to&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;104.625%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;102.312%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of par; February 1, 2024 through February 1, 2025 at&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101.541%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of par; February 1, 2025 through February 1, 2026 at&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100.770%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of par; and February 1, 2026 and thereafter at&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the 2028 Indenture, the Company will be required to make an offer to purchase each holder&amp;#8217;s 2028 Senior Notes at a price equal to&amp;#160;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;101%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;2042 Notes &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On January 29, 2018, the Company announced that pursuant to the terms of the indenture for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Convertible Senior Notes due 2042 (the &amp;#8220;2042 Notes&amp;#8221;), holders of the 2042 Notes had the option of requiring the Company to repurchase their 2042 Notes on March 1, 2018 at a repurchase price payable in cash equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the put date. The accreted principal amount of the 2042 notes will be &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$206.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; as of the repurchase date. The Company also announced on January 29, 2018 that, it had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the redemption date. Holders also have a right to convert their 2042 Notes. Based on a closing price of the Company&amp;#8217;s common stock of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$42.75&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share (the closing price for the Company&amp;#8217;s common stock on December&amp;#160;29, 2017), the conversion value for the outstanding 2042 notes would be &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1,371&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1,000&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of original principal amount of the notes, or &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$282.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in the aggregate. The conversion value of the notes would increase or decrease to the extent that the trading price of the Company&amp;#8217;s common stock increases or decreases. The Company has elected to settle any conversion of the 2042 Notes entirely in cash.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
	<us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-EDF915EB49DAC055B6B12012DE02508E">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Derivatives&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Interest Rate Cap - Cash Flow Hedge&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense) in the Consolidated Statements of Income.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During fiscal 2015, the Company entered into separate interest rate cap agreements with multiple counter-parties to help mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 6). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for the interest rate cap agreements was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$13.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which was the initial fair value of the instruments recorded in the Company's financial statements. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During fiscal 2017, the Company entered into new separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for the interest rate cap agreements was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which was the initial fair value of the instruments recorded in the Company's financial statements. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The critical terms of the interest rate caps were designed to mirror the terms of the Company&amp;#8217;s LIBOR-based borrowings under its Prior Credit Agreement and Amended and Restated Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of principal, which ended on December 29, 2017 and which will end on December 30, 2018 for the interest rate cap agreements entered into in fiscal 2015 and fiscal 2017, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial, and all changes in the fair value of the interest rate caps were recorded in the Consolidated Statements of Comprehensive Income as a component of AOCI.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$2.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, was reclassified from AOCI to the Company&amp;#8217;s Consolidated Statements of Income related to the interest rate cap agreements. The Company expects to similarly reclassify a loss of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; from AOCI to the Consolidated Statements of Income in the next twelve months.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The aggregate fair value of these interest rate caps was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$5.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, and is included in Prepaid expenses and other current assets on the Company&amp;#8217;s Consolidated Balance Sheet. Refer to Note 2 &amp;#8220;Fair Value Measurements&amp;#8221; above for related fair value disclosures.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Forward Foreign Currency Contracts&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company enters into forward foreign currency exchange contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company has not elected hedge accounting for any of the forward foreign currency contracts it has executed; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. During the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company recorded net realized loss of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$0.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and a net realized gain of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, from settling forward foreign currency contracts and unrealized gains of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$8.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, on the mark-to-market for its outstanding forward foreign currency contracts. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro, UK Pound, Australian dollar, Canadian Dollar and Japanese Yen with an aggregate notional amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$157.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Financial Instrument Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;: &lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivative instruments designated as a cash flow hedge:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:42px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid expenses and other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:42px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivatives not designated as hedging instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid expenses and other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivatives not designated as hedging instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents the unrealized gain recognized in AOCI related to the interest rate caps for the following reporting periods:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.8125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amount of gain (loss) recognized in other comprehensive income, net of taxes:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.53125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:36%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:30%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Derivatives not classified as hedging instruments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount of Gain (Loss) Recognized in Income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Location of Gain (Loss) Recognized in Income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other income, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
	<us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted contextRef="FD2018Q1YTD" id="Fact-60659DE0BFC4A058D19D2012DE02F017">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;New Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles-Goodwill and Other (Topic 350)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. This guidance simplifies how companies calculate goodwill impairments by eliminating Step 2 of the impairment test. The guidance requires companies to compare the fair value of a reporting unit to its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value. The guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2020. Early adoption is permitted. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In October 2016, the FASB issued ASU No. 2016-16, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Income Taxes (Topic 740).&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; The guidance requires companies to recognize the income tax effects of intercompany sales and transfers of assets, other than inventory, in the income statement as income tax expense (or benefit) in the period in which the transfer occurs. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of the adoption of ASU 2016-16 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2016, the FASB issued ASU No. 2016-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Statement of Cash Flow (Topic 230)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The guidance reduces diversity in how certain cash receipts and cash payments are presented and classified in the Statements of Cash Flows. Certain of ASU 2016-15 requirements are as follows: 1) cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities, 2) contingent consideration payments made soon after a business combination should be classified as cash outflows for investing activities and cash payment made thereafter should be classified as cash outflows for financing up to the amount of the contingent consideration liability recognized at the acquisition date with any excess classified as operating activities, 3) cash proceeds from the settlement of insurance claims should be classified on the basis of the nature of the loss, 4) cash proceeds from the settlement of Corporate-Owned Life Insurance (COLI) Policies should be classified as cash inflows from investing activities and cash payments for premiums on COLI policies may be classified as cash outflows for investing activities, operating activities, or a combination of investing and operating activities, and 5) cash paid to a tax authority by an employer when withholding shares from an employee's award for tax-withholding purposes should be classified as cash outflows for financing activities. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted. The adoption of ASU 2016-15 is not expected to have a material effect on the Company's consolidated financial statements. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842).&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; The guidance requires an entity to recognize a right-of-use asset and a lease liability for virtually all of its leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as a finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The guidance is effective for annual periods beginning after December&amp;#160;15, 2018, and is applicable to the Company in fiscal 2020. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-02 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2016, the FASB issued ASU No. 2016-01, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. This guidance changes how &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#333333;"&gt;entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. A practicability exception will be available for equity investments that do not have readily determinable fair values, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;however; the exception requires the Company to consider relevant transactions that can be&amp;#160;reasonably known to identify any observable price changes that would impact the fair value&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#333333;"&gt;. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Early adoption is permitted. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-01 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In May 2014, the FASB issued ASU No. 2014-09,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt; Revenue from Contracts with Customers (Topic 606)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which provides guidance for revenue recognition. This ASU is applicable to any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets. ASU 2014-09 will supersede the revenue recognition requirements in Topic 605,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt; Revenue Recognition&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and most industry-specific guidance. The standard&amp;#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to receive in exchange for those goods or services. In doing so, companies will need to use more judgment and make more estimates than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December&amp;#160;15, 2017, which is fiscal 2019 for the Company. The Company will adopt Topic 606 effective September 30, 2018 and has established a cross-functional team to evaluate and implement the new revenue recognition rules. The Company will adopt Topic 606 using the modified retrospective method but has not finalized evaluating the anticipated impact of the adoption of ASU 2014-09 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
	<us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="FD2018Q1YTD" id="Fact-A0C015220107D2C607322012DE0277D3">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Stock-Based Compensation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following presents stock-based compensation expense in the Company&amp;#8217;s Consolidated Statements of Income:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Cost of revenues&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Selling and marketing&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;General and administrative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Restructuring&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company granted &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; stock options during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, with weighted-average exercise prices of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$40.82&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$37.62&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. There were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;6.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; options outstanding at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; with a weighted-average exercise price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$31.20&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.2421875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected volatility&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected life (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Dividend yield&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average fair value of options granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company granted &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; restricted stock units (RSUs) during each of the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, with weighted-average grant date fair values of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$40.79&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$37.58&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per unit, respectively. As of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; unvested RSUs outstanding with a weighted-average grant date fair value of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$37.72&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per unit. In addition, the Company granted &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;background-color:#ffffff;"&gt;0.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; performance stock units (PSUs) during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, to members of its senior management team, which have a weighted-average grant date fair value of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$40.86&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$37.64&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per unit, respectively. Each recipient of PSUs is eligible to receive between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;zero&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the target number of shares of the Company&amp;#8217;s common stock at the end of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; provided the Company&amp;#8217;s defined Return on Invested Capital metrics are achieved. The Company is recognizing compensation expense ratably over the required service period based on its estimate of the number of shares that will vest. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; market based awards (MSUs) to its senior management team during the three months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. Each recipient of MSUs is eligible to receive between &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;zero&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the target number of shares of the Company&amp;#8217;s common stock at the end of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three years&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$49.45&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$48.90&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; per share using the Monte Carlo simulation model. The Company is recognizing compensation expense for the MSUs ratably over the service period.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, there was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$37.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$98.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of unrecognized compensation expense related to stock options and stock units (comprised of RSUs and PSUs), respectively, to be recognized over a weighted-average period of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.1&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years, respectively.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
	<us-gaap:EarningsPerShareTextBlock contextRef="FD2018Q1YTD" id="Fact-C44FB4ECB6003AE072B22012DE0252CC">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Net Income Per Share&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;276,856&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;278,663&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common stock equivalents from assumed exercise of stock options and stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,212&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,143&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Incremental shares from Convertible Notes premium&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;280,802&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;284,224&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted-average anti-dilutive shares related to:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outstanding stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,272&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,442&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has outstanding Convertible Notes, and the principal balance and any conversion premium may be satisfied, at the Company&amp;#8217;s option, by issuing shares of common stock, cash or a combination of shares and cash. The Company's current policy is that it will settle the principal balance of the Convertible Notes in cash. As such, the Company applies the treasury stock method to these securities and the dilution related to the conversion premium of the 2042 and 2043 Notes is included in the calculation of diluted weighted-average shares outstanding to the extent each issuance is dilutive based on the average stock price during each reporting period being greater than the conversion price of the respective Notes.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
	<us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-803A2920EDB93A4ADA002012DE025930">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Fair Value Measurements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has investments in derivative instruments consisting of interest rate caps and forward foreign currency contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of the Company's interest rate caps and forward foreign currency contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 6 for further discussion and information on the interest rate caps and forward foreign currency contracts. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has a payment obligation to the participants under its Nonqualified Deferred Compensation Plan (&amp;#8220;DCP&amp;#8221;). This liability is recorded at fair value based on the underlying value of certain hypothetical investments under the DCP as designated by each participant for their benefit. Since the value of the DCP obligation is based on market prices, the liability is classified within Level 1. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value at Reporting Date Using&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance as of December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;Prices&amp;#160;in&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Active&amp;#160;Market&amp;#160;for&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Identical&amp;#160;Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Observable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Inputs&amp;#160;(Level&amp;#160;2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Inputs&amp;#160;(Level&amp;#160;3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap - derivative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;52.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Assets Measured and Recorded at Fair Value on a Nonrecurring Basis&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets consist of cost-method equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements for the three months ended December 30, 2017 and December 31, 2016.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Disclosure of Fair Value of Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, interest rate caps, forward foreign currency contracts, insurance contracts, DCP liability, accounts payable and debt obligations. The carrying amounts of the Company&amp;#8217;s cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&amp;#8217;s interest rate caps and forward foreign currency contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value, and the related DCP liability is recorded at fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amounts outstanding under the Company&amp;#8217;s Amended and Restated Credit Agreement and Securitization Program of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.6 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$200.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; aggregate principal, respectively, as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&amp;#8217;s 2022 Senior Notes and 2025 Senior Notes had a fair value of approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.1 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$358.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; based on their trading prices, representing a Level 1 measurement. The fair values of the Company&amp;#8217;s Convertible Notes were based on the trading prices of the respective notes and represents a Level 1 measurement. Refer to Note 5 for the carrying amounts of the various components of the Company&amp;#8217;s debt.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The estimated fair values of the Company&amp;#8217;s Convertible Notes at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:83%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2042 Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;284.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2043 Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;285.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
	<us-gaap:IncomeTaxDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-CBB613E031E7600233D42012DE029558">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In accordance with ASC 740, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Income Taxes&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s effective tax rate for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(324.5)%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; compared to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;  for the corresponding period in the prior year. The benefit recorded in the current quarter is primarily due to the impact of the Tax Cuts and Jobs Act (the "Act") enacted on December 22, 2017. As a result of this law, US corporations are subject to lower income tax rates, and the Company is required to remeasure its US net deferred tax liabilities at a lower rate, resulting in a net benefit of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$355.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; recorded in the provision for income taxes. Partially offsetting this benefit, the Company recorded a charge of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$26.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for transition taxes related to the deemed repatriation of foreign earnings. For the current quarter, in addition to the items noted, the effective tax rate was lower than the statutory tax rate primarily due to the impact of earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit. For the three months ended December 31, 2016, the effective tax rate was lower than the statutory tax rate primarily due to the tax benefit from restricted stock units upon vesting, earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;US Tax Reform&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Act reduces the US federal corporate income tax rate from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred, and creates new taxes on certain foreign sourced earnings.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;At December 30, 2017, the Company has not completed its accounting for the tax effects of enactment of the Act; however, as described below, the Company has made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax, and recognized a provisional net benefit of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$329.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which is included in income tax expense. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (&amp;#8220;SAB 118&amp;#8221;) directing SEC registrants to consider the impact of the US legislation as &amp;#8220;provisional&amp;#8221; when it does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. In accordance with SAB 118, the additional estimated net income tax benefit of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$329.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; represents the Company&amp;#8217;s best estimate based on its interpretation of the US legislation as the Company is still accumulating data to finalize the underlying calculations, or in certain cases, the US Treasury is expected to issue further guidance on the application of certain provisions of the US legislation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In the three months ended December 30, 2017, the Company revised its estimated annual effective rate to reflect a change in the federal statutory income tax rate from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The rate change is administratively effective at the beginning of the Company&amp;#8217;s fiscal year, using a blended rate for the annual period. The Company's blended statutory income tax rate for fiscal 2018 is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Deferred tax assets and liabilities&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;: The Company re-measured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24.5%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for fiscal 2018 reversals and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for post-fiscal 2018 reversals. However, the Company is still analyzing certain aspects of the Act and refining its calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts. The provisional net benefit amount recorded related to the re-measurement of the Company&amp;#8217;s deferred tax balance was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$355.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Foreign tax effects&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:  The one-time transition tax is based on the Company&amp;#8217;s total post-1986 earnings and profits (E&amp;amp;P) which were previously deferred from US income taxes. The Company recorded a provisional amount for its one-time transition tax liability related to the deemed repatriation of the earnings of its foreign subsidiaries, resulting in an increase in income tax expense of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$26.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The Company has not yet finalized its calculation of the total post-1986 foreign E&amp;amp;P for these foreign subsidiaries. Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets. This amount may change when the Company finalizes the calculation of its post-1986 foreign E&amp;amp;P previously deferred from US federal taxation and finalizes the amounts held in cash or other specified assets. No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax and any additional outside basis difference inherent in these entities as these amounts continue to be indefinitely reinvested in foreign operations. The Company continues to evaluate this assertion in its ongoing analysis of the effects of tax reform on the Company's strategic initiatives. The Company believes that determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings not subject to the transition tax and additional outside basis difference in these entities (i.e., basis difference in excess of that subject to the one time transition tax) is not practicable.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Further, starting in fiscal 2019, the Act subjects a US shareholder of a controlled foreign corporation to current tax on &amp;#8220;global intangible low-taxed income&amp;#8221; (GILTI) and establishes a tax on certain payments from corporations subject to US tax to related foreign persons, also referred to as base erosion and anti-abuse tax (BEAT). &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Because of the complexity of the new international tax provisions not applicable to the Company until fiscal 2019, the Company is continuing to evaluate these provisions of the Act and the application of ASC 740. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Non-Income Tax Matters&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company is subject to tax examinations for value added, sales-based, payroll and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2018, the Company settled an ongoing state tax audit for approximately &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$11.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, resulting in a reversal of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.0 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; recorded to general and administrative expenses in the first quarter of fiscal 2018.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
	<us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-EAFE942A97A2A83D2D172012DE02BFEA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Intangible Assets and Goodwill&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Developed&amp;#160;technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,528.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,266.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,528.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,186.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;556.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;402.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;552.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;393.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;310.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;161.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;310.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;156.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Distribution agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-competition agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Business licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total acquired intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,487.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,837.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,483.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,742.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Internal-use software&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;65.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;64.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capitalized software embedded in products&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,569.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,887.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,562.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,790.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for each of the five succeeding fiscal years is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:87%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Remainder of Fiscal 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;283.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;366.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;354.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;333.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;320.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company conducted its fiscal 2017 impairment test on the first day of the fourth quarter, and used a discounted cash flow method (DCF) to estimate the fair value of its reporting units as of July 2, 2017. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing Step 1, all of the Company's reporting units had fair values exceeding their carrying values, and as such, Step 2 of the impairment test was not required. However, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;one&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of its reporting units, Medical Aesthetics, had a fair value as of the measurement date that exceeded its carrying value by &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; with goodwill of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$683.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The Medical Aesthetics reporting unit is solely comprised of the Cynosure, Inc. business, which the Company acquired on March 22, 2017. In connection with the Company's annual strategic planning process and annual goodwill impairment test, it lowered its estimated financial projections for this business as a result of its then current operating performance being below expectations, which the Company primarily attributed to the significant turnover in the U.S. sales force in 2017 following the date of acquisition. The Company is continuing its efforts to rebuild the U.S. sales force and this continues to affect short term performance. The Company&amp;#8217;s long-term outlook for the Medical Aesthetics business has not materially changed. The Company is continuing to monitor the operating performance of this reporting unit compared to the projections used in the annual impairment test, as well as current market and business conditions, to determine if an event has occurred or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. The Company has evaluated these factors and determined that no significant events occurred or circumstances changed during the period ended December 30, 2017 that would suggest it is more likely than not that the fair value of the reporting unit has declined below its carrying value. In the event the Company is unsuccessful in its efforts to rebuild the U.S. sales force or its efforts take significantly longer than expected, or other adverse conditions are identified, future operating performance may be below forecasted projections. If this occurs, the Company may need to revise its long-term growth rates or increase discount rates, and these factors could result in a decline in the fair value of the reporting unit and the Company may be required to record a goodwill impairment charge.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
	<us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock contextRef="FD2018Q1YTD" id="Fact-EF5C25167EAA838F8FC12012DE021AC2">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Disposition&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Blood Screening Business&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On December 14, 2016, the Company entered into a definitive agreement to sell the assets of its blood screening business to its long-time commercial partner, Grifols for a sales price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.85 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in cash, subject to adjustment based on an estimated closing amount of inventory. The divestiture was completed on January 31, 2017, and the Company received &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.865 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The sale resulted in a gain of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$899.7 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; recorded in the second quarter of fiscal 2017 within operations in the Consolidated Statements of Income. As a result of this disposition and proceeds received, the Company recorded a tax obligation of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$649.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which was paid in fiscal 2017. Upon the closing of the transaction, the Company's existing collaboration agreement with Grifols terminated, and a new collaboration agreement was executed as part of this transaction pursuant to which the Company provides certain research and development services to Grifols. In addition, the Company agreed to provide transition services to Grifols over the next &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;two&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; years depending on the nature of the respective service, including the manufacture of inventory. The Company also agreed to sell Panther instrumentation and certain supplies to Grifols as part of a long term supply agreement. In determining the accounting for the multiple elements of the overall arrangement, the Company allocated &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$13.1 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the proceeds to these elements based on their estimated fair values. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company determined this disposal did not qualify to be reported as a discontinued operation as the blood screening business was deemed not to be strategic to the Company and has not had and will not have a major effect on the Company's operations and financial results. Under the previous collaboration agreement, the Company performed research and development activities and manufacturing, while Grifols performed the commercial and distribution activities. The blood screening business was embedded within the Company's molecular diagnostics business, and the Company retains ownership and will continue to use the intellectual property for the underlying technology of its molecular diagnostics assays and instrumentation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income from operations of the disposed business presented below represents the pretax profit of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business and are now incurred by Grifols. As noted above, the Company is performing a number of transition services and the financial impact from these services are not included in income from operations presented below. The Company is in effect serving as a contract manufacturer of assays for Grifols for a two to three year period from the date of disposal. Revenue and income from operations of the disposed business for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; month period ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; was &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$65.2 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$28.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively. Under the long term supply agreement, transition services agreement to manufacture assays and research and development services, the Company recorded revenue of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for the three months ended December 30, 2017.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
	<us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="FD2018Q1YTD" id="Fact-ED06DB095C7671B9F72C57AB094AA87B">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;New Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2017, the FASB issued ASU No. 2017-04, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Intangibles-Goodwill and Other (Topic 350)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. This guidance simplifies how companies calculate goodwill impairments by eliminating Step 2 of the impairment test. The guidance requires companies to compare the fair value of a reporting unit to its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value. The guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2020. Early adoption is permitted. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In October 2016, the FASB issued ASU No. 2016-16, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Income Taxes (Topic 740).&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; The guidance requires companies to recognize the income tax effects of intercompany sales and transfers of assets, other than inventory, in the income statement as income tax expense (or benefit) in the period in which the transfer occurs. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of the adoption of ASU 2016-16 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In August 2016, the FASB issued ASU No. 2016-15, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Statement of Cash Flow (Topic 230)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The guidance reduces diversity in how certain cash receipts and cash payments are presented and classified in the Statements of Cash Flows. Certain of ASU 2016-15 requirements are as follows: 1) cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities, 2) contingent consideration payments made soon after a business combination should be classified as cash outflows for investing activities and cash payment made thereafter should be classified as cash outflows for financing up to the amount of the contingent consideration liability recognized at the acquisition date with any excess classified as operating activities, 3) cash proceeds from the settlement of insurance claims should be classified on the basis of the nature of the loss, 4) cash proceeds from the settlement of Corporate-Owned Life Insurance (COLI) Policies should be classified as cash inflows from investing activities and cash payments for premiums on COLI policies may be classified as cash outflows for investing activities, operating activities, or a combination of investing and operating activities, and 5) cash paid to a tax authority by an employer when withholding shares from an employee's award for tax-withholding purposes should be classified as cash outflows for financing activities. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted. The adoption of ASU 2016-15 is not expected to have a material effect on the Company's consolidated financial statements. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In February 2016, the FASB issued ASU No. 2016-02, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Leases (Topic 842).&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; The guidance requires an entity to recognize a right-of-use asset and a lease liability for virtually all of its leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as a finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The guidance is effective for annual periods beginning after December&amp;#160;15, 2018, and is applicable to the Company in fiscal 2020. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-02 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In January 2016, the FASB issued ASU No. 2016-01, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. This guidance changes how &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#333333;"&gt;entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. A practicability exception will be available for equity investments that do not have readily determinable fair values, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;however; the exception requires the Company to consider relevant transactions that can be&amp;#160;reasonably known to identify any observable price changes that would impact the fair value&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;color:#333333;"&gt;. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Early adoption is permitted. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-01 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In May 2014, the FASB issued ASU No. 2014-09,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt; Revenue from Contracts with Customers (Topic 606)&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, which provides guidance for revenue recognition. This ASU is applicable to any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets. ASU 2014-09 will supersede the revenue recognition requirements in Topic 605,&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt; Revenue Recognition&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, and most industry-specific guidance. The standard&amp;#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to receive in exchange for those goods or services. In doing so, companies will need to use more judgment and make more estimates than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December&amp;#160;15, 2017, which is fiscal 2019 for the Company. The Company will adopt Topic 606 effective September 30, 2018 and has established a cross-functional team to evaluate and implement the new revenue recognition rules. The Company will adopt Topic 606 using the modified retrospective method but has not finalized evaluating the anticipated impact of the adoption of ASU 2014-09 on its consolidated financial position and results of operations.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
	<us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-76AC10A3514739CDEBC957A680413BB8">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:16px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Basis of Presentation&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements of Hologic, Inc. (&amp;#8220;Hologic&amp;#8221; or the &amp;#8220;Company&amp;#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&amp;#8220;GAAP&amp;#8221;). These financial statements should be read in conjunction with the consolidated financial statements and related notes for the year ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; included in the Company&amp;#8217;s Form&amp;#160;10-K filed with the SEC on November&amp;#160;21, 2017. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company&amp;#8217;s financial position, results of operations and cash flows for the periods presented.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&amp;#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;September&amp;#160;29, 2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;On March 22, 2017, the Company completed the acquisition of Cynosure, Inc. ("Cynosure"), which resulted in the Company expanding into the medical aesthetics market. Cynosure develops, manufactures and markets aesthetic treatment systems that enable medical practitioners to perform non-invasive and minimally invasive procedures. Cynosure's results of operations are reported within the Company's Medical Aesthetics reportable segment. The Company's acquisition of Cynosure is more fully described in Note 3.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Recently Adopted Accounting Pronouncements&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In December 2016, the FASB issued Accounting Standards Update No. 2016-19, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Technical Corrections and Improvements&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (ASU 2016-19). This guidance changes how companies classify internal-use software from classification within property, plant, and equipment to intangible assets. The amendments in the update are effective for annual periods beginning after December 15, 2016, and were applicable to the Company in fiscal 2018. The Company adopted ASU 2016-19 in the first quarter of fiscal 2018. As a result of the adoption, the Company has reclassified &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$17.6 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$18.4 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of internal-use software from property, plant, and equipment to intangible assets as of December 30, 2017 and September 30, 2017, respectively. Additionally, the Company reclassified &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.9 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$12.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of capitalized software embedded in its products from other assets to intangible assets as of December 30, 2017 and September 30, 2017, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Subsequent Events Consideration&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events recorded in the unaudited consolidated financial statements as of and for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. On  January 19, 2018, the Company completed a private placement of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; aggregate principal amount of senior notes, allocated between (i) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$600 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of its &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.375%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2025 (the &amp;#8220;New 2025 Senior Notes&amp;#8221;) at an offering price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount of the 2025 Senior Notes, plus accrued and unpaid interest from October 10, 2017, and (ii) &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$400 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of its new &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.625%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2028 (the "2028 Senior Notes," and together with the New 2025 Senior Notes, the "New Notes") at an offering price of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the aggregate principal amount of the 2028 Senior Notes. In connection with the offering of the New Notes, the Company has called all of its outstanding &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.250%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Senior Notes due 2022 (the "2022 Senior Notes"), in aggregate principal amount of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.0 billion&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:174%;text-align:center;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Additionally, on January 29, 2018, the Company announced that pursuant to the terms of the indenture for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.00%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; Convertible Senior Notes due 2042 (the &amp;#8220;2042 Notes&amp;#8221;), holders of the 2042 Notes had the option of requiring the Company to repurchase their 2042 Notes on March 1, 2018 at a repurchase price payable in cash equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the put date. The Company also announced on January 29, 2018 that it had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100%&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the redemption date. Holders also have a right to convert their 2042 Notes. In connection with holders&amp;#8217; right to convert the 2042 Notes, the Company announced that it would settle all conversions of 2042 Notes entirely in cash. &lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
	<us-gaap:ProductWarrantyDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-19E551ED42615D5B5F032012DE0241BE">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Product Warranties&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Product warranty activity was as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.9453125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Beginning&amp;#160;of&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Provisions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Settlements/&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;End&amp;#160;of&amp;#160;Period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Three Months Ended:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
	<us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="FD2018Q1YTD" id="Fact-FE936FCDA4094F0E70172012DE027A5A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-bottom:24px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Property, plant and equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Equipment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;363.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;357.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Equipment under customer usage agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;379.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;368.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Building and improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;172.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;172.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Leasehold improvements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;61.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;60.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Land&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Furniture and fixtures&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,043.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,026.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Less &amp;#8211; accumulated depreciation and amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(576.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(553.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;467.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;472.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
	<us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-FB7F8424D6EE105103D32012DE025647">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Restructuring Charges&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. In addition, the Company continually assesses its management and organizational structure. As a result of these assessments, the Company has undertaken various restructuring actions, which are described below. The following table displays charges related to these actions recorded in the fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; year to date period (&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended December 30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;) and fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (the year ended September 30, 2017) and a rollforward of the accrued balances from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.421875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2018 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2017 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2016 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;"&gt;Restructuring Charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2017 charges:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Workforce reductions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Facility closure costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2017 restructuring charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2018 charges:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Workforce reductions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2018 restructuring charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.5703125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:35%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2018 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2017 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2016 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;"&gt;Rollforward of Accrued Restructuring&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance as of September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2018 charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Severance payments and adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance as of December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fiscal 2018 Actions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;During the first quarter of fiscal 2018, the Company decided to terminate certain employees across the organization, including a corporate executive and sales and marketing personnel in its Diagnostics and Medical Aesthetics reportable segments. The charges were recorded pursuant to ASC 712, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Compensation-Nonretirement Postemployment Benefits &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(ASC 712) or ASC 420, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Exit or Disposal Cost Obligations &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(ASC 420) depending on the employee. As such, the Company recorded severance and benefits charges of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.8 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in the first quarter. Included within this charge is &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; related to the modification of equity awards.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fiscal 2017 Actions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In connection with its acquisition of Cynosure, the Company decided to terminate certain Cynosure executives in the second quarter of fiscal 2017 and recorded &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; in severance and benefits charges. During the third and fourth quarters of fiscal 2017, the Company terminated additional executives and employees and recorded &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$4.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;, respectively, in severance and benefits charges. &lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-style:italic;"&gt;Fiscal 2016 Actions&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:24px;text-align:left;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In connection with the closure of the Bedford, Massachusetts facility, during the first quarter of fiscal 2017 the Company recorded &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$3.5 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for lease obligation charges related to a section of the facility that the Company had determined met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it can obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it will take to obtain a subtenant at the Bedford location and as a result recorded an additional &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$1.3 million&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; lease obligation charge. These estimates may vary from the actual sublease agreements executed, if at all, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
	<us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="FD2018Q1YTD" id="Fact-963AFC5AF5D705153D1C2012DE02ABDE">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Three Months Ended December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Pension Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Hedged Interest Rate Caps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Beginning Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(18.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(16.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;5.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Amounts reclassified to statement of income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Ending Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(13.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(1.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(11.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="20" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:46%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:8%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Three Months Ended December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Foreign Currency Translation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Marketable Securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Pension Plans&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Hedged Interest Rate Caps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;font-weight:bold;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Beginning Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(26.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(3.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(32.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Other comprehensive income (loss) before reclassifications&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(15.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(12.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Amounts reclassified to statement of income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;Ending Balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(41.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(0.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;(42.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:7pt;"&gt;&lt;font style="font-family:inherit;font-size:7pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
	<us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="FD2018Q1YTD" id="Fact-C63060F91048851542292012DE026C54">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The estimated fair values of the Company&amp;#8217;s Convertible Notes at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:83%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2042 Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;284.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2043 Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;285.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
	<us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="FD2018Q1YTD" id="Fact-1F5ECAE516EF255232692012DE0219F5">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents the unrealized gain recognized in AOCI related to the interest rate caps for the following reporting periods:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.8125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:67%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Amount of gain (loss) recognized in other comprehensive income, net of taxes:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
	<us-gaap:ScheduleOfDebtTableTextBlock contextRef="FD2018Q1YTD" id="Fact-9AB53ABD5720C132748B2012DE024034">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company&amp;#8217;s borrowings consisted of the following:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:74%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revolver&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;120.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Securitization Program&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;200.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Convertible Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;205.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;484.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total current debt obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;572.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,150.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Long-term debt obligations, net of debt discount and deferred issuance costs:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Term Loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,430.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,190.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2022 Senior Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;982.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;981.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2025 Senior Notes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;345.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total long-term debt obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,757.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,172.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total debt obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,329.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,322.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
	<us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock contextRef="FD2018Q1YTD" id="Fact-CD6171D34A9CAF19ECD62012DE029A5F">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;: &lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:49%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:19%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance Sheet Location&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivative instruments designated as a cash flow hedge:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:42px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid expenses and other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;padding-left:42px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivatives not designated as hedging instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Prepaid expenses and other current assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Derivatives not designated as hedging instruments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Accrued expenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
	<us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="FD2018Q1YTD" id="Fact-644FE1ED24652573BB4B2012DE023920">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:71%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Basic weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;276,856&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;278,663&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average common stock equivalents from assumed exercise of stock options and stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,212&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3,143&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Incremental shares from Convertible Notes premium&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,734&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,418&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diluted weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;280,802&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;284,224&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted-average anti-dilutive shares related to:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Outstanding stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,272&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,442&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;216&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
	<us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="FD2018Q1YTD" id="Fact-8B1FF64FD75D6283C3F62012DE02F387">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:38%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:12%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fair Value at Reporting Date Using&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance as of December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Quoted&amp;#160;Prices&amp;#160;in&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Active&amp;#160;Market&amp;#160;for&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Identical&amp;#160;Assets&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;(Level&amp;#160;1)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Observable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Inputs&amp;#160;(Level&amp;#160;2)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Significant&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Unobservable&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Inputs&amp;#160;(Level&amp;#160;3)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Interest rate cap - derivative&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Deferred compensation liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;52.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;49.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
	<us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="FD2018Q1YTD" id="Fact-0E8F6CDEE5608220B17D2012DE02DEC1">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Intangible assets consisted of the following:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:45%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;"&gt;Description&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;As of September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Acquired intangible assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Developed&amp;#160;technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,528.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,266.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4,528.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,186.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;In-process research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Customer relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;556.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;402.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;552.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;393.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Trade names&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;310.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;161.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;310.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;156.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Distribution agreement&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;42.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Non-competition agreements&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Business licenses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total acquired intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,487.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,837.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,483.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,742.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;height:20px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Internal-use software&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;65.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;48.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;64.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;46.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capitalized software embedded in products&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;15.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;14.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,569.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,887.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5,562.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,790.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
	<us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="FD2018Q1YTD" id="Fact-2AF665A37DAC1C888CA92012DE023715">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:73%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Inventories&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;114.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;95.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Work-in-process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;44.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;45.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Finished goods&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;199.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;190.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;358.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;331.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
	<us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock contextRef="FD2018Q1YTD" id="Fact-3C6AF62DFF9FE7A19B1D2012DE027CBA">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.53125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="10" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:36%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:14%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:30%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Derivatives not classified as hedging instruments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Amount of Gain (Loss) Recognized in Income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Location of Gain (Loss) Recognized in Income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Forward foreign currency contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;9.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other income, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
	<us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="FD2018Q1YTD" id="Fact-10503DD81025A82F2B302012DE024515">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Product warranty activity was as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.9453125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="16" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:53%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Beginning&amp;#160;of&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Provisions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Settlements/&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Balance&amp;#160;at&lt;/font&gt;&lt;/div&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;End&amp;#160;of&amp;#160;Period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Three Months Ended:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;17.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;16.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December 31, 2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
	<us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock contextRef="FD2018Q1YTD" id="Fact-BB5986ABA9151B481BFD2012DE027889">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The following table displays charges related to these actions recorded in the fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2018&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; year to date period (&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three months ended December 30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;) and fiscal &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; (the year ended September 30, 2017) and a rollforward of the accrued balances from &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;September&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; to &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.421875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="17" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:52%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:9%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2018 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2017 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2016 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;"&gt;Restructuring Charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2017 charges:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Workforce reductions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Facility closure costs&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2017 restructuring charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2018 charges:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Workforce reductions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2018 restructuring charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
	<us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="FD2018Q1YTD" id="Fact-885DEB0EDC78D21484F12012DE0236E0">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.5703125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="21" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:35%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:10%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2018 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2017 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Fiscal 2016 Actions&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Total&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;"&gt;Rollforward of Accrued Restructuring&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance as of September 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2018 charges&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Stock-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(1.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Severance payments and adjustments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(2.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(3.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Other payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(0.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Balance as of December 30, 2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
	<us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock contextRef="FD2018Q1YTD" id="Fact-AD4FDF4202018C4AF76F2012DE02912A">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;75.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;77.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Europe&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Asia-Pacific&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Rest of World&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
	<us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="FD2018Q1YTD" id="Fact-25637AF675BB18F9181F2012DE028AA7">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Segment information is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.203125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:69%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total revenues:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;284.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;325.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;288.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;273.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;91.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;107.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;114.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;791.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;734.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income (loss) from operations:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;146.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation and amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;64.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;84.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;115.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capital expenditures:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Identifiable assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,583.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,621.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;840.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;824.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,723.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,751.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,477.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,494.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,396.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,262.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,048.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,979.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
	<us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="FD2018Q1YTD" id="Fact-256C23C12D7D429E0E122012DE02C66C">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.2421875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected volatility&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;35.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Expected life (in years)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Dividend yield&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Weighted average fair value of options granted&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;13.00&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;12.18&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
	<us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="FD2018Q1YTD" id="Fact-B7C139B2B7328E032CE12012DE020862">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; for each of the five succeeding fiscal years is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="4" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:87%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:11%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Remainder of Fiscal 2018&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;283.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2019&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;366.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2020&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;354.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2021&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;333.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Fiscal 2022&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;320.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
	<us-gaap:SegmentReportingDisclosureTextBlock contextRef="FD2018Q1YTD" id="Fact-7D07DA882ED7B473E7BF2012DE023568">&lt;div style="font-family:Times New Roman;font-size:10pt;"&gt;&lt;div style="line-height:120%;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;font-weight:bold;"&gt;Business Segments and Geographic Information&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company has &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, acquisition related fair value adjustments and integration expenses, restructuring, divestiture and facility consolidation charges and other one-time or unusual items.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Identifiable assets for the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; principal operating segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;five&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; reportable segments. The Company has presented all other identifiable assets as corporate assets. There were &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; inter-segment revenues during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;. Segment information is as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.203125%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:69%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:13%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Total revenues:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;284.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;325.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;288.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;273.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;91.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;107.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;114.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;19.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;20.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;791.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;734.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Income (loss) from operations:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;36.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;41.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;89.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;85.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(23.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;30.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;(5.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;134.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;146.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Depreciation and amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;64.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;84.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;5.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;28.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;22.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;121.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;115.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Capital expenditures:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#8212;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;0.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;21.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;24.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="8" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:15%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;September&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Identifiable assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Diagnostics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,583.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;2,621.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Breast Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;840.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;824.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Medical Aesthetics&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,723.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,751.2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;GYN Surgical&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,477.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,494.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Skeletal Health&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;26.8&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;25.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,396.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;1,262.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8,048.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;7,979.6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&lt;br clear="none"/&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company had &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; customers that represented greater than 10% of consolidated revenues during the &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;three&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; months ended &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;30, 2017&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; and &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;December&amp;#160;31, 2016&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, &lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;no&lt;/font&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt; single country accounted for more than 10% of consolidated revenues. The Company&amp;#8217;s sales in Europe are predominantly derived from France, Germany and the United Kingdom. The Company&amp;#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &amp;#8220;Rest of World&amp;#8221; designation includes Canada, Latin America and the Middle East.&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;font-size:12pt;"&gt;&lt;font style="font-family:inherit;font-size:12pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;div style="line-height:120%;padding-bottom:24px;text-align:center;font-size:10pt;"&gt;&lt;div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"&gt;&lt;table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"&gt;&lt;tr&gt;&lt;td colspan="6" rowspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="width:65%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:16%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;td style="width:1%;" rowspan="1" colspan="1"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;Three Months Ended&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;30, &lt;br clear="none"/&gt;2017&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"&gt;&lt;div style="text-align:center;font-size:8pt;"&gt;&lt;font style="font-family:inherit;font-size:8pt;font-weight:bold;"&gt;December&amp;#160;31, &lt;br clear="none"/&gt;2016&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;75.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;77.9&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Europe&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;11.5&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;10.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Asia-Pacific&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.7&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;8.4&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;Rest of World&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;4.3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;3.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"&gt;&lt;div style="overflow:hidden;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:right;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;100.0&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"&gt;&lt;div style="text-align:left;font-size:10pt;"&gt;&lt;font style="font-family:inherit;font-size:10pt;"&gt;%&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
	<link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
	</link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>holx-20171230.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20171230" xmlns:holx="http://www.hologic.com/20171230" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import namespace="http://fasb.org/us-gaap/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-roles/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-roles-2017-01-31.xsd" />
  <xsd:import namespace="http://fasb.org/us-types/2017-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2017/elts/us-types-2017-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/currency/2017-01-31" schemaLocation="http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/exch/2017-01-31" schemaLocation="http://xbrl.sec.gov/exch/2017/exch-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/naics/2017-01-31" schemaLocation="http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20171230_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20171230_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20171230_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20171230_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple" />
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetail" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail">
        <link:definition>2419402 - Disclosure - Accumulated Other Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2119100 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2319301 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentation" roleURI="http://www.hologic.com/role/BasisOfPresentation">
        <link:definition>2101100 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisOfPresentationDetails" roleURI="http://www.hologic.com/role/BasisOfPresentationDetails">
        <link:definition>2401401 - Disclosure - Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAndCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangements">
        <link:definition>2105100 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAndCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail">
        <link:definition>2405403 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAndCreditArrangementsAdditionalInformationDetailCalc2" roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetailCalc2">
        <link:definition>2405403 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>2405402 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail">
        <link:definition>2405404 - Disclosure - Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAndCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables">
        <link:definition>2305301 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>2403402 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationProFormaInformationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails">
        <link:definition>2403405 - Disclosure - Business Combination - Pro Forma Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationPurchasePriceAllocationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails">
        <link:definition>2403404 - Disclosure - Business Combination - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationPurchasePriceConsiderationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails">
        <link:definition>2403403 - Disclosure - Business Combination - Purchase Price Consideration (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>2103100 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>2303301 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsAndGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation">
        <link:definition>2114100 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail">
        <link:definition>2414402 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail">
        <link:definition>2414404 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsAndGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail">
        <link:definition>2414403 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsAndGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables">
        <link:definition>2314301 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingencies" roleURI="http://www.hologic.com/role/CommitmentsAndContingencies">
        <link:definition>2108100 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsAndContingenciesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail">
        <link:definition>2408401 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003000 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1004000 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1002000 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfComprehensiveIncomeParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical">
        <link:definition>1002501 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfIncome">
        <link:definition>1001000 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.hologic.com/role/Derivatives">
        <link:definition>2107100 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails">
        <link:definition>2407402 - Disclosure - Derivatives Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" roleURI="http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails">
        <link:definition>2407403 - Disclosure - Derivatives Fair Value of Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" roleURI="http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails">
        <link:definition>2407405 - Disclosure - Derivatives Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>2407404 - Disclosure - Derivatives Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleOfDerivativeAssetsAtFairValueTables" roleURI="http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables">
        <link:definition>2307301 - Disclosure - Derivatives Schedule of Derivative Assets at Fair Value (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Disposition" roleURI="http://www.hologic.com/role/Disposition">
        <link:definition>2112100 - Disclosure - Disposition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionDetails" roleURI="http://www.hologic.com/role/DispositionDetails">
        <link:definition>2412401 - Disclosure - Disposition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DocumentAndEntityInformation" roleURI="http://www.hologic.com/role/DocumentAndEntityInformation">
        <link:definition>0001000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.hologic.com/role/FairValueMeasurements">
        <link:definition>2102100 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>2402403 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail">
        <link:definition>2402404 - Disclosure - Fair Value Measurements - Estimated Fair Values of Convertible Notes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail">
        <link:definition>2402402 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>2302301 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.hologic.com/role/IncomeTaxes">
        <link:definition>2116100 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.hologic.com/role/IncomeTaxesDetails">
        <link:definition>2416401 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwill" roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwill">
        <link:definition>2117100 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillAdditionalInformationDetails" roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails">
        <link:definition>2417404 - Disclosure - Intangible Assets and Goodwill Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail">
        <link:definition>2417403 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail">
        <link:definition>2417402 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAndGoodwillTables" roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables">
        <link:definition>2317301 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShare" roleURI="http://www.hologic.com/role/NetIncomePerShare">
        <link:definition>2110100 - Disclosure - Net Income Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail">
        <link:definition>2410402 - Disclosure - Net Income Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareTables" roleURI="http://www.hologic.com/role/NetIncomePerShareTables">
        <link:definition>2310301 - Disclosure - Net Income Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.hologic.com/role/NewAccountingPronouncements">
        <link:definition>2120100 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsNewAccountingPronouncementsPolicies" roleURI="http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies">
        <link:definition>2220201 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformation" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation">
        <link:definition>2113100 - Disclosure - Other Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail">
        <link:definition>2413402 - Disclosure - Other Balance Sheet Information - Other Balance Sheet Information of Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail">
        <link:definition>2413403 - Disclosure - Other Balance Sheet Information - Other Balance Sheet Information of Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationTables" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables">
        <link:definition>2313301 - Disclosure - Other Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranties" roleURI="http://www.hologic.com/role/ProductWarranties">
        <link:definition>2118100 - Disclosure - Product Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesProductWarrantyActivityDetail" roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail">
        <link:definition>2418402 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesTables" roleURI="http://www.hologic.com/role/ProductWarrantiesTables">
        <link:definition>2318301 - Disclosure - Product Warranties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringCharges" roleURI="http://www.hologic.com/role/RestructuringCharges">
        <link:definition>2104100 - Disclosure - Restructuring Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesAdditionalInformationDetail" roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail">
        <link:definition>2404404 - Disclosure - Restructuring Charges - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail">
        <link:definition>2404403 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail">
        <link:definition>2404402 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringChargesTables" roleURI="http://www.hologic.com/role/RestructuringChargesTables">
        <link:definition>2304301 - Disclosure - Restructuring Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.hologic.com/role/StockBasedCompensation">
        <link:definition>2111100 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail">
        <link:definition>2411403 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail">
        <link:definition>2411402 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockBasedCompensationTables">
        <link:definition>2311301 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail">
        <link:definition>2411404 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element abstract="true" id="holx_A2022NotesMember" name="A2022NotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_A2025SeniorNotesMember" name="A2025SeniorNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_A2028SeniorNotesMember" name="A2028SeniorNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_A2042NotesMember" name="A2042NotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_A2043NotesMember" name="A2043NotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_AccountsReceivableSecuritizationMember" name="AccountsReceivableSecuritizationMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_AccumulatedOtherComprehensiveIncomeAbstract" name="AccumulatedOtherComprehensiveIncomeAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_AccumulatedothercomprehensiveIncomelossHedge" name="AccumulatedothercomprehensiveIncomelossHedge" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="holx_AcquiredintangibleassetsMember" name="AcquiredintangibleassetsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_AcquisitionPriceAdjustment" name="AcquisitionPriceAdjustment" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="holx_AllOtherCountriesMember" name="AllOtherCountriesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_AmendedCreditAgreementMember" name="AmendedCreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_AmendedRevolverMember" name="AmendedRevolverMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_AmendedTermLoanMember" name="AmendedTermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_AmortizationOfDeferredFinancingCosts" name="AmortizationOfDeferredFinancingCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_AmountAssessedInDamages" name="AmountAssessedInDamages" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="holx_AssetsofBusinessHeldforSaleAbstract" name="AssetsofBusinessHeldforSaleAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_BasePrincipalAmountForAccretionValue" name="BasePrincipalAmountForAccretionValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_BedfordMember" name="BedfordMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_BloodScreeningBusinessMember" name="BloodScreeningBusinessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_BreastHealthMember" name="BreastHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability" name="BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" name="BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_BusinessLicensesMember" name="BusinessLicensesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_CapitalizedsoftwareMember" name="CapitalizedsoftwareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_CashPerOriginalPrincipalAmountofExchangeNotes" name="CashPerOriginalPrincipalAmountofExchangeNotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="holx_CashSeverancePayments" name="CashSeverancePayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_CreditAgreementMember" name="CreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_CustomerRelationshipsContractsMember" name="CustomerRelationshipsContractsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_CynosureMember" name="CynosureMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_CynosureShareholdersMember" name="CynosureShareholdersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_DebtInstrumentCashAccruedInterestPercentage" name="DebtInstrumentCashAccruedInterestPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate" name="DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" name="DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" name="DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" name="DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" name="DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" name="DebtInstrumentPercentageRedemptionPriceSixthPeriod" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_DebtInstrumentPeriodicPaymentPrincipalPeriod" name="DebtInstrumentPeriodicPaymentPrincipalPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility" name="DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse" name="DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_DeferredTaxesReacquisitionofEquityComponent" name="DeferredTaxesReacquisitionofEquityComponent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="holx_DetailsOfCertainBalanceSheetAccountsTextBlock" name="DetailsOfCertainBalanceSheetAccountsTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_DevelopedTechnologyMember" name="DevelopedTechnologyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_DiagnosticsMember" name="DiagnosticsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_DirectThirdPartyCostsinterestExpense" name="DirectThirdPartyCostsinterestExpense" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal" name="DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_DistributionagreementMember" name="DistributionagreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_EarningsPerShareLineItems" name="EarningsPerShareLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_EarningsPerShareTable" name="EarningsPerShareTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount" name="EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_EmsorMember" name="EmsorMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_EquipmentUnderCustomerUsageAgreements" name="EquipmentUnderCustomerUsageAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="holx_EstimatedFairValueOfFinancialInstrumentsLineItems" name="EstimatedFairValueOfFinancialInstrumentsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_EstimatedFairValueOfFinancialInstrumentsTable" name="EstimatedFairValueOfFinancialInstrumentsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_FacilityClosureCosts" name="FacilityClosureCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_Fiscal2016ActionsDomain" name="Fiscal2016ActionsDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_Fiscal2017ActionsMember" name="Fiscal2017ActionsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_Fiscal2018ActionMember" name="Fiscal2018ActionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_GrifolsMember" name="GrifolsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_GrossProceedsonSale" name="GrossProceedsonSale" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_GynSurgicalMember" name="GynSurgicalMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities" name="IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_InterestCoverageRatio" name="InterestCoverageRatio" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_InterestRateCapAgreementsAggregatePremiumPayable" name="InterestRateCapAgreementsAggregatePremiumPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="holx_Internalusesoftware" name="Internalusesoftware" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="holx_InternalusesoftwareMember" name="InternalusesoftwareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_LeverageRatioMaximum" name="LeverageRatioMaximum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_LongTermDebtObligationsWithoutConvertibleNotes" name="LongTermDebtObligationsWithoutConvertibleNotes" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="holx_ManufacturingEquipmentAndSoftware" name="ManufacturingEquipmentAndSoftware" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="holx_MarketBasedAwardsMember" name="MarketBasedAwardsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_MaximumRangeofPresentValueofCashFlowPercentage" name="MaximumRangeofPresentValueofCashFlowPercentage" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_MedicalAestheticsDomain" name="MedicalAestheticsDomain" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_MedicorMedicalSupplyMember" name="MedicorMedicalSupplyMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_NotionalAmount" name="NotionalAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="holx_NumberofProjects" name="NumberofProjects" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue" name="Numberofcountrieswithgreaterthan10ofconsolidatedrevenue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_OfferingPriceofPrincipalAmount" name="OfferingPriceofPrincipalAmount" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant" />
  <xsd:element id="holx_OtherRestructuringPayments" name="OtherRestructuringPayments" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_PercentageAddedtoEurodollarRateMember" name="PercentageAddedtoEurodollarRateMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_PercentageOfRevenues" name="PercentageOfRevenues" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" name="PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_PrincipalAmountOfBorrowings" name="PrincipalAmountOfBorrowings" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element id="holx_PrincipalConvertibleToCommonStock" name="PrincipalConvertibleToCommonStock" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="holx_ProceedsFromSaleOfBusiness" name="ProceedsFromSaleOfBusiness" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_Proceedsallocatedtomanufactureofinventory" name="Proceedsallocatedtomanufactureofinventory" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element abstract="true" id="holx_ProductLineLineItems" name="ProductLineLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_ProductLineTable" name="ProductLineTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_PurchasePriceAllocationLineItems" name="PurchasePriceAllocationLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_PurchasePriceAllocationTable" name="PurchasePriceAllocationTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_PurchasePriceAllocationTableTextBlock" name="PurchasePriceAllocationTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_ReductionOfWorkforceExpenses" name="ReductionOfWorkforceExpenses" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete" name="ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element id="holx_RestructuringChargesUnderExitOrDisposalPlan" name="RestructuringChargesUnderExitOrDisposalPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_Restructuringchargesgross" name="Restructuringchargesgross" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_RevolverMember" name="RevolverMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_ScheduleOfGeographicalSegmentsLineItems" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_ScheduleOfGeographicalSegmentsTable" name="ScheduleOfGeographicalSegmentsTable" nillable="true" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" name="ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_SecuredTermLoanMember" name="SecuredTermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_SegmentReportingDisclosureLineItems" name="SegmentReportingDisclosureLineItems" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" name="ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" name="SharedBasedCompensationArrangementRestrictedStockVestingPeriod" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_SkeletalHealthMember" name="SkeletalHealthMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element id="holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit" name="TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit" name="TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration" />
  <xsd:element id="holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit" name="TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_TermLoanMember" name="TermLoanMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_TwoThousandAndThirteenNotesMember" name="TwoThousandAndThirteenNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_TwoThousandAndTwelveNotesMember" name="TwoThousandAndTwelveNotesMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_TwoThousandSeventeenMember" name="TwoThousandSeventeenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
  <xsd:element abstract="true" id="holx_TwothousandeighteenMember" name="TwothousandeighteenMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>holx-20171230_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BasisOfPresentation" xlink:href="holx-20171230.xsd#BasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BasisOfPresentationDetails" xlink:href="holx-20171230.xsd#BasisOfPresentationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangements" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetailCalc2" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsAdditionalInformationDetailCalc2" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:href="holx-20171230.xsd#BusinessCombinationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationPurchasePriceAllocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationPurchasePriceConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:href="holx-20171230.xsd#BusinessCombinations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:href="holx-20171230.xsd#BusinessCombinationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsAndContingencies" xlink:href="holx-20171230.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="holx-20171230.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:href="holx-20171230.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="holx-20171230.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfIncome" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:href="holx-20171230.xsd#Derivatives" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:href="holx-20171230.xsd#DerivativesAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:href="holx-20171230.xsd#DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:href="holx-20171230.xsd#DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:href="holx-20171230.xsd#DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:href="holx-20171230.xsd#DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:href="holx-20171230.xsd#Disposition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:href="holx-20171230.xsd#DispositionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DocumentAndEntityInformation" xlink:href="holx-20171230.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:href="holx-20171230.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:href="holx-20171230.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:href="holx-20171230.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:href="holx-20171230.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwill" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShare" xlink:href="holx-20171230.xsd#NetIncomePerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:href="holx-20171230.xsd#NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShareTables" xlink:href="holx-20171230.xsd#NetIncomePerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:href="holx-20171230.xsd#NewAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:href="holx-20171230.xsd#NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:href="holx-20171230.xsd#ProductWarranties" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:href="holx-20171230.xsd#ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:href="holx-20171230.xsd#ProductWarrantiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringCharges" xlink:href="holx-20171230.xsd#RestructuringCharges" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:href="holx-20171230.xsd#RestructuringChargesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:href="holx-20171230.xsd#RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:href="holx-20171230.xsd#RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesTables" xlink:href="holx-20171230.xsd#RestructuringChargesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:href="holx-20171230.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:href="holx-20171230.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:type="simple" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_c4b01a56-17cc-50a6-4d4b-5246d14da9dc" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_c4b01a56-17cc-50a6-4d4b-5246d14da9dc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e38d562c-e1dd-d525-b8c6-f86d8a100397" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e38d562c-e1dd-d525-b8c6-f86d8a100397" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_ac65944e-d0a3-7081-a0ad-366dc25783e8" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_ac65944e-d0a3-7081-a0ad-366dc25783e8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_f3faa0de-4469-1212-5127-2012ee50381e" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_f3faa0de-4469-1212-5127-2012ee50381e" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BasisOfPresentation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BasisOfPresentationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetailCalc2" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_7e14882f-7ab9-8302-20ff-24c510ab8806" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_f61bf97e-c3a5-ba72-7591-eba8e7bb6a44" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7e14882f-7ab9-8302-20ff-24c510ab8806" xlink:to="loc_us-gaap_LongTermDebtCurrent_f61bf97e-c3a5-ba72-7591-eba8e7bb6a44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_822b66ff-44a1-e66b-5e0c-09356970a23d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_7e14882f-7ab9-8302-20ff-24c510ab8806" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_822b66ff-44a1-e66b-5e0c-09356970a23d" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_1ba9bb67-398f-5b40-d538-c6d5b7e79933" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9a2cdf1-6f49-806b-7b55-b9320bcfa87f" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_1ba9bb67-398f-5b40-d538-c6d5b7e79933" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9a2cdf1-6f49-806b-7b55-b9320bcfa87f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_6998acca-43aa-59af-b14d-5e2253d7d1df" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9a2cdf1-6f49-806b-7b55-b9320bcfa87f" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_6998acca-43aa-59af-b14d-5e2253d7d1df" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmortizationOfDeferredFinancingCosts" xlink:label="loc_holx_AmortizationOfDeferredFinancingCosts_c408569f-a3f4-75ae-80aa-2012eecdd565" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9a2cdf1-6f49-806b-7b55-b9320bcfa87f" xlink:to="loc_holx_AmortizationOfDeferredFinancingCosts_c408569f-a3f4-75ae-80aa-2012eecdd565" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BasePrincipalAmountForAccretionValue" xlink:label="loc_holx_BasePrincipalAmountForAccretionValue_96436854-a2c4-0049-aac5-2012eeae7a55" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9a2cdf1-6f49-806b-7b55-b9320bcfa87f" xlink:to="loc_holx_BasePrincipalAmountForAccretionValue_96436854-a2c4-0049-aac5-2012eeae7a55" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d5d85dda-6e86-9458-9e20-bdb390e35a60" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_1ba9bb67-398f-5b40-d538-c6d5b7e79933" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d5d85dda-6e86-9458-9e20-bdb390e35a60" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5a23735a-10c2-64f7-3d5a-453792d1607d" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_5a23735a-10c2-64f7-3d5a-453792d1607d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_b38eb112-4bad-525a-3e5b-069aa6bff7d5" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_b38eb112-4bad-525a-3e5b-069aa6bff7d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_95ec2852-df8b-d033-5d13-a8d506cf481d" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_95ec2852-df8b-d033-5d13-a8d506cf481d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_de234906-4555-79c4-6c13-51f5af410421" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_de234906-4555-79c4-6c13-51f5af410421" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4e5d7007-764c-d3cb-5dbd-3a33b1b3941c" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_4e5d7007-764c-d3cb-5dbd-3a33b1b3941c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_e9cfbc01-ec7a-ebc3-f488-1f351e7b5937" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_e9cfbc01-ec7a-ebc3-f488-1f351e7b5937" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9481f0ea-bead-3f1d-7474-6ec0c6f5f2a6" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_9481f0ea-bead-3f1d-7474-6ec0c6f5f2a6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_89fa0401-d505-b313-96b2-bcca909a734a" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_89fa0401-d505-b313-96b2-bcca909a734a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_c000f8d0-343f-35ad-f8ec-31236fb55109" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_c000f8d0-343f-35ad-f8ec-31236fb55109" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ea5f0c55-82ec-3013-b10d-5cbd46212889" xlink:type="locator" />
    <link:calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_ea5f0c55-82ec-3013-b10d-5cbd46212889" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_f54f861c-821c-f61f-8552-032ba9f25ff0" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_f54f861c-821c-f61f-8552-032ba9f25ff0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_93a64cae-271a-5e6b-8c83-5adf9f941142" xlink:type="locator" />
    <link:calculationArc order="12" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_017de627-23c1-637c-52df-ee2eb736b728" xlink:to="loc_us-gaap_Goodwill_93a64cae-271a-5e6b-8c83-5adf9f941142" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ca4e9616-e6c5-3909-8bbd-9acc52adbb44" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_bc66fcc7-4638-7e93-2948-b833e774a337" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ca4e9616-e6c5-3909-8bbd-9acc52adbb44" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_bc66fcc7-4638-7e93-2948-b833e774a337" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_f61bf97e-c3a5-ba72-7591-eba8e7bb6a44" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_LongTermDebtCurrent_f61bf97e-c3a5-ba72-7591-eba8e7bb6a44" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_7a72b51a-735c-1ad4-bd3f-d9bcf2d6a26d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_AccountsPayableCurrent_7a72b51a-735c-1ad4-bd3f-d9bcf2d6a26d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3fe8f96b-142b-97b1-3b39-b8d22cd10e98" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3fe8f96b-142b-97b1-3b39-b8d22cd10e98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_98f473f8-2d19-99d7-6142-37f86ccd14ec" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_DeferredRevenueCurrent_98f473f8-2d19-99d7-6142-37f86ccd14ec" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_76865e4e-2049-cac6-edec-da1c3f948f32" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f5e246cf-e80f-d00b-c8ed-4796aa2df4b4" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_76865e4e-2049-cac6-edec-da1c3f948f32" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_822b66ff-44a1-e66b-5e0c-09356970a23d" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_822b66ff-44a1-e66b-5e0c-09356970a23d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_efe2512e-d4d4-64d6-9c0d-99078496415f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_efe2512e-d4d4-64d6-9c0d-99078496415f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_314eb579-3ee1-408c-39f2-e62f2f37befc" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_314eb579-3ee1-408c-39f2-e62f2f37befc" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_11e98ceb-5737-f44d-6a16-2d8b64b1228d" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_11e98ceb-5737-f44d-6a16-2d8b64b1228d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f234998c-5e05-09d0-d53e-5c44423c97c0" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f234998c-5e05-09d0-d53e-5c44423c97c0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_058e01e4-b9a1-623e-29f5-1b5c79bf095a" xlink:type="locator" />
    <link:calculationArc order="7" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_CommitmentsAndContingencies_058e01e4-b9a1-623e-29f5-1b5c79bf095a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:type="locator" />
    <link:calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_159dcb00-b17e-17db-7098-be4159799459" xlink:to="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_4fb6195d-d905-dac7-e5a0-79f324993f79" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_PreferredStockValue_4fb6195d-d905-dac7-e5a0-79f324993f79" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_c3f7606a-e7e9-61d5-b60b-b4b059f68b26" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_CommonStockValue_c3f7606a-e7e9-61d5-b60b-b4b059f68b26" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2d1b9d27-8b19-82d9-2843-5b3d292b7fbb" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2d1b9d27-8b19-82d9-2843-5b3d292b7fbb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_065cb284-7fca-cc9b-5752-2feaf74d0011" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_065cb284-7fca-cc9b-5752-2feaf74d0011" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_40678492-c421-af67-b276-f663f9ff2f98" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_TreasuryStockValue_40678492-c421-af67-b276-f663f9ff2f98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_4b158f76-5f04-5e4d-ead3-d80e1f9943db" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04f0961a-a0bc-88cf-6658-3f950da4a458" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07da1db4-2708-4446-4250-1fdd5956185e" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_07da1db4-2708-4446-4250-1fdd5956185e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd7775cd-f4ab-5607-9b31-1ee98f605818" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd7775cd-f4ab-5607-9b31-1ee98f605818" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaap_PrepaidTaxes_02645454-7101-7c15-39a1-317d5d74cc69" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_PrepaidTaxes_02645454-7101-7c15-39a1-317d5d74cc69" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e844b255-713b-0357-7991-a8c78d02cb50" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_8a47066b-3628-88d1-49db-ed09aecc7fc7" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e844b255-713b-0357-7991-a8c78d02cb50" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1944a381-5c4e-ce3c-9111-13ccd1c639db" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1944a381-5c4e-ce3c-9111-13ccd1c639db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fe06082-076b-052d-6e2e-930afe9d6b2d" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1fe06082-076b-052d-6e2e-930afe9d6b2d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_93a64cae-271a-5e6b-8c83-5adf9f941142" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_Goodwill_93a64cae-271a-5e6b-8c83-5adf9f941142" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9b27fab9-d497-627b-4cfb-6b585220b978" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c6057b1d-6685-8249-2051-6c57f3a16a9e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9b27fab9-d497-627b-4cfb-6b585220b978" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_b4463f01-8926-c348-9c78-89e2ab0ed145" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_Depreciation_b4463f01-8926-c348-9c78-89e2ab0ed145" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization_0b36ab30-8e3e-508d-4854-83e9460175f2" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_AdjustmentForAmortization_0b36ab30-8e3e-508d-4854-83e9460175f2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9a2cdf1-6f49-806b-7b55-b9320bcfa87f" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_e9a2cdf1-6f49-806b-7b55-b9320bcfa87f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_e3eecf87-b290-4567-8a59-5b0a8e27c85b" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_ShareBasedCompensation_e3eecf87-b290-4567-8a59-5b0a8e27c85b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f75d01b7-d271-b07d-c4a7-6ae60293303d" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f75d01b7-d271-b07d-c4a7-6ae60293303d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_371a4d3e-148a-313f-f556-b3ca6797139e" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_371a4d3e-148a-313f-f556-b3ca6797139e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dd4bfa5e-1979-c817-e8a9-371104c0d4f7" xlink:type="locator" />
    <link:calculationArc order="9" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dd4bfa5e-1979-c817-e8a9-371104c0d4f7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_bf3f9720-ba63-7ecd-52ae-e754a6f349db" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_bf3f9720-ba63-7ecd-52ae-e754a6f349db" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_5d7837b7-98c8-0196-1ce4-30f9afa3cfc8" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_5d7837b7-98c8-0196-1ce4-30f9afa3cfc8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c998cbd2-a633-c2ec-1932-e3bfedecbc9f" xlink:type="locator" />
    <link:calculationArc order="12" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c998cbd2-a633-c2ec-1932-e3bfedecbc9f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a8b6fe35-4809-bddf-7ef6-3144a6c89165" xlink:type="locator" />
    <link:calculationArc order="13" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a8b6fe35-4809-bddf-7ef6-3144a6c89165" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_74be5b6b-5c06-c74c-89da-2d9660b81d9b" xlink:type="locator" />
    <link:calculationArc order="14" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_74be5b6b-5c06-c74c-89da-2d9660b81d9b" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_91397648-589d-3b53-47c8-16b8909c78f4" xlink:type="locator" />
    <link:calculationArc order="15" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_444b1ac7-f47a-4ce3-0caa-537f7e4ab8c3" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_91397648-589d-3b53-47c8-16b8909c78f4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9d35c912-5b2d-89f7-eeb3-812a0511db5e" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9d35c912-5b2d-89f7-eeb3-812a0511db5e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fee12b15-6b42-6245-2e2f-ff030b98332c" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fee12b15-6b42-6245-2e2f-ff030b98332c" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_8547cf3b-f885-5f6a-0ab2-2012ef4a5996" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_8547cf3b-f885-5f6a-0ab2-2012ef4a5996" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_d3d89aab-5be8-f6a4-66e9-41f55e0839cd" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_d3d89aab-5be8-f6a4-66e9-41f55e0839cd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9c014c8e-ef65-6055-d342-3e048173d471" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_70319186-e7bd-7189-88d2-eba26fb93350" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9c014c8e-ef65-6055-d342-3e048173d471" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2b72fe5f-3c0e-d5e0-8e5c-ad01818e58e5" xlink:type="locator" />
    <link:calculationArc order="1" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2b72fe5f-3c0e-d5e0-8e5c-ad01818e58e5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_29550c2c-a38c-020e-eefe-8b4f4fff4b3f" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_29550c2c-a38c-020e-eefe-8b4f4fff4b3f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_01212795-787b-c56b-3988-b431e20a7b15" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_01212795-787b-c56b-3988-b431e20a7b15" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_1050dc04-f8c2-03a3-34af-47f0ecaba5f4" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_1050dc04-f8c2-03a3-34af-47f0ecaba5f4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_9da40861-8335-5a8e-60b4-2c6d2263d7f3" xlink:type="locator" />
    <link:calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_9da40861-8335-5a8e-60b4-2c6d2263d7f3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_bce346aa-ba15-aeef-61ad-e8ce13a3f0b4" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_bce346aa-ba15-aeef-61ad-e8ce13a3f0b4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_0e65f67a-86e3-c84f-fab4-e2c0fc4b175d" xlink:type="locator" />
    <link:calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_0e65f67a-86e3-c84f-fab4-e2c0fc4b175d" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f19a6911-0ca9-0f7f-0ae8-f18c6d766244" xlink:type="locator" />
    <link:calculationArc order="8" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_f19a6911-0ca9-0f7f-0ae8-f18c6d766244" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_d59a921e-6301-0411-46e6-49b6a981f8a0" xlink:type="locator" />
    <link:calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_d59a921e-6301-0411-46e6-49b6a981f8a0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_8f563464-80d3-5024-06bd-d0b7c03ce96e" xlink:type="locator" />
    <link:calculationArc order="10" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_8f563464-80d3-5024-06bd-d0b7c03ce96e" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_1ba5c285-0e88-1992-0001-2012ee8e7b97" xlink:type="locator" />
    <link:calculationArc order="11" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_deb49b68-c030-7624-a39d-ea301caa5dbf" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_1ba5c285-0e88-1992-0001-2012ee8e7b97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_8629a772-7004-5d77-9980-0f501e29c5c8" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_dd2e9db6-10f9-d78a-ba84-b18268245a83" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_8629a772-7004-5d77-9980-0f501e29c5c8" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_499015ce-2160-aed2-85a3-080e8c4c6cdf" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_499015ce-2160-aed2-85a3-080e8c4c6cdf" xlink:to="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_499015ce-2160-aed2-85a3-080e8c4c6cdf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4230dd8a-1a56-db80-c035-2fabf7b960fd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4230dd8a-1a56-db80-c035-2fabf7b960fd" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_548688b8-2d34-462c-5a92-aa79f1c44c1a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_548688b8-2d34-462c-5a92-aa79f1c44c1a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_ab3008c3-c5c2-a86b-0613-39cbd9b94527" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_ab3008c3-c5c2-a86b-0613-39cbd9b94527" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1162958e-3b54-7f44-ae96-63b659f5cdba" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1162958e-3b54-7f44-ae96-63b659f5cdba" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_fa9da15a-1d5e-2612-cfe1-3b4e53f80f70" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_fa9da15a-1d5e-2612-cfe1-3b4e53f80f70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_aa99f772-8337-cbc2-0b89-25fbb3108271" xlink:type="locator" />
    <link:calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_72d12753-e25c-cdc0-88b6-98db8d7b7fae" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_aa99f772-8337-cbc2-0b89-25fbb3108271" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_33f76b65-31cf-be04-0849-25af345446d5" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:to="loc_us-gaap_Revenues_33f76b65-31cf-be04-0849-25af345446d5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_318cebec-2b05-42bf-a988-02b2e99cecfb" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_33f76b65-31cf-be04-0849-25af345446d5" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_318cebec-2b05-42bf-a988-02b2e99cecfb" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_ad6c862c-c374-70de-502e-5f168b553492" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_33f76b65-31cf-be04-0849-25af345446d5" xlink:to="loc_us-gaap_SalesRevenueServicesNet_ad6c862c-c374-70de-502e-5f168b553492" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_23c68b7c-81fb-cba2-1814-b7ab4991d5d0" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:to="loc_us-gaap_CostOfGoodsSold_23c68b7c-81fb-cba2-1814-b7ab4991d5d0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSoldAmortization" xlink:label="loc_us-gaap_CostOfGoodsSoldAmortization_0c7e6634-7e7a-b5d0-a0ad-d4685a23104e" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:to="loc_us-gaap_CostOfGoodsSoldAmortization_0c7e6634-7e7a-b5d0-a0ad-d4685a23104e" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_578bfc43-608e-bdc8-e57a-2803c355c0d9" xlink:type="locator" />
    <link:calculationArc order="4" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_aaae347c-fa91-e2c3-dd05-1b008b13fd0c" xlink:to="loc_us-gaap_CostOfServices_578bfc43-608e-bdc8-e57a-2803c355c0d9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_23a4428c-a5e3-3b9c-fc88-04ae5be27ab3" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_9894e895-7695-402a-9f03-08d60b7373b8" xlink:to="loc_us-gaap_OperatingExpenses_23a4428c-a5e3-3b9c-fc88-04ae5be27ab3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_25ae5ce2-b413-b975-9a84-c7503d2496cf" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_23a4428c-a5e3-3b9c-fc88-04ae5be27ab3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_25ae5ce2-b413-b975-9a84-c7503d2496cf" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_460c4e45-6b19-c446-6991-97e38cf5aa17" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_23a4428c-a5e3-3b9c-fc88-04ae5be27ab3" xlink:to="loc_us-gaap_SellingAndMarketingExpense_460c4e45-6b19-c446-6991-97e38cf5aa17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_87411e46-c979-a1ff-e8b3-f4f75d86b855" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_23a4428c-a5e3-3b9c-fc88-04ae5be27ab3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_87411e46-c979-a1ff-e8b3-f4f75d86b855" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ae796c5c-1c01-d654-6a3c-3b5dd2c89517" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_23a4428c-a5e3-3b9c-fc88-04ae5be27ab3" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ae796c5c-1c01-d654-6a3c-3b5dd2c89517" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_78594f6e-0c1a-d6f6-6a22-c95b7bf56846" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_23a4428c-a5e3-3b9c-fc88-04ae5be27ab3" xlink:to="loc_us-gaap_RestructuringCharges_78594f6e-0c1a-d6f6-6a22-c95b7bf56846" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_27459a92-428a-e415-bdb1-176ed2662e11" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_InvestmentIncomeInterest_27459a92-428a-e415-bdb1-176ed2662e11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_7c9599ab-2a77-022c-c720-63fecff6a62c" xlink:type="locator" />
    <link:calculationArc order="3" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_InterestExpense_7c9599ab-2a77-022c-c720-63fecff6a62c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3db65903-3171-d63c-a688-532ba00b8108" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_250c3b2f-7db5-7088-68cc-1dd831a2c2d7" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_0eb47183-f513-314d-ceda-ee2412d9eee8" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_250c3b2f-7db5-7088-68cc-1dd831a2c2d7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_78b7d85e-8366-fe6d-cb1f-faac5a041b79" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_641b1cab-a2b3-2e0e-8389-1455ff3f8581" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_78b7d85e-8366-fe6d-cb1f-faac5a041b79" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomePerShare" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_223fd9c8-68e8-e433-7c40-f98b238e79de" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_86e61cf2-b7b2-e230-65f1-5a2b152f3a30" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_223fd9c8-68e8-e433-7c40-f98b238e79de" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_86e61cf2-b7b2-e230-65f1-5a2b152f3a30" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cee10fe8-a4bb-491c-22f6-69a723d6a718" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_223fd9c8-68e8-e433-7c40-f98b238e79de" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_cee10fe8-a4bb-491c-22f6-69a723d6a718" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities" xlink:label="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_b5fb98bf-6222-d833-b255-2012ee7fdadd" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_223fd9c8-68e8-e433-7c40-f98b238e79de" xlink:to="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_b5fb98bf-6222-d833-b255-2012ee7fdadd" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomePerShareTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d8866e11-7330-6a9a-9ba0-56d88707d8ec" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d8866e11-7330-6a9a-9ba0-56d88707d8ec" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a3451b87-a72a-9fff-128b-969b95aecb3a" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a3451b87-a72a-9fff-128b-969b95aecb3a" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b077ba6e-d590-fd28-6cc4-ab52e924ed70" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_7eab44cf-1ea1-ca2a-420f-21f7b5343fc3" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b077ba6e-d590-fd28-6cc4-ab52e924ed70" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1944a381-5c4e-ce3c-9111-13ccd1c639db" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1944a381-5c4e-ce3c-9111-13ccd1c639db" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ManufacturingEquipmentAndSoftware" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_560962ef-7c78-bacb-9e5d-2012ef1bb8fd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_560962ef-7c78-bacb-9e5d-2012ef1bb8fd" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EquipmentUnderCustomerUsageAgreements" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_aa2f2a78-d7fb-85ef-2bcd-2012ee7f7531" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_aa2f2a78-d7fb-85ef-2bcd-2012ee7f7531" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_bfe00325-30ef-aa76-d96c-ca247f562c4f" xlink:type="locator" />
    <link:calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_bfe00325-30ef-aa76-d96c-ca247f562c4f" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_f0ea2165-5b3b-6de9-7b02-17c18660730c" xlink:type="locator" />
    <link:calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_f0ea2165-5b3b-6de9-7b02-17c18660730c" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land" xlink:label="loc_us-gaap_Land_a51e8738-e58c-e4f4-3ef7-22747a152cee" xlink:type="locator" />
    <link:calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:to="loc_us-gaap_Land_a51e8738-e58c-e4f4-3ef7-22747a152cee" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_4cb0d2ac-0cb3-6a50-d84b-44ca2020e7fe" xlink:type="locator" />
    <link:calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_fe5a8e8b-5934-3dc5-9dae-7d40983185cf" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_4cb0d2ac-0cb3-6a50-d84b-44ca2020e7fe" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5551841b-83e0-4644-fca8-d4027d932c0a" xlink:type="locator" />
    <link:calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_1944a381-5c4e-ce3c-9111-13ccd1c639db" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5551841b-83e0-4644-fca8-d4027d932c0a" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringCharges" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_92057e75-68a1-ad88-5a1c-2012ef3aef7d" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ReductionOfWorkforceExpenses" xlink:label="loc_holx_ReductionOfWorkforceExpenses_16fbb7a9-7d03-5661-7584-2012eebde8fd" xlink:type="locator" />
    <link:calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_92057e75-68a1-ad88-5a1c-2012ef3aef7d" xlink:to="loc_holx_ReductionOfWorkforceExpenses_16fbb7a9-7d03-5661-7584-2012eebde8fd" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_FacilityClosureCosts" xlink:label="loc_holx_FacilityClosureCosts_ea9ceb55-f43a-00f4-2f1c-2012ee6f2454" xlink:type="locator" />
    <link:calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_92057e75-68a1-ad88-5a1c-2012ef3aef7d" xlink:to="loc_holx_FacilityClosureCosts_ea9ceb55-f43a-00f4-2f1c-2012ee6f2454" xlink:type="arc" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended" />
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>holx-20171230_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BasisOfPresentation" xlink:href="holx-20171230.xsd#BasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BasisOfPresentationDetails" xlink:href="holx-20171230.xsd#BasisOfPresentationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangements" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:href="holx-20171230.xsd#BusinessCombinationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationPurchasePriceAllocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationPurchasePriceConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:href="holx-20171230.xsd#BusinessCombinations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:href="holx-20171230.xsd#BusinessCombinationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsAndContingencies" xlink:href="holx-20171230.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="holx-20171230.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:href="holx-20171230.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="holx-20171230.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfIncome" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:href="holx-20171230.xsd#Derivatives" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:href="holx-20171230.xsd#DerivativesAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:href="holx-20171230.xsd#DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:href="holx-20171230.xsd#DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:href="holx-20171230.xsd#DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:href="holx-20171230.xsd#DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:href="holx-20171230.xsd#Disposition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:href="holx-20171230.xsd#DispositionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DocumentAndEntityInformation" xlink:href="holx-20171230.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:href="holx-20171230.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:href="holx-20171230.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:href="holx-20171230.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:href="holx-20171230.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwill" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShare" xlink:href="holx-20171230.xsd#NetIncomePerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:href="holx-20171230.xsd#NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShareTables" xlink:href="holx-20171230.xsd#NetIncomePerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:href="holx-20171230.xsd#NewAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:href="holx-20171230.xsd#NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:href="holx-20171230.xsd#ProductWarranties" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:href="holx-20171230.xsd#ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:href="holx-20171230.xsd#ProductWarrantiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringCharges" xlink:href="holx-20171230.xsd#RestructuringCharges" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:href="holx-20171230.xsd#RestructuringChargesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:href="holx-20171230.xsd#RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:href="holx-20171230.xsd#RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesTables" xlink:href="holx-20171230.xsd#RestructuringChargesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:href="holx-20171230.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:href="holx-20171230.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:to="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:to="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_BF957CE1E6BBA7CD236871092B666D21" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_BF957CE1E6BBA7CD236871092B666D21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8A3330F5451153D1A77A71092B6671D1" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8A3330F5451153D1A77A71092B6671D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_165F5DC4E14287BDED5771092B660F42" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_165F5DC4E14287BDED5771092B660F42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/BasisOfPresentation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/BasisOfPresentationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_5EEEF4E53C0B5827B71857D3E33C8678" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:to="loc_us-gaap_DebtInstrumentAxis_5EEEF4E53C0B5827B71857D3E33C8678" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5EEEF4E53C0B5827B71857D3E33C8678" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5EEEF4E53C0B5827B71857D3E33C8678" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_24F78701A02CF157B76057D3E33C06A8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2025SeniorNotesMember_24F78701A02CF157B76057D3E33C06A8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2028SeniorNotesMember" xlink:label="loc_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2022NotesMember" xlink:label="loc_holx_A2022NotesMember_4E7099B2D7B90B2318A757D3E33DB595" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2022NotesMember_4E7099B2D7B90B2318A757D3E33DB595" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2042NotesMember" xlink:label="loc_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:to="loc_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Internalusesoftware" xlink:label="loc_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_OfferingPriceofPrincipalAmount" xlink:label="loc_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_D78F52534EFE7C59754571092BF2A42F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_D78F52534EFE7C59754571092BF2A42F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D78F52534EFE7C59754571092BF2A42F" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D78F52534EFE7C59754571092BF2A42F" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2028SeniorNotesMember" xlink:label="loc_holx_A2028SeniorNotesMember_0B46069058B257EB214F71092BF241DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_A2028SeniorNotesMember_0B46069058B257EB214F71092BF241DF" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_SecuredTermLoanMember" xlink:label="loc_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_DBACF906D916F2D5ED3C71092BF202FE" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_A2025SeniorNotesMember_DBACF906D916F2D5ED3C71092BF202FE" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_RevolverMember" xlink:label="loc_holx_RevolverMember_828D8488C8856A5B57C971092BF250CC" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_RevolverMember_828D8488C8856A5B57C971092BF250CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_8AA9E186F2D3C1D703CE71092BF23ED7" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_us-gaap_SeniorNotesMember_8AA9E186F2D3C1D703CE71092BF23ED7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_26CB5B4F4765D840952B71092BF3C6D5" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_26CB5B4F4765D840952B71092BF3C6D5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedTermLoanMember" xlink:label="loc_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_E2FB3FE785D6D32A7C1971092BF3BCE3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_DebtInstrumentAxis_E2FB3FE785D6D32A7C1971092BF3BCE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_E2FB3FE785D6D32A7C1971092BF3BCE3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_E2FB3FE785D6D32A7C1971092BF3BCE3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedTermLoanMember" xlink:label="loc_holx_AmendedTermLoanMember_48F2DE1826503E24114F71092BF36C4D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AmendedTermLoanMember_48F2DE1826503E24114F71092BF36C4D" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TermLoanMember" xlink:label="loc_holx_TermLoanMember_AA2D215FB26068389BA771092BF3204A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_TermLoanMember_AA2D215FB26068389BA771092BF3204A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedRevolverMember" xlink:label="loc_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedCreditAgreementMember" xlink:label="loc_holx_AmendedCreditAgreementMember_E970CD3BDC9CC453FE3F71092BF372D4" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AmendedCreditAgreementMember_E970CD3BDC9CC453FE3F71092BF372D4" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2043NotesMember" xlink:label="loc_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2028SeniorNotesMember" xlink:label="loc_holx_A2028SeniorNotesMember_7B3550A504D04BC0FA2C71092BF3411C" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2028SeniorNotesMember_7B3550A504D04BC0FA2C71092BF3411C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2042NotesMember" xlink:label="loc_holx_A2042NotesMember_B8EC72D3AECB6055591771092BF39FF5" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2042NotesMember_B8EC72D3AECB6055591771092BF39FF5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndTwelveNotesMember" xlink:label="loc_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CreditAgreementMember" xlink:label="loc_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_6DED4EFD3EE6D95A627371092BF37646" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2025SeniorNotesMember_6DED4EFD3EE6D95A627371092BF37646" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2022NotesMember" xlink:label="loc_holx_A2022NotesMember_EEC66C8A4E1CE0885A2F71092BF39079" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2022NotesMember_EEC66C8A4E1CE0885A2F71092BF39079" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_36B0FBC40D331302829671092BF35E95" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_us-gaap_SeniorNotesMember_36B0FBC40D331302829671092BF35E95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_D3F8159DDD4DAC20996171092BF452E5" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_D3F8159DDD4DAC20996171092BF452E5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_C8988DE67F8DF5FCF21971092BF467CD" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_C8988DE67F8DF5FCF21971092BF467CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_C2481672DA9107D4770C71092BF46FE8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_RangeAxis_C2481672DA9107D4770C71092BF46FE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_C2481672DA9107D4770C71092BF46FE8" xlink:to="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_C2481672DA9107D4770C71092BF46FE8" xlink:to="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_050B8AA4E0204EE369A371092BF451DF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:to="loc_us-gaap_MinimumMember_050B8AA4E0204EE369A371092BF451DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_16ED4C096783C66F9A1B71092BF4BC97" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:to="loc_us-gaap_MaximumMember_16ED4C096783C66F9A1B71092BF4BC97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtSecurityAxis" xlink:label="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:to="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:to="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentageAddedtoEurodollarRateMember" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_54CBCEA2C51BAC263C8271092BF45564" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_54CBCEA2C51BAC263C8271092BF45564" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_54CBCEA2C51BAC263C8271092BF45564" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_54CBCEA2C51BAC263C8271092BF45564" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_816EBE94D3B2BEE4947B71092BF47F43" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC" xlink:to="loc_us-gaap_SubsequentEventMember_816EBE94D3B2BEE4947B71092BF47F43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_6CD5B28458241969796771092BF57976" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LongTermDebtCurrent_6CD5B28458241969796771092BF57976" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPeriod" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_LeverageRatioMaximum" xlink:label="loc_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility" xlink:label="loc_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_InterestCoverageRatio" xlink:label="loc_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DirectThirdPartyCostsinterestExpense" xlink:label="loc_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:type="locator" />
    <link:definitionArc order="18" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:type="locator" />
    <link:definitionArc order="19" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_CE7B253C1DDB1B051F3E71092BF53AF3" xlink:type="locator" />
    <link:definitionArc order="20" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_CE7B253C1DDB1B051F3E71092BF53AF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1B97F48CF74AA24E1A6A71092BF5F9AD" xlink:type="locator" />
    <link:definitionArc order="21" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1B97F48CF74AA24E1A6A71092BF5F9AD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_OfferingPriceofPrincipalAmount" xlink:label="loc_holx_OfferingPriceofPrincipalAmount_A7C3A008E187D8BFE61571092BF582B0" xlink:type="locator" />
    <link:definitionArc order="22" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_OfferingPriceofPrincipalAmount_A7C3A008E187D8BFE61571092BF582B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_DB9F572DEFEB3821DD2871092BF5DA21" xlink:type="locator" />
    <link:definitionArc order="23" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_DB9F572DEFEB3821DD2871092BF5DA21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:type="locator" />
    <link:definitionArc order="24" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:type="locator" />
    <link:definitionArc order="25" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:type="locator" />
    <link:definitionArc order="26" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:type="locator" />
    <link:definitionArc order="27" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:type="locator" />
    <link:definitionArc order="28" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:type="locator" />
    <link:definitionArc order="29" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:type="locator" />
    <link:definitionArc order="30" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:type="locator" />
    <link:definitionArc order="31" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:type="locator" />
    <link:definitionArc order="32" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:type="locator" />
    <link:definitionArc order="33" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:type="locator" />
    <link:definitionArc order="34" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DeferredTaxesReacquisitionofEquityComponent" xlink:label="loc_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:type="locator" />
    <link:definitionArc order="35" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:type="locator" />
    <link:definitionArc order="36" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalAmountOfBorrowings" xlink:label="loc_holx_PrincipalAmountOfBorrowings_03BCC4347305D57A432971092BF655BA" xlink:type="locator" />
    <link:definitionArc order="37" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_PrincipalAmountOfBorrowings_03BCC4347305D57A432971092BF655BA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:type="locator" />
    <link:definitionArc order="38" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:type="locator" />
    <link:definitionArc order="39" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CashPerOriginalPrincipalAmountofExchangeNotes" xlink:label="loc_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:type="locator" />
    <link:definitionArc order="40" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalConvertibleToCommonStock" xlink:label="loc_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:type="locator" />
    <link:definitionArc order="41" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:type="locator" />
    <link:definitionArc order="42" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TermLoanMember" xlink:label="loc_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_RevolverMember" xlink:label="loc_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2022NotesMember" xlink:label="loc_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:to="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedCreditAgreementMember" xlink:label="loc_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:to="loc_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_RevolverMember" xlink:label="loc_holx_RevolverMember_8CB388CA6A77EF74060E71092BFD0EB4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:to="loc_holx_RevolverMember_8CB388CA6A77EF74060E71092BFD0EB4" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_B26C9BDDC3353C5C592471092BFDE745" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_B26C9BDDC3353C5C592471092BFDE745" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate" xlink:label="loc_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionLineItems" xlink:label="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionTable" xlink:label="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_FB3D098DCF811CA1E7CF714C3659920B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_FB3D098DCF811CA1E7CF714C3659920B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_FB3D098DCF811CA1E7CF714C3659920B" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_FB3D098DCF811CA1E7CF714C3659920B" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmortizationOfDeferredFinancingCosts" xlink:label="loc_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BasePrincipalAmountForAccretionValue" xlink:label="loc_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentCashAccruedInterestPercentage" xlink:label="loc_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureShareholdersMember" xlink:label="loc_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:to="loc_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_069728CA05677A60025371092C299D31" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_RangeAxis_069728CA05677A60025371092C299D31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_069728CA05677A60025371092C299D31" xlink:to="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_069728CA05677A60025371092C299D31" xlink:to="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_73958FC23D7A7FD9C1DF71092C290B64" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:to="loc_us-gaap_MinimumMember_73958FC23D7A7FD9C1DF71092C290B64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_0EF8BC36D4CA6B8CC59D71092C29873D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:to="loc_us-gaap_MaximumMember_0EF8BC36D4CA6B8CC59D71092C29873D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3AC470DE9E47ADEBF25271092C2A73CD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3AC470DE9E47ADEBF25271092C2A73CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3AC470DE9E47ADEBF25271092C2A73CD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3AC470DE9E47ADEBF25271092C2A73CD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_72F7481D0B6766BF8E7471092C2AEB03" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_72F7481D0B6766BF8E7471092C2AEB03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DistributionagreementMember" xlink:label="loc_holx_DistributionagreementMember_2C4D990BEB89B7E8864D71092C2A061A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_holx_DistributionagreementMember_2C4D990BEB89B7E8864D71092C2A061A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_9DF9D38E7AE57C32323471092C2AD2B3" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_TradeNamesMember_9DF9D38E7AE57C32323471092C2AD2B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_560178F1E4CADFF39EC971092C2AA015" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_560178F1E4CADFF39EC971092C2AA015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_560178F1E4CADFF39EC971092C2AA015" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_560178F1E4CADFF39EC971092C2AA015" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_2C50AB2EC19C94E67DC871092C2A0289" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:to="loc_holx_CynosureMember_2C50AB2EC19C94E67DC871092C2A0289" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicorMedicalSupplyMember" xlink:label="loc_holx_MedicorMedicalSupplyMember_A8897925C0FCD4692EBC71092C2AC47F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:to="loc_holx_MedicorMedicalSupplyMember_A8897925C0FCD4692EBC71092C2AC47F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EmsorMember" xlink:label="loc_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:to="loc_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_BD4D026EE0DF5918BD8971092C2A5AFD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_BD4D026EE0DF5918BD8971092C2A5AFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_NumberofProjects" xlink:label="loc_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete" xlink:label="loc_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_FEBEA0F27433AA1A3B8771092C2B0349" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_FEBEA0F27433AA1A3B8771092C2B0349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1B93FC2C9147CB3AC21971092C2B2BD1" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_Revenues_1B93FC2C9147CB3AC21971092C2B2BD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A252416671B08DD4824271092C2B7FE7" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A252416671B08DD4824271092C2B7FE7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability" xlink:label="loc_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:type="locator" />
    <link:definitionArc order="14" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B9079A372A84370934CB71092C2B0E84" xlink:type="locator" />
    <link:definitionArc order="15" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_Goodwill_B9079A372A84370934CB71092C2B0E84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:type="locator" />
    <link:definitionArc order="16" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:type="locator" />
    <link:definitionArc order="17" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EA3F8A30AFF5A38D3FA657BBF665AD5B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EA3F8A30AFF5A38D3FA657BBF665AD5B" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5A9F85756D7964CCE4B557BBF66583A7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EA3F8A30AFF5A38D3FA657BBF665AD5B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5A9F85756D7964CCE4B557BBF66583A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5A9F85756D7964CCE4B557BBF66583A7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5A9F85756D7964CCE4B557BBF66583A7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_67A6FBB17E1DC5C6DACD57BBF66511E8" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441" xlink:to="loc_holx_CynosureMember_67A6FBB17E1DC5C6DACD57BBF66511E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationLineItems" xlink:label="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationTable" xlink:label="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9718395FFCFA03F9943757BBF6659405" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9718395FFCFA03F9943757BBF6659405" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9718395FFCFA03F9943757BBF6659405" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9718395FFCFA03F9943757BBF6659405" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_82B4063A0AFED95C987F57BBF675A319" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802" xlink:to="loc_holx_CynosureMember_82B4063A0AFED95C987F57BBF675A319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24F3B10FADEE8823AF0F57BBF67599CB" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24F3B10FADEE8823AF0F57BBF67599CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24F3B10FADEE8823AF0F57BBF67599CB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24F3B10FADEE8823AF0F57BBF67599CB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_7BC66FE2F7F44A57829D57BBF6755B52" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_7BC66FE2F7F44A57829D57BBF6755B52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_0B150FB1464FEC5244ED57BBF675ED70" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_0B150FB1464FEC5244ED57BBF675ED70" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DistributionagreementMember" xlink:label="loc_holx_DistributionagreementMember_E331D8DD38515736289157BBF6753E16" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_holx_DistributionagreementMember_E331D8DD38515736289157BBF6753E16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_C8818F0211AB6AC79ECF57BBF6750B36" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_CustomerRelationshipsMember_C8818F0211AB6AC79ECF57BBF6750B36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_7129090A051FD7D420A057BBF675423A" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_TradeNamesMember_7129090A051FD7D420A057BBF675423A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_DE56BDCD0D77EC05D84757BBF675F470" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_DE56BDCD0D77EC05D84757BBF675F470" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_494DE134750E243361DE57BBF6759577" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_494DE134750E243361DE57BBF6759577" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_51724E4BF235E9B8704D57BBF675F00F" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_Goodwill_51724E4BF235E9B8704D57BBF675F00F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D292F2615FB670D203C057BBF67562BC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D292F2615FB670D203C057BBF67562BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D292F2615FB670D203C057BBF67562BC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D292F2615FB670D203C057BBF67562BC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_7AA8C9A8651C4CFB476857BBF6758D1B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:to="loc_holx_CynosureMember_7AA8C9A8651C4CFB476857BBF6758D1B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicorMedicalSupplyMember" xlink:label="loc_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:to="loc_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AcquisitionPriceAdjustment" xlink:label="loc_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_SegmentReportingDisclosureLineItems" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:to="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:to="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:to="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="loc_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:to="loc_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:label="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue" xlink:label="loc_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfGeographicalSegmentsLineItems" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfGeographicalSegmentsTable" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:to="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:to="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:to="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EuropeMember" xlink:label="loc_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AsiaPacificMember" xlink:label="loc_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AllOtherCountriesMember" xlink:label="loc_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentageOfRevenues" xlink:label="loc_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:to="loc_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_54E32B3342D72C324AC557BBF5E3F935" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_54E32B3342D72C324AC557BBF5E3F935" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_54E32B3342D72C324AC557BBF5E3F935" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:to="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:to="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DiagnosticsMember" xlink:label="loc_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BreastHealthMember" xlink:label="loc_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_GynSurgicalMember" xlink:label="loc_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_SkeletalHealthMember" xlink:label="loc_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicalAestheticsDomain" xlink:label="loc_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfIncome" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:to="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:to="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:to="loc_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4E76580DFCA80D2AC46A57BBF62EAEF7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4E76580DFCA80D2AC46A57BBF62EAEF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4E76580DFCA80D2AC46A57BBF62EAEF7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4E76580DFCA80D2AC46A57BBF62EAEF7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_B2F7AB4EEB557F703C1D57BBF62E64B9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:to="loc_us-gaap_InterestRateCapMember_B2F7AB4EEB557F703C1D57BBF62E64B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_A1FF9E481EBA8D6FFA4957BBF62EB3A9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_A1FF9E481EBA8D6FFA4957BBF62EB3A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:to="loc_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6938F810695EA18F9CB457BBF62AAC70" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6A13B6CF67B1D31B6A7157BBF62A2555" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6938F810695EA18F9CB457BBF62AAC70" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6A13B6CF67B1D31B6A7157BBF62A2555" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1E1D29E5B0575375214D57BBF62A933A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6A13B6CF67B1D31B6A7157BBF62A2555" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1E1D29E5B0575375214D57BBF62A933A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1E1D29E5B0575375214D57BBF62A933A" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1E1D29E5B0575375214D57BBF62A933A" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9" xlink:to="loc_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_CC8612E55CCD863A5F6957BBF62AABC0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6938F810695EA18F9CB457BBF62AAC70" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_CC8612E55CCD863A5F6957BBF62AABC0" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BloodScreeningBusinessMember" xlink:label="loc_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:to="loc_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:to="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:to="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_GrifolsMember" xlink:label="loc_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:to="loc_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:to="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:to="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:to="loc_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:to="loc_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_GrossProceedsonSale" xlink:label="loc_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ProceedsFromSaleOfBusiness" xlink:label="loc_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedIncomeTaxes" xlink:label="loc_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Proceedsallocatedtomanufactureofinventory" xlink:label="loc_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DocumentAndEntityInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_8BE0351D2F52B4B073ED57BBF6841A3A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:to="loc_us-gaap_DebtInstrumentAxis_8BE0351D2F52B4B073ED57BBF6841A3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8BE0351D2F52B4B073ED57BBF6841A3A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8BE0351D2F52B4B073ED57BBF6841A3A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CreditAgreementMember" xlink:label="loc_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_B2FFE41F3FC0B21CDD7457BBF684B043" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_B2FFE41F3FC0B21CDD7457BBF684B043" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_C2C6822E63A4442980E257BBF684B4D0" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_holx_A2025SeniorNotesMember_C2C6822E63A4442980E257BBF684B4D0" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalAmountOfBorrowings" xlink:label="loc_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:to="loc_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_EstimatedFairValueOfFinancialInstrumentsLineItems" xlink:label="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EstimatedFairValueOfFinancialInstrumentsTable" xlink:label="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:to="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:to="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndTwelveNotesMember" xlink:label="loc_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:to="loc_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndThirteenNotesMember" xlink:label="loc_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:to="loc_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:to="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_2A82B0BAD2864B610F3B57BBF684117D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_InterestRateCapMember_2A82B0BAD2864B610F3B57BBF684117D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:to="loc_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_083C9EBAE6E414126FDD71092B90488A" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_083C9EBAE6E414126FDD71092B90488A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_083C9EBAE6E414126FDD71092B90488A" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_083C9EBAE6E414126FDD71092B90488A" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_610E06DA6EBFE068B61571092B917035" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06" xlink:to="loc_us-gaap_SubsequentEventMember_610E06DA6EBFE068B61571092B917035" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_F7F14E78F3154214853F71092B9108FF" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_F7F14E78F3154214853F71092B9108FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_F7F14E78F3154214853F71092B9108FF" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_F7F14E78F3154214853F71092B9108FF" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse" xlink:label="loc_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_ProductLineLineItems" xlink:label="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ProductLineTable" xlink:label="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E86C15F60B27DB49D00D71624C394172" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E86C15F60B27DB49D00D71624C394172" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E86C15F60B27DB49D00D71624C394172" xlink:to="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E86C15F60B27DB49D00D71624C394172" xlink:to="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicalAestheticsDomain" xlink:label="loc_holx_MedicalAestheticsDomain_748C6E9F0BA9D099971C71626AC47D28" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2" xlink:to="loc_holx_MedicalAestheticsDomain_748C6E9F0BA9D099971C71626AC47D28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DevelopedTechnologyMember" xlink:label="loc_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:to="loc_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CustomerRelationshipsContractsMember" xlink:label="loc_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:to="loc_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_AB453A0DEB6D146192FC714C35F07ABE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:to="loc_holx_CynosureMember_AB453A0DEB6D146192FC714C35F07ABE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportingUnits" xlink:label="loc_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="loc_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="loc_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_554843DEE1252DFA5D41714C35F746FB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_554843DEE1252DFA5D41714C35F746FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_554843DEE1252DFA5D41714C35F746FB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_554843DEE1252DFA5D41714C35F746FB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DevelopedTechnologyMember" xlink:label="loc_holx_DevelopedTechnologyMember_EF011ACF3EAFB73AF557714C35F894CA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_DevelopedTechnologyMember_EF011ACF3EAFB73AF557714C35F894CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CustomerRelationshipsContractsMember" xlink:label="loc_holx_CustomerRelationshipsContractsMember_4D1C58322FF27668EA3D714C35F82C91" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_CustomerRelationshipsContractsMember_4D1C58322FF27668EA3D714C35F82C91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DistributionagreementMember" xlink:label="loc_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessLicensesMember" xlink:label="loc_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AcquiredintangibleassetsMember" xlink:label="loc_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_InternalusesoftwareMember" xlink:label="loc_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CapitalizedsoftwareMember" xlink:label="loc_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomePerShare" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_EarningsPerShareLineItems" xlink:label="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EarningsPerShareTable" xlink:label="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:to="loc_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities" xlink:label="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomePerShareTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringCharges" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5DF09573220840B556DB71092C0579AA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5DF09573220840B556DB71092C0579AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5DF09573220840B556DB71092C0579AA" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5DF09573220840B556DB71092C0579AA" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_50028F81021DB4A9683971092C05BCD9" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5" xlink:to="loc_us-gaap_RestructuringChargesMember_50028F81021DB4A9683971092C05BCD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_CE95DB10C82727BE97A771092C05DD6D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:to="loc_us-gaap_RestructuringPlanAxis_CE95DB10C82727BE97A771092C05DD6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_CE95DB10C82727BE97A771092C05DD6D" xlink:to="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_CE95DB10C82727BE97A771092C05DD6D" xlink:to="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_BF865872152FBF63B61D71092C05B46C" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:to="loc_holx_CynosureMember_BF865872152FBF63B61D71092C05B46C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BedfordMember" xlink:label="loc_holx_BedfordMember_03C722A67847B5C324D971092C05003E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:to="loc_holx_BedfordMember_03C722A67847B5C324D971092C05003E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:to="loc_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_FacilityClosureCosts" xlink:label="loc_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:to="loc_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_78AB0E59533511ED1C6E71092C0B1B90" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_78AB0E59533511ED1C6E71092C0B1B90" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_E5BCCD7F25BFC4F7127871092C0AC52E" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_E5BCCD7F25BFC4F7127871092C0AC52E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_E5BCCD7F25BFC4F7127871092C0AC52E" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_E5BCCD7F25BFC4F7127871092C0AC52E" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_B527893A7D3FAA29E45B71092C0A081B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234" xlink:to="loc_us-gaap_RestructuringChargesMember_B527893A7D3FAA29E45B71092C0A081B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_00C8F775C1DC1A797E4C71092C0A7C16" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:to="loc_us-gaap_RestructuringPlanAxis_00C8F775C1DC1A797E4C71092C0A7C16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_00C8F775C1DC1A797E4C71092C0A7C16" xlink:to="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_00C8F775C1DC1A797E4C71092C0A7C16" xlink:to="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandSeventeenMember" xlink:label="loc_holx_TwoThousandSeventeenMember_6CEADD99A3778EA8A6C171092C0A186B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:to="loc_holx_TwoThousandSeventeenMember_6CEADD99A3778EA8A6C171092C0A186B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwothousandeighteenMember" xlink:label="loc_holx_TwothousandeighteenMember_2C55500ADC835B24F58471092C0B737E" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:to="loc_holx_TwothousandeighteenMember_2C55500ADC835B24F58471092C0B737E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_C6067934124EBA582E8D71092C0B6CE4" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_C6067934124EBA582E8D71092C0B6CE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_C6067934124EBA582E8D71092C0B6CE4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_C6067934124EBA582E8D71092C0B6CE4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2018ActionMember" xlink:label="loc_holx_Fiscal2018ActionMember_72E972F6C796C51A8B0971092C0BE8BA" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_holx_Fiscal2018ActionMember_72E972F6C796C51A8B0971092C0BE8BA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2017ActionsMember" xlink:label="loc_holx_Fiscal2017ActionsMember_8A97AAB228E0F0A6A5E871092C0BB647" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_holx_Fiscal2017ActionsMember_8A97AAB228E0F0A6A5E871092C0BB647" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2016ActionsDomain" xlink:label="loc_holx_Fiscal2016ActionsDomain_81316A5CF9EE3E5D0C7471092C0B5869" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_holx_Fiscal2016ActionsDomain_81316A5CF9EE3E5D0C7471092C0B5869" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_78AB0E59533511ED1C6E71092C0B1B90" xlink:to="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Restructuringchargesgross" xlink:label="loc_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CashSeverancePayments" xlink:label="loc_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_OtherRestructuringPayments" xlink:label="loc_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:to="loc_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2018ActionMember" xlink:label="loc_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:to="loc_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2017ActionsMember" xlink:label="loc_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:to="loc_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2016ActionsDomain" xlink:label="loc_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:to="loc_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:to="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:to="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BedfordMember" xlink:label="loc_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandSeventeenMember" xlink:label="loc_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwothousandeighteenMember" xlink:label="loc_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ReductionOfWorkforceExpenses" xlink:label="loc_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="loc_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_FacilityClosureCosts" xlink:label="loc_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="loc_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6C08C6CF8D47A4CF744757BBF610AF46" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6C08C6CF8D47A4CF744757BBF610AF46" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6C08C6CF8D47A4CF744757BBF610AF46" xlink:to="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7BA4E0CFA599080C1FA457BBF610C919" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7BA4E0CFA599080C1FA457BBF610C919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MarketBasedAwardsMember" xlink:label="loc_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:type="locator" />
    <link:definitionArc order="6" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:type="locator" />
    <link:definitionArc order="7" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:type="locator" />
    <link:definitionArc order="8" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:type="locator" />
    <link:definitionArc order="9" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:type="locator" />
    <link:definitionArc order="10" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:type="locator" />
    <link:definitionArc order="11" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:type="locator" />
    <link:definitionArc order="12" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:type="locator" />
    <link:definitionArc order="13" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:type="arc" xbrldt:closed="true" xbrldt:contextElement="segment" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_841A940D1931506B9D5E57BBF61451CC" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_841A940D1931506B9D5E57BBF61451CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE_default" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_841A940D1931506B9D5E57BBF61451CC" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE_default" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_841A940D1931506B9D5E57BBF61451CC" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:type="locator" />
    <link:definitionArc order="2" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:type="locator" />
    <link:definitionArc order="3" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:type="locator" />
    <link:definitionArc order="4" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_7CC500299227C7E41E3F57BBF6156693" xlink:type="locator" />
    <link:definitionArc order="5" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_RestructuringChargesMember_7CC500299227C7E41E3F57BBF6156693" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:type="locator" />
    <link:definitionArc order="1" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:to="loc_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:type="arc" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended" />
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:type="extended" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>holx-20171230_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D" xlink:to="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07E64608822080EC36F957BBF6192F71_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07E64608822080EC36F957BBF6192F71" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07E64608822080EC36F957BBF6192F71" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07E64608822080EC36F957BBF6192F71" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07E64608822080EC36F957BBF6192F71" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02" xlink:type="arc" />
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DD87681374E9DD020D0271092B8C061E_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DD87681374E9DD020D0271092B8C061E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DD87681374E9DD020D0271092B8C061E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DD87681374E9DD020D0271092B8C061E" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DD87681374E9DD020D0271092B8C061E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_048230008A4F2F62391957D3EDC4B707_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_048230008A4F2F62391957D3EDC4B707" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_048230008A4F2F62391957D3EDC4B707" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_048230008A4F2F62391957D3EDC4B707" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_048230008A4F2F62391957D3EDC4B707" xlink:type="arc" />
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66" xlink:type="arc" />
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statements of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Assumptions Utilized to Value Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_79AB8A09851E975C629B71092C10CE0E_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_79AB8A09851E975C629B71092C10CE0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_79AB8A09851E975C629B71092C10CE0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_79AB8A09851E975C629B71092C10CE0E" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_79AB8A09851E975C629B71092C10CE0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:to="lab_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:to="lab_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:to="lab_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:type="arc" />
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:to="lab_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:type="arc" />
    <link:label id="lab_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476_terseLabel_en-US" xlink:label="lab_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2018 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476_label_en-US" xlink:label="lab_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal 2018 Action [Member]</link:label>
    <link:label id="lab_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476_documentation_en-US" xlink:label="lab_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal 2018 Action [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2018ActionMember" xlink:label="loc_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:to="lab_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:type="arc" />
    <link:label id="lab_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948_terseLabel_en-US" xlink:label="lab_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2017 Actions [Member]</link:label>
    <link:label id="lab_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948_label_en-US" xlink:label="lab_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal 2017 Actions [Member]</link:label>
    <link:label id="lab_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948_documentation_en-US" xlink:label="lab_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal 2017 Actions [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2017ActionsMember" xlink:label="loc_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:to="lab_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:type="arc" />
    <link:label id="lab_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5_terseLabel_en-US" xlink:label="lab_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2016 Actions</link:label>
    <link:label id="lab_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5_label_en-US" xlink:label="lab_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fiscal 2016 Actions [Domain]</link:label>
    <link:label id="lab_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5_documentation_en-US" xlink:label="lab_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fiscal 2016 Actions</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2016ActionsDomain" xlink:label="loc_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:to="lab_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:to="lab_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="lab_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:type="arc" />
    <link:label id="lab_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1_terseLabel_en-US" xlink:label="lab_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cynosure</link:label>
    <link:label id="lab_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1_label_en-US" xlink:label="lab_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cynosure [Member]</link:label>
    <link:label id="lab_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1_documentation_en-US" xlink:label="lab_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cynosure [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:to="lab_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:type="arc" />
    <link:label id="lab_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B_terseLabel_en-US" xlink:label="lab_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bedford [Member]</link:label>
    <link:label id="lab_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B_label_en-US" xlink:label="lab_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bedford [Member]</link:label>
    <link:label id="lab_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B_documentation_en-US" xlink:label="lab_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bedford [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_BedfordMember" xlink:label="loc_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:to="lab_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:type="arc" />
    <link:label id="lab_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8_terseLabel_en-US" xlink:label="lab_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen [Member]</link:label>
    <link:label id="lab_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8_label_en-US" xlink:label="lab_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen [Member]</link:label>
    <link:label id="lab_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8_documentation_en-US" xlink:label="lab_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand Seventeen [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandSeventeenMember" xlink:label="loc_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:to="lab_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:type="arc" />
    <link:label id="lab_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166_terseLabel_en-US" xlink:label="lab_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Two thousand eighteen [Member]</link:label>
    <link:label id="lab_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166_label_en-US" xlink:label="lab_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two thousand eighteen [Member]</link:label>
    <link:label id="lab_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166_documentation_en-US" xlink:label="lab_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand eighteen [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TwothousandeighteenMember" xlink:label="loc_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:to="lab_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:type="arc" />
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51_terseLabel_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Workforce reductions</link:label>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51_label_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reduction Of Workforce Expenses</link:label>
    <link:label id="lab_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51_documentation_en-US" xlink:label="lab_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ReductionOfWorkforceExpenses" xlink:label="loc_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:to="lab_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:type="arc" />
    <link:label id="lab_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9_terseLabel_en-US" xlink:label="lab_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Facility closure costs</link:label>
    <link:label id="lab_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9_label_en-US" xlink:label="lab_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Facility Closure Costs</link:label>
    <link:label id="lab_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9_documentation_en-US" xlink:label="lab_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_FacilityClosureCosts" xlink:label="loc_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:to="lab_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:type="arc" />
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5_totalLabel_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Fiscal restructuring charges</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5_label_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges Under Exit Or Disposal Plan</link:label>
    <link:label id="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5_documentation_en-US" xlink:label="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total restructuring charges under exit or disposal plan.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:to="lab_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingAbstract_A267AD7C642CE9110468714C36122352_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract_A267AD7C642CE9110468714C36122352" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_A267AD7C642CE9110468714C36122352" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract_A267AD7C642CE9110468714C36122352" xlink:to="lab_us-gaap_SegmentReportingAbstract_A267AD7C642CE9110468714C36122352" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E_label_en-US" xlink:label="lab_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:to="lab_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35_label_en-US" xlink:label="lab_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:to="lab_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="loc_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:to="lab_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:type="arc" />
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_SegmentReportingDisclosureLineItems" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="lab_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:to="lab_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:to="lab_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809_label_en-US" xlink:label="lab_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:to="lab_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer represented greater than 10% of consolidated revenues</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Disclosure of Major Customers</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:label="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:to="lab_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:type="arc" />
    <link:label id="lab_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E_terseLabel_en-US" xlink:label="lab_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Countries with greater than 10% of consolidated revenue</link:label>
    <link:label id="lab_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E_label_en-US" xlink:label="lab_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of countries with greater than 10% of consolidated revenue</link:label>
    <link:label id="lab_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E_documentation_en-US" xlink:label="lab_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of countries with greater than 10% of consolidated revenue</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue" xlink:label="loc_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:to="lab_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:type="arc" />
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfGeographicalSegmentsTable" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D_terseLabel_en-US" xlink:label="lab_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D_label_en-US" xlink:label="lab_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:to="lab_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17_label_en-US" xlink:label="lab_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="lab_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:type="arc" />
    <link:label id="lab_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38_terseLabel_en-US" xlink:label="lab_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38_label_en-US" xlink:label="lab_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:to="lab_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:type="arc" />
    <link:label id="lab_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D_terseLabel_en-US" xlink:label="lab_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D_label_en-US" xlink:label="lab_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EuropeMember" xlink:label="loc_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:to="lab_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576_terseLabel_en-US" xlink:label="lab_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576_label_en-US" xlink:label="lab_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AsiaPacificMember" xlink:label="loc_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:to="lab_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:type="arc" />
    <link:label id="lab_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AllOtherCountriesMember" xlink:label="loc_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:to="lab_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:type="arc" />
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfGeographicalSegmentsLineItems" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:type="arc" />
    <link:label id="lab_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F_label_en-US" xlink:label="lab_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentageOfRevenues" xlink:label="loc_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:to="lab_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4" xlink:to="lab_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4" xlink:type="arc" />
    <link:label id="lab_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18_terseLabel_en-US" xlink:label="lab_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Price Allocation</link:label>
    <link:label id="lab_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18_label_en-US" xlink:label="lab_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Price Allocation [Table Text Block]</link:label>
    <link:label id="lab_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18_documentation_en-US" xlink:label="lab_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Table Text Block] for Purchase Price Allocation [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationTableTextBlock" xlink:label="loc_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:to="lab_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pro Forma Information</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Information [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charges Taken Related to Restructuring Actions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charges Taken Related to Accrued Restructuring Actions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2_label_en-US" xlink:label="lab_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="lab_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:type="arc" />
    <link:label id="lab_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F_label_en-US" xlink:label="lab_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DiagnosticsMember" xlink:label="loc_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:to="lab_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:type="arc" />
    <link:label id="lab_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89_label_en-US" xlink:label="lab_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89_documentation_en-US" xlink:label="lab_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_BreastHealthMember" xlink:label="loc_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:to="lab_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:type="arc" />
    <link:label id="lab_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GYN Surgical</link:label>
    <link:label id="lab_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630_label_en-US" xlink:label="lab_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_GynSurgicalMember" xlink:label="loc_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:to="lab_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:type="arc" />
    <link:label id="lab_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089_label_en-US" xlink:label="lab_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_SkeletalHealthMember" xlink:label="loc_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:to="lab_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:type="arc" />
    <link:label id="lab_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E_label_en-US" xlink:label="lab_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medical Aesthetics [Domain]</link:label>
    <link:label id="lab_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medical Aesthetics [Domain]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicalAestheticsDomain" xlink:label="loc_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:to="lab_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE_label_en-US" xlink:label="lab_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:to="lab_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:to="lab_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:to="lab_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F_terseLabel_en-US" xlink:label="lab_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F_label_en-US" xlink:label="lab_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:to="lab_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_ED9C8266C3538521A38357BBF61CD456_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_ED9C8266C3538521A38357BBF61CD456" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ED9C8266C3538521A38357BBF61CD456" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ED9C8266C3538521A38357BBF61CD456" xlink:to="lab_us-gaap_EarningsPerShareAbstract_ED9C8266C3538521A38357BBF61CD456" xlink:type="arc" />
    <link:label id="lab_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3_label_en-US" xlink:label="lab_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_EarningsPerShareTable" xlink:label="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:to="lab_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Stock Options</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Compensation Plan [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:to="lab_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:type="arc" />
    <link:label id="lab_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_EarningsPerShareLineItems" xlink:label="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="lab_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and stock units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:type="arc" />
    <link:label id="lab_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C_terseLabel_en-US" xlink:label="lab_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incremental shares from Convertible Notes premium</link:label>
    <link:label id="lab_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C_label_en-US" xlink:label="lab_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable To The Conversion Of Debt Securities</link:label>
    <link:label id="lab_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C_documentation_en-US" xlink:label="lab_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the treasury stock method</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities" xlink:label="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:to="lab_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:type="arc" />
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_GuaranteesAbstract_D31F06E9D13577A060B971092B77BF18_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract_D31F06E9D13577A060B971092B77BF18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteesAbstract" xlink:label="loc_us-gaap_GuaranteesAbstract_D31F06E9D13577A060B971092B77BF18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract_D31F06E9D13577A060B971092B77BF18" xlink:to="lab_us-gaap_GuaranteesAbstract_D31F06E9D13577A060B971092B77BF18" xlink:type="arc" />
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A" xlink:to="lab_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_CAA55B1E4EA6E55AFAC371092B777713_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual_CAA55B1E4EA6E55AFAC371092B777713" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at End of Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaap_ProductWarrantyAccrual_CAA55B1E4EA6E55AFAC371092B777713" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual_CAA55B1E4EA6E55AFAC371092B777713" xlink:to="lab_us-gaap_ProductWarrantyAccrual_CAA55B1E4EA6E55AFAC371092B777713" xlink:type="arc" />
    <link:label id="lab_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE_terseLabel_en-US" xlink:label="lab_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Line [Table]</link:label>
    <link:label id="lab_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE_label_en-US" xlink:label="lab_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Line [Table]</link:label>
    <link:label id="lab_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE_documentation_en-US" xlink:label="lab_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Product Line [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ProductLineTable" xlink:label="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="lab_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:type="arc" />
    <link:label id="lab_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DevelopedTechnologyMember" xlink:label="loc_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:to="lab_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:type="arc" />
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CustomerRelationshipsContractsMember" xlink:label="loc_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:to="lab_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:to="lab_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:type="arc" />
    <link:label id="lab_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1_terseLabel_en-US" xlink:label="lab_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Line [Line Items]</link:label>
    <link:label id="lab_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1_label_en-US" xlink:label="lab_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Line [Line Items]</link:label>
    <link:label id="lab_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1_documentation_en-US" xlink:label="lab_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Line Items] for Product Line [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ProductLineLineItems" xlink:label="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="lab_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportingUnits" xlink:label="loc_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:to="lab_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:label id="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F_label_en-US" xlink:label="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:to="lab_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA_label_en-US" xlink:label="lab_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:to="lab_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance charges</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:to="lab_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:type="arc" />
    <link:label id="lab_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F_verboseLabel_en-US" xlink:label="lab_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Facility closure costs</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_FacilityClosureCosts" xlink:label="loc_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:to="lab_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:type="arc" />
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:type="arc" />
    <link:label id="lab_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:to="lab_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:type="arc" />
    <link:label id="lab_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9_terseLabel_en-US" xlink:label="lab_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distribution agreement</link:label>
    <link:label id="lab_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9_label_en-US" xlink:label="lab_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:label id="lab_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9_documentation_en-US" xlink:label="lab_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Distribution agreement [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DistributionagreementMember" xlink:label="loc_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:to="lab_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:type="arc" />
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:to="lab_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:type="arc" />
    <link:label id="lab_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8_terseLabel_en-US" xlink:label="lab_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business licenses</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8_label_en-US" xlink:label="lab_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Licenses [Member]</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8_documentation_en-US" xlink:label="lab_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business licenses.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessLicensesMember" xlink:label="loc_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:to="lab_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:type="arc" />
    <link:label id="lab_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AcquiredintangibleassetsMember" xlink:label="loc_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:to="lab_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:type="arc" />
    <link:label id="lab_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_InternalusesoftwareMember" xlink:label="loc_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:to="lab_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:type="arc" />
    <link:label id="lab_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CapitalizedsoftwareMember" xlink:label="loc_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:to="lab_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15_label_en-US" xlink:label="lab_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15" xlink:to="lab_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Assets at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Adjustment to Fair Value within the Consolidated Statements of Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_F92391995D1ECC5C4A5D71092BFCA771_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract_F92391995D1ECC5C4A5D71092BFCA771" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_F92391995D1ECC5C4A5D71092BFCA771" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F92391995D1ECC5C4A5D71092BFCA771" xlink:to="lab_us-gaap_DebtDisclosureAbstract_F92391995D1ECC5C4A5D71092BFCA771" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:to="lab_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:to="lab_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="lab_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:type="arc" />
    <link:label id="lab_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD_label_en-US" xlink:label="lab_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD_documentation_en-US" xlink:label="lab_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TermLoanMember" xlink:label="loc_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:to="lab_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:type="arc" />
    <link:label id="lab_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7_terseLabel_en-US" xlink:label="lab_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7_label_en-US" xlink:label="lab_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7_documentation_en-US" xlink:label="lab_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_RevolverMember" xlink:label="loc_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:to="lab_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:type="arc" />
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987_label_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987_documentation_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:to="lab_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:type="arc" />
    <link:label id="lab_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475_terseLabel_en-US" xlink:label="lab_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Notes</link:label>
    <link:label id="lab_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475_label_en-US" xlink:label="lab_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Notes [Member]</link:label>
    <link:label id="lab_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475_documentation_en-US" xlink:label="lab_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Notes [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_A2022NotesMember" xlink:label="loc_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:to="lab_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:type="arc" />
    <link:label id="lab_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C_terseLabel_en-US" xlink:label="lab_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C_label_en-US" xlink:label="lab_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C_documentation_en-US" xlink:label="lab_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:to="lab_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:to="lab_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:to="lab_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:type="arc" />
    <link:label id="lab_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7_terseLabel_en-US" xlink:label="lab_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7_label_en-US" xlink:label="lab_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7_documentation_en-US" xlink:label="lab_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Credit Agreement [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedCreditAgreementMember" xlink:label="loc_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:to="lab_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="lab_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number of Fiscal Quarters Ending on Measurement Date</link:label>
    <link:label id="lab_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B_label_en-US" xlink:label="lab_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number of Fiscal Quarters Ending on Measurement Date</link:label>
    <link:label id="lab_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B_documentation_en-US" xlink:label="lab_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number of Fiscal Quarters Ending on Measurement Date</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate" xlink:label="loc_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:to="lab_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:to="lab_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:to="lab_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:type="arc" />
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3_terseLabel_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long term debt obligations. excluding convertible notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3_label_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long Term Debt Obligations Without Convertible Notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3_documentation_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long term debt obligations without convertible notes.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:to="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32_label_en-US" xlink:label="lab_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:to="lab_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2" xlink:to="lab_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in unrealized holding gains and losses on available-for-sale securities, net of tax of $0.2 and $1.5 for the three months December 30, 2017 and December 31, 2016:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statements of income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Changes in pension plans, net of taxes of $0.6 for the three months ended December 30, 2017</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in value of hedged interest rate caps, net of tax of $(4.9) and $0.5 for the three months ended December 30, 2017 and December 31, 2016:</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statements of income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35" xlink:type="arc" />
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16" xlink:type="arc" />
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:type="arc" />
    <link:label id="lab_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D_terseLabel_en-US" xlink:label="lab_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medicor Medical Supply</link:label>
    <link:label id="lab_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D_label_en-US" xlink:label="lab_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicor Medical Supply [Member]</link:label>
    <link:label id="lab_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D_documentation_en-US" xlink:label="lab_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medicor Medical Supply [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicorMedicalSupplyMember" xlink:label="loc_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:to="lab_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:type="arc" />
    <link:label id="lab_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB_terseLabel_en-US" xlink:label="lab_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition Price Adjustment</link:label>
    <link:label id="lab_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB_label_en-US" xlink:label="lab_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisition Price Adjustment</link:label>
    <link:label id="lab_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB_documentation_en-US" xlink:label="lab_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment for working capital adjustment</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AcquisitionPriceAdjustment" xlink:label="loc_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:to="lab_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price withheld</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:to="lab_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:to="lab_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, less reserves of $11.5 and $9.8, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320" xlink:type="arc" />
    <link:label id="lab_us-gaap_InventoryNet_397F37FEDCC91CEC09E557BBF6B3C4E2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet_397F37FEDCC91CEC09E557BBF6B3C4E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_397F37FEDCC91CEC09E557BBF6B3C4E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet_397F37FEDCC91CEC09E557BBF6B3C4E2" xlink:to="lab_us-gaap_InventoryNet_397F37FEDCC91CEC09E557BBF6B3C4E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2" xlink:to="lab_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B" xlink:to="lab_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF" xlink:to="lab_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C" xlink:type="arc" />
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4" xlink:to="lab_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_Assets_D6A71705F4E020CEB8BB57BBF6B32177_totalLabel_en-US" xlink:label="lab_us-gaap_Assets_D6A71705F4E020CEB8BB57BBF6B32177" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D6A71705F4E020CEB8BB57BBF6B32177" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets_D6A71705F4E020CEB8BB57BBF6B32177" xlink:to="lab_us-gaap_Assets_D6A71705F4E020CEB8BB57BBF6B32177" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0" xlink:to="lab_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B" xlink:to="lab_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of capital lease obligations</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Lease Obligations, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E" xlink:to="lab_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA" xlink:to="lab_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_08167AEE1E340E702A7457BBF6B34D34_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent_08167AEE1E340E702A7457BBF6B34D34" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_08167AEE1E340E702A7457BBF6B34D34" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_08167AEE1E340E702A7457BBF6B34D34" xlink:to="lab_us-gaap_LongTermDebtNoncurrent_08167AEE1E340E702A7457BBF6B34D34" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital lease obligations, net of current portion</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Lease Obligations, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE" xlink:to="lab_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Note 7)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F" xlink:to="lab_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="lab_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533" xlink:to="lab_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 288,750 and 287,853 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964_label_en-US" xlink:label="lab_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964" xlink:to="lab_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756" xlink:to="lab_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756" xlink:type="arc" />
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost &#8211; 12,560 shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D" xlink:to="lab_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C" xlink:type="arc" />
    <link:label id="lab_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02" xlink:to="lab_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95" xlink:type="arc" />
    <link:label id="lab_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F_label_en-US" xlink:label="lab_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:label id="lab_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F_documentation_en-US" xlink:label="lab_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DocumentAndEntityInformationAbstract" xlink:label="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="lab_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:type="arc" />
    <link:label id="lab_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F_terseLabel_en-US" xlink:label="lab_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F_label_en-US" xlink:label="lab_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F" xlink:to="lab_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F" xlink:type="arc" />
    <link:label id="lab_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1_label_en-US" xlink:label="lab_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1" xlink:to="lab_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1" xlink:type="arc" />
    <link:label id="lab_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1" xlink:to="lab_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A" xlink:to="lab_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A" xlink:type="arc" />
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43" xlink:to="lab_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43" xlink:type="arc" />
    <link:label id="lab_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2_label_en-US" xlink:label="lab_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2" xlink:to="lab_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2" xlink:type="arc" />
    <link:label id="lab_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B" xlink:to="lab_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B" xlink:type="arc" />
    <link:label id="lab_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A" xlink:to="lab_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A" xlink:type="arc" />
    <link:label id="lab_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C_label_en-US" xlink:label="lab_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C" xlink:to="lab_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C" xlink:type="arc" />
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388" xlink:to="lab_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in unrealized holding gains and losses on available-for-sale securities. tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Changes in pension plans, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in value of hedged interest rate caps, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2" xlink:type="arc" />
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6_terseLabel_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Balance Sheet Information</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6_label_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Details Of Certain Balance Sheet Accounts [Text Block]</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6_documentation_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Details of certain balance sheet accounts.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:to="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_0FF5549393FE0218838B57BBF6844298_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract_0FF5549393FE0218838B57BBF6844298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0FF5549393FE0218838B57BBF6844298" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0FF5549393FE0218838B57BBF6844298" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract_0FF5549393FE0218838B57BBF6844298" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:type="arc" />
    <link:label id="lab_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F_label_en-US" xlink:label="lab_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CreditAgreementMember" xlink:label="loc_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:to="lab_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:to="lab_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:type="arc" />
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Borrowed principal</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalAmountOfBorrowings" xlink:label="loc_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:to="lab_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:to="lab_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:type="arc" />
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, reserves</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Allowance for Doubtful Accounts Receivable, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA" xlink:to="lab_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750" xlink:to="lab_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62" xlink:to="lab_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62" xlink:type="arc" />
    <link:label id="lab_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE" xlink:to="lab_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_EABFEB67FE8D631C3FD2714C36276E97_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_EABFEB67FE8D631C3FD2714C36276E97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_EABFEB67FE8D631C3FD2714C36276E97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_EABFEB67FE8D631C3FD2714C36276E97" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_EABFEB67FE8D631C3FD2714C36276E97" xlink:type="arc" />
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:to="lab_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:type="arc" />
    <link:label id="lab_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_A2028SeniorNotesMember" xlink:label="loc_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:to="lab_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:type="arc" />
    <link:label id="lab_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC_terseLabel_en-US" xlink:label="lab_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2042 Notes</link:label>
    <link:label id="lab_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC_label_en-US" xlink:label="lab_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2042 Notes [Member]</link:label>
    <link:label id="lab_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC_documentation_en-US" xlink:label="lab_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2042 Notes [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_A2042NotesMember" xlink:label="loc_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:to="lab_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:to="lab_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:to="lab_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:to="lab_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:type="arc" />
    <link:label id="lab_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="lab_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:type="arc" />
    <link:label id="lab_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF_terseLabel_en-US" xlink:label="lab_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Internal-use software</link:label>
    <link:label id="lab_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF_label_en-US" xlink:label="lab_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal-use software</link:label>
    <link:label id="lab_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF_documentation_en-US" xlink:label="lab_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Internal-use software</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_Internalusesoftware" xlink:label="loc_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:to="lab_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:type="arc" />
    <link:label id="lab_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150_terseLabel_en-US" xlink:label="lab_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offering Price of Principal Amount</link:label>
    <link:label id="lab_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150_label_en-US" xlink:label="lab_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Offering Price of Principal Amount</link:label>
    <link:label id="lab_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150_documentation_en-US" xlink:label="lab_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Offering Price of Principal Amount</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_OfferingPriceofPrincipalAmount" xlink:label="loc_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:to="lab_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:type="arc" />
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7_terseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7_label_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7_documentation_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest rate cap agreements aggregate premium payable.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:to="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:type="arc" />
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_44635391D003B008A56D57BBF63314E6_terseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings_44635391D003B008A56D57BBF63314E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalAmountOfBorrowings" xlink:label="loc_holx_PrincipalAmountOfBorrowings_44635391D003B008A56D57BBF63314E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings_44635391D003B008A56D57BBF63314E6" xlink:to="lab_holx_PrincipalAmountOfBorrowings_44635391D003B008A56D57BBF63314E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_8392E5B2065FD9E56B3457BBF6331E9E_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_8392E5B2065FD9E56B3457BBF6331E9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statement of income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_8392E5B2065FD9E56B3457BBF6331E9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_8392E5B2065FD9E56B3457BBF6331E9E" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_8392E5B2065FD9E56B3457BBF6331E9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Cash Flow Hedge Asset at Fair Value</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C_label_en-US" xlink:label="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C" xlink:to="lab_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C" xlink:type="arc" />
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2" xlink:to="lab_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2" xlink:type="arc" />
    <link:label id="lab_holx_NotionalAmount_E78817646178927E676957BBF633A2F4_terseLabel_en-US" xlink:label="lab_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_E78817646178927E676957BBF633A2F4_label_en-US" xlink:label="lab_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_E78817646178927E676957BBF633A2F4_documentation_en-US" xlink:label="lab_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Notional Amount</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_NotionalAmount" xlink:label="loc_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:to="lab_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_88C2AF61D187E634F42E57BBF59EB4CF_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract_88C2AF61D187E634F42E57BBF59EB4CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_88C2AF61D187E634F42E57BBF59EB4CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88C2AF61D187E634F42E57BBF59EB4CF" xlink:to="lab_us-gaap_AccountingPoliciesAbstract_88C2AF61D187E634F42E57BBF59EB4CF" xlink:type="arc" />
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:to="lab_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:to="lab_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:type="arc" />
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E_terseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E_label_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E" xlink:to="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6" xlink:type="arc" />
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Expense under Convertible Notes</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D_label_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D_documentation_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of interest expense under convertible notes.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:to="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7" xlink:type="arc" />
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61_label_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61_documentation_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AssetsofBusinessHeldforSaleAbstract" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:to="lab_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:type="arc" />
    <link:label id="lab_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9_terseLabel_en-US" xlink:label="lab_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Blood Screening Business [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9_label_en-US" xlink:label="lab_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Blood Screening Business [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9_documentation_en-US" xlink:label="lab_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Blood Screening Business [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_BloodScreeningBusinessMember" xlink:label="loc_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:to="lab_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:type="arc" />
    <link:label id="lab_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4_label_en-US" xlink:label="lab_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:to="lab_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:type="arc" />
    <link:label id="lab_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E_terseLabel_en-US" xlink:label="lab_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E_label_en-US" xlink:label="lab_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:to="lab_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:type="arc" />
    <link:label id="lab_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD_terseLabel_en-US" xlink:label="lab_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grifols [Member]</link:label>
    <link:label id="lab_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD_label_en-US" xlink:label="lab_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grifols [Member]</link:label>
    <link:label id="lab_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD_documentation_en-US" xlink:label="lab_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grifols</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_GrifolsMember" xlink:label="loc_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:to="lab_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2_terseLabel_en-US" xlink:label="lab_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2_label_en-US" xlink:label="lab_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:to="lab_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:type="arc" />
    <link:label id="lab_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F_terseLabel_en-US" xlink:label="lab_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F_label_en-US" xlink:label="lab_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:to="lab_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:type="arc" />
    <link:label id="lab_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7_terseLabel_en-US" xlink:label="lab_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7_label_en-US" xlink:label="lab_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:to="lab_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807_label_en-US" xlink:label="lab_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:to="lab_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:type="arc" />
    <link:label id="lab_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF_terseLabel_en-US" xlink:label="lab_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds on sale</link:label>
    <link:label id="lab_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF_label_en-US" xlink:label="lab_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Proceeds on Sale</link:label>
    <link:label id="lab_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF_documentation_en-US" xlink:label="lab_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gross Proceeds on Sale</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_GrossProceedsonSale" xlink:label="loc_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:to="lab_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:type="arc" />
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD_terseLabel_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD_label_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Sale Of Business</link:label>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD_documentation_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from sale of business.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ProceedsFromSaleOfBusiness" xlink:label="loc_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:to="lab_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedIncomeTaxes" xlink:label="loc_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:to="lab_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:type="arc" />
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290_terseLabel_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal</link:label>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290_label_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal</link:label>
    <link:label id="lab_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290_documentation_en-US" xlink:label="lab_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:to="lab_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:type="arc" />
    <link:label id="lab_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560_terseLabel_en-US" xlink:label="lab_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds allocated to manufacture of inventory</link:label>
    <link:label id="lab_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560_label_en-US" xlink:label="lab_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds allocated to manufacture of inventory</link:label>
    <link:label id="lab_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560_documentation_en-US" xlink:label="lab_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds allocated to manufacture of inventory</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_Proceedsallocatedtomanufactureofinventory" xlink:label="loc_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:to="lab_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:to="lab_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:type="arc" />
    <link:label id="lab_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="lab_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:type="arc" />
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:type="arc" />
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE_terseLabel_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE_label_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:label id="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE_documentation_en-US" xlink:label="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive Income loss Hedge</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:to="lab_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:type="arc" />
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ECFA09DD7AD0917F91C557BBF5DC2443_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract_ECFA09DD7AD0917F91C557BBF5DC2443" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ECFA09DD7AD0917F91C557BBF5DC2443" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ECFA09DD7AD0917F91C557BBF5DC2443" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract_ECFA09DD7AD0917F91C557BBF5DC2443" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:to="lab_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:to="lab_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate cap - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:to="lab_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:label id="lab_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C_label_en-US" xlink:label="lab_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionTable" xlink:label="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:to="lab_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD_label_en-US" xlink:label="lab_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionLineItems" xlink:label="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="lab_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:type="arc" />
    <link:label id="lab_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743_terseLabel_en-US" xlink:label="lab_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of deferred financing costs</link:label>
    <link:label id="lab_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743_label_en-US" xlink:label="lab_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Of Deferred Financing Costs</link:label>
    <link:label id="lab_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743_documentation_en-US" xlink:label="lab_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The component of interest expense representing the periodic charge against earnings to reflect amortization of debt issuance costs over the life of the related debt instruments.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AmortizationOfDeferredFinancingCosts" xlink:label="loc_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:to="lab_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:type="arc" />
    <link:label id="lab_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1_negatedTerseLabel_en-US" xlink:label="lab_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Principal accretion</link:label>
    <link:label id="lab_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1_label_en-US" xlink:label="lab_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Principal Amount For Accretion Value</link:label>
    <link:label id="lab_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1_documentation_en-US" xlink:label="lab_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Represents the amount of principal accretion at the applicable rate pursuant to the terms of the debt agreement, which is recorded as interest expense.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_BasePrincipalAmountForAccretionValue" xlink:label="loc_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:to="lab_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA_totalLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2.00% accrued interest (cash)</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:to="lab_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash accrued interest percentage</link:label>
    <link:label id="lab_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB_label_en-US" xlink:label="lab_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Cash Accrued Interest Percentage</link:label>
    <link:label id="lab_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB_documentation_en-US" xlink:label="lab_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Cash Accrued Interest Percentage</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentCashAccruedInterestPercentage" xlink:label="loc_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:to="lab_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:to="lab_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:to="lab_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Balance Sheet Information of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Balance Sheet Information of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:to="lab_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:type="arc" />
    <link:label id="lab_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:to="lab_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA_label_en-US" xlink:label="lab_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Goods, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA" xlink:to="lab_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA" xlink:type="arc" />
    <link:label id="lab_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2_label_en-US" xlink:label="lab_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Revenue, Services, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2" xlink:to="lab_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2" xlink:type="arc" />
    <link:label id="lab_us-gaap_Revenues_7FE1F0975B79EE9A701F71092C6AC354_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues_7FE1F0975B79EE9A701F71092C6AC354" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_7FE1F0975B79EE9A701F71092C6AC354" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues_7FE1F0975B79EE9A701F71092C6AC354" xlink:to="lab_us-gaap_Revenues_7FE1F0975B79EE9A701F71092C6AC354" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:to="lab_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods Sold</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22" xlink:to="lab_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods Sold, Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSoldAmortization" xlink:label="loc_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440" xlink:to="lab_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440" xlink:type="arc" />
    <link:label id="lab_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5_label_en-US" xlink:label="lab_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Services</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5" xlink:to="lab_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5" xlink:type="arc" />
    <link:label id="lab_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054_label_en-US" xlink:label="lab_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054" xlink:to="lab_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="lab_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:type="arc" />
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F" xlink:to="lab_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F" xlink:type="arc" />
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D" xlink:to="lab_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA" xlink:to="lab_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2F2E915369B70F3F170F71092C6B707F_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_2F2E915369B70F3F170F71092C6B707F" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_2F2E915369B70F3F170F71092C6B707F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_2F2E915369B70F3F170F71092C6B707F" xlink:to="lab_us-gaap_OperatingIncomeLoss_2F2E915369B70F3F170F71092C6B707F" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6" xlink:to="lab_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1_label_en-US" xlink:label="lab_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1" xlink:to="lab_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Benefit) provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetIncomeLoss_FFF75C6330F5213302E471092C6C2027_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss_FFF75C6330F5213302E471092C6C2027" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_FFF75C6330F5213302E471092C6C2027" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss_FFF75C6330F5213302E471092C6C2027" xlink:to="lab_us-gaap_NetIncomeLoss_FFF75C6330F5213302E471092C6C2027" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per common share:</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:to="lab_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635" xlink:to="lab_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F" xlink:to="lab_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88CE380AFDA2BB4D273D71092C6C80A3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88CE380AFDA2BB4D273D71092C6C80A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88CE380AFDA2BB4D273D71092C6C80A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88CE380AFDA2BB4D273D71092C6C80A3" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88CE380AFDA2BB4D273D71092C6C80A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F78D7C1463F3E68E4F2971092C6CD4A7_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F78D7C1463F3E68E4F2971092C6CD4A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F78D7C1463F3E68E4F2971092C6CD4A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F78D7C1463F3E68E4F2971092C6CD4A7" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F78D7C1463F3E68E4F2971092C6CD4A7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement Inputs, Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8" xlink:type="arc" />
    <link:label id="lab_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F_terseLabel_en-US" xlink:label="lab_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Fair Value Of Financial Instruments [Table]</link:label>
    <link:label id="lab_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F_label_en-US" xlink:label="lab_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Fair Value Of Financial Instruments [Table]</link:label>
    <link:label id="lab_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F_documentation_en-US" xlink:label="lab_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Estimated Fair Value Of Financial Instruments [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_EstimatedFairValueOfFinancialInstrumentsTable" xlink:label="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:to="lab_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:to="lab_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:type="arc" />
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:type="arc" />
    <link:label id="lab_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A_verboseLabel_en-US" xlink:label="lab_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">2042 Notes</link:label>
    <link:label id="lab_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A_label_en-US" xlink:label="lab_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Twelve Notes [Member]</link:label>
    <link:label id="lab_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A_documentation_en-US" xlink:label="lab_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and twelve notes.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndTwelveNotesMember" xlink:label="loc_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:to="lab_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:type="arc" />
    <link:label id="lab_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B_terseLabel_en-US" xlink:label="lab_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2043 Notes</link:label>
    <link:label id="lab_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B_label_en-US" xlink:label="lab_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Two Thousand And Thirteen Notes [Member]</link:label>
    <link:label id="lab_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B_documentation_en-US" xlink:label="lab_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and thirteen notes.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndThirteenNotesMember" xlink:label="loc_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:to="lab_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:type="arc" />
    <link:label id="lab_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689_terseLabel_en-US" xlink:label="lab_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Fair Value Of Financial Instruments [Line Items]</link:label>
    <link:label id="lab_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689_label_en-US" xlink:label="lab_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Fair Value Of Financial Instruments [Line Items]</link:label>
    <link:label id="lab_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689_documentation_en-US" xlink:label="lab_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Estimated Fair Value Of Financial Instruments [Line Items]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_EstimatedFairValueOfFinancialInstrumentsLineItems" xlink:label="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:to="lab_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated fair values of debt instruments</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF" xlink:type="arc" />
    <link:label id="lab_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3_terseLabel_en-US" xlink:label="lab_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3_label_en-US" xlink:label="lab_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3_documentation_en-US" xlink:label="lab_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_SecuredTermLoanMember" xlink:label="loc_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:to="lab_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:to="lab_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:type="arc" />
    <link:label id="lab_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99_terseLabel_en-US" xlink:label="lab_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99_label_en-US" xlink:label="lab_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99_documentation_en-US" xlink:label="lab_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedTermLoanMember" xlink:label="loc_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:to="lab_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:type="arc" />
    <link:label id="lab_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA_terseLabel_en-US" xlink:label="lab_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Revolver [Member]</link:label>
    <link:label id="lab_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA_label_en-US" xlink:label="lab_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Revolver [Member]</link:label>
    <link:label id="lab_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA_documentation_en-US" xlink:label="lab_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Revolver [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedRevolverMember" xlink:label="loc_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:to="lab_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:type="arc" />
    <link:label id="lab_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04_terseLabel_en-US" xlink:label="lab_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2043 Notes [Member]</link:label>
    <link:label id="lab_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04_label_en-US" xlink:label="lab_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2043 Notes [Member]</link:label>
    <link:label id="lab_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04_documentation_en-US" xlink:label="lab_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2043 Notes [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_A2043NotesMember" xlink:label="loc_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:to="lab_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:type="arc" />
    <link:label id="lab_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E_terseLabel_en-US" xlink:label="lab_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Two Thousand And Twelve Notes [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndTwelveNotesMember" xlink:label="loc_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:to="lab_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:type="arc" />
    <link:label id="lab_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E_verboseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Credit Agreement</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CreditAgreementMember" xlink:label="loc_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:to="lab_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Security [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487_label_en-US" xlink:label="lab_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Security [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtSecurityAxis" xlink:label="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:to="lab_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:type="arc" />
    <link:label id="lab_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA_terseLabel_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Types of Debt Securities [Domain]</link:label>
    <link:label id="lab_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA_label_en-US" xlink:label="lab_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Types of Debt Securities [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:to="lab_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:type="arc" />
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6_terseLabel_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6_label_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6_documentation_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentageAddedtoEurodollarRateMember" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:to="lab_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Secured Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:to="lab_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:type="arc" />
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:to="lab_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D_label_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal, Period</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPeriod" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:to="lab_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:type="arc" />
    <link:label id="lab_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average interest rates</link:label>
    <link:label id="lab_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18_label_en-US" xlink:label="lab_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:to="lab_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:type="arc" />
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:to="lab_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense amortization of debt discount and deferred financing costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:type="arc" />
    <link:label id="lab_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35_terseLabel_en-US" xlink:label="lab_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leverage Ratio Maximum</link:label>
    <link:label id="lab_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35_label_en-US" xlink:label="lab_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leverage Ratio Maximum</link:label>
    <link:label id="lab_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35_documentation_en-US" xlink:label="lab_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leverage Ratio Maximum</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_LeverageRatioMaximum" xlink:label="loc_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:to="lab_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:type="arc" />
    <link:label id="lab_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893_terseLabel_en-US" xlink:label="lab_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decreased Net Leverage Ratio Pursuant To Senior Secured Credit Facility</link:label>
    <link:label id="lab_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893_label_en-US" xlink:label="lab_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decreased Net Leverage Ratio Pursuant To Senior Secured Credit Facility</link:label>
    <link:label id="lab_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893_documentation_en-US" xlink:label="lab_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Decreased Net Leverage Ratio Pursuant To Senior Secured Credit Facility</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility" xlink:label="loc_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:to="lab_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:type="arc" />
    <link:label id="lab_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0_terseLabel_en-US" xlink:label="lab_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest Coverage Ratio</link:label>
    <link:label id="lab_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0_label_en-US" xlink:label="lab_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Coverage Ratio</link:label>
    <link:label id="lab_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0_documentation_en-US" xlink:label="lab_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Coverage Ratio</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_InterestCoverageRatio" xlink:label="loc_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:to="lab_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:type="arc" />
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:type="arc" />
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA_terseLabel_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum Range of Present Value of Cash Flow Percentage</link:label>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA_label_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Range of Present Value of Cash Flow Percentage</link:label>
    <link:label id="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA_documentation_en-US" xlink:label="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum Range of Present Value of Cash Flow Percentage</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:to="lab_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:type="arc" />
    <link:label id="lab_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402_terseLabel_en-US" xlink:label="lab_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Direct Third Party Costs interest Expense</link:label>
    <link:label id="lab_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402_label_en-US" xlink:label="lab_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Direct Third Party Costs interest Expense</link:label>
    <link:label id="lab_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402_documentation_en-US" xlink:label="lab_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Direct Third Party Costs interest Expense</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DirectThirdPartyCostsinterestExpense" xlink:label="loc_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:to="lab_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Second Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Second Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Second Period</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Third Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Third Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Third Period</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fourth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fourth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fourth Period</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fifth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fifth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Of Redemption Price Fifth Period</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:to="lab_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:type="arc" />
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94_terseLabel_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage Price of Principal Amount for Repurchase of Senior Notes</link:label>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94_label_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Price of Principal Amount for Repurchase of Senior Notes</link:label>
    <link:label id="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94_documentation_en-US" xlink:label="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage Price of Principal Amount for Repurchase of Senior Notes</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:to="lab_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:type="arc" />
    <link:label id="lab_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC_label_en-US" xlink:label="lab_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:to="lab_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Senior note interest rate per year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for conversion of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:type="arc" />
    <link:label id="lab_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Taxes, Reacquisition of Equity Component</link:label>
    <link:label id="lab_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A_label_en-US" xlink:label="lab_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Taxes, Reacquisition of Equity Component</link:label>
    <link:label id="lab_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A_documentation_en-US" xlink:label="lab_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Taxes, Reacquisition of Equity Component</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DeferredTaxesReacquisitionofEquityComponent" xlink:label="loc_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:to="lab_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:type="arc" />
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Redemption Price Sixth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172_label_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Redemption Price Sixth Period</link:label>
    <link:label id="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172_documentation_en-US" xlink:label="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Percentage Redemption Price Sixth Period</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:to="lab_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:type="arc" />
    <link:label id="lab_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:label id="lab_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685_label_en-US" xlink:label="lab_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:to="lab_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:type="arc" />
    <link:label id="lab_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11_terseLabel_en-US" xlink:label="lab_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Per Original Principal Amount of Exchange Notes</link:label>
    <link:label id="lab_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11_label_en-US" xlink:label="lab_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Per Original Principal Amount of Exchange Notes</link:label>
    <link:label id="lab_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11_documentation_en-US" xlink:label="lab_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Per Original Principal Amount of Exchange Notes</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CashPerOriginalPrincipalAmountofExchangeNotes" xlink:label="loc_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:to="lab_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:type="arc" />
    <link:label id="lab_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172_terseLabel_en-US" xlink:label="lab_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal Convertible To Common Stock</link:label>
    <link:label id="lab_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172_label_en-US" xlink:label="lab_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Convertible To Common Stock</link:label>
    <link:label id="lab_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172_documentation_en-US" xlink:label="lab_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal Convertible To Common Stock</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalConvertibleToCommonStock" xlink:label="loc_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:to="lab_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:to="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="lab_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688_terseLabel_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688_label_en-US" xlink:label="lab_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:to="lab_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:label id="lab_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4_label_en-US" xlink:label="lab_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Unspecified [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:to="lab_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E_terseLabel_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
    <link:label id="lab_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E_label_en-US" xlink:label="lab_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario, Forecast [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:to="lab_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:type="arc" />
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:type="arc" />
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company's effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:type="arc" />
    <link:label id="lab_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6_terseLabel_en-US" xlink:label="lab_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax benefit for remeasurements of deferred tax deferred tax liability as result of change in tax rate</link:label>
    <link:label id="lab_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6_label_en-US" xlink:label="lab_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Change in Tax Rate, Deferred Tax Liability, Income Tax (Expense) Benefit</link:label>
    <link:label id="lab_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6_documentation_en-US" xlink:label="lab_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Cuts and Jobs Act of 2017, Change in Tax Rate, Deferred Tax Liability, Income Tax (Expense) Benefit</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:to="lab_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:type="arc" />
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E_terseLabel_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Charge for transition taxes related to the deemed repatriation of foreign earnings</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E_label_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount</link:label>
    <link:label id="lab_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E_documentation_en-US" xlink:label="lab_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation,Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:to="lab_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:type="arc" />
    <link:label id="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1_negatedTerseLabel_en-US" xlink:label="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Estimated net benefit effect of existing deferred tax balances and transition tax due to change in tax rate</link:label>
    <link:label id="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1_label_en-US" xlink:label="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1_documentation_en-US" xlink:label="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:to="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Blended statutory income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:type="arc" />
    <link:label id="lab_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8_terseLabel_en-US" xlink:label="lab_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Projected tax rate at which deferred tax assets and liabilities positions will reverse</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8_label_en-US" xlink:label="lab_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets and Liabilities, Projected Effective Rate At Which Position Will Reverse</link:label>
    <link:label id="lab_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8_documentation_en-US" xlink:label="lab_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets and Liabilities, Projected Effective Rate At Which Position Will Reverse</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse" xlink:label="loc_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:to="lab_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:type="arc" />
    <link:label id="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574_negatedTerseLabel_en-US" xlink:label="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Provisional net benefit amount recorded for remeasurements of deferred tax balance due to change in rate</link:label>
    <link:label id="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574_label_en-US" xlink:label="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574_documentation_en-US" xlink:label="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:to="lab_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Settlement liability of state tax audit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination, Liability (Refund) Adjustment from Settlement with Taxing Authority</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:to="lab_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:type="arc" />
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7_negatedLabel_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Reversal of selling and administrative expense due to settlement of state tax audit</link:label>
    <link:label id="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7_label_en-US" xlink:label="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Adjustments, Settlements, and Unusual Provisions</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:to="lab_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D" xlink:type="arc" />
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5" xlink:to="lab_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5" xlink:type="arc" />
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:type="arc" />
    <link:label id="lab_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1_label_en-US" xlink:label="lab_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1" xlink:to="lab_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of acquired intangibles</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C" xlink:to="lab_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_C6D486ADBA29286F55E857BBF6A48D70_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_C6D486ADBA29286F55E857BBF6A48D70" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_C6D486ADBA29286F55E857BBF6A48D70" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_C6D486ADBA29286F55E857BBF6A48D70" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_C6D486ADBA29286F55E857BBF6A48D70" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0" xlink:type="arc" />
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of available-for-sale marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC" xlink:type="arc" />
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other activity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Repayments of) Other Long-term Debt</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of amounts borrowed under accounts receivable securitization program</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Accounts Receivable Securitization</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550" xlink:to="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from senior notes</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65" xlink:to="lab_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_653FCB3342E058EB3D1E57BBF6A49DC1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt_653FCB3342E058EB3D1E57BBF6A49DC1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments to extinguish convertible notes</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_653FCB3342E058EB3D1E57BBF6A49DC1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt_653FCB3342E058EB3D1E57BBF6A49DC1" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt_653FCB3342E058EB3D1E57BBF6A49DC1" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from amounts borrowed under revolving credit line</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayments of amounts borrowed under revolving credit line</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367" xlink:type="arc" />
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_5541225B3E76A37AD9E757BBF6A4F4D5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts_5541225B3E76A37AD9E757BBF6A4F4D5" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5541225B3E76A37AD9E757BBF6A4F4D5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5541225B3E76A37AD9E757BBF6A4F4D5" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts_5541225B3E76A37AD9E757BBF6A4F4D5" xlink:type="arc" />
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock pursuant to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments under capital lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4" xlink:to="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4" xlink:type="arc" />
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:type="arc" />
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283" xlink:type="arc" />
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_A1921389806C8F25A26D57BBF6A4EEAC_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_A1921389806C8F25A26D57BBF6A4EEAC" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_A1921389806C8F25A26D57BBF6A4EEAC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_A1921389806C8F25A26D57BBF6A4EEAC" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_A1921389806C8F25A26D57BBF6A4EEAC" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0EBF2E2994A85D33810C57BBF6A43619_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0EBF2E2994A85D33810C57BBF6A43619" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0EBF2E2994A85D33810C57BBF6A43619" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0EBF2E2994A85D33810C57BBF6A43619" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_0EBF2E2994A85D33810C57BBF6A43619" xlink:type="arc" />
    <link:label id="lab_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4_terseLabel_en-US" xlink:label="lab_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4_label_en-US" xlink:label="lab_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:to="lab_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B_terseLabel_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B_label_en-US" xlink:label="lab_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:to="lab_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:type="arc" />
    <link:label id="lab_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454_terseLabel_en-US" xlink:label="lab_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cynosure Shareholders</link:label>
    <link:label id="lab_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454_label_en-US" xlink:label="lab_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cynosure Shareholders [Member]</link:label>
    <link:label id="lab_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454_documentation_en-US" xlink:label="lab_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cynosure Shareholders [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureShareholdersMember" xlink:label="loc_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:to="lab_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:type="arc" />
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:type="arc" />
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:to="lab_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:type="arc" />
    <link:label id="lab_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54_terseLabel_en-US" xlink:label="lab_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Emsor</link:label>
    <link:label id="lab_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54_label_en-US" xlink:label="lab_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Emsor [Member]</link:label>
    <link:label id="lab_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54_documentation_en-US" xlink:label="lab_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Emsor [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_EmsorMember" xlink:label="loc_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:to="lab_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Share Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:to="lab_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96_label_en-US" xlink:label="lab_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Inputs, Discount Rate</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:to="lab_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:type="arc" />
    <link:label id="lab_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A_terseLabel_en-US" xlink:label="lab_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of projects</link:label>
    <link:label id="lab_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A_label_en-US" xlink:label="lab_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Projects</link:label>
    <link:label id="lab_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A_documentation_en-US" xlink:label="lab_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of Projects</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_NumberofProjects" xlink:label="loc_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:to="lab_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:type="arc" />
    <link:label id="lab_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389_terseLabel_en-US" xlink:label="lab_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated costs to complete</link:label>
    <link:label id="lab_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389_label_en-US" xlink:label="lab_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Assets Acquired, Expected Remaining Cost to Complete</link:label>
    <link:label id="lab_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389_documentation_en-US" xlink:label="lab_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and Development Assets Acquired, Expected Remaining Cost to Complete</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete" xlink:label="loc_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:to="lab_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:type="arc" />
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:to="lab_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:type="arc" />
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:type="arc" />
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period for payment of contingent consideration liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82_label_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Period for Payment of Contingent Consideration Liability</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82_documentation_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Period for Payment of Contingent Consideration Liability</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:to="lab_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:type="arc" />
    <link:label id="lab_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Period of cumulative revenue to trigger payment of contingent consideration liability</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39_label_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Period for Achievement of Cumulative Revenues For Payment of Contingent Consideration Liability</link:label>
    <link:label id="lab_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39_documentation_en-US" xlink:label="lab_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination, Period for Achievement of Cumulative Revenues For Payment of Contingent Consideration Liability</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability" xlink:label="loc_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:to="lab_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:type="arc" />
    <link:label id="lab_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04_terseLabel_en-US" xlink:label="lab_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assessed damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04_label_en-US" xlink:label="lab_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amount Assessed In Damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04_documentation_en-US" xlink:label="lab_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount assessed in damages.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_AmountAssessedInDamages" xlink:label="loc_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:to="lab_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment of settlement compensation</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF" xlink:to="lab_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:to="lab_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:type="arc" />
    <link:label id="lab_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:to="lab_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:type="arc" />
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:type="arc" />
    <link:label id="lab_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:to="lab_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:to="lab_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:to="lab_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:type="arc" />
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:to="lab_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:to="lab_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:type="arc" />
    <link:label id="lab_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298_terseLabel_en-US" xlink:label="lab_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Price Allocation [Table]</link:label>
    <link:label id="lab_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298_label_en-US" xlink:label="lab_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Price Allocation [Table]</link:label>
    <link:label id="lab_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298_documentation_en-US" xlink:label="lab_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Price Allocation [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationTable" xlink:label="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:to="lab_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:type="arc" />
    <link:label id="lab_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1_terseLabel_en-US" xlink:label="lab_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Price Allocation [Line Items]</link:label>
    <link:label id="lab_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1_label_en-US" xlink:label="lab_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Price Allocation [Line Items]</link:label>
    <link:label id="lab_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1_documentation_en-US" xlink:label="lab_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Line Items] for Purchase Price Allocation [Table]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationLineItems" xlink:label="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="lab_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capital lease obligation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Capital Lease Obligation</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:type="arc" />
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678" xlink:type="arc" />
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Fair Values of Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of Fiscal 2018</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2019</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E" xlink:type="arc" />
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4" xlink:type="arc" />
    <link:label id="lab_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:to="lab_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="lab_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Period beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:to="lab_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:type="arc" />
    <link:label id="lab_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7_terseLabel_en-US" xlink:label="lab_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fiscal 2018 charges</link:label>
    <link:label id="lab_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7_label_en-US" xlink:label="lab_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring charges, gross</link:label>
    <link:label id="lab_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7_documentation_en-US" xlink:label="lab_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restructuring charges, gross</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_Restructuringchargesgross" xlink:label="loc_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:to="lab_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:type="arc" />
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E_negatedTerseLabel_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E_label_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Expense Included Other Restructuring Costs</link:label>
    <link:label id="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E_documentation_en-US" xlink:label="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share based compensation expense included other restructuring costs.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:to="lab_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:type="arc" />
    <link:label id="lab_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654_negatedLabel_en-US" xlink:label="lab_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Severance payments and adjustments</link:label>
    <link:label id="lab_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654_label_en-US" xlink:label="lab_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Severance Payments</link:label>
    <link:label id="lab_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654_documentation_en-US" xlink:label="lab_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Severance payments.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_CashSeverancePayments" xlink:label="loc_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:to="lab_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:type="arc" />
    <link:label id="lab_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E_negatedLabel_en-US" xlink:label="lab_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other payments</link:label>
    <link:label id="lab_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E_label_en-US" xlink:label="lab_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Restructuring Payments</link:label>
    <link:label id="lab_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E_documentation_en-US" xlink:label="lab_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments to settle other restructuring charges.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_OtherRestructuringPayments" xlink:label="loc_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:to="lab_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:type="arc" />
    <link:label id="lab_us-gaap_RestructuringReserve_54BE8C49C34D6ABEBE7971092C0B2425_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve_54BE8C49C34D6ABEBE7971092C0B2425" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Period end balance</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_54BE8C49C34D6ABEBE7971092C0B2425" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve_54BE8C49C34D6ABEBE7971092C0B2425" xlink:to="lab_us-gaap_RestructuringReserve_54BE8C49C34D6ABEBE7971092C0B2425" xlink:type="arc" />
    <link:label id="lab_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:to="lab_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:to="lab_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:type="arc" />
    <link:label id="lab_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:to="lab_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:type="arc" />
    <link:label id="lab_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B_terseLabel_en-US" xlink:label="lab_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Based Awards</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B_label_en-US" xlink:label="lab_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B_documentation_en-US" xlink:label="lab_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_MarketBasedAwardsMember" xlink:label="loc_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:to="lab_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average exercise prices</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, stock option outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average exercise price of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units (RSUs), weighted average grant date fair values</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested RSUs outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:type="arc" />
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested RSUs weighted-average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:type="arc" />
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:type="arc" />
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:type="arc" />
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD_verboseLabel_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance stock units vesting period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD_label_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shared Based Compensation Arrangement Restricted Stock Vesting Period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD_documentation_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Period of time that must lapse in order for the restricted stock units to vest.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:to="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:type="arc" />
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average period for recognition of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:type="arc" />
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59" xlink:to="lab_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Hierarchy [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quoted Prices in Active Market for Identical Assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:to="lab_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:to="lab_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:to="lab_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:type="arc" />
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Eligible Item or Group for Fair Value Option [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:to="lab_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:to="lab_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:type="arc" />
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation, Share-based Payments [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:to="lab_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:to="lab_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:type="arc" />
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:type="arc" />
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest Rate Cash Flow Hedge Asset at Fair Value</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contract, Asset, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:to="lab_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:type="arc" />
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:type="arc" />
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:type="arc" />
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_ManufacturingEquipmentAndSoftware" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:type="arc" />
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:href="holx-20171230.xsd#holx_EquipmentUnderCustomerUsageAgreements" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:type="arc" />
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1" xlink:type="arc" />
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB" xlink:to="lab_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB" xlink:type="arc" />
    <link:label id="lab_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18_terseLabel_en-US" xlink:label="lab_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18_label_en-US" xlink:label="lab_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land" xlink:label="loc_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18" xlink:to="lab_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18" xlink:type="arc" />
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890" xlink:to="lab_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C" xlink:type="arc" />
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less &#8211; accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C" xlink:type="arc" />
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_C56E8AE02F17DFD1DDAE57BBF5F456D7_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet_C56E8AE02F17DFD1DDAE57BBF5F456D7" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_C56E8AE02F17DFD1DDAE57BBF5F456D7" xlink:type="locator" />
    <link:labelArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_C56E8AE02F17DFD1DDAE57BBF5F456D7" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet_C56E8AE02F17DFD1DDAE57BBF5F456D7" xlink:type="arc" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>holx-20171230_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!--XBRL Document Created with Wdesk from Workiva-->
<!-- -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveLoss" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:href="holx-20171230.xsd#AccumulatedOtherComprehensiveLossTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BasisOfPresentation" xlink:href="holx-20171230.xsd#BasisOfPresentation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BasisOfPresentationDetails" xlink:href="holx-20171230.xsd#BasisOfPresentationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangements" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables" xlink:href="holx-20171230.xsd#BorrowingsAndCreditArrangementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:href="holx-20171230.xsd#BusinessCombinationNarrativeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationProFormaInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationPurchasePriceAllocationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails" xlink:href="holx-20171230.xsd#BusinessCombinationPurchasePriceConsiderationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:href="holx-20171230.xsd#BusinessCombinations" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:href="holx-20171230.xsd#BusinessCombinationsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables" xlink:href="holx-20171230.xsd#BusinessSegmentsAndGeographicInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsAndContingencies" xlink:href="holx-20171230.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:href="holx-20171230.xsd#CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:href="holx-20171230.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="holx-20171230.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfCashFlows" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfComprehensiveIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsOfIncome" xlink:href="holx-20171230.xsd#ConsolidatedStatementsOfIncome" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:href="holx-20171230.xsd#Derivatives" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:href="holx-20171230.xsd#DerivativesAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:href="holx-20171230.xsd#DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:href="holx-20171230.xsd#DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:href="holx-20171230.xsd#DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:href="holx-20171230.xsd#DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:href="holx-20171230.xsd#Disposition" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:href="holx-20171230.xsd#DispositionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/DocumentAndEntityInformation" xlink:href="holx-20171230.xsd#DocumentAndEntityInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:href="holx-20171230.xsd#FairValueMeasurements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:href="holx-20171230.xsd#FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:href="holx-20171230.xsd#FairValueMeasurementsTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:href="holx-20171230.xsd#IncomeTaxes" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:href="holx-20171230.xsd#IncomeTaxesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwill" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables" xlink:href="holx-20171230.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShare" xlink:href="holx-20171230.xsd#NetIncomePerShare" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:href="holx-20171230.xsd#NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomePerShareTables" xlink:href="holx-20171230.xsd#NetIncomePerShareTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:href="holx-20171230.xsd#NewAccountingPronouncements" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:href="holx-20171230.xsd#NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:href="holx-20171230.xsd#OtherBalanceSheetInformationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:href="holx-20171230.xsd#ProductWarranties" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:href="holx-20171230.xsd#ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:href="holx-20171230.xsd#ProductWarrantiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringCharges" xlink:href="holx-20171230.xsd#RestructuringCharges" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:href="holx-20171230.xsd#RestructuringChargesAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:href="holx-20171230.xsd#RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:href="holx-20171230.xsd#RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringChargesTables" xlink:href="holx-20171230.xsd#RestructuringChargesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:href="holx-20171230.xsd#StockBasedCompensation" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:href="holx-20171230.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:href="holx-20171230.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_7DE662561436CB7FDAF771092B669937" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_7DE662561436CB7FDAF771092B669937" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_42BB1E4C92951F6A32CA71092B66F793" xlink:to="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_B98621BEC756FA6F715371092B665742" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_1C527D848B819394DDA271092B660919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_EB2311D53502C7963B9A71092B668D1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember_5DEB959F276EDFA384A671092B668345" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_EB5DA0744555AD6F02A971092B669BB0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9D60ABAEB7D84740CBCA71092B66DC42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_B609B8B759EB16FA0E5471092B66A777" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_C95917DD4439CADDFD2D71092B66ECF0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_130EC0BAB0711B774EAE71092B66FD23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_E83A015173D8EB32462371092B669C9C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedothercomprehensiveIncomelossHedge" xlink:label="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_holx_AccumulatedothercomprehensiveIncomelossHedge_34E9BAC21506476B1FEB71092B6685DE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_BF957CE1E6BBA7CD236871092B666D21" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_BF957CE1E6BBA7CD236871092B666D21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8A3330F5451153D1A77A71092B6671D1" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_8A3330F5451153D1A77A71092B6671D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_CA8A07B81C1ACFFADB1F71092B662512" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_165F5DC4E14287BDED5771092B660F42" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_165F5DC4E14287BDED5771092B660F42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_77977659D99A19F721AC71092B66FF07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_109AC63195076BFB942F71092B664497" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_FED15CC4866A64153D3571092B66AF00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_B36A1DFE1BCA30BBFA6C71092B66BDD0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_1FF82E3E9580A2A8AFB671092B6613C3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_CF5DBA33B7BE61D215B7716CBD79DE0D" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_4994794FED00865420117170133E17A3" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_8E606B4490C5897700E071092B669EF0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_8E606B4490C5897700E071092B669EF0" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_C00B0AF83E8D1D5E162671092B668E4D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisOfPresentation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_048230008A4F2F62391957D3EDC4B707" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_048230008A4F2F62391957D3EDC4B707" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1BE8C223827E44D6517757D3EDC46E66" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisOfPresentationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_676F063131C9467F053457D3E33B4817" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_676F063131C9467F053457D3E33B4817" xlink:to="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_5EEEF4E53C0B5827B71857D3E33C8678" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:to="loc_us-gaap_DebtInstrumentAxis_5EEEF4E53C0B5827B71857D3E33C8678" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5EEEF4E53C0B5827B71857D3E33C8678" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_24F78701A02CF157B76057D3E33C06A8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2025SeniorNotesMember_24F78701A02CF157B76057D3E33C06A8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2028SeniorNotesMember" xlink:label="loc_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2028SeniorNotesMember_9AA31C94E8AF5AA4215C57D3E33CB597" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2022NotesMember" xlink:label="loc_holx_A2022NotesMember_4E7099B2D7B90B2318A757D3E33DB595" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2022NotesMember_4E7099B2D7B90B2318A757D3E33DB595" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2042NotesMember" xlink:label="loc_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_CEE7CE2C20B3C28597FD57D3E33C98AB" xlink:to="loc_holx_A2042NotesMember_875CEE6B1D1ECD305E8157D3E33D88BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_2A6B47878871D219C7BC57D3E33D06F6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_38EB0A29336FF0BFA24857D3E33D9193" xlink:to="loc_us-gaap_SubsequentEventMember_5029C76C575BD45470D357D3E33DC002" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_60ABD683F0EA569B2C1157D3E33BA2BC" xlink:to="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Internalusesoftware" xlink:label="loc_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_holx_Internalusesoftware_4133C12F84CD4045E0E457D3E33EE3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalizedComputerSoftwareNet" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_213DAA24868814466A3657D3E33E18F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_A388D379E6EC9116D5AB57D3E33E4C0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_ACE74405182D5912BFFC57D3E33E083A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_OfferingPriceofPrincipalAmount" xlink:label="loc_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_holx_OfferingPriceofPrincipalAmount_D7D43A882D9D8A787C7B57D3E33E6150" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0FAB979D1334ADB142B057D3E33ED118" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_5B079C53CFF26B999C8057D3E33E751A" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_0F2B5AC04044F4B2526557D3E33E65F8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3C37955460CA1D452B6B57D118144676" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3C37955460CA1D452B6B57D118144676" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_21F2C802545A7EECC70457D1181C74A5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_E172C510C3848AD4C88E71092BF20957" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_E172C510C3848AD4C88E71092BF20957" xlink:to="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_D78F52534EFE7C59754571092BF2A42F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_D78F52534EFE7C59754571092BF2A42F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_D78F52534EFE7C59754571092BF2A42F" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2028SeniorNotesMember" xlink:label="loc_holx_A2028SeniorNotesMember_0B46069058B257EB214F71092BF241DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_A2028SeniorNotesMember_0B46069058B257EB214F71092BF241DF" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_SecuredTermLoanMember" xlink:label="loc_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_SecuredTermLoanMember_34D9429A93931440031971092BF2C8B3" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_DBACF906D916F2D5ED3C71092BF202FE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_A2025SeniorNotesMember_DBACF906D916F2D5ED3C71092BF202FE" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_RevolverMember" xlink:label="loc_holx_RevolverMember_828D8488C8856A5B57C971092BF250CC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_RevolverMember_828D8488C8856A5B57C971092BF250CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_8AA9E186F2D3C1D703CE71092BF23ED7" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_us-gaap_SeniorNotesMember_8AA9E186F2D3C1D703CE71092BF23ED7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleDebtMember" xlink:label="loc_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_us-gaap_ConvertibleDebtMember_2BA6E6C359E72CFA6A4471092BF3A34A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_26CB5B4F4765D840952B71092BF3C6D5" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_26CB5B4F4765D840952B71092BF3C6D5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedTermLoanMember" xlink:label="loc_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3494B560CA627287EBA471092BF298CA" xlink:to="loc_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_E2FB3FE785D6D32A7C1971092BF3BCE3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_DebtInstrumentAxis_E2FB3FE785D6D32A7C1971092BF3BCE3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_E2FB3FE785D6D32A7C1971092BF3BCE3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:type="arc" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AmendedTermLoanMember_721383FE571E0CA1573471092BF36E99" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TermLoanMember" xlink:label="loc_holx_TermLoanMember_AA2D215FB26068389BA771092BF3204A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_TermLoanMember_AA2D215FB26068389BA771092BF3204A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedRevolverMember" xlink:label="loc_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AmendedRevolverMember_EB256F748421761ACB8E71092BF38CEA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedCreditAgreementMember" xlink:label="loc_holx_AmendedCreditAgreementMember_E970CD3BDC9CC453FE3F71092BF372D4" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AmendedCreditAgreementMember_E970CD3BDC9CC453FE3F71092BF372D4" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2043NotesMember" xlink:label="loc_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2043NotesMember_27C12197FF380B55978B71092BF39E04" xlink:type="arc" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2028SeniorNotesMember_0B46069058B257EB214F71092BF241DF" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2042NotesMember" xlink:label="loc_holx_A2042NotesMember_B8EC72D3AECB6055591771092BF39FF5" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2042NotesMember_B8EC72D3AECB6055591771092BF39FF5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndTwelveNotesMember" xlink:label="loc_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_TwoThousandAndTwelveNotesMember_932BC7D46BF1AF97082E71092BF3D03E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CreditAgreementMember" xlink:label="loc_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_CreditAgreementMember_98A3FD1C3532E543BFB171092BF39B0E" xlink:type="arc" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2025SeniorNotesMember_DBACF906D916F2D5ED3C71092BF202FE" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2022NotesMember" xlink:label="loc_holx_A2022NotesMember_EEC66C8A4E1CE0885A2F71092BF39079" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_A2022NotesMember_EEC66C8A4E1CE0885A2F71092BF39079" xlink:type="arc" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_us-gaap_SeniorNotesMember_8AA9E186F2D3C1D703CE71092BF23ED7" xlink:type="arc" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_3435EA8F7F00CDE01EC071092BF3ECA6" xlink:type="arc" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1387A3EF37AA4BB47A6C71092BF3D4B3" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_26CB5B4F4765D840952B71092BF3C6D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_C2481672DA9107D4770C71092BF46FE8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_RangeAxis_C2481672DA9107D4770C71092BF46FE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_C2481672DA9107D4770C71092BF46FE8" xlink:to="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_050B8AA4E0204EE369A371092BF451DF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:to="loc_us-gaap_MinimumMember_050B8AA4E0204EE369A371092BF451DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_16ED4C096783C66F9A1B71092BF4BC97" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_C764B75237A57C70701571092BF4F279" xlink:to="loc_us-gaap_MaximumMember_16ED4C096783C66F9A1B71092BF4BC97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtSecurityAxis" xlink:label="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtSecuritiesDomain" xlink:label="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecurityAxis_53A2F204EBBE4E5F96EA71092BF4E487" xlink:to="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentageAddedtoEurodollarRateMember" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MajorTypesOfDebtSecuritiesDomain_D85B3B14158ACC5807E471092BF4D0CA" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_5753FFBD14401B2390B171092BF4EDA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_54CBCEA2C51BAC263C8271092BF45564" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_54CBCEA2C51BAC263C8271092BF45564" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_54CBCEA2C51BAC263C8271092BF45564" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_816EBE94D3B2BEE4947B71092BF47F43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9BAD2005F348F040454F71092BF436CC" xlink:to="loc_us-gaap_SubsequentEventMember_816EBE94D3B2BEE4947B71092BF47F43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_BBCBC18EE177775C0B5A71092BF2DA89" xlink:to="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_65AD298C30EABFD7206C71092BF4DD1F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_BB85EE99987293542E5571092BF4088F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_DF22B1E4B2EE847E1C4171092BF5C200" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LinesOfCreditCurrent" xlink:label="loc_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LinesOfCreditCurrent_97B65015DE020973426D71092BF5B77F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_6CD5B28458241969796771092BF57976" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LongTermDebtCurrent_6CD5B28458241969796771092BF57976" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_EBD4BCC02FDABAA5DBA371092BF5FC64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_5926460301D768877F6471092BF5825F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPeriodicPaymentPrincipalPeriod" xlink:label="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod_1D019678238C601B061371444CD9C66D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageDiscountRatePercent" xlink:label="loc_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_WeightedAverageDiscountRatePercent_33B7539933E2B25127C271092BF59C18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_97EB345FD1CAAACA702D71092BF5D25F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_InterestExpenseDebt_F1C1DD9D1B6D392614AA71092BF575FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_58B143E001DB81CE357671092BF5CB21" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_LeverageRatioMaximum" xlink:label="loc_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_LeverageRatioMaximum_70357FB6B71084FD73EB71092BF5CB35" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility" xlink:label="loc_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility_E9922C00F48A428EEDB371092BF50893" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_InterestCoverageRatio" xlink:label="loc_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_InterestCoverageRatio_CCB7BE04CCFF8E8423AE71092BF5E8E0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_259D7C66797CAC36610A71092BF58946" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MaximumRangeofPresentValueofCashFlowPercentage" xlink:label="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_MaximumRangeofPresentValueofCashFlowPercentage_5595483F6976550C65FA71092BF560CA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DirectThirdPartyCostsinterestExpense" xlink:label="loc_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:type="locator" />
    <link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DirectThirdPartyCostsinterestExpense_51F8EE3ABDA8A0288D9571092BF54402" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:type="locator" />
    <link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_957AA1C1D99A7C49764571092BF5E09F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_CE7B253C1DDB1B051F3E71092BF53AF3" xlink:type="locator" />
    <link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_CE7B253C1DDB1B051F3E71092BF53AF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1B97F48CF74AA24E1A6A71092BF5F9AD" xlink:type="locator" />
    <link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_1B97F48CF74AA24E1A6A71092BF5F9AD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_OfferingPriceofPrincipalAmount" xlink:label="loc_holx_OfferingPriceofPrincipalAmount_A7C3A008E187D8BFE61571092BF582B0" xlink:type="locator" />
    <link:presentationArc order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_OfferingPriceofPrincipalAmount_A7C3A008E187D8BFE61571092BF582B0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_DB9F572DEFEB3821DD2871092BF5DA21" xlink:type="locator" />
    <link:presentationArc order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_DB9F572DEFEB3821DD2871092BF5DA21" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:type="locator" />
    <link:presentationArc order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_490B783D2BA58ED94C0971092BF6645B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:type="locator" />
    <link:presentationArc order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod_61EC012A544E7437D82271092BF694FE" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:type="locator" />
    <link:presentationArc order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod_1744226EBAECA903D0E371092BF66F97" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:type="locator" />
    <link:presentationArc order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod_73D670604B1CAB16BA5D71092BF6B171" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:type="locator" />
    <link:presentationArc order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod_64DDD7001A4BB3E467B471092BF61BF7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes" xlink:label="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:type="locator" />
    <link:presentationArc order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes_35FD6630F9550B0A2F4571092BF66A94" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotes" xlink:label="loc_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:type="locator" />
    <link:presentationArc order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_SeniorNotes_CFAD71E1490756871BFD71092BF6E8BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:type="locator" />
    <link:presentationArc order="31" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_0FAE9F545AF55A43F0AB71092BF6C3AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:type="locator" />
    <link:presentationArc order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_EF9F47890449B31F86D471092BF699AD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:type="locator" />
    <link:presentationArc order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_844427F384A412A4183171092BF6CADE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:type="locator" />
    <link:presentationArc order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_008F2928E64C2CED88CA71092BF6484E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DeferredTaxesReacquisitionofEquityComponent" xlink:label="loc_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:type="locator" />
    <link:presentationArc order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DeferredTaxesReacquisitionofEquityComponent_680D391C4B43F0E9C93571092BF6E17A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:type="locator" />
    <link:presentationArc order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_DAB23E4FAD386354533B71092BF67BBB" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalAmountOfBorrowings" xlink:label="loc_holx_PrincipalAmountOfBorrowings_03BCC4347305D57A432971092BF655BA" xlink:type="locator" />
    <link:presentationArc order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_PrincipalAmountOfBorrowings_03BCC4347305D57A432971092BF655BA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod" xlink:label="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:type="locator" />
    <link:presentationArc order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod_C502C332B7731D585AFB71092BF60172" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:type="locator" />
    <link:presentationArc order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_SharePrice_383277C10AF48C37139671092BF6D685" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CashPerOriginalPrincipalAmountofExchangeNotes" xlink:label="loc_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:type="locator" />
    <link:presentationArc order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_CashPerOriginalPrincipalAmountofExchangeNotes_E9B9D3E8D9B4B49A1AED71092BF6CC11" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalConvertibleToCommonStock" xlink:label="loc_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:type="locator" />
    <link:presentationArc order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_holx_PrincipalConvertibleToCommonStock_D7B6B240DF05A4E4370571092BF65172" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:type="locator" />
    <link:presentationArc order="42" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_AD7AAE4BB4AC86D3212C71092BF49004" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_8AA766E3F4729C75C71A71092BF63F02" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_F92391995D1ECC5C4A5D71092BFCA771" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_F92391995D1ECC5C4A5D71092BFCA771" xlink:to="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ABC3A51F226D567DA4BE71092BFCD9D8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TermLoanMember" xlink:label="loc_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_TermLoanMember_F5561B016A6ABD85C5C371092BFC13CD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_RevolverMember" xlink:label="loc_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2022NotesMember" xlink:label="loc_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_A2022NotesMember_3A7B02E81BCDFDC6BBE471092BFC6475" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_A2610B3F04C90C8A9D9571092BFCBDB4" xlink:to="loc_holx_A2025SeniorNotesMember_9C1F942C1B57A7A0161471092BFCC18C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:to="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_D3F6A08268E00FB8428D71092BFD013F" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmendedCreditAgreementMember" xlink:label="loc_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:to="loc_holx_AmendedCreditAgreementMember_3336468841344CB7A2DD7147D3BB35C7" xlink:type="arc" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:to="loc_holx_RevolverMember_3BEEC889203E253C557071092BFC19F7" xlink:type="arc" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_816F42C3D0F53B77735E71092BFD6522" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_A325420FAD0621BBDC7671092BFC6987" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_274ACBC6C6E17AC3669771092BFC903E" xlink:to="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate" xlink:label="loc_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate_47790C98ABF81E1DB2BF7147B58F8F2B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_LongTermDebtCurrent_3C40B7CE416DD0D2EE7A71092BFDCC35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_A0A33CC369233EEF251971092BFD065C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_5734814B56B555768F5771092BFD0DC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_D9AC3EE203D8F0A9BE3071092BFDC146" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_5B0EB792C8481765ECF271092BFDA413" xlink:to="loc_us-gaap_LongTermDebt_655BD09D40239B50BC9D71092BFD8A32" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_22B94610FFE77E8C275B714C3659EA31" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionTable" xlink:label="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_22B94610FFE77E8C275B714C3659EA31" xlink:to="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_FB3D098DCF811CA1E7CF714C3659920B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_FB3D098DCF811CA1E7CF714C3659920B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_FB3D098DCF811CA1E7CF714C3659920B" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleNotesPayableMember" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3DDC4DD5C1E3B8F4C007714C365AF482" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_20E1BE41FA435E1D7031714C365A814A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtConversionLineItems" xlink:label="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionTable_8243791B50704CED4581714C3659993C" xlink:to="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_C11A1020402424BE083F714C365AF1DA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmortizationOfDeferredFinancingCosts" xlink:label="loc_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_holx_AmortizationOfDeferredFinancingCosts_FF220D72D505BEF9D5B7714C365AF743" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BasePrincipalAmountForAccretionValue" xlink:label="loc_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_holx_BasePrincipalAmountForAccretionValue_257FAD77EA1A77440C56714C365A20E1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_677EDB313AB3C2474B79714C365A90CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_4EFD0B217763D0ABB72F714C365A5E60" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_us-gaap_InterestExpenseDebt_14022D1A6F589D7D721F714C365A2058" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DebtInstrumentCashAccruedInterestPercentage" xlink:label="loc_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtConversionLineItems_81FFCADB3BE216C11FB2714C365A79BD" xlink:to="loc_holx_DebtInstrumentCashAccruedInterestPercentage_BE2206E1C1F06F65CADF714E24B1A8DB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9C5DFA7C6D25E52347DF57D11AEA8950" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9C5DFA7C6D25E52347DF57D11AEA8950" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_F1EDB4568DF00317709557D11AEB85E6" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9C5DFA7C6D25E52347DF57D11AEA8950" xlink:to="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_56631B99E8159CE4D9FD57D11AEB8D1D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6A25570855F0034DD63271092C292815" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6A25570855F0034DD63271092C292815" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CounterpartyNameAxis_9B48F78B15375597C41471092C2964E4" xlink:to="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureShareholdersMember" xlink:label="loc_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RepurchaseAgreementCounterpartyNameDomain_EA18E590F6082075BAAA71092C29CE8B" xlink:to="loc_holx_CynosureShareholdersMember_0A23084E80282DAADADA71092C29B454" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_069728CA05677A60025371092C299D31" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_RangeAxis_069728CA05677A60025371092C299D31" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_069728CA05677A60025371092C299D31" xlink:to="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_73958FC23D7A7FD9C1DF71092C290B64" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:to="loc_us-gaap_MinimumMember_73958FC23D7A7FD9C1DF71092C290B64" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_0EF8BC36D4CA6B8CC59D71092C29873D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_4825B09CCD981C1C735971092C290E5B" xlink:to="loc_us-gaap_MaximumMember_0EF8BC36D4CA6B8CC59D71092C29873D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3AC470DE9E47ADEBF25271092C2A73CD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3AC470DE9E47ADEBF25271092C2A73CD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3AC470DE9E47ADEBF25271092C2A73CD" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherIntangibleAssetsMember" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_620D482AAAB3D952D04771092C2AFDD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_72F7481D0B6766BF8E7471092C2AEB03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_72F7481D0B6766BF8E7471092C2AEB03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_21F086DED4A17F62CA0271092C2A8212" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DistributionagreementMember" xlink:label="loc_holx_DistributionagreementMember_2C4D990BEB89B7E8864D71092C2A061A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_holx_DistributionagreementMember_2C4D990BEB89B7E8864D71092C2A061A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_CustomerRelationshipsMember_1A60810731A44B41B70271092C2AB87C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_9DF9D38E7AE57C32323471092C2AD2B3" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_BD7763999E93A4AAFF2771092C2AEDBC" xlink:to="loc_us-gaap_TradeNamesMember_9DF9D38E7AE57C32323471092C2AD2B3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_560178F1E4CADFF39EC971092C2AA015" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_560178F1E4CADFF39EC971092C2AA015" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_560178F1E4CADFF39EC971092C2AA015" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_2C50AB2EC19C94E67DC871092C2A0289" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:to="loc_holx_CynosureMember_2C50AB2EC19C94E67DC871092C2A0289" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicorMedicalSupplyMember" xlink:label="loc_holx_MedicorMedicalSupplyMember_A8897925C0FCD4692EBC71092C2AC47F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:to="loc_holx_MedicorMedicalSupplyMember_A8897925C0FCD4692EBC71092C2AC47F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EmsorMember" xlink:label="loc_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_AADCFB86BB594F45B2A671092C2A86ED" xlink:to="loc_holx_EmsorMember_1DAA1EFF9E1B41B05CAF71092C2A5F54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9A07F3C20BBF16615BF671092C297E2A" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_E32EC0EF6A35862D197571092C2ABF43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_BD4D026EE0DF5918BD8971092C2A5AFD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_BD4D026EE0DF5918BD8971092C2A5AFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_B74AB012E1EA3DA4589671092C2AABCD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="loc_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_FairValueInputsDiscountRate_3B733109226A68149A2D71092C2BAE96" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_B4B592D53A52BFE459CC71092C2B5311" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_NumberofProjects" xlink:label="loc_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_NumberofProjects_7058AA88AC1F7CBFB33C71403DE7ED7A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete" xlink:label="loc_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete_BE4AF3D272DE6E6D1BDE71092C2BF389" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_FEBEA0F27433AA1A3B8771092C2B0349" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_FEBEA0F27433AA1A3B8771092C2B0349" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1B93FC2C9147CB3AC21971092C2B2BD1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_Revenues_1B93FC2C9147CB3AC21971092C2B2BD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_OperatingIncomeLoss_0584408D631284B6FCD871092C2BC6E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_CF69C38A7F0C0459D07C71092C2B5FC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A252416671B08DD4824271092C2B7FE7" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_A252416671B08DD4824271092C2B7FE7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability" xlink:label="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability_E59F5966DEA3D9BD6AEE713A983A7A82" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability" xlink:label="loc_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability_5D6206C553214541DAEF713E4C108A39" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_B9079A372A84370934CB71092C2B0E84" xlink:type="locator" />
    <link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_Goodwill_B9079A372A84370934CB71092C2B0E84" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:type="locator" />
    <link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7CFD6D437B9E2B9385AB71092C2B3819" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:type="locator" />
    <link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3EC6D8C8FDE2F9A3D2D271092C2A3C3D" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_65BC52E37EC4B7E674DF71092C2B600B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3B08B7790DEF5539E6FB57BBF6652C37" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EA3F8A30AFF5A38D3FA657BBF665AD5B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3B08B7790DEF5539E6FB57BBF6652C37" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EA3F8A30AFF5A38D3FA657BBF665AD5B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5A9F85756D7964CCE4B557BBF66583A7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EA3F8A30AFF5A38D3FA657BBF665AD5B" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5A9F85756D7964CCE4B557BBF66583A7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5A9F85756D7964CCE4B557BBF66583A7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_67A6FBB17E1DC5C6DACD57BBF66511E8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_747719FB9E77908CCBAB57BBF665C441" xlink:to="loc_holx_CynosureMember_67A6FBB17E1DC5C6DACD57BBF66511E8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_EA3F8A30AFF5A38D3FA657BBF665AD5B" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_8D38B38F99F2F3F7599257BBF665FAEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_4D8C67885823BAC475D057BBF665D5F5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_B544239627258D9F76B857BBF665F0FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_75222600F9BB5EF46A5757BBF665502F" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_8FBE3568FD923DC1F5F257BBF665D138" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_78C309098030F96855A457BBF665AF38" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationTable" xlink:label="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_78C309098030F96855A457BBF665AF38" xlink:to="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9718395FFCFA03F9943757BBF6659405" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9718395FFCFA03F9943757BBF6659405" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9718395FFCFA03F9943757BBF6659405" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_82B4063A0AFED95C987F57BBF675A319" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_06BA737CE1500DC4FE8557BBF6755802" xlink:to="loc_holx_CynosureMember_82B4063A0AFED95C987F57BBF675A319" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24F3B10FADEE8823AF0F57BBF67599CB" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24F3B10FADEE8823AF0F57BBF67599CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_24F3B10FADEE8823AF0F57BBF67599CB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_7BC66FE2F7F44A57829D57BBF6755B52" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_7BC66FE2F7F44A57829D57BBF6755B52" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_0B150FB1464FEC5244ED57BBF675ED70" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_0B150FB1464FEC5244ED57BBF675ED70" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DistributionagreementMember" xlink:label="loc_holx_DistributionagreementMember_E331D8DD38515736289157BBF6753E16" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_holx_DistributionagreementMember_E331D8DD38515736289157BBF6753E16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaap_CustomerRelationshipsMember_C8818F0211AB6AC79ECF57BBF6750B36" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_CustomerRelationshipsMember_C8818F0211AB6AC79ECF57BBF6750B36" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_7129090A051FD7D420A057BBF675423A" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D0162A27A4F6C03432ED57BBF6756962" xlink:to="loc_us-gaap_TradeNamesMember_7129090A051FD7D420A057BBF675423A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationLineItems" xlink:label="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationTable_D3D82565F34D8EA6011657BBF665F298" xlink:to="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2DAE413C9FAACB56E5A557BBF675D22B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_C126BCA593102FC70BF157BBF675772B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6722A6B38268E6A41AE657BBF6750B97" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_21680D9C17CE53562E2357BBF67522E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_DE56BDCD0D77EC05D84757BBF675F470" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_DE56BDCD0D77EC05D84757BBF675F470" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities_78A641B9E0246BB46CE957BBF675F464" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_24E9B88272079A4245FC57BBF675CCD4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_0EFD280E81D034619BE557BBF675BE78" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_51D78D5575B0411CAD5657BBF6759CD6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_494DE134750E243361DE57BBF6759577" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_494DE134750E243361DE57BBF6759577" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent_1E22927C2469002980AA57BBF6759C38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_51724E4BF235E9B8704D57BBF675F00F" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_Goodwill_51724E4BF235E9B8704D57BBF675F00F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_PurchasePriceAllocationLineItems_9DF0D3DE47D8017AA29757BBF675A4D1" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_D80110C94E1DF9C90E4C57BBF675A9F8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_C47AF91438348EE2D15D57BBF67591FB" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_C47AF91438348EE2D15D57BBF67591FB" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_D292F2615FB670D203C057BBF67562BC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_D292F2615FB670D203C057BBF67562BC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_D292F2615FB670D203C057BBF67562BC" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_7AA8C9A8651C4CFB476857BBF6758D1B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:to="loc_holx_CynosureMember_7AA8C9A8651C4CFB476857BBF6758D1B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicorMedicalSupplyMember" xlink:label="loc_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_18240C818C69C4A6E7AC57BBF67545F1" xlink:to="loc_holx_MedicorMedicalSupplyMember_95593C0D03D95F7D8ADA57BBF6750E3D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_2ECB65AA382EF4F0ADB657BBF6750883" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AcquisitionPriceAdjustment" xlink:label="loc_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_holx_AcquisitionPriceAdjustment_E700D59D0179A8C8BF9057BBF6756DBB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7136C74CE8D055E8564F57BBF6750291" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_090F15389FCD216B86DD57BBF675CB37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_FB33F9B6739C35A945B657BBF675A1C6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_9296FB267B03496EAF2957BBF6754227" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_160A3B874F4370B5BA0857BBF684E076" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_160A3B874F4370B5BA0857BBF684E076" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_33C8154351714B20FE2A57BBF684BD17" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PurchasePriceAllocationTableTextBlock" xlink:label="loc_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4" xlink:to="loc_holx_PurchasePriceAllocationTableTextBlock_042262ECFBA868CB111457BBF6841B18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_FDD52CC3ADBF9660A7C457BBF68437B4" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_6626EA47A1F8D2DEB89F57BBF6848059" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_701EFAB75692C0B6A88757BBF5ED1907" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_701EFAB75692C0B6A88757BBF5ED1907" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_C64EF0181DC7D2346A9557BBF5ED5E2B" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_A267AD7C642CE9110468714C36122352" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_A267AD7C642CE9110468714C36122352" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsAxis" xlink:label="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:to="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConsolidationItemsDomain" xlink:label="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsAxis_66675E6C42FE25D27DC2714C3612D54E" xlink:to="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="loc_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConsolidationItemsDomain_BEFBF9355E8658DFD20D714C36121F35" xlink:to="loc_us-gaap_IntersegmentEliminationMember_DCE1DAB657C2768389AC714C3612F0F3" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_SegmentReportingDisclosureLineItems" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_5BA530EE85CE24F6052C714C361242CA" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_NumberOfOperatingSegments_5E5898938C5F23D3923D714C361320AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportableSegments" xlink:label="loc_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_NumberOfReportableSegments_34FF1A9897A89AE234C4714C3613B951" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_Revenues_1B327E197EF77A05820D714C3613D809" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingDisclosureOfMajorCustomers" xlink:label="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_us-gaap_SegmentReportingDisclosureOfMajorCustomers_6D8584E59E973C25FF4F714C361301D7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue" xlink:label="loc_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_871F99A8E340DBA5264C714C36124E7C" xlink:to="loc_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue_D4FD96C0B6920960C989714C3613B48E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_C0973D487C5268EB83F657BBF5DF487B" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfGeographicalSegmentsTable" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_C0973D487C5268EB83F657BBF5DF487B" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:to="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementGeographicalAxis_CCB8A13F7C01C3DBC9F857BBF5DF718D" xlink:to="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US" xlink:label="loc_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_country_US_CE0834F6FDD3A65B3BE357BBF5DFAB38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EuropeMember" xlink:label="loc_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_us-gaap_EuropeMember_69F71CB1C457631C0CBC57BBF5DFA47D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AsiaPacificMember" xlink:label="loc_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_us-gaap_AsiaPacificMember_279DA3ED35A8AAE22B3B57BBF5DFA576" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AllOtherCountriesMember" xlink:label="loc_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentGeographicalDomain_DEAE35C32535900237C057BBF5DFFD17" xlink:to="loc_holx_AllOtherCountriesMember_7E0AD7346D0A8C3606E457BBF5DF3784" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfGeographicalSegmentsLineItems" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_99392EEB205BA2B54ACF57BBF5DF8DF7" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PercentageOfRevenues" xlink:label="loc_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_4D419E60E7F02BDC7C8C57BBF5DFC280" xlink:to="loc_holx_PercentageOfRevenues_43F7996DA5CB75A61F3857BBF5DFBA5F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_41F73DA3CEAE3AE57F3557BBF5E349E0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_54E32B3342D72C324AC557BBF5E3F935" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_41F73DA3CEAE3AE57F3557BBF5E349E0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_54E32B3342D72C324AC557BBF5E3F935" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_54E32B3342D72C324AC557BBF5E3F935" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_B02CC031D8CB62F9F05857BBF5E3532D" xlink:to="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DiagnosticsMember" xlink:label="loc_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_DiagnosticsMember_0F385B71B28A2D196CBE57BBF5E3D68F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BreastHealthMember" xlink:label="loc_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_BreastHealthMember_D9EDE759B82736ACA07E57BBF5E47A89" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_GynSurgicalMember" xlink:label="loc_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_GynSurgicalMember_EE9E2931D5EA8B7C29C657BBF5E4B630" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_SkeletalHealthMember" xlink:label="loc_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_SkeletalHealthMember_F0042AAC49E03D99511C57BBF5E4F089" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicalAestheticsDomain" xlink:label="loc_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_holx_MedicalAestheticsDomain_F1710C8B0746B7B8C45D57BBF5E4332E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateMember" xlink:label="loc_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_BFBC636664932767E25957BBF5E3ADF2" xlink:to="loc_us-gaap_CorporateMember_3ED0FAA4E5DA8FA7519557BBF5E40EDE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_54E32B3342D72C324AC557BBF5E3F935" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_Revenues_630F060FADBA3D2F5C6D57BBF5E4C0C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_OperatingIncomeLoss_127C64917AC82B28B28557BBF5E430DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_C7ED73E958EFDA815E6D57BBF5E4F59F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_F151D6DFC0DD55600C3457BBF5E4FD43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_C607347F28572A23D8E857BBF5E4D8E6" xlink:to="loc_us-gaap_Assets_36E53E61DD33B094DAC957BBF5E4BC0F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaap_SegmentReportingAbstract_CB22B424A63049A10EBA57BBF5EB0EF8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_CB22B424A63049A10EBA57BBF5EB0EF8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_6A566F7D977F215C4E5D57BBF5EB03AC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_CB22B424A63049A10EBA57BBF5EB0EF8" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_04239EED182236D444BC57BBF5EB5326" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsAndContingencies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39E824E62E56E074B6F157BBF625C080" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_39E824E62E56E074B6F157BBF625C080" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7E2BBEBCB571F26A0C2C57BBF62561A4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AmountAssessedInDamages" xlink:label="loc_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:to="loc_holx_AmountAssessedInDamages_8102F98F2AB861C6495057BBF6234E04" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_6833A3F84ADC1C62311657BBF62335F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LitigationSettlementExpense" xlink:label="loc_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_B31FC3215935638DEA8457BBF6238742" xlink:to="loc_us-gaap_LitigationSettlementExpense_43452F200AF3E5CD06C757BBF6234FFF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264" xlink:to="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_AA06D1F1325EEFC42B4F57BBF6B3E1E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1FE906F12F8E9B3F26F257BBF6B33320" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_397F37FEDCC91CEC09E557BBF6B3C4E2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:to="loc_us-gaap_InventoryNet_397F37FEDCC91CEC09E557BBF6B3C4E2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidTaxes" xlink:label="loc_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:to="loc_us-gaap_PrepaidTaxes_E3D4A1908C073D15BBF757BBF6B3DDC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_E7457BBAA2358E9E383457BBF6B3917B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4E1EEA7354426146CE8F57BBF6B39E8B" xlink:to="loc_us-gaap_AssetsCurrent_DF8FA6B417BE5AFA5F1F57BBF6B3E9CF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4EF497B0E4E61A29646557BBF6B3A82C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_56E64FC33891350483F757BBF6B3FE62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_11463674E97E8D79EE7157BBF6B39B0C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:to="loc_us-gaap_Goodwill_11463674E97E8D79EE7157BBF6B39B0C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_54021F12A1D066A6F88C57BBF6B369A4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_D6A71705F4E020CEB8BB57BBF6B32177" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87EBF563FB16B4F5D75E57BBF6B330F2" xlink:to="loc_us-gaap_Assets_D6A71705F4E020CEB8BB57BBF6B32177" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3FC30384E00CDECDFF0357BBF6B3D264" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaap_LongTermDebtCurrent_F0F023A6ACD211246AF457BBF6B3674B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:to="loc_us-gaap_LongTermDebtCurrent_F0F023A6ACD211246AF457BBF6B3674B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:to="loc_us-gaap_AccountsPayableCurrent_4F67ED01BCC4D7107F3757BBF6B369A0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_D19428A99E24264149EA57BBF6B36861" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:to="loc_us-gaap_DeferredRevenueCurrent_5ACB0D6444D9F3258D5757BBF6B3710B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_6F8395E80C3B318CB70257BBF6B3186E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2BC2626A0303E4EF152E57BBF6B3CDD8" xlink:to="loc_us-gaap_LiabilitiesCurrent_1734AE9697FADA60F5C657BBF6B3E3AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_08167AEE1E340E702A7457BBF6B34D34" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_08167AEE1E340E702A7457BBF6B34D34" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_8E1BC20972CCD323413257BBF6B381AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNoncurrent_9E6E737166C08157663F57BBF6B3E5EE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_89470636CBC9F267C94A57BBF6B3C470" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_147B3E4024437C94656557BBF6B3DE87" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_CommitmentsAndContingencies_E2680086F4E49937FD0957BBF6B3347F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="loc_us-gaap_PreferredStockValue_5CF27287D0F54E8D181457BBF6B3E533" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="loc_us-gaap_CommonStockValue_639E77BE019ED95D183157BBF6B3E964" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="loc_us-gaap_AdditionalPaidInCapital_7B86A6B99E2B3D5019E857BBF6B39756" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_D5C90F9A9AF47D00E9B257BBF6B3E5B6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="loc_us-gaap_TreasuryStockValue_2D82568D29E00CD4FBDA57BBF6B3473D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5B8AC6126C33391A1AD557BBF6B3786C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_DAE0D29911557E521B4657BBF6B3EAF4" xlink:to="loc_us-gaap_StockholdersEquity_175E7A9AF06A612EA18A57BBF6B3FE02" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_230B3758AD35958E62F057BBF6B3A4A3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_B65A3402D027974CC3FD57BBF6B39C95" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_80303319194267AE8D7C57BBF6A4BAA3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5FBC6CE37E8AFD682AFC57BBF6A4352B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_66FBC7644A309C667B9357BBF6A4880C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4E123050723C31EEB46657BBF6A44FEA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_EC7AC3071BDD824D06E657BBF6A49294" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_CEDBD748C1FBC5200B9457BBF6A4E750" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_CommonStockSharesIssued_F1CA194734A51C86DEA857BBF6A42C62" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_52112575119E35318D6257BBF6A4E8C8" xlink:to="loc_us-gaap_TreasuryStockShares_FB5E7DDA9AC260A751A857BBF6A433EE" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_1AE489CF78254B63B48357BBF6A47B2C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:to="loc_us-gaap_NetIncomeLoss_1AE489CF78254B63B48357BBF6A47B2C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="loc_us-gaap_Depreciation_81CC5313E7F2A27FC7DE57BBF6A4C7A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="loc_us-gaap_AdjustmentForAmortization_DA381892E29A0EEDEB2B57BBF6A4AD8C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_C6D486ADBA29286F55E857BBF6A48D70" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_C6D486ADBA29286F55E857BBF6A48D70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_D0B0040761ED2CC9978157BBF6A4749C" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="loc_us-gaap_ShareBasedCompensation_D0B0040761ED2CC9978157BBF6A4749C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_A9213050798C2791F84C57BBF6A40530" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_123969266ABBDEAFD17657BBF6A4FD41" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_123969266ABBDEAFD17657BBF6A4FD41" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNoncashIncomeExpense" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_D5D1FF1CDDBA2847AAFB57BBF6A4DB98" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_A742CCFD0D26A6235D8857BBF6A4D5C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2883A94DE7674F61E02757BBF6A40312" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_E2600A7351EF248B392757BBF6A44FD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_F21B3774AA91A51E575357BBF6A4EC37" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1AE46B712DEF3E9CBFB057BBF6A4FE48" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_429F11F62068EA3C487257BBF6A4D2F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_EB130928041344F75A7357BBF6A4A27A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3BE8BD2E32CB557BED6457BBF6A499AB" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_DB00083416CF56A41F8057BBF6A4CA92" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_226171C1C473F137A20257BBF6A408AA" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_E012B517F7F7AFB41FE457BBF6A4ACF3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_EBB28A8DEA2F970812FC57BBF6A4019D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1F7641F81290AF4C2D1B57BBF6A401F0" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_836723574152039299C857BBF6A499CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities_EA0A00D953DE0323F9EB57BBF6A478DC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_8673A46401BB17DE2ADF57BBF6A48515" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_576EF64D69AF6204B01B57BBF6A44F03" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_E29A9722D19CE5D4349B57BBF6A41C75" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_2AC7EE7796E3D0C3AC2157BBF6A4C1EB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_276A62C0D48B00F57A6257BBF6A4F91D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_52CA036C999CA543971E57BBF6A4E550" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_3F3A9870B97D9D3D955457BBF6A4FC65" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_653FCB3342E058EB3D1E57BBF6A49DC1" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_653FCB3342E058EB3D1E57BBF6A49DC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_2460C95A9396E8A91D4857BBF6A4D678" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_58F9479CEB5917EDC3AA57BBF6A45367" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5541225B3E76A37AD9E757BBF6A4F4D5" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_5541225B3E76A37AD9E757BBF6A4F4D5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_A725CEF64EFF5C46686957BBF6A44E2E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_C183FFEC56FE4CAF8FAD57BBF6A4A6F4" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_D2C18980BF945A6415C757BBF6A4421C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4452A74D4141926570B857BBF6A4AD38" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1AF4A7F011148F598CD357BBF6A42283" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_F9A0B0D3F6AD223B290257BBF6A46D1D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_97C39595FE0A79371CFF57BBF6A4039D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_A1921389806C8F25A26D57BBF6A4EEAC" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_A1921389806C8F25A26D57BBF6A4EEAC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0EBF2E2994A85D33810C57BBF6A43619" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_9924B6C8373672C2C78A57BBF6A46377" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0EBF2E2994A85D33810C57BBF6A43619" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_NetIncomeLoss_C85A0503D849F1BAB86171092C63F9F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_FA1CAA3A7170E11C00B971092C64835A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_BB070C5566D9175EB49571092C645EF9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_5B56B0840942C684D95871092C646C8B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_E06466F42A05D834AD1E71092C646F81" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_5ABE93D2646F2778BAE271092C644D4C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_DF4D9FECAC5079716F4D71092C646BAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_47D983B5DA67BAB5D9E171092C644B35" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7657153E75110E9107E971092C6307DF" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2986B3A27EEF7B9E567271092C64FE16" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_22DF1EAD47C7FBCA4EEB71092C603BD7" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_22DF1EAD47C7FBCA4EEB71092C603BD7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_FD1752165AEC395E776E71092C603953" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_22DF1EAD47C7FBCA4EEB71092C603BD7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent_D7EFA43080B6EEE92F7B71092C60055F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_22DF1EAD47C7FBCA4EEB71092C603BD7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_61773CBD20AF70BA732171092C604073" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsOfIncome" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:to="loc_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:to="loc_us-gaap_SalesRevenueGoodsNet_4D379FF9159EDABF234B71092C6A12DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueServicesNet" xlink:label="loc_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:to="loc_us-gaap_SalesRevenueServicesNet_4B27943887245D45F8C171092C6A95C2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaap_Revenues_7FE1F0975B79EE9A701F71092C6AC354" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4D7CD9AC865800E1CD6B71092C6A92B2" xlink:to="loc_us-gaap_Revenues_7FE1F0975B79EE9A701F71092C6AC354" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenueAbstract" xlink:label="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:to="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:to="loc_us-gaap_CostOfGoodsSold_445676417B200D03197371092C6B0C22" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfGoodsSoldAmortization" xlink:label="loc_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:to="loc_us-gaap_CostOfGoodsSoldAmortization_25FB560191B189C8045871092C6B5440" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfServices" xlink:label="loc_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:to="loc_us-gaap_CostOfServices_60E97495DB1093C3B7C771092C6BBCD5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_30284DCDF17ABAD1B59971092C6A65EA" xlink:to="loc_us-gaap_GrossProfit_3147219D64C9E0AA1EE271092C6BA054" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:to="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8DEBE38E9EC4CEA6B53C71092C6B456D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_SellingAndMarketingExpense_68EDC1DB1BAC995974B271092C6B269F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_C79BCA2F9C49CFA52D1E71092C6B2D74" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7EEFD918FC569D55619371092C6BF486" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="loc_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_RestructuringCharges_5E1211AF367D4FDF9DC471092C6B7A2D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_OperatingExpenses_02718243190037EC3FF471092C6B4DAA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaap_OperatingIncomeLoss_2F2E915369B70F3F170F71092C6B707F" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_OperatingIncomeLoss_2F2E915369B70F3F170F71092C6B707F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_InvestmentIncomeInterest_829FE3B3DB00BDB7B19371092C6BC7A6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_InterestExpense_9174C7B9233D9EFB230871092C6BEBC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_40E1A22FC6C1967194E771092C6B7D3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_CDFD207A99513D25576471092C6B4926" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_35D2EF924A4A52DDCD2D71092C6B493D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_FF2B899A09A0051D8F0571092C6CE767" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_FFF75C6330F5213302E471092C6C2027" xlink:type="locator" />
    <link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_DA2E7634075861FB177371092C6BD501" xlink:to="loc_us-gaap_NetIncomeLoss_FFF75C6330F5213302E471092C6C2027" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:to="loc_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:to="loc_us-gaap_EarningsPerShareBasic_EFA44B801B0C0199EFD571092C6CF635" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3BCE6C60BB0EBD00484F71092C6C4E07" xlink:to="loc_us-gaap_EarningsPerShareDiluted_C2734B9E9509D69A587A71092C6C3E7F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5A58AEC023BF9F003CAE71092C6A762B" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88CE380AFDA2BB4D273D71092C6C80A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_88CE380AFDA2BB4D273D71092C6C80A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F78D7C1463F3E68E4F2971092C6CD4A7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_EB073A980BC0E5081CD571092C6CC9B8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_F78D7C1463F3E68E4F2971092C6CD4A7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D242745CA74BF5374EA157BBF636E461" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_D242745CA74BF5374EA157BBF636E461" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9B03D8C7A18280C1CFB457BBF636F535" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_512803DB9262E2ECA0EA57BBF632ACB7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalAmountOfBorrowings" xlink:label="loc_holx_PrincipalAmountOfBorrowings_44635391D003B008A56D57BBF63314E6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_holx_PrincipalAmountOfBorrowings_44635391D003B008A56D57BBF63314E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_8392E5B2065FD9E56B3457BBF6331E9E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_8392E5B2065FD9E56B3457BBF6331E9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_1394AFB55A2949BEA30E57BBF6339972" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_39FBBD7E1869BECB8A5357BBF633B38F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments" xlink:label="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_F78371BECC6DA71E2CE257BBF633A82C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax" xlink:label="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax_174553F696FC308F947E57BBF633BAB2" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_NotionalAmount" xlink:label="loc_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_180647E8DED8C92AF89457BBF6321FDD" xlink:to="loc_holx_NotionalAmount_E78817646178927E676957BBF633A2F4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3F3BB59AAB3170028BE857BBF62EB788" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3F3BB59AAB3170028BE857BBF62EB788" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationAxis" xlink:label="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_HedgingDesignationDomain" xlink:label="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_76850B916519E28035AE57BBF62E093B" xlink:to="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_F9BDFF870620220080D557BBF62EFF29" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NondesignatedMember" xlink:label="loc_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_25B1256202B45A94F23A57BBF62E8B1E" xlink:to="loc_us-gaap_NondesignatedMember_77A160AD04B3EFE2150557BBF62EB34B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4E76580DFCA80D2AC46A57BBF62EAEF7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4E76580DFCA80D2AC46A57BBF62EAEF7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4E76580DFCA80D2AC46A57BBF62EAEF7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_B2F7AB4EEB557F703C1D57BBF62E64B9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:to="loc_us-gaap_InterestRateCapMember_B2F7AB4EEB557F703C1D57BBF62E64B9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_A1FF9E481EBA8D6FFA4957BBF62EB3A9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_503075F08CF86B0ACE8057BBF62E757E" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_A1FF9E481EBA8D6FFA4957BBF62EB3A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_07E689B289FE0545A70957BBF62E0F9B" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_4D65C672DE6D76DB3F1457BBF62E06EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="loc_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:to="loc_us-gaap_OtherAssetsMember_C4149986D237EE7F18BF57BBF62FC923" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesMember" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9F51BE4BA5AA0C43887557BBF62EE74F" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_519FFEC112038EDC0A6457BBF62F05C3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0584A5DE97A901DF71A157BBF62E0129" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_272DC2010B4B73E4AC6157BBF62F1D4E" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_835F51ABC08B25FB2F8057BBF62FD630" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5403D6D712831CD65CA357BBF627ACDF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5403D6D712831CD65CA357BBF627ACDF" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_F8A7B2B7DF1FEC25559457BBF627F5F2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeForwardMember" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9B4462740FD55C8FE29857BBF627A4FB" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_56416864FDB01B04F36C57BBF6272BC9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_66FB942CA857658F14B157BBF6273F33" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_68570EB6F5081AAEAA0F57BBF627CD8A" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_E4A6E984D8799C374CB057BBF6271030" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8FAFE9D932AABE213AB257BBF62A8DBC" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6A13B6CF67B1D31B6A7157BBF62A2555" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8FAFE9D932AABE213AB257BBF62A8DBC" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6A13B6CF67B1D31B6A7157BBF62A2555" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_1E1D29E5B0575375214D57BBF62A933A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6A13B6CF67B1D31B6A7157BBF62A2555" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_1E1D29E5B0575375214D57BBF62A933A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_1E1D29E5B0575375214D57BBF62A933A" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_8030F765BEBD5FC2E0EE57BBF62A29A9" xlink:to="loc_us-gaap_InterestRateCapMember_41626B0DDC159D51174F57BBF62ABC89" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6938F810695EA18F9CB457BBF62AAC70" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_6A13B6CF67B1D31B6A7157BBF62A2555" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6938F810695EA18F9CB457BBF62AAC70" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_CC8612E55CCD863A5F6957BBF62AABC0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6938F810695EA18F9CB457BBF62AAC70" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet_CC8612E55CCD863A5F6957BBF62AABC0" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_5B31E23078763592BC2757BBF635E0D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_D69830128825918EF64357BBF635E3DF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1338B1C2E929D474221757BBF6359C1C" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1569F7EC8CF4CA72CEC957BBF635F16D" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_EABFEB67FE8D631C3FD2714C36276E97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_EABFEB67FE8D631C3FD2714C36276E97" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_0FA68222303D2D87B8B5714C36273FA5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_5A250B3BB17C93147271714C36257495" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AssetsofBusinessHeldforSaleAbstract" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:type="locator" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_5A250B3BB17C93147271714C36257495" xlink:to="loc_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract_9A89E4E8B2B70D0353B7714C36259F61" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_05C488F2FF03DF5E848C714C3625FDC1" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BloodScreeningBusinessMember" xlink:label="loc_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_300BC76521DD2035F4AA714C3625557E" xlink:to="loc_holx_BloodScreeningBusinessMember_D46B48020845DCB8FB1A714C362502C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3B0C8EF083BD7AAC4D2A715A692312D4" xlink:to="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_GrifolsMember" xlink:label="loc_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5E009C8D1BB3DFF58F03715A6923D23E" xlink:to="loc_holx_GrifolsMember_7AB45103E3D003D43CAD715AD0C4CDFD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeAxis_53DA1AD09FA0885D8978715B59938AF2" xlink:to="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:to="loc_us-gaap_MinimumMember_A821F595FAA7391FC7DC715B7D8727E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RangeMember_0D6B89D371EC90D2586C715B59AA528F" xlink:to="loc_us-gaap_MaximumMember_CD5990CEB063E4A956A2715BDA630807" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_A6C1A956F4E66AD94E06714C36253B33" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_GrossProceedsonSale" xlink:label="loc_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_GrossProceedsonSale_A7835E5B3B65D4E1E3FB714C362548CF" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ProceedsFromSaleOfBusiness" xlink:label="loc_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_ProceedsFromSaleOfBusiness_A1BA2831AA0607A822A5714C362594FD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_E49AA5FF9B0361F7EA88714C3625F24C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedIncomeTaxes" xlink:label="loc_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_AccruedIncomeTaxes_A413628C3E6A4FF64AA6714C36256008" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal" xlink:label="loc_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal_561D76264500D5069953715A19D16290" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Proceedsallocatedtomanufactureofinventory" xlink:label="loc_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_holx_Proceedsallocatedtomanufactureofinventory_236499E032F19DA55D7E714C36257560" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_CEAE65E2D985B3B88677714C3625AFB3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_83FC8F14CA2EDC96C415714C36251BB7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_BAEF4BFA3AAC61604483714C3625394A" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DocumentAndEntityInformation" xlink:type="extended">
    <link:loc xlink:href="holx-20171230.xsd#holx_DocumentAndEntityInformationAbstract" xlink:label="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_DocumentType_599B3FA67A941448921E57BBF6CC4E8F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_AmendmentFlag_F01199C2568580CF624757BBF6CCA8A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_DocumentPeriodEndDate_D4DBE4453BC0E4409DFC57BBF6CCECD1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_DocumentFiscalYearFocus_938DCEE19F900F19ABF957BBF6CCEA9A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_DocumentFiscalPeriodFocus_29BFFDC9ADBEF47E73C757BBF6CC5B43" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_EntityRegistrantName_2B809A1A1588EAA16F8457BBF6CC3DA2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_EntityCentralIndexKey_C4BE0D0E347AACDCF2FA57BBF6CC119B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_CurrentFiscalYearEndDate_EDF1996D4B6472FBC1C757BBF6CCBB0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_EntityFilerCategory_633F5746D8A0990EDC4957BBF6CCB45C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_DocumentAndEntityInformationAbstract_8E39FFE0D38F4BC6F70B57BBF6CCC56F" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_E6B5847F6BAB229C1C4557BBF6CC2388" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2F7FA741C69ACBA2F7A157BBF694C2B0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2F7FA741C69ACBA2F7A157BBF694C2B0" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_AA9A127FD0FE9E24863757BBF694EDA8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0FF5549393FE0218838B57BBF6844298" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0FF5549393FE0218838B57BBF6844298" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaap_DebtInstrumentAxis_8BE0351D2F52B4B073ED57BBF6841A3A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:to="loc_us-gaap_DebtInstrumentAxis_8BE0351D2F52B4B073ED57BBF6841A3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8BE0351D2F52B4B073ED57BBF6841A3A" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CreditAgreementMember" xlink:label="loc_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_holx_CreditAgreementMember_8B9338CF1FB9ADED50A557BBF6843C3F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AccountsReceivableSecuritizationMember" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_B2FFE41F3FC0B21CDD7457BBF684B043" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_B2FFE41F3FC0B21CDD7457BBF684B043" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeniorNotesMember" xlink:label="loc_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_us-gaap_SeniorNotesMember_8A0212375425647C3EDB57BBF684FC2B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_A2025SeniorNotesMember" xlink:label="loc_holx_A2025SeniorNotesMember_C2C6822E63A4442980E257BBF684B4D0" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_D68A0E6DD6781BD7DD8857BBF684BEDD" xlink:to="loc_holx_A2025SeniorNotesMember_C2C6822E63A4442980E257BBF684B4D0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_58D3D06FA0D88AE1261757BBF6842246" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_PrincipalAmountOfBorrowings" xlink:label="loc_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:to="loc_holx_PrincipalAmountOfBorrowings_3ADBC6AC45E5CFD7BCE057BBF68411F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentFairValue" xlink:label="loc_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_72CB3DA2786FEB220C2C57BBF684B67E" xlink:to="loc_us-gaap_DebtInstrumentFairValue_C56D73D2315B3B9FFEF057BBF68488C8" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2CF04B50FB77223D21B957BBF6846119" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EstimatedFairValueOfFinancialInstrumentsTable" xlink:label="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2CF04B50FB77223D21B957BBF6846119" xlink:to="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:to="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_413BAF2EB17CA484C4FA57BBF6848BC2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndTwelveNotesMember" xlink:label="loc_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:to="loc_holx_TwoThousandAndTwelveNotesMember_30430606ED47E38A460B57BBF684BC8A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandAndThirteenNotesMember" xlink:label="loc_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_745D5EE04D35621A36AE57BBF684CA04" xlink:to="loc_holx_TwoThousandAndThirteenNotesMember_AD09126F797552D8313357BBF684A43B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EstimatedFairValueOfFinancialInstrumentsLineItems" xlink:label="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsTable_63F704A3C151EBB9D68157BBF684C15F" xlink:to="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EstimatedFairValueOfFinancialInstrumentsLineItems_CD63D692EF72D578A91A57BBF684B689" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_04B79722283200227A3F57BBF6844740" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_345E72B4C4B02012579557BBF6847888" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_345E72B4C4B02012579557BBF6847888" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_A1F3DE4D9CDFA89F4CF557BBF68479E7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_25F929E27CCDDFA449A057BBF6840888" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_3A5D495F31DFD79BFA3B57BBF68471D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_EED2430CC7D7E8C93DBC57BBF6845380" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_EF1310E93B9C88FDBB9E57BBF68495F8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:to="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_44B7D196B731238BB11657BBF684784B" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCapMember" xlink:label="loc_us-gaap_InterestRateCapMember_2A82B0BAD2864B610F3B57BBF684117D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_InterestRateCapMember_2A82B0BAD2864B610F3B57BBF684117D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignExchangeContractMember" xlink:label="loc_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_ForeignExchangeContractMember_F59F746734E6A7E0B5C057BBF68404A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredCompensationShareBasedPaymentsMember" xlink:label="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_DeferredCompensationShareBasedPaymentsMember_5DB72E9350C90962FD7A57BBF684508E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForwardContractsMember" xlink:label="loc_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6D2F4E76D389EEC51EFE57BBF684A4ED" xlink:to="loc_us-gaap_ForwardContractsMember_72408AC4C589DDB9B62D57BBF684B02F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_9EA43CC887942F4D35D057BBF684DCFC" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_D42E597FF020ECDBD57D57BBF684CCE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestRateCashFlowHedgeAssetAtFairValue" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue_D7CFC2C9E74661C7522B57BBF68418B2" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_A93119FD05EE2BF1BAD957BBF6849DC5" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_708E9DA6B8615A31E89857BBF68490D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_03048D973FF14660C64357BBF6845DBD" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_744BE9D8CDFF39B14AFB57BBF68423F3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_D09D04665C34BF01E62957BBF684FC1C" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_6E432F922BE8FD47C1B357BBF684DB38" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6453D4E295E705C5474357BBF694C9AF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6453D4E295E705C5474357BBF694C9AF" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_31DE5121EAF26A7F1BBE57BBF694E678" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6453D4E295E705C5474357BBF694C9AF" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_44D769AFAC82DD20C04057BBF694286E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ECFA09DD7AD0917F91C557BBF5DC2443" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ECFA09DD7AD0917F91C557BBF5DC2443" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_742EF51EE3BDC474039457BBF5DCCA00" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_C83FB9A25BE44C14787271092B90D005" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationTable" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_C83FB9A25BE44C14787271092B90D005" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementScenarioAxis_FB8FB3EC7A147CA834A371092B901688" xlink:to="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScenarioForecastMember" xlink:label="loc_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScenarioUnspecifiedDomain_243CE427CEC8C695BFC171092B907BA4" xlink:to="loc_us-gaap_ScenarioForecastMember_341CCF2FB71598A7A8E171092B90446E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_083C9EBAE6E414126FDD71092B90488A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_083C9EBAE6E414126FDD71092B90488A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_083C9EBAE6E414126FDD71092B90488A" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaap_SubsequentEventMember_610E06DA6EBFE068B61571092B917035" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_9917A517B8750BC8629C71092B912A06" xlink:to="loc_us-gaap_SubsequentEventMember_610E06DA6EBFE068B61571092B917035" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_37948B5692F96860351C71092B91BEA6" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_77E039891A83036A3CCA71092B91D824" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_6D88F14AB9B25E2EC17C71092B91D65B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_F7F14E78F3154214853F71092B9108FF" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_F7F14E78F3154214853F71092B9108FF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_F7F14E78F3154214853F71092B9108FF" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_8885593D1F41CCB680FE71092B91E7AF" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_BCCDDA4378C1F3FB6E7171092B9125C9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationLineItems" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_86FF4B3CAE8E29FE970471092B90EEE9" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7530687E1F42519D4DFE71092B91F70B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_121C963B99AD5B9C463A71092B9149C6" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount" xlink:label="loc_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount_265F5BCB7634DF8BC6DA71092B91A55E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit_DE90936911D7E00C2DF071092B9183F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_70608CC6711412A4C2C671092B916794" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse" xlink:label="loc_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse_8D1C8C2A3D90135C486671092B9174D8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit" xlink:label="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit_49B13BA42C0530787D9071092B92F574" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority" xlink:label="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority_FC63C009AF8D74B1D81771092B92C911" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions" xlink:label="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_44312423CE426653411271092B91ADFC" xlink:to="loc_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions_F9FBA2DC524B5EBA9B8D71092B9291D7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwill" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DD87681374E9DD020D0271092B8C061E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_DD87681374E9DD020D0271092B8C061E" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_7C34531F85D27A55623071092B8CF927" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18C57778B71382D6CD6F714C35F0A1D5" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ProductLineTable" xlink:label="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_18C57778B71382D6CD6F714C35F0A1D5" xlink:to="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_E86C15F60B27DB49D00D71624C394172" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_E86C15F60B27DB49D00D71624C394172" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_E86C15F60B27DB49D00D71624C394172" xlink:to="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MedicalAestheticsDomain" xlink:label="loc_holx_MedicalAestheticsDomain_748C6E9F0BA9D099971C71626AC47D28" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8B358148A7CCCAACCB6F71624C49EBE2" xlink:to="loc_holx_MedicalAestheticsDomain_748C6E9F0BA9D099971C71626AC47D28" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_86F38E30F6C5B0439688714C35F0EE67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DevelopedTechnologyMember" xlink:label="loc_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:to="loc_holx_DevelopedTechnologyMember_8E9A0EB2D6C7DE1FB8B9714C35F01140" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CustomerRelationshipsContractsMember" xlink:label="loc_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_D883D113FB2A37240415714C35F01CAD" xlink:to="loc_holx_CustomerRelationshipsContractsMember_1C71A7A38E9FE810F8CB714C35F05BD0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_F9E3253A95006F3C1738714C35F02B11" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_AB453A0DEB6D146192FC714C35F07ABE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_71B07DD25AEBCFE0AE9D714C35F0F872" xlink:to="loc_holx_CynosureMember_AB453A0DEB6D146192FC714C35F07ABE" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ProductLineLineItems" xlink:label="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ProductLineTable_ED8DB3C38ABA48D99756714C35F0C0AE" xlink:to="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NumberOfReportingUnits" xlink:label="loc_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="loc_us-gaap_NumberOfReportingUnits_6A04313256BB460FD6F2716166666892" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount" xlink:label="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="loc_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount_A7FF020DF93CFD476B36714C35F0EA3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ProductLineLineItems_08DBA1F2473AAF1EB5E4714C35F0A1D1" xlink:to="loc_us-gaap_Goodwill_0A8810250D0B14FACF61714C35F153AA" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06E1B12FE51BA8CF88E671092B810DA3" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06E1B12FE51BA8CF88E671092B810DA3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_A7A68F80112A7A6C6BF271092B81CDC6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06E1B12FE51BA8CF88E671092B810DA3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_711046DD68E61EBEF29071092B81CC95" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06E1B12FE51BA8CF88E671092B810DA3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2FBDB2B28BDB98F70FB471092B81CB03" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06E1B12FE51BA8CF88E671092B810DA3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_3977053870F64D85A38D71092B8119D3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_06E1B12FE51BA8CF88E671092B810DA3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_AA049EB46C66A0B30BD371092B816F0E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7CE906D48858087198ED714C35F70C15" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7CE906D48858087198ED714C35F70C15" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_554843DEE1252DFA5D41714C35F746FB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_554843DEE1252DFA5D41714C35F746FB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_554843DEE1252DFA5D41714C35F746FB" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DevelopedTechnologyMember" xlink:label="loc_holx_DevelopedTechnologyMember_EF011ACF3EAFB73AF557714C35F894CA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_DevelopedTechnologyMember_EF011ACF3EAFB73AF557714C35F894CA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_E87BBBF10C7914D6409C714C35F82983" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CustomerRelationshipsContractsMember" xlink:label="loc_holx_CustomerRelationshipsContractsMember_4D1C58322FF27668EA3D714C35F82C91" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_CustomerRelationshipsContractsMember_4D1C58322FF27668EA3D714C35F82C91" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradeNamesMember" xlink:label="loc_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_us-gaap_TradeNamesMember_421ED8CFD37E0448C037714C35F8FC3A" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DistributionagreementMember" xlink:label="loc_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_DistributionagreementMember_DE87514EB49CC4A10A94714C35F816E9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_4991DF562A78F51F8C41714C35F81556" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BusinessLicensesMember" xlink:label="loc_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_BusinessLicensesMember_5022273AD263E32DFE0E714C35F8A3E8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_AcquiredintangibleassetsMember" xlink:label="loc_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_AcquiredintangibleassetsMember_64A377CDA0B3C2C0AA94714C35F8D0C5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_InternalusesoftwareMember" xlink:label="loc_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_InternalusesoftwareMember_988214A7E7FC6444AEFE714C35F8BD33" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CapitalizedsoftwareMember" xlink:label="loc_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ADF40CD843485116A598714C35F8B40A" xlink:to="loc_holx_CapitalizedsoftwareMember_9A9C0E9AC7809C893354714C35F8D8F6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_DC00E3F0A4D7D2A35012714C35F7FEB1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_BBDA385EAD1862568027714C35F93474" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0596EDC1E42238A0B0E2714C35F8D829" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0881DB2ED995974504D9714C35F9BC52" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94D4176AFE16CCDC9F4771092B8A7120" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94D4176AFE16CCDC9F4771092B8A7120" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0B3F7919458F3DF700A171092B8AF1DA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_94D4176AFE16CCDC9F4771092B8A7120" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_0AC13C9AC4F45EE9E90471092B8A6DF7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomePerShare" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_A3200409A74B7719A9CD57BBF621138F" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_A3200409A74B7719A9CD57BBF621138F" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_B99FA43871C6082BEEAE57BBF6218B59" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ED9C8266C3538521A38357BBF61CD456" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EarningsPerShareTable" xlink:label="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ED9C8266C3538521A38357BBF61CD456" xlink:to="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3957CF145797DA71DD6757BBF61C2459" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="loc_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:to="loc_us-gaap_StockCompensationPlanMember_1C027A64680EF0F6BD2457BBF61CB765" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_F33726CE4E9A9CA97BFD57BBF61C8D33" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_27C77B2D15734E44A22257BBF61DCD29" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EarningsPerShareLineItems" xlink:label="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_306F4E8A7198881E669A57BBF61C1FC3" xlink:to="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_999E25E24DD978E373A657BBF61D2298" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_21B47D040FE6C6E38A7257BBF61D41B5" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities" xlink:label="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities_09121C4D9D279D53213C57BBF61D282C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_63E246B243721D5A78F657BBF61DC547" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_8D8749E7D1AD237CD20557BBF61D2E00" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_3FE7E22E6E4999824EF357BBF61D0058" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0321E3E781EB77DFAA6F57BBF61DB4AB" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomePerShareTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6933458A35A426265DA657BBF61F6E97" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6933458A35A426265DA657BBF61F6E97" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_DD59D1B0D0D4A7C541C757BBF61F5A68" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_850F161617B56117894E57BBF5A1AEA0" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_850F161617B56117894E57BBF5A1AEA0" xlink:to="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6810011F4DF125ECB0FC57BBF5A18F3E" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_88C2AF61D187E634F42E57BBF59EB4CF" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88C2AF61D187E634F42E57BBF59EB4CF" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ADD786EC77E74075D42D57BBF59E5C54" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1F45B8FE11DF90B648E057BBF601604A" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1F45B8FE11DF90B648E057BBF601604A" xlink:to="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_FE1E93399CE0CA06045157BBF60132D6" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_959DDA0F26836365F46557BBF5FB8D1C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_902D33A952E620CA8AF357BBF5FCD633" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_F93E292AFA5EA29D284657BBF5FCE656" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_266830FCE9C066784AC957BBF5FB518E" xlink:to="loc_us-gaap_InventoryNet_9BE1EB5A2568023D8EA357BBF5FCEA15" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ManufacturingEquipmentAndSoftware" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_D40C207EFE965E95B2FD57BBF5F41F61" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_EquipmentUnderCustomerUsageAgreements" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_43D6F05CBA017354A7C857BBF5F49DE0" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BuildingsAndImprovementsGross" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_6DF3A43F1E98C69DDCA957BBF5F444A1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LeaseholdImprovementsGross" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_1D56C1ABA4C999A8DDA557BBF5F437AB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Land" xlink:label="loc_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_us-gaap_Land_C5158C551A1C6333D60557BBF5F4CD18" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_142F997EFEF1AD63751D57BBF5F4B890" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_6D8CE2A38FB1113884BE57BBF5F4735C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_238EBB47F6AEBDA038E557BBF5F4E40C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_C56E8AE02F17DFD1DDAE57BBF5F456D7" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_B7C002CF7ECD8C22E1A457BBF5F4CFC7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_C56E8AE02F17DFD1DDAE57BBF5F456D7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EBBB9F957D0A2E9CED3B57BBF5FF380D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EBBB9F957D0A2E9CED3B57BBF5FF380D" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_D8AE1B84224F61D0344D57BBF5FFEAC1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_EBBB9F957D0A2E9CED3B57BBF5FF380D" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_53C8E94EF2310B4C48BD57BBF6007EC1" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteesAbstract" xlink:label="loc_us-gaap_GuaranteesAbstract_F3A4C2ADCCD4220BD9AC57BBF5B58067" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_F3A4C2ADCCD4220BD9AC57BBF5B58067" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_D12C3A58512983C8DEE157BBF5B513C7" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteesAbstract" xlink:label="loc_us-gaap_GuaranteesAbstract_D31F06E9D13577A060B971092B77BF18" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_D31F06E9D13577A060B971092B77BF18" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:to="loc_us-gaap_ProductWarrantyAccrual_090D6F479120364ED84271092B77FF3A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5560B448AC425E70630C71092B77FC23" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_52CC8E6C8F7BEF4077BF71092B77D8B5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductWarrantyAccrual" xlink:label="loc_us-gaap_ProductWarrantyAccrual_CAA55B1E4EA6E55AFAC371092B777713" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_19BA1F5A17F46EBEF52F71092B77D607" xlink:to="loc_us-gaap_ProductWarrantyAccrual_CAA55B1E4EA6E55AFAC371092B777713" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GuaranteesAbstract" xlink:label="loc_us-gaap_GuaranteesAbstract_7A774AC2BCE8F7B501E171092B798C37" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_7A774AC2BCE8F7B501E171092B798C37" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_EC14E6B9AE40A892C94271092B79EBEF" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringCharges" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8F341BA0DF52168E8C8B71092C149C13" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8F341BA0DF52168E8C8B71092C149C13" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_D742AE149628278B694371092C15A4E2" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8ED02979AF189F962D8D71092C059A54" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_8ED02979AF189F962D8D71092C059A54" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5DF09573220840B556DB71092C0579AA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5DF09573220840B556DB71092C0579AA" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5DF09573220840B556DB71092C0579AA" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_50028F81021DB4A9683971092C05BCD9" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_EDDE82F9ED4216FBF0DD71092C059FA5" xlink:to="loc_us-gaap_RestructuringChargesMember_50028F81021DB4A9683971092C05BCD9" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_CE95DB10C82727BE97A771092C05DD6D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:to="loc_us-gaap_RestructuringPlanAxis_CE95DB10C82727BE97A771092C05DD6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_CE95DB10C82727BE97A771092C05DD6D" xlink:to="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_BF865872152FBF63B61D71092C05B46C" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:to="loc_holx_CynosureMember_BF865872152FBF63B61D71092C05B46C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BedfordMember" xlink:label="loc_holx_BedfordMember_03C722A67847B5C324D971092C05003E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_27D5990351D90A0B2FA171092C055FA3" xlink:to="loc_holx_BedfordMember_03C722A67847B5C324D971092C05003E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_F5D6500A64677BE9B71271092C05937E" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SeveranceCosts1" xlink:label="loc_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:to="loc_us-gaap_SeveranceCosts1_6EDEF9526C9767D5FC9371092C05B176" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost_CC5D8360F08861D6BE2571092C05A95D" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_FacilityClosureCosts" xlink:label="loc_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_988B13C944DA22FE9C7B71092C050854" xlink:to="loc_holx_FacilityClosureCosts_B86176A82960667778FA71092C059D0F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9B95FE6663A1D7BECEA071092C0A8B71" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9B95FE6663A1D7BECEA071092C0A8B71" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_E5BCCD7F25BFC4F7127871092C0AC52E" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_E5BCCD7F25BFC4F7127871092C0AC52E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_E5BCCD7F25BFC4F7127871092C0AC52E" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_B527893A7D3FAA29E45B71092C0A081B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_43DAE9C826620F7F43BF71092C0AB234" xlink:to="loc_us-gaap_RestructuringChargesMember_B527893A7D3FAA29E45B71092C0A081B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_00C8F775C1DC1A797E4C71092C0A7C16" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:to="loc_us-gaap_RestructuringPlanAxis_00C8F775C1DC1A797E4C71092C0A7C16" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_00C8F775C1DC1A797E4C71092C0A7C16" xlink:to="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandSeventeenMember" xlink:label="loc_holx_TwoThousandSeventeenMember_6CEADD99A3778EA8A6C171092C0A186B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:to="loc_holx_TwoThousandSeventeenMember_6CEADD99A3778EA8A6C171092C0A186B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwothousandeighteenMember" xlink:label="loc_holx_TwothousandeighteenMember_2C55500ADC835B24F58471092C0B737E" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_794BCB0D85186186CF5271092C0ACE3D" xlink:to="loc_holx_TwothousandeighteenMember_2C55500ADC835B24F58471092C0B737E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_C6067934124EBA582E8D71092C0B6CE4" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_C6067934124EBA582E8D71092C0B6CE4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_C6067934124EBA582E8D71092C0B6CE4" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2018ActionMember" xlink:label="loc_holx_Fiscal2018ActionMember_72E972F6C796C51A8B0971092C0BE8BA" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_holx_Fiscal2018ActionMember_72E972F6C796C51A8B0971092C0BE8BA" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2017ActionsMember" xlink:label="loc_holx_Fiscal2017ActionsMember_8A97AAB228E0F0A6A5E871092C0BB647" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_holx_Fiscal2017ActionsMember_8A97AAB228E0F0A6A5E871092C0BB647" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2016ActionsDomain" xlink:label="loc_holx_Fiscal2016ActionsDomain_81316A5CF9EE3E5D0C7471092C0B5869" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_holx_Fiscal2016ActionsDomain_81316A5CF9EE3E5D0C7471092C0B5869" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherRestructuringMember" xlink:label="loc_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_30733AAFAADDD3D7578671092C0B5C57" xlink:to="loc_us-gaap_OtherRestructuringMember_321C76B197E4DF03F3E271092C0BAC3F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_78AB0E59533511ED1C6E71092C0B1B90" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_BF5D9898496C409EBA5571092C0AEAAF" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_78AB0E59533511ED1C6E71092C0B1B90" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserveRollForward" xlink:label="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_78AB0E59533511ED1C6E71092C0B1B90" xlink:to="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_us-gaap_RestructuringReserve_083248B9FF4BEB999B3E71092C0BE681" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Restructuringchargesgross" xlink:label="loc_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_Restructuringchargesgross_563BF71BD9428E13FC4071092C0BF9A7" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts" xlink:label="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts_7301574E239E8424107A71092C0BFE7E" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CashSeverancePayments" xlink:label="loc_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_CashSeverancePayments_2D548D0948DC6730B54771092C0BC654" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_OtherRestructuringPayments" xlink:label="loc_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_holx_OtherRestructuringPayments_F23C8FFF39817FE7E5AC71092C0B870E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="loc_us-gaap_RestructuringReserve_54BE8C49C34D6ABEBE7971092C0B2425" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_D838ED084CD990B0095971092C0B91E4" xlink:to="loc_us-gaap_RestructuringReserve_54BE8C49C34D6ABEBE7971092C0B2425" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_79AB8A09851E975C629B71092C10CE0E" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_79AB8A09851E975C629B71092C10CE0E" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_B781AABE7F40F21E117171092C10AC6D" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_1E7B691FE2AECB0EC83671092C10473A" xlink:to="loc_us-gaap_RestructuringChargesMember_E8A11E9889CB01BBCED571092C1046EF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TypeOfRestructuringDomain" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_D45440B343D65229758771092C10118D" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2018ActionMember" xlink:label="loc_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:to="loc_holx_Fiscal2018ActionMember_D596E2CDC6C384769EE971092C102476" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2017ActionsMember" xlink:label="loc_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:to="loc_holx_Fiscal2017ActionsMember_E05A2F967F802DDF002A71092C10B948" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_Fiscal2016ActionsDomain" xlink:label="loc_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_17E7F9FFB17D21D65A9671092C106C5B" xlink:to="loc_holx_Fiscal2016ActionsDomain_58049340C5142897C38071092C10E3E5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_C28FAE01C7527444A61A71092C1023CB" xlink:to="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_CynosureMember" xlink:label="loc_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_CynosureMember_CEB4A86AA401A4E0197271092C102AF1" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_BedfordMember" xlink:label="loc_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_BedfordMember_9E315526EEC5ACB9F3CB71092C10E00B" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwoThousandSeventeenMember" xlink:label="loc_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_TwoThousandSeventeenMember_DB6A7289DC936F3148A571092C1154E8" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_TwothousandeighteenMember" xlink:label="loc_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_49133C7E743C464B2E0071092C10589F" xlink:to="loc_holx_TwothousandeighteenMember_FB5FB57D58D0910B3FEF71092C114166" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_E91C03917C6351A9F90F71092C107A51" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ReductionOfWorkforceExpenses" xlink:label="loc_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="loc_holx_ReductionOfWorkforceExpenses_699C1788C866551F06CF71092C115E51" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_FacilityClosureCosts" xlink:label="loc_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="loc_holx_FacilityClosureCosts_7403333C8641BC3FA0C871092C1133A9" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_RestructuringChargesUnderExitOrDisposalPlan" xlink:label="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_89197953D01F56FC604D71092C112972" xlink:to="loc_holx_RestructuringChargesUnderExitOrDisposalPlan_ACF4E7DE408F9FFAA70E71092C11AEC5" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringChargesTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5B3484D1B2DBB000C43D71092C13031D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5B3484D1B2DBB000C43D71092C13031D" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_51056B6681458793897E71092C1324A3" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5B3484D1B2DBB000C43D71092C13031D" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_E0903CC8CF12D1ABDA4971092C1356E9" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07E64608822080EC36F957BBF6192F71" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_07E64608822080EC36F957BBF6192F71" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9B286656B6EF39F205AD57BBF619BF02" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48EA438196C52771E9F257BBF6101CBA" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6C08C6CF8D47A4CF744757BBF610AF46" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48EA438196C52771E9F257BBF6101CBA" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6C08C6CF8D47A4CF744757BBF610AF46" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6C08C6CF8D47A4CF744757BBF610AF46" xlink:to="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_525EDDCD25B3076786EE57BBF610A136" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2D1E5681099D53EA277157BBF61006F1" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7BA4E0CFA599080C1FA457BBF610C919" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7BA4E0CFA599080C1FA457BBF610C919" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PerformanceSharesMember" xlink:label="loc_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_us-gaap_PerformanceSharesMember_45713C4902F5B560C57857BBF61073E1" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MarketBasedAwardsMember" xlink:label="loc_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0EB509E6AC21377F663357BBF610C3BF" xlink:to="loc_holx_MarketBasedAwardsMember_C3FA6CC1C42ACDA0C9DC57BBF610865B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6C08C6CF8D47A4CF744757BBF610AF46" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_4D3A8CF765AED433E55657BBF6102C4F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_26D2EC469656EB1A706957BBF6118187" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_C7D316BF35E27871DE1957BBF6119D7B" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_CC4340D33A426641461957BBF6110A54" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_794B5FEF36A53C5E4E7757BBF611C7E6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:type="locator" />
    <link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_E5B4360CA0647DD48B6D57BBF6110406" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:type="locator" />
    <link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64BD70290603B534BE5E57BBF611CD0A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:type="locator" />
    <link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3BE9D479A7C682CBFCD557BBF611D95C" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:type="locator" />
    <link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_5CF665AF0C170EA7497757BBF6118A36" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:type="locator" />
    <link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_16F6293FF43055D852D757BBF6113106" xlink:type="arc" />
    <link:loc xlink:href="holx-20171230.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:type="locator" />
    <link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_74EADF0F238216BD9E8857BBF61106BD" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:type="locator" />
    <link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_BE31EC49714E6EA03ADA57BBF61141F4" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:type="locator" />
    <link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_548D7555BCEF3F8D5F4E57BBF610D04A" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2C700F2E1081564AECF057BBF6114692" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9148C921C0A9BB424AFA57BBF61467CE" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9148C921C0A9BB424AFA57BBF61467CE" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_841A940D1931506B9D5E57BBF61451CC" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_841A940D1931506B9D5E57BBF61451CC" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_841A940D1931506B9D5E57BBF61451CC" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfSalesMember" xlink:label="loc_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_CostOfSalesMember_788BEC33ED96EAC113F357BBF61521C6" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_BF105DB4F2D4B463EDF757BBF615213C" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_94BCC5AAF7C281E4C59357BBF615FE42" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_C48572BA1F96216C1AB257BBF615EF9E" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestructuringChargesMember" xlink:label="loc_us-gaap_RestructuringChargesMember_7CC500299227C7E41E3F57BBF6156693" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0F4A4D2687029FC1978657BBF6155FCE" xlink:to="loc_us-gaap_RestructuringChargesMember_7CC500299227C7E41E3F57BBF6156693" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6A43CA6304B5C38CEF5157BBF614F024" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_471B9A2B8DDE2AFF8EE357BBF615491D" xlink:to="loc_us-gaap_ShareBasedCompensation_989A9323AB9895176CDF57BBF615487F" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6F54671602D57E0A3C9057BBF6173025" xlink:type="locator" />
    <link:loc xlink:href="holx-20171230.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6F54671602D57E0A3C9057BBF6173025" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5DC9DCB5E79DB884F5AB57BBF617D05A" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6F54671602D57E0A3C9057BBF6173025" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_E8ADB6452F648D63438357BBF617F5D4" xlink:type="arc" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4F13C486FE2D35942F4D57BBF60BC84D" xlink:type="locator" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8" xlink:type="locator" />
    <link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4F13C486FE2D35942F4D57BBF60BC84D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_119B7C029785E57D9C0157BBF60B7CE8" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D" xlink:type="locator" />
    <link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4F13C486FE2D35942F4D57BBF60BC84D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_9DE9567A477500C652A157BBF60B362D" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F" xlink:type="locator" />
    <link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4F13C486FE2D35942F4D57BBF60BC84D" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ED43A503654B28B1F11157BBF60B528F" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5" xlink:type="locator" />
    <link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4F13C486FE2D35942F4D57BBF60BC84D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_19F511F8B7901A3076AC57BBF60B53C5" xlink:type="arc" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423" xlink:type="locator" />
    <link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4F13C486FE2D35942F4D57BBF60BC84D" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_21C73CDDAB48E524101857BBF60BD423" xlink:type="arc" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>hologiccostaricalease_image1.gif
<TEXT>
begin 644 hologiccostaricalease_image1.gif
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MTI++EI__GJW$L:O_JJ/ PK[ P[?1T]"*C,R?H<6GBLNZM?2"@L"_P=.MWL#
MO\7'R<C*UL[0TM'-R=#-TM;7V-?8XM'_T-[@X?[9V>#@W^?GZ.CH\.[R[^_P
M\/#O[_#O\/#P[_[^_A,3%"P      0-( 4<(_P#]"1Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFPB=-7"&\,M.?]P:A&E 5((_>1*(*FW@!9] G5\&8ENJ%-O =DF7EA%(M4'!
MH%VI1N4FP9E3HMPP^DQ;$%]2>4]_$O3)TQ_1@7<%3J5:)J]!I&&W(L3*%ZU
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MUW\3UE=,_+ ">O<=?L9""^  (K W 0X@ %>@F $#F+"<K>P*84M8!!0(-BC
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MW!(LH3(/^G*0 6C&,Y8P1LU)+P*[:\82\F8TB(W@ 9:X!\(\P($_[HP#(5!
M/$!(  *LC0G1: <[3BDQ=HBS&>R(1SM61@9>YLYI\&PGTK8QA1:\X)XU.,(+
M]'G_SW[>LP4 M:<_^]F"5UC#"@ =J$(7RM B$ ,6#&4H%0>(2CE:[(#"Y"0=
M-\HQ.T(,C^=30"4_$@_IF51UPVND2E?*TI:ZM)$?3*#\Z#?2]5W2830CPS,T
MQLHK$#-B%!S ->[1CG9LXQXEI9P[=/;&9L2#94JC)=H22#Q+@%(<\8B'-(C'
MU:[F3F4+(P/G!)@P ASP='V;J%D#2,6U0M!F.K->QBS!N8Q1T8I'L!@!CE"*
M4Y2B%'SUZRD4 (-3^/6O?>WK"PA0@\0B]K O<&Q@%8O8OP)0 00 (PQ@0,7%
M;JR,$7B&YN2Q!(UR-&-F-&W(/(J^/"*LIB;A:@1H2A!!_T+2I$LHI"%?VM+=
M\O:WO7UD)(<*6W?=='\KNP8)PD>S=/JC&1%3 %JOD=5XW$-WFAMG,\1AB7AT
M5VG2@*/#+!$ A:T,"G';&=# ME,%3/"]_,LMRV# "1A<09\P0 (2%'!/&"CA
M!0HH A*X> ,:**$(-8A ?KT(U:B^EP00OIO=WDOA" BXPE=X!C5<P,7&<G&?
M:ZN!%6%PA!'?P+TPN,&';\ "!=  P#< \#YEC(,(Z+?#"A"C>]W[WLU:D**;
MO!G+,BC6\DV2'>H]K9*Q1@*)"?,9*",!&=+WVN*2!,G#,UI'VO>^DT)5948;
MWAB!2^8RNU1O/PU;/*R<DN/2+/]L2;[HE]MY#;JJ%F1CB]K"Q"&-):!7J! T
MFL7*:%)!\TS0#0P>5Q7 CF8$0'/AR^Q?3Y%7Q.:5KY:E(N<(V+='A]1C!L08
M%1-[:<3"(+)]M:*EKXC8*DX:C(=5-5]+_5?.*LP2.[W9HZ^QA,S!;(/"&Z(\
M">C!#-Y99#<$7Z@[:D H++>C15,="!6P.M>*E,TD>:#P8,D2XF7N'HV^+2'G
M;.9RFSNX*X.D O*'[8>XF7_Y^[0N9W8QNBKY9'Z.VP8'B;,I\SJ#2Z-W^7#=
MP @L]ZNB=9\2XC&QW45: 90^!8 QG=?&\A6S"C-?IY5 [SE2W-5]15C$ 6QI
MQDZ:OY3_+@47 5N*Q4ZVBH?%>"<9/D1X(NV4VOXJ&:\A0 0.<X[)'NNR 6C
M #A;M6$=\OY JL=VA^0>B@XT2]@AW]R%[2+M$S<A>^G(J*M-VN<..[HA*#]9
MV@]_T'T8S]9^9XB5$<(FA;#<YQYWEUW4?,K\LY.3IMZ%C>WOVR"#P$E@B89Q
M;N& = ?+H"JQ9WR:'9;8AM+D?=&;-1-B=1OCS"Y_L6:T[[EAX_?"BGT/I/ZT
MC>V[!SVV(;0&OX]N1T-G.O?MP7LTP^!L(_L@\\<\<6P#RD2K,_%6UT"^92X
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M,JSGPXHM!*^Y$$OFB8%0. !SLJWEX0AKFG9. 5<U]U%K HD^JN6U-1%Y#R8
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MC!&-8]SPAC0T1MN88(49BJT89,N,H]Z6'M*4)UH%*<(4&)<6N9%*CI\2H^E
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MP%YOT1]!B842_(G, 9\)/ML.<=P,,=H).EIQP9SS$5BB$!C11=1$*9_P;12
M>=3U]>#8I,UF1$ )+('Y45OZ'?_AT[&?%#1!7V +"#XA%$*&DCW#3BB,IG1/
MF+S,300 %W:A%W9AOK53QX3$$GB%G\G9),4+46@$^+#%$O"/3)"6 Q*(S=2'
M-.C-'.:A'J*0DE"$:>"8@]0&\^2=))4)/ '%(/[=G%P60%7<0$5A%,:#?)B1
M#=Y>"^(>#2F=^%W4)0[7HAW7\,G@H8#?0U4B#D8:"33!^B$A*SH8^T4!U)@&
M?D B+=8B0>TA+IJ6'&9,1V!6YB1'4Y2AO?CBO6#ARWAA3:@$=KB+3MP#.VQ.
M@LC'+.5B:6D"+EPC-N)"*,1 N<5 *&0C-H;"FO"25Q03'PIBN0T%ZXWCP/ 6
MH=DB/.[_B20&Q29:8B=FW+&EH$;9( O>HT1-5=.U8K:M7_O5A2S&(T(F9/U1
M(T,V)"Y:SZ]XA2]2(17"!EE 1)>L5'<8HTV (49X"'8 XTI\(R[$ +DYI$#(
MP#6*(T)0Q*ST3_]1S;K]Q)4T8NPI)$X6FL381A% 5._=(\@9%\Q!U%.P(D%&
M@9S,D_SE)%,VY1.J$HOPTGQ #;E\H4="I$&D!,B081GZ6J_5DT:8(;/!%8B\
M&TJ>98Q 9"UD(RTT@VB%$Q7>SD:8(;W EL8@!#(VA#*Z0C;F0JI5RE%%!6Q
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M:$$B/'4(C$!N,X "< !O)\) I$$R) $QQ8,Z ,$9^ $31  3^$$A7%85ZL!
MZ  )Z((F$, ,B (HE  !*  !@$(M@/=WU_41',&Z'<%>$\1ZK_=<O_= M/=
MO  ,Z(3]7=&!1.>: >)AOQ[%W:0U[Z2J_%'M %)>Q1]E@R>X98>0?68\U$A%
M8+0TN LS,J,X5">&PV5U&DE+NV513)(ZL<,] (Q&1$=L8)9D6P=(]$Z>W'9N
M"\1N]_9O![= %( 9J (2J..#*\$$9(!+D$ &;/\&9I6' RC !$S *"#!*^3
M=]="+:P G*GT=R-!,^!U05AY?P\$ <  #'PW"@E0EJ=C8C^B)FO%JLB5IA2X
MF@?/[-A':R<X4RYX>0SB/.',B%>$,CY%Q#00/<0#;<]=/^&6*8TXO+3%6P4%
M9LU3;?BFT3A6,[0#Q"QG_7A7QMR',XY&0V@! X0 !P@$)'  !X2 0'" "#
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M/+'/=[6'RU+<!W]K^P7)G0MU.R9+(GUE)!:9N],__6O$QK6H^[I/F)RK5HP
M!5&(R+>@"15>=(M-XF':SVR N$/PTJVGO7BH?81'V3: %L^4!_B4!Y+Y6F=-
MN"EI\T 36530B',41DN,852X=T'0=<L31 LD?@OL=;+/-;.[]^,S/K+/^N0K
M_[N8"(1>4[L"O,#/_X7 J#31G_28?W(\-$Y'*($_*+U<- =+0;WKK[GB+/J;
M5SWRV 6W1-)T"J!=Q)\NX_E]B(51# 0QQ42E$$7& ,Q@F$7 8\\:>B& H(4S
MO;95JM/!?"$Z_=)-7,,2?)YI*, IE$(-H!1N: 02G((I* $2: 3CF,(II#\2
MD"5"O-4K3<1?L#QZ%T0IE,)YG\(IW'4-##M U"AUY,614C4**B"@H%1#@0-K
MP%!@D&##%R]J$'C1\$@-!1]!*KBB1,$+&"<7OABPDB5+!4NN7&N&S]^U""%Q
MYM2YDZ?.""1N]N3I4L$ $E<&*+"TI!G2C_Z@1I4ZE?]J5:M7L6;5NI5K5Z]0
MKRFY,G:)DF9:[UT;J82M$IA7FC4C,Y=N7;MUFP;]>.5N7[]_ 0>F&W?D1R77
M[GU5O)AQ8\>/'>,<<$6:TJ26E$B+D%3RE7B?KRBPV2R>V@A0V"X1J80SSIMZ
M/S+].* IZ@%A6_=L2:(HR %*W"W9=HTX\6W;W,KVR+O%BU.E2DHD(9'C1 4W
M7S \2&  F<V]<PZPQ'.AQR,X87A4 ./\^HPE0;:W3@!&]I0*+RI0/W^B1HD:
M%=+)OY,&B.":LBR)J9D#QPN !*CND88UH2BLT$(+5XK@"DN:$0NN!2T)0"FF
MG%( LA-13%'%JZYX:RP#'TO_*S0%VO(P+K]$&JM%D03KT<<? 8NK*=5$0FS%
M(Y%,4L7.*K,DJ68LN8:$W$+2T3 RGDFNQK8F:PHNILQ:(L$-Q6N&,]J:8@VW
M"WF2YIF/I*21)*5D@FNI)9: HBP]E8BB13R9LD3// &% C6X2%J)A$'U--30
M0@=-[5% RZ+1T4O'0NU2*'1DU-!.*<53QU Y[#"FLA:42:Z8!A7Q&6F\NVDR
MJ&:<;20JV<PU1QUYO>([717P$L0 ECBP*<Z43%;99:'RD"P%XDDVK0ZW+(N,
M7H',5MMM^[IQ1K.B95;<<1]CTK)@8YIP)Y<("Z"E=^&--P"SFEDBJ:34LFU-
M8$.B_TV:/#F]PE$%YRT1IR-8.4\C5$J!@;Y33GEAH:**M80N7W$M2HEXY#'3
M0HU8*:6%AT]I[XA3/"*@AI =5B#D(Q8J!>6/CD!%81@2EEB!Y_8K:D'?B@64
MMFO VRNXE0Y34%U^)7.V5[[L#4^II\>BL#L\FY'&2:4(0Y;<K\'VJA^GEX@@
M,;#C&6M..=D:ZT9NX8X[6V\-(RWLN\<U=^NF]IV-A&:*#N\*=MBYAO#C"#<\
M<<(+)[R9 *"\%_(\U52UPWM'"BNL;<B XEX2L'2-A-&!&OVF:T(4BTKZ&BJ9
MH>?.,ZBAEHL"_5Z8,@ZOF7MXOR>>P&-^#CK93ZD/8E0\@O]XH(ED/F6BXTU2
MWJ/6AX>X^(G%*^X:,H+&LT"9RC+*J0&>N>89ELA0-W<V)]-0B0C@CY\WGN*O
M7\,I=1-6Z\M(]!KO_P%8$Z>)Y6YJ&=5AJ,*.#K'-0V20B]P@&$&_"*DP10K@
M!;^BMR<E+3<#R%-KDL(.DM@O?B(A')&4( ZU7*=^P2+#F>JE+\M-:#+%.LQA
MN/<Y!V)()@5;G7-D=IZ&-(1Y,J-=@;STHGNMA&D!&N+P!E*\%S ,>3L+HG:(
M6+-2H")Z5QP($65F1.Q=83A"6M#[CG,-6%EL+I;@$#O(X$8Y?JB)G;D?"UM(
M/Q**!']#41N(^'>LIV"0D.0RE97_SA*V7JDF7%U)"TFVQ)>W"48LA"$)7R28
M2;Q8<B_7*"0&.V.3O<'%8$49"Y4\YALH7&,X,OE5;U(UG"L$P% AJ23E;C/#
M>W'O0)H3U.<L\2;)0,&!3=':X,PD%G?U)BGT.0+MCH"$^"C,-Q$@ TBJ]A'X
M@62;/NEF-Z?YD0<@X3P/> ![)$*S\\"/G-=Y0!'DPQYIJM.=\%3  T)B"7G$
MPTPL"4!8W 4O#44@;0MJA@+CLCY=M<]7==Q+']>U(;>]<$2"--$G,:JL18KF
M;HM4PME0]$@&BL6!<TD3K]BB297ZB),TVEU&D]699I! +6:)@%RT:992YC-1
M X#<E%8"_]"6&*@H3Z*-^HX2P\K%Y1GXZPX9U!+5>GWN9[YQ25*(I28R!%0T
MEA#'@F89+[&RY#!+X*I+*@DE)0"U0"1QD*HX9=*6R&E*/V%A43,4 1&M50D<
M6DO75!,!:1 G+\V(0&K6\I$I5,,=_534^)[1.]8,M+%%F1=Q2K2V"[7U3+ZJ
M51VO %&=>/"2<@EDB6":6B1M%*3DNL<BK_ U=GRK+#9ZX$IQJZV6FJ6UJNV*
M3)7B4.'Z)JFX)&SY:+BA[2VW&9ZK75QZ\]&"ZHA#"N!>OT0BDLVLDBJ\(QII
M@@DAJ)1&'NS@W7>4:+BFL*,T<2F<JJ01C\(!+ECL-9SV&G??QO]ESCC%*5QI
MB*- PIHQ+O$HWS9$J+V1#(YQ]!V -.B1-O:VPU?QJ R-1&)1X3(4K^\:"KQH
M*=KPD B0%46M;U$,F7@,,+9A.]"HBG6W)+:(P86ID=MNFUL=]\A;<QI<BJ4B
M4P,MI5XRP2,)ZV?3E10S+FZ,RY3H16 *@K"X,LS:FLHDD^4^P[E&*9\"2/#>
MPC$03FG3[&SB1;K7M(4$;BUJ0)F8D^^,5:S]FFN!@#+"H8!95O'RC0(V59P.
M/8,="H"S3H#R(K$0M24QV6D3.5SG=8$8"B)N6OIBLC4BGQC(G59,6'BE(1GS
MJBSLZ"BIK]!;JO!S2VZ1)-S2!!(E['C_6Q3TL:D+&<H(C+(9PJ00T4 ,EV5:
MB3;AT=.9JLP::;!CL.*@85RT?%"UW.LP1,MP.V2B!#@KBCA;XZ;BM'P- "M.
MOJ4Q,+/EL0UZL#=QQ'&'.]@=CVVTHW'L$,>]M^$.!%^#WL0I#;/E>X]MF/N^
MZY9OXL3!N'(CYAKT:#@[UFVJ>S7%H.V(+\7?JSU6"GHL9YNM6!0@CVGS!2X4
M'6ZD_3SI=X58H4CDR_Y,[#]/SYPK,PZ-)\,VX[*H6EPN>LMC6,U F!2S6V5!
MZ:QIK4E;T^C'Y-)@L/IJ[5^_TE;]O"\_@Z7REF3M5L09+);),-CR-4.%7:8I
ML(<6F@UAQI(S_U5HU:5,=>)*.2YBZ6-W"$R<\$39C-A=B92?,?9;P5+*L]FU
M?O6=-7?<HW!4T]'\  T%II/@&8DL"V*0\B2'HAQ>'UYYI5N^:[&@[K0RISG-
M2\,B4F\,*[.]25KMTF.7XAHKL+W;BD<5$VG5M$8P:1M9QI)TX9MTMT9*T=,I
M+G6AV(1*7?K[9Q28]0K1QKBMQ'*OHTT<L^O],H7K4H<( X5G&(PEAV7+3]J,
M9/77#RCK5W_[W?_^^,\_*'/64!PM)F[S92U5]U4C<<9O= Z%QD(C'GQ'2&3D
M[=C'LS8LM!2P*:)$T_IGD$YO7%1E3@  FW3$C-2FDJZ%E$C)6=HB^/]@;$X@
MZ?=*3FY:*B9F*_>>H8!0C?:^1FUR:@0_9/AP<),J*"9X[BJ0#]#HRVI:(@"(
ML C'"D.4ZL&TY]D T'PPZW/T3F-4Z!GB01RVP0I5J/$4<+A"0H%2+2W*9[:T
M+\#801X<Z#,P(_W:0J](J2;\(;008UJ::Z^6(&VVX:!((VI^XS-4A0SDBUK,
M9TYPA3;D*R;04#0,</R4@+T>C6DBK8XFP])R(C1NBJ(VS?0J\$A,A>XZ$,>D
M;,$^,05-:L&>Y@-KRVEZA:0RZ9!T1 DRD ?)Y0.!KY&^!A4_2BIDI-5P+ =S
MJ\?.[R/6(2N0;RR:ZNT\Z!J@P&/H"W".JO+_ L=JDG# L"S_'$TFS*ZJ1DR]
M8@(9MQ!#/J1KSN3-MLW#9,W0E@D\V"(<K6NF",/1BBEP[.\CB-"?R/%>DK'_
M-*[75,/_%D0:4B7CTD8=V><H.DM#GG&A')!"A,42)_"B,C%%#JFVOI'N/C&M
M*'(A)VC!9-'Q2' M/,0#XX856T05-^FZ7(H63\3G.BYL< _X6JPK%.@$?V^2
M B--*(A&(J@=VT+6C&\QD"_JEF:8PL+0X +J!*8HY\)=JJT;J<_*G@QS'$T:
M%.0:@_ 9?P,I#,2Y1BM*6,ES_NZ@$H-W#) =W,&30 JD<(WQW,XHB.-:R$?,
M[N%]_*LL#S(GSBQ8_\1M\0SP,^@M5<Q,'.2K.#)O);:1&7%B).UNE?3OH AG
M1K:G&Z>/ 2$SHB2Q7[@G,R30HAXR1=*&*2Z2$R7I,PELHG@L?5R$(WDE?9!.
M!<F&)%EJ2.H&)='"66 BD< &U,B"*50DZ&[LU4P*%5^B)G62+0R-1GKR2(;Q
MC#*F2VKS1E)%+H4E_&*B^11@\;RDT@"GZU0E2W:),D[E#J_1UXAB-E1G,L8O
MF"@N/:$-H2P&V@A+D@9K3/ QXS9.XZXA"]FA':R/W\S'35ZE\BAH+>Q3C88D
MJ81D[$33C 2-J094,*$K.5:O+&#B'B=3*#B/'$>+TBK3-R3J&3*3TS;S1/_"
MXGT @.\"-$$_DS3GAEI*T5J\9"9S#$A.JA574X)DSX*F C=I#.? YFD02%Q$
M*C7:AN@\4B^:[FY^,DJ"\L_.1T2^Y$,J3RHQ@T-8 W)V"E]>J4MP8\#<KBBN
M!1E[Z9>>JRKW+O-BRZF8:&WFL3?801&SYC"V(2;N4"XRXQX2Y%I<Q"PTIJ>6
M@N1XA3C*YIIB8D/7Y:Z0IO*<Y"IKA%-0@RT,I2THIRTXA:_TA!0==2TF52Q@
M141.3C)3+D,_CU U9B0\M/0H,$078T1=,;:(YB7]88'89@-1E -%,?;H3A9U
M\2^&$\<Z\0;](C0&* -=4\=NDM1B+&S(!EK")B[_CRZUDG/:AL) BC+K1N*F
M:(,$Y@6LEE,TLE0NN)-+D^N&-J=S=,C71JL\KZ =XO(PTL+4S&MW E,T[#0]
M#3"TEL +D^(C6XTX;6FD:N2,LDM!1FL@A>1)-&2J1J+-,N4$ ^:2RN<]O6TV
MQL.J?":5&M @)0U4AQ#T+/2F*.-#,1%5L4)5 P  ;!,L1$(K%LPJ5BR[,H T
MU"8#76I(AK0P, FWAA/V/'(B4^,MAI76LI-7,BS6BJ0'0\H6C3991 BE7#77
M^H4R+&/7...S=",IX,)\'O9RC)%;0<BP1N*?[I(G4F.%*$29F,ZF)A82R40T
M/++5F,YM3K'5FJ$='NC*_\CT-Y!C"_\N+/8F;GU%"0)&3]XV4X+%"KW.C>XL
M;:\J';GP0N=*Z_R)8RG$5R(GYDY59*F"6B(  %X2<$ZV)E(V*U;6'])FS3Q1
M2,3BDBSR13]"6&M$UGRU%U=E!'UQZ&+T1VZW)M5N5.XO2(B6MQYC:5NQ:2UP
M]7C4:3FT20HD8KD00U:.-%0U5*17>JL%3Y2 T/XD5-SS0(*+0DC@JWIB0P(@
MU<(6PWQCMB /)TB@+%ECK<Y5A)K/0%9L'!W$ZIJ"-TCNDAR()(AI1ZQK,\Y/
M1  %2TB"!"B%-1RM$?F%H6"#:1+20A/$M"S7(3'W5<_/9#UW*C)8*EJU*II"
MUO]L<"(MR;9PC%Y<K0,;R%A/$837QB)E=W;)+ -?[^A\-&Z3X_7*L2PTA$95
MT$M>[Z6R0B1OZM1&15D_28.D%G+I;(F9F%V(9"?L1P$.C-X8AW"P34AD(E9$
MPBO'8T%8S0!]QQ],+5K,:R]]QW?*+8SE08S#)!(II,]"PJF*Y(FK9GVN<O!H
M0RMG8S7VEG"^CBR_#MP"3,M8XR@X]3)$0H7<LU\2I7$]JX'YY8%U0V J]Q(O
M-Q-'='-O,2HVF).#)4=%@M56EX(D4H1MS90[I*2(CQ2Q!851\8! \'4-XQM+
M<Y3-"$_;AA--="3>YJ1D<2Y0&#4U4J6\)2A^;*-DD%S_/"IIPP:)F1=H]+B:
M3,Y[2:>:K=ET.@3]KGF;[>Q,QK=-<6<VCDT\=K@W/'8VW$5$CJ)\VV;6V"(>
MR("FVI8MT@2H;L((BV*5M,VEUN8M)CE-)DZ/&_58;@.+'];K !"L:NN#\[57
MFDO*-,-GSJ]")_E^D*PG+EJ2AX)>0/:2.PUP2+3% .=X7_63H\(T%( )"($8
MHB$:F$!?3S=!1X+)+G+6<K>86%F8_70$C2['E( 88*%$VQ8D?.]#.G%6ZP65
M;8TF!\,T==H4$4MM:G6E=I<L,O"@ON:UF/:(GU9YDWCON@:;F I%:8AK/C-*
MY"X40D$&9& %Z",&-&%B(JHT_VQ:G.V%G)NA$#3 "/BZK_M:#P+A#>0@$%[A
M%5JA%6!A$Q1;$]1:L1U;$W) +&R8+<+B5_85Y :%>_<B--YNG2<N^KBIS3Q&
M;1JZ5U[OH(MC,PS$C +/U62B?"K(*"['D=V'_4:G)TQ'?NY' 8W"@;8&IT,6
MR+[EDDJ:I.F+I8NA&*+!"F@D&HB!$)@@ Y@.J:.3NFV:I7+ZJ:W%+GXZJ&^V
M+F(:J6WY(GGYIC<)!75:1Z[E9VVTJFUVDW[W.$74YWX4E+HZ:I^Y>7,%30RM
M-0B  &(@!A3BO^7Z(U9 !A1 $P*DZI)"-<;9$CPV5)2 L35!$V#!F+8A:Q4(
MJ@3LM?^9,0 6  SFN4;LV3#@3RP:E9AZ0_*,D?+ 8V@,TV_ZR4"(YGW:S##$
M!R[T8FWR-9\^8MG<TTB;*RC'$S(96,[V#)(UNIN9Z$:&IB$S,31H#W JA4:4
MVZ53.KF3>[DWU[J&>11M.;RI.Y7-.TBR6VV6(#"ZFW-U5ZGIU,U%L[Q7],Q)
MT :%I!?1^[!DM/B8V8-)+0*2^7^<F:+UVV]0AR[8Y"1.HDS/Y% J:?\$[>NH
M81<HG19V 1UVH1K,BQPH?1=H@=/)@1P^?1?(X<+WA2C6*D,^(GT/\QI^0_D,
M@V@.Z]6I]B/&[R,<RRQ80SPHD:_68B2LU[ B>-$*1.T6R$G_BG"O((\P!9$9
M-<^4( E/4 .'GQ9CQ>=Q"UT>-<14*7CFI!PJ0/HCK( )7F)MF" :BN&EI;K,
M!X-&>Q/.Z>ZZ;?66@=F5?P](UOR[!2--QGO,;9+=X?O.Z?2P1)&4AW2$28JI
M7S,( :!D2Q3@<1<V3[(JEMF^DQ>_";W0!V"5@B*><T=+WLZ'['HEQF-?(NGC
M97E=R-8G5!W,_+4M*F^'\I4W)D,KV;+#EMAV)L,!HZQ6KO*[<.-]J UU"5-5
M! 8S.DOL4O<;V\9\;F*%!;?:ZST5,W[Z"'*"HUP!" '=HX$0YL0*M!S=#<,5
M,XP7.5"9V&(*2 (!IAOBMR7?B;FE_V" +8K@LG>2.(6:P'!V5202IVFW,&26
M7^5D-5X"A:9Z[Z]ELX'/XFW%J_,[VRVD7G:27[:)-\BN1#;^KL>##/S!N1;5
M*>S^Y;<$ZG)G,PIDU46?7H@#?VZE0-QRXV>JJPRJUZZ@\NJ$.,3AA7A]3Q&#
M3,',(Y]V>YHB2X)E5?QQ_/3P10ZK+$B'7]MJA-;PS"+MD,=3,E+?[K=$M9W"
MDKL=IAI/ 8I N8V!) AAR[U>W.O^I$KK?:K\\'4+5F%T-$$.E6G0,*:@"&:9
MZ+0%[O=\O>U?[0%"R14RS9I=N:)$@4*%2AHV/!C 84.% 11(5+)DHH(( PN2
M^0@RI,B1'_\](EP882( BQ(!"$0H4$E!A"N7V,RH8"#)G3Q[AC3X\F##F0D%
M7O.'-*G2I4R;.EVZ4.& *](46!H0X6K4K5R[>OT*5F&SA&'+1AW0S-V5 5*A
M+!DPP)*":^VN%74(92W+BQ/Y\KUR#:;$"&P)8U7 UN_#:P6;(2:!$"[")9:N
M-"-1U=+#@U!>YGU)9NW4*XAEQO-W;2'6*V_9PE5"6"&)9L\&$E9BJ9DTTF2D
M*7$-N+'P@M=(8 VLA$3#SV157^%(0F&$Z!$B?"W,D(3U*\:]PBULV1(9M->6
M&&2KX*GZ]>OC!2:M) .3*X0:$[J//[_^A%>($6*"0$(9B7223B7_C:4 3CDU
MX]-/I!G8(%!7! "A3P8M:!!,4TP! T.6>?336,3  L"'(#5VDD4;8M312!(R
M&.%!#S98TA4N-1;:8 MU9))U*Z7DHT4?%N@B34H0-)-@_ GU$H@T/MG36#(>
M%,$241*E$&#L;:G45E-EAI569HU))E<#0&%7=9>A=]T5EEQS33SBL$,G8Y<)
MA-Z9K9&QQ#7LA*8;<>S *2-Q<#8#)YS29"AC7E->T1E&#SU#EA*,P11I3$;!
M^<QPS6QC5YX*=)K;A\-U:N=Y:#E66'7610785K"]Q@Z#<(IED#2,,?8;8@=M
MQ":;LG7F:G4"J2K5<Z$]*I2P44$!K5O0_YK7G5FA:86D7NEQR6U2&2A!2#3%
M$$,N,=%$XQ\3ZMY7D'[N[B>6C EY6A!_]"(4P84- <#O0IOQV)B'3D*Y$XH1
M\,MLPJ$I8 6YL$RAQ!3]E4MQQ38&E3"SCBE $,%0XKC20# MQ"^_*254T5XH
MF7@BD2(!Y1))0.5T()/',B@8CQY'B?$2'.U\(I8Y'=6MEU19%::S4=W$=--.
M/PTUU#+%-N:9S_ D397C297O-KHJ^G5></99FY_ZT'G/-=NXYZ?8<((ZYZ#2
M@/IUHHKZ*4W==N_-]][B](K87'T/#N=X US3:4*6=!H/X"E=XRH462L768*P
M<?3,=!I)]>)[C__N)I!7!QGWG&01D.&6TX!S];1,U88U@$Q;6V*>MMW>7G'N
MNI=[;C2$6*$N?<WX5Q]\-RKA$L>>DF&OISC1.]Q'\BJT$D.:IJA R=IK3[V'
M $,/?KU"(DF0[E=8$?'Y0H;//E!![J42  'T:[U#7@5U8%'MBR]3A@WAA+R;
MM2R ,G-9A'#F$%/EK&,>ZYE @!:B'#G$)@JXQWJ,!J:L*,UH9>K@62SUEJ@H
M@5)  2!L9@6%Z-C/(N=1C4R<=2;_F><B[(#"1J#0C,4Q1@'-&%1JO@.7DR7G
M9*^3BFH")Y7OJ"9/$0A55$*5&+X@\7#-8 M@=A@XNU#H&17QTZ#B<:'_!"'*
M(,;IGT-:B)BQT&I0"$&4GXS3#,-(PQ^ 2\A4#/.<YWBP*]S9H%<8Q!;:H?%V
MW3*7N':'R$22JQCGL@*&F'>CB\'(@"?"R<[">"0:$84T2TA1<^HGF.RMA'L"
M6UY(CC0C)'F*-4HH0H<0T*]^52<CF^N>2PJ%HE\9:&8$0U F&U24 C;/9ONZ
M)8X(0DD('DB"30+*9D"TL>I,R28)*1&,(JBD3N(D(LTXS>TPB#0-@N4XB &B
M.<^)SG2NRC*6@=Q4[+(1!2@G@<FI'UFB:+U@O=!+.&038TAPC=WH"EH?6@*:
M_'2-CW@)C0O96%1H<Q9SEA.($?52[(3SG(*0_ZJ<C('+/#]JD<"]ZI/_N\A!
M:'D3OA"4-4LH(D,4(HTBLD4W$RK='4FS1Z[TL6J6"63MT$-(;AECJ,8X1C2.
M48S_S"=<Z%*D4QFI/_X9I'H5(H@E/8;)CR'D0;XDGQ[A=Q!H-N:$-I/50RR7
M$J[\:ZP6"1J3T.<OH=#L93*:*S(3TLM@TDBO=.5/D0AH$H>DA%_]4Z9;!=-)
M^" E,*5D94QTEDU6*H";W@SJ4\!Y%7%>IXF%@ARCWC2E2ST*3HLC3FU$$AB[
M>>1-"5U6QMA9J \E9#:T2=5P;"N.75V*A8VI"YW&B%&%7$HD[+#,::_HQMTD
M"F=N[!M(/ 1:=S@&,O\4BD  (C"M3CY#A:_M+J0<Y=WIN0E.N4U<OMR(1%/1
M2PD!( ,>.9)3H[GT.B28W4\58MDMM>L*ZV+D48DZ5*.*2ZGT.=>XG)K)DV)H
M+)&\$8.:<=5>XO27%@(*&0[ DBRQ[&-\Y8EC;&17"W780B>12(=8HLL!<HS#
M;=UKB_LZ5Q05926PF=]U6=3)E."41PL,[ 0E>Z/*$O(>8*SFT"R87\MB=J;;
M]2-;XG&/**-F+NS81F[908( #"  Y=$R7.:"C^=,I*?Q+=-44$<<:41KS6QF
M,Z<.HD,(3\D2<@NK-(IKGD4]XQD!1:Y!$+6-;3 K+\:!2YSRI!/.*"%U91;_
MTA)D ZF1GB1VOV(+H3UD1XYP1U8SV=N@)#(6Y6B'!/.THWM-A]-&3V6^WH&,
M3P>99/4$KS[$RP\QFG$?=37,&/\%,*^C88S?,<$*A#!7,<8EO4;UAQ#?:LP2
M(ED1O&)UPC4C2Q%6U,R?C#BO+_9P3D+VI*Z&.YD'<N:&BA!2G8FXVSW1:V!?
M6DWYI42;-I%L  20 2OX]]C^_8]"J'":M)%F)=V,M<$/OJ4E\Q"C#$?1#IEG
M"3"J5X$-GPF.<F-Q%%7\SQGO.,=GXHYM_$F5$]^X9<R4D0W&#G"?7F=LM+65
MZO@*(X*S4YRB,Y#4 B8>[NF4"OO$#M]8"DZK>TP\_RQ!CPFI;5 1N4<S[M$0
M,-:*0NYAQT;N\8Q[*#U1P9J-0*!0&<[\$#$1D :?HM4K4[^7-.F\SCD#D$(_
MFLG55KGOMA"^%'[KG=?&( ;PEEH?=]TZU\,F!J^/X>M?!QMXQ&;DL<GE.]XB
M*"<3HO#+A";"L%Y3D]MFL>5E]NT0\XS=42*WAT_2,26A6\-L_7RV'OU2ZLD;
MQ_7>)KX;9F!^GRM=PR9$OY70!"E$00P : ;>CX]\]2A<-U#PHR5(#?WH2W_Z
MU*^^]:^/_>H7*_O7QY-J.J/RE"N$C4U,*'I@WI6IT/P:TG(+/#EBD&+)7,LO
M:;N7%HZ@(5VT( K!^%L*N_\1C4$Z,^$L*2%GM1,K<N<OB'%J-S51$N4=;Q=W
M54-W@F0[R8<4>J>!&[AW!J943, N@H=K2D5LBN=K D8,@[ NS'8D_!-O_G(S
M*,(0RB1N0%.#W@9B554PG5<PIM>#TA8TPH%,K$$R)1-2_8(1K>,OQ18-PW-K
MN,9?2^5X>G<N_Z$$41 %PH>%6SA\Q8>!7XB!"B<>Z <K.R(5*;=RK]$:BW9^
M9N@KR2(5&/$:S3< KE:'>C$5<&@ZKR$:=L@17X:'-B6(<,0?,%0YR4(U"E$7
M8=4XYZ> ZO=HM2(<Q6$)\G H"\)S"!$  =!#6I(4\3 H=$(G[> RMR$>OP%_
M. 7_=FIT.K23)951&CGT26+Q#):06XE2*Q(!*7Y1&7#1@'GT@!05@>8$=ZR6
M?A5H=V#(@<O(C,OH@>H"@K2F'X-'@KYW+HF'+D40$UGR8$D22B03%2<34F8%
M&E%E@SSX$Z&G@S*#CG^U(/)22_!F9*)$/R?S6H]6$SA!8TSH5+K3#+[#7_^3
MA5Q(D 79A<8'A@F)<,O7BZ+CA@. A@VAAG/8AED"AV]8&FM(AW9(=WGXAGM(
M:1XE&G]H1<#Q7I)1:"6Y1-ZG&F5G&.-W&0;Q0RK9)NLW%[,A#^S53JPB$',C
M#K^2*F&E$U/D&B10*^SP%F[T#&<"*G8Q=-M !A3B0Q8!_S>_X495I!K*D8BE
MP1B6D!O/@$3I]XOPU6B^8HQSIQ<6"%1?Z(&,9WC UHQQ*9?7*&Q+-3S3.()1
M6&S'8 V#,"2L=# 9@&XFLU9"*#/7-#VRAQ)],8L9MA&J-# ET4G@%B(8Q239
M(T)%84O\DC(LD5CA-4T*$A49(!\/X5H(H6\;V#MU*3S_F"X"F85::)"S29L'
MJ9"W&6O+YR;"XE!EZ9N_"9SQM2J(LI6P,QES\6=Q,B$!L"AL)Q#L$ \%0B?6
M 9&,4BC;@"@/XI76(3NHR$ZOJ!EAXHHY 8O[5W2Q4YQQ@1".XF7J-)9LIVH[
M919W^&H7B(%S.6!NN6]RR9\<2/^7?R<\M=8,\X$S,K($ 6 NB.=K;2F%O>.@
M]_&-_E)OY7:8.')2#6$=*5,]"G$ HR1**3-OGPF:%]J8WP(N3.B@XN*,^;DN
MAM2$R780_"DNZ#.0M6FC-TJ0Q(>0N,FCWW061Z,5C<&;P4FD16JD7T$:%'*6
M9G*<=G-E=J,W7O1;?6-.K%(_-C0FJ98EUU,6;&@F<80>U1$=&S$=UB&FKZ*'
M9\$QZ2=^94:?=0=K]]F?S,B@C9=[<XJGO6,%EG&:!VIK4*AKA&"" /:?+;I[
M_4@,_M4[Y1*%Y$@%0HDQE\,5T(@?C4$N(D@(4=@P4XBGG;I[!&9(NE<,-"J;
M.&JJIZK_HSVJJMRBFTLI0BM5D1#Y&VE(JW)HD;?JD;DJA[&SD<UWAF0@%X^8
M+VY2:"29$\!13H,8+#L2JW$GJZXQ (N2$S@D(Z%1:-Z!$&00C.K$K4#$=M^!
M,2/*+%%#KDQS!:!()U=&)]M03OFR6X%"&I:P*'(1%=K:%?;J)5[JIL@8I\G7
MJ?]Z;"QJIW )L &[I[[0IP@Z8+/6+NXR@H$ZJ$1UC7YGJ >&J+KC.[(S34H
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M&]#R*#0W9H8^GP+7QO0(GZ;L:RCO"M#9;A,AA0'S=@IE[?_Y%(G!A-@G*U[
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M1-=R/8+, ST8&,4R1;V 4U,Q5,?[;+42]4NEP\"#E#N_U%.!'5B!Y=,"_5-
M9:U\)-2,,]0!^,)N##C>6[M45(+:RT*.$\TL;#<%( ,Z)#F>&P!X#+B,LU1Y
M/<NPR[L155FZ4[IK_X""N?N[CE11%G715:5-%W7- 8"#&KW1A6,"-HB## B
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M6T(7M\BC*5F"@\WR((9JR+(UU1!%EXL2AJ"00J-8 C_S(R(M'R4@ C7#9.Q
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M.,] 1,#%><^2--6';5:&A!2)I=1%G$AI>=HLP5[*[5(,E=K#Q-N $ \-41X
M9 SK"!7KL2 0U4ZHR1[ ?-@,WM.6K8KA<)'4B5GPC=%0D,!? " I$<218(B(
ML <)L%M#E,XUS(4_Q)A.85]6Y%WX"([W9=0E$82P$02'4<G"),7L9.$7ZLK_
M_&4-&;;60&S>N5%&&5Z$)5'')>F(^"6%'#;@[P0%UFP<G6S6Y%$>O]20*V'>
MNXQ42ZD8!W8@RMV22)@,>="8R7B$@"270@A$"F[,"K+@ZKF@GJ!::L7@FG$8
MFFU4*(IBG.3=3]B/*4H7XC"=#5Y27UA/H'!%1%P2#_(-+(W&B9W9?$#!40B$
MAZF(GF!@O%4$%TT%IQE)11A$=DRAW$$0F$07^+1%RV0,?JW(I)" \'P$-%J)
M>B17J_1>5#2:1?A%DZE' ,1%67D0O(V5KU6@Q_V,2;4'% 1BE)R(2)1<(<+4
M(=K:_!'(-IC,&>:+33G,RKF:Z/D#WP%3I>06IEB*_Z5<HNP@$XML(A')7D9X
M6&PYUY;\2D1X5 0TR5&00 2<64<,!;6P60WF7I?A8+[0!5ULPYAU#QGXH)^A
M".%@Q(!P%#N48I0$P,2L4[LHP#U,%, )95&>2)FLV1)%F=$!AO%(U15*1Y11
M!O$DA6"0!43$@V84G"O]69J\B<T$!5VLSNKLXE'$PS528QP*A'@(A"4U101X
ME)*U(V?1"ES89:WDQ5W:)7[,8P+"B:QL8#[J(Z@1)"Z9S,L5Q(F8H( @24[P
MW6X12,U%"*MYGQ( 0(P\I$H ER:V$*D<V:"<B+N\1T38CX-(D>70XW,,3;+1
M4=-AD<!]65565*308O H@?\_F,:DS(@7T@N[R8,\;$.[+$QT4(8T@(?O>52Z
MI4DK9L16%$Y&C%,N1I2K>%=QBL,S'&=R;L.S349T:,4X5>=WD5#A2:4,207#
M8<UD<,R>#)D3)@12-.#$>51:R&4_32 U0@G';9,\IM08F1OGG=Q@MAB,+(%
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M:7N2DHMFN(BG=DB#(AJAS$JUMPU@@:@WOO$/0Z 0T69 85(<4HW_0N INFL
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MJ-[IJLYR+:=<+"%ZBHI.XCPI-%G81X,<SF>SXP%4'R%HR$$/_TL JO:LGI9
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MC&?8XJHBB-(:8 FWVE*Q)JHJ;/!2M$9UB285*QS@QXL&*&HW"Y,B,8"JN(K
MJHOFDFBK7+FZ B:.W&J0(TQ='0"*394@X?\:K2R!@J)*E:BL0+9H@M98)?1[
M1IJQ' RQ0[N@ !>*'<<EMUQSST4W77*OB(<==]]U]YH"*XTH)GH_PO JF^["
M]\<>4YTK2+LX8A2A/@_&+LG#$NNNR3ZAI.PRS (@YC3&M&/"2M"<4P[CQ+P$
MTV(Q62LS39.[8]--S)1 &4^-LZPS9CJWQ',ZQA#VZTLFE BO4)]_1N_0@H<F
MVB%\[X.T/ZE 6@M3354\UE,E0%6@:5(Q+%5J5.4*X)HK FC)U:G$!IA66ZM>
M]0I=U>:50';^NRMNM#8UEM<EV"&Q&2CDU5>!"2.DB@RNN&K&W7;Q?L:N  9G
MO''''X<\<LDG9US_ULP>)R/! &T2'-_,+9SIU93*IFO@AXHFZ$N<5[^M,#(;
M-N:Z-:\@P\TE"''XK])BQ_BXCK7L6#K23 M9-9(;+N9DV-9L465--XOM-MVV
MNQ)FF:_W;,O>%;OY2.8!!3K\0J600HPH2E! UGA09[]]?^R;U"*B2%CZ(ZM=
M>II3JK065E27AHV(J3[%%1) (0+7D%?8@!425FFN;/NJ%*[8MJM<74$<K1)6
M__Y'MTUAAATLL@L[-(<OC$@+*]#"S#4,QXYX(%!9&V(@Y%Q2*<HQ;H8<H1Q)
MJ+(6D%B"0/6"RT6>H:L2BBYT%_*7P(;4OFI800%%X%[N5O<P,V&L3+%S_TPS
M+-&9BCG)2X4AV97F%#PR,2ED(.,,]1AS)N9E1&+/,QF3II>Q*_T.>W<4X_:8
M!)EB,&$)@1)?(,U#/O.5@ !=69_[%,D^MECB&A'8""1),*F1V$HB7)&5$@*0
MR4WRII.7NR2O9M@240[ <IV$PN(*N#A3*A!P=8O+U_:UN*HM#FPN =M6<CDX
MM-TJ@IB$ DP"H*E-BFL;2KL"BU[5P&764)3X6L(U-*)",DC#(LU0E@*4((T/
MCL6%",1FX1)X3&UZ\YC8_":D="B2K.BJ*DN8T Q+PI1M@-,2"YPG1O"Y$M(I
MD6"+%,@]^J/-*$X19]EYG6D,VI@O*LEWUJO>'/^C>,:&JI$P+0/+&Y4 />7!
M1H[;RR,>[TC&UC")>3T39"#))QY#=N4> (5I^^PC#OJYA$28L5"W=+I3GG;K
MB"')T4=Z.E2B\D8!>(."7919DJ JB(>E&@M8JFF6RF3$:XN+P!*J5CL:E<4J
MEGA&5:(E0P%EI8.XTJ9EB(@O*-03G"9<BD3X-;HD"NF?,27(/:KQGXWN<:%4
M3&-K8/?7P%PLC';TC)SP--$S7DR-8\F-1SMZ,H22*:0B;<YS.F899)$ ?"G]
MV4K/UZ!KO!2OIV5DO[P&A:^M2)^BZU%L&2@VH,K6MA]IQS,L4S@>C0TF/7JJ
M3;1)DQDA2P$EX@UG%0#_*FHMH42[(1 ):N6?VV*E/URQQ%QG*)?=S- 2VY#&
M-9QU(=K*I*ZFPPMJ$7(/%A'4KX3UGL*6U#WX)@R,EMW8<A1;1N(5+TD6G6R
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MP!2D.YE8KN18O.S3HMJ1P< 3EZ&BD,"S#(WP)G#*OLJPEG)*'U.RH0BH"OU
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-IN9JMN9KQF9%#@@ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>hologiccostaricalease_image2.gif
<TEXT>
begin 644 hologiccostaricalease_image2.gif
M1TE&.#EA( -+ ?<  !86%QH<(QPD$QPC*QTG,1DV*1XS.R,;$R(>)"HJ&2(F
M*R$H,"LV(RPR.C,L*#(N,C<V*#4V.1<<=!PZ01H@;3L+4S@83CH54#<[1"<M
M=C4Z?@Y,&QA()AA2(Q!P&C9"'3E%+1M"21E+4AA46AA<8A5O=#Q"23QI22IM
M<E 5&T4<(U<=(U,W'$4V*W06&V<;(6LA'6P\#F0\%GHG%W0["W,Z$F@G*D$3
M6DP+:$$^0U,N:G ]06,X>D1&'$U*-5-P#U5D.&U %'Q$#G5#$6E3-&QP#VUK
M.4M.4E59:5EE3EUB;V9:3&==9W!J4FMO<RHMCB<IK0I[@!-[@"9^@G4KCT)'
MAUE=@5)6D%)4JUUC@UYBF7!UB7%UI&AJP0N6$QJ=(1&J$!VX(BV'-2>J*SRC
M0PC$"0?J"!WK'BG.+"?5*B#G&R+F)"CS*3GG/#GS.5> 'UZW"W>%/&FH%TR6
M4UN<8TVS4ENG8GB$47B#=$G+2T[ 4EK 7E/955_08D_@4DKZ25KJ6UST7&O'
M;F[V;@J A0Z.D@Z6F1*$B1.-D1"3EQ">H0VCI@ROLBB/DSZKK%>2EE"?HE&D
MIWR"C7R#HG.HK(\3%H0=(IDG#XDO,*\.$: <(+P>(* F#K K+84]0*P]0(=(
M"H=%%91,!IY0 I!4&855+Y)Q%HIS-J-1 ;1!"*A?.*=R-HU-4(A?9(UV4H9Y
M:[)/3J)[3JAM;\\+#<TN,/L! >8N+\Y,3,QP<88OE8A'GH54F)10J8-\B*%=
MMJM_@J9KN9>$.;6+$*>1.K>E/9:$4XZ'<JB)5*J4<+FF2[>F=\&8%]6B!^2O
M!<*;3\&=9\VS3\ZR=/_. =3#7-O#=NO8=O#@?HJ.DY&4JI>AG)VBJZ29CZ*=
MI:^HE:RML9ZAP;6VR87/B87]A+7$M+C_MKW!S+_XP,&1D\NVD,6YL>JXN<&7
MT,"^S];#C]/'L>K5B.76M_3BD/3FLL_-TLO.X,[2X=78Y-S?\-'LTM[@Y./;
MT./.ZN'=X>WDU/[^_A86%RP     ( -+ 4<(_P#]"1Q(L*#!@P@3*ES(L*'#
MAQ C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DQJQ45C)<F45+O8NJKRRD0O-
MA5HH#+1'@<O >5PRN/R&,<,5+N 28M.B(:G%E4Y!JL06<MZ5E1E"8LLJTMX5
MJBC]:1%*(>I%J!57/ISJ<"M&MP+9?KP*EB(X"C?E(J0K4"W)>1FHWFV)]0K1
MMW@YVESX[>I*+6;]J22<F" 7#2[K]M5ID O6>?8"A\TXF?)G@8,M]S18A0+5
MF9L/4LCJV2?"NS<1?J-PV%\5K@AKGRTKEL*\@54T;$YZ5WE!SUHDKR8X#^W5
MR+Z-2\_M+S5!V-(UH_^>3=!O0?('O?OC.W!E3()WN;)O3]R?>8/766L'/Y"]
MWOG=5>9/=<[IUQM]Q]E7GT-\J63;3VBI5,5YVO7G6FP!<C80>&P-QD6"!IG'
M7T+JB7AA@!,*1*! ^174&H@$7?6@BG[=E^%X>5W8G$%"@>67>G%5YEY!.7$7
MXX(9FI;!@[@5!-Z0!!498($#]1A>9SH*B) ]E[54UTH'KL?;E06QAQ4%8VD9
M8H6C2:07B6K&A1D%56@V(CAIXA4FET)I(-XW<\+85W1!FF5:2]@]A)9 /%'P
MWG($?=,:!1K,N"%F?BH8%9=SUOG=B3@Z6=E4@QV:&YYD&::0>BW"E]-L'Q[_
M&=FB\TPJWDY=TFDGJ"R"&A1YK5('I4)\/C8KDDYV2E1\WV%*581JVF@F9TU^
MFF-=C;$$&76VOCG@JTO&Q%ZM*V'C+;,&<9J90G1996Q!>!KK7;5O2@JKF#Y2
MJ^:=DVHQC[<$"06?J;?:&^Z=K_H[(C:8+2FF6=A,6NFC_@"ZDJ #93N401&O
M6Y"ZNE)XVTJY>99HFRBGK/+*++?L\LLPQRSSS#37;//-..>L\\X\]^SSST '
M+?30 BU@M-$#-."--T@X,0 &2WMSC1-'1*#  %@K</367'?M]==@ARWVV&27
M;?;86I\-=M9>#W!$U'##[337"M1M=]U/7W.$$Y)@_XT$-@U@@ '?DAS1@!/7
M#*#VXHPW7O;56&.]0 -'[+W%-9CS3;43"U"]=^=[.X&X-N5XL\  35]^A.(+
M$.WZZ[#'7C/727NS>=ZL.R[V $XHH80W 40>>0!.S#//ZDAO@40 UT@M==\8
M&+]T\WM7KK?;5#?MA#?J^+,\!OSXXT3P6@]PB DEB'#U!%.@KW4 (Z" P@CO
M@V&&%Z=3O0 55'CQAQ^8JP,@VF""Q!VA%U1 0AK&D ,='($6F:A;"VS0@-,I
M  .X2!S6'! $ @1A"!!0@ -&2,(2FO"$(U0 "U@@0A2Z\(4FE,$1$J< RC5M
M 5K3AC<PH#C1(2]LQ//& /_2IKLB&O%K6KO&Z5)W/:/M3!]0C*(4ISC%>4#1
M>%C,HA:WR,4N>O&+8 RC&,=(QC**D1UH3*,:UXA&<+CQC7",HQSG2,<ZVO&.
M>,RC'O?X1F]@0Q+*0X(@!TG(0AKRD(@4I$)HI[3;80!SB?L:]D3'P^W%+6KS
MN"0FX0:.N'72!*P;P!9LISAO5&Y \W "!I#P2,Q-SY4+&&7O$"<ZT2D!<4C8
MPMP44((2-*($)*A;+W\9 @48P)>**('6.  &4_B >&^SG0?J4 >JV:$.@C"!
M)*;FA!M<P -E.$$NC@ +%Q"@!9E(YPN,I@#,:8T #AB"-HC  AC8\YXSN,0]
M]\G_SWZN\)\ #:A !RK0%BR   A-* '8R4*U#8!X\^#A$2=*41PN0(FH<X+J
M6/=$*GKTHQXUWA5%.E(SFO2D*$VI2E>J179DD8TP?2,[^$C3FM;TCUM00B)W
MRM-"^NZG0 VJ4(/:N\H9U00@ ($)(A"!16ZM=HZ<FNF(N#7F9;(<V&#>%J"6
M2;T=P00F^&HN%3< W^DMK-=H !8'M !3AK)X2F!=#;>P@"-@PWC:R*0W]-J
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MME(3E'D=RFCBLHDK? 4 ="7#&-[P 01\X 0)-H$R(!@?"+ A(?\!)<""XG-
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M;P&+.=_Y1O, 17EF48MQ  0B  [=%)!(X>K/*U[A"@7.TP>G4%<Y1+I'""2
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M"XH@C<S)1J$,DS("(P"!HDP I#2I)$B"DUJ"DA)"'P0!!@" ;>J*&JS!$$P
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M:NL'=^B&7HF@K01!.?6X_)O*#\B_'Q39(?3*!)# L!2?#Z1* ##9">Q .&6
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MA2>U+ARE@Z9;&BDCE0B0-VHBEW?ZKH]CA3]PBN^N>>$^ETA<FQ%( -'RJE*
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M:Q[[X(4']% '8]FA#X(P@<WX50$+#.!;.#C"+5Q @!6P A9.:-:P:-$) BR
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MR_DQ\'3SZ%G.G #!(T#0E\ T5ARSI0!B*2$"0!N:T1*KS",D(0F0FZOGY@?
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M1-  88"_; '8B9TVB);9L0O:60R_3 SI-$#1D Z('4ODY(S1\,NP'(P)%-P
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MI5F>)5H"X2O\W/[TRR^FI2L4@UP>PS'(93'0)5XB S+0)49J(CC$8BLB8][
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MQ,R#L7D+ID78/,S>N&CL',92^V" /YP5T7R-,CL.L@1 ='G#(BJ "+I+W6$
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MKF@"RA*01&B@ T(M(\M%[H0-",0$&]]HT7(<T,&#*4 [; 3:TCH40.R8Z*X
M>*,@XUBI.>(H MXXB=6H!C6$F( GB_H(E"2'+2GYI$LVZ5&BMCF2HS3 !$9)
MRF$]55CCH<H)DD!4^BCGK,V9CG, "MM/GJ8F<#;)5C]*5-AH"2I/Z78J[8R;
MDUZG-L0))7$=VD(Y9FL4;+D3)%)!)+9*4[OG8@L\3K+E<L_$VQRUY&DU04@
MR)FJ!DB"1^7E49?2N0 KF;>\DA@MU^AT*WD^KYYN*8MKG;68AO]()*MV&5]=
MUB<^?SB$H <U\($1/"6#0K)PTJJ+LS*ZOP@\X&A&TQ\I'4G($"W'"1A:6@!!
M#.+L?&M=P)F'/OC2P)DVX0 ). "'M[&-F-(T@LAP!3SZ<0QH[)C'/.ZIP0YV
MGA "0 $T\X$#ZC/A%;IB&RV  '?J\P#WG$<!2G4/9T(HG_LL@:BJZ1A1'0"
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M@2ML[(-B$,$'HM$9RKOX&2"D,#4M=G'5FV ,T8"Q@R#H>@A1#IL3RL<)6D_
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M#G?>*,?T,*" :V /";W[7?"*!\,8RM!FQU,;[P: @6N@CG5W UWB&F Z;S0
M T0L(@:6YXW\8>\:23S" G[GO=(%( "S4Z'S'M> !1P!&UNHG38&$(#_ "X
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MH@0D*%QZ"U&"$"C  $=51 D,=]6L;I6*3/#"'P81UCH,X@R.G)P3*G ![^F
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M*I(G-;'.,("J6CF0T!-)X&PD,Z*1N@:W.S"&Z6OJ,A18(!.[V*F.*W/#'8]
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ML/U*0A1/S^FO@\"YOM.5RF$HH\!5F6A+%E,251&P7;U5BP 61]2\3VF>!<,
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M^(J E5[I%HB  =JD ?(&3SYCE%6/44:08S#E,J[,?-2.FE  IS:8LX[JS0,
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M:\T6[2+:)$/<I   FR+*\::.\1SO\1ZOJJ96S+ZR0+#>GJ4F+B+H!K)66'1
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M2^G44ZZW K K<5=E!2S+RX(O;%VI+?H]65B%YI#56Z!$\VY5_8K72A#!W.-
M%\(E26=OY?84_D6G)F2W40+,=I8BM UG.9*0A#<D 3!\/096#6C_P+N\ 1'1
M$*8Z@H$?;201&+!Y" /7\@M7:G.$HV$ :MNA"-22@A?^*( B2$#.-9 P@%#-
MD#%H*5A^:NB-FJV%-(:A2VB69IR(:(4J6RG/7=3C1/;0Q8E.=$+-Q$<1;4A'
M,QX46M+^(Q$,$2A#78304QX4$?^ L"(-N5#7NL8AU]"+AO+ZH+PHTI(.9>8(
M)^%<YW)0MA3!+2%E:]';X-:40QZ%;M$SBE)LDK>]\<UO10)</_2AC\$1KDI-
M2$8\K*&X3U:#&LSS4N\(%0$'2&Y/#CC3$2!P.C:E*4YJ.IV*PH3 RK&M;95K
M 2]IF:;/+01(KG/C-5Z!+(P4@W8>\0'N_]I1CF>6 RY@8N822 6Y:Q*/4ZBZ
M5?68<B.F4.\HWAPG(Y.2O0/QBGN_XHKYE"C%=\(SGO*49P!.$P"<"8LV,DL9
M/X_ F "\3SKZZPP#:0.?QTPP9RD2H7Q,H#"'*LP[$\1 9>13T?JHI:(1B"!5
M$!J6"480H1.T6<XVVM&0@N5=%)4.^F ',^3,157D\9I$\CB (@Y(&P%$0A3I
M<K0T2H(BD?G9]^IB'"<$X#:D(4]G[@E/]J@JGE0D*5GPPIC\."%H_1GCA);&
M(8I$B*O^6V-#- .5KX*-F*I)(UN71C[R=0@E+3G.=>"#H@/>\I:?65M2"FFC
M%@EE*(H$+-U:A/\W'T'2DI+DB1.V@:1*ZD-*4H)2/^"!#%!B5I0\Z5("$)(4
M5$8@3IMBFP)0F9 6R.1/:B)40B#PHAR(* >P%1%!3"D<4ZZV!<$\E%<I8LQC
MND*9"3B"*Z"!CG(@BGYU? XVV.1!26 #"0# )O/ Z3SLG:HG._+)JKJ)/>TI
M49U:82=;;JJL\"UK ":8X7DGAH0M2&0@M^E6:((:,KNL! D1X(VZ?DC2F[(O
M7= AS70R],/<4 V@\W "$JSFC7)DAD-^<1&+J,JB>&VH8QE& FPBTI(M\'<V
M ^E1:K[E+9U2)(4WA==6(J+?6=E&$KT:S1'*$3:X4!%:74M674(%&'C_P?A;
M*G1-Q3033;F@Q2L*,(%?(J8S?J6+J4D<EA.J.E5AN8<B6-7J L2*(+?"[JVP
M@4NB(++& G55-P\,&9N1=2_ H(1;V<H*=G :D;)%[):T"B2%(^83I"HRT(+6
MT3<!8%A'(C9(ENP;  [ 6,>F0[*2IJP\I"2/=U0#T]#(]#L<5R17Z,,=GBWM
M*2=7)MCZ8$P'4=- QH00!_P2EWM"8)GV%";2MD@A04J43N'J9D:YH@FU$P!Q
MH=&-Y$($&XA2#3:^%=272)<G0 D*]K"+J\"2L]I% F]5Q.L]L_2*K>(>-]@D
MT0"]:$8\7A%-E0T69X+L]SM]H@Q!=,;#JLRF_XK$<8*,U:.9!3AU.SG;EKO8
MY\#8C$R]WE!/5.,5,26^1<;H3<@U$HX!CJWGX2QB.%TD48YSL5$2W@D/"Q=
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MZ27$$A@#[;C(00@'J2%$>-3>/#R3-RA?LW4-^_P:\ 17,=CB, Q#\ W?LBE
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MDCL80P(8P3$<@RL000((@ "@Y34= /  #PCPS@&<TBJ5E@,TP>\T@:N!  .
MB7 L3P*(I>JY".IUAC$(VXM4#F)BQ"5B0#2!9DG086O(XBPV07 %5S"HIBXB
MFP711N 96L;(9LJ@S&S"S/_)R*;,K86?O2$Q?A<Z;8_U%8=H=.-3U>13V 60
M1%/9-40T=<B9N631F$!Q+F1UPE-2)<LU>)/=*1(\-8#([9D*6=5Y3 U2E09:
MG-]-P9 +Z<L"#%A63 5CL"+'I9L$IL8:41!\$!R_;<%IU$98W)0]F, \;$$
M7(@3^(-6/$2&/ :!.E#.$&A#W%2")EB&F$""QI2]92=V8,-PQ&=J!!78K,0.
M>F3)8%!B0%&YD*19F*1^H*18>0,WM%%9'6'7"(AF$"$ ;<T91<5*EI&866&9
M&%A,JH:, HG56(A;$1-*W-E29N*FM,U7;!YXA$=44D51.(&U-4].Q"$DTL@J
MQ83_8)+*:#"6"3@FL=U./[@#,\6$8P( 7Z))\"!#-RS!![@",KA"G* ).B!#
M$R03$40F!(BE8Q(/$3 3$"3!FNR$Z8U2$[Q"$RR!7NXEF"2 5L:$ #" (_H
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M\(!B+TX;4!!7GI[O$6#O2_0"-]3A[6"F70 /2N!!8CYJ^"(EO$7 JT; ^9H
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M$FG<N-ZV.&D2%6S_VP0"!"3PZ]4'6[U^SQ)FZ]9' J]^03 @+( M7P&!]P(
M@%BO8"!G&3CN*L!R7\()((068':O6R")3X/XD&1O$A"7FS1) $"RW\N2+2MN
M<D?V6<&+RUKV8<P5D29&BKGR8439MF[;C!5M8A>"@IC7FOA( K;L[00M(F3G
M>42)$R1*V"-QKV1]W2WPX;NW?]_]$8$* O /L$"A #"P2(DM##2P0 ,O,NE
M!?'+[XBJ)/3'H0$:\*:@@S#0R!L !1H@)B<DD02# 2C:*:(%D/CPB!)S.L)$
M!59D"(F(0&Q @0%,@%&@%2G2*<89033!1  ;$+'$AQX:  .,E(BQ 21,_ZP(
MQXA\!+%$)GG<+T4564Q21@"'+!+$:Y#8T:1K)'%""1,H4G*@ >"3I($B*1H
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M&"FDE+&,U\#&QC"6D:.]K&,YA)I'*G2I@FQ!0->(@#:^UA"M'60  5@;GK:
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M"E#A"1]PA"PB]6<<]$\'$6!3$;**55HTX52)VA\ [?^+JP$@  '^<S <(N%
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M&DJ9E]FA'EJ0GEF(XA*:#F,Z114MC2@G"^ K"&$HRW),DL YVA M1_!(C\6
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M$ 1E&ZYGRVXR\V*[8@_W8E($[$4PB3$%;%GX.5#K&H]S6[<0;*!Z.\%*B76
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M0R:[0M?01$:C41/S/M<P@ '@L&&$/P5$)=SYR]Z0)4H37,T2L'D<Q>?KE@K
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M>D:H0G!L5=<'=JJ"(<FC!H=L9!$FTLEB]-\C(6<! KS0HM B88LYH3@HU(E
M5"^F2I$)*$FE-6(>EJ$%^/ F?&O(.DUPF6N4V\"\W]3?@%:T!;Q+VA0S6*?<
MN4YO1#9A^9C,?Y>PJ"8#I?=$8@L*Q>GQL@6 VO3U$1)(WI<(*,'*"WDZ7)S
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MN;"Z #O&7WU&5RC68AT[9 U6=( '9,A  M%:MKQ:9)W&LFL"(O !'X" !#@
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M Y,!V.?XQ%0<BC\=.M\:0DI&7E^=A>0CDN3Y+5"BVP)$?0!7Q61(Q?]DIA7
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M#8L#82ZUU 82!$#$;,$@9A"PU.BTMHY6#,5:[/ RE95.]&C\*(!/9(RZ*MH
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M)]<:##CBS<G!:P>=;'D($8D3;!$:+&AP! F& 0*/8!BH\=H1)Y*N7?.6TDF
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M(:&T:8DF.=R4G!"T0B$N34*;!S8D<2"3P"@A,.+;$1J0)(,,Z2<':8 D&!*
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MQBZ3#&)S8 \)!V*+*D223( KMN"(1F:AF.EO^L,*F6T!*HV<R(E2' \AZ.S
MAJ;W#'(H9$*5,B+ER$DJ$") 8@0-GZ)*(@5&L('*%&)!IF0>).(M&D!#NL<M
M7B6,F"FN3" "^(8F"B2TE$#.>$+T%$!R6.>5"D^5((EV")+-(/%2J FZ,L,R
M+M$?3*(LTH(ME8<A[##MP(=[YBDE)F2A'""^'F!V4F86"4X6_3(P"PZ)&(X[
MV 'B; 48L^4@7L$;4$,TE $9WD$>^F$K^J$?Y"$>JJ$:6N  $L!;$L"F[*5]
M7JPWZ) ;7XXX>$,!0>[C6@K_>EKNQ6RC7, A8F[. A<F/- Q6WR '=WQ*[PC
M.MC"?PY&!#]37*3()5IP'__18YISBMC/X)8"(-$"0&)0B[HL+"7KZB0!);3.
M!GWKBVS&*GWICE[$&P!%N]#N);Q2.4CRT90@ I"@V#RM<  G\*ZPDI1C"L>B
M2E3/*&S&)1=B2F)"E23'?NQ3)I)B*JW"SW1M[%0B3+"A3"SG= @CFSQB^E9B
M?W0GCHBC"0F".)R*."1GSW8DDP@"]X B ") *HLK)QK1$05B+)VK+*O)G8HE
M+9UO>-B2$R4FNNRP5KHG[;XPVW(N):(L)SIBK>X29$XFB<@/, 7SOVX1B@"N
M,+&!_X?T03$!X-T><S24H1LN4RLN$S,S<S-;   D* $ZKMY>L\:X*S@(T#C<
MY>5@CJ9F+ #_[PC()6 B !PH\#;+<6%>03?%(QT!H#?;42_ X9,88AM-0BXD
M=0EBHS>M+&22TTFMU#F?-#JGB,DP-2"E;@:UDP9O, >_["Z+:1Y\$,Z*"1(Q
M0$Z(PT#PI#]:]-%"PDUP(DE:5"0Q8(GF2I441BIZ(K8F:T!>POG"Q$96[2">
M+12S26A:CYFBC3Q'0CY[S7:,X@BR9+80DKH<XB!4)$!P57?ZDD%JXA")M75$
MJU:,#4971E'D]4)DR_B>:YNDJQRU+7F^L"'V-2U+CR& Q_]XUFW[+*;="F,X
M6(Y.P8E4;H)ESA7]I'1*:U']IHSAM$$;M)1+'0+#'I,TT$%,*S,KS#0SX^%D
MTU1-NR4!RL5?RL4WRJW7ZB,Y2D[F(N !/ Z<9,IF1>P94^A/;1-8<.X[AM%0
MBP%1YTNHQD)[FL 8C. V0( W* H<4J() , (B(!Y3H:(B&Y^V ^)!L(?67 ?
MT\\$ATA497 @2]7+#%+ZLA-G9H5&@*55S3.3QB(AGF16I23EF$WE)$>55,Z1
M?C7EY"-GU+8O4S22]',Y]&H[\/9!?NMJ3L<JJ;!T2+0XM.LFB]6XH.)[C,T$
M=,8AJ) I7W6V7J*84**YD$":QE7_9PCG(S H*-HG(>A#5@MBS[X2$9-B=(U#
MDX)K ?8'^J[A?Z:+>"UF/HV"+*L-7X]GNMX#7P$C>O]5*_Y&W5:"7YT/5MBM
M+B>B>U,B.<@IG%0J.!A)(QS)A.8C2<MO8BD6QYX4P/P-8[-48K:4@CJV@?2A
M'T)V3+5"'DSV9.,A95<V-J+'3[GQ@XRC56RJ@Y;@@F N L()9W'V9\M%W-(%
M8"[H",HA4-]Q4%FB:#%0316U&\I->VSCG&(#!$! $L#A*1ZB-WT@ XO.B"YV
M4TDRA305X  L.<D6;;%S;:EN*J@V)4#I;74BN8K)6EG$1>RV]?)V/6NU/F[U
MT7X")#$W_UV79$DV B-FER N]!I8ZW*,54"*+5E3(DR$5R6R1$D6=&BHT@20
MIX6O(A8MQXV#\D".@F7R^+8,=V@&YT&&[4W"*"4>2D?D1-A:I#V+(PH)I0]#
M,F4F"4U.@B6HB_%,0A*3C[H: [I"<=7(@BL&1H4X0E9F GF^HA/!PE]3(F#G
M,KT4)E<*@G!%;#@(]V%=D0%8QK_0CR.MM&+5CXJV]OTR5DN7P'Y3PF-1(W_W
MMQ_TP60WLQH .("SA5O*ATW/"H,"1H5\PP&"XU]:@&9- KZD@X-DZ@%B><12
MCE]FC,;2"%\4 %!WRI4GHE##PQ4R<%62(9V:H'P>\#;*1]&< /\$E,"?RV=<
MA$AC",S /B;IILBIWG<YN3:BM<6'IPZ(O^Q4;\M4DUB3EAB/Q"(^^L9&#&2R
MF$1)%G<Y].0BYH/2?K4F@FT@(BMP_I8^Z"-AW&P.&X?U%,T[%D(!D* ]#<]V
M8[4H:5=!C"M6C.8?/\UEIN1/+*4P6#4 5E>;2B<?O"%HQD2OO#<E)*%*PJ1W
MRF25<G==?\(E-N*.7A0L@Z(!E"",9<E<CS@H3" FN+#-:G1Y;]2#_\(MD^>5
M]80K6L#\KN%D<FH3U<V:^E5/C%0OVDV>/T<O2)1PM>NI; *%HD<!6BB%='D6
M;5&''SH%/08!.D9^B=F85:(T2,-_]5?_9.OK9*OA'5[[9-\! J:YFMFTWN+C
MIMIG-!4X7U93.NR%G#%H7W9;A;QMQEJV7@!0@XX GLG1E5^A(4#8GOG9%?+Y
M<2"@FB]H76(X 6PC"8SAA'/C-CP31##FLQ$Z%QG:* B;%A_:!(.(HDG5HKD*
M)DS/BQ1 (K3:.[J3J[OG(9GXZO3010.TMS1"<N1D+&J)\(RP;P#9N;!!7G.M
M#Z-LN(XB O8B*I9-#3WB*M50+7DB4A"W2@(E(<R$*K-4W>8$ ^!R<*X((5>&
MN@A9N;(I8284:]CB=MGDK!-"9I4#">!ZF"#G\;R:*1H1)&XI6>%ZDX W0!4"
M+C8$^:K)2(WT_SOX>GAJ)3.T:2MR1=WV!/M*3RL,EE:^@IU6.2NH_$CI:49Z
MPX2H,22B3$(*XB()[K+-C_PXLE-_V>"X]DJ%>7YO11^*.5PZEIE3^S*7N0F2
MP;6?>3.I@;95MIJQ:S3QY9O2A;AMZIM3<S:P60&X!7I4Z %4:-0S&P#Q16O;
M9X/C^6"_BRV&L1CL682;H!V3I1R Y1JR&P3@ZVEM&P0JM7P@(+YDN,"(_:"E
MZ,!R\5/#9:&V5KX/E[XE:W/FQ->,."_X EA2^6*"IZ-]31)DI73V.V%H!G^X
MNG<4YD%DU79%![-HABU2(B%J8G/H<$?VIB$J(B[IR1^^$R<EZBE.HO\[G56B
M]'O,A N.02V/-VT@[SA"MF!(9<4F&2)+58)JL=IUV<QV+IY80^)"C/ AT+4G
M&J"GOH.U1'Q*S 1S5FW))>4I*D5KI@FOE<<41S&OHZLLSAS-?1Q7BV.==;[G
M@4=Z2Z).H^Q\1X61* 1ZPH]]_ZMC0*9CF-Z\T1OA=%$; -U6!-U^M^$:TH&9
M3:-,]U<>%+W1&YT:,G" ??OD]H5<0DR#9*,V!DE?'(!Y(B"S/4ZS&0K4?59?
M7,JY!16Z7?T5[NV>78'6DZ51*=6[I\,)$@ $6N"?;;M24T6B,Q7![M'H_@U<
M*C]<G-V(H7TG,."+@T=UK-U6;/T@ F#;3<+_)2PILWRKMY)K7HL+]GU+]J_H
M963_(S+:MF[_=;'FU22Y;W"B?5Z:<Z^BTN2J*^4J=E)K170&UFSW/GJ<(4\G
M= ,@UH1<49")_)A)Y1M29UI>>:4\YJ5+O&"%$KG"$H'41WUT$XNL_=V_>>?B
M($)N.)R@Y6R"Z"T[RLHEZ0.38WZ9%@$B@,"! 108!( P #9MV.8Y?#A/G[XE
M""L"<++M6KI^$OMY[(>N6S]XQZ)5.XGR)+4$%@\D2.# @8*8$1PD\'$DP4P?
M+6(J.'*D!02?,!W@[*D@0M((3('FB'"$*5,($*0Z@ JT101P$.>!\P8V[+6Q
MKYR8??7*E2N6"8ZX_X*&KEPY<.6\ 8W@0Y)9;&V=*-ARC<G-ER\1Z@0PT*)%
M@0D#+$:,F"  !14=)T3H+[/FS0LZ=Q[0P)N3(TX&8+@VP+/J!::!NGX-.[;L
MV;2/7#N2>K7NU0.P79,$/'CPL0%NYS9];5[8Y6"1./$V[PA8P.7F^7/HSUMU
MY<HQ,-?^$*SR[\O'DS^/'CIJSZ:_IC_/^LB\L29.8]MBK[2"!0T6(+D6@0DF
M(.$-!@(J@40# Y@P6GT$"GB7:@-H,QIUDFR!X85;/#>:$QCDYID"#9B%FQ*X
MF>9$ [?-MML"3BQ VS4-[-<B;[9=PYIS@.'6V68^_K@9>6-=X\0UW@")I/]F
M1UZ7&5B9*0=@;;)!1:54KS7E&I:P267EC45>@T&8KOG U (&+<!4F%SV%R*-
M!AGDUYMRODE0G7;*62=B;U:V4$-=13218A=EM)$^'WD44C_RP*-H2BBMI)A+
M,#$UDTR5*@4!4#[PA%<+0D70PA%-+!%!54XYT (&42F5YE-,6;K4JU=Q!9%[
MRPUIUEEI-<&66W#-!<Y71FISC6].8 -!K@LQ81A;"4!@V6.7+19M9-4FUIAE
MT2;I#V^A=8@<B+H-0&X 'I*+;KKJKLMNN^D6YXTD'[)WHR1C.8%AKF8!-MH1
MSNE;I D@#A"!-PK..0"^3I@0@(H"'_&A$_.4LX#_D=X@T9LW1LY7G$/0S?/A
M '..3*X"Z[*F+LHIH^S;P-X=T0!02 #5@*K^ L5: %MXP]II8^TW@+F_ 76N
M?-Q!&<$ I-V+1-+_28)N:&9^A@UN^VFL,89&)O=PTI_E)N(1K)E(+@9.1.!$
M .VVZ)>[*=)88X@JXCB CL;UR"V26(LWEEVD%5DD-WL3^5V11SZ4G75@W=9A
MOW\#_!J)4C8A96R&>\-E9TQI)=7(GFL> 9H1S"BR G%ZK@ "JMO)>D$&V3G9
M00GU^:=$@2J&D4:'?I2H/!^]\ZA)[S@0Z4;&.' $F4J]B6I52B$/ZJ94*?#
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MP31$LD%A<@T^X@U@Y2XS:"!)-8/M_V(R6D=20#<:/P%T)_49?W-_]V<X6]
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M')/$)"H8>!I96@"2I7/9(EJK&W4I?MHU,MKU+&D* DFP*4?03!81:H_* $X
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M7'G<N)N"IF=JN6E\!W=0J<6P/<!E+GDR&8\Q>0DT0 3#\6A[ICXP&I$- D[
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MSV :2,JDY6 CZ\*#6>N7'!DF7UP:KBFES=0, NF,Q)(N^@"WS#""! ""#V"
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MXJAT*))X\8O/&R-'/Q0 /]I'&^C*8[HB=(V%GN2.0B(E*ENZ)I+"-)<4V<(
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MZ4EE>5J-=V)CQBVC7[:A["T&C7XFNT3,9O3JKR[ C=;""V"#$F2+5!)I@;Q
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MKNH".S'_$IS#JO]>H9YF(N?1ZYJ>>>3@LBI&<AT!*WP"+=A"%LY")E2""R!
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I]5_#FD\#\O6"!& ;]F$C=F(K]F(S=F,[]F-#=F1+]F13=F5W:4   #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>hologiccostaricalease_image3.gif
<TEXT>
begin 644 hologiccostaricalease_image3.gif
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M2?.I;1E"N!PTR4</?^"C;6MKG>O6RM9E ,%U/VB&X%# UKG2M8+/S-_^GE>
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M '.]6.,-VY)%7HDPU7C 7L[57FK%7Z[=UJD5W<?=V<OM7GKEVL5%6=]5WHQ
M7UC]UK(%W]RM@-V]V T87?QU7//%U0&VB.D]7V"=(^6=UL %WJ7=7G^8W8PP
M8 C>78T 5J65B-*5 A-&6N^]V,;%U?258>?=X,.M7@#^VY*=V!..W<3578HH
MWXO(W@O^5 &N !KFVB*>B",NWHHP54\5XOB]B)/]7(J%6E!-6&<UW<ZM *4%
MX'C@UO\=!EW#&M<TUM0V=N,W!I"3A>,YIN-/Q>##4MWA]=XV)M8Z]N,_!N1
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M@1/( X-0 "GX@P/7 X. @!+0@P/WZXGVA61 AG?XF 9!@1 (@;_X@1#H\)3
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M'B4P.(! !#MX8M"&+2C$0@L(-*@>>R>I!P-^$S@X4G[8"46<5<A)]5-9RQ0
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M:>+FEW<>1IKVQ%3>] :4M?AD&^^S#JU N8PKL F**%":->XHC0+T;: H8.*
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M^Z*FP\Z:.3JZCWY>BWGTVS+JUQR58ES2>;Y"X:SV%R%<84<:".1")=WZFSB
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M!B2I$ 63'!23L,G)50>0D"0$D 5E?MA?@"3PB6=^?0Z4R(BN,(<X359$CL5
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M0"(ZH1NXH@]ZH"=ZH0NZGT]ZGT_Z'0D(K90*$JH%L&C1!OV(AZ[+I4-611:
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M"(S"60I  R0#'TJ09])B TDF'K;A?OA"!TO@!/  #TZ@!*AE.[OS.\.3._4
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M)=+CB-HC7O_61>[5#W/".T2")>8/;A\&9N1!/<3H2AW@8:[P!W"34"_"#H3
M&@J!0A# =(&@$.#'(%@W=1EB AY "?+A!X(@9GM"%9V$2@W$9)#3*XJ@"'2"
M1\9A&ZIQ18>W"%!A&HH@!EH@ J0W BJT 38!!R)@ K1W>R> !6KU>_TR1,5W
M?"\T>J770J<7!0TC+H!&!X]&/3!R:C^H:@?26/.H#$&0&[W66<'V,D1S;(/C
M-4;#^G1#-H(4.E#S;IC58?RF;OB'@%TS^F S:[X5/&P31C[#.K4V<-'U*ZPA
MK__6;1P5%S_XSTE0!Q8YPG*E=DN/ F0XAQSUPE4"XW-I&$J9< 0_\%1(%UKT
M41)YN%F N(>=0@.4LXBE(1YR2$L. #<Q<&])E!^=Y2VE>(K?TB[QLF>GF/\B
M%$)1AXJ]6(HAX(O%>(S)>(JCN(RE.$(C@ 5\EDR>UEY;5'XOLVTRLW[Q1P%S
M8T^(@W]Q=%  V#8&YG$$& "6IS<@,%/0<#;,]OE.@PUQ@X 5N6[H]C6[%0[Q
M-D&29S"HQ7? 0US+KWE*IX6HM%U-Y5QA9A BPBCP(RY88H6'@GB@&&I6Y@I/
MI0RQU"9N1$RE0G:NHD>(DSA[&2UVZ$RKH@Q-A16M8F7_SI448( '9C4P*6%6
M8W4O.11\K?F:L9D4M)E"&X!IWW*-VW@R"X "@#5^Y3A\Z'=&"S*/]_<@^_@V
MND@) EDS9(0G4L20%[@W$I@U(9DV)'E_N-5N+1E)L6(&DX4B>0(QQ%5:RJ]V
MG-%?QZ-YD%?]WJ)TRA T(K<EKL :#K!,R?&CP[%YN)%YFD%+?J"(45HE:J*$
M3AJEE?-U7#JE8;H*GRA.-, '@3 G<D5"KSB<'0 &!C,OHWDPHSF:&R "*"&I
M@UJH*=1 J5>I"3.IBYIGB3JH+0&J*6$"8$"I!Q,)U'4'@<4!J-<!O!D!P!F#
M:QDU-"".S]D@6&)?7!1.TKF*_XZ514#P6O'E8<#T7)JC?RTC>9B04@9Y1?&Y
M1A,9@0^;@"S%*Y!S,R+8C2:8_"H8D['"5H3";[7610YPH9_E@Z_G)L>A+Q27
M#T.&B$%#>6A"_;Q4_0H 0/C#_G"%9'3H> \7>6T[_9J'>:SQHL]OF,<A')OQ
MMU&[ 7;@$BXA+UD@>R\AFG<5JIFV :3ZJ)6:5]FXN*.Y(6C"G%M"IP>#IWD6
M0@NB2*![N?-RN1.S!2C!0)O[$F# 0I/Z0G< O(O[N&?5N&\UJ^LRJ>V2J%N
M!2H4:"GAN#W4IW]VK,MZ DBA%;>11'\ _2"E<$LVEB5\PBG\:0[V2W3B *H0
M*_86*O\Z@B&XT&KM%X^NYWH*ME/"B&M3Q&#]&@#$MI_IN30(FU'RN6X26P)A
MW+%/PQHV)0394#':+\B/CU\BVUPG6RH@>BDV6ASCX60$=_D@H!ENLL1#.SQ
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M0#B//KWZ]>HI0HC',>,@:Q5_%  23UKGSA#ZUK=V!1#6"!;/6X3_5<0?80U
M(,0/0@ AV \_ "'A 5? A]$R%)#7$0(3'+2#3PBP "(,XY%H4PLHU>??1OZ%
M5)A),-8U8HDCH;C#5 T(E2("+8"X0P,^ MG CB!.%8%0(4Z@$I 1U&@3#!P>
M,!H^@P@1#WQ<>348E=8LMDQ)!5R!@G<>':"!7!0).%YY;F:4EP97F,<>! ZX
MT$J>J;P0P0NIY-G*"W4Z( 1DY1W0#%QFC5<?9X8Z4%VDU"G1P!"E_-!"<C<
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M.Y%!7;!,HY:R $  !/B%A KTI2^MI51UNYMQ^+8,OVV.=%SL(G DQ)G_T &
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M5K""C*XB$@&$C"11C+ "(\DHC<LHC<@(5B91C;#2?]C65H%F/B#11TJ0)DH
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M [T!- C^D(OF,E=A!1\-TA]@^=1G,AJQZT(#*4GI@YUFJ%<B83E"D-Q++2%
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MQ>N'103 $3%G3&P:A8DW<N(OO1D<WEA#<00ITC<;  '$['&+6B*,8\;V)PH
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M]4 X@[W<8"DID\W>%=]#N"QK\()B5CMF?8REI#'&-,<6\V,5'EO5WF7,!7'
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MPC.<@J&I!ADFD;Q >7&T"V%-RFFJ:FJV6&Q%5WPF$*2\H@RBH\2FS;L""E!
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M)C(#+$LA+X'PMLX@'.PDG.\5BZMP#O-)FE$JG>8XBTE"C[$X7T:Y@DDJ@.H
M'OE=0IJQ7VXS7[J!1$:Y7T8)7[$ 8/X%FP,!GK#9,QS#QN-0)4]! 7GPI$A2
M( [-5[S!V_/Q%B$ 'FGX*P7J6[P8MI>)3,:@C4N:VVW0"RW9+AYL4H)9,;5H
M-K$X"9H%K)Q%B)WUT!$-408\/1+=R. DU: UU<6["0ULUJ$$@-^M)IDA7IE@
M*PUD$9M@*RCND"E^JYC8-'>!B5)DQ14YC(C#6J.T7M#QU8 #)Q2H+H. MN-
M$$MAXW.ZBM9PU^X-)3=&"CNF7SQF&CUN,2G:6<#_L./:R,A!ELY"'I:-(TV,
M5&1K28M!L!I):3VKV"NVG#T-F.""G3%/P>!LT6#%$0L*V 9VJHQXR[$M,0R;
MXM?#P)[%(&4#06%]6Y7YE >VC(>NL 9&E,.'T&60M2@'Z-/%>(HZE&0)9HR,
M[=P9>AK@V!+:H%3YL0S&2!4V/AA)RD@-H&!0]50![ U0[92?Y8K$,V(5U=W.
MZ0PCBIMD:F*53)4K_B&&*"*IC8FX*I>49!>6 ,$2<5YYF>+*8RL.F5X;->-^
MV3R*;(WMLHH^?N-(6>.%KF- GJ4VIN/X 60^GFB[(&1!_F-I2>2\.>2.WFC:
M;>2/-I BH=V26L%>W T(_V*V/E*,IKB"*D&0!K!?N]TK#5:/ OB.8*Y8G)K;
MO]H2QUB,>/C;5HN'H-$ ?=*@R5HC<!+4*$0(8(E"@9AJ+OH?3"J=Q1@'^F!+
ME8D*[_OJW($C8&HUA7T,2;;FG95HO4+I4>W$U,S=KCHB)=@T KCKNUX-O-[K
M);:0>::TF+OG<Q%>EWAGDB"K&15LW"1CW21H?T%CNV0?V(5ARJYL$[VXVJ7A
M-,N+%@9. =1@]J)#7FF(^ED-91$(0^PK\3*^I69 L3V0O\H+QV"*JL:C^/E3
M_B /046/U#54]9"N1*T,R<#"F/+%+TX+8GGAB5UKV+4YT;0YMS86V_5$4#3G
MC?\8Q::Z:YCTW1WJC1X21>PF[(Z@ %-D.<I3['-![Y% ;+^.%ZLE2L;V(<=^
M;.SUN37)'<@28LO>;_X^G:5@B+PTF+RYWX&PWZO8-L]85H&("-8S#,Q8#19*
M\/Q$3,3$AP=/B/E!@40!@NA+C0Y'C035I\]3O>P[#>Q9"1'W/()2\>P+E%BJ
MJ@8 );%0RX>J\4/)NN;@X?[T##SMDM1;'Z44YU+%W2,^YWO9(9SXW=FD'(:(
M5>IU"?4^["EN";)Z[^G=:RS/<BW?<HZ8[X*N[R:2CKW*[_XN<S,/ND+&"VXN
M3;P-I<![<SBGX3R4QJG1"D_Q;&0I)[S0YD^Z::J @#K_Y[,8YU"W@D@N88S=
M.@#%(1::9>NOL"4!3&0,$_(B)O)RONYE:@ Q/HR=8!HFYJ*GY11RZ1H&F7)Z
MJAXG;Y$G]X@EMY JAPG3(.^@S$WY]G)Q(36"X+.QP)V)9FB,DN,\-@@[EN@Y
M;EMIN>@YSFA EG3&X;:B,;R#T*WFN&9'-FE/@<1J1^G*C)3A""4)0L%?]W;?
M$*>$>ZGT? I](BSEU@HW]HRV.\A=R23U.\F<"3MZOW=\S_=QH <*[_<+B\I(
MH4J^41"_6+4LXMZ#YCI*O]V2NW0>HNO6[ AVY@CV9I<=JOB18$D-6761,*L,
M>76-*$64()>E70A:7ZN=(._T_]!T:_ )6[]U,.<F@G#;O7+H7M<4.+;Y8H=H
M:2'V8!=GEA:69.?HA7-E1/77U;U;/??H/!QI;"_IPIO;218..?[VJ8_C/I;@
M9E!YTO I8,(+K]=+P7B*M9G;N76=0Z+*,P>ZG7];_7[71%204N,YJZ S;YKN
MN"YRX TK,N-N>&8,\8[BP(=GM2U\PS_\4&'UI>(<@8X)K/R)EP\705==7FRU
MI ^+_2#?]5U@\4U?^/5?]-7\^&U?/E;?T4><T!L+_H77NUG!NS!@ >9\Q(']
M_I5]Q"'@/AH$T;]]UNLCSX<V1:TE3F9=:+/[;PID=3P)!HG/&GG.OB"@?6RO
M*D'/3?__#(G"H]E""UJ!C!AB+X'$<P$E"PNJX;\@.$%9]ZJ,(<5Q8+Q9O:U#
M';P7VOLBVIB32*5EXJ;UYE-I$9J;<JK]?X   .!' X$&E1A,J' APX8 _$&,
M*'$BQ8H6+V+,J%&B@XX>'1Q08FU9 VL:#C@8.:C9#Y0?7\*,*7,FS9HV8S9P
ML.RDS -76MX,*G3HS ,:\,4#HN3*('_2'.2LV6 9"I=$:1X85/7E@1_+?HR,
M9\V:DF54(2P;:>U*6B40IE8%,E:MDI4BKW1=5M:L-&M;KUX]0!9ER&56/39
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M8$A2R$?_@Z3%]EQ!W^2$IRI!&W !&*!!-S"K->Q#'_B!'8@'!?"#(=C!'90
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M)-"YG=]YGM<YG>]YG_<Y)#!"45,")>S H!=Z40MZH1.ZH1NZH"_ZHB,ZHD=
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MH7.ZORB7TKD"_YLX*W/%H[RJ20U@]Y8_^#/)?GG>W!US5_^SAF^ >[!.?R'
M=V?F[WW?2>_I)7AY+EWW*QT@<I#BYJ*6MC=&0:=D//RK$%BOFX]/Q%] X ['
M^ZPE3Z)^/;AW2J7REC:^=7(Y3E)EI!O @TU48A.=J$:G21&*3OS"&L(8ABJ7
MT8E.D,(:TPC&7Z7GDZJP$2H'\+E3@![2@RT'=&&7F,.P!_9!FB^0W@_[Q&#0
M=1B,M/X-T\3[%G;DKE,"!I! " Z.9!AG'#0@ M(NN)1,-9#H!Q3'KL9!YV:.
M BO0 B\0= X- RG0\^ZNN;I$[\JD3%@)9\KC[WCO* 2/3:SK\M1D@2AH\:S*
M\2R# '()3UH09WHF!^5B,K2FF![_#S,R[[DVKSDHP*?@"Z_@:O0.P)]*YJ["
MA&HF+AY0JE*4 ./B(7(V[F,ZSO9R3['\:<(T(+1$*W*L8@Q1@''8:;%*1E76
M$ B08OX"J20N >D00$>L;B,:0.D:( *Z#MELBNCJD"+*R?-6:OR:HOR$[B'&
M 0CTL.N2[A(^@A*P1T>0[D:,#D9V0/X>$0;H4",HX6#J+Q);8/YDC$?LL.C"
M[D6&*SN *P$=H-I@  P9S7(Z)SE4[ KZ2!=WD1=[T1=_\;\F#:6HL$PRI>4\
M4-ST+KY220>ORP3))+Z08O!8,()>\*OL[3$H#PC5[#).@P!^)H,(@&FLP?*
M4 B'<"@*_X6:;&6'?.HUX*A$Y HW^LJ.+B7U\L52\H@>2J16E$ >\D@K2@0X
ME((+/\7B3J[1_N556*S1CN('^*IQ/"U,Y&09A  .C6Z07J+K4!$/?VW^^- /
M9<PB-G(0P>^]#I$I$O'\' MTGL[JEDX2*1$C+]%%7D035R<.WZ?KM.Y@PFX4
M2U&0;$KKK&X5R>\5>^(AVB(KCH<M$J7TM@*3_.$'MN%ODD+ND@LK)F(K*K(W
M_(49K6.4PDV !*[1\$U.  "+NL)H5-"!=+ %L^B88+#>&$]G9G ;2:@; 8
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M#&G/C#;S/O>G*+8! FB#Y21J !>M&2C_(!$^PAJ*(#H%Z7T. $9*[2,2\'U
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MP5;!)( ^ H#Q R(2YF'W@W!<U( .^( -6#\BYGXC)C,X5"U<XR?-(&C_Y-(
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M?4,6V#5=<I(?&C (<"%%I1*06/A&S+%/1X)%+B$Z-[.8S/AQ?*(3C@>)681
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M_SZE><NM"5-^  1_88Y#0MI=N^YGP?O5RK]_/DY7N>.(M#1"D_9ZTE?J]NE
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M,Q1(*IL:_[,.@9"[(8@)S!ED$157B162;+1G7!Y*51$8Q45! A2DN-2;8,7
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M0BGU(U$WHKLNN^OV.!17[1(E+KWU?F6D-6G5E"2)VOK;)'36-)-2,R_!E=#
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M,@ET--0Y^EM>6H56+08E5H6=%45?GN!?<AY[O4?&;5PG%B81'>;!J$="8A.
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MI$GUP6\=Q>]FJ<QXN.U'L$J:K,TH.0#_EFFEME6QT>O=PLV#TJ?>5DES^"W
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M89=$R]'&&,.'<VA?ABN-!@6'FJ!9OO&LD9(C/A 0UJ$*/F!'M-LW$-!#L3F
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0VFJOS7;;;K\-=]R2!@0 .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>hologiccostaricalease_image4.gif
<TEXT>
begin 644 hologiccostaricalease_image4.gif
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MUYFZE,#[+$!>ZVF/?/#C'M,*$+!Z5:]ZRWR ]0I@36AVD&@_ZX#Y>D6[%Q3
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M306@.PF3>M"#2Q1T>PBC:M,E+TI ,A+07M-%/]KUC-;F!-&@,C%F+@6@!,^
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M+X=*;,($LY]).M7_!B_2]6N'JCUHJJ:V%HOA$[&;V:<!DS!>A*G<U0 4T
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MF/A[&D=(P 1&L JOP N]P I*^V,X$P2.X JH?PS*@ O=VJWFO=(Q^01,@#-
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MO=G G*FAP0IA DF0!$NHA'B0P4K P9FHP:F!)AE,@A>$DS+I#5"[$\6S&&N
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M(0E@S(R>(<4ISFXO)YDB%J>H(Q6EI$760%  H+%$0:V,/DY"@I9R% !K9"$
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M:$/NL!->J3%H=VY)%",B2$%]0 (?(?0$4DXR)'_\8P20A%0NI?*/7&014%]
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M0(!)Y&$MJ3."!%#W7.8L^LB)QIY7F7Q]CUF4(IXS>[4<@;5(?1!/I8V>D9E
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M1I4D@,DR$04 ]-[A;:% &>/9,!%1HR_Y4B_EL$5G$0=.$35(48($&$-(1Y%
M71_(0BRL0BOP0B^LPB06VTD-1A <@2N\0B\<@S+<@BQ(4<GU3,]\ X5<[CK(
M@M,P#>B,<1GS@BNDL45#)@].41]'PS/<M!1-=$;GA)2"CE5KS11)]3,(LCK
M SRLPQ1'M19-#PX?6RT,0R\D S,XPSNHPTV[2DX8T[%D6.P\(#$-AD>!5+'1
M]46GQ4534>JD'$X3&EJ,B"L?+)O(<BEEA!1A1G4RD5=)$6B-H\HT669-_^RF
MI(33@-9IV0Y#E-9/6,-X?'8&!@!%ZJ_:7?,TS\?+T9QZ2.J(-)5-L))GZ01)
M3,TZQZ--E/-C4UT2G!U($(:5),E9E1::G807837M/,'>_8?-G@AHS;9X/(%
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M7-HUF;)T2=7$K BSB!*!:O4FO$:JEF4OD3PF":H;C<GC *LKQ 2X_56[%@0
MM""L3,Z(=PWO>N]T:[<6N^ /_K'S@I![N2PT>[SW-R2<="\(.+EON+][^12E
M_WBS)Y:S'SB"6[B&V_N][\+C]\(P# ,QZ*TNU6 \W$/FXL,]K(,3J(T-4((Z
M+(,RL *)/< 1+(/NQT(-2.(1#$,S+$,LW#XK+(,Z//%@R((ZL ,>I_X]/+\^
M](0_^$-04 4^('%!MN0E-P%-KBA/_J1/\HWF9SGY-\*W22($/,1"/,0#J U/
M>LY!Z*4]E92$:E3N>5/(#^/(8XY+@2T9D01 /$$"(@D2:TL"('F6),($"$@$
M@D""Y$*$"!<F5IR@T2)$$ DL0I@@+0($BQ83+ 29X(FU"<^L/7G2!]JSF<^>
M2<L"$\F+DB=3)@&)4B!(DRFM_8P XL($IA9!,'UZTO_DR9(@0;QX$76I5J8)
M$B")]Q$"V*$HCQXU6_;L28I60V*<..'%P))LS8(MV^=%VP1)DD@+*_0OQ"=)
MEB16[! NC4R<($>.G(D&7,LHI;T(\&2)S:'_0(<6/9IT:=.G4:?^ARI+:]>O
M86?I,[L/3MNW<>?6O=O:-FO6XL5;M\Y=-2<3;02QI6Y9\UM! $1_4.36,F7*
MEL4"\D"ZHV'8LUN  ,%&K&7JU*W[#3SX/??W_)'>]Z]?/WSU@J.S-DV6+)F'
M)YHHB?^R0.6V:6IQ!1)(6EG000=U^47""75IQ<)7>,F0EUYV<<2))V3!:3UK
MOAGQMVIJ6<7"!UE<L)%%B,C_048B%EE0%UU:='"1'1M9T,(??V3E"":<"*(!
M !X8[P$C5'3%D2**",*&*:F<DH('L+0@B"VYW/+#2BIYP@G5R$3-*I.D6:*H
MVI;(R\W-_@D.'WQ @&;$<?YKB;.H0,@BGF=J@J:S)]PLU-!#$06KCR2>&2@K
MK2"-5-*M'H4TJB=LRO._9Q*3Z,^HK&GM!34S)3#4F&S*HB&<Z$R@K!?^'&>]
M.9,(P- )<#4+K@0FB.<)/'N%YL\$UNLC &FD@6DSW\:)P,]GMDE@"5_CN6 E
MB1;Z[39?!U+HMVV"B^<W:?J( "*P"GHB"TUELG;7"=A5-XNV+@/J"<TX\\RB
M,OGM_]??T7:C36"!74/%X(-W2_B9V%ZSTYJ:UBVHAQXFPE3$WKX)-YYZZB&&
ME59X.4:9]#269V..-=:XGG5J::1'EWM\,,()?]&0Y@EYT6476Q3&S99:<F11
M%U]NKO#'5S#<L!>><:/&Q!%1_#'H%G>LT<8;L<:111Y]/!II6&ZIQIIJF&B@
M@0<L> "(55X!F^D#JZEFFKGIEALG6< $TPDGF.B;B7_]/3."--?$B=X($GB!
MTR5:2PS3Q!H?-#&;)N=,\L=)=7QQS&=*K _+.U_B\\H]MYSRRQ='77/%9CJ+
M)23H-2D+:WG]4R9 ^V+)W<L2 $&F"&S+"H1&(WB!=CZ=\O_=FG&RH*N@YY&@
MRG6]$*=^K>K!NBI[O+3W"PEH)D+\ N,7':JJ7;<*B]#"U(UW=Z#@9;>UP^ME
M"=]!/P-<__U)8WBGGI]A,-P8:( ',^!K9(+  N4&;S)!S@4L8($+7(!* 9*2
M#28BI2!4#";LR<_31F2+2\0L:#.[V0DEQ(M=%,,=*7.AQLX!M*[ER(04 A+2
M,M2+8;QM-YJJ1"RD-C4=Y8!&/LH:UC[QH*K5Z(9) YO8GF&#LT5P2:[H12]P
M48W<Q$M^MEG/-GR3#OZ127"$@UT?=E(5D3QC-D^8 %AZ A:)P#%W%'$50Q!G
M1P@PQ"1\G #L+.)'V"5ND''L72'_Z^B0L"3RCC])@DGVZ,BR8&0H8?E<^V!W
M/OAA:ETFRE06 %D_WST!>$\(0$+^(9!Q]:$LF H.3WY3ET$FJE=+V(8;_S2L
M>$C#&L\(0"^5E85>QB,"?<AE!)X0CR2,Q75(8 Q*1A(33"5%DU91'[H@LBYV
MO0^:\9I?O2QCO\W@;U]C-"?@Y-4:A1F0@+=I)P#AF3 NR@1,[ J3/65RG  A
M84L]B,H%4K"E?0X44W9*1WN"8[(7+I2AX4H'.FP1B4@XJ!6N<-(1' &)&@(#
M&$:[4 Y[88P6QL,WP$R8+("X(B&6\(@W$J+70!J+2J B"0^8H@6 P(I7Z+ 6
ME?#?.WL&_PV'_>:<9J+*X-0$.U ^@S&]FQ?BJI*]JZ"DDE$%BE5#@@3 .!!Q
M%J& (20#&4'08#QGT2I@"G)5&P@BK)PP! 7<(I."1*\LEZGK5/%ZUY\0"IE4
M=14X>R>39X*3L' A)4H&1+_"(BX+'T&)8632%\ NH5:%2FSO7&*3[P&/LDQM
M5"7=J,FPA!(H$U'L8HER/WU%H*BM+=,\$_@:V[#&F_^;;3QQF]M2P39>]P13
M?QKXA'OFTX("E5(&]YF<#0X4(H#R8$.AJ[%UX.)CK4A:+XBQCNB^D#CMD.%*
M6]12ET[M:!KJQ2U"U*@I0O (5M0A#WO&,$UI\PFN+8W@I F[1O\]0[+6U.HI
M)V*K%]0J(4@XY1(^PA+$!0#!8"$E2-8W@4J  C*6  N\ %Q97I$R"]5$7%'L
M1;L'(Q,L-^ $*$!!@?7YSE:N$D@\XI2I9\#85Z<<\(&G)9/:/$.Q$)@=_1*5
MEX0(I;2AZF ?K-$37CISQL#TY,-N&8%8*@[)O1QJ+'OLX;^L#PF@/,P;3SL>
M:/T&C6\L;.+X>UK WFN<J[7OFTT3&][.$S:ZM?.=\;S;.=].-_ZIA&WP5@G_
M"(2Y_+S@<KE4Z(DT0;@=E.YPA@-=$)K(%@H";WA;^HDDYNB&YL7%;V1!@;/9
MX (U: 0L=(C>/.-DQZRN#9Q%$TX0]'+_>(A;0I*'-TL/HW:Q9ZT$)D"1"=2*
MI,-P,4FY>'T22V "$Y)(*S@-\H\Y@<97O.O506PYCOZ&\PG<3'8>B?QM<8\[
MV6&!!N)6>V:M'JYW?4 "]]2D%&NZ4<VI;3-?60MK??\C@.ST-VWINV>!Q_8U
M0%WUP>$Y<(4+][?!K2<]AZO/Y2JZ2XGF9PHF&*!I/C=E!PW7.M!Q#ES4@A*.
M<!F$=,&A7>S"HDZJ12UL88MI5.-GKK#N=7681?4V8((6*$(L6.&(6%0C9?+H
M93IA,QMX[OL?J 5)9VS#F8E$2M&(<=Q_"-::':,QMIPI2"'":@@;().I94W
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M! FD 2)JXWM 0"0@ %/.8 S(( P4AZL1; GPX0E@0$#B(3$"Q!K$CR?J(@;
M8 4N  16  Q2H'DHQ2!LPQ,081 ,(1-TP!# 2A/, 1L["!NE'%G$;T3B/#BD
M?%QJD9>2I9= J<7,8C,,+"&D_/X,)0"2(,9SI\01/=$5/0D_S/*HT"-?.;<E
M?=(W>J1'F=)]6Y9#6M.!FQ[DX7.">8[E(;ZQ ;QG PX<1TW&X9!W>AO2Q'/(
M13;&FQ[&83:D(1J6X)QYF0VHF9?[0+^CX1N0Q;T).:?#H;G_:QT)F)FNR25
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M.&  2%@3#ST@& 9"CA>T^(0T3PQ$H MVV.'"14(2F9.0>+" 41#(M *5B="
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MYD:WD:A+OU+6!8H0!"=4XE</TAY5?V75%"6 3$T9T8MV\I,D>#)0='J33RA
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MEB/Y0 "% % P@2^ ' Y" -\+54Y"9Q*<9%]F"7!8 J:SXN$BAMB331%*3)\
MC8%$^JJ>N0"-LA /C#_CF%)S(E!I;)@;BQ64$T/1$H3B1B:B:!I2>]_0'#Y5
M7*JL(M.PXO=FGH0)0.T^Y+M9_,BGF0?!%)<]-\Q5_W]U'ZK*XJHP7;K29=$'
M63C]JHQ%T8\BCLNS'<T:R\KQC&),FBS@ Q_0<)FSH-'21"<E)R"HF]MI^E5%
M:P@H%;F1-(Y8RH/K_2JJ)"T]5%:9C><E5' AK7]4N^FK;(-NM6WU80;S IA<
MX-6[@?6[PB2-:)@F6^C%UFV.>T_RCGM>RF%.!*\5'N@N9S$7;$YSVC7/UJCS
M-NX=%P"Q#?MNM:8XXB8W;&P/0-X@H6#K>4#3D "3_= ^!0,+PDQHG:YKK8:^
M]4W!8SU7+X1&IU[O0IAT"IJ<>84S3%,9OL'0M_=_)!S$6!SK1>K5E++#9/[S
M?Y14>K<SH<(G ,\8.<E!$/\/1_<K\= ' 3 82I01C[!D&3%7AG5D%,!5(;)2
M-($@/2%8^& -];(4"D !D; (;^)F:L:!3798B[ (<44!)I@#(XAD<G6"+ B"
M).@3+T!D^<=U!X@B&I@32Q /:)< (* L*))VB-9@4A1%DJ9$$S.!4C1I2-%@
M8A(U(&" ,69IZ8=I8U$9K$(R?0 _Y$1T8A,-CE<\ _($V_ 6H^86;8$/I39:
M]. CC;<$T)<;&<88T9!+]/%-T9);Y5$>Z+,]LP$;ZE( V^)/X25^&50=&80=
M%F 3ZT5=2  'R)1.%G8:\F4<OF0MZV43*0!/T&%"IS<<$G0:Z"5]S2% NV9Z
MJ''_ , G?0FT:[KA7$!0&RC B$&@'(OQ!$YP+=>"!-O3BTH0!+3U?(;A%/$B
M'3$Q&%\D 3I78>DD?N "3KZ6?NLW%3XR.@IB8T318!78%&M3--YX(N,P9&NC
M=6P3 $#58OM7$;^R*#_X(^\8<:M3(@:BC3_C=G1#4SUC@"*F$R-H@E)F@@T8
MD'+V.1%P1R02+.['$Q0Q=F,W-CVA5R:(5@$YD1(9D8M0D1AYD1G)D1>)$21B
M,S?3?S?H=5Q'%4VQ8$&Q,A.R(3NCD(H6-P-RCW13@3N1$S,I$Z5D%#DQ%09B
M#5)(2E5HA1S6-?)@3!\5<;X"/;JT/9N(/BYC(*TR#M2"_ULO  >MDA=D,2J@
M$AG',A5=UR+/$Q6MEAN3R%L)59;[$4'MQ7G[8U_TU6TH('W/(6Z'V!P 0QZ6
MB!H0%&L#=6'@U&SK(2_F0@#-IEL(E$#6H9BF>!G(5V\*PU#Q<AT0M!B1& W7
M(WURV6W1F&NR" 3L]01V^ QH(UO55!K?1&#S5AV,-A@706 0%6Z%:8CM0@"Z
M]8P=HW?KAQ@/<HU/,(0)$'%P(YS#R4<G(IP.1YQP\W&(HH[6X"OMR#E3,17Q
MF'_TN!-(0#:0I8\'R!,E&) A.&9S-5?UB'4/TE(4 DIG]IT7:0,!>8(7"9Z+
M$)_M^9WN&9\02"*<9'6D01 70/^.;U-DRODV< -PHI-H/V$8<6.$)P,R1CA'
M+PD!69 $]P>4E<8Z0PE:MK6)V?)<SU=ANR5!3VD-GS(6\L!UO $'([H7)8H7
M\: 9]Q$-SZ ?$] !"_($CK$KX_$1 ",=$#0PA\A/]Q2-[ )"_K9 B@D=&+08
M2,!]XX&DT#&'QG6*1$J;G4B75#H=1_JDKGAZSB@!,R$!AP.,@1B,Q9-AI6$:
M_P2BFW@M81(-I(%,O&$-WR-A[Y8%2S !J&$3$E U$J <)%1"%U!\J1BD=ODP
M&%1\TVB3*Q(5(R-CU_@,3>@36?";63,0/5@4T$" 50054C@A4/$CS<F.$Q*=
M\%@I\QC_4TN%(!,:%6-I#2M%&BVB1Y@U9P\0 :11"97@,D7P )"%*,NR('#4
M+#?J&48UK)\Q&KA*"?PI"[H*&I6PK#<*K3?Z#,WZ&5G0K"XSK;A:"9&6!94@
M"\Y"&E=R-$LU(4#U13N3!9P4&M)I'TOPDH^"H.,*K,#*H#8Y ?4*K*3QDA<2
MA9V5=Q@:6J;X>9N9&TMPF7# 2[@A3<%H+3T"&<>4&+H!!S5"%I!QL?'@/E^I
M894':Z?AI^_R$0!%?(,Z?0K%APGD:_\TLB=TI8GI3\UA'>LA'1.3*'W@+^6Q
M'..">NS2;GM9B(#J':I9'9AQ 4B:+TC:&I[IL-C"6]HA &A9_Y:T91J\A:)P
MX 33!8G ^$N+L7'1D!O% V2G<0 -U%#5L6\6P$'PPK(EVRZQ"4_;UAZ*6I X
MMB#.F2("P2!QEY^D(3="15581)PH@G0_PHUPVIS/2:KO^ Q+0)U!92 [<R/P
MYF"EVC,V.)H'\E6!!5;:."$SD4)$H6!QTW:2%0$ AP1WBGQCY#1/D 23]JFA
M"UD!T")QPV(9<KK862)1] SXL*X 8" 252*5P#:6116"%0_?,T;K*A07<+H7
M #V8=27Q:H&^N3,Q:50]E80\951<DA3^&JH *Y0"BTJSMHFQ%AVY@3[T46YR
MF8ER:1-*$#WTT#.0^"M!5QK:H[]/H/^KN9A=;-D>"%4P!05KU_*Q?3E0O9=?
MUC)[FIAL'F2(*""+NO%?)>2,DTFSU!$Q![ OVK8=^K(OBBF83VH=#A8 SU$O
MUB&T4,J)#[!?_F,MZ82H^"1>T9AL!@R)3I"6M=6(L=%/)#POUN$ ]Z8>']2R
MTV>RXO= U4&W" (--L6/:O=)%Q*I-K:.YKFX[OJXJ-J-.&,-4.,L$GHA-:F=
M':(5'1(S\;!:6&'&Y'@?AY8$)!*=%?$]1)5R8L)303$5A&O'"^)B1>6<,%-4
M>GMW?)0V%8$CT+!-*$(B$4 C$;<V+-*\%-(C44QRV*NORW*OGY.OF7RC_?HL
MX1N4%TJ^043_'MAQ+[QEF[H%+]/Q08V98?JA3L'H!-,RIM(2#;+P!KZDO]I3
M7_A$P!!E,"!A:^467^HAFQ/DOO5D7^[[/YRY+B@LJ'19'7YZ>A;&'(91'S0!
M0>R"'$FJM(>*I J"!"I,'9/''-VL'=B1B-@LFP,D+J'GF;.X7YPH+_4UBXX8
M0%.*&^<DE\+!M$&0F/A"8"X+,:^WE^SR,%JJF$W,DQ7Q% 1Q1"0B1F&4 )QD
M15+88JGV(*&A8Z';DCZ!N%;,Q]#)N!!WJD@0N3-B=8KE&8!D=$/A$XCB36;#
M(>1X(AY"#_@08STS/,[9-4-C-'W41SB-TT5]-G.*(@'(U'TT#OBP_PT8Z*(!
M6!%^9-1L<QCM:#:P^KI%QE-LDR.0I8$? LDNRDE.<S>'0KTP28Q&=6@+R;V#
MW*]0+,H6^EFE?$JN+&!@Q*,'_2XLA 3484+--BZPB$"K."[[%56^+'J\%1T*
M\WH(+5"EAZCW9&O0],LH\%W6\L*TIXL +8OA\ARU>!IH>P%L>]"/#0'PH005
M[$ D_++PA1H- -NU[4_PM%M!>]O[7&W5%HR-F!J*74^T9Q.K0;#)MGQ5^D_6
M$4-)FXCQA1WFH1Y*++3QXM A\V%IPR)\NY">!58SUKL8& $KU9N)D4?2*:I8
M[(Y:G-*1:S9$TSM@9XU8+-)9\:J]8]304/]HA1:/5V0?I,%8W\/455W4XK@V
M??2--2(4JZ+'4H/4O5M%!&@@5TV.S-*294-4/-@S42-C_.DL.18!'Z(R'V(-
MG 2[5<%)\*IV\RJN;O18HA37-^6]2%$B4^$8%>I9>(U*@"H=UO&EY%$O]R(?
MZ*%AP!A-LR700;MK^D3+3O!+/_O8$Q+D"$T=:=NEG)EL[37<^B,$H2W!]81>
M^\4_QB&*PX:DXH$<"YW.\+3"L(T:)93FS]$ -L $%%#;%' !M*V8*BMZ/PNT
M=/EZ5+J7[*%."2U^=+E;0?Q!X?>,[E5?+NL=$.,=_!0QL??#UTU$!7(E7]RO
MWKU$)QDU21  Y%W_*,Q)TJ.ZWJ8JCRH=4RSMNR!@(%=2?B&]J%+D8.:J8-\;
M6=QMND4Q1J&;95*.ZPDB[%4#5L<W:2TF:2(2+#MQZU6AQDN-@?KY<F+#16M-
MX]CKUMN;O3.>9:F+*#\IOJ2LXQYCVP_ 0<Z1004$/3B6']'REB=;B?(54,)E
M7ZQAFVN^'6$:'OKB;7=9,/KC;."$W!*<SV]Y&Z$];OL5BO@DVD:\'-LEZ E$
MM$8,Z3/[0=,,0B!$ 0W@\1#0 );S !Y_\<_M7-+WYU6Z+J9''HBNW//2',T%
MI"4/ +7X;=#!'/MF??-&0F];? \TB)$>]/"$Z2F5-C_9Z67GK9%F'YMQ_R*'
M$8#X5^I5S'^$ZX.I7HWM'5,:3A#R(282!17QH.(Z05.WZK<&YKPK[A,Y$7:^
MB2 ::"&.\B)O#2F_7C47#1.RWC.[\K<SH1-/#5.1' &]:XY)8)S87B@QV>(O
M\^)PW;W>;A0U;E/B/LIW7>ZMT^:U70 ' P$?,4%&5U6]."!JFQSU55\U81-J
M&Z:TR=#R(K(#?/)!</#Y;!SB]Z-];O"_?;(][,'<UMA[&9CE!=MSOCA ?$+[
MIIH-<'Q/D )!;ML*](S@,HL6ID^AM_(==)OG6^C,9EV..-V,.!.V>$((/5[7
MMFOP]$^R6?39?:-27RBW:D5"4Q':2SHUGMX77O^JTZGUC(*>83<8/P(0T59$
M(%C0X$&$"1423 #BV;,G#ZT]FPC16A]IUB9"@V9-GK4LS^+%LS:R#S1\(TF6
M7"ERHD:-VT;*'!?O18($$ZS)C#>NS[:)("+"M ;MH=&C%9])>P9!9+PE%YZ0
MO+G0*D$(!1,D0?+$Z]>O$Q(<S D6;):Q"QL^6Y+%&H@ 3Y9 3/O/[EV\>?7N
MY=O7[]]_3RY ( P! ( "!0XGD' !"9(E7D]*RUC1"1(FF35OYMRY<Y$B3(H$
M"6+#@N'$$E(\. S@P>L'*5*01E$[!8K8MVT'>6  !1#:*(*LS@W[01 G0X(
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MP@DEE M".>*T2^UE9]7];L*+7VO8.L44%,\"WB ,"=MJF'B,TY^-F2L_W[/
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M>>F@7"3! 3U7RI"B;CU,;V41;P478(! ;<3%$RQ@ QK"#_A'8DS >L3634T
M+.X%8E2"(51@=2U!LC60<?7%R) :;BWC+4X ".C+2D5 :,1=LIW7NJ3&$>%>
M,1K1!(CA-X(C"*P'0Y'CA9GC.:)C.JKC.M[,$[B)D+G4:H!&!,CC!&"&@:',
M #E>'\F63#6A$ZX;%T6ABDUAU-1;Z=W;%2HDXW A_SO) CHYS\ITCFB(Q57!
M"U:08;PLG/>DU3NRX4=N536P0JQH&3$4$DBB0^FTB%X1(N08XOF54N9P&<70
MV505 9[1GRVP'(K$V!8R#2>J6CCI!6L\D&$PHVV98FXUFBK^5J055VTT8"9
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M->E/)3(U)>O)[(A I>+_V5 ELEI[ONN!P^?\^[@R% \EC^1.C/V*GO?/(R(
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MU1RPU9YASXXO&NHN'B2P ^MNY;:!R.IN&QK-&N2E[J@!!%,N"R8PY5Z0"71
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M-NWK!:PA'D0M L:+O=0N B:@[IX!&I9 UE3M M(1OU8-'=(!UUY@'N0A*2&
M 5P  JR3.EV !5B OC*@!;8SMTJ@#,S  K1K":@A%5* "T[  4U #)0@'I\
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M)HE@<BE702-T!3%0&J;!#:-60SLD*<NU7)NR#:%21.%5=>E!&MQU=5677K/
MR'9+KW@TK[R64O&11Y<18?>J]$POO$ROU<+K#2*+LH" X(1 "!@6!1QV#5+K
M^$Q/J^HM7QL.M%RKM"J+RJ;L,[E49A>S,0N   " ,1-S%W,1XD*691GSX0#N
M3=O7 7O@ B0@Z$S6,M7LRD*QK,YR"5[@:/6,[1* 4L'5MB8 _LK+^P:0S,;0
MS\SP"9 U'+LK HYR0B,0[\BQUA"P&PFPU3;7[E;-YUP@#_; !=HV#_( ;O=
M#U"5"QJ!5?$NP+H (E>M&^I@!=*NNWB !,K_@ U.H0DV@0)LP! ,(1,$00&\
M%5F5E0F<@%D5UXD)P8FC6(JC. <F]W(QUR41=.IL@ ((>#8#8,^\F'1'S71!
M] W5]75GZJ_ND*C\((U'E,.P(1KVM<4$\:["2Z^@(;"*,Z^(DT[Q35Z +/8N
M3[P*%@XR2_FB3_HVJ_DJZ[,&;DC9@ W.+QKVRK5(:Q@-*^(BKK0^<^%:EGQ9
MEGQ+-I1!6619-DM%-F5GUI2[=&8E -5(ZP)8]I,AH&0EX 7^; )2X 4X=O5X
MS&O_ET_[#+;&-<]8#0E\ZPD"@)F9V=3B<2$3V/V@\!DF5-1HD\>F&0*@ =,8
M,@(B+0&<UM+VK'_E_Z]0'1"V7@":U99MK_-M<RMNN5,!OJ 57O@""' %T, -
M@E,.TN"&,2T><$L!*" 3%N$9(BV(DU6]"#"):\ )**$&%&"X%*"*L?@E+=>B
M$S0' -0&+$"BE^LWK6$;1G>,.;2,T?6,P^F-Z2$?6KJEW\JE!:]UWU78"&^E
MH\H/>CE[7^L5R?'9^ \#([ /\@H?2Z^0 XSB+)DS42!+)3/,P&QE!^[@;)%Y
MBU2R'JY,!:X8<S;-TLP"$A-E7YDQ(4!FR1>4PWI+"\ ""LME"<"PPMI*>YE-
MOUHQ1?;AEG2\!NP%DF"O6*Q,+4"8V:_/%-"8;6O1=+,#W8^W3#!2^PNWS/]S
M:B$@"QCM'_ A'G+SFELL[0@0":0A AYP[I[0&EY3(S<2U0@0&CXX 5A 5#,
M F1 #SR5 =S94P$T"'YA&%1MKY^A#=R #6+-#=R !.(SF1/@B .@":J9F9&
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M N5Y?1TJX7E,$'8A^#(%S+9:CB"OJ"  \>!!"H(/"#Q D4)@ 0(  #RP\ #
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M!SO^&H\-3D@D3IS,CNCU6.?XPPAH#NPP"R68. BF$0B^&!4)X!?H%Y!93NT
MONI $?$:(,D(_X 1DC<7\9<7&HVS.8GL0.#9H"K<A&.;D2A(#:B36&6 >0(P
MZH,#\PV<1!IE0Y)+O#_B+>4;40XS,LDU=:&3E."K"AC+Z,\+QF"QB@=TL 9J
MH ;DJ,F!,;ALGJ]GP%L4]N9O9H(B$.=Q+H(@L $+&,>H1(GU"<!-DKL'K.$0
MG4O:@5*^ Y\(O)YL730.U<QBA&(29+5-J<Q_GK],@31CJ9U&8R:&90E^Q5>
MC8BHW(G,Z$"'?I8+0$QA&1Y)4TU'4^/)8&/K\DTJ]+<;D=^,W0_J()$EN*[E
MO9<VY<*)9*]YFM-G<.D;XN-H8&2D7 (2\J[@.)%XH(=M,#!R"YFC#O\9D$FW
MY)B,JV0HJTD0AY2OG"DOL.G3[YVV_+ &>;!$[J*0_1U):Z"/TABF)^!D-D*9
M\K@14R0XH=F/; ,_CNUC_1*;H30;HTR\&WH&9K;@IGQF//I.E03GP09G%2YG
M&Y#1D0BE^#NG0!L,2%G88A$+;#(7* 6=5H+<=Y8+/OI% 'R>4.)7^8-*17N
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M@H1/(B0H:3(!A(\03IJ,\"3!1Y +GU@#$8#@LY<:__'LZ?,GT*!"AQ(M^@\
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M2?2114TW+<'O3M=JO350/=B !%:4@>UU#UY+1@%74FG_YE54%C3P@ ,. -
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MC48!()O;O.8"3]C&.*1Q7I,NX0I96*]*W5OC]Z8V!+&5[<\:,K-MF!$?68A
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M<]$%7L"=JP#2W358@C%!#=H*KOA*9S#DW@&+10(+$]A H$$ S:&*S2W'- H
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MI!/Q25,\21E,= CX1 !;PL0K!D@<BF+ZF*E#0(!#3!P]-";$]$'(58@&)4C
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M=SX#B2^YYDIJ6),R)>MQ'L]U=LK"E6LHF&?YREG6>I#SG1G$-"G(35CL>H!
M:)7$!=#/>$6\1LQ,F<Y> ;4+-/\@4%>IMHO8X05#2XS0!,5*"9=2$\=U"W*K
MX3>%:/Q,(H8.EN>A2(OQ;)^_8I]?8LQ7T[?L#[N)1"V:Z?RDD_6UR\>A(IWV
M$UJ!>M2*^MF2^K7 M=9O_1,T6U)86A4# ,8$2"RT DYK^-U^3EA(1@TT D[W
M K"[@B.TSB#-_1&,15?!W8K\S'V!388[NY,'OI2++N]>JA.\ =RJ=>''9Q!E
M'=]O>T]WARS4 BST0C(D S,TPS+8 HOK>WLJP5LS*EA@ZA&X_=O7 B7,6.#[
M07R+U"*_?B(K,HR1\D>?=36HPSJ< X4K_M8_0[%GY\&WLL*G5=(L<)GQ",$<
M6>DUB,7_\PR & 11QDB+T%M]$ ==X1O*H_:(M8?%2U":<LOC<1P$4!RY45Y.
MR)#--\F'2"D[2\0%N8\&E\C!Q/^-L4_/K,0P"2PI406FJ_"9(0% Q(MG+1,G
M3C0B)%2XD&'#A10,<E*8X,F+ $^6/'N2(.$_CQ]!AA0YDF1)DR?_/5.YDF5+
MER]90I,)K>43FT^0Y 1Q 0( GS^! H6 Y,BJ5KQX-6KPL\8BITX;M7K%Z]@Q
MI+Q^_=*E"^DO5T%LY R"Q(D3)3F38%SRQ(DKK+Q<59*ELD\?NGULHD)5B:]-
M.'"<!!$<Q(FL:M$T/E&20@*2LVB31([<Q.8SF2IIQG(E]6JO_V&V+%]F^T1E
MM&BRE P6'+55KUI.D$A.LH3V;-IJL_2!)DW:3-^^+:O$M:Q9NW?'VU5K*<O6
M,&7,G"''!9-Z]94HL9M<""&"M+5($F3AZ9!\>?/G(T#(DO@)"([H&=[L@\2:
MM0L<$X#82!%$EGC@]<L)B3XB2. "$!!$\ 6=D%#00043> 8\AB!(X(4")W#O
M!1 $[! )TIZQ9J,)<$H@OV=>,-$FBC221J,LEK KL97<0R*+&NG#)PN&/DQL
MPPDJI*^/]9Z   1KLGA"1!>7P$_"A#B<8(((.$PO/R266# VG=XK,(D/+R@P
M(4,,PL&AH6Y*\Z;UGDGR"4D,VF3()?](M @CC=[+3L\]^0S)NC\!I<[--)N(
M#"T/<W*"B:*F>L65N9Z9II9&%FF$TD6.XJ678[+*2A=(0-WJLVE84NPQVI:(
MC E7.FTE$E=JB=6566?=Q=9=>LG5,^60 $*U)ZJQIAI9V"J+B2<,E0RRM4)C
M*996I)I*T\^"8VF::63)5I9* K.A!B!8@\61V&0K5S;:<J-II;K8;=<N66J!
M)5=FZ"UN6)5DT4PJ78]19IAL PVT3SZWZ^Z[\,:#3^&%$^+.FADG9+A $P.8
MH+[["M1/1?VLN3# G B, %$!)QBYPPF@:<_# B],($,37[@ B0LN^/$%=25T
MN406DP@@ KO_>J3NX24^K!'%!&(3R!KWTGLB"_!R$CG%A%R>DJ,*)PC3Q(4B
M[!$$HG,*(,D 7A#QPS278)KJ+R-XP6VW=3 HDRZI+CI!!2<P46\(2M[$($LT
M4JD^V_#L:.##$1<IX,49;_R96(SBQ5%('[^4TJBFRK533UO9ZI=1KR6UDC3=
M3+6MS;O:7/75=Z&DK"* ^+:PT&FOA D!S8V,V9GPA3Q:I#P#S27*KU4I=%M8
M:<455HK8<LO<)5O+W;JRJ)[ZZI.D)/G?IR4&G?JJF90USGJY!6#'84H<NX*]
M*U$\[B2.WSRDGPC 1/C/TUM_O2U>&C^-^6.-@2 ()R#+&*)B)K(._VE)2\^(
M1Q(.=+?T@$!,[K$0AS:$A RNQ!I)R,_.<+*2W*1-2SG)H 8UN!9HU*@B2+,&
M/N+QC(D@X1EI2]#.7B"X^O#M80)$@C3BT:0"V<1Z-JE+F\ S 8T@08$8:5"7
M$O"E)[ ,60F(" 4<8J*OH<AG&VD(!")2H8N0!@00$!%>\J0^-0X,?6UTH[-6
M\8I7* ]2T[#%Y2Z7J:JH[E.0T,4O=N&((C"!D$QP E^P9Y,EE(55G<+*ZB#9
MJ5T(3UO:PE<E9>&$(FQRD(4DY&Q(P[MGY"MYKX %\/Y5"3=E 1H"B<<Z!/*-
M^ECC&_&HQF9<<82104]W3V@7]H 9S"=0PO\1T)*C',N'BUF.DA*Q<.8S8^$$
MFWRI0R!B5TW4Y!>5K%$["N%.^\#S/OF-,XM*F@\2@#2_(^7&&N/8QD"J)PTE
M3>B#&WL&D^93L20\(PD4%!EI>@B-%.(%)U\B&D8$2C<Q<7"??9B2UOA7GW?V
M3'\78:+>^"DBJ;UM06YKT$525#2D00.&SX  =_!20_LEX"(>1!IFUC.!?5KF
M">H2(D4R@DXNR=0]UG,)7K@F13&52!!R^Z+>]).W"'B1(07AA"#J1AJ++.%A
M3.7F5;,3S-P,*9C3>^,;J^$[.=Y".2JAA*70BCE-]8*/6^%*+X@1+'2@8U@@
M>L:0;M*61_YBKY'_5!TOAG&.;6RC/M^0Y2QY8YIJG,,6CF@$J"!QJ44P@I..
ML.QE'6O,SO3"$90(T2Q!V\[!NM*6FV&%+G=)37+U<JM<59,PM6?,8[ZB$0\
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M'X9!913+JE>5L7QE&+73L;+W'7 T>9Q0&)M1LA=KL9*AJ*Z32GBQL2!;LDD
M"IB "9F&JS&+'-# J2<+L=[&LX;1!^IC2K:"EX>IHW^137\!JK3REFN8!**Q
MHN'''XAA<@E7M8QB._DF1<HREKMUANZ"2[S15Y?E.KO40QO'9!>PCM;JFCR:
MK0YTI!:DD,%H:/"1DH#H?4<:<P_S)D_0MWP[-3,'I;\YN.I*B59:#?3_^C3W
MJISH@"-B*IYE6J]:$K@#JYX21B3@:AGT^8768SA8IBS$:BX&2;K3AP215WA,
M4+J"L;(?5F+!49"GJVV+LRZGNUC3]P3-0KO2LCS!DCNLR99VB+1:!14D>!E+
M\%EUDQC;09'?4SMB>55QE)],N#F&X[+99!61T2K5,@$4!:G6RBCH"'+<T5MN
M^[8,9*PL>3!&@K>:"ZZZF:0PEZ1*FJONQUW8I7XZET)SU$+I(%&V0*\^LZ78
M>8GI8,#K< Z/&Y[]JB._1KFU\V 40%V8>VQVEY)H\PR<ZQ<2R:K/AQ7'0WTO
MVFW:Q@0&!!NM^Y5]<&V$QZG>B(36\ _/<&/>_YC!SN,ZLM*,ME*M+#N]UF:T
MJB)PVS)],E9PID&:XO*BU:L88Q@8%\ 429 D=!9._%:T.<I.;8NMY_LW"".N
M0&J;[@O&]7&D0E.N;;*D-+E=Q'EIQ6F3'X,WMQ8+<2P+U=!>*J1LU5 TD%M@
M!N80I@BPPM8 'E0QCC R;MJ'*N<PG\FYVH$9;VDI,LP1:"O"+PR#E#HO)UQ8
MJW)M24@_2XB$JV&[C\6IGCP[O8LD/6R:.^S#PSO)K0RC,@Q+8T@GWW)5HML7
MUG$<M@-NA\.H5TR^(J?%#H1!AKB2&31<88S,5".N+)E?O4F3VB6<@\LQT]#&
MJI9W0)?'"SPE?-P0L/]6@43Y#,-&4#;0"!XX#!9<I(O,R*QJO<J"0GRE<:0;
M((+7!*!0@SAPR<.3R79U;>'8>!0P+Y_52PU2+LLA*R4[&N&$%ZJL9S_LR@^-
MHU)L9WWV59C5!_D) 1IGQ<$!??-RK2,7S.B[D/PTS%DYC.V;S"E-'\N<F5-C
MQKZI?C;W00BEKFQ<S=:<)-%P:V)*8$OY15LT$>J%"PY5"6@DP180!!U(=U-3
M.."JSGM2/5>AP@%@'?4#&;B\HO0A#52;A@XC>_C3%0$4CTA0A%1L<*2I9=A!
M+I),'>X("B6,6R] ;J,G*]8#/XEQ+R\P0'O-UP#$RA -V.\C#;HQT=11E_O_
M#$IVD12?E06D2J*RC)J_C(<A[2_Z,=*)7,Q[F#!?K-+(S-(LZ5STBXB6V:0,
ME;_2G#^NAXED5@VQX&F.$ G_Q44QLA"?P,T%X< 8,=3H4 D:>-1!4!+'M@RI
M]E2'3!]<:1F%\]0'M-6O:G*M BD3< %9H7.QMT\,2;<<0;70@!C0(#Y(8L\U
MV D,V-5'4DZEL=7KJ*P<)Z&"8!BN+!A=XB>5T:KHM+H%&=CYO2?/\ *<-*-]
M5FV//7#* ZF*Q''6P9I5X9CN])J4/4^7G;X/6=+]=)7Y8=R=K7*?[9#F>H@G
M5-,ZQUTZ]X@-U5YSXW,2=0Y@R@J.4"),(IXS!0F1__#:0H=UDWMLL1!0%K"F
M%)#4L' 2%P(BT+"^W;?<58%EB'&.@3+:36UR+_75O^H68NU\ED(H 2 (-V@(
M#E :FB'#T^TGMUHX3W4D&98$/2"AG" (VO+>K9P %T!F65$__ZW?<_[0\$8L
M[!;"F;0<O1%-?[)B'4V6D%T5_,W@YNO@Y\%$Q*7H!K-HNCF;B8[A8)R5&GZ9
MSA493%JXUH6_D:BNNK=Z1U*E$'6</G<.-S)T_K<+45,+MH +#,9T*S%>5S<A
M"?C 4-D  H($LF +LH +W\!"OP,?%K1$0E/DLXQM,,'=*LG%J)IY)_0PB?@P
M31"71 @*F68?QX$<RN< @O\PA#>X"94 7F(>&1I73@F^'(.Q#1$P&.!$Y^W.
MYG01AMZ1Y]HAONFSFJ 1&GI9?2,Z>H1>OEE\Z.8AB-XJI)3.7)'>V?(QI*B@
MX?F508T6,9!&D\'D)YYN4!13DS>=G00,4>E@#0#<B3Z.$:[ "AN1J\J2P];
MOR"2#I8YX?<!L3#/Y,4^'4&\+GPQ+?[!%=5]J_:C/-I6(],P>91'>9"G;4-/
M]#.KI%^=J84'?,KR34@B/HHH'4-<%;*2.]T;&>;N[EW/3F(KMO-^.@Q]RR@D
MJZ/ZD09D#9+=X %O'GP(X2UWW91N/PYO?@BOTG3_D(T6&4K@X6H\G)IN4-)-
MW:G_S7,/XDO%(P^^M"',::7,N?CXD)P\5#?&G)LG+5Q-3?->/\+CE@3_5H4.
M, ."((26@+J<:@F:H B6T$3((C"6>:JGOSP5?RW)I^Z?/N8.IQJGBV;>PSI<
MS_G![Y'' 7%BKQW\SK;U;=@-R_:&[O;C09O$11\KF=EZ_Y!XW]G6?XAPX(J/
M!J47+QU)0?C &JQ-L!F*J'NZ,3$< W^8R&PCZ)*K]U+IBY6Q1'+"GQV<+-_<
MIO\Q."Y!#! 1)H! DN3),VOQ%,:S]NQ9GRQ/GBPQ*!'B,XE+D("8D"!! ) @
M)R!,&(]D0XQ(7DR(X-$EA @Q9<ZD6=/F39PY=>[4F0#)_Q*)2)XDX"G39Y:6
M18V^Z-.Q: (0UD $F(B1:(1_6;5NY=K5ZU>P8<7^<UC6[-EGJ-2N197%[=N(
M$N7.I5O7[EV\$M'NY=O7[U_ @?,.)FS78;5J&(,B8=RX\8L+D25'=ERYL63&
M0?$&-GO0;[2&3S+/35*1;I]GTJRM'MLZK%+8L67/IMW2I4>8!"OVC4NQ8I8^
M?1HF0?+L1<N0 3P.%)HEM31IBC=VO)T 9FWLV6_Z-)A%Z%78"9@BP8T3 E&)
M297ZE$IUB=68KN7/I\_UV5N'65 Y;+L?;5NXX"IL0 ('Y.Q !!/\JT#"X$!+
M+EG.DL@)RRJT<+$+A"KL0;WV>O\B0L_VJ@8EAT1K;+?5%E)1H?KHT^Y%&&.4
M[;SJ(KC@!0U1VRNNTI( Z@G4W#+Q MM"\B@"@H!T")H2B6.I.NMDE'(F[@X"
M82C:SKLR(I5 N$ WB9)0+S;VIJH*2ZQ:5'/-KO+SSZ^U I23KK@8M),N!?/4
M4\^Z2KQS,[-DH4O0NRRT3"[&G%AL,,[ZY"NAU4XJ:45*562SM2DSU713\VID
MKKNRF.QLHH),\Y,X$"(XS\C<"@KQ(1-3A9+3IPIZ[TKP:J,1REQG2^")]LZ\
MZE)BU<Q3K;34>DLB >5:]D] ]Y1V6@1?]1#:PF2!HZY*[&+"4"<H5"+<<1GT
M,T2)X(C_D*\15YMT(7DJE9?%8L&B]5Y\\Y5IU_((:LZLZ$2-2"-;GW +5M%6
M0LY()'\*D<F@%.;U.J7.HWB[@H2Z $U]PP-VJB66Z /->DMVC<2]WH3S/F;Q
MX^]9;)V3JZPZYZ+VY@0[Y!-;B2)T]^?5$E/,KDJ&QE,Z13,SFD!V?Y[W::CC
M,=FK['"; $<?)R+NL1= \'("EF+BEU<H(3#[XH[3OFELHFYT.%3HRAJY-,9^
M?$@Q5!<&J6T<E80FTOLH0N*")V^+0"B26%:I\.4&MNB%7M7&*8%GH'F!*L^&
MG7ISKW[&V2]9UN4KP+GFC/9SU/G26;!1>5[];W>OY7EI#4O4_W NT=L%^MVH
M>Y>7\ZU\C:"BQGZL*V2Z*WQA>1PK+,WXP9 G#C)5JT-;\GQG_=1@AU2S)CJ6
M"1[-.2%1G6#5O1.X6BC48A^:..@=\APC\T53KCSLJ00!H8XP@H9DX 7P'[M+
M'6#88CK76:LO,QM: <NRN@/9;$]Y:53KT#68VSGJ: CQ70<]N! !_B,\+\@"
M<8*RL*N$K7HN24YR>#43L('-:R!HGF.>!SVY"*Y@.60,1VQCN/QU;&PPR="_
M*N<^Z9S((BQ+V)-8%0$<+<$Y".G>,S0D%+M]#W#26<D0:043A#PA $@(#C3(
M$Y\0<FYW6W1@9W8D)&<U"X%W>: "%_\H08S<T8Y^86 ;!4.8.G;H=( Z&N^>
MYJYQ*.0;B)S7.!SY0:D)D"?HT8AW7'*[P8F-8F#[$@UK6"H<Y@5YCEF>U\!F
M%!;>#TE1G(L.=YB1'C(.?T'$%]L$PLKNS2],)P(*<)(H*Q<V#"CR$U5&)$)"
M'9TD/PDCDO5JPY[[$"6/'$NC&M>(1#^>!4!RBHM^T@*S#94(,(81IX0@F$UT
M]BF!2RM+BB#Y3GF-8QNKV4;40J@3F(AF(D>2" B.I*FSD4V@UQE(\TP#RZX5
M297K.^@3ML:8K,EE>JGBU_5HN2GM$00H.OH9D^;FF(T&9V0:X<A'&*;1$($/
M2*6KHFI*1%+_ZKR$)OQLB#7(L[_,S:2:F[LFT-"IS0 IJYO<K)FY9'>ZGR:5
M0ZT[Z@;/ C1X1K6#\OS9-A))KP#F) $&"9E'F.+/B^JJ1@W+H$,7]T-5DA5Z
MXAO-$HXSR["JS98TK!WL8C>RRNPF.*22V$DS@QHF%5."TOB;1U^E(_)0#DC_
MZ]5.I];3-;816?D)$,LH*U1P_LF-@62:4M/IU*,^%;+N9(A4HW;5J#J2-9+<
MCFBRT!$0-"5R<972V 0")M),YX>&8P[B;$<=B](6>[9<GQ3EYR["CI0QS6,6
MPAC33%9-X*_R"U6)_!F %SP#*$QR"DT<:[+17C-U*IOB-YO5,M*MV/-<=+1@
M'\_IV6GUT2^Z"V]]37O?%3D2M>.XYTWTZ1&*S%:X<O44UNC2PY@8#@3$H\Z
M'3P3LWD*3,=U'U\-"J0@D:JD>T-2$AQ2&BIVMR;?+5E]Q8O.;0:5/]M,(&C%
M:4?#N!B^J#-QC:^)7ZGJ%[7QT"^)??QC( =9R$,F<I&)9>/(XBRH;)ELRM32
M8D'N,8+NG;&TD'SE*^/X@SI6"'^-_&4PAUG,8R9SF<U\9C2G6<UK9G.;W?QF
A.,=9SG.F<YWM?&<\YUG/>^9SG_W\9T '6M"#_DI    [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>hologiccostaricalease_image5.gif
<TEXT>
begin 644 hologiccostaricalease_image5.gif
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M2,!"#$)JR,B? ]<]"#_PX=U\*$3Q DB+^=51%G[(-[SWS8=!J&X0=@AXP.5
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MH/ZG#69@2L_E!"O 2DX0"L7@#>H0#^6P"]JGE&S@HFEPAD-)E-AG![* :[0
M!NF'IM=:?8,(F.0SB-R'AM+'?:4HI]W7E5"0!FI(?7=*IMAZAV] #5?I9\7
MIXEXH@G7!_0*I,.'!XZ9AG\(?WAI?:N9B-8WJVJ B"3 ?N=*E25*IG5G#-8
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M?.NJNVQ<!U2+FOLZQ8[+!F6*KCT*LI2XKUY;LH#[?HDXLJJ+L"0PO$#:).1
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MNX@8NNN'AW80!XT+Q*>MQV,NEKR'N\[GZ6+<>PA- @ O HGHF)T)!M9P%.C
M#,E0!4ZPWG#>JZNT71.@!1=ZW=Z YP)A<7#LP[*0S8A(PZFJVX;:Y.AJZ;-M
MVUN&FF:);XJ^FHWYJ9R)[F?_/@B<3LYF6P=XP [.;&3+;+/W\(O]X(LMSG1N
MI@[,\ IF@-E00.NM'@5,O]T91F&Z/O44Y6J\WFDGC@[B8():SVA0C;/R -4W
M]XOAZVA]H.Q:#06I,&>GFLK08WU[\'V_EV_-UZ_MY\KR#L&)2.5L0*AG..:'
M.'PP2N:I6[(8AXAXV)FJN>[I?OBTK)J5.+"XB^:=20)B7GZ'W7N&.O!A&?!
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M9^U8F^79GKU96J %7?!9CF6"!1B "QA6]! ;H*$ A3RCGV':#>!&[( :4\0
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MZ*5J?1F@,823BKN(3C-[*4M>$!.KPGPF+WP171\&,QH[V.4]'BR;+)AQ#IX
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M::&'Z@+5&BT-!LQ?-L>&AMHJX&!$L9%FX8']4L<4V<$N#"<ZP",$WU 3&$!
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M(/S0T]X#PW<"%ZK@A3*$PA?5KP3T?\ #'/3@!S_H0?)Q,/P%#,  2.C!!*J
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MJG:UK(6=0]&UCG[T8Q]=E$X=4@(&<I #%LES7AL]*L?]B-1@;%S82OF@('*
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M-HD55,G_:^!F!W.0=59R$YZ"J#@1;<"4"B<&FAB#J$H$FGAPJ"]10MKY'ZG
MJX'E-]0@AVJY#*. !(P&J>(S/@!*A\UZ7N9U7C,'(8[T!.'B&H)Q&<GAH_?
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MNU?PWKY[\]0M+#9E"A0H3YY N5/OWCE9;][4J:/Q#9LW?3JR(:EQ))M5>-Y
MZ9@&(A27&UE2><ER)90W?ERFL>,'YLZ7'6N^H4FQ*,4Z-9-"H1GBI0B64)Q"
M@2K"*A0_/H.F>D/":QH_==*X/$-"3CE_]ZI,0#)APH,'2-;5FX>.V:]7JUX5
M\T9.W;QZ@0?N([POL+A7J&A9FQMXWCIRJ)XL69(D"1+,2)AP*:-E3*5*9;@X
MF9 C1V;,3%2KUNS$B438L67/CJTEE+!EWG2+4W?/7]IRM*[]3L=LV?$RJF=#
MI/WD"ZIE?^7)6SA=WCS_[-FU;P<<V/OW[X__8O?>'?QO].G5KV??WOU[^/'E
MSZ=?W_Y]_/GU[^??7_["A<01<$ !T0$00.NJ0Y"Z P$T<)Z#^D%HH('J60?
M5!QZZ*4[X+EGG5WFX*@CC4HZJ<0W["@I(XA(/(JII6IBZ8Z@[( H#8Y<@DBC
M%E]4:BDJZNBCIB!K"N'($$B 0J272*B**BK\N$E)/VRTPQU_ZC&.F61^*:88
M7]9ZP  #GC#O.WOJ$4<85E!YA1ER&@/LH(,$DM"@.A,*[*!ZD$$%C)J><(*U
MS"AK[E!$FZMB42T:9;11+<QP)3?=CDNFC$2;8TY3**8PXQ=QL&/P.NW "X\[
M_\? (\_4>OQS]5588Y5U5EIKM=4^ @U4!QU>>6WP5^NF^]5!=,1!YSJ+"C+,
MHL<>N_ .#1WJ](YU/C3FC3CB()%$-C@BZ5LVLHWC#3!6">HFIG;LP\<6T962
MJ)ED/!>B(*5XZ0T:@XH1BCG@E1>B.]!ULJ99?%OG.&8J78:WZ;);Y@O7UC)
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MG&+XA5#H#3S!D_VZ(H%P053A)Z2##;>@A8& C+"H S;H W1)(2H8M*"80ZD
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M!W  !T@ HW-!#PP!#^  #T@ !-BY 8SZJ*.QF_-YG?>YG1_N#^QVYW+NK>Y
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M^MM[IBJL@BH@?N*G_>(S?N,OOBL\_MI+_N2O/2L0?BBP BL(?BB4:>>7*2B
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MTJ6I?<A5<^T\X,%DHP'2M.IA/XS!'+(F>]1!&(!C#%9@ A;  ![P 1=@ I#
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M-&_VU&D54)(6K,C"X'/CJJB*PDH6'BWGSA -/VSFUDD.%.U9H=75?O^.#=H
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ME4>QC:42'&P !ZF0"BKKGU'YLCE(EM5%E=7R;^[HCN+H%BG[/U1 "/C #!<
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M5G!<;R1WHSC<=\4-0@L/49ODL%BI24)ND%3(@MT<:N?=[T +6"29W+#P_1L
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M$I@W$M32)]B15^BRY)I&<5FP>#VJ>1"'>GV%8C@A=1B.Z5D'2U."'/   P"
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M*(@0"9B8PE#<R=TCM[!%*&[-B3D8M!!2*$7%TNMPF330PL)UA4I@@@GHP0E
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MW3%'1FEPM-8;,0Z4"HT,2931&W-4M!9#?6 T$!6K^$%-7^289!(SOZQ@ )4
M+. 24#QI.=26/37X$TQ"?5F4/TX]9113#Z(9E4_>H/+%5VRE-2>===HY)Y%Y
M0O'6D1F)\8HX\P157WV]-6;;8(4YYU<YF[6G*&#+^>,.!1LPFIA[G/U%*06@
MR?_V%V/.2=J7?.#)AIQZU7WJUSW702:9I=H9MMNK?GWGSSV'_B4??<@IYE=A
MK!':%Z48F.?/-!BT5U\>:DQFK%_RU9(I>()1&JL_Y6#JSVOCF48!K=0A.RMP
M]/G5&&C#5M=??P$2>%]^[KK+'X '"K@@O$3M<P]2]^2TGSA@9-4$5AM&Z.&'
M!;%Q$!45Q;$BQ"H.M(J0)Q(9T4%I]+CGCWNN8A!!'7=L8AUW#&3B0%(PY$<<
M;\A2V3HH/5F2%@_83*4!".2@TY@O=8D3F#S5I*7/,HFYDTXPJ=/4FD]%Q911
M9;)9SSK%F!$70ETY@1843WP5Q9UAVRGG6% L,5=&<6;_),5;>9I1C+J"&4H!
MHHCAMH$=XI8SMV.S,1:9/Y.ENYFXP#&' 6[.D2OW8]4^EW@MZ0:+6V/A_G5K
M88[3ZL^JJ@D;=V"0QKV9'<1AD"YPFEM7J^!]4=ZW>XA[YMRMC,K>V'2@]\6N
MO0C^)R^"P \XX+V]*[B@H$#9PV]4\U 8K\!9+7'5*QPR\V%$;S3\!HML8(PR
M1!)A=(<?#&],$8IK+83D*@BE<B-"*\;A!XGU>_]&WO[L(\[,)0GS!2O$\04J
M36" !I@ .H*2/ 7^S&A%DT>!;G*3+3'P9Q,$FE(R*#6D),4O:*J'.HH!!BA@
MC6QSPA"=G+ ULISM3B3L&@O/_R;#LYE-AGI:RUM4AA#=\; OHJN.?'[EE\E0
M9S/3V,RQD B83R&N;N<A5^6>TYKF%.IS@]'6;U1EQ=3YXX?G M=KCO6MPNFN
M,+I1EZ(F1SG5V0HZ2NQ+$ZL3Q^.0JW:!<8<Q5I/%N/'N=\';2X(2)*!X!0A>
M^_F/'WW'LZ#T:U\OX0\SOE"65'#(&MHKF8M&!+$^+ PA08(?%-IWD(XQ9(10
M,-E!2( 0(QWD#K3X41KN,+(2:?(-?A#1&^(P"WSX0QTGZ5\EVM*U+RSC%1-(
MQCV2\02\+#!,/6N@,[.T$YL +2]&(UJ#GI*4,SV-7TKI"U3J08Y65&4B3X A
M6BYD%?^S; T)[GPG$K0RO;',\PDS;.%5[JE/M-50GS?,DQ2DT$,>>E$PFX%"
M9>YA#-F)BPZ($R)P<E,9:TP&<(V95K;HT!CGR&<#K7%'9S"ZJL*<3HJ$V@P%
M(H<LQ)FG<USDEF^R<P_Y8 97B+/#1!FJ+DZ91Z$8P!9@W($XE<[4-ZB[7'"&
MY=!M^; Q.,U69W1ST;Z40Z-U3"I5*Y4=7%UF4>J:5Q_=];M  F^0\,(/[]2Q
MCGJD:1\^89Y0)D0A9J"S*Y3,QSK(80<1501\H\1(VT:YL3Z@$@I@D(@I53F0
MBN'02&(X4?E.ME<3T7)$WJN#+&Q3#YG-S!55.(LK*N@E:<;_Y*T/+"U19"+!
MF5SP)Z2-IC4=*$T'085?W+1M!C\X#S>5$X99.\M 2M@U$](S"?.L9U>68-Q]
M,O>>_6SN#/^YPX&"KJ""J6IC,$ '8VP&HIPZ*N&F,9D-P *\D^%,'LHQ1^\\
M*P^HZYQ0M^@Y,@JF%J*! D8MU\9JL7>C6V645>EPCU51L3K66"H&GMI&KU85
M<0GV%F#L6)WO!F8:5MV >R]W7BBD-XX2]D<M>O-@'K8+>/@1)( $"=;G[8<F
M_WF>/(#"E*"P*2<L+D9PO_ %,9BAQ]7#JUZID+",4$&6..S8&T0)AB(CA 2*
MA0(K*?*6PD+!#W9("(M"U#WOR8%)__YP4O^&489SSLD,"81F:E_;6F@ZSR87
MQ,D$WSP/=+ Y3&>*6IF<\E:F-&5JO,4:5HAK%N'6-6S'A2ZB$UU#Z=:0NHY^
MM'KI]NA)4[K2EKXTI@$3:2=F&M-EE1=:T3J\^X"UQ35A%TW\LQ>V^F1Y45$'
M,XKQBE>THA6H0$6/S? $XV:E#_< LAU4UC D=6S8:[G#D>J@BXXQ%DBHG(,I
M1TG*CZW(EGM]F3]BUK]EC.*S9I'+<K%"S**U>2;5%%-JH6D@-\N50*G>"S7K
M++2;T#:#''2D;9TF%&98:)TNS$A9IB=P1-LST09?KG+/MMP\):'AG7YXL#+\
M\(E3O.(61_]C8R1^<4K[!WC>0)!^3GQB>>F'Q?BZ#SE23HYRK"-FN$8%+5YQ
M!U2\HAC,4&M,)$B39+A"&,)XA1FJHMP[_!H>Y(@L%5(!,H3X08<3Z8..ZJ C
M*$]$L4D_WT1NJ=@DBX@-^=N'-[8M#"UP)2M(H($]R=+PKD!!&*Q=+4VXM,#9
MDMO<+!9>@#XN#KB[.<[)8W-KV7KGW/;+*?W0WT^J9H;ATDE.A@4#H*673^@V
MO.$&9^YS$YT$AF^\\Y[_/.A#+_J)GSA>@2R](0EIUOS<G1SK<,<ZO%$,5H2B
M]K8W \W)<8X^[ZO&,]$/.>-R3BA\ 6Q$S\<]R"&+BU A1.H#&<;_]@3*CT'D
M?.G;4V2=[&2(T,^R=J &:'RY[5!X^RHKQ,H%XEDVL[@BSGV/=\]BF_.X.X_U
MJ>^[:N4,V[FS^N]M7FT]Q%B]#=Z]+<5/J,,O1)LPM04]Z5,,-9?E*1?"59ZB
M980-76 $,DQ&C!X'=J '?B (4AR]3 C %-)>!(]8#9)-'(BMV9X+UE[N'85M
M==-KS40JP$FA/<$=U /R*=^'M,C2A<_U(<3ZG%)D#80L]0D17AD4*!;$Q($=
MV(%MW -G/<G_U(D[!5S:=849!,K;X5^6Y 6%O(N!!$B\_9^Y_1Y^G!K]P1G1
M($4 "DIIP43S#(V#X);AF0D>L@DZO$*T_QW$5R!:!-I0YNT3PEU>=)G-6O#3
M1+P!'LP"-9S#6@%%"%:B)5XB)EIB6@72@*B8\9!@?P##K=7>*S"#Z^$$U)Q)
M[X63\ZB6.G0"#HX%&/!@\M'"B(0,15P$*2&$L4T,QQB6$F9,&MS2R51;-/0%
M_VQ;)51!^6F-"JE0$B!!$S3!.TU><N$35EB!,,@?G)WA[WW:WJD;&YX:ZY6;
M'/;$U.A+7KP66S%-;N46W9'#*O267""B/R5B/1[B7,C0(#J7(JZ%'<@"-;!<
M_%%B)AXD0B:D0EJ:JAV2Z:D8BM4+Z\%83;P"*H0"*F!)._*9-^W+O?6+[\F$
M.MQ!+'+A.O2@+O^\@<I43/0=1)1E1&'5P2I066%IG_;94O<,0CQDV[8M@RN(
M!5D\HQ,P 5'"TSL13!9B!7*5!12\@LZQV*BUH32]WX3,7Y<\T/NU8<XUD^#=
M&U/ EOPYR$=ZY=3PGT^0P]05(B'NXS[U$Y&@#:+5(T/@02U8PSG 0T'VS$+N
M)5_VI5_VQ<FQ2V"26L?%"PE*)3G0@BWH0C%L)$="S3O.8$C&Q$B6)%8@P1><
MY#V8@X= P1OT 2=ES"@%X4&D0F2% !70 A2$0!-^2!/:Y!F,B!^T!MAMFYA=
MA?J9GPHQP5 2I6_^9E%F!1/D9E;D8%:$0J"<&H!XP\?)U5/2A#5EI9O_^=_\
M/:4Y-A C/8A;N19JS2$=-@5(;E,ZMF.#B ,J_.-!$.)$\),A;EZ>J.<<#,(N
M:,,ZX"5IY258^L1?[B=_]F<'W@=:O4M:&1)^S(L B@DZN (H>,$8_()C<J12
MJ,E1B"=J@1!5"-]8S(%FG@,S*,P;[,'%+!T5F!*3E>8<L*;%O"84L,$N^0,Z
M]"0KE-]N[J9O/F.-_B:-$F57Q%.AP5#E5=XT?H$W4(B*N0O?#<TTO=\76F5U
MYA]KU9UI%6284)#@1:@WK8D"A6'R?01<'MR/?BDC0@$DNMXZ("G=>>>4>F?1
MH)M_MJF;OFFGH=Z II7^3>G'_0+M(:>,34U;_Q$>/(;0K14#7JC#8W5%&<#@
M2>*5)=T/*%$$01S)]E$=:X; '(C2B<0!%$CA2/2D,(R!;N;H< (G;^(H;_;F
M;U:C^?&F5B!!$B17$U1></Y"&9X@R=&?5CZG5G9GW'$CDOY?5LH6?C:3_\G8
M.TXHG[U$G_D,U5B-(DI@/_+CEWJF'_3!%#3<0.#!.33(',:6:]7@/*S#N=4#
MG(XKN99KW!22JH5:ZO''<^:G3Z##+PC#+V@DC16K4M0#.@A#,5C#.A@%N<D#
M.8!!58A;&12L&9QD/ZR#-G2=C:A!1M0!&%"9BA+$B1X$]7DF->B#/WA#,@S#
M,,Q,*&2%4(*JJ);JR/^>['!NQ5:,Q=E)8U<85S3"$Q,@)SBB:ZXZ:3/AA;:F
M8=U1I5PES7T(RJZ&85YFZ4O0VY5&YK&B&\[U8;5&*\? PBY8@^L]4-(DSP2-
MB9I^R3G&!+CFQ-<FC[F.+=F.+<@-)N^D6MQ=K;ONPSJ4Q"]X@SUP$&0>GM2$
MT"^\ BTPPSKLB^&%I(%X0_0\ 3-6@18P(QB00SXDK#8$&Q(>24N>4I^00 B@
MZ"DAQ!W(0BI40@'YW,<N0S(L0S  Y?F=[%#:J,F:[LFJK%&.Q=90HSL1S%54
MGE$BP1AX _'XT41J95A**1H>K?Y)IW7VA%EJ;3?:85M!YF,^$E>*DR1R(V7_
M7J>6+)+66I.W?FO8&@BXBFO9=J_W]F?PK.N<5N50T)B:,,.MH8*@^JLX% .N
MY5HJN$12C*='EF5,1-)83,%5).[BYA43$H0?!".Q'80(3"H2:H0V%,,$', $
M7(!6]%S'EH$*B2Q6F.ZHEJRH@NH[A6I9N&SMONP&Q],O-.3NFFGUDI;PKIDY
MXBJ2QMW-:FL8^BJ,M9B@<*1'UM:Q[L3VPD3+\;!:E>DUX2QE5F7\I:E,A*V6
M?*\2+_%"%@^[.N?S$&_R0 U@& 4MF,$=9/$=F(' @H$9M$(Q" A1\$N6+FV;
M38@R&.=57 $Y&$5>^4$=T$@O/MF>@.A:[ (OB<,3_TP $DR '_NQIZ:NZHYL
MR<ILJ!*EJ?8QZ]:N.UDK#+T3#<#3JSY!$TR/[!(,<DIG*_[=,U5G"D_G4Y:C
MKSKG_\D5SV9I*5<E15)35]8MG_6> ^4G3NR'TNB$_B7-T':R#@LK]S*Q+_\R
M"()<?TP0^=)??M!A;OW%.ZY#*MQ!'[Q",@B(\/)?FW'MU]8#CGV;-;CQT064
M9^XB$2($'E0&272L,*#"'Z?S!!SRC)IJZEXP(V\%!OMF/$MR6\3)['[P6=QN
M"O/R.LKPNE&3K4JE3[3A.)[QBWVR^]DR"[.8F[5C'J[)XN(P-XK6(^D':\DP
MN+Y9L,9R3  S2(=TZ,TIV/_FQ_:ZXSLZ4I:,(X6D6KM)LUFYW[J9I=)4I!J?
M$S-P,RPDA+2F4J1"@1C4 9/T0S*:A#FK,Q_GJ#NC[*F^4PX8,@;+\SLYP0=/
MHS"14#[#TYS(:LGA7Q!_H5=+;YVV(G36G\ZIG@E.)%D;\;8J34)3)"DG;08]
MYHPAL12+Y.YN\K\L]/:F6] <<2^+M& /=J?QSB1"=$H#KD+;G_ 03ZFQ&UAF
M-$V@@MHAP=8HP^$EGRRLTEK(PDZ*WY.$;C!4P5/[<1]/@!F4 3W3LSP79>WF
M &S'ME$*I3L]=6M+<LQFX0M9Q0ME=1(TP0LM9594PMZ5\*\J:==^-0/]ZTS#
MF33_CZ&!TEN%RJ&RUB!+!W2,,4^:S/7R2G'==4ES4\CO5:CQP@1AGS=Z4QJX
M/B8.KXGO(3$YKB HQHO:'F;-FJ%-$*T8.N=(=H42N-,*&4-F)R;F'H2FWD/8
M*:-OQO935T(H2' 5N!-P&B6#5[AL&_)L#V4]SVZ@$9<)U1,)30&T5AXE"RF[
M?6*O0F]IR5ET0N5UMC!VJVUWIAG7.M,FURE;X;#RTO6:<LEW<V/+?:U='W-!
MIK>1'SGH*$4^]-[1'+'22 A4MABI#5(AK9MCWW?-QAAYUY]_#*YNJNH3%,.
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IJU>Q9M6ZE6M7KU_!AA4[EFQ9LV?1IE6[EFU;MV_AQI4[EV[=D@$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834115568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Feb. 05, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">276,529,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document And Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834631872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueGoodsNet', window );">Product</a></td>
<td class="nump">$ 650.7<span></span>
</td>
<td class="nump">$ 613.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueServicesNet', window );">Service and other</a></td>
<td class="nump">140.4<span></span>
</td>
<td class="nump">121.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">791.1<span></span>
</td>
<td class="nump">734.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Product</a></td>
<td class="nump">213.7<span></span>
</td>
<td class="nump">198.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSoldAmortization', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">79.8<span></span>
</td>
<td class="nump">73.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfServices', window );">Service and other</a></td>
<td class="nump">73.1<span></span>
</td>
<td class="nump">57.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">424.5<span></span>
</td>
<td class="nump">404.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">54.8<span></span>
</td>
<td class="nump">54.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">139.5<span></span>
</td>
<td class="nump">110.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">77.9<span></span>
</td>
<td class="nump">69.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">21.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">290.4<span></span>
</td>
<td class="nump">258.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">134.1<span></span>
</td>
<td class="nump">146.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(41.0)<span></span>
</td>
<td class="num">(40.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">95.8<span></span>
</td>
<td class="nump">116.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(Benefit) provision for income taxes</a></td>
<td class="num">(310.9)<span></span>
</td>
<td class="nump">29.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 406.7<span></span>
</td>
<td class="nump">$ 86.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic</a></td>
<td class="nump">$ 1.47<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted</a></td>
<td class="nump">$ 1.45<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic</a></td>
<td class="nump">276,856<span></span>
</td>
<td class="nump">278,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted</a></td>
<td class="nump">280,802<span></span>
</td>
<td class="nump">284,224<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the costs of intangible assets over the expected benefit period of such assets. This element applies only to intangible assets used in the production of goods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to services rendered by an entity during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=96948231&amp;loc=d3e4984-109258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueGoodsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueGoodsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueServicesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueServicesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819861392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 406.7<span></span>
</td>
<td class="nump">$ 86.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="num">(15.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Changes in unrealized holding gains and losses on available-for-sale securities, net of tax of $0.2 and $1.5 for the three months December 30, 2017 and December 31, 2016:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statements of income</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in pension plans, net of taxes of $0.6 for the three months ended December 30, 2017</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Changes in value of hedged interest rate caps, net of tax of $(4.9) and $0.5 for the three months ended December 30, 2017 and December 31, 2016:</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statements of income</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="num">(10.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 411.2<span></span>
</td>
<td class="nump">$ 76.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e557-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569643-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41638-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6821932144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Changes in unrealized holding gains and losses on available-for-sale securities. tax</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent', window );">Changes in pension plans, tax</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Changes in value of hedged interest rate caps, tax</a></td>
<td class="num">$ (4.9)<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e,f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6835361168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 664.4<span></span>
</td>
<td class="nump">$ 540.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less reserves of $11.5 and $9.8, respectively</a></td>
<td class="nump">548.0<span></span>
</td>
<td class="nump">533.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">358.2<span></span>
</td>
<td class="nump">331.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">22.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">53.5<span></span>
</td>
<td class="nump">50.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,638.4<span></span>
</td>
<td class="nump">1,478.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">467.1<span></span>
</td>
<td class="nump">472.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">2,681.3<span></span>
</td>
<td class="nump">2,772.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,176.7<span></span>
</td>
<td class="nump">3,171.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">84.8<span></span>
</td>
<td class="nump">84.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">8,048.3<span></span>
</td>
<td class="nump">7,979.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">572.1<span></span>
</td>
<td class="nump">1,150.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">160.3<span></span>
</td>
<td class="nump">166.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">412.7<span></span>
</td>
<td class="nump">375.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">163.2<span></span>
</td>
<td class="nump">171.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital lease obligations</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,309.9<span></span>
</td>
<td class="nump">1,865.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,757.7<span></span>
</td>
<td class="nump">2,172.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Capital lease obligations, net of current portion</a></td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNoncurrent', window );">Deferred income tax liabilities</a></td>
<td class="nump">586.4<span></span>
</td>
<td class="nump">973.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">18.8<span></span>
</td>
<td class="nump">20.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">159.2<span></span>
</td>
<td class="nump">140.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 7)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 288,750 and 287,853 shares issued, respectively</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,628.9<span></span>
</td>
<td class="nump">5,630.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,976.0)<span></span>
</td>
<td class="num">(2,382.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 12,560 shares</a></td>
<td class="num">(450.1)<span></span>
</td>
<td class="num">(450.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="num">(16.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">3,194.0<span></span>
</td>
<td class="nump">2,784.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 8,048.3<span></span>
</td>
<td class="nump">$ 7,979.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84164758&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84164817&amp;loc=d3e45280-112737<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84164758&amp;loc=d3e45023-112735<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82911808&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The noncurrent portion of deferred revenue amount as of balance sheet date. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized, and is not expected to be recognized in the next twelve months. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6935-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(c).Q3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3(b).Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31958-109318<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84176650&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5865-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6787-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834239680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, reserves</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 9.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,623,000<span></span>
</td>
<td class="nump">1,623,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">288,750,000<span></span>
</td>
<td class="nump">287,853,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">12,560,000<span></span>
</td>
<td class="nump">12,560,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84173941&amp;loc=d3e5074-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834573648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 406.7<span></span>
</td>
<td class="nump">$ 86.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">27.0<span></span>
</td>
<td class="nump">20.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of acquired intangibles</a></td>
<td class="nump">94.2<span></span>
</td>
<td class="nump">94.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">8.7<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">16.4<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(390.7)<span></span>
</td>
<td class="num">(24.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="nump">21.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(23.3)<span></span>
</td>
<td class="num">(20.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">8.1<span></span>
</td>
<td class="num">(0.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(7.1)<span></span>
</td>
<td class="num">(17.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">48.9<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(10.6)<span></span>
</td>
<td class="num">(14.5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">169.1<span></span>
</td>
<td class="nump">169.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(4.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(10.2)<span></span>
</td>
<td class="num">(11.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(11.6)<span></span>
</td>
<td class="num">(13.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities', window );">Proceeds from sale of available-for-sale marketable securities</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other activity</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(26.2)<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(1,331.3)<span></span>
</td>
<td class="num">(18.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt', window );">Proceeds from long-term debt</a></td>
<td class="nump">1,500.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization', window );">Repayment of amounts borrowed under accounts receivable securitization program</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from senior notes</a></td>
<td class="nump">350.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payments to extinguish convertible notes</a></td>
<td class="num">(296.9)<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from amounts borrowed under revolving credit line</a></td>
<td class="nump">495.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayments of amounts borrowed under revolving credit line</a></td>
<td class="num">(720.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(11.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock pursuant to employee stock plans</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Payments under capital lease obligations</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(14.3)<span></span>
</td>
<td class="num">(16.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(20.3)<span></span>
</td>
<td class="num">(40.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">123.8<span></span>
</td>
<td class="nump">97.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">540.6<span></span>
</td>
<td class="nump">548.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 664.4<span></span>
</td>
<td class="nump">$ 646.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based compensation arrangement. Issuance includes, but is not limited to, exercise of stock options and similar instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from other long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of debt and equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=82896770&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825462448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). These financial statements should be read in conjunction with the consolidated financial statements and related notes for the year ended </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;21, 2017. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending </font><font style="font-family:inherit;font-size:10pt;">September&#160;29, 2018</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 22, 2017, the Company completed the acquisition of Cynosure, Inc. ("Cynosure"), which resulted in the Company expanding into the medical aesthetics market. Cynosure develops, manufactures and markets aesthetic treatment systems that enable medical practitioners to perform non-invasive and minimally invasive procedures. Cynosure's results of operations are reported within the Company's Medical Aesthetics reportable segment. The Company's acquisition of Cynosure is more fully described in Note 3.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In December 2016, the FASB issued Accounting Standards Update No. 2016-19, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Technical Corrections and Improvements</font><font style="font-family:inherit;font-size:10pt;"> (ASU 2016-19). This guidance changes how companies classify internal-use software from classification within property, plant, and equipment to intangible assets. The amendments in the update are effective for annual periods beginning after December 15, 2016, and were applicable to the Company in fiscal 2018. The Company adopted ASU 2016-19 in the first quarter of fiscal 2018. As a result of the adoption, the Company has reclassified </font><font style="font-family:inherit;font-size:10pt;">$17.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$18.4 million</font><font style="font-family:inherit;font-size:10pt;"> of internal-use software from property, plant, and equipment to intangible assets as of December 30, 2017 and September 30, 2017, respectively. Additionally, the Company reclassified </font><font style="font-family:inherit;font-size:10pt;">$12.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$12.3 million</font><font style="font-family:inherit;font-size:10pt;"> of capitalized software embedded in its products from other assets to intangible assets as of December 30, 2017 and September 30, 2017, respectively.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Subsequent Events Consideration</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events recorded in the unaudited consolidated financial statements as of and for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">. On  January 19, 2018, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of senior notes, allocated between (i) </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;"> of its </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2025 (the &#8220;New 2025 Senior Notes&#8221;) at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2025 Senior Notes, plus accrued and unpaid interest from October 10, 2017, and (ii) </font><font style="font-family:inherit;font-size:10pt;">$400 million</font><font style="font-family:inherit;font-size:10pt;"> of its new </font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2028 (the "2028 Senior Notes," and together with the New 2025 Senior Notes, the "New Notes") at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2028 Senior Notes. In connection with the offering of the New Notes, the Company has called all of its outstanding </font><font style="font-family:inherit;font-size:10pt;">5.250%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2022 (the "2022 Senior Notes"), in aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. </font></div><div style="line-height:174%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, on January 29, 2018, the Company announced that pursuant to the terms of the indenture for the </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due 2042 (the &#8220;2042 Notes&#8221;), holders of the 2042 Notes had the option of requiring the Company to repurchase their 2042 Notes on March 1, 2018 at a repurchase price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the put date. The Company also announced on January 29, 2018 that it had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the redemption date. Holders also have a right to convert their 2042 Notes. In connection with holders&#8217; right to convert the 2042 Notes, the Company announced that it would settle all conversions of 2042 Notes entirely in cash. </font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819450128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has investments in derivative instruments consisting of interest rate caps and forward foreign currency contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of the Company's interest rate caps and forward foreign currency contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 6 for further discussion and information on the interest rate caps and forward foreign currency contracts. </font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a payment obligation to the participants under its Nonqualified Deferred Compensation Plan (&#8220;DCP&#8221;). This liability is recorded at fair value based on the underlying value of certain hypothetical investments under the DCP as designated by each participant for their benefit. Since the value of the DCP obligation is based on market prices, the liability is classified within Level 1. </font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value at Reporting Date Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance as of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;Prices&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active&#160;Market&#160;for</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical&#160;Assets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs&#160;(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs&#160;(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap - derivative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets consist of cost-method equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements for the three months ended December 30, 2017 and December 31, 2016.</font></div><div style="line-height:120%;padding-top:24px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Disclosure of Fair Value of Financial Instruments</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, interest rate caps, forward foreign currency contracts, insurance contracts, DCP liability, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate caps and forward foreign currency contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value, and the related DCP liability is recorded at fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts outstanding under the Company&#8217;s Amended and Restated Credit Agreement and Securitization Program of </font><font style="font-family:inherit;font-size:10pt;">$1.6 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal, respectively, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2022 Senior Notes and 2025 Senior Notes had a fair value of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$358.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> based on their trading prices, representing a Level 1 measurement. The fair values of the Company&#8217;s Convertible Notes were based on the trading prices of the respective notes and represents a Level 1 measurement. Refer to Note 5 for the carrying amounts of the various components of the Company&#8217;s debt.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated fair values of the Company&#8217;s Convertible Notes at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:83%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2042 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2043 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825467264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Combinations</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cynosure Inc.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On March 22, 2017, the Company completed the acquisition of Cynosure and acquired all of the outstanding shares of Cynosure. Each share of common stock of Cynosure outstanding immediately prior to the effective time of the acquisition was canceled and converted into the right to receive </font><font style="font-family:inherit;font-size:10pt;">$66.00</font><font style="font-family:inherit;font-size:10pt;"> in cash. In addition, all outstanding restricted stock units, performance stock units, and stock options were canceled and converted into the right to receive </font><font style="font-family:inherit;font-size:10pt;">$66.00</font><font style="font-family:inherit;font-size:10pt;"> per share in cash less the applicable exercise price, as applicable. The acquisition was funded through available cash, and the total purchase price was </font><font style="font-family:inherit;font-size:10pt;">$1.66 billion</font><font style="font-family:inherit;font-size:10pt;">. The Company incurred </font><font style="font-family:inherit;font-size:10pt;">$18.8 million</font><font style="font-family:inherit;font-size:10pt;"> of transaction costs, which were recorded within general and administrative expenses. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cynosure, headquartered in Westford, Massachusetts, develops, manufactures, and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women&#8217;s health. Cynosure also markets radiofrequency (RF) energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure's results of operations are reported in the Company's Medical Aesthetics reportable segment from the date of acquisition and the goodwill within this reportable segment is solely related to Cynosure.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total purchase price was allocated to Cynosure&#8217;s preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of March 22, 2017, as set forth below. The preliminary purchase price allocation is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.5390625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets and liabilities, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">736.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Distribution agreement</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(315.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">683.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase Price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,657.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Cynosure&#8217;s business. The Company has not yet obtained all of the information related to the fair value of the acquired assets and liabilities, primarily taxes, to finalize the purchase price allocation.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As part of the preliminary purchase price allocation, the Company has determined the identifiable intangible assets are developed technology, in-process research and development ("IPR&amp;D"), a distribution agreement, customer relationships, and trade names. The preliminary fair value of the intangible assets has been estimated using the income approach, and the cash flow projections were discounted using rates ranging from </font><font style="font-family:inherit;font-size:10pt;">11%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">12%</font><font style="font-family:inherit;font-size:10pt;">, except for the IPR&amp;D assets in which the Company used a range of </font><font style="font-family:inherit;font-size:10pt;">14%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;">. The cash flows are based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The developed technology assets are comprised of know-how, patents and technologies embedded in Cynosure's products and relate to currently marketed products. The developed technology assets primarily comprise the significant product families of Cynosure, primarily SculpSure, Icon, and PicoSure.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">IPR&amp;D projects relate to in-process projects that have not reached technological feasibility as of the acquisition date and have no alternative future use. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying project or expected commercial release depending on the project. The Company recorded, on a preliminary basis, </font><font style="font-family:inherit;font-size:10pt;">$107.0 million</font><font style="font-family:inherit;font-size:10pt;"> of IPR&amp;D related to </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> projects, which were expected to be completed during fiscal 2018 and 2019 with a preliminary cost to complete of approximately </font><font style="font-family:inherit;font-size:10pt;">$18.0 million</font><font style="font-family:inherit;font-size:10pt;">. During the fourth quarter of fiscal 2017, the Company obtained regulatory approval for </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> projects with an aggregate fair value of </font><font style="font-family:inherit;font-size:10pt;">$61.0 million</font><font style="font-family:inherit;font-size:10pt;"> and these assets were reclassified to developed technology. The remaining project is expected to be completed during fiscal 2019 with an estimated cost to complete of approximately </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">. Given the uncertainties inherent with product development and introduction, there can be no assurance that any of the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. All of the IPR&amp;D assets were valued using the multiple-period excess earnings method approach.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The distribution agreement intangible asset relates to Cynosure's exclusive distribution rights for the MonaLisa Touch device in certain geographic regions. The customer relationships intangible asset pertains to Cynosure's relationships with its end customers and related service arrangements and distributors throughout the world. Trade names relate to the Cynosure corporate name and primary product names, and the Company used the Relief-from-Royalty Method to estimate the fair value of this asset.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology, distribution agreement, customer relationships and trade names are being amortized on a straight-line basis over a weighted average period of </font><font style="font-family:inherit;font-size:10pt;">11.8</font><font style="font-family:inherit;font-size:10pt;"> years, </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;"> years, </font><font style="font-family:inherit;font-size:10pt;">7.7</font><font style="font-family:inherit;font-size:10pt;"> years and </font><font style="font-family:inherit;font-size:10pt;">8.9</font><font style="font-family:inherit;font-size:10pt;"> years, respectively. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill are based on several strategic and synergistic benefits that are expected to be realized from the Cynosure acquisition. These benefits include the expectation that the Company's entry into the aesthetics market will significantly broaden the Company's offering in women's health. The combined company is expected to benefit from a broader global presence, synergistic utilization of Hologic's direct sales force, primarily its GYN Surgical sales force, with certain Cynosure products, and the Company's entry into an adjacent cash-pay segment. None of the goodwill is expected to be deductible for income tax purposes. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In fiscal 2017, Cynosure's revenue and pre-tax loss, which excludes acquisition expenses incurred by the Company, for the period from the acquisition date to September 30, 2017 were </font><font style="font-family:inherit;font-size:10pt;">$207.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$96.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The pre-tax loss includes amortization expense, the impact of the step-up in inventory, retention and integration expenses including legal and consulting fees, and restructuring charges. The following unaudited pro forma information presents the combined financial results for the Company and Cynosure as if the acquisition of Cynosure had been completed at the beginning of the prior fiscal year, September 26, 2015 (fiscal 2016):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.34375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited pro forma information for the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> December 31, 2016 (the first quarter of fiscal 2017) was calculated after applying the Company's accounting policies and the impact of acquisition date fair value adjustments. The pro forma condensed consolidated financial results have been prepared for comparative purposes only and include certain adjustments to reflect pro forma results of operations as if the acquisition occurred on September 27, 2015 (the beginning of fiscal 2016), such as increased amortization for the fair value of acquired intangible assets. The pro forma information does not reflect the effect of costs or synergies that would have been expected to result from the integration of the acquisition. The pro forma information does not purport to be indicative of the results of operations that actually would have resulted had the combination occurred at the beginning of the period presented, or of future results of the consolidated entities. </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Medicor Medical Supply</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On April 7, 2017, the Company completed the acquisition of MMS Medicor Medical Supplies GmbH ("Medicor") for a purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$19.0 million</font><font style="font-family:inherit;font-size:10pt;">, which includes a working capital adjustment of </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;"> that was paid in the fourth quarter of fiscal 2017, and a holdback of </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> that is payable </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> years from the date of acquisition. Medicor was a long-standing distributor of the Company's Breast and Skeletal Health products in Germany, Austria and Switzerland. Based on the Company's preliminary valuation, it has allocated </font><font style="font-family:inherit;font-size:10pt;">$5.4 million</font><font style="font-family:inherit;font-size:10pt;"> of the purchase price to the preliminary value of intangible assets, which have a weighted average life of </font><font style="font-family:inherit;font-size:10pt;">7.7</font><font style="font-family:inherit;font-size:10pt;"> years, and </font><font style="font-family:inherit;font-size:10pt;">$8.9 million</font><font style="font-family:inherit;font-size:10pt;"> to goodwill. The remaining </font><font style="font-family:inherit;font-size:10pt;">$4.7 million</font><font style="font-family:inherit;font-size:10pt;"> of purchase price has been allocated to the acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Emsor, S.A.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On December 11, 2017, the Company completed the acquisition of Emsor S.A. ("Emsor") for a purchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;">, which includes a holdback of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> that is payable </font><font style="font-family:inherit;font-size:10pt;">eighteen</font><font style="font-family:inherit;font-size:10pt;"> months from the date of acquisition, and contingent consideration which the Company has estimated at </font><font style="font-family:inherit;font-size:10pt;">$2.0 million</font><font style="font-family:inherit;font-size:10pt;">. The contingent consideration is payable upon Emsor achieving predefined amounts of cumulative revenue over a </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> year period from the date of acquisition. Emsor was a distributor of the Company's Breast and Skeletal Health products in Spain and Portugal. Based on the Company's preliminary valuation, it has allocated </font><font style="font-family:inherit;font-size:10pt;">$2.8 million</font><font style="font-family:inherit;font-size:10pt;"> of the purchase price to the preliminary value of intangible assets and </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> to goodwill. The remaining </font><font style="font-family:inherit;font-size:10pt;">$6.8 million</font><font style="font-family:inherit;font-size:10pt;"> of purchase price has been allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819377024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring Charges</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Restructuring Charges</font></div><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluates its operations for opportunities to improve operational effectiveness and efficiency, including facility and operations consolidation, and to better align expenses with revenues. In addition, the Company continually assesses its management and organizational structure. As a result of these assessments, the Company has undertaken various restructuring actions, which are described below. The following table displays charges related to these actions recorded in the fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> year to date period (</font><font style="font-family:inherit;font-size:10pt;">three months ended December 30, 2017</font><font style="font-family:inherit;font-size:10pt;">) and fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> (the year ended September 30, 2017) and a rollforward of the accrued balances from </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2018 Actions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2017 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2016 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Restructuring Charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2017 charges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workforce reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Facility closure costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2017 restructuring charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 charges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workforce reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 restructuring charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.5703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2018 Actions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2017 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2016 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Rollforward of Accrued Restructuring</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of September 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Severance payments and adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal 2018 Actions</font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">During the first quarter of fiscal 2018, the Company decided to terminate certain employees across the organization, including a corporate executive and sales and marketing personnel in its Diagnostics and Medical Aesthetics reportable segments. The charges were recorded pursuant to ASC 712, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation-Nonretirement Postemployment Benefits </font><font style="font-family:inherit;font-size:10pt;">(ASC 712) or ASC 420, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Exit or Disposal Cost Obligations </font><font style="font-family:inherit;font-size:10pt;">(ASC 420) depending on the employee. As such, the Company recorded severance and benefits charges of </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;"> in the first quarter. Included within this charge is </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> related to the modification of equity awards.</font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal 2017 Actions</font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In connection with its acquisition of Cynosure, the Company decided to terminate certain Cynosure executives in the second quarter of fiscal 2017 and recorded </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> in severance and benefits charges. During the third and fourth quarters of fiscal 2017, the Company terminated additional executives and employees and recorded </font><font style="font-family:inherit;font-size:10pt;">$4.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, in severance and benefits charges. </font></div><div style="line-height:120%;padding-top:24px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fiscal 2016 Actions</font></div><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;"></font><font style="font-family:inherit;font-size:10pt;">In connection with the closure of the Bedford, Massachusetts facility, during the first quarter of fiscal 2017 the Company recorded </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> for lease obligation charges related to a section of the facility that the Company had determined met the cease-use date criteria. The Company made certain assumptions regarding the time period it would take to obtain a subtenant and the sublease rates it can obtain. During the third quarter of fiscal 2017, the Company updated its assumption regarding the time period it will take to obtain a subtenant at the Bedford location and as a result recorded an additional </font><font style="font-family:inherit;font-size:10pt;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> lease obligation charge. These estimates may vary from the actual sublease agreements executed, if at all, resulting in an adjustment to the charge. The Company has vacated other portions of the building but not the entire facility, and at this time does not meet the cease-use date criteria to record additional restructuring charges.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825418624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Borrowings and Credit Arrangements</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s borrowings consisted of the following:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current debt obligations, net of debt discount and deferred issuance costs:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolver</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securitization Program</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current debt obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,150.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt obligations, net of debt discount and deferred issuance costs:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,430.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022 Senior Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">982.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">981.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2025 Senior Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,757.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,172.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt obligations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,329.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,322.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amended and Restated Credit Agreement</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 3, 2017, the Company and certain of its domestic subsidiaries entered into an Amended and Restated Credit and Guaranty Agreement (the "Amended and Restated Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto. The Amended and Restated Credit Agreement amends and restates the Company's prior credit and guaranty agreement, originally dated as of May 29, 2015 (the "Prior Credit Agreement"). The proceeds under the Amended and Restated Credit Agreement of </font><font style="font-family:inherit;font-size:10pt;">$1.8 billion</font><font style="font-family:inherit;font-size:10pt;"> were used, among other things, to pay off the Term Loan of </font><font style="font-family:inherit;font-size:10pt;">$1.32 billion</font><font style="font-family:inherit;font-size:10pt;"> and the Revolver then outstanding under the Company's Prior Credit Agreement. Borrowings under the Amended and Restated Credit Agreement are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company's U.S. subsidiaries, with certain exceptions.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The credit facilities (the &#8220;Amended and Restated Credit Facilities&#8221;) under the Amended and Restated Credit Agreement consist of:</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A </font><font style="font-family:inherit;font-size:10pt;">$1.5 billion</font><font style="font-family:inherit;font-size:10pt;"> secured term loan to the Company ("Amended Term Loan") with a maturity date of October 3, 2022; and </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A secured revolving credit facility (the "Amended Revolver") under which the the Company may borrow up to </font><font style="font-family:inherit;font-size:10pt;">$1.5 billion</font><font style="font-family:inherit;font-size:10pt;">, subject to certain sublimits, with a maturity date of October 3, 2022.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At the closing, the Company borrowed </font><font style="font-family:inherit;font-size:10pt;">$345 million</font><font style="font-family:inherit;font-size:10pt;"> under the Amended Revolver, which was fully repaid during October 2017. As of December 30, 2017, the Company had </font><font style="font-family:inherit;font-size:10pt;">$120.0 million</font><font style="font-family:inherit;font-size:10pt;"> outstanding under the Amended Revolver. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings under the Amended and Restated Credit Facilities bear interest, at the Company's option and in each case plus an applicable margin as follows: </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amended Term Loan</font><font style="font-family:inherit;font-size:10pt;">: at the Base Rate, Eurocurrency Rate or LIBOR Daily Floating Rate (as defined in the Amended and Restated Credit Agreement),&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Amended Revolver</font><font style="font-family:inherit;font-size:10pt;">: if funded in U.S. dollars, the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate, and, if funded in an alternative currency, the Eurocurrency Rate; and if requested under the swing line sublimit, the Base Rate.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The applicable margin to the Base Rate, Eurocurrency Rate, or LIBOR Daily Floating Rate is subject to specified changes depending on the total net leverage ratio as defined in the Amended and Restated Credit Agreement. The borrowings of the Amended Term Loan initially bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate equal to </font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;">. The borrowings of the Amended Revolver initially bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to </font><font style="font-family:inherit;font-size:10pt;">1.50%</font><font style="font-family:inherit;font-size:10pt;">. The Company is also required to pay a quarterly commitment fee calculated on the undrawn committed amount available under the Amended Revolver.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is required to make scheduled principal payments under the Amended Term Loan in increasing amounts ranging from </font><font style="font-family:inherit;font-size:10pt;">$9.375 million</font><font style="font-family:inherit;font-size:10pt;"> per </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-month period commencing with the three-month period ending on December&#160;29, 2017 to </font><font style="font-family:inherit;font-size:10pt;">$37.5 million</font><font style="font-family:inherit;font-size:10pt;"> per three-month period commencing with the three-month period ending on December&#160;23, 2021. The remaining balance of the Amended Term Loan and any amounts outstanding under the Amended Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the Amended and Restated Credit Agreement, the Company is required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by the Company,&#160;first, to the Amended Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans (as defined in the Amended and Restated Credit Agreement),&#160;third,&#160;to the Amended Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit (as defined in the Amended and Restated Credit Agreement) and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the Amended and Restated Credit Facilities without premium or penalty.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings outstanding under the Amended and Restated Credit Agreement and the Prior Credit Agreement for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> had weighted-average interest rates of </font><font style="font-family:inherit;font-size:10pt;">2.75%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2.05%</font><font style="font-family:inherit;font-size:10pt;">, respectively. The interest rate on the outstanding Amended Term Loan borrowing at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">3.07%</font><font style="font-family:inherit;font-size:10pt;">. Interest expense under the Amended and Restated Credit Agreement aggregated </font><font style="font-family:inherit;font-size:10pt;">$12.4 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, which includes non-cash interest expense of </font><font style="font-family:inherit;font-size:10pt;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> related to the amortization of the deferred issuance costs and accretion of the debt discount. Interest expense under the Prior Credit Agreement aggregated </font><font style="font-family:inherit;font-size:10pt;">$9.8 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, which includes </font><font style="font-family:inherit;font-size:10pt;">$1.1 million</font><font style="font-family:inherit;font-size:10pt;"> of non-cash interest expense related to the amortization of the deferred issuance costs and accretion of the debt discount.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Amended and Restated Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting the ability of the Company, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the Amended and Restated Credit Agreement requires the the Company to maintain certain financial ratios. The Amended and Restated Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the Company.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company, with certain exceptions. For example, borrowings under the Amended and Restated Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program. The Amended and Restated Credit Agreement contains total net leverage ratio and interest coverage ratio financial covenants measured as of the last day of each fiscal quarter and an excess cash flow prepayment requirement measured as of the end of each fiscal year. The total net leverage ratio was </font><font style="font-family:inherit;font-size:10pt;">5.00</font><font style="font-family:inherit;font-size:10pt;">:1.00 beginning on the Company's fiscal quarter ended December 30, 2017, and then decreases over time to </font><font style="font-family:inherit;font-size:10pt;">4.50</font><font style="font-family:inherit;font-size:10pt;">:1.00 for the quarter ending March 27, 2021. The interest coverage ratio was </font><font style="font-family:inherit;font-size:10pt;">3.75</font><font style="font-family:inherit;font-size:10pt;">:1.00 beginning on the Company's fiscal quarter ended December 30, 2017, and remains as such for each quarter thereafter. The total net leverage ratio is defined as the ratio of the Company's consolidated net debt as of the quarter end to its consolidated adjusted EBITDA (as defined in the Amended and Restated Credit Agreement) for the </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;">-fiscal quarter period ending on the measurement date. The interest coverage ratio is defined as the ratio of the Company's consolidated adjusted EBITDA for the prior four-fiscal quarter period ending on the measurement date to adjusted consolidated cash interest expense (as defined in the Amended and Restated Credit Agreement) for the same measurement period. The Company was in compliance with these covenants as of December 30, 2017.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company evaluated the Amended and Restated Credit Agreement for derivatives pursuant to ASC 815, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives and Hedging</font><font style="font-family:inherit;font-size:10pt;">, and identified embedded derivatives that required bifurcation as the features are not clearly and closely related to the host instrument. The embedded derivatives were a default provision, which could require additional interest payments, and a provision requiring contingent payments to compensate the lenders for changes in tax deductions. The Company determined that the fair value of these embedded derivatives was nominal as of December 30, 2017.</font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to ASC 470, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt </font><font style="font-family:inherit;font-size:10pt;">(ASC 470), the accounting for the Amended and Restated Credit Agreement was evaluated on a creditor-by-creditor basis with regard to the Amended and Restated Credit Agreement to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the Amended and Restated Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> in the first quarter of fiscal 2018 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification because on a creditor-by-creditor basis the present value of the cash flows between the two debt instruments before and after the transaction was less than </font><font style="font-family:inherit;font-size:10pt;">10%</font><font style="font-family:inherit;font-size:10pt;">. Pursuant to ASC 470, subtopic 50-40, third-party costs of </font><font style="font-family:inherit;font-size:10pt;">$1.7 million</font><font style="font-family:inherit;font-size:10pt;"> related to this transaction were recorded as interest expense and </font><font style="font-family:inherit;font-size:10pt;">$4.9 million</font><font style="font-family:inherit;font-size:10pt;"> was recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2025 Senior Notes</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October&#160;10, 2017, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$350 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of its </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2025 (the &#8220;2025 Senior Notes&#8221;) at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2025 Senior Notes. The 2025 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &#8220; 2025 Domestic Guarantors&#8221;).</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2025 Senior Notes mature on October&#160;15, 2025 and bear interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year, payable semi-annually on April&#160;15 and October&#160;15 of each year, commencing on April&#160;15, 2018. The Company recorded interest expense of </font><font style="font-family:inherit;font-size:10pt;">$3.5 million</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended December 30, 2017 which includes non-cash interest expense of </font><font style="font-family:inherit;font-size:10pt;">$0.1 million</font><font style="font-family:inherit;font-size:10pt;"> related to the amortization of the deferred issuance costs and accretion of the debt discount.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company may redeem the 2025 Senior Notes at any time prior to October 15, 2020 at a price equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2025 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before October&#160;15, 2020, at a redemption price equal to </font><font style="font-family:inherit;font-size:10pt;">104.375%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2025 Senior Notes on or after: October&#160;15, 2020 through October 14, 2021 at </font><font style="font-family:inherit;font-size:10pt;">102.188%</font><font style="font-family:inherit;font-size:10pt;"> of par; October 15, 2021 through October 14, 2022 at </font><font style="font-family:inherit;font-size:10pt;">101.094%</font><font style="font-family:inherit;font-size:10pt;"> of par; and October 15, 2022 and thereafter at </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the 2025 Indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2025 Senior Notes at a price equal to </font><font style="font-family:inherit;font-size:10pt;">101%</font><font style="font-family:inherit;font-size:10pt;"> of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 19, 2018, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of senior notes, which included </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;"> of additional </font><font style="font-family:inherit;font-size:10pt;">4.375%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2025 (the &#8220;New 2025 Senior Notes&#8221;), issued under a supplement to the 2025 Indenture. See &#8220;Subsequent Events&#8221; below.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2022 Senior Notes</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's </font><font style="font-family:inherit;font-size:10pt;">5.250%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2022 (the &#8220;2022 Senior Notes&#8221;) mature on July 15, 2022 and bear interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">5.250%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year, payable semi-annually on January 15 and July 15 of each year, commencing on January 15, 2016. The Company recorded interest expense of </font><font style="font-family:inherit;font-size:10pt;">$14.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$15.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and December 31, 2016, respectively, which includes non-cash interest expense of </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, related to the amortization of the deferred issuance costs and accretion of the debt discount.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the offering of the New 2025 Senior Notes and the Company&#8217;s </font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2028, the Company has called all of its outstanding 2022 Senior Notes, in the aggregate principal amount of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;">, for redemption on February 15, 2018 at an aggregate redemption price equal to the principal amount of the outstanding 2022 Senior Notes, plus the applicable premium and accrued and unpaid interest through the day immediately preceding the redemption date. See &#8220;Subsequent Events&#8221; below. </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On various dates during the first quarter of fiscal 2018, the Company entered into privately negotiated repurchase transactions and extinguished </font><font style="font-family:inherit;font-size:10pt;">$39.3 million</font><font style="font-family:inherit;font-size:10pt;"> principal amount of its </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due 2042 (the "2042 Notes") for total payments of </font><font style="font-family:inherit;font-size:10pt;">$52.8 million</font><font style="font-family:inherit;font-size:10pt;">. This amount includes the conversion premium resulting from the Company's stock price on the date of the transactions being in excess of the conversion prices of </font><font style="font-family:inherit;font-size:10pt;">$31.175</font><font style="font-family:inherit;font-size:10pt;">. As a result, on a gross basis, </font><font style="font-family:inherit;font-size:10pt;">$13.4 million</font><font style="font-family:inherit;font-size:10pt;"> of the consideration paid was allocated to the reacquisition of the equity component of the original instrument, which was recorded net of deferred taxes of </font><font style="font-family:inherit;font-size:10pt;">$3.8 million</font><font style="font-family:inherit;font-size:10pt;"> within additional paid-in-capital.</font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> On December 15, 2017, pursuant to the provisions of the indenture governing the Company's </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due December 15, 2043 (the "2043 Notes"),  the Company redeemed or repurchased an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$201.7 million</font><font style="font-family:inherit;font-size:10pt;"> in original principal amount of the 2043 Notes then outstanding for an aggregate repurchase price of approximately </font><font style="font-family:inherit;font-size:10pt;">$244.1 million</font><font style="font-family:inherit;font-size:10pt;">, representing the then accreted principal amount of the 2043 Notes. The remaining </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> in original principal amount of the 2043 Notes were converted, and the Company elected to settle these conversions, which will occur in the second quarter of fiscal 2018.</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The term "Convertible Notes" refers to the 2042 Notes and the 2043 Notes.</font></div><div style="line-height:120%;padding-top:24px;text-indent:36px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense under the Convertible Notes was as follows:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.859375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of deferred financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal accretion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00% accrued interest (cash)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Subsequent Events</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;">2025 Senior Notes and 2028 Senior Notes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">On January 19, 2018, the Company completed a private placement of </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amount of senior notes, allocated between (i) an additional </font><font style="font-family:inherit;font-size:10pt;">$600 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amounts of its 2025 Senior Notes pursuant to a supplement to the indenture governing the Company's existing 2025 Senior Notes, at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2025 Senior Notes, plus accrued and unpaid interest from October 10, 2017 and (ii)  </font><font style="font-family:inherit;font-size:10pt;">$400 million</font><font style="font-family:inherit;font-size:10pt;"> aggregate principal amounts of its </font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due 2028 (the "2028 Senior Notes") at an offering price of </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the aggregate principal amount of the 2028 Senior Notes. The new 2025 Senior Notes have the same terms as the existing 2025 Senior Notes. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries of Hologic (the &#8220;2028 Domestic Guarantors&#8221;).</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The 2028 Senior Notes were issued pursuant to an indenture (the &#8220;2028 Indenture&#8221;), dated as of January 19, 2018 among the Company, the 2028 Domestic Guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;</font><font style="font-family:inherit;font-size:10pt;">4.625%</font><font style="font-family:inherit;font-size:10pt;">&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year, commencing on August 1, 2018. The 2028 Indenture contains covenants which limit, among other things, the ability of the Company and the Guarantors to create liens and engage in certain sale and leaseback transactions. These covenants are subject to a number exceptions and qualifications.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the Indenture. The Company may also redeem up to&#160;</font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;">&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;</font><font style="font-family:inherit;font-size:10pt;">104.625%</font><font style="font-family:inherit;font-size:10pt;">&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;</font><font style="font-family:inherit;font-size:10pt;">102.312%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par; February 1, 2024 through February 1, 2025 at&#160;</font><font style="font-family:inherit;font-size:10pt;">101.541%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par; February 1, 2025 through February 1, 2026 at&#160;</font><font style="font-family:inherit;font-size:10pt;">100.770%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par; and February 1, 2026 and thereafter at&#160;</font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;">&#160;of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the 2028 Indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;</font><font style="font-family:inherit;font-size:10pt;">101%</font><font style="font-family:inherit;font-size:10pt;">&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">2042 Notes </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 29, 2018, the Company announced that pursuant to the terms of the indenture for the </font><font style="font-family:inherit;font-size:10pt;">2.00%</font><font style="font-family:inherit;font-size:10pt;"> Convertible Senior Notes due 2042 (the &#8220;2042 Notes&#8221;), holders of the 2042 Notes had the option of requiring the Company to repurchase their 2042 Notes on March 1, 2018 at a repurchase price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the put date. The accreted principal amount of the 2042 notes will be </font><font style="font-family:inherit;font-size:10pt;">$206.0 million</font><font style="font-family:inherit;font-size:10pt;"> as of the repurchase date. The Company also announced on January 29, 2018 that, it had elected to redeem, on March 6, 2018, all of the then outstanding 2042 Notes at a redemption price payable in cash equal to </font><font style="font-family:inherit;font-size:10pt;">100%</font><font style="font-family:inherit;font-size:10pt;"> of the accreted principal amount of the 2042 Notes, plus accrued and unpaid interest to, but not including the redemption date. Holders also have a right to convert their 2042 Notes. Based on a closing price of the Company&#8217;s common stock of </font><font style="font-family:inherit;font-size:10pt;">$42.75</font><font style="font-family:inherit;font-size:10pt;"> per share (the closing price for the Company&#8217;s common stock on December&#160;29, 2017), the conversion value for the outstanding 2042 notes would be </font><font style="font-family:inherit;font-size:10pt;">$1,371</font><font style="font-family:inherit;font-size:10pt;"> per </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> of original principal amount of the notes, or </font><font style="font-family:inherit;font-size:10pt;">$282.6 million</font><font style="font-family:inherit;font-size:10pt;"> in the aggregate. The conversion value of the notes would increase or decrease to the extent that the trading price of the Company&#8217;s common stock increases or decreases. The Company has elected to settle any conversion of the 2042 Notes entirely in cash.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819377024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Interest Rate Cap - Cash Flow Hedge</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense) in the Consolidated Statements of Income.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2015, the Company entered into separate interest rate cap agreements with multiple counter-parties to help mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 6). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for the interest rate cap agreements was </font><font style="font-family:inherit;font-size:10pt;">$13.2 million</font><font style="font-family:inherit;font-size:10pt;">, which was the initial fair value of the instruments recorded in the Company's financial statements. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During fiscal 2017, the Company entered into new separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for the interest rate cap agreements was </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;">, which was the initial fair value of the instruments recorded in the Company's financial statements. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Prior Credit Agreement and Amended and Restated Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on </font><font style="font-family:inherit;font-size:10pt;">$1.0 billion</font><font style="font-family:inherit;font-size:10pt;"> of principal, which ended on December 29, 2017 and which will end on December 30, 2018 for the interest rate cap agreements entered into in fiscal 2015 and fiscal 2017, respectively.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company determined that the existence of hedge ineffectiveness, if any, was immaterial, and all changes in the fair value of the interest rate caps were recorded in the Consolidated Statements of Comprehensive Income as a component of AOCI.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$2.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, was reclassified from AOCI to the Company&#8217;s Consolidated Statements of Income related to the interest rate cap agreements. The Company expects to similarly reclassify a loss of approximately </font><font style="font-family:inherit;font-size:10pt;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> from AOCI to the Consolidated Statements of Income in the next twelve months.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair value of these interest rate caps was </font><font style="font-family:inherit;font-size:10pt;">$5.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$4.8 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, respectively, and is included in Prepaid expenses and other current assets on the Company&#8217;s Consolidated Balance Sheet. Refer to Note 2 &#8220;Fair Value Measurements&#8221; above for related fair value disclosures.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Forward Foreign Currency Contracts</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company enters into forward foreign currency exchange contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company has not elected hedge accounting for any of the forward foreign currency contracts it has executed; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded net realized loss of </font><font style="font-family:inherit;font-size:10pt;">$0.2 million</font><font style="font-family:inherit;font-size:10pt;"> and a net realized gain of </font><font style="font-family:inherit;font-size:10pt;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, from settling forward foreign currency contracts and unrealized gains of </font><font style="font-family:inherit;font-size:10pt;">$1.5 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$8.4 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, on the mark-to-market for its outstanding forward foreign currency contracts. </font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro, UK Pound, Australian dollar, Canadian Dollar and Japanese Yen with an aggregate notional amount of </font><font style="font-family:inherit;font-size:10pt;">$157.4 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instrument Presentation</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative instruments designated as a cash flow hedge:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the unrealized gain recognized in AOCI related to the interest rate caps for the following reporting periods:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.8125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.53125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:30%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives not classified as hedging instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss) Recognized in Income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain (Loss) Recognized in Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819450128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-top:8px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Litigation and Related Matters</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On June&#160;9, 2010, Smith&#160;&amp; Nephew, Inc. ("Smith &amp; Nephew") filed suit against Interlace Medical, Inc. ("Interlace"), which the Company acquired on January&#160;6, 2011, in the United States District Court for the District of Massachusetts. The complaint alleged that the Interlace MyoSure hysteroscopic tissue removal device infringed U.S. patent 7,226,459 (the '459 patent). On November&#160;22, 2011, Smith&#160;&amp; Nephew filed suit against the Company in the United States District Court for the District of Massachusetts. The complaint alleged that use of the MyoSure tissue removal system infringed U.S. patent 8,061,359 (the '359 patent). Both complaints sought preliminary and permanent injunctive relief and unspecified damages. On September&#160;4, 2012, following a two week trial, the jury returned a verdict of infringement of both the '459 and '359 patents and assessed damages of  </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">.&#160;A two-day bench trial regarding the Company&#8217;s assertion of inequitable conduct on the part of Smith&#160;&amp; Nephew with regard to the '359 patent began on December&#160;10, 2012 and oral arguments on the issue of inequitable conduct were presented on February&#160;27, 2013. On June&#160;27, 2013, the Court denied the Company&#8217;s motions related to inequitable conduct and allowed Smith&#160;&amp; Nephew&#8217;s request for injunction, but ordered that enforcement of the injunction be stayed until final resolution, including appeal, of the current re-examinations of both patents at the United States Patent and Trademark Office (&#8220;USPTO&#8221;). The Court also rejected the jury&#8217;s damage award and ordered the parties to identify a mechanism for resolving the damages issue. The USPTO issued final decisions that the claims of the '459 and the '359 patents asserted as part of the litigation are not patentable, which decisions Smith &amp; Nephew appealed to the U.S. Patent Trial and Appeal Board ("PTAB"). In 2016, the PTAB (i) affirmed the USPTO decision with respect to the '459 patent, holding that the claims at issue are invalid, and (ii) reversed the USPTO decision with respect to the '359 patent, holding that the claims at issue are not invalid. The Company and Smith &amp; Nephew have appealed the decisions by the Patent Trial and Appeal Board on the '359 patent and the '459 patent, respectively, to the U.S. Court of Appeals for the Federal Circuit ("Court of Appeals"). Briefing on both appeals is completed. Oral arguments were held in the '459 patent appeal on October 24, 2017 and in the '359 patent appeal on December 7, 2017. On January 30, 2018, the Court of Appeals issued a decision in the '459 patent appeal that affirmed-in-part and reversed-in-part the PTAB ruling and remanded the matter to the PTAB for further proceedings. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On April 11, 2017, Minerva Surgical, Inc. (&#8220;Minerva&#8221;) filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including in lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2012, Enzo Life Sciences, Inc. ("Enzo") filed suit against the Company's subsidiary, Gen-Probe Incorporated ("Gen-Probe"), in the United States District Court for the District of Delaware, alleging that certain of Gen-Probe&#8217;s diagnostics products, including products that incorporate Gen-Probe&#8217;s hybridization protection assay technology (HPA), which include the Aptima line of products, infringe Enzo&#8217;s U.S. patent 6,992,180 (the '180 patent). On March&#160;6, 2012, Enzo filed suit against the Company in the United States District Court for the District of Delaware, alleging that products based on the Company's Invader chemistry platform, such as Cervista HPV HR and Cervista HPV 16/18, infringe the '180 patent. On July 16, 2012, Enzo amended its complaint to include additional products that include HPA or TaqMan reagent chemistry, including the Progensa, AccuProbe and Prodesse product lines. The Company counter-claimed for non-infringement, invalidity and unenforceability of the '180 patent. On September&#160;30, 2013, Enzo filed its infringement contentions which added products including "Torch" probes (e.g., MilliPROBE Real-Time Detection System for Mycoplasma), PACE and certain Procleix assays. Both complaints sought preliminary and permanent injunctive relief and unspecified damages. Summary judgment and Daubert motions were filed by the parties on December 15, 2016. A hearing on the summary judgment motions was held on April 4, 2017, and on June 28, 2017, the Court ruled that the '180 patent is invalid for nonenablement. Final judgment was entered on July 19, 2017, and on August 18, 2017, Enzo filed a notice of appeal with the Court of Appeals for the Federal Circuit. Enzo&#8217;s opening appeal brief was filed on November 28, 2017, and the Company&#8217;s responsive brief is due March 8, 2018. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 27, 2015, Enzo filed an additional suit against the Company in the United States District Court for the District of Delaware. The complaint alleges that certain additional Company molecular diagnostic products, including, inter alia, the Procleix Parvo/HAV assays and coagulation products, including the Invader Factor II test and the Invader Factor V test, also infringe the '180 patent. The complaint further alleged that certain of the Company&#8217;s molecular diagnostic products, including the Company&#8217;s Progensa PCA3, Aptima and Procleix products using target capture technology infringe Enzo&#8217;s U. S. Patent 7,064,197 (the '197 patent). On June 11, 2015, this matter was stayed pending the resolution of summary judgment motions in the other related suits involving the '197 patent. The litigation remains stayed. On March 30, 2016, Hologic filed two requests for inter partes review of the &#8216;197 patent at the USPTO. The USPTO instituted the two inter partes reviews on all challenged claims on October 4, 2016. Combined oral arguments for the two inter partes reviews were held on June 1, 2017. On September 28 and October 2, 2017, the PTAB issued final written decisions in the two inter partes reviews finding that all of the challenged claims of the &#8216;197 patent are unpatentable. In response to the final written decisions, Enzo filed notices of appeal on November 29, 2017, and the United States Court of Appeals for the Federal Circuit consolidated Enzo&#8217;s appeals on December 14, 2017. Enzo&#8217;s opening brief is due March 12, 2018. At this time, based on available information regarding this litigation and the related inter partes reviews, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On October 3, 2016, Enzo filed an additional suit against the Company in the United States District Court for the District of Delaware. The complaint alleges that all of the Company's Progensa PCA3, Aptima and Procleix products infringe U.S. Patent 6,221,581 (the '581 patent). On November 28, 2016, the Company filed an answer and counterclaims of non-infringement, invalidity and unenforceability. On June 30, 2017, Hologic filed its initial invalidity contentions, which provide support for finding that the asserted claims of the '581 patent are invalid based on anticipation, obviousness, lack of adequate written description and enablement, and indefiniteness. On August 31, 2017, the Company and Enzo filed supplemental invalidity charts and supplemental infringement charts, respectively. The parties filed their proposed claim constructions on September 28, 2017. The parties&#8217; claim construction briefs are due in April 2018. On October 4, 2017, the Company filed for inter partes review of the &#8216;581 patent with the USPTO based on Enzo&#8217;s asserted claims. Enzo filed its preliminary response on January 19, 2018. A decision on whether to institute inter partes review is expected in April 2018. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 3, 2017, bioM&#233;rieux, S.A. and bioM&#233;rieux, Inc. (collectively &#8220;bioM&#233;rieux&#8221;) filed suit against the Company in the United States District Court for the Middle District of North Carolina. The complaint alleged that the Company&#8217;s Aptima HIV-1 RNA Qualitative assay and Aptima HIV-1 Quant Dx assay, as well as products manufactured by the Company and sold to Grifols, S.A. and Grifols Diagnostic Solutions Inc. (&#8220;Grifols USA&#8221;) for resale under the names Procleix HIV-1/HCV assay, Procleix Ultrio assay, and Procleix Ultrio Plus assay, infringe U.S. Patent Nos. 8,697,352 and 9,074,262. On April 3, 2017, the Company and Grifols USA filed a Motion to dismiss asking the Court to dismiss the complaint in its entirety for bioM&#233;rieux&#8217;s failure to state a claim upon which relief can be granted. On June 9, 2017, Hologic and Grifols USA filed a supplemental motion to dismiss for improper venue. bioM&#233;rieux filed a response to the venue motion on June 30, 2017, and Hologic and Grifols USA responded by filing a brief in further support of their motion to dismiss for improper venue on July 14, 2017. On January 3, 2018, the district court judge for the Middle District of North Carolina granted the parties&#8217; consent motion to transfer the case to Delaware. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 27, 2016, plaintiff ARcare, Inc., individually and as putative representative of a purported nationwide class, filed a complaint against Cynosure.&#160; The plaintiff alleges that Cynosure violated the Telephone Consumer Protection Act by: (i) sending fax advertisements that did not comply with statutory and Federal Communications Commission requirements that senders provide recipients with certain information about how to opt out from receiving faxed advertisements in the future; and (ii) sending unsolicited fax advertisements.&#160;The complaint sought damages, declaratory and injunctive relief, and attorneys&#8217; fees on behalf of a purported class of all recipients of purported fax advertisements that the plaintiff alleges did not receive an adequate opt-out notice. On September 30, 2016, Cynosure answered the complaint and denied liability. On September 7, 2016, the plaintiff sent a demand letter seeking a class settlement for statutory damages under Massachusetts General Laws, Chapter 93A &#167; 9 (&#8220;Chapter 93A&#8221;). On October 7, 2016, Cynosure responded denying any liability under Chapter 93A, but offering the plaintiff statutory damages of $25 on an individual basis.&#160;In March 2017, Cynosure and ARcare entered into a settlement agreement, subject to court approval, which requires Cynosure to pay settlement compensation of </font><font style="font-family:inherit;font-size:10pt;">$8.5 million</font><font style="font-family:inherit;font-size:10pt;"> notwithstanding the number of claims filed.&#160;If approved, Cynosure would receive a full release from the settlement class concerning the conduct alleged in the complaint.&#160;As a result of the settlement agreement, Cynosure recorded a charge of </font><font style="font-family:inherit;font-size:10pt;">$9.2 million</font><font style="font-family:inherit;font-size:10pt;">, in the period ended December 31, 2016, which is still accrued on the Company's balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March&#160;17, 2017, a purported shareholder of Cynosure, Michael Guido, filed an action against Cynosure in the Court of Chancery of the State of Delaware pursuant to Section&#160;220 of the Delaware General Corporation Law seeking the production of certain books and records, including books and records related to the acquisition of Cynosure by Hologic. The action follows Cynosure&#8217;s rejection of Mr.&#160;Guido&#8217;s demand for these books and records on the ground that he had not met the requirements of the statute. In addition to books and records, the complaint seeks reasonable attorneys&#8217; fees. The Company filed an answer to the complaint on April 10, 2017. At this time, based on available information regarding this matter, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or range of estimates, of potential losses.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450, Contingencies. Legal costs are expensed as incurred.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825448000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net Income Per Share</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of basic and diluted share amounts is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">276,856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278,663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common stock equivalents from assumed exercise of stock options and stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,212</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incremental shares from Convertible Notes premium</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280,802</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284,224</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average anti-dilutive shares related to:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has outstanding Convertible Notes, and the principal balance and any conversion premium may be satisfied, at the Company&#8217;s option, by issuing shares of common stock, cash or a combination of shares and cash. The Company's current policy is that it will settle the principal balance of the Convertible Notes in cash. As such, the Company applies the treasury stock method to these securities and the dilution related to the conversion premium of the 2042 and 2043 Notes is included in the calculation of diluted weighted-average shares outstanding to the extent each issuance is dilutive based on the average stock price during each reporting period being greater than the conversion price of the respective Notes.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819295232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Stock-Based Compensation</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and marketing</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company granted </font><font style="font-family:inherit;font-size:10pt;">1.6 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.9 million</font><font style="font-family:inherit;font-size:10pt;"> stock options during the </font><font style="font-family:inherit;font-size:10pt;">three months ended</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, with weighted-average exercise prices of </font><font style="font-family:inherit;font-size:10pt;">$40.82</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$37.62</font><font style="font-family:inherit;font-size:10pt;">, respectively. There were </font><font style="font-family:inherit;font-size:10pt;">6.7 million</font><font style="font-family:inherit;font-size:10pt;"> options outstanding at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> with a weighted-average exercise price of </font><font style="font-family:inherit;font-size:10pt;">$31.20</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.2421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value of options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company granted </font><font style="font-family:inherit;font-size:10pt;">0.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.9 million</font><font style="font-family:inherit;font-size:10pt;"> restricted stock units (RSUs) during each of the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, with weighted-average grant date fair values of </font><font style="font-family:inherit;font-size:10pt;">$40.79</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$37.58</font><font style="font-family:inherit;font-size:10pt;"> per unit, respectively. As of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">2.0 million</font><font style="font-family:inherit;font-size:10pt;"> unvested RSUs outstanding with a weighted-average grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$37.72</font><font style="font-family:inherit;font-size:10pt;"> per unit. In addition, the Company granted </font><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;">0.4 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.1 million</font><font style="font-family:inherit;font-size:10pt;"> performance stock units (PSUs) during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively, to members of its senior management team, which have a weighted-average grant date fair value of </font><font style="font-family:inherit;font-size:10pt;">$40.86</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$37.64</font><font style="font-family:inherit;font-size:10pt;"> per unit, respectively. Each recipient of PSUs is eligible to receive between </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;"> of the target number of shares of the Company&#8217;s common stock at the end of </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;"> provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company is recognizing compensation expense ratably over the required service period based on its estimate of the number of shares that will vest. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted </font><font style="font-family:inherit;font-size:10pt;">0.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">0.1 million</font><font style="font-family:inherit;font-size:10pt;"> market based awards (MSUs) to its senior management team during the three months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">, respectively. Each recipient of MSUs is eligible to receive between </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">200%</font><font style="font-family:inherit;font-size:10pt;"> of the target number of shares of the Company&#8217;s common stock at the end of </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;"> based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at </font><font style="font-family:inherit;font-size:10pt;">$49.45</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$48.90</font><font style="font-family:inherit;font-size:10pt;"> per share using the Monte Carlo simulation model. The Company is recognizing compensation expense for the MSUs ratably over the service period.</font></div><div style="line-height:120%;padding-bottom:24px;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;">$37.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$98.4 million</font><font style="font-family:inherit;font-size:10pt;"> of unrecognized compensation expense related to stock options and stock units (comprised of RSUs and PSUs), respectively, to be recognized over a weighted-average period of </font><font style="font-family:inherit;font-size:10pt;">3.1</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2.1</font><font style="font-family:inherit;font-size:10pt;"> years, respectively.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -URI http://asc.fasb.org/subtopic&amp;trid=2208855<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825467264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Dispositions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Disposition</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Blood Screening Business</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">On December 14, 2016, the Company entered into a definitive agreement to sell the assets of its blood screening business to its long-time commercial partner, Grifols for a sales price of </font><font style="font-family:inherit;font-size:10pt;">$1.85 billion</font><font style="font-family:inherit;font-size:10pt;"> in cash, subject to adjustment based on an estimated closing amount of inventory. The divestiture was completed on January 31, 2017, and the Company received </font><font style="font-family:inherit;font-size:10pt;">$1.865 billion</font><font style="font-family:inherit;font-size:10pt;">. The sale resulted in a gain of </font><font style="font-family:inherit;font-size:10pt;">$899.7 million</font><font style="font-family:inherit;font-size:10pt;"> recorded in the second quarter of fiscal 2017 within operations in the Consolidated Statements of Income. As a result of this disposition and proceeds received, the Company recorded a tax obligation of </font><font style="font-family:inherit;font-size:10pt;">$649.5 million</font><font style="font-family:inherit;font-size:10pt;">, which was paid in fiscal 2017. Upon the closing of the transaction, the Company's existing collaboration agreement with Grifols terminated, and a new collaboration agreement was executed as part of this transaction pursuant to which the Company provides certain research and development services to Grifols. In addition, the Company agreed to provide transition services to Grifols over the next </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years depending on the nature of the respective service, including the manufacture of inventory. The Company also agreed to sell Panther instrumentation and certain supplies to Grifols as part of a long term supply agreement. In determining the accounting for the multiple elements of the overall arrangement, the Company allocated </font><font style="font-family:inherit;font-size:10pt;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;"> of the proceeds to these elements based on their estimated fair values. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company determined this disposal did not qualify to be reported as a discontinued operation as the blood screening business was deemed not to be strategic to the Company and has not had and will not have a major effect on the Company's operations and financial results. Under the previous collaboration agreement, the Company performed research and development activities and manufacturing, while Grifols performed the commercial and distribution activities. The blood screening business was embedded within the Company's molecular diagnostics business, and the Company retains ownership and will continue to use the intellectual property for the underlying technology of its molecular diagnostics assays and instrumentation.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income from operations of the disposed business presented below represents the pretax profit of the business as it was operated prior to the date of disposition. The operating expenses include only those that were incurred directly by and were retained by the disposed business and are now incurred by Grifols. As noted above, the Company is performing a number of transition services and the financial impact from these services are not included in income from operations presented below. The Company is in effect serving as a contract manufacturer of assays for Grifols for a two to three year period from the date of disposal. Revenue and income from operations of the disposed business for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> month period ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$65.2 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$28.6 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Under the long term supply agreement, transition services agreement to manufacture assays and research and development services, the Company recorded revenue of </font><font style="font-family:inherit;font-size:10pt;">$12.6 million</font><font style="font-family:inherit;font-size:10pt;"> for the three months ended December 30, 2017.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6668039920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock', window );">Other Balance Sheet Information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Balance Sheet Information</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">331.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, plant and equipment</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment under customer usage agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and improvements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less &#8211; accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(576.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(553.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">467.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Details of certain balance sheet accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DetailsOfCertainBalanceSheetAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819450128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business Segments and Geographic Information</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> reportable segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical and Skeletal Health. Certain reportable segments represent an aggregation of operating units within each segment. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, acquisition related fair value adjustments and integration expenses, restructuring, divestiture and facility consolidation charges and other one-time or unusual items.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets for the </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> principal operating segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> reportable segments. The Company has presented all other identifiable assets as corporate assets. There were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> inter-segment revenues during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Segment information is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">288.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from operations:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,583.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,621.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">824.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,751.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,477.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,494.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,396.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,262.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,048.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,979.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> customers that represented greater than 10% of consolidated revenues during the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">December&#160;31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company operates in the following major geographic areas as noted in the below chart. Revenue data is based upon customer location. Other than the United States, </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, Germany and the United Kingdom. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of World&#8221; designation includes Canada, Latin America and the Middle East.</font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues by geography as a percentage of total revenues were as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:24px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia-Pacific</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of World</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6647387664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Taxes</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with ASC 740, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes</font><font style="font-family:inherit;font-size:10pt;"> (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">(324.5)%</font><font style="font-family:inherit;font-size:10pt;"> compared to </font><font style="font-family:inherit;font-size:10pt;">25.5%</font><font style="font-family:inherit;font-size:10pt;">  for the corresponding period in the prior year. The benefit recorded in the current quarter is primarily due to the impact of the Tax Cuts and Jobs Act (the "Act") enacted on December 22, 2017. As a result of this law, US corporations are subject to lower income tax rates, and the Company is required to remeasure its US net deferred tax liabilities at a lower rate, resulting in a net benefit of </font><font style="font-family:inherit;font-size:10pt;">$355.2 million</font><font style="font-family:inherit;font-size:10pt;"> recorded in the provision for income taxes. Partially offsetting this benefit, the Company recorded a charge of </font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;"> for transition taxes related to the deemed repatriation of foreign earnings. For the current quarter, in addition to the items noted, the effective tax rate was lower than the statutory tax rate primarily due to the impact of earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit. For the three months ended December 31, 2016, the effective tax rate was lower than the statutory tax rate primarily due to the tax benefit from restricted stock units upon vesting, earnings in jurisdictions subject to lower tax rates, and the domestic production activities deduction benefit.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">US Tax Reform</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Act reduces the US federal corporate income tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">, requires companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred, and creates new taxes on certain foreign sourced earnings.</font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 30, 2017, the Company has not completed its accounting for the tax effects of enactment of the Act; however, as described below, the Company has made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax, and recognized a provisional net benefit of </font><font style="font-family:inherit;font-size:10pt;">$329.2 million</font><font style="font-family:inherit;font-size:10pt;">, which is included in income tax expense. </font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (&#8220;SAB 118&#8221;) directing SEC registrants to consider the impact of the US legislation as &#8220;provisional&#8221; when it does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete its accounting for the change in tax law. In accordance with SAB 118, the additional estimated net income tax benefit of </font><font style="font-family:inherit;font-size:10pt;">$329.2 million</font><font style="font-family:inherit;font-size:10pt;"> represents the Company&#8217;s best estimate based on its interpretation of the US legislation as the Company is still accumulating data to finalize the underlying calculations, or in certain cases, the US Treasury is expected to issue further guidance on the application of certain provisions of the US legislation.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the three months ended December 30, 2017, the Company revised its estimated annual effective rate to reflect a change in the federal statutory income tax rate from </font><font style="font-family:inherit;font-size:10pt;">35%</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;">. The rate change is administratively effective at the beginning of the Company&#8217;s fiscal year, using a blended rate for the annual period. The Company's blended statutory income tax rate for fiscal 2018 is </font><font style="font-family:inherit;font-size:10pt;">24.5%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Deferred tax assets and liabilities</font><font style="font-family:inherit;font-size:10pt;">: The Company re-measured certain deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is </font><font style="font-family:inherit;font-size:10pt;">24.5%</font><font style="font-family:inherit;font-size:10pt;"> for fiscal 2018 reversals and </font><font style="font-family:inherit;font-size:10pt;">21%</font><font style="font-family:inherit;font-size:10pt;"> for post-fiscal 2018 reversals. However, the Company is still analyzing certain aspects of the Act and refining its calculations, which could potentially affect the measurement of these balances or potentially give rise to new deferred tax amounts. The provisional net benefit amount recorded related to the re-measurement of the Company&#8217;s deferred tax balance was </font><font style="font-family:inherit;font-size:10pt;">$355.2 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Foreign tax effects</font><font style="font-family:inherit;font-size:10pt;">:  The one-time transition tax is based on the Company&#8217;s total post-1986 earnings and profits (E&amp;P) which were previously deferred from US income taxes. The Company recorded a provisional amount for its one-time transition tax liability related to the deemed repatriation of the earnings of its foreign subsidiaries, resulting in an increase in income tax expense of </font><font style="font-family:inherit;font-size:10pt;">$26.0 million</font><font style="font-family:inherit;font-size:10pt;">. The Company has not yet finalized its calculation of the total post-1986 foreign E&amp;P for these foreign subsidiaries. Further, the transition tax is based in part on the amount of those earnings held in cash and other specified assets. This amount may change when the Company finalizes the calculation of its post-1986 foreign E&amp;P previously deferred from US federal taxation and finalizes the amounts held in cash or other specified assets. No additional income taxes have been provided for any remaining undistributed foreign earnings not subject to the transition tax and any additional outside basis difference inherent in these entities as these amounts continue to be indefinitely reinvested in foreign operations. The Company continues to evaluate this assertion in its ongoing analysis of the effects of tax reform on the Company's strategic initiatives. The Company believes that determining the amount of unrecognized deferred tax liability related to any remaining undistributed foreign earnings not subject to the transition tax and additional outside basis difference in these entities (i.e., basis difference in excess of that subject to the one time transition tax) is not practicable.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Further, starting in fiscal 2019, the Act subjects a US shareholder of a controlled foreign corporation to current tax on &#8220;global intangible low-taxed income&#8221; (GILTI) and establishes a tax on certain payments from corporations subject to US tax to related foreign persons, also referred to as base erosion and anti-abuse tax (BEAT). </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Because of the complexity of the new international tax provisions not applicable to the Company until fiscal 2019, the Company is continuing to evaluate these provisions of the Act and the application of ASC 740. </font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Non-Income Tax Matters</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is subject to tax examinations for value added, sales-based, payroll and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2018, the Company settled an ongoing state tax audit for approximately </font><font style="font-family:inherit;font-size:10pt;">$11.0 million</font><font style="font-family:inherit;font-size:10pt;">, resulting in a reversal of </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> recorded to general and administrative expenses in the first quarter of fiscal 2018.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819416160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets and Goodwill</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets consisted of the following:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Description</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of September 30, 2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed&#160;technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,528.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,266.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,528.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,186.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">556.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">402.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">552.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution agreement</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-competition agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business licenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total acquired intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,487.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,837.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,483.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,742.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal-use software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized software embedded in products</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,569.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,887.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,562.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,790.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated remaining amortization expense of the Company's acquired intangible assets as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> for each of the five succeeding fiscal years is as follows:</font></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of Fiscal 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company conducted its fiscal 2017 impairment test on the first day of the fourth quarter, and used a discounted cash flow method (DCF) to estimate the fair value of its reporting units as of July 2, 2017. The Company believes it used reasonable estimates and assumptions about future revenue, cost projections, cash flows, market multiples and discount rates as of the measurement date. As a result of completing Step 1, all of the Company's reporting units had fair values exceeding their carrying values, and as such, Step 2 of the impairment test was not required. However, </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> of its reporting units, Medical Aesthetics, had a fair value as of the measurement date that exceeded its carrying value by </font><font style="font-family:inherit;font-size:10pt;">2%</font><font style="font-family:inherit;font-size:10pt;"> with goodwill of </font><font style="font-family:inherit;font-size:10pt;">$683.5 million</font><font style="font-family:inherit;font-size:10pt;">. The Medical Aesthetics reporting unit is solely comprised of the Cynosure, Inc. business, which the Company acquired on March 22, 2017. In connection with the Company's annual strategic planning process and annual goodwill impairment test, it lowered its estimated financial projections for this business as a result of its then current operating performance being below expectations, which the Company primarily attributed to the significant turnover in the U.S. sales force in 2017 following the date of acquisition. The Company is continuing its efforts to rebuild the U.S. sales force and this continues to affect short term performance. The Company&#8217;s long-term outlook for the Medical Aesthetics business has not materially changed. The Company is continuing to monitor the operating performance of this reporting unit compared to the projections used in the annual impairment test, as well as current market and business conditions, to determine if an event has occurred or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. The Company has evaluated these factors and determined that no significant events occurred or circumstances changed during the period ended December 30, 2017 that would suggest it is more likely than not that the fair value of the reporting unit has declined below its carrying value. In the event the Company is unsuccessful in its efforts to rebuild the U.S. sales force or its efforts take significantly longer than expected, or other adverse conditions are identified, future operating performance may be below forecasted projections. If this occurs, the Company may need to revise its long-term growth rates or increase discount rates, and these factors could result in a decline in the fair value of the reporting unit and the Company may be required to record a goodwill impairment charge.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825368976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranties</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Product Warranties</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product warranty activity was as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.9453125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Beginning&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Provisions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Settlements/</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">End&#160;of&#160;Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819437824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Accumulated Other Comprehensive Loss</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended December 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hedged Interest Rate Caps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Beginning Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Amounts reclassified to statement of income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ending Balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hedged Interest Rate Caps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Beginning Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(26.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(32.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Amounts reclassified to statement of income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ending Balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(41.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(42.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first quarter of fiscal 2017, one of the Company's cost-method equity investments became a marketable security, and the Company recorded the increase in value on a gross basis of </font><font style="font-family:inherit;font-size:10pt;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;"> to other comprehensive income.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6660927456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350)</font><font style="font-family:inherit;font-size:10pt;">. This guidance simplifies how companies calculate goodwill impairments by eliminating Step 2 of the impairment test. The guidance requires companies to compare the fair value of a reporting unit to its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value. The guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2020. Early adoption is permitted. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU No. 2016-16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740).</font><font style="font-family:inherit;font-size:10pt;"> The guidance requires companies to recognize the income tax effects of intercompany sales and transfers of assets, other than inventory, in the income statement as income tax expense (or benefit) in the period in which the transfer occurs. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of the adoption of ASU 2016-16 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flow (Topic 230)</font><font style="font-family:inherit;font-size:10pt;">. The guidance reduces diversity in how certain cash receipts and cash payments are presented and classified in the Statements of Cash Flows. Certain of ASU 2016-15 requirements are as follows: 1) cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities, 2) contingent consideration payments made soon after a business combination should be classified as cash outflows for investing activities and cash payment made thereafter should be classified as cash outflows for financing up to the amount of the contingent consideration liability recognized at the acquisition date with any excess classified as operating activities, 3) cash proceeds from the settlement of insurance claims should be classified on the basis of the nature of the loss, 4) cash proceeds from the settlement of Corporate-Owned Life Insurance (COLI) Policies should be classified as cash inflows from investing activities and cash payments for premiums on COLI policies may be classified as cash outflows for investing activities, operating activities, or a combination of investing and operating activities, and 5) cash paid to a tax authority by an employer when withholding shares from an employee's award for tax-withholding purposes should be classified as cash outflows for financing activities. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted. The adoption of ASU 2016-15 is not expected to have a material effect on the Company's consolidated financial statements. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:10pt;">. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842).</font><font style="font-family:inherit;font-size:10pt;"> The guidance requires an entity to recognize a right-of-use asset and a lease liability for virtually all of its leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as a finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The guidance is effective for annual periods beginning after December&#160;15, 2018, and is applicable to the Company in fiscal 2020. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-02 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;">. This guidance changes how </font><font style="font-family:inherit;font-size:10pt;color:#333333;">entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. A practicability exception will be available for equity investments that do not have readily determinable fair values, </font><font style="font-family:inherit;font-size:10pt;">however; the exception requires the Company to consider relevant transactions that can be&#160;reasonably known to identify any observable price changes that would impact the fair value</font><font style="font-family:inherit;font-size:10pt;color:#333333;">. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019</font><font style="font-family:inherit;font-size:10pt;">. Early adoption is permitted. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-01 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">, which provides guidance for revenue recognition. This ASU is applicable to any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets. ASU 2014-09 will supersede the revenue recognition requirements in Topic 605,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;">, and most industry-specific guidance. The standard&#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to receive in exchange for those goods or services. In doing so, companies will need to use more judgment and make more estimates than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December&#160;15, 2017, which is fiscal 2019 for the Company. The Company will adopt Topic 606 effective September 30, 2018 and has established a cross-functional team to evaluate and implement the new revenue recognition rules. The Company will adopt Topic 606 using the modified retrospective method but has not finalized evaluating the anticipated impact of the adoption of ASU 2014-09 on its consolidated financial position and results of operations.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819437824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles-Goodwill and Other (Topic 350)</font><font style="font-family:inherit;font-size:10pt;">. This guidance simplifies how companies calculate goodwill impairments by eliminating Step 2 of the impairment test. The guidance requires companies to compare the fair value of a reporting unit to its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value. The guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2020. Early adoption is permitted. </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU No. 2016-16, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740).</font><font style="font-family:inherit;font-size:10pt;"> The guidance requires companies to recognize the income tax effects of intercompany sales and transfers of assets, other than inventory, in the income statement as income tax expense (or benefit) in the period in which the transfer occurs. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted as of the beginning of an annual reporting period. The Company is currently evaluating the impact of the adoption of ASU 2016-16 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU No. 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flow (Topic 230)</font><font style="font-family:inherit;font-size:10pt;">. The guidance reduces diversity in how certain cash receipts and cash payments are presented and classified in the Statements of Cash Flows. Certain of ASU 2016-15 requirements are as follows: 1) cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities, 2) contingent consideration payments made soon after a business combination should be classified as cash outflows for investing activities and cash payment made thereafter should be classified as cash outflows for financing up to the amount of the contingent consideration liability recognized at the acquisition date with any excess classified as operating activities, 3) cash proceeds from the settlement of insurance claims should be classified on the basis of the nature of the loss, 4) cash proceeds from the settlement of Corporate-Owned Life Insurance (COLI) Policies should be classified as cash inflows from investing activities and cash payments for premiums on COLI policies may be classified as cash outflows for investing activities, operating activities, or a combination of investing and operating activities, and 5) cash paid to a tax authority by an employer when withholding shares from an employee's award for tax-withholding purposes should be classified as cash outflows for financing activities. The guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019. Early adoption is permitted. The adoption of ASU 2016-15 is not expected to have a material effect on the Company's consolidated financial statements. </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:10pt;">. The guidance requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis. The income statement reflects the measurement of credit losses for newly recognized financial assets, as well as the expected credit losses during the period. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. Credit losses relating to available-for-sale debt securities will be recorded through an allowance for credit losses rather than as a direct write-down to the security. The updated guidance is effective for annual periods beginning after December 15, 2019, and is applicable to the Company in fiscal 2021. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-13 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842).</font><font style="font-family:inherit;font-size:10pt;"> The guidance requires an entity to recognize a right-of-use asset and a lease liability for virtually all of its leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as a finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The guidance is effective for annual periods beginning after December&#160;15, 2018, and is applicable to the Company in fiscal 2020. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-02 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;">. This guidance changes how </font><font style="font-family:inherit;font-size:10pt;color:#333333;">entities measure equity investments that do not result in consolidation and are not accounted for under the equity method. Entities will be required to measure these investments at fair value at the end of each reporting period and recognize changes in fair value in net income. A practicability exception will be available for equity investments that do not have readily determinable fair values, </font><font style="font-family:inherit;font-size:10pt;">however; the exception requires the Company to consider relevant transactions that can be&#160;reasonably known to identify any observable price changes that would impact the fair value</font><font style="font-family:inherit;font-size:10pt;color:#333333;">. This guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP. This guidance is effective for annual periods beginning after December 15, 2017, and is applicable to the Company in fiscal 2019</font><font style="font-family:inherit;font-size:10pt;">. Early adoption is permitted. The Company is currently evaluating the anticipated impact of the adoption of ASU 2016-01 on its consolidated financial position and results of operations.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue from Contracts with Customers (Topic 606)</font><font style="font-family:inherit;font-size:10pt;">, which provides guidance for revenue recognition. This ASU is applicable to any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets. ASU 2014-09 will supersede the revenue recognition requirements in Topic 605,</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> Revenue Recognition</font><font style="font-family:inherit;font-size:10pt;">, and most industry-specific guidance. The standard&#8217;s core principle is that a company will recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to receive in exchange for those goods or services. In doing so, companies will need to use more judgment and make more estimates than under current U.S. GAAP. These judgments may include identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 is effective prospectively for fiscal years, and interim reporting periods within those years, beginning after December&#160;15, 2017, which is fiscal 2019 for the Company. The Company will adopt Topic 606 effective September 30, 2018 and has established a cross-functional team to evaluate and implement the new revenue recognition rules. The Company will adopt Topic 606 using the modified retrospective method but has not finalized evaluating the anticipated impact of the adoption of ASU 2014-09 on its consolidated financial position and results of operations.</font></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825339072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value at Reporting Date Using</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance as of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Quoted&#160;Prices&#160;in</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Active&#160;Market&#160;for</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Identical&#160;Assets</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Level&#160;1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Observable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs&#160;(Level&#160;2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Significant</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Unobservable</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Inputs&#160;(Level&#160;3)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap - derivative</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred compensation liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:52px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Estimated Fair Values of Convertible Notes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated fair values of the Company&#8217;s Convertible Notes at </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> were as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.4140625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:83%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2042 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2043 Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819437824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationTableTextBlock', window );">Purchase Price Allocation</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The total purchase price was allocated to Cynosure&#8217;s preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of March 22, 2017, as set forth below. The preliminary purchase price allocation is as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.5390625%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:75%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketable securities</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inventory</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, plant and equipment</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets and liabilities, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts payable and accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred revenue</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital lease obligation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(25.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">736.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Distribution agreement</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred income taxes, net</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(315.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">683.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase Price</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,657.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro Forma Information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following unaudited pro forma information presents the combined financial results for the Company and Cynosure as if the acquisition of Cynosure had been completed at the beginning of the prior fiscal year, September 26, 2015 (fiscal 2016):</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:77.34375%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:81%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(unaudited)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenue</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">856.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">74.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PurchasePriceAllocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Purchase Price Allocation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PurchasePriceAllocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6597536224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Charges Taken Related to Restructuring Actions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table displays charges related to these actions recorded in the fiscal </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;"> year to date period (</font><font style="font-family:inherit;font-size:10pt;">three months ended December 30, 2017</font><font style="font-family:inherit;font-size:10pt;">) and fiscal </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> (the year ended September 30, 2017) and a rollforward of the accrued balances from </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:52%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2018 Actions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2017 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2016 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Restructuring Charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2017 charges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workforce reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Facility closure costs</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2017 restructuring charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 charges:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Workforce reductions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 restructuring charges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Charges Taken Related to Accrued Restructuring Actions</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:84.5703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:35%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2018 Actions</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2017 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal 2016 Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Other</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Total&#160;&#160;&#160;&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Rollforward of Accrued Restructuring</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of September 30, 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2018 charges</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock-based compensation</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Severance payments and adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3.4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other payments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819376736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s borrowings consisted of the following:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current debt obligations, net of debt discount and deferred issuance costs:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolver</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securitization Program</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Convertible Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">205.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">484.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current debt obligations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">572.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,150.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long-term debt obligations, net of debt discount and deferred issuance costs:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Term Loan</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,430.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,190.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2022 Senior Notes</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">982.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">981.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2025 Senior Notes</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">345.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total long-term debt obligations</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,757.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,172.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt obligations</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,329.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,322.9</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock', window );">Interest Expense under Convertible Notes</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-indent:36px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense under the Convertible Notes was as follows:</font><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.859375%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of debt discount</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of deferred financing costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Principal accretion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-cash interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.00% accrued interest (cash)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6660245408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives Schedule of Derivative Assets at Fair Value (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Derivative Assets at Fair Value</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;">: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:95.3125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance Sheet Location</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative instruments designated as a cash flow hedge:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:42px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives not designated as hedging instruments:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the unrealized gain recognized in AOCI related to the interest rate caps for the following reporting periods:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.8125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:67%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate cap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Adjustment to Fair Value within the Consolidated Statements of Income</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:</font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.53125%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:36%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:30%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivatives not classified as hedging instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain (Loss) Recognized in Income</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain (Loss) Recognized in Income</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forward foreign currency contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other income, net</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of gains and losses on derivative instruments (and nonderivative instruments) designated and qualifying in cash flow hedges recorded in accumulated other comprehensive income (loss) during the term of the hedging relationship and reclassified into earnings during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for other derivative instruments not designated as hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825486784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of basic and diluted share amounts is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.2109375%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:71%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">276,856</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">278,663</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average common stock equivalents from assumed exercise of stock options and stock units</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,212</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incremental shares from Convertible Notes premium</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,734</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,418</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted weighted average common shares outstanding</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">280,802</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284,224</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average anti-dilutive shares related to:</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding stock options</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,272</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,442</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stock units</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">216</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834265056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statements of Operations</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of revenues</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Research and development</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Selling and marketing</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restructuring</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:middle;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Utilized to Value Stock Options</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</font></div><div style="line-height:120%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.2421875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.6</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td colspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dividend yield</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average fair value of options granted</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.00</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825396000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Other Balance Sheet Information of Inventories</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Inventories</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Raw materials</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Work-in-process</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Finished goods</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">190.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">331.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Other Balance Sheet Information of Property, Plant and Equipment</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.21875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Property, plant and equipment</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">363.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">357.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equipment under customer usage agreements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">379.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building and improvements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">172.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and fixtures</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,043.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,026.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less &#8211; accumulated depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(576.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(553.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">467.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">472.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819608976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:83.203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:69%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">284.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">288.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">273.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">91.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">114.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20.9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">791.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">734.4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income (loss) from operations:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">134.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">146.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">84.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital expenditures:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Identifiable assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diagnostics</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,583.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,621.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Breast Health</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">824.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical Aesthetics</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723.9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,751.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">GYN Surgical</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,477.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,494.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Skeletal Health</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,396.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,262.7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,048.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,979.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revenues by geography as a percentage of total revenues were as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:24px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:73.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td style="width:65%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;30, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December&#160;31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">United States</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">77.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Europe</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.5</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia-Pacific</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Rest of World</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8813-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825392768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets consisted of the following:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:45%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Description</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As of September 30, 2017</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Carrying</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Amortization</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquired intangible assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed&#160;technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,528.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,266.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,528.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,186.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In-process research and development</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">556.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">402.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">552.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">310.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution agreement</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-competition agreements</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Business licenses</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total acquired intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,487.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,837.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,483.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,742.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Internal-use software</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">65.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitalized software embedded in products</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14.3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:44px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,569.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,887.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,562.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,790.2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated remaining amortization expense of the Company's acquired intangible assets as of </font><font style="font-family:inherit;font-size:10pt;">December&#160;30, 2017</font><font style="font-family:inherit;font-size:10pt;"> for each of the five succeeding fiscal years is as follows:</font></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td style="width:87%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of Fiscal 2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">283.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2019</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">366.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">354.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">333.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fiscal 2022</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">320.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825426080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Product Warranty Activity</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Product warranty activity was as follows:</font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.9453125%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td style="width:53%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Beginning&#160;of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Period</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Provisions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Settlements/</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Adjustments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Balance&#160;at</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">End&#160;of&#160;Period</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Three Months Ended:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 30, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17.0</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5.1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16.2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6825396000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended December 30, 2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hedged Interest Rate Caps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Beginning Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(18.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1.6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(16.2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">5.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(4.3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">1.8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Amounts reclassified to statement of income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ending Balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(13.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(1.0</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(11.7</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.2265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:46%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Three Months Ended December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Foreign Currency Translation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Marketable Securities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Pension Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Hedged Interest Rate Caps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Beginning Balance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(26.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2.5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(3.4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(32.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Other comprehensive income (loss) before reclassifications</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(15.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(12.7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Amounts reclassified to statement of income</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">0.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">Ending Balance</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(41.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">2.1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(2.5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(0.6</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">(42.8</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">)</font></div></td></tr></table></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6835956992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 29, 2018</div></th>
<th class="th"><div>Jan. 19, 2018</div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Internalusesoftware', window );">Internal-use software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.6<span></span>
</td>
<td class="nump">$ 18.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Capitalized Computer Software, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.9<span></span>
</td>
<td class="nump">$ 12.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering Price of Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering Price of Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember', window );">2022 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt Instrument, Interest Rate During Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember', window );">2022 Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2042NotesMember', window );">2042 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2042NotesMember', window );">2042 Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Internalusesoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Internal-use software</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Internalusesoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OfferingPriceofPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering Price of Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OfferingPriceofPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2042NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2042NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6836299056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest Rate Cash Flow Hedge Asset at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">52.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure', window );">Foreign Currency Contract, Asset, Fair Value Disclosure</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember', window );">Deferred compensation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">49.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Market for Identical Assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">49.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Market for Identical Assets (Level 1) | Interest rate cap - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest Rate Cash Flow Hedge Asset at Fair Value</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Market for Identical Assets (Level 1) | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Market for Identical Assets (Level 1) | Deferred compensation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">49.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted Prices in Active Market for Identical Assets (Level 1) | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">5.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Interest rate cap - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Deferred compensation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs (Level 2) | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Interest rate cap - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Foreign Exchange Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Deferred compensation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Liabilities measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs (Level 3) | Forward Contracts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign Currency Contracts, Liability, Fair Value Disclosure</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractAssetFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=82895926&amp;loc=d3e24584-111560<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=75030427&amp;loc=d3e22054-111558<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DeferredCompensationShareBasedPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834528752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="nump">1,600.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="nump">200.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">2022 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">1,100.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">$ 358.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13433-108611<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=77997519&amp;loc=d3e13476-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6822095088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Estimated Fair Values of Convertible Notes (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EstimatedFairValueOfFinancialInstrumentsLineItems', window );"><strong>Estimated Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Estimated fair values of debt instruments</a></td>
<td class="nump">$ 285.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_TwoThousandAndTwelveNotesMember', window );">2042 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EstimatedFairValueOfFinancialInstrumentsLineItems', window );"><strong>Estimated Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Estimated fair values of debt instruments</a></td>
<td class="nump">284.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_TwoThousandAndThirteenNotesMember', window );">2043 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EstimatedFairValueOfFinancialInstrumentsLineItems', window );"><strong>Estimated Fair Value Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Estimated fair values of debt instruments</a></td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EstimatedFairValueOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated Fair Value Of Financial Instruments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EstimatedFairValueOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_TwoThousandAndTwelveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_TwoThousandAndTwelveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_TwoThousandAndThirteenNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_TwoThousandAndThirteenNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6839186192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 11, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 07, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2017 </div>
<div>USD ($) </div>
<div>project </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($) </div>
<div>project</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,569.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,562.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">791.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 734.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 146.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,176.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,171.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionSharePrice', window );">Purchase price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 207.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 683.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MedicorMedicalSupplyMember', window );">Medicor Medical Supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability', window );">Period for payment of contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_EmsorMember', window );">Emsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability', window );">Period for payment of contingent consideration liabilities</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability', window );">Period of cumulative revenue to trigger payment of contingent consideration liability</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="nump">$ 13.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NumberofProjects', window );">Number of projects | project</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete', window );">Estimated costs to complete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 736.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete', window );">Estimated costs to complete</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">11 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember', window );">Distribution agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember', window );">Distribution agreement | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 310.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum | Other Intangible Assets | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MinimumMember', window );">Minimum | In-process research and development | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum | Other Intangible Assets | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RangeAxis=us-gaap_MaximumMember', window );">Maximum | In-process research and development | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CounterpartyNameAxis=holx_CynosureShareholdersMember', window );">Cynosure Shareholders | Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,660.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Period for Achievement of Cumulative Revenues For Payment of Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationPeriodforAchievementofCumulativeRevenuesForPaymentofContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Period for Payment of Contingent Consideration Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationPeriodforPaymentofContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NumberofProjects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Projects</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NumberofProjects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Assets Acquired, Expected Remaining Cost to Complete</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ResearchandDevelopmentAssetsAcquiredExpectedRemainingCosttoComplete</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MedicorMedicalSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MedicorMedicalSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_EmsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_EmsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CounterpartyNameAxis=holx_CynosureShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CounterpartyNameAxis=holx_CynosureShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777365008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination - Purchase Price Consideration (Details) - Medicor Medical Supply<br> $ in Millions</strong></div></th>
<th class="th">
<div>Apr. 07, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AcquisitionPriceAdjustment', window );">Acquisition Price Adjustment</a></td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="nump">$ 19.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AcquisitionPriceAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payment for working capital adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AcquisitionPriceAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MedicorMedicalSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MedicorMedicalSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837434560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination - Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jul. 01, 2017</div></th>
<th class="th"><div>Mar. 22, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationLineItems', window );"><strong>Purchase Price Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,176.7<span></span>
</td>
<td class="nump">$ 3,171.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationLineItems', window );"><strong>Purchase Price Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities', window );">Other assets and liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(75.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Capital lease obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(315.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 683.5<span></span>
</td>
<td class="nump">683.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,657.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure | Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationLineItems', window );"><strong>Purchase Price Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">736.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure | In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationLineItems', window );"><strong>Purchase Price Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure | Distribution agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationLineItems', window );"><strong>Purchase Price Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationLineItems', window );"><strong>Purchase Price Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure | Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchasePriceAllocationLineItems', window );"><strong>Purchase Price Allocation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PurchasePriceAllocationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Purchase Price Allocation [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PurchasePriceAllocationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary difference assumed at the acquisition date that are classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=84160947&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161108&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6660261136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Pro Forma Information (Details) - Cynosure<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue | $</a></td>
<td class="nump">$ 856.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income | $</a></td>
<td class="nump">$ 74.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6836682032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Jul. 01, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember', window );">Bedford [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two Thousand Seventeen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two thousand eighteen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Fiscal 2018 Action [Member] | Two Thousand Seventeen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Fiscal 2018 Action [Member] | Two thousand eighteen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Fiscal 2017 Actions [Member] | Two Thousand Seventeen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Fiscal 2017 Actions [Member] | Two thousand eighteen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Fiscal 2016 Actions | Two Thousand Seventeen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Fiscal 2016 Actions | Two thousand eighteen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ReductionOfWorkforceExpenses', window );">Workforce reductions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RestructuringChargesUnderExitOrDisposalPlan', window );">Fiscal restructuring charges</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FacilityClosureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FacilityClosureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ReductionOfWorkforceExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents severance and related benefit charges for the termination of employees under an exit or disposal activity. Charges are recorded either as one-time termination benefits, which are recognized ratable over the required service period to receive such benefit, or under an ongoing benefit plan arrangement once the charge is probable and reasonably estimable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ReductionOfWorkforceExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RestructuringChargesUnderExitOrDisposalPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total restructuring charges under exit or disposal plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RestructuringChargesUnderExitOrDisposalPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_BedfordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2017ActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2017ActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2016ActionsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2016ActionsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6836665072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="num">$ (1.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two Thousand Seventeen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period beginning balance</a></td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two Thousand Seventeen [Member] | Fiscal 2018 Action [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period beginning balance</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two Thousand Seventeen [Member] | Fiscal 2017 Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period beginning balance</a></td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two Thousand Seventeen [Member] | Fiscal 2016 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period beginning balance</a></td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two Thousand Seventeen [Member] | Other Restructuring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period beginning balance</a></td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two thousand eighteen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Restructuringchargesgross', window );">Fiscal 2018 charges</a></td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(3.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period end balance</a></td>
<td class="nump">10.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two thousand eighteen [Member] | Fiscal 2018 Action [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Restructuringchargesgross', window );">Fiscal 2018 charges</a></td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period end balance</a></td>
<td class="nump">1.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two thousand eighteen [Member] | Fiscal 2017 Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Restructuringchargesgross', window );">Fiscal 2018 charges</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period end balance</a></td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two thousand eighteen [Member] | Fiscal 2016 Actions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Restructuringchargesgross', window );">Fiscal 2018 charges</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period end balance</a></td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring | Two thousand eighteen [Member] | Other Restructuring [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Restructuringchargesgross', window );">Fiscal 2018 charges</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts', window );">Stock-based compensation</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashSeverancePayments', window );">Severance payments and adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OtherRestructuringPayments', window );">Other payments</a></td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Period end balance</a></td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CashSeverancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Severance payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CashSeverancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherRestructuringPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to settle other restructuring charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherRestructuringPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Restructuringchargesgross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charges, gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Restructuringchargesgross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation expense included other restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ShareBasedCompensationExpenseIncludedOtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2018ActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2017ActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2017ActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2016ActionsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=holx_Fiscal2016ActionsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_TwothousandeighteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6822648880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Charges - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Jul. 01, 2017</div></th>
<th class="th"><div>Apr. 01, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost', window );">Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Incremental Compensation Cost</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_CynosureMember', window );">Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember', window );">Bedford [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FacilityClosureCosts', window );">Facility closure costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FacilityClosureCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents charges incurred to close or restructure a facility in connection with an exit or disposal activity. Such costs include clean-up costs and lease obligations. Costs are recorded as the activities are incurred except for lease obligation charges, which are recorded upon termination of the lease obligation or at the cease use date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FacilityClosureCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An excess of the fair value of the modified award over the fair value of the award immediately before the modification.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_BedfordMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_BedfordMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6822959904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 572.1<span></span>
</td>
<td class="nump">$ 1,150.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Convertible Notes</a></td>
<td class="nump">205.4<span></span>
</td>
<td class="nump">484.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,757.7<span></span>
</td>
<td class="nump">2,172.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">$ 3,329.8<span></span>
</td>
<td class="nump">3,322.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditAgreementMember', window );">Amended Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate', window );">Debt Instrument, Number of Fiscal Quarters Ending on Measurement Date</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 46.7<span></span>
</td>
<td class="nump">121.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">1,430.1<span></span>
</td>
<td class="nump">1,190.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">120.0<span></span>
</td>
<td class="nump">345.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">200.0<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2022NotesMember', window );">2022 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">982.6<span></span>
</td>
<td class="nump">981.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">$ 345.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Fiscal Quarters Ending on Measurement Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentNumberofFiscalQuartersEndingonMeasurementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongTermDebtObligationsWithoutConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term debt obligations without convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongTermDebtObligationsWithoutConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6846502064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 29, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 19, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Oct. 10, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 25, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 03, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 19, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 572,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense amortization of debt discount and deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,700,000<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Cash paid for conversion of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,900,000<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxesReacquisitionofEquityComponent', window );">Deferred Taxes, Reacquisition of Equity Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal Amount Of Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember', window );">Amended Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from Issuance of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember', window );">Amended Term Loan [Member] | Percentage Added to Eurodollar Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedRevolverMember', window );">Amended Revolver [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of Credit, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedRevolverMember', window );">Amended Revolver [Member] | Percentage Added to Eurodollar Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt Instrument, Basis Spread on Variable Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditAgreementMember', window );">Amended Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeverageRatioMaximum', window );">Leverage Ratio Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility', window );">Decreased Net Leverage Ratio Pursuant To Senior Secured Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestCoverageRatio', window );">Interest Coverage Ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumRangeofPresentValueofCashFlowPercentage', window );">Maximum Range of Present Value of Cash Flow Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DirectThirdPartyCostsinterestExpense', window );">Direct Third Party Costs interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payments of Debt Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2043NotesMember', window );">2043 Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Cash paid for conversion of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 201,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Senior note interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering Price of Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2042NotesMember', window );">2042 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Cash paid for conversion of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2042NotesMember', window );">2042 Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Debt Instrument, Repurchase Amount</a></td>
<td class="nump">$ 206,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_TwoThousandAndTwelveNotesMember', window );">Two Thousand And Twelve Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt Instrument, Convertible, Conversion Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31.175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfSecuredDebt', window );">Repayments of Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,320,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageDiscountRatePercent', window );">Weighted average interest rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.069%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense amortization of debt discount and deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal Amount Of Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense amortization of debt discount and deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Senior note interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering Price of Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember', window );">2022 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense amortization of debt discount and deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Senior note interest rate per year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember', window );">2022 Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember', window );">2022 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal Amount Of Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering Price of Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan [Member] | Amended Term Loan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering Price of Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal Amount Of Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2022 Senior Notes | 2028 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod', window );">Debt Instrument Percentage Of Redemption Price Second Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod', window );">Debt Instrument Percentage Of Redemption Price Third Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.312%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod', window );">Debt Instrument Percentage Of Redemption Price Fourth Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.541%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod', window );">Debt Instrument Percentage Of Redemption Price Fifth Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.77%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes', window );">Percentage Price of Principal Amount for Repurchase of Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod', window );">Debt Instrument Percentage Redemption Price Sixth Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2022 Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_OfferingPriceofPrincipalAmount', window );">Offering Price of Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod', window );">Debt Instrument Percentage Of Redemption Price Second Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod', window );">Debt Instrument Percentage Of Redemption Price Third Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102.188%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod', window );">Debt Instrument Percentage Of Redemption Price Fourth Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.094%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod', window );">Debt Instrument Percentage Of Redemption Price Fifth Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes', window );">Percentage Price of Principal Amount for Repurchase of Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2022 Senior Notes | 2025 Senior Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member] | 2042 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CashPerOriginalPrincipalAmountofExchangeNotes', window );">Cash Per Original Principal Amount of Exchange Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,371<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalConvertibleToCommonStock', window );">Principal Convertible To Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Debt Instrument, Convertible, If-converted Value in Excess of Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 282,600,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member] | 2042 Notes | Subsequent Event Type [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Debt [Member] | Two Thousand And Twelve Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense amortization of debt discount and deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AmendedTermLoanMember', window );">Amended Term Loan [Member] | Amended Credit Agreement [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod', window );">Debt Instrument, Periodic Payment, Principal, Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AmendedTermLoanMember', window );">Amended Term Loan [Member] | Amended Credit Agreement [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CashPerOriginalPrincipalAmountofExchangeNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Per Original Principal Amount of Exchange Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CashPerOriginalPrincipalAmountofExchangeNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Fifth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceFifthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Fourth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceFourthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Second Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceSecondPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Of Redemption Price Third Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageOfRedemptionPriceThirdPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument Percentage Redemption Price Sixth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPercentageRedemptionPriceSixthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentPeriodicPaymentPrincipalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Principal, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentPeriodicPaymentPrincipalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decreased Net Leverage Ratio Pursuant To Senior Secured Credit Facility</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DecreasedNetLeverageRatioPursuantToSeniorSecuredCreditFacility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxesReacquisitionofEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Taxes, Reacquisition of Equity Component</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxesReacquisitionofEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DirectThirdPartyCostsinterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Direct Third Party Costs interest Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DirectThirdPartyCostsinterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestCoverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Coverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestCoverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leverage Ratio Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumRangeofPresentValueofCashFlowPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum Range of Present Value of Cash Flow Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumRangeofPresentValueofCashFlowPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OfferingPriceofPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Offering Price of Principal Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OfferingPriceofPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Price of Principal Amount for Repurchase of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentagePriceofPrincipalAmountforRepurchaseofSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalConvertibleToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal Convertible To Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalConvertibleToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=51819886&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=64930739&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12317-112629<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49170532&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average discount rate applied to insurance contracts to determine future policy benefits to be paid to or on behalf of policyholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65670685&amp;loc=d3e14881-158438<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecurityAxis=holx_PercentageAddedtoEurodollarRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecurityAxis=holx_PercentageAddedtoEurodollarRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedRevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedRevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2043NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2043NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2042NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2042NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_TwoThousandAndTwelveNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_TwoThousandAndTwelveNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2022NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2022NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AmendedTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AmendedTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823685360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Debt Conversion [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="nump">$ 14.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentCashAccruedInterestPercentage', window );">Cash accrued interest percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionLineItems', window );"><strong>Debt Conversion [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="nump">$ 5.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmortizationOfDeferredFinancingCosts', window );">Amortization of deferred financing costs</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BasePrincipalAmountForAccretionValue', window );">Principal accretion</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Non-cash interest expense</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">2.00% accrued interest (cash)</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, net</a></td>
<td class="nump">$ 5.7<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmortizationOfDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The component of interest expense representing the periodic charge against earnings to reflect amortization of debt issuance costs over the life of the related debt instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmortizationOfDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BasePrincipalAmountForAccretionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of principal accretion at the applicable rate pursuant to the terms of the debt agreement, which is recorded as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BasePrincipalAmountForAccretionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentCashAccruedInterestPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Cash Accrued Interest Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentCashAccruedInterestPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823554208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 26, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Interest Rate Cap Agreements Aggregate Premium Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="nump">$ 13.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Principal Amount Of Borrowings</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statement of income</a></td>
<td class="num">(2.3)<span></span>
</td>
<td class="num">$ (2.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue', window );">Interest Rate Cash Flow Hedge Asset at Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments', window );">Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax', window );">Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="nump">$ 157.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notional Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=d3e41638-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6843472512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives Fair Value of Derivative Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Interest rate cap - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">$ 5.3<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Interest rate cap - derivative | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">3.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member] | Interest rate cap - derivative | Other Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Prepaid Expenses and Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | Accrued Liabilities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Cash Flow Hedge Derivative Instrument Assets at Fair Value</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6795640176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Changes in value of hedged interest rate caps, net of tax of $(4.9) and $0.5 for the three months ended December 30, 2017 and December 31, 2016:</a></td>
<td class="num">$ (4.3)<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate cap - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Changes in value of hedged interest rate caps, net of tax of $(4.9) and $0.5 for the three months ended December 30, 2017 and December 31, 2016:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6767824496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Forward foreign currency contracts</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6777338608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 04, 2012</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmountAssessedInDamages', window );">Assessed damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Payment of settlement compensation</a></td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation Settlement, Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountAssessedInDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount assessed in damages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountAssessedInDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823609136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">276,856<span></span>
</td>
<td class="nump">278,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average common stock equivalents from assumed exercise of stock options and stock units</a></td>
<td class="nump">2,212<span></span>
</td>
<td class="nump">3,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities', window );">Incremental shares from Convertible Notes premium</a></td>
<td class="nump">1,734<span></span>
</td>
<td class="nump">2,418<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding</a></td>
<td class="nump">280,802<span></span>
</td>
<td class="nump">284,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">2,272<span></span>
</td>
<td class="nump">1,442<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the treasury stock method</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IncrementalCommonSharesAttributableToTheConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1500-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1505-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96947427&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6822647600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 16.4<span></span>
</td>
<td class="nump">$ 19.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837838160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise prices</a></td>
<td class="nump">$ 40.82<span></span>
</td>
<td class="nump">$ 37.62<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation, stock option outstanding</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options outstanding</a></td>
<td class="nump">$ 31.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">3 years 1 month 22 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 40.79<span></span>
</td>
<td class="nump">$ 37.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested RSUs outstanding</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested RSUs weighted-average grant date fair value</a></td>
<td class="nump">$ 37.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 98.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 1 month 22 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 40.86<span></span>
</td>
<td class="nump">$ 37.64<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember', window );">Market Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 49.45<span></span>
</td>
<td class="nump">$ 48.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time that must lapse in order for the restricted stock units to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized cost of unvested share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6775678240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">35.30%<span></span>
</td>
<td class="nump">36.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
<td class="text">4 years 8 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 13.00<span></span>
</td>
<td class="nump">$ 12.18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average expected volatility rate of share-based compensation awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=96867065&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834411040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition (Details) - Blood Screening Business [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 14, 2016</div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Apr. 01, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrossProceedsonSale', window );">Gross proceeds on sale</a></td>
<td class="nump">$ 1,850.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsFromSaleOfBusiness', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,865.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 899.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Accrued Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 649.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Proceedsallocatedtomanufactureofinventory', window );">Proceeds allocated to manufacture of inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Disposal Group, Including Discontinued Operation, Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_BloodScreeningBusinessMember', window );">Grifols [Member] | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal', window );">Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_BloodScreeningBusinessMember', window );">Grifols [Member] | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal', window );">Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Period to Provide Transition Services After Disposal</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DisposalGroupIncludingDiscontinuedOperationsPeriodtoProvideTransitionServicesAfterDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrossProceedsonSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross Proceeds on Sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrossProceedsonSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Proceedsallocatedtomanufactureofinventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds allocated to manufacture of inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Proceedsallocatedtomanufactureofinventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due.  This amount is the total of current and noncurrent accrued income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=64827811&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) from sale or disposal of an organization or integrated set of activities (for example, but not limited to, a partnership or corporation) engaged in providing a product or service in a commercial, industrial, or professional environment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_BloodScreeningBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_BloodScreeningBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_GrifolsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_GrifolsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834164272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Other Balance Sheet Information of Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 114.2<span></span>
</td>
<td class="nump">$ 95.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">44.6<span></span>
</td>
<td class="nump">45.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">199.4<span></span>
</td>
<td class="nump">190.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 358.2<span></span>
</td>
<td class="nump">$ 331.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68049868&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6819626704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Other Balance Sheet Information of Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Equipment</a></td>
<td class="nump">$ 363.7<span></span>
</td>
<td class="nump">$ 357.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment under customer usage agreements</a></td>
<td class="nump">379.0<span></span>
</td>
<td class="nump">368.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">172.7<span></span>
</td>
<td class="nump">172.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">61.1<span></span>
</td>
<td class="nump">60.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">46.4<span></span>
</td>
<td class="nump">46.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">20.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,043.9<span></span>
</td>
<td class="nump">1,026.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less &#8211; accumulated depreciation and amortization</a></td>
<td class="num">(576.8)<span></span>
</td>
<td class="num">(553.5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 467.1<span></span>
</td>
<td class="nump">$ 472.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=82887183&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824210000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>Customer</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | Segment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues | $</a></td>
<td class="nump">$ 791,100,000<span></span>
</td>
<td class="nump">$ 734,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureOfMajorCustomers', window );">Customer represented greater than 10% of consolidated revenues</a></td>
<td class="text">0<span></span>
</td>
<td class="text">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue', window );">Countries with greater than 10% of consolidated revenue | Customer</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of countries with greater than 10% of consolidated revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Numberofcountrieswithgreaterthan10ofconsolidatedrevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureOfMajorCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the extent of enterprise reliance on its major customers. For example, includes revenues from transactions with a single external customer amounting to 10 percent or more of the entity's revenues, the total amount of revenues from each such customer, and the identity of the segment or segments reporting the revenues. A group of entities that the entity knows to be under common control generally will be considered a single customer for inclusion in this item. The federal government, a state government, a local government (for example, a county or municipality), or a foreign government each will generally be considered as a single customer for inclusion in this item.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=68060357&amp;loc=d3e9054-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureOfMajorCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6823770256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 791.1<span></span>
</td>
<td class="nump">$ 734.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">134.1<span></span>
</td>
<td class="nump">146.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">121.2<span></span>
</td>
<td class="nump">115.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">21.8<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">8,048.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,979.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">284.6<span></span>
</td>
<td class="nump">325.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">36.5<span></span>
</td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">64.7<span></span>
</td>
<td class="nump">84.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">11.9<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,583.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,621.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">288.0<span></span>
</td>
<td class="nump">273.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">89.7<span></span>
</td>
<td class="nump">85.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">5.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">3.5<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">840.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">824.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">107.5<span></span>
</td>
<td class="nump">114.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">30.2<span></span>
</td>
<td class="nump">25.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">25.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,477.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,494.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">19.7<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsDomain', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">91.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(23.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">28.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,723.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,751.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">$ 7.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 1,396.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,262.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=98514028&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824357088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">75.50%<span></span>
</td>
<td class="nump">77.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">11.50%<span></span>
</td>
<td class="nump">10.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=us-gaap_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">8.70%<span></span>
</td>
<td class="nump">8.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=us-gaap_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=us-gaap_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6837107504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Oct. 01, 2018</div></th>
<th class="th"><div>Jan. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Company's effective tax rate</a></td>
<td class="num">(324.50%)<span></span>
</td>
<td class="nump">25.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit', window );">Income tax benefit for remeasurements of deferred tax deferred tax liability as result of change in tax rate</a></td>
<td class="nump">$ 355.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount', window );">Charge for transition taxes related to the deemed repatriation of foreign earnings</a></td>
<td class="nump">26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit', window );">Estimated net benefit effect of existing deferred tax balances and transition tax due to change in tax rate</a></td>
<td class="nump">329.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit', window );">Provisional net benefit amount recorded for remeasurements of deferred tax balance due to change in rate</a></td>
<td class="nump">355.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member] | Selling, General and Administrative Expenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions', window );">Reversal of selling and administrative expense due to settlement of state tax audit</a></td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event Type [Member] | State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority', window );">Settlement liability of state tax audit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember', window );">Scenario, Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Blended statutory income tax rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse', window );">Projected tax rate at which deferred tax assets and liabilities positions will reverse</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.50%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets and Liabilities, Projected Effective Rate At Which Position Will Reverse</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DeferredTaxAssetsandLiabilitiesProjectedEffectiveRateAtWhichPositionWillReverse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation,Tax Cuts and Jobs Act of 2017, Transition Tax on Accumulated Foreign Earnings, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017TransitionTaxonAccumulatedForeignEarningsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Change In Tax Rate, Deferred Tax Asset, Provisional Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts And Jobs Act Of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Cuts and Jobs Act of 2017, Change in Tax Rate, Deferred Tax Liability, Income Tax (Expense) Benefit</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TaxCutsandJobsActof2017ChangeinTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28446-109314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=96869850&amp;loc=d3e28511-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6838105024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 5,569.1<span></span>
</td>
<td class="nump">$ 5,562.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,887.8<span></span>
</td>
<td class="nump">2,790.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,528.8<span></span>
</td>
<td class="nump">4,528.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,266.7<span></span>
</td>
<td class="nump">2,186.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">46.0<span></span>
</td>
<td class="nump">46.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">556.7<span></span>
</td>
<td class="nump">552.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">402.8<span></span>
</td>
<td class="nump">393.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">310.3<span></span>
</td>
<td class="nump">310.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">161.1<span></span>
</td>
<td class="nump">156.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember', window );">Distribution agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">42.0<span></span>
</td>
<td class="nump">42.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember', window );">Business licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Acquired intangible assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">5,487.8<span></span>
</td>
<td class="nump">5,483.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,837.0<span></span>
</td>
<td class="nump">2,742.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">65.8<span></span>
</td>
<td class="nump">64.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">48.2<span></span>
</td>
<td class="nump">46.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">15.5<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DistributionagreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6835501136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of Fiscal 2018</a></td>
<td class="nump">$ 283.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2019</a></td>
<td class="nump">366.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2020</a></td>
<td class="nump">354.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2021</a></td>
<td class="nump">333.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Fiscal 2022</a></td>
<td class="nump">$ 320.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6824105648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 30, 2017 </div>
<div>USD ($) </div>
<div>unit</div>
</th>
<th class="th">
<div>Sep. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProductLineLineItems', window );"><strong>Product Line [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,176.7<span></span>
</td>
<td class="nump">$ 3,171.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember', window );">Cynosure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProductLineLineItems', window );"><strong>Product Line [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount', window );">Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 683.5<span></span>
</td>
<td class="nump">$ 683.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsDomain', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProductLineLineItems', window );"><strong>Product Line [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProductLineLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Product Line [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProductLineLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of fair value of reporting unit in excess of carrying amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_CynosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_CynosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6834596544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties - Product Warranty Activity (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance at Beginning of Period</a></td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance at End of Period</a></td>
<td class="nump">$ 16.2<span></span>
</td>
<td class="nump">$ 5.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.8.0.1</span><table class="report" border="0" cellspacing="2" id="idp6838092960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Sep. 24, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Marketable Securities, Unrealized Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">$ 5.5<span></span>
</td>
<td class="num">(15.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Changes in unrealized holding gains and losses on available-for-sale securities, net of tax of $0.2 and $1.5 for the three months December 30, 2017 and December 31, 2016:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Changes in value of hedged interest rate caps, net of tax of $(4.9) and $0.5 for the three months ended December 30, 2017 and December 31, 2016:</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(11.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (16.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="num">(15.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</a></td>
<td class="num">(13.0)<span></span>
</td>
<td class="num">(41.8)<span></span>
</td>
<td class="num">(18.5)<span></span>
</td>
<td class="num">$ (26.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Changes in unrealized holding gains and losses on available-for-sale securities, net of tax of $0.2 and $1.5 for the three months December 30, 2017 and December 31, 2016:</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(2.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedothercomprehensiveIncomelossHedge', window );">Accumulated other comprehensive Income loss Hedge</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet', window );">Changes in value of hedged interest rate caps, net of tax of $(4.9) and $0.5 for the three months ended December 30, 2017 and December 31, 2016:</a></td>
<td class="num">(4.3)<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other Comprehensive Income (Loss) before Reclassifications, Tax</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="num">(12.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Restructuring Reserve, Translation and Other Adjustment</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (11.7)<span></span>
</td>
<td class="num">$ (42.8)<span></span>
</td>
<td class="num">$ (16.2)<span></span>
</td>
<td class="num">$ (32.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedothercomprehensiveIncomelossHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated other comprehensive Income loss Hedge</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedothercomprehensiveIncomelossHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated appreciation or loss, net of tax, in value of the total of available-for-sale securities at the end of an accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=64808268&amp;loc=d3e32022-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84234895&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net change in the difference between the fair value and the carrying value, or in the comparative fair values, of marketable securities categorized as trading held at each balance sheet date, that was included in earnings for the period, which may have arisen from (a) securities classified as trading, (b) the unrealized holding gain (loss) on held-to-maturity securities transferred to the trading security category, and (c) the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) on available-for-sale securities transferred to trading securities during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27357-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=82897076&amp;loc=d3e27405-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=84161450&amp;loc=SL4573702-111684<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569643-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=96868048&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=79507043&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=84228862&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=84158357&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M^L/O)NR\L0?[CXVO@K*%7W<AOP!02P,$%     @  H-(3)E<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
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M>H\/?ZLC.BGP)E*76>I-<W?F3$4KU.Z]"')TUV9&Q'Y A#,$GA!(V9X$0I?
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MGM."PD7J::;F?&@APT*R;FR/:.K1Q5]02P,$%     @  H-(3*3D-;(5!
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MDJ.L"<F1,O-EC#+&* .,LL0H SY2%JMU'.EB'R@88Y0!1EEB=!1-P[:93+J
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M=/YE8_\K1 =>RN;&CU#C/]AL**A<.'[T9S..V6@X[*8?Q.9OG/\&4$L#!!0
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M[']EC >4LKG!$6KP@\V&A,J'XR<\VW',1L.;;OI!;/[&^1]02P,$%     @
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MP0\V&PHJ'XXW>+;CF(V&-]WT@]C\C?,W4$L#!!0    (  *#2$R)V=*DM0$
M -(#   9    >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;'U386_;(!#]*X@?
M4!+'7;+(MM1TFCIIE:).VSX3^VRC N<"CMM_/\"NYVW6O@!WW'OW[CBR <VS
M;0$<>552VYRVSG5'QFS9@N+V!CO0_J9&H[CSIFF8[0SP*H*49,EF\X$I+C0M
MLN@[FR+#WDFAX6R([97BYNT$$H><;NF[XTDTK0L.5F0=;^ ;N._=V7B+S2R5
M4*"M0$T,U#F]VQY/:8B/ 3\$#'9Q)J&2"^)S,+Y4.=T$02"A=(&!^^T*]R!E
M(/(R7B9..J<,P.7YG?USK-W7<N$6[E'^%)5K<WJ@I(*:]](]X?  4SVWE$S%
M?X4K2!\>E/@<)4H;5U+VUJ&:6+P4Q5_'7>BX#^-->CO!U@')!$AFP"'F86.B
MJ/P3=[S(# [$C+WO>'CB[3'QO2F#,[8BWGGQUGNOQ7:_S]@U$$TQIS$F6<;,
M$<RSSRF2M12GY!]XL@[?K2K<1?CN#X6'=8)TE2"-!.E_2UR+^?A7$K;HJ0+3
MQ&FRI,1>QTE>>.>!O4OBF_P.'Z?]D9M&:$LNZ/S+QO[7B Z\E,V-'Z'6?[#9
MD%"[<-S[LQG';#0<=M,/8O,W+GX!4$L#!!0    (  *#2$QV&:U_LP$  -(#
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;'U386_<( S]*X@?4')<
MNIU.2:1>IVF3-NG4:>MG+G$25(@S()?NWP](FF9;UB^ C=_SLS'9B.;)M@".
M/&O5V9RVSO5'QFS9@A;V!GOH_$V-1@OG3=,PVQL0501IQ7B2O&-:R(X66?2=
M39'AX)3LX&R(';06YM<)%(XYW=$7QX-L6A<<K,AZT< W<-_[L_$66U@JJ:&S
M$CMBH,[IW>YX2D-\#/@A8;2K,PF57!"?@O&YRFD2!(&"T@4&X;<KW(-2@<C+
M^#ESTB5E *[/+^P?8^V^EHNP<(_J45:NS>F!D@IJ,2CW@.,GF.NYI60N_@M<
M0?GPH,3G*%'9N))RL [US.*E:/$\[;*+^SC=I+<S;!O 9P!? (>8ATV)HO(/
MPHDB,S@2,_6^%^&)=T?N>U,&9VQ%O//BK?=>B]TAR=@U$,TQIRF&KV.6".;9
MEQ1\*\6)_P/GV_#]IL)]A.__4/B?_.DF01H)TC=+W(KY6R5;]52#:>(T65+B
MT,5)7GF7@;WC\4U>PZ=I_RI,(SM++NC\R\;^UX@.O)3DQH]0ZS_88BBH73B^
M]V<SC=ED..SG'\26;US\!E!+ P04    "  "@TA,%;.U>+0!  #2 P  &0
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M=V]R:W-H965T<R]S:&5E=#(Q+GAM;'U3VV[;, S]%4$?4"5*V@:!;:!I46S
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MTT&+-Y6Q6G@T;<U<9T&4$:05XYO-#=-"MC1/H^]H\]3T7LD6CI:X7FMA_QQ
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MGD8S3$-XNE7/TCC!/DJP#P3[?TK,;DJ,8>[C(EE4)(L0/-R(Q#"'&Q&R:9P
MW88G:U"E1AG&9>-=I^*1AL;_A<\C]97IMI<&791USR<TN5'*@DLEN7.Y=&Z*
M5X-#8_WVP>WU_)9GPZIA&5.R_BO*/U!+ P04    "  "@TA,7P)/#<8!   W
M!   &0   'AL+W=O<FMS:&5E=',O<VAE970R."YX;6QU5-MNW" 0_17$!P2;
M7:?IRK:4356U4B.M4K5Y9NWQ1>'B EXG?U_ CFMMZ(MAAC/GS#",\TGI%],!
M6/0JN#0%[JP=#H28J@/!S(T:0+J31FG!K#-U2\R@@=4A2'!"D^26"-9+7.;!
M=])EKD;+>PDGC<PH!--O1^!J*G"*WQU/?=M9[R!E/K 6?H+]-9RTL\C*4O<"
MI.F51!J: M^GAV/F\0'PNX?);/;(5W)6ZL4;W^L")SXAX%!9S\#<<H$'X-P3
MN33^+)QXE?2!V_T[^]=0NZOES P\*/[<U[8K\!U&-31LY/9)3=]@J2?#:"G^
M!UR .[C/Q&E4BIOP1=5HK!(+BTM%L-=Y[658I_DDRY:P> != N@:<!=TR"P4
M,O_"+"MSK2:DY[L?F&]Q>J#N;BKO#%<1SESRQGDO)4T^Y^3BB1;,<<;0#29=
M$<2QKQ(T)G&D'\)I/'P7S7 7PG=;]>PV3K"/$NP#P7ZKGR97)<8P_RDRBXID
M$0)Z)1+#[*Y$R*9Q G0;GJQ!E1IE&)>-=YV*>QH:_P\^C]0CTVTO#3HKZYY/
M:'*CE 672G+C<NG<%*\&A\;Z[2>WU_-;G@VKAF5,R?JO*/\"4$L#!!0    (
M  *#2$P&F7GMQ0$  #<$   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM
M;&U488^<(!#]*X0?<*RLWFTW:G)[3=,F;;*YIM?/K(Y*#L0"KM=_7T#/VBU?
MA!G>O#?#,.:3TJ^F [#H38K>%+BS=C@28JH.)#-W:H#>G31*2V:=J5MB!@VL
M#D%2$+K;W1/)>(_+//C.NLS5: 7OX:R1&:5D^O<)A)H*G.!WQS-O.^L=I,P'
MUL)WL#^&LW8665EJ+J$W7/5(0U/@Q^1XRCP^ %XX3&:S1[Z2BU*OWOA2%WCG
M$P(!E?4,S"U7> (A/)%+X]?"B5=)'[C=O[-_"K6[6B[,P),2/WEMNP(?,*JA
M8:.PSVKZ#$L]&49+\5_A"L+!?29.HU+"A"^J1F.57%A<*I*]S2OOPSK-)VFZ
MA,4#Z!) UX!#T"&S4,C\([.LS+6:D)[O?F"^Q<F1NKNIO#-<13ASR1OGO98T
M27-R]40+YC1CZ :3K CBV%<)&I,XT?_":3Q\'\UP'\+W6_7L0YP@C1*D@2#]
MI\3LIL08YCXNDD5%L@C!PXU(#'.X$2&;QDG0;7BR!E5J[,.X;+SK5#S2T/B_
M\'FDOC'=\MZ@B[+N^80F-TI9<*GL[EPNG9OBU1#06+]]<'L]O^79L&I8QI2L
M_XKR#U!+ P04    "  "@TA,S'#F2,X!  "<!   &0   'AL+W=O<FMS:&5E
M=',O<VAE970S,"YX;6QU5&UOVR 0_BN('U!LDGA;9%MJ.DV=U$I1IVV?B7U^
M4<&X@./NWP^PXUD>_1*X\_-R1SC24:I7W0 8]"YXIS/<&-,?"=%% X+I.]E#
M9[]44@EF;*AJHGL%K/0DP0F-HH0(UG8X3WWNK/)4#H:W'9P5TH,03/TY 9=C
MAF-\2[RT=6-<@N1ISVKX >9G?U8V(HM*V0KH="L[I*#*\'U\/"4.[P&_6ACU
M:H]<)Q<I7UWPO<QPY H"#H5Q"LPN5W@ SIV0+>-MUL2+I2.N]S?U;[YWV\N%
M:7B0_'=;FB;#GS$JH6(#-R]R?(2YGP-&<_-/< 5NX:X2ZU%(KOTO*@9MI)A5
M;"F"O4]KV_EUG/5OM#"!S@2Z(9#)R%?^E1F6ITJ.2$UGWS/W%\=':L^F<$E_
M%/Z;+5[;[#6G\9>47)W0C#E-&+K"Q N"6/7%@H8L3O0_.@W3=\$*=YZ^6[LG
M'PCL@P)[+[!?^]-HTV((\T&3AZ#)(2! -R8AS"YLD@1-DH# ?F,2PAPV)F1U
M.P2HVL^%1H4<.C^3J^PR>O?4WZY_\&ENGYFJVTZCBS3VCOJ;5$EIP)82W=F&
M&_M4+ &'RKCM)[M7T\!,@9']_!:0Y4'*_P)02P,$%     @  H-(3%,:X-NV
M 0  T@,  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL;5/;;N,@$/T5
MQ >4A*1I%-F6FE;5KK25HE:[^TSL\47EX@4<MW_? 3M>;]<OP SGG+DP)+VQ
M;ZX&\.1=2>U26GO?'AAS>0U*N!O3@L:;TE@E/)JV8JZU((I(4I+QU6K'E&@T
MS9+H.]DL,9V7C8:3):Y32MB/(TC3IW1-KXZ7IJI]<+ L:44%K^!_MB>+%IM4
MBD:!=HW1Q$*9TOOUX;@-^ CXU4#O9F<2*CD;\Q:,[T5*5R$AD)#[H"!PN\ #
M2!F$,(T_HR:=0@;B_'Q5?XJU8RUGX>#!R-]-X>N4[BDIH!2=]"^F_P9C/;>4
MC,7_@ M(A(=,,$9NI(LKR3OGC1I5,!4EWH>]T7'OAYO;*VV9P$<"GPC[2&!#
MH)CYH_ B2ZSIB1UZWXKPQ.L#Q][DP1E;$>\P>8?>2\;Y+F&7(#1BC@.&SS#K
M"<%0?0K!ET(<^7]TODS?+&:XB?3-//INORRP71381H'M/R7>?2EQ"?,U")OU
M5(&MXC0YDIM.QTF>>:>!O>?Q3?["AVE_%K9JM"-GX_%E8_]+8SQ@*JL;'*$:
M/]AD2"A].-[AV0YC-AC>M.,/8M,WSCX!4$L#!!0    (  *#2$Q9IZ,7Q0$
M #<$   9    >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;'54;6^;,!#^*Y9_
M0$U,LG01(#6=ID[:I*C3VL\.'&#5+]0VH?OWLPVE**-?L._\W//<^7QD@S8O
MM@5PZ$T*97/<.M<="+%E"Y+9&]V!\B>U-I(Y;YJ&V,X JV*0%(0FR1<B&5>X
MR*+O9(I,]TYP!2>#;"\E,W^/(/20XPU^=SSRIG7!08JL8PW\!O>G.QEOD9FE
MXA*4Y5HA W6.[S:'XR[@(^")PV 7>Q0J.6O]$HP?58Z3D! (*%U@8'ZYP#T(
M$8A\&J\3)YXE0^!R_\[^/=;N:SDS"_=:///*M3F^Q:B"FO7"/>KA :9Z=AA-
MQ?^$"P@/#YEXC5(+&[^H[*W3<F+QJ4CV-JY<Q7483_;;*6P]@$X!= ZXC3ID
M%(J9?V..%9G1 S+CW7<LM'ASH/YNRN",5Q'/?/+6>R\%I5\S<@E$$^8X8N@"
MLYD1Q+//$G1-XDC_"Z?KX>EJAFD,3Y?J^T_TMZL$VTBP7>JGR56):YA/1':K
M(KL5 GHELH9)KT3(HG$23!.?K$6E[E4<EX5WGHH[&AO_ 1]'ZA<S#5<6G;7S
MSR<VN=;:@4\EN?&YM'Z*9T- [<)V[_=F?,NCX70WC2F9_Q7%/U!+ P04
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M7/;7[>6H]7)CS<D=(R?7L^SM+U!+ P04    "  "@TA,?&\ E!T"   +!P
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M:LRGDSI-)!OF2P@M-V'Q%U!+ P04    "  "@TA,_VOWT8D#  "G$0  &0
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MX- !;QVP*P<<.XB@@PAD$%G-ZC235E-V*S:R.K'L:]@HPHF,82)CD,@8.YA
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MD_CSQO?R>.K'&\EV?2Z.\@_9_WE^:X>KY)9E7]:RZ4K51*T\;.(7\OPJV#A
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M"GR P@=L:XABT^/B'J0Q*#);( A>G1YC+5#Y&,U6E\I\1NE\J- '*'TR\:-
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MZ"#Y_!:EH(,4((BL4J2C@F//WI2Q)O8P##('0>8 2&R!M)IT$"3PD 4":29
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MWQ<2_D5@YQ38O;T5B5,@^6\KBN0-+O'J #(0M;VK$I5\Z)3YU:OH,@X> G.
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MKC*19V2TX/K7R*Y<T+)CD:F4^+T=\TJ/3<=_#X,#W"[ [0/DV?\+\+H [R/
MU^+;S+343UC@=<IH8[#V;=58?13HQ9-F9FI3>Z>?2;5<[M[601"F]DT1=9AM
MBW$'&-0C;,G>'^%"1VS=2;C[>, .0'CP"1XHPM/QWH.("";P00)?$_A#A<@?
MN=!B(HVI6DQHC4 [ )18+IQ* *823%()@A@F"$&"<+D9$4@0+3"CQ<0#G:XU
M?JL09D9)#"823Q+Q9JQ,P/ADN1/(@:O#6>!%!WH4&HS, $$S;J"94D53/V;*
M!(&5N$'N$X[ I8:\)8YX@-AD[ @$FDL&+ELTK5O/GV& JPT%3S@"UQL*ES@2
M3L1&TV]D"D+.P+?';.#B1=/J#8(Y"KCL4/R$)W#EH62))\GTS]+RQIZT(%4^
M/<H9Y6(/+KN2L+/N"[B1T6LEU+4RV.U[CXVK+LO1_E;U)/H2_:!I&YKOF)WS
MBAL'*N15K"_,$Z6"R!0=2WY#%]E#]8N"G(2:1G+.VD:B70A:=TV2W7=JZW]0
M2P,$%     @  H-(3&&='VQ3 P  F@X  !D   !X;"]W;W)K<VAE971S+W-H
M965T-3DN>&ULE5?=;ILP&'T5Q , -A!#E41J,DV;M$E5IVW7-'$25, 9.$WW
M]K,-9<0<3UTO"G;.]V=SCOTMKZ)][DZ<2^^UKIINY9^D/-^%8;<[\;KH G'F
MC?KE(-JZD&K8'L/NW/)B;XSJ*J11M CKHFS\]=+,/;3KI;C(JFSX0^MUE[HN
MVM\;7HGKRB?^V\1C>3Q)/1&NE^?BR+]Q^?W\T*I1.'K9ES5ONE(T7LL/*_^>
MW&UIK@T,XD?)K]WDW=.E/ GQK >?]RL_TAGQBN^D=E&HQPO?\JK2GE0>OP:G
M_AA3&T[?W[Q_-,6K8IZ*CF]%];/<R]/*SWQOSP_%I9*/XOJ)#P6EOC=4_X6_
M\$K!=28JQDY4G?GO[2Z=%/7@1:52%Z_]LVS,\SKX?S/#!G0PH*,!3?YI$ \&
M\6A C$'89V9*_5#(8KULQ=5K^]TZ%_JC('>Q6LR=GC1K9WY3U79J]F6=+J)E
M^*(=#9A-CZ$3#!D1H?(^AJ HQ(;.S.EM@"U Q#A"#(N(C7UR4X0CQ00Z2(R#
M>.H@9=A!"AVD( .KRDV/R0RFZ9<Q6%@K,<=$08X36<!$%B"1V$JDQ^23($D4
M9/:FS%$Q"R9%W23#8#(,))-8R;!9Q8O L?09#)*!(*D5))O70@)'*3F,DH,H
MUN9M>@R);I8,!]$@Q,8(A&$V'1$H<\1QL)[,7:2IPP5D]3VA[^<,P;0EB+>Y
M76T,*)%9WRH$.7A#L 209)X,FREA@JC#<CN=.4QQ)W7M$984 C2%$3NA'I1.
M(CD^:X+U@@#!8+9R$:@%S!4)BP%!:F!3: "Q2:0\"Y)H\N<0=H+5@2!YF#$*
M@)CC!")8'P@0")9@%Q23GT;O9Q3%O*: US-&#:!;LEBRO(4@U[&/%8+2=S!J
M -F'D7TN I@^C5P+C/6& KUA#M6C6"7H?]P4*.8U17>%V1ZABT!L+PH"N?8(
MTY\B^L_V"%P8\B!)[70 +'.I,,4B08%(,%LD(,BU"5@6*&)\9L=!(%<]6!8H
MD(5LMKX(9.]C.+G1U[P]FN:G\W;BTDA]=Y[,C@W6/=4=@36_48U7WR;]==-W
M;5^+]E@VG?<DI.HW3%=P$$)RE6,4J&_MI!K%<5#Q@]2O3+VW?;?4#Z0X#YU@
M.+:CZS]02P,$%     @  H-(3%Z&)*8F @  A@8  !D   !X;"]W;W)K<VAE
M971S+W-H965T-C N>&UL?57;CILP$/T5Q >LN>1"(H*T256U4BM%6W7[[)!)
M0&MC:CMA^_>U#:'$.\T+MH=SSIPQ]I!W0KZI"D '[YPU:A-66K=K0E19 :?J
M2;30F#<G(3G59BG/1+42Z-&1."-)%"T(IW43%KF+[661BXMF=0-[&:@+YU3^
MV0(3W2:,PUO@I3Y7V@9(D;?T##] _VSWTJS(J'*L.32J%DT@X;0)G^/U+K-X
M!WBMH5.3>6 K.0CQ9A=?CYLPLH: 0:FM C7#%7; F!4R-GX/FN&8TA*G\YOZ
M9U>[J>5 %>P$^U4?=;4)LS XPHE>F'X1W1<8ZIF'P5#\-[@",W#KQ.0H!5/N
M&907I04?5(P53M_[L6[<V WZ-QI.2 9",A*2V4-".A!2CT!Z9Z[43U33(I>B
M"V3_L5IJST2\3LUFEC;H]LZ],]4J$[T6\RS)R=4*#9AMCTDFF'A$$*,^IDBP
M%-OD ]U+L$,0*9XA18M('3^=&ES^Q^(,%9@Y@=G=+J3>+F"8F5<(AIGC1N:H
MD3DBL/",8)BE9P3#9+B1!6ID@0BL/",(9A5Y1AYC[HPL42-+1"#VC/28.'*@
MQH%\'P\A=S8RU$:&V/#O2?8Q1^R=HEV/64TAR5/L?QHRN;X<Y-EU.A64XM)H
M>U$FT;&9/B?V^GOQK6FR?4_\)]-WZ.]4GNM&!0>A37-Q+> DA 9C,GHRQZ<R
M/X5QP>"D[71IYK)OC?U"BW;H^F3\]11_ 5!+ P04    "  "@TA,8+#CQ7\"
M   5"0  &0   'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6R55FVOFR 4_BO&
M'Z#B"^J--=GM;;,E6]+<Y6Z?:4M;<U4<T/;NWP_0NA9/E^Z+ CXOYP '*<Z,
MOXL#I=+Y:.I6S-R#E-V3[XO-@39$>*RCK?JR8[PA4G7YWA<=IV1K2$WMAT&
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M!\X# A>ANCO99^8F, -!A^F20_--6_T#4$L#!!0    (  *#2$RGAA*)<P(
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ME8A @NAC):80'/@C)2!, .>Q /-8  0A3+ $"9;W*X%<N#7<C[4 ,#C (S%
M4#23RTR;(H!BYM-"8!MND/<)1> ^0_X=BDPQ.%B.%0% H3N3"]RR:-IL.)PK
M!^XV%'Y"$;C?$+Y#D2D&A^,C$ 2-#T%G<*J7E)_- !16RBZ5U.?GP-H/V8VG
MI\+(OM7#UTR+-YIV<O\D_)Q7PCHPJ6:.F0PGQB15.;H/2J],71;Z34%/4B\C
MM>;MQ&PWDM7=;<#IKR3)?U!+ P04    "  "@TA,RZU'B+\"  !S"@  &0
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MPV3I<KE,\60!"Y"^G*?9N6!GPSUP0LH2Y.9%717Z!$RJW!5[W4Z\A7,#GN"
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M=\&B-CF&=@3\;-? 7D 5*TC,@<-RLBWH54N2H.$BK^&778D6EO@.U,]UDUH
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MY#-;(Q,L"9Z9K#'D;5S/.R6&P)*=F!V4CM3TAT9JPK,Q+?D6U.-F0_((NA\
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M@ HBY^.RSATI_'AD\HF#8D@2 BH$C>_E?!MVWSAD<\$**)QXSN5V5GLE!$)
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M\>'C^Q>OHH\@89U_PAS#EXE>GQLVN^ >W^X7.9Q,N8[A^GRXO'H5<25DON$
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M@3XM:79$]@L1 !J7SWG?[ :MP.5_NE[C_/)#/?5YFK_]M_\]& Y_ (39?>F
M+'K9Y5)BU6_8#(I=PA6Q-6FD\NBQ#HJG$/NWZ7*Y"FD^.1^BJ[@ %I_%C\;_
M5"5[H?0_7?]RWH\^OKN,_HK5N[:2@4[V2W9 FL?^2D5H7HJYI6--^HY)K %/
M;S$7US4*#2D-2"3D6OZQ2&_S56D@+I_ )IV:<B.R>QEZ@O3)GV\N/;#9!X^E
MS7SV<A:OD])S,MK%]S]=_:(;<-_\O *XYFY?EOW)5Q^H-@E_W\@(WV&FPJPS
MN9AVAF,.)KGH]*:CSF R,.ZN81L)-IMRUI*WN>N>E);K%/-$RM^\KH888K[;
M!AB0<J=EKEBQY121!DPE9+B%"ZXU&1 /J?H)$E7JB,M\4,QCBY@"0*B]LR@Y
M)L[.\-FV/07,8UW;(%'=-7(&.,//28;A$Y5ENZ&JLC<]KF/F-0F *FVTK(Z'
M6B;2Q)>=MRKT9D[Q5B' 58HZ9@/>5C8RJH]S5%M/U5(O^((.%_74Y'@BH*=B
M[8Z.22*@G,8;:?OJ6[DI"ZG XB7)__N8P5-8 9V'6+@F6'D([TQZ"TK5QP4Y
M,I#@X$VG[N%<&9+CWK "5"P&8]^(^C/;-+E6"/%W#FUZ0-&1@HD[#FT-E1:V
M<+7/*!A6Q!NWF$!^UX<B$!)7FI$=?4I6R>8>$[XP:AJT\@))EUK2+P%-YOOG
M%(53BEGD-@8"OJ3:8*4$5M/X&B)-R]NS-(/48+?-Q6SN%,Q\O=YE6NB1_@3,
M9SQP?8MEU%+Z7:H878#,LDE]50*U7EELBN=P^)A"AFB2;[:("^QAYAH1L@L$
M9K@/S0ZC#+(??#"0;GU'"O$BY<S-*ABJ/%2<!^( Z% Y.RRVH."H^0XD$7L+
M3V3)WET]ZF5'<7/W\>JVBB>$'/3A:F6A@YCK'FH[LVTCNNA):D4-TCY%BP!P
MGN=<0BM=),WN'[@0#ME8+Q-D,YB;+=6AODJMUN4'FUI]SR^2J!#&W:RY!"E9
M[WPL H.#ZS&Y]K0>#35B@'E\$.N+#EI"SS<QF@FN[N,-#GTQO 1!K3^!@[CP
M,1_^2Q\L:-2":0T.GD' MO<<V[/W>Y<%F7$EK%*K)%> 4-L0QL\.QJP3&K+#
MM83)TB16>6)EYGB60K+"?-38@M!E='1L&5=F,91T_MG76) ;7/HIL, B)6ZZ
M\1;:TE;,JB<SDQT(B(47VR7BD1S&]6(QYYCU8R*%L"M)>O^,-3_=A _2CE>0
M%ZXSW0RJ5NM3CNUZ"&> PRU,+6\7&RN2L-8S4A0.VD6H4M<,-(,$KH,J:KK,
M;4XN@@Q,F<=WI&[*S7"A &@MQH(56O6NYB(_+NG-&)O[4R?O& )"Q>BXH",%
M*<F.T!4+.TE6T8^[=)EWC#TFC/IQ(' I.F*$O*)0GL+YEDF/L3:IH'KEC? E
MN(/Z@GM.K^^51%S@<W"5'6T@J+*:(7BGO&.>Y[^5$FN'!Q2X-6I?UKH-A7T]
MW$Y!$!1I46L]2K@0=1YPSQGGX:^)6]K;HLL@]8$G3/!$F -,KB],#O^NP.1/
M)O#P)V:V(C5?)U+/VO)8Q5NB)TE0NQ7WUP"9D(XC<$LOBB7-W"N,1:C:[ 2.
M?E#GH>Z[#M._1YID#\^_I"3Y*5Q2''&_75B3]A)BEQ*0((XBT>A.-G1*5+%4
MV\MWIH%,K52 K< 73CQ'X<.U6>>BW()G>:DAIZ78#>=X=%3&8DNUV#B2699I
M%Y@7NC[UIRDM2+<A?$,?FVVI+G4WM5 -BS!8IY?*VB "X*Y\4K K(,B-89 R
M<ST#5T6",1S=5EC3D>I/4]'?:GIEI6R6=!XOG9F,.U+@@05GZC*DB^ KAP_T
M3$K2[)RO"UTMAWZ,+W-GA*#NS&.X!4'N6C=Z0_@@'<R*1%-5I=,R94DL:[4E
MWR5;31+\ &/?($FO/O-*"QRX)PXDV#4-&%T2J<BPK)MC\"B$L,Z\3%<[QT]<
MX;CT=_1D>4%C/R18!@X! !@24ZT-KNB)\U2:I4TGG=EX C]GG<ED&/VM[54J
M!HK$$DZ?G94H.P"%V&$$5?(E*18IWRTIN6IJV?,GH.1@?Y'.H#\ /;T_&B*X
M"C5>R-IHU'JC&BV"UN],AR,88]2?@>K.T'O*;F>]SJPW@)^CSF P<KL]UU?1
MA7!.QX+2DHS@6=SSZ+T9+=PH;&PZ@ 6.1@/@VV;#_4G4']9JAMAEU?;KO96^
MCJS*+J05A:55%3IK2@^+4)8L,=RJ$[78*WG-'>3*Z FFS0BT;H,3[W!2/MW@
M!7FM'1K+"T1ZL7AKI<ND)B=M4$<D>L[1?ENN*>8[*#5LT3G6JFB@A6)1VL20
MQHKA#_OC23^U;4$5A_9R2,#N[W,54DIJQ[0KN-*B0II//:_U;6Z <VY*V<;4
M%,@UD:J476)KT&JAX2[PYK*"M@[W&O U+#U*M-EU;$3OL2)J$!'JQC,MXJ3]
M7B-UEX)U=]3KPA0,JO:'TVU[=Y34>:Y20L+^<R[^?&6TFUK!79^W+*70G!ZD
M"<A72-0[3$REVMT'+7+73HK;%E#)N7?9]@0I&3Y0Q[2S5%@!\?A"9T^DWKA;
M?!DS8;*=U%H8T+\S+%B8D$["UH+/R2K?D&XU 'T1'[B1A '\GJO$$,GK7L#_
M4Z<0$/E8@J"&AD^VM4UA@'X/GL.:B.CT8V3I=X>N",9)U)]0U8D^ZF>6EJF5
MM&]J6>,</5-P+224RV]4_J=2I@[M7[4[Y?B2Z7 XZG5G?&]/AM/N9! U>%A1
M<<9_)J9AGJ[?7M#&*FW2L.&1Q=!:AOTN*&^A!+JC\A\1T-I\G9)9?YE0*7@O
M8I-=+B@2DRH:ZS)YS-H:B&'+1G98W_8?3.EX("&.(0,G/14S]$UIG4KABB?B
M^<>T_.W\%E\(JWU@&<+O )-F\.\K=:N:0KQ#K,+R732< *Z9)U:88G$**\,J
M7>59-()#P_]?HMD'BU?N4PR94ES6GS51)X2H[E\1''!_V.WUN&$<B!]-EZ!G
M"_A5+@%N$ST-22@/G7Z\^1G6; ET?OO/N1RT:JY+Z[?N[LCTPMV1\8S*W.."
MGU2B4V_1P*2R[X"I4/4FW'=PE]JN3>,R^?9,NR!RZ=(JO5:VC><SJIR/KWL)
MPY#23/8A>T ?[ %]XX/!DH/TB&LC)_W/N,H[%W])XK6:N$0'? *,D-I-/+4;
MM9[D*Y8-Q&2.[^+&*<)AE=ZESCK AD1M./B/I,A%!O)]*B1LU1LJO7#9Q$8#
M%4,+N&+\^ZV FNZU[W33- 9%Z2!644T&%(6N%=&NN*]K1&E_"R9HL%?4\I<U
MHX-6_DFI)V6#* "$BI13;'5H+4APJS&/9N&,E4XF(\=QJ>:3VXH-5T##Y=-0
M,L95DS%WZ\J[5^KU'3<860M5LX;O<%P*UK87@V:4<O@<AL%5APZ*0;)!G\_M
M5N=6EG*QQH:N*_XJ#ENOHM2X8PA2%0&XAF_I&F)$3NLM^4,N:=/->/NO=3,8
M4!1>P(@MWA^QZ');:FNTYLHET@;@<\)]Z/0*;1)X LVF&SX^VBS1<:(JZ),#
MLG+1'7']YI/1K'O1,TU:)'3]GL4!+!=:K*A<KRI!)- \_>8YSSVNIW8-P]M'
M-M(#7 G+[P(Y[(5E&"]F84MK+*WEBDHU4P.O*QXV>YQ2^;"42,(M\SX*C$&D
M;F *\Z!I!6VR@>K+180!AUWNKH@2%.%$!8<;5*]-SF;Z)JV,[&MXU._#YB3\
M&B#3CX@>AU0P,T&]=XO_+GJQRF$'-PM 9G(VO= :KN_KT=25:->*BT[B-,G+
MY6JY4[^(%;?6T/K&8OVEB4LWL2L>*Q1FE6=WY]2N#R\A"N[4*KS89F@]UV@7
M3G?&0*G22/4@P8Y=[76Q603>0E/:S42O.O*Y=#V.3'OZ#-L2YX5$@"Y3HN>4
M%H+8["I&V/!&'Z):R=%28K6DM4[\8GEP"OQBBS&+_+&OD#J[N# Z4;74^:$V
MUU.M2F?*&!_?(Z3F7R3[AT<DRD34_HRZO98:L3'6ZS/-:6EC$R!IX\:6"=(V
MRVZE&_V\$7.+'I52>%^4-)C=MD'&N,=XKFXYCZTD 2MJL:X7NU;D,;6H:'W5
M% P.R]B@Y<VO*7 @UFNKB8Q5^A9&;58'H;>E"3\\((#30HE,NFXEN"8^NH:A
M/%V7DNLYV\(\SULFZDF1<\A<1Y6*D4J&KV9GF=C*AOL5R"Q^]41,/@#XN+J?
M%C#T&1>N+>Q.C9%^3^988J(OW!"&'MW[LR0PJJZOJZT4E*8-: N29!7Z+Q%V
MZ-6)"W*UL-L]. W7-QS;LO0MRQ._,%\C9RYU,UA#(Z@9GF 9!;+:\\)T9W!W
M%NLU25P--[K=.ZXG/G:J"+NTO,B1#6U6W4K"\3)P\U.:@4<F<U>"X8IAVP(Z
M-JWBC>YAJDV,<C%_($ZW7P'JWM,67NQ*"R_O@A.O&U +%T6[P<AQ]&6VW.3P
MI$0I39;M%S'V;<[8\J=H3<(^7'' $,5 /YSXF)6QL3<*#11S-H+[4?DX#\(:
MN?2R5G94H=.4,^F]KTV\B1L[YP_ :LO[=.-/1)$!CW!7^K9-%$:^8Z<P[%$"
M=,FOBH!?48B1R9X4&:!Y9293M7+#NZYB*GJIS*G+Q6'<QK!7A8ZO9,=EGEV4
M8ZG(@)R(*[+H*+Z,/96"1P#S5,G2-W.FZ40'-&R0#TM6AO8DK=JK51;RC&K^
MYZ6T6^,^Y^(D]=7=YWPMI)T)GH</0*_ODM@3N;X?_%CPM.,+EW2[U%E>"SX0
MM&2MQ>M&32Q"D<74ON86#!K*5";F85=8S'MDTN83K!Q433M!Y99O/XV.*RU-
MLRS+36CM@D2(AJ&L6&-E*L6[6*SP6.,5]M?@T&=&R:=AH,LI]?KP(^%4K!U-
MQI62^2>#F3'Q5W5D3^#:&5NG^42ML&Z9LKF'CTHA+8*>.%)8*+?=-AN@TFHE
MJ"E/7-LW+(Q^[2-NJH^'#ZIGRSN_#JE1CTP5+C8,/;T6@089P\?XP<6-4)WB
M_H@K%8]!EO];7OQ&-=>0[0/&C$8 J-$8E./7Z"6ZA\7>Y=@+HP^B_PC^1:OV
M230<SVB,X1!=/Q^$\%+TMX2THF&,C^F5^PV>GPQA4GQ_"N/X;SC&8P%Z48YQ
MU[N2W!6^?/9P>@%+&DYF\/:+7<HU!>E&K"GHD9_J3]'9A?_VHC<8XX@6C_"1
M21]$GDD/%OT&7Q^A8PO^&4:O=T7&&A5S\2];.IT!=M(:H&F_W^F-AK!H^#G
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M ^1G-"(T_/0;A4,KO3'VX3-F:!M\9R)HS"1E=L,1[6"A?\8%?<8%?<8%_3_
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M6@RG/:-RC#>?ZB5((TN\<"NL;1-"_3%+NH-L[TR95Y7%'I=C?O7VP2O60'X
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M8F]O:RYX;6S%FMU/VSP4A_\5JU?LHFOS64" Q,>8D/:R:J#MVB1N:Y'$E9W
M]M^_3MIN)R/]:3>'7M$FKO/(P7[..?;9J['/3\8\BY]E4;GST:JNUZ>3B<M6
MJI3NHUFKRM]9&%O*VG^URXE;6R5SMU*J+HM).)VFDU+J:G1QMNMK;B<79^V'
M[UJ]NC_7VZ]"9K5^48_RZ7PT'?EV$]*PZW3W=T-T:O^%R2P6.E,W)FM*5=4;
M**L*66M3N95>NY&H9*G.1[LF0E:Y^%35NOXE[JI-5[[M2'2/OLO/1X'_7,O:
M_^9%._U4J)&PI]K?L'=YT(+S05[[[Z;0N7]Z+AY:B/8'3IB%9\T,@0P!9'@P
MR&M3K@ED!""C0T+&!#(&D/$[0E[)0E:9$@_=5"" "0!,#@8HCN:20*8 ,CW<
MJY9N12!G '+&"WDEG>Z0YE8YW_3O1><8H!WSHMU*;<5W631*_*>D:^QF_ C<
M"8 [81ZWQNE*.=?.VB==;1K0Q7J*5NLI+]PWY6K;9'5C=;44URMIEZH'!U7"
M[)(K8ZUY]6"N4]ZU5;FNQ:6ULEKZ-TPQD4P"9IO<**M?9!L9]$8.J2-@=T=9
MZGJSB'1#9WRXX >MRG0?$JDC8';'O>^WC0E*)>;*^D59VMX[1=8(F+7Q4)OL
M>>R7/)5W(8&JW)L@"PDC8#;&C79KX_3?2$@/ ;,?OM8K_Q9[BMT7GB)5!,RN
M^+T</ZCEGPGR69FEE>N5IIA(&@&S-;83XU'^[$W8$,DB9);%G9=^M6P?*BZ=
M4[NA,R9_U45!*9$U0F9KS*W)O='$#]F*HNXO>"',.IA%<9GY)DW117F;V=(N
M+5:M_.KB[4$QD3Q"9GG<^TS7HYJF<X8/]TSE/V=O8JH0R2-DEP> %/<4$WDD
M9/;(GLA4'#U*#](;3:23D%DG@S'J#O(#I42&"9D-,QBL#E(BP83<@D%1:WA"
M,9%@0F;!D*A5//C^\L8OZSZ[VUZG-1#DG(C9.4-!XM KCY!R(F;E[(L6MZ 4
M$_DG8O8/C-"BB&+"NA>S?V"$%M'"5X0,%#$;"$=#@F(B T7,!GH;#@U.'V2?
MB-D^,"Z*9A03Z2<Z1 %,'-VH6NJB/YK(/]%ABF%B++H[%!/Y)V+VSW[,R]P+
MDY:WD7]B9O_LQ_SD:EU23&2@F+M4-A# ><;[=M)[QU-,9*"8V4![,.>-S5;>
MGA03&2A^+P,-8<:]K1>X]\)LH'V8UHA;WQ_%1 :*F0TT'+:/!ZK-,;)0S&PA
MB!E3"\7(0O%!DJ#MJJGI!FN,+!0?,@N*:184(PO%W)LS"#.9TCU,9*&$V4(8
M,Z"8R$()LX5H3KG]?ZQD\3O'H)C(0LG[;=@(XO==\DLQD8429@OMR]#;+6%Q
M2^NM";)0PFPABOE9:A\1?S'.?1#>1>W@4DQX#H#]( #8$A-CBHDLE#!;:+#>
M,1;?5&8\:>^E(PLES!;:6_$8B_86Q4062I@M!##;]8EB(@LES!8"F#^47M)#
M*LA"*;.%R*;C8-J;(O>DS.Z!Q:TTI)C(/>DA:W IK<&ER#WI(6MP*<V 4N2>
M]+TRH$',A&(B]Z3,[L&8*<6$I]"8W4/WG(<G.%).RJP<6&]-CRDF4D[*K!R,
M21.?%"DG93]? #!G-/&9(>7,F)4S4+WN"AS;BQ03R6?&+!]8P9Y1^<R0?&:=
M?"9=8W=QEJN%7S;R>_\(YZ]GLLCF5K1_-F?>XJ0]HK)HBN+:7_M:?3&RO=[U
ML3NW?O$_4$L#!!0    (  *#2$S\FJ>/5@(  #TK   :    >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'/%VDUNVS 0AN&K&#I :,Z0HZ2(L^HFV[07$&SZ
M![$E0621Y/95O:D*)/JZ,#YM;!@V9MZ%\4"@]/B2SDTY=6T^GOJ\>K^<V[RI
MCJ7TWYS+VV.Z-/FNZU,[?K/OADM3QH_#P?7-]K4Y)"?KM;EA.J-Z>IS.7#WO
M-M7PO//5ZF<S'%+95.[][-ZZX34?4RK97=_\W;A@_,E'G_YG?;??G[;I>[?]
M=4EM^:3B[X+*?1XD\T%"#]+Y(*4'A?F@0 ^*\T&1'F3S048/JN>#:GK0_7S0
M/3WH83[H@1[DUT#&-3\)8<W7V@.N/=]K#\#V?+$](-OSS?8 ;<]7VP.V/=]M
M#^#V?+D]H-OS[?8 ;\_76X#>PM=;@-ZRP+4VNMCFZRU ;^'K+4!OX>LM0&_A
MZRU ;^'K+4!OX>LM0&_AZRU ;^'KK4!OY>NM0&_EZZU ;UW@K 0=EO#U5J"W
M\O56H+?R]5:@M_+U5J"W\O56H+?R]5:@M_+U#D#OP-<[ +T#7^\ ] Y\O0/0
M.RQPUHT.N_EZ!Z!WX.L=@-Z!KW< >@>^W@'H'?AZ!Z!WX.L=@=Z1KW<$>D>^
MWA'H'?EZ1Z!WY.L=@=YQ@7N5Z&8E7^\(](Y\O2/0._+UCD#OR-<[ KTC7V\#
M>AM?;P-Z&U]O WH;7V\#>AM?;P-Z&U]O WK; L^:H(=-^'H;T-OX>AO0V_AZ
M&]#;^'K70.^:KW<-]*[Y>M= [YJO=SW1.Q^;(>U^E.'4'O*M2_X9_F7-!.Y<
M/L[I]AG7J5_NGRA=QBW)75]O_D^Y3OT3X:85^>DW4$L#!!0    (  *#2$S5
M7/90"P(  $XJ   3    6T-O;G1E;G1?5'EP97-=+GAM;,W:RT[C,!0&X%>I
MLATUKJ\=$&4#; $)7L"3G#91D]BR#92WQPD7"=210+32OVF:'.></ZGUK7IV
M_^PISG9]-\15T:3D3QF+54.]C:7S-.3*VH7>IGP:-LS;:FLWQ,1B85CEAD1#
MFJ>Q1W%^=DEK^]"EV<7K];'UJK#>=VUE4^L&]CC47YK.WQJ6@;II36Q:'__D
M!<7L:I>[Q'QM5>1J+-@W)GR]<3S/]]T\4@AM33^*YM;KMJ+:50]]OJ6,/I"M
M8T.4^JZ,C0U4WZ70#INWO+<VI&O;Y\9LU[%/"\KCY4C/'>T/,%4..3GE;4'[
M1DV%UT_^JX'ONZ%R@>8^Y&I([9['RY%N<S6R<>$A'Y'&K5-3_:WAN?7Q?M@G
M%[;3]WTO_*,8V73XW5L_7 X!DD."Y% @.31(#@.28PF2XR](CA.0''R!$@1%
M5(Y"*D<QE:.@RE%4Y2BL<A17.0JL'$56@2*K0)%5H,@J4&05*+(*%%D%BJP"
M15:!(JM D56BR"I19)4HLDH4626*K!)%5HDBJT215:+(*E%D52BR*A19%8JL
M"D56A2*K0I%5H<BJ4&15*+(J%%DUBJP:15:-(JM&D56CR*I19-4HLFH4636*
MK!I%5H,BJT&1U:#(:E!D-2BR&A19#8JL!D56@R*K09%UB2+K$D76Y1%EG8YE
M;]OA?TG^.;=]G\^FOY&>OP!02P$"% ,4    "  "@TA,'R// \     3 @
M"P              @ $     7W)E;',O+G)E;'-02P$"% ,4    "  "@TA,
M9O,+8((   "Q    $               @ 'I    9&]C4')O<',O87!P+GAM
M;%!+ 0(4 Q0    (  *#2$QZDJOQ[P   "L"   1              "  9D!
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  *#2$R97)PC$ 8  )PG
M   3              "  ;<"  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @  H-(3*4:VFU6 @  KP<  !@              ( !^ @  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  *#2$RDY#6R%00  ,T2
M   8              "  80+  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q0
M2P$"% ,4    "  "@TA,*"=?H90"  "R"   &               @ '/#P
M>&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @  H-(3"90J'D(
M @  ;@4  !@              ( !F1(  'AL+W=O<FMS:&5E=',O<VAE970T
M+GAM;%!+ 0(4 Q0    (  *#2$Q_!L8,3P0  !$5   8              "
M =<4  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    "  "@TA,
M(4T9HT\"  #+!P  &               @ %<&0  >&PO=V]R:W-H965T<R]S
M:&5E=#8N>&UL4$L! A0#%     @  H-(3-B#^H$*!0  'QH  !@
M     ( !X1L  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (
M  *#2$S7D6<7L0$  -(#   8              "  2$A  !X;"]W;W)K<VAE
M971S+W-H965T."YX;6Q02P$"% ,4    "  "@TA,E*-+Y[0!  #2 P  &
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M970Q,RYX;6Q02P$"% ,4    "  "@TA,583$1+0!  #2 P  &0
M    @ &@+   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    (
M  *#2$QU/N;IM $  -(#   9              "  8LN  !X;"]W;W)K<VAE
M971S+W-H965T,34N>&UL4$L! A0#%     @  H-(3""E";^S 0  T@,  !D
M             ( !=C   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"
M% ,4    "  "@TA,T>Y H;8!  #2 P  &0              @ %@,@  >&PO
M=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (  *#2$R)V=*DM0$
M -(#   9              "  4TT  !X;"]W;W)K<VAE971S+W-H965T,3@N
M>&UL4$L! A0#%     @  H-(3'89K7^S 0  T@,  !D              ( !
M.38  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    "  "@TA,
M%;.U>+0!  #2 P  &0              @ $C.   >&PO=V]R:W-H965T<R]S
M:&5E=#(P+GAM;%!+ 0(4 Q0    (  *#2$R$)3D,M0$  -(#   9
M      "  0XZ  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%
M  @  H-(3._@D6"T 0  T@,  !D              ( !^CL  'AL+W=O<FMS
M:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  "@TA,*DS]@;,!  #2 P
M&0              @ 'E/0  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+
M 0(4 Q0    (  *#2$QQ2IR4M0$  -(#   9              "  <\_  !X
M;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @  H-(3!U\)1JW
M 0  T@,  !D              ( !NT$  'AL+W=O<FMS:&5E=',O<VAE970R
M-2YX;6Q02P$"% ,4    "  "@TA,8=?E3\4!   W!   &0
M@ &I0P  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  *#
M2$SW JLQQ0$  #<$   9              "  :5%  !X;"]W;W)K<VAE971S
M+W-H965T,C<N>&UL4$L! A0#%     @  H-(3%\"3PW& 0  -P0  !D
M         ( !H4<  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4
M    "  "@TA,!IEY[<4!   W!   &0              @ &>20  >&PO=V]R
M:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (  *#2$S,<.9(S@$  )P$
M   9              "  9I+  !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
M4$L! A0#%     @  H-(3%,:X-NV 0  T@,  !D              ( !GTT
M 'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    "  "@TA,6:>C
M%\4!   W!   &0              @ &,3P  >&PO=V]R:W-H965T<R]S:&5E
M=#,R+GAM;%!+ 0(4 Q0    (  *#2$PF],T=Q0$  #<$   9
M  "  8A1  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @
M H-(3,P5A#;% 0  -P0  !D              ( !A%,  'AL+W=O<FMS:&5E
M=',O<VAE970S-"YX;6Q02P$"% ,4    "  "@TA,(\C[?,4!   W!   &0
M            @ & 50  >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4
M Q0    (  *#2$S#"7U_MP$  -(#   9              "  7Q7  !X;"]W
M;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @  H-(3)B,*CZV 0
MT@,  !D              ( !:ED  'AL+W=O<FMS:&5E=',O<VAE970S-RYX
M;6Q02P$"% ,4    "  "@TA,[+GZ!2,#   G#P  &0              @ %7
M6P  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (  *#2$S&
M_?D!]0,  -<6   9              "  ;%>  !X;"]W;W)K<VAE971S+W-H
M965T,SDN>&UL4$L! A0#%     @  H-(3'QO )0= @  "P<  !D
M     ( !W6(  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  *#2$P,.5#,]0$  !4%   9              "
M 9QR  !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @  H-(
M3/]K]]&) P  IQ$  !D              ( !R'0  'AL+W=O<FMS:&5E=',O
M<VAE970T-BYX;6Q02P$"% ,4    "  "@TA,:J&-5N<#  #%%   &0
M        @ &(>   >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0
M   (  *#2$PSI9?E60(  .('   9              "  :9\  !X;"]W;W)K
M<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @  H-(3/:LT&,@ P  VPP
M !D              ( !-G\  'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q0
M2P$"% ,4    "  "@TA,?2 P=X,)  "'00  &0              @ &-@@
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    (  *#2$RQ&Q0E
MBP(  , (   9              "  4>,  !X;"]W;W)K<VAE971S+W-H965T
M-3$N>&UL4$L! A0#%     @  H-(3/\"$)V3 @  A0@  !D
M ( !"8\  'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    "  "
M@TA,/+S<)DT"  !/"   &0              @ '3D0  >&PO=V]R:W-H965T
M<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    (  *#2$PRG)AZ]P$  $@%   9
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M970U."YX;6Q02P$"% ,4    "  "@TA,89T?;%,#  ":#@  &0
M    @ %/H   >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    (
M  *#2$Q>AB2F)@(  (8&   9              "  =FC  !X;"]W;W)K<VAE
M971S+W-H965T-C N>&UL4$L! A0#%     @  H-(3&"PX\5_ @  %0D  !D
M             ( !-J8  'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"
M% ,4    "  "@TA,";0N^OX!  !U!0  &0              @ 'LJ   >&PO
M=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (  *#2$RGAA*)<P(
M #P(   9              "  2&K  !X;"]W;W)K<VAE971S+W-H965T-C,N
M>&UL4$L! A0#%     @  H-(3$]P,TU$ @  ,0<  !D              ( !
MRZT  'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    "  "@TA,
MT (7Z=<$   H&0  &0              @ %&L   >&PO=V]R:W-H965T<R]S
M:&5E=#8U+GAM;%!+ 0(4 Q0    (  *#2$S5NR "8P(  )X(   9
M      "  52U  !X;"]W;W)K<VAE971S+W-H965T-C8N>&UL4$L! A0#%
M  @  H-(3,NM1XB_ @  <PH  !D              ( ![K<  'AL+W=O<FMS
M:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    "  "@TA,;R4^,O,#  "[%
M&0              @ 'DN@  >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+
M 0(4 Q0    (  *#2$SKI"(OZP$  /X$   9              "  0Z_  !X
M;"]W;W)K<VAE971S+W-H965T-CDN>&UL4$L! A0#%     @  H-(3$IA>O]0
M @  6@<  !D              ( !,,$  'AL+W=O<FMS:&5E=',O<VAE970W
M,"YX;6Q02P$"% ,4    "  "@TA,%U"*QR$"  #_!0  &0
M@ &WPP  >&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    (  *#
M2$SS"GVC$P0  ,H3   9              "  0_&  !X;"]W;W)K<VAE971S
M+W-H965T-S(N>&UL4$L! A0#%     @  H-(3&%[[+('B@  ,#T" !0
M         ( !6<H  'AL+W-H87)E9%-T<FEN9W,N>&UL4$L! A0#%     @
M H-(3-[6^*IK @   PX   T              ( !DE0! 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    "  "@TA,>S53WA<%   F+P  #P              @ $H
M5P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @  H-(3/R:IX]6 @  /2L
M !H              ( !;%P! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @  H-(3-5<]E + @  3BH  !,              ( !^EX!
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %$ 40 I%@  -F$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.8.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>270</ContextCount>
  <ElementCount>337</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001000 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsOfIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002000 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002501 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsOfComprehensiveIncomeParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Income (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003000 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1003501 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1004000 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101100 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisOfPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102100 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103100 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2104100 - Disclosure - Restructuring Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringCharges</Role>
      <ShortName>Restructuring Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2105100 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsAndCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2107100 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2108100 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2110100 - Disclosure - Net Income Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomePerShare</Role>
      <ShortName>Net Income Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2111100 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2112100 - Disclosure - Disposition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Disposition</Role>
      <ShortName>Disposition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2113100 - Disclosure - Other Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformation</Role>
      <ShortName>Other Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2114100 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2116100 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2117100 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsAndGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2118100 - Disclosure - Product Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarranties</Role>
      <ShortName>Product Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2119100 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2120100 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2220201 - Disclosure - New Accounting Pronouncements New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncementsNewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NewAccountingPronouncements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2302301 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Restructuring Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesTables</Role>
      <ShortName>Restructuring Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/RestructuringCharges</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsAndCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsAndCreditArrangements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Derivatives Schedule of Derivative Assets at Fair Value (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleOfDerivativeAssetsAtFairValueTables</Role>
      <ShortName>Derivatives Schedule of Derivative Assets at Fair Value (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2310301 - Disclosure - Net Income Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomePerShareTables</Role>
      <ShortName>Net Income Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomePerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2311301 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockBasedCompensation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2313301 - Disclosure - Other Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationTables</Role>
      <ShortName>Other Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/OtherBalanceSheetInformation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2314301 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsAndGeographicInformation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2317301 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsAndGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IntangibleAssetsAndGoodwill</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2318301 - Disclosure - Product Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesTables</Role>
      <ShortName>Product Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/ProductWarranties</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2319301 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2401401 - Disclosure - Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisOfPresentationDetails</Role>
      <ShortName>Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BasisOfPresentation</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2402402 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2402403 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2402404 - Disclosure - Fair Value Measurements - Estimated Fair Values of Convertible Notes (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsEstimatedFairValuesOfConvertibleNotesDetail</Role>
      <ShortName>Fair Value Measurements - Estimated Fair Values of Convertible Notes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2403402 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2403403 - Disclosure - Business Combination - Purchase Price Consideration (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationPurchasePriceConsiderationDetails</Role>
      <ShortName>Business Combination - Purchase Price Consideration (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2403404 - Disclosure - Business Combination - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combination - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2403405 - Disclosure - Business Combination - Pro Forma Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationProFormaInformationDetails</Role>
      <ShortName>Business Combination - Pro Forma Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2404402 - Disclosure - Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToRestructuringActionsDetail</Role>
      <ShortName>Restructuring Charges - Charges Taken Related to Restructuring Actions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2404403 - Disclosure - Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesChargesTakenRelatedToAccruedRestructuringActionsDetail</Role>
      <ShortName>Restructuring Charges - Charges Taken Related to Accrued Restructuring Actions (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2404404 - Disclosure - Restructuring Charges - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringChargesAdditionalInformationDetail</Role>
      <ShortName>Restructuring Charges - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsAndCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2405403 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsAndCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsAndCreditArrangementsInterestExpenseUnderConvertibleNotesDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense under Convertible Notes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2407402 - Disclosure - Derivatives Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesAdditionalInformationDetails</Role>
      <ShortName>Derivatives Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Derivatives Fair Value of Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesFairValueOfDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivatives Fair Value of Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Derivatives Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Derivatives Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2407405 - Disclosure - Derivatives Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesGainLossOnFairValueHedgesRecognizedInEarningsDetails</Role>
      <ShortName>Derivatives Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2408401 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsAndContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - Net Income Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomePerShareReconciliationOfBasicAndDilutedShareAmountsDetail</Role>
      <ShortName>Net Income Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2411402 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseInConsolidatedStatementsOfOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2411404 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedToValueStockOptionsDetail</Role>
      <ShortName>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2412401 - Disclosure - Disposition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionDetails</Role>
      <ShortName>Disposition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Disposition</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2413402 - Disclosure - Other Balance Sheet Information - Other Balance Sheet Information of Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfInventoriesDetail</Role>
      <ShortName>Other Balance Sheet Information - Other Balance Sheet Information of Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2413403 - Disclosure - Other Balance Sheet Information - Other Balance Sheet Information of Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationOtherBalanceSheetInformationOfPropertyPlantAndEquipmentDetail</Role>
      <ShortName>Other Balance Sheet Information - Other Balance Sheet Information of Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2414402 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2414403 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2414404 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsAndGeographicInformationRevenuesByGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2416401 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IncomeTaxes</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2417402 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2417403 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsAndGoodwillScheduleOfEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2417404 - Disclosure - Intangible Assets and Goodwill Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsAndGoodwillAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets and Goodwill Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2418402 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail</Role>
      <ShortName>Product Warranties - Product Warranty Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20171230.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2419402 - Disclosure - Accumulated Other Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>holx-20171230.xml</File>
    <File>holx-20171230.xsd</File>
    <File>holx-20171230_cal.xml</File>
    <File>holx-20171230_def.xml</File>
    <File>holx-20171230_lab.xml</File>
    <File>holx-20171230_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2014-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0000859737-18-000002-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-18-000002-xbrl.zip
M4$L#!!0    (  *#2$P2SR53O8X! ,99&  1    :&]L>"TR,#$W,3(S,"YX
M;6SLO5EW(T>2)OI\YU?HZOFFY/NBTZTYOJJR)J5,)5-=HZ<ZD4"01!<(L )
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MTO&YN;S[8XJF+3W_*WSS8?30</U9<OT> RQ).__\$FU/Y\LLJHD=?)G%V\_
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MG6H]G[<P6SB7=2YV]!)D<M$S L6J0/]0!6HH(.$=G>=C<5TY[X351+66J-4
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MGM)I$P1+!2#./OF>$L^IDCX%O*CF8!)YL(Q\X$09CNBF%./-,W\&0#NF;V]
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MB,\9 3;!><&8G^0DO/2868VD-2JDP]HQQ'*+04M=$<1JZ>#&E2)_BO/Q**C
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MJ!*_/RDB*\M]OP9,&U)N1!!"@QT5"/5@A' <6*"$6@WVH%F#PIECL-]"1U&
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M<:7,"I6KR1^[H7;%.'=Z:W!>3!VF-"J) E:1&,PHUBQ@P-EBHZ@VIK(-J2=
M'P[FCWD[?W@<SC:!UXB%"<P$K"RLWXQ_GHVM!0:60MI1KY'FF"1 (R>61L^9
MCDL5$F=R :^#;RT81\3O7.2KI1Q+*Y"DAB-'F1&$@=F? LXZ*G5N.)(QCF=D
M\RL!&LJG=F$,I\1P#+8_\X)&)-/IB[HTH-/C]_R0X.$M?4\"$]A+;0AEV.)
M&?/@;@JG0I1U?(=^H&N5^B&A6\C6F,34TYV@-=H'D(V;5O9YN !(6^8=BYHY
M%QW(5L48)UH%Y3W32YL3SR+,6I0W4>QQ5+3NL\%I4DD"QSZ&M#GC L8A"J<5
M"\@'\$V1XM7:W@BOYNQN'O\39WHFL8_E!-R A16@@RE#R5(D5 M.C /_,5B
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M3"X GMKG?H;[4 0Q?(AEQ\9(@2U2; %;4J:5?T_L<S_992?-K#/,H$!U67L
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M3X-!9Y2T^^T",$*H J(0LY0H;PB2O')II::)LN3@^*[0MHZ._>G<UG_K!(5
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MBK++.IYD'0_4L0@;%]&VJ#8*ZT ]JTNY:4#^T:7,KB2_+.5)E_(@'<N1)T:
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MO?M/Y1\_M.?;_==N>_#I*$C'M[NUEK7YS'Z.%E9^P8&H7BU!:F_A@)=>[K
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M[TZ"M@XF<I<A->->HP1D4Q1*]]/+"-Z)'I5,/."=@X>^$^&KWEMOSTY>C=7
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M!2=*+OH$]7DWY I;=SPE=,>KPXL?0-''5K[!E,_P<;?>'&0'\JFJ0.,")Q*
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M27^1D5^<*!^)&5AGL((_*I]"(=LUZ=_R&C;@/#(:]9Q'&0?IB "Z WL).2;
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M V?B%8*'<**S%,Y<GF4^A?,7'3S!.4 IG<C)*&7:K,T=#7R[6])3DG27-OP
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MHP]G"2V,*P7' Z-+$=PF?BC95Z@<PMM:9B$\15AQ0^33* O-S^E*E#0WEQ:
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M$A=-/$J748B.M\YDGS@*_$FW/2; '=U,TYB797E+-;4?Z)Q!BM29'1Z-:HA
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MD?@# U,1R3YR(X]3=-/G G0*^)*FJ,W54"\5"0.22&=1@*0A_2MBT8N?L"O
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M6Y?B?@L0'^@SSU*I<TZR=$:/!R&8QR7=1 E8V838\-1HMN:H4XF68R:B4D3
M<8!]KC]AN7G'&][SK1=I!H($]G;TZ2:!YW^,)MS[4"[EY<6GCQ]>>9]!!@1X
M9G<>292H$\%7W>O(Y>D![L^B G8,F\/W@7A1KYNQVVW1J[/F.%"VU["80%_>
MCY.&5]Z'OXQ*\HVH[Q@C3805^33-$(/ Y  )S<'H2F\YYO7SA%!F"I8_/D^
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MZ=!OUH6'FB88/\!':BX\YE%(]"B='!6"2WY*V,B\&!=H6$9(G-=1E@-U(O4
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MWKR*S>=Q1.VNX,$99Z+(;I6Q.N/Y-*4^ O"CP'89L+XHC]0&\ [I#TP3L^D
M=;-:AK5:G]\;^G0[_#'0*\1%!G&!O914>RS@#8'N_0%WA@LQP-(KN1S\TTL
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MJX#'X4L_\FL>>SXFH ,.2*FRT-T\KPF:K?==O;?613$L^T?4&B.F11R6K=E
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M5A"T#@[S2Y%R\@:.NMQ25&W)FP$6Q[<UG&5B2D=-?R"V :W@M1V/!4%:X%W
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M\"WG]G^;<H^+/)JQG(=>QF<L2N#M'INE@$C_931MAG^?8^]C+YUX.5Q_D<X
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M@U>2%^K&(H+&AQ2P*0^O>2,2>TX6+/O?V'TCIHQL-4AQ0L_,==@+"^%F.8R
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MS#AJFANUX^QU#Z=K+K)9>7G)^C:.P,WOI 6NTVIT4.!4"AR:?@<]*6>&YUK
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M0D%"-A*9Y@WR!$-*CK(@KRQ@<)7%@<(FTS@(8PITA+D-'F](SS#/R;Z47K&
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M@_XPL>O+$"U=COG3T(3!LZ/UD;_J[EUU$;!#)%"A8*%@G9Q@X<Z% H8"5J*
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MG9S059*<T#EN<\3+2F<'X-QQ[KK/'<.6M8B5:!4.N:8NUQ!SNM+U.N_1QLE
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M:".(+0 UF.XY ?'A86Z.<>*F(;5$/3('*-'X1=Z?C$$2"P@1 "G9100H0_P
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MF.Y+CP:9_H4HE8NB]16&I759Y;)W9-QXZRP0'3R& 2UDW4I$ZI-L^-%L':#
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MZ,\+S_[ESS]]YL]QKOC___+_ U!+ P04    "  "@TA,QFC-J%D6   +_@
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M5C=P;=\H2=M@:]3ZF\#&2IVQ-*[&K19]-J+0NX:I#!#2J'3L.-@1[%/ F<.
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M1'O\K/A&V.%1V.-]X%C0]JGDHK*HI:L7'S:L3[ECX;4#Y+PGY%QC2H&B@%A
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MB%+=XHN_#!=H=]AT[NA\>8"3?FOJYMS?4V0H0 9CI#G'T%(1++&*M6&DS6-
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M%59_6(W50-$\>K*W$(2N1=<:E//X+&M<I?S\X<ABSQ00B D'@->"(%%ZVRV
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MV88%D"&%N"*>&8 )1LZ6>##)1JY4]"+YEK=N-$/T;Z:-4B6Y1(*=AUC]7;[
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MC@@1)[40B*.BK!-!A'I3RL(8VYSUG5=VN1S6=XWZ]_$%V&13&:=^0ND@XXB
M\Q8)X 2T !,&I7:5XTL[WCP%H?,BZY?\!;1#_2*_@/@^7<:S=TD0UM7G67JS
M[FXP/_JNET<46BYL )IJ0" TRM+*]I?&-C_LZ[S,_ 5QO0NH+Y'@EW-C$Y'$
M.HB##04<(A@S& RL4A:4MZA4U'G5_<OA?=>P7^(G4.YJG^)O3W[Y:/4,] 4<
M&T8$'4(2<1/L+0D D@(H];@8M4A?[O["@,OY #I&?2C^GU+]F$(>3!6B/<*T
ML%@X(%7(A >@>1&%[N\"Z)<W#1$9^9I6SFJW[R;I8?DZ]L:H$ L$1A('K9=&
M D<JR[BHI-6<<7^-L\". 3YW/89GY76_Q^JTQ9V(7FK&<=@1@@ (U969H*"I
M99'U,]MS5J=%S@08E,(".4\\4/81%2#$D/?2-Z].6UNT;:O3GH;67Z18A VJ
MET<,4A\D "P"V%1!F@QI,R"%^JU.6UOZ-6M(G ;<]U$7  I$@!%0&"8-4<QQ
M56V*A/H+K4Y;6Y(G%PAHAM=?@ROGX4C#&A+GHTA'B5*-:D@$+5P8J02CT!#C
M->%,E&,3%HXHI+P'O _4D#@-E\8R^R69II,L7_\1SSZN[N]G#X?EM[]%)"F5
M@;068"NI#T:6LI63!;@G=WF</5:Z9UEVAE%CN3ZK"EB8P]-_K1;+/>%K1UI$
MC@-@BULY(0^,-$)[^;@R67T9WVAS8Z!;>,[HAQKX]E(.,3.<&"<LH-0)RLAC
M8AZ2S7?G\U0.;FI#]@_=4)3:7C:X^)1M%\ER:LGF\O<#_#G6- (2>$BQD-Y8
M!)D6S%;.7*/QB/(.>B5+QSB==['I]R8TB23S&C&N 2:2.>51%;I($&K.F//4
M >YV>>D$LS-XG/=YE+?#Z/IMGY[E7/7WSH\;O]U"S:<_)]E-'M_?II,GE[V=
M?P1J.EUW'L]>W4'7Q,F_6RO=#N)#<I_EQ09HTT7A]@Q6SR'G?=VFD>#0RZ""
M.4R U8HB1@R'Q& &$7&\EI^Q;P?^RWD\05L_;']9WX=?N[>(!CPP<$&5, X1
MSP!%C]@@,^2M'_NK.W<JY+VN_+Y &[4WO]@3LEDZ74]SC>019_[N!A%C174=
M9@CR#E&+N#6HA,12XL;OR^]!_"^KE70!W6!E;%X-]JAC=E^32#L?C%]<6"R,
M"NLM K:<(?28CMMWWU9L1UG0"J7OD0^C],^/A0;G$?_;L$7EVXW)S=*[K:9<
MH^3=@7:1-0Y:51@T 30F@OFJJI74 S]D$$%-6ZV]V%[5M.L.H*'(\.NJ&-S5
M]=7]VIB<WY16Q $B[&T344>%%!(+0SW"%A>7T&SGB!%0([IXKG=EM"N0AB;"
M!HQ-L9;:3'C=*,+$>ZC"/+D*3'<($T/*66I)1^0:'HP*K5$:B@O;M+%#DB\?
MB:#&B#LHN?.<*T#%XV*)K0#-;PCH)X*T3SDWQ&0HJ>Z?^M7UIH3?M@3C(;G7
M[R1B5E!!')5.<FP0]9[X$@4 [8B\M_U[)OI"K?'I\69-RJ[7F=)YFBR^ILO;
MFSR)@PJSO(WG$!2_*Q6D9)KOS2-NTUUDB;>2&:"91$ R8(JEL%S_B&CN:^BG
MT$D?'!D0OZ&\_<<\T>5"J1_*7S]T[H>NG$&/(XAGY<".^Z+K-8^()5 Z!ASW
M &EKN!&;V!%JO4&B5J&>3F9T\%+ &DTC*8,BZIQ&@&J%-"5J6V,WS"380"VR
M-KOT'G<MEJQ7E$;M+OZX# M)\;:GLSWB,=[;)C)&"P6QYP9 @ZTVTHL2& Y%
M\\"P/F\+[%3B+[?\CJ :6#M\.MJC7L&];2+KE,/48$0Q+;(Q,=]&NH8Y>@OY
MN-W$'<ANMP+8&5+?)RM&Z2P>$QG:D&"13/YQDWUYLU$Q'S8<V/[CI?BW/XY^
M^[A#SH^_C(P# A//O+58,:IQ<?OT=KQ*M\ET[\OIVP'V64L8AOIVW:JH>'C4
MK?_TL8C)P%RCH2&4,PP-,+I2G!3A(XSO[DZ@'0 RE&C5(HW?QY/T.IT<E>^K
M9R/$I57864R54,HA% A;S2E,<SPNN_Z$W!:5YF'[L]FZ=HLI+?W#N1A['H^X
M \IR3)@%2@1S'S!'RM%B+II7$NPM-+([&78(3&,QO@\F1IA-?),4?OV][O*]
MST8DZ U2,JNHT9PJ!CVNE >M:(MB'_UXOOJTO#L :"RNK>WO.XFP[,7K_V1D
MA[Q@IS2/# /AB^,>!0$AA; 5;BLJ5URB.XJR"F>+RB0.AZT$$V0Y"FL<489N
ML<%%D,&Y_6K]"+J+R,R3@+L,5]NK5:2FNVU7NT@#9 PH[LTSFB$O/:"E,##%
M:'0NMT'(L,\+UP&" _M<ZOI9RJ EKPW#C#$B,>*,.T1E.1=E_<COT.Y(3KL=
M+:T0NFRIC]NC=D9A=V0&V#2^F6>+93HY8L>]>C "A3ZK.=1(*&2A9$:[<H26
MB1$9 "T1SCJ$H;&@=)[$B^5_)?%L>7M84J^?C*QTUG$JM4 <,V44X.4821&X
M-5JO6!M1M<:AL:Q^?IA_7.4WA8%Y6%2O'HR<DP[)L'A0IX3F!DG#RA%JAIM?
MG-.W:ZN-I-K"T%A0'_](9L&ZG=7YK'8]&WD "%+*$.F*:AF20FC*<7K0XL/J
MVXO51EP=(-&N&$P\4\EB>9L4J_!>?>/0XY$/_0(C-."$::Z%(=26H\48C2AL
MJT.Y=0/&<$D^>;"J@J)U_+[RYT]&V%G@E2*.6B6\XA3*TM8B(&P C87;^=5,
MW0BW&QS&&)L=5GH/6)B$U0I;Y*EA%3,-J%?N]"PJ9C]>J(:X#"79*E/D[7R2
MW27O#I=;V?%T!!$W@?60*R-04*C#_RK&8F";5^'L6T_M1][M(1I*]#:YSY-)
MNBG3<%= \>?F[_.IFDSRI/C[X0KA-7N(#'>68R>I<#XL:Y"Z1^I[*IM;G7TK
MR/U0I!_8AJ+-JU)"[_-LNIHLTR_;.N4'"'.T;=!K*+3,>@.LI90!8#"IYFQ)
M\XS.OI7S?JC2-6##Q8H<8<)V])@YBAV#UF*L@216&5G9C*;%[1-]Z_3]B+L1
M*F,YA>Z[Z)')[N[293F$JM;=)#W32T\O;=3)>![S<70\B^>3Y.-M\N1;&_"5
M[^/B#IRU61H/-.7*B[^XNC;QXM;/LJ\#3?W9J[.[L(7?%D</7Y*-HC>*09Q9
M(GTC89,\_1(7FU^/,G_RD@-?^# #\'&:_W<\6R57UX\_]>D\?(-I,:C%,E^M
ML3_WO2F/HWLRJ+!@_E<RO0D+IBHTELTEH57RXL%\N$[ZC1!'UH01 TUT4*2)
M,@QNRA(B#VV]HE+]X%4)=O%$VD\7UW?;6X;TP^,#Q>Z3QY/EIS!<_;"%P":+
M]&;^N $? +._ET: "J*H=9(K"6"1B:!*I!V J+E/O>. HX'XE(T4^%$'++V>
MXI%(I=T-HJ*B/= 2,@JE0P)@JEP%B<1#EA4_*41I#"S)>D!X*)OS]6"/QK7L
M:Q(AJB&B# &D25$TUR.LRAD*#=VX YO:BNTH"UJA]#WR890A3V.AP;G<VYMQ
M)E.UV []<<\_>CY9HW7DI;;>"PZ*J2, !+"TG+?W@RH]-9U7[47XRI7=-4Q#
MT>/7+)A&Y>"/TF''TQ'G"C*@+" :.^\0I*":E\:DN9[1V\%7Y^)O#\MPJ\%K
MQ?]#NOCCB(IYJ%E$'&<TL-D;%?X?*4-8A9IR+:J7G$Z 2U<T.\1Y>$8]A>:H
MBG&H640!!L4ET\)XP310Q@E0SI13/G*ULQLA[F5&9WA]SPP9I2(Z/F*<AQ#K
M6KW)8ODA;)<FOJ]7_/CE\Y%&GBM-G--A7_4<8 -M.3=&] C5SFY$M:OP<4MP
MAA*\S_(D;)3NV^0VGM\DX9]?X_RXUGFH6:2@]](1 9U6PC+O%9&/>I8:87Y
M+S3H$*.AV+!+U3IV!?:>)A'@C@FID9#> 1J4=PZJ&8)@>0T86G7I.FA'&)^3
M1<?O/M[;*)*>0NV(5E0I8 @6@E=VF^/$CUOW;"^\&FQHA=3WRHM1:IQCHL.9
MPC3SY#Y.I^[;?8 L*<XX-Y5K5GD1(K()-#NJ@-3O)"*64<,XLHY9SJS&'I(*
M6.9&F%G:A4A?AFOVA==@Z0#%<&N2X]6SD2&02"F819@'G#P4VI?GXT:BYL&[
M_=W,VST'VL(R6(CN9)*ODFEY.?"AHF#'FD042N^=@1 !+)PU0+&2S!Y0TUSP
M_=VRV[W@.T)GL%R];?ADH48GNSPT&PZK9:6J'V#&Z9U% M, M-(&"(VH#X9[
M9?!YVR9K>@ WQI#!0[U#VW?\^!,#[^< <Y$1=36O!KN>UN)#,LENYNF?R?3M
MW,7Y/, YSIC&<@;OF@8OONH@8H)RX#3S% BHE NK3KD]<&-%K?NKSH! 98!_
M2&;KY7-QF][KATT,<!45O,N,?^X$/A:U.-P@(L:\EL4-G$$BC(J@D>GR$^78
MXR&ODSL]BK$%L6H<QHT"\5&'+_9QPNR%XAII;CT,"@2BE,I2<^">#EIIZ23O
MWA@9=,J)\VFX7_)YHM2$A$D1X"VE1GB'I"AGJHC7X_;Z=2/$4PX6F^'U/3-D
ME/Z_\1'C^SEXI(Q )ACQ5@.H ?&8F7*F2)M+.W^N+;A3#AY/PV@H-IQD?AV@
MQTG]1,'494X*8@67TF!.C"ZM40[!Q1CZW>G7?<(WH#'_6%+WF8MB$12YV6I:
MS$%-)JN[U:P(#MV6S7^5L?J7,?(E%EY P"1U"@HOC2[W'*4,;W9GW]]&?A.#
M04&LF?&,:V@QU$SQTF!0A2YP:49^76*=T<@_"?&_G)$/';1(.EHLZQ1SBB I
M0]:4Q'C(^^M':^379= I1OYIN%^R"2>"FN YH]II2[U!#CA7P2>5O& CO[80
M3['EFN'U/3/D\HS\LQ#CDL/*@\&*F ;6&DBEI1!R4EHS2IL699'/8];7%E6M
ML/+3P#EG4ENU S\U)O=97^[Z.ED7DWM?%#,[7NZQ^]=%Q@@&D:/4!).9844]
MDY7^JLT%>P?Z4,R'0?DL3H3''[X*:.B[LIQ-%_?98MUND)><V^GQ0@M_&@M5
MU""MJEX]B6,)&OIZ_/'LYSQ;W6^=/$7X?7AF715OE4RWM6^#LE_'<S+@*"*!
MO2G.!HU"SAK)# GV0_@G9HA"K6NEZEZJ+([Y7@8:0:28@4I2YHEC3%E)'&"E
M#+ >3W3%*'GY2DL9H\Q&[;KI'[(C3J!A!A !:H@0'GD/L/74"2),*3(?]->Q
MNI-&1^G!/[D&XAO,TCAE'K_&=S7<$<UZC#  V@2[#D%K$<#4$Z5*?.CH2R2,
MC40O;8]!A?(W>5_B-$HWVU^4LR=S=<\=@+,LFWZ<Y$E2'.>7M=2/W 9XH$UD
M"=-$  0$H=9HX36LQ@W0*,-O^I90U@]VIZU/BV3RCYOLRYMIDA9+$RG^4O"!
M/%F1PH^B=\E-/'-AWLN'/0KCCJ<BK($1S@.!M>7%E6T6%6=@BDF$(;*DL=1[
MKC4U5JVN/<;]L&,SG+T;T,M'(NH D$;88"R&5=-3$5;/<LP6X9&J0ZW0SSJ%
MXC+$."K%X"S2ZV@[_CE/K[/9D?WWV4-144^(0H =MB"H)@0;98N166"(L7[(
M*^^/;+C-0<TZFOU0*OV'(N3VB+^E>B:BV"H81BR] D)0*R0780Z:2HF%:I%&
MTW.1G+%NGFT1'I0E1X_#GSP5 <NTD#9\),Y(8!$5S&SFH11%8N1%<!K(8Y=$
M6V%QN;(=U1Y['I&>1Y2_!$CO5G='A?GLN4@)!#V5U >C$$OH#;?KN7 K..*N
M>?7=WNS@1I+(NL-@,'G&W^K)\^ESD;&!R< X#5A1'2%L1PH5<[&*82# D-64
MAY1G"PQ:*,'98O$^SR9),EUD\X_QSO/A?8]&B@M,'=58,VJ)@PY[7:H+1)@1
MEGH:\Y%N1S W)D/Y5A]0*]Y[=5TZS?9Q8G^+2$&MD,!0*<  #\L34M7D)6EA
M*_7V$8^>&IVA/7R6X5$Z'6L2.5*LG]Y+#3"#GCLE1'4H@$CSR\5[*RPU9CYU
M#/? E<HVR'Z*OR6'J/3ZX4@1&"8@#'9,$>\94:HR;QD HC&)>KM3^A)(U!KH
MQCO6LXD>F>?[)$^SZ3(+J^B7=)I\RN/Y)@;S8Y)_22?)0ETOD[SL<=^.U]\;
M(\J@Y0PQ0@&P%# IZ=I%!Z6%#,GF\<^]W8 ]9G*.2UJM=;)XMA9X$@9X%\]7
MU_%D&>#,@K2_!.2S_.&8BG:T@PAA1J1T ",?)J$HM<%NW"+,PU?;F'_L+\N_
MOL _2[S,8:@^)&$J!RM#GMY99)QRC#IDI2BL'R$8YR4JRNOF@<+\KTC)P00Q
M0GIN_U)<2E<(J-!YNZ'JCHXCK9PGVBNLBM*>#! B<'6*(DGS/&[Q-VT'$DKO
MB4_99%.R=3[=G-,^N5?^^4BZS#RJ\JA^2>)"B.N,LH%?]TBF)U/>Y$'M&<F
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M:WR<%*W7+1_VDZT[[(92;0[O5M4TCEK@)_43.6=1, ",X98[822VNCJ<H5B
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MRGZG9LBHAI-TCM:R?74777^H#<4@=WV=3(K15KOP.M8^FR_3^:I(.0L;^='
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M+2YT[*U6R# Z0F>0#7;*EZU3^(L,_G*\Q[_W_8TB(B6TGC*DN/ 4>F$JM5I
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M=04$+)#;GDEJ_4.2YT'TO$*2 !CA.:<&6@,5E]P1TXZ-&YCN."LH))EJ4^1
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M]JO%?;7^MD!+%I-V:X[Q>GM?U+AZ>*R+^V+3E%^+]RR>/13HIMG6^7*[P%E
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M4></5<,+L5_??LF_+8(T1CATO1!#"!,7N8B,9Q*B.)1ZFL:T[0GSJ?[)O$/
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M*9$FA4KJ8X$]W:7\RSQ+<(P6<<&1I'&68B/KPWFA46)$460^C'6R@]2)$AQ
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M@AE^;O&%Z2T%ROIS6T[M:N9@$-B#_:4N;JK]$"R$$ '?L3WB)=30!'@8)DQ
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M+]>O#ED#EC -1KUU$J :,ZF>E-,KXI><JG+,-YA $OC$3>*('2%'41".#R?
M% D]/:!!O&&;X2NK5WQ&FTI%?N'+#*[L$KV;TO>]H;]S)1>F$^E'C0XR(SVI
MT\"I5I4ZL-3 P_U?RMLNZ<I.<#8(DA2@%'H0XL );  B;VS-'P.AIVTUJV(<
M/X]&#.</W8FG-KZ6\I]R[M;M.MT\+NJUM7G]#;S5</P<1_YR?#_+6'GNGX^Q
MP"'Y\?ZX9SN!Z\,=>US]_J'.[_*R*1[SD_3N0184V#&*4.C'!#E!"FWB]P\O
M!@&DJY+@\;DZP?H/U@==K599ZYFVSQE![A$OM7[@/I-?QP7"I_4*T==UG,^-
MY/1!OWJ'F,&Y>DQ[71R@"S_N]\J'VTCDW\?B\,0TJ$KZS^Z=#^ BY!" 8S?V
MG32 GHOA(#,-8Z%4QCQ)FAFST\DZ*275QVLFF'PLN!R.8K0G#*&>][FGT)F@
M,C6HFL%=BFQY^22V0H1XV>F%J+X'*T%^ NT0 -_W81*DM@OC05:,$-=IWCP)
M"[.19*LQ2?3X:$@_<//H9Z5.9&_",L$[\V T@V]FVE"I'%C2N\FV?F'?[F;A
M[I_'YL"HKF^2@N(H<!U$<.C3P(ORF<-J%SKA?@B$VI4J$KG@#C*MZKRX+2U\
MK.N\W#Y9)V4M>#C4Q??C@46H;<525K=S3ZBCL6IO".\FEW*$_#Y2AP]T[RPG
M4.7;4ZIPBQD,J=JHR_M(=9A)<.BG_/"WLLZS??$?5O+^F'?BAWLTO1H.]MTP
MB4"$(B?V8I DK.54IX8=.US/BFD3OB"O4H6MDY[6^64R7;2JR$'"!+N\;^2I
M5H-;=#,M%[Q\G*O64\:QKV+S+O.P#APE&#G);XHRWZ&\I'\Y?*:#OGFU+!#D
M>HZ3^!Y[C"R, P_%X]8]2ARN_A.:1"_(QKVZ5J^OU2J\1*BKQ$7"C+RT=^3Y
M6)MC=+,R!\1\G*S25\8QLE+C+O.Q>@SEXN-A 6"=+9*\H7NZ]O2G_K^.=*FX
M>2K*6YPU=^F^^O'?^>XV'Q8*/R$H]N/4#0.2I-"+ +LSVJOF 5\^9M:DT,)Q
M]'F4UG9V84I;3&NK4UMG2*W+IS)AM@'NG!=ZZ_/D E&X'/K<D;EFYQJW-BQ@
M\F0$OPC>"BN?>OEQ$M@00<(Z^8,0V!B=SN(2+)VNGBE5]XIPC3]H(_FY@"NK
M;]* M2!=SX%YK5HF$9I5A+QQ7*K*+O$2)BGD%->#?AP;(R,O@$Z2$H>*]VR$
M4LB>/NK40$DB5#R@7+A9=:$?91OVJW>*,@+5YP_YL%>1*]:L%!TAG5\M*NZ=
M7X9K)<V3JQJ5Q9'_H:?Z7WD; GS-M\>Z.!1Y<TIY#Z'S!M-(V F3!  OQC!)
MTL1-!N$$IT)\JTBD9I8]:6F=U+RR3HJ>[W%%'Y!2@SD?G:X MQB)JD%:TWM4
M/-A-L*5B\,W@2-5&O7K:2@-FBB-1^)@5>Z9B6M6LK>A)TU,^^E-^N+[YEOW<
M.)Y-L(T@LD/'06$(""1C56WB"M7?KZ&?2?'LE36:]OM-5?_>=CL^67=VHG35
M)B*K&]9H4TO@JW8,*(V-5W._QO!9L>?7C+-%W#,_%-<R&,Q8B59%0"Z@U^@-
MQ6O<B\-6]NVJA&7W.Y^KYE#GAZ)N+Y.T)[&CUB3RH.WX3N@E$4&>"P)WK%",
M<8PW97[;5CDJ7_:TJ<S%@7''@:^L4\:'OW66_LEBMEZ]65-Q965M2TE=BYZ^
M0:%T 5QW(&A9#!4Y?\UU3]8K\]= [>/AEUH/]:,AMS8NY"6NMJ1G*E=,_/:U
MRGNJ<GMDO/$ B1'$KN/; 0@#Y*0$C6?%?D*X.Y,JE;K@OJU5UMJ^%;TS?;NB
M#X&FF6K1GUY:U@5>?I$P&W.!7J6K82_7KE2=#_@ZEHK \\9*J0]B _J6ZK&K
MTCTXQ?9KEY;,R6K886W\7-7M-;*S8H]O55?JL<$P@G:((@<[$*<I3*C"@[JN
M[[C#1HUOC[::FA*;,[&5;GXXWCZB_B7?[K.F*6Z*;<LXSU)6;U?C+!O&Z_+@
M1/R^^J Q(W!?'X;*L,FLAB+9Y$3Y357G+R=?P_8-81B'8>#'21Q#)TY#E^HT
MYM=2.Y3(5&G29)D$U/LU+-];$UY1&65 X8R3+I_Q)9+6])-4Z*_+-XNN)-/H
M2JP3BMQE]BJ@RDA.CE>**2^#OQ3%JO4YTD9=*XU#]XS-Z=S$CB$./"?V;1J%
MIR@&[KC( !#+\/JB^BW#]E_RYE ?V1,,K,$P_5=>/^97UEGSB39L[8CGM,J+
ML?RR?N7C?O-\*;4BO-I/M#>M^ [5K_HF-(?^H;+USLQ5.F-B 5G%YV8L*^N8
M7ADPY[2<BX]:I"1Q?(Q!% 0P ([O)9X_]G)-;7MSJ [97ND!-[=LH=S_J*:R
M'"A+B1EY!*GN2%'8%6:0@3;KY([\)%%4/*7[QFQ#7[8WVV^=R"=-(Y=X)/8C
M&[HP@BD:+X8Z'M91SJE4/[/*.5_UQ#L//Q>LYE0[!)06LZSF?:W5G"H=O^:*
M(N*=^:N.EK'P2ZU,>A"06[TT>H-WA>N4H9_/GG2A8=>QSN%WNJ_/MH<-P2FT
MXR0)86+'3IC&#O;]$*'43[ + "]-S1&ACVYZ.F&':R>]K#\&S1:^83F!T<2D
M5X&L&9-7B265^G$W>S)]RW\>$+7T7YL0N"3U'4(\E&!V]]V+P2 20UOH#N0L
M09H#N-/$RB_OX33 )TU&>I!3PD9,-:O5;7T^&F$2(R1Q=(UE) E3WJ<D67QX
M.0D=FZ+,FX:&(-^+L@TNWA+N>3AR?.#Y3N@ Y-HI<6$K/(@ 2ARA5](4B=3,
M4X.6UIF:@H2E"EL^ZEH!5C$2>PM1,^B,#[H)8E.,O1D4I]JH2NMX%7S2;'N7
M[X[[_/KFZUU6YRAK\AW;A=$M6+?!JNEFZ[:]"]"@I]//?,Z>V-?@CZS>=4^N
M!1!X& :>#9"/O0@SCN[T<T!JNT#H^;/%M-),GH,A++/2JOG[=Z:G=6Z,=6Z-
M]?WIV0_V%EFM27*O3R[H8CZ"-M.[8AR^L&/U//^FR@\3"\+ROC9CS5C![I=/
MT*V$/._*@ZOF0'7+]F,KT#"*$,&>1Y(X(! [CI=ZO1S?=7 @LH*(?[KFE8 I
MU)(%4TFRR:8$9'R,K!<M,685!$H+,[["8X+AY+$S@ZEFZ%^I&D6B-8Q-3G_V
M#I:[)'_,]]5#^]+F3T9M0P--E#JVGR"0N@E (* :I.%)LH=%N$2%/,WL,JC8
M5A+N3DJ*%A$J ):/<9;&5(R#GL%YII_5*[@2+7& -EF:IPYR,ZA+J46O"NE4
MH\6])<_W]+NW5'#7HHW^_;G8&"",?0C3$+L1>T?8CT=638E8R_+9PG1OH#O]
MVHEX/V@HN/^=C2?GMG9)* 5WJV<HCLJM3&;OP36UJ52%M!DTILZ<EUM M3CQ
M$MA?\C*OLST5"W?W15FPL^1#\9@_EXU!Y(<N@DX:!ZX38 <B=Y!-TIBKF8=:
MB9JIK%>RG839,S7%^$P1O'RDMCRR8LQV#NIS#5>F-R[@)CA.+?!F$)UBFRJ=
M0U4P9GLOQ78IP_9Q;#P.0@?%T$51DA 7IFE$R,C%(!9[67(!=73'?1PY]7=2
MZA]E7V18PIF<(:59?A0,.I=QH9[@=#;P4^'K<EXU@_>7-/AE"+PTUO-6C$T<
MQ3#V7 \B^C??"0.<I*.P*$SGKP+OBM#-[(=J^Z]^NF_/:2'OUFD57/T^C'/X
M5RF":CC5!'849CQN'$UF,7XCN)A)$!/^BFLZ4_/F\"4[Y#A[Z&-AX 1N@.PD
MP8X?)[[CA*"7Y4*$HUBLU%I&@O8:ZTXIB^X$<FN;/5B_6W24%(\2VVY)"/F(
M1C]Z8CPS L<4LJA&*^VBW\1ELK!Z#HYF\,Q,&UZ54L]'A)=EDOS[ 5?E(YVH
ME,JZXI'(!5X8.\BW0QM@D@ _8@6,V O\.([%#F)E/E\SPS"5K)-.<A5Z4KCQ
M$8MNR,1H110M+9SR!B03C#('0#/X9)8%E;KA)%H>QJ0<"BKA4W7(&[HW8])Z
M_G)MXB "G!0"SR=.$MK>(!-&#H ;^KO?*_YBL3FR1*;+N5H"%5&C>E:KG]4K
M*%H]-@M1/KY9#DHQYKF(X6H59A,X35:;J<#7#&)29,NK*C1U",D%/J?44>2D
M*88)\A!ISQJ<%+F#M#!&0CE]61E+!T#2:7=I$&4B(3WXS8R&5DMW7\"&.RP2
M1],,!IIMQ61X)(L*=]>E>]8 ^C]MWNCZALEF]\:J8WGX7.?WQ?%^0R5!QW9M
M8+O !8C8D9<.<E,G@4(]E&9+T\Q$YPJR O(=FUZ[7D?!9D;SD>4CI65!%:.G
MEWBV=#6H9_W6*[CP4\'O C;!6>K -H.]%-KSLB^/8J3XGH)Z(?0FK^M\EQ9E
M5FZ+\I;=+F@V:>JZ=A*ZB6_[B*1QXJ-PE!L"KJYPZJ0MSFB=EM;-H*:U97J*
MO#ZD!.1I<EL'WQGD=LW(K8=VU-#"JT K\J#3TA#+/>3T[2YO#WJKDE5VT&%<
M#(<+_8FO5></]-_TNPSV _WQA[8/;;&UMG=9?9M;V6U6E.P7LKJD/].PEUOH
MHK+/MP<K>VO9+YKF2%'(N_EA530B:S]X7]RT5W;9W^N\:Z+7_4+)FG2WER'_
M//<A*0ZWO+%*J7>I"0]'*;6GTC7X!58I=F+[N2ZHD(=L3Y6@:V):U7"[98\F
M5N7?L_TQW[A^F,(D# ET8!@"8&,_&.2R#(1 8WQU0KEF^NQN]Z.:5C:H)\"A
M:M#E6)Z60U2N10Q5SSI!V2G(>GE:HXI6J^/BV JL3XMC++<^?1E6GZ9=%K(.
M:[I(/+P>RE9VZ'[HX6%?;-O\<5M:\'"LV8)S8 L3^SY=X.Z;8:%I%YCLML[S
MKM/JC[MB>T>7*+H";1G][JRL>;4HSEV%>,"_M HI=9P!JY!:>RI=0WQ.]N?Y
MPL<N+?8;MF834,D)\AP/(@^[( 0HC ?QL8VA4/]\54*%=D[BC?,_5>7OVZRY
M>S6MYN2!YF LDPY:"%X%6:$/0[C=:MK=FAYT73,_=!E![C21 B>8F"U28=9D
MTD@9;J(ECOUU'S8NR<_M_KAC-R#/5-L DB8V<ITP#+S$A@B%[IBZ\DD@V&!6
MD5#-F23WS[;]?[1AS)&&&R,I_L8X\G(&5S/.?)RX"L1BG#A62_8Z7K6L>&6-
M>EKGBJY30?D>?!Q%E<H\8 8AJC?K0NFE8MQF$.+& ;;K)@X,4C^*DS )72<]
MA:)^)!(+RGR^YK#OPXMH[\HJ<\&C/RG4I)E,*6 J2&MU<A+C(6[\C*4<?@O>
M9Q=!-+CRG>QS/XS)<4SC!=A%$8/\SSD=7^4AN\TWB+BN'1 '.ZD=I(&/8<+$
M$Q<@!T8)XCZ<4RE4<V3%E'L=6#V,^@DDZ)1"S9$#70ME,9[J-IBCFE=6BWBO
MJ36RV.?5$1?(C*Z%O%R"5)T'^%*7 NA<RF#J -B 1*86LRK- U/N'0:X_?>Q
M:(KVM8'/=956]7WV)7_,RV.^B1(O0EZ4QG'JIEX:^G'<]_ (_!02H;(V%?(T
M+S&]&G)O+LS"D2^N71I"P:.TX;6%,_6N+*J?U2IHO8>NUH<6)B";"(15 FY&
M8*S4H@OO*ZA#2P67?<H/IP?N-B")<!!&D1^Y'H(8A'YB#_(3/_55,9J85,V\
MQEZ<+%IMU%&;(*SS"4X?HFIICH'][&E0<PCO&822M"?G!O/)3](N 0J<@]P,
M(AS$D[ZDCP:60T>,8KM!/@"N%P=NZ/I1$J=A@**1C^U4J V.<N&::;%5XE3J
M^-"]^GY?E5;#=+1^*TIK5^WW6=U]L_VJX"&.>H=(,^EROE!+J(.^;-_;]3"[
MLEJ=5R?6243%^%6-<XRE647FO<^V*G'40+I)L3\>\MTF2A'Q_"!*D]CU$KJQ
M]],Q#$X<+])$N[SB-1-OKX8YU,OM%N7DJ\,C^NFWU]I8 N[U4T/!HB[ZY4A8
MV$!Y&I;#4OR-Q0_E8UY2^)^ZI^P/;0.5TQ./202)@R+@NB -G,3V $BZEVW3
ME#V?(_>$XDRAFDGW^G!')S#*]FW]X->[O-VGWC O#26&@P&%Z$/9ZH#G(]A5
M,!>CU?-W"T<EKZQ>S;XAD[7: [2\"$Y0J'(GF$&<ZLVZ^%Z@4MQX29)2,XVH
M#D^?Z7 ]P')'*&FW3^Z<!/L>CD@,2.IZCHT !A'J! >V'1(Q>E0@;GUB'(R@
M<1$SHZV['@T1HTH5\/.1Y,+(B]'C)**KL^/[T$WPHD+<S6!$E095VL:H:,TF
MR\1^/62']JX8_,X>L=@>-C[T*>MBV_50&J<4+ Q)Z-BQBP,8!NY[Y3YS/UYG
M%6)[)#&J9/TQ*+5XI]DWH9DL1YP'IAFS:+85K\H25:#"_Q1H>W[;C&) $N(D
MAC@*_,BVB8.3  UB8A<)O8TG_.'+U($T_TOT54]1C/C(1"L\8BPRJ+(:>[S$
M8H(VI&$S@R_DU7_UP.8L'+B3+^PYXE[67ZIJUWS*F2@OC-,T=OR8)!#1-1R,
MHAQ7K"^:E #-3$'CE]UQ*[@%D$.*,S.B&R3!+$C[MGBOSY75:G3%2B06SG:\
M@<I49F,.B&:PQSP37F8LYN,APR)?\_JQV.:=-.2&,?"B*'2!GP _C; S<I:/
MQ9[BE92AF4MZ5=JM<,5R$O*L(H2<.+'H FT6MPQ*K4PO9]AP,HP,FN:1C)05
M$SPCCXKHEF83IL1)[3CT41@3$L/09I>YNH_'G@]$[FIR?Z@0F8A?T!ST6"<Z
MYXC*N0$R8ZB+JWTA"A>TF_\5A^9P?=,+&2-]SW8CD. D=4*(8.(@/XX'68$O
M=G]#3H+F-;-K@U+=6+7<EET2-KXE4S]B8@LFTX=AU6NTVA[^35PF*&,>CF;P
MQTP;7CV],!\1,69IP_ZOU7ZW < /P@ X(:(X)+;GQ*'72T$V=H4B<='/-G$W
M+XR/"'GH@4:.-EI=+*;,&G0Q(O$N48AC9A)%2&C_)CG(HB!)"\_:K+A^BOS
M=F('.5&,(QOXT2#1!T"H\=,<.9KIXF6'MHS5O]5==P+Z<^T32%G3Y+S-K95
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M?>-3C.Z^;N_RW7%/R?9S7>V.V\,_LKK.RL/3QR+[7NR+PU-;>7(JD"38 21
M,23 AE'LXAAT#Z)3[0@B0C?DE0O73(2]EM:@I@6WA^*1JBE&?.HQYV/!5>$6
MH\1!5;;*O$)]5+<O@K-6J_(6172",+4YQPSVU&=>M= @%\B-?,VWE+)WW_+Z
M_F.5E4-V'23THV,8>['G $!!=+IK.2AU<82X+IS.^'C-W-@K93&M+*:63%Y6
M$CB./(5^S 0);D6X!/()^F&3RQE(P,>7$WC3X$O[_GGH&+"WGVE I6RDS-JC
M][)<! ,28,^/2>CB% 80@%Z6!ST 9^S*.25HIMB7^T1!RIB)GM1.6P-P\_;6
MXCRA8S-]D5;4P&A&R#?3ANDMLA0B$OS2GJ)]SIY8S#ARFN<3&*5A:MLX(;9#
ML#W()%CL)=IYDA;DF^ZHO5=O_4GT&BR^R30#9.,FU1Q;+D^NV0AQ[9 @#?EV
MKZ*%T'6\R$N)'SK$QM#Q0V^<S0&)^4^(Y3Y>\W3JE9H7\DL"Q[%#TH^9V,J]
M)EP".R3]L,GMD"3@X]LAO6GPI1W2/'0,V"'--*!2-E+$R?5+_ECM*:WW@@AR
M_2 -001<)PP<B%%$!D$1)ES;HQD?OQ"Y#EK-( M1W/BY52-D<MRZ EKBU*H1
MM7G4RH^>$+,^M_<=9I4$QQQFE37@#6:=A04?L[(2[O/"2C?$CNO$84H_TD:^
M'X<1&F3$A._6J=PG:^;34ZVZ%#<(X\1#HCHA$N//I=$1(4V=*,GQI0A:G$SY
MPLB+)"D+A@G\**U[I6(X*+RH&7LNPF$" I0Z,(U#.W)'(DYLC\C>\!$6I)DS
M9]XX7/5J'"]T!DP,9::(7(T3PX=KVN ZWQ4'>%OG;4^Z05 $O31QL.=[+O&!
MAU+DC/,3V43@5K.< )%)(G67N5/+&O6:.2'>M/+2-)@'B0&#?Z8!E;+A(7:B
MPHYLVA/BXO#4=I3Q/>BF=&TB"!% _#0.".S%  (BH9[.PA^N>1UHSQD'A:0Z
M28G#Q7<ZJQ4IL1!:""0MQTDOP9@X09+&S8Q#(WGU*T7C1XPM_IK]LZK[GB-G
M(HM\Z#:21#[RD ,</X(8^Y$=DB%I"A(;"Y5ZS!:FF4U:_:Q6058->SYOBERV
MD]-\A/D(9U%PQ0AH+JY:..D]O"8X2AG49G"6.G,J34-2(-3_G-,Q6!ZRVQSN
M=OGN4)%C7>VJ_3ZKOV2'X9S=#WTO35'""N4<Y'JQ/89>K/<T5V&)0G&:>>VD
MI-5J:1TJZZ2GQ1252:XI@IHC'[D\RF($9S;  BG-Y8&6RW,J 9QOT\L%R:5-
ML%H\#=@4*S:HTC;VQ,+@SW6US?-=DU)K/S3-,:-(=&O6)O!AXL81]FP"49J$
MKAW@<8U*'*%;>#/$Z%XB>LTLYF]KT&V(UL0BWCE@\L6Z"^$HN C(0:@EN+T,
MT$18JP!5,P):%894RD><&"-]R1^RI_:J__5-?^&CE890Y!,2QW$4NK'G Y?X
M_B#-CB(A.I*5H9F+3FJU#Z/V]X_$>4@:0CX26@(],0:2 $X+^UQ 9H)ZYF)I
M!N_,MJ)2.\+$&.=C45)*ZXXJTFS;7N#]:_:SN#_>HZJNJQ]%>8NS!_J=P],F
M25T7.00@EY (A,3!8 C#?$RQ$Z$AI8(U<Q/3E4VN_F1M4/?*ZA6V1HVM064Q
MTE+K!3XF6\T!8O2F$GLMO">"XP09:G&'&0RIQ[1J@>$LSJ7-H ,^UC4E\4T<
MHL"W'3\AMFO'H0?<(!E$H3 4"MVD!"S*C5=6KY8X_XDCQ\]S6D&;PV?OXZ6-
MLUYB\@XW24-H#@?)F_ &U\S$0Z2PX]2=C[T:WGQ]J/-L=UW^/:L+=HN0Y<F<
M#4$)0!C;;II !*&?(.@-XE,<"+W/HTSH$H4@)T6OK%95J]/5JDIKT+;-#8N7
MB*@!GH^F5L%<C+H4P:VMV(0'OG>*4)1ZP SF4V_6&T4K&G"38\C/>5U4NV+[
MN=M#?ZZ+<EL\9/N-'[L!"&S/=I(PB")*R,%PZNQ'+M^[OXI%+LV.@Z)6KRG]
MRJ#K'&Z4AUR&&1=!>R8OR@"] "M>@HZ;$V=C;R(CSC=JD@\58<95!L,GN?OZ
MQDEL)P["R/4B'-@.L@.'LC$  "<Q#H*$NQI&J52#.''XID#MAEH'3-/CNMCK
M8\C581>HG%D-?KD"&J5NX"ND$4'H4CV-%I0-**O18U>E>WR*A>?_R(O;NT.^
M@X]YG=VV';>K8WE@.X*^]F?C>2CTO3CV/.(BUW?<$+O#2AAC)Q()S16(T[P$
M#1I:6:>B593T4_+F8-49]]-E*M'EB\(7!E9L?1DQ[;6S!O7:3$1+9=O%DZSO
M(S81>"N$VXR@6Z5!E;:A.?_P_$,_FYGTY$@I]K:GUS@DR ,^N_L'(<0PM-TQ
M/YP()B"4"M;,=Q_.Z6W^L;@\OO+'XHM J^A8?(2[+8?NM!4-Y;2=BU\"4O!<
M?+8_S*!$/:9QG(LKPH^7)@=QY.=#7C9M>]E-ZF G2>+$04'BQ6[@ #A<;/1#
M/Q5B0YG/7XKT\DZG9:?>&X!,S+ Y\)DQD6994*D;3&+3 MY7]:'X3[N%']]B
M*V]QU1P:6.Z&,*;9^!%R@$=LVTE0Y&#B^6$P5JL@U^%K6:%<K,@4DFID\:DJ
M?]]FS=UIA]3/)BL[LV%\*&TWQ/RL/<PNO\EK5@A[,QAH;9F%RTY$7JPG9J=R
M=YDQ9=6;56D>Y@)Y^(]YMQ/YPJ3W16B;T*:?G** =8.*0)J$'D$G.9[/G6^7
M^G3=56"]3E:KU%";*9#"E8.,(T.N'2W!N'T=H 1RVMH!D\M="P+'EYU^R]9+
M6>A9N!B0;9ZG?Z5JA @=9V[K/&ORW:?\\$SFYV/-+F,=OE5?\[*HZOZ:Q/--
MSH;$L>MBVTY!!($;$9*@L=S$CF+^]\ TZZ']R+/7WJ+J6R^FT6"!]:VR.AO&
M&T0O,@M"QW%Z_<9U+FJ,RT1/2O^G>4OH.-48K\D>L.KU'N^9ZQP8+Y_"+N(<
M U;*I2RMEA_Z JOOD C!U9DV&XQ1B(@-,$[3B$3 ]>#0I],G$>&Z CCCXY=*
MVPU:=5-7@$TE4>-8TO0#)K92K8:5P(*B'S.Y=4(4.S[>?]/:2W0^#QH#6'JF
M 96R82*6]?U+5I3-QZII\N:Z)#\/17E[+)H[-H;ZUA*N'R<A#H(P#C'$7A X
M]IAMCF(0;,K\-COD.[YT[WQY7-,A[J;#N6IB96GY,]6L/=5XV5SMNT!-)&G5
M@6Q&=E:A/96NX2@0RO0YBB]TT.75S6<Z%*FXOV?[(_T7SIJ[=%_].#6BVOA^
M[(/(2X,X#'S?QH&?CAH$G-U/=<C5'/P,%^I;==FI2J^PU6K<%ANPPQBFM'72
M6F"]5^T&CJ!I10^(15._'/@"4=B*3I +SQ0[@R]Z$T/I4EBG"6L#XCU=EE7Z
M1ZI(SKNH\^WAVUU1[SYG]>&I/:\LGM<D;'R'!J3$@RB!$;3=*$KBH160#X#M
M\F>V54C3G;]N=;1:):U62ZM5\U050-ZIL=&%,D\>>FF !;/-QF(KDC5>&F/)
MW/!LK#FSOQQP7,SQJH32@#5#K3V5KD$GV+9V; _77N_I^U*V"FSHYT/(JM7B
M&(88T'4)C!*)'8OUK9TA1_.:\/FLXV%WJ6UHO(HGB[S4XSF]!BP-I1C[RZ*H
MIWGM98@F$B\J@#4CY:+$DI?]:Y6A(]>,XTN^R^\?V"KYN2ZV^2EROKX9+Q_"
M^_:N#OW)_#[?;4!LHS#R$A=!/R))#+ =]VH%5$,DWZ9#@S+:*S=>7-<]F6"U
M-ER=[3Z[;6IOA]498@V6S&GOH<.)?*QIE/]$RSBTNVZ!AB'BD$]0]6+>-(//
MES-WLOV(=ISE&I.,2KS0[VM.X=WUMY$"AV#;<2&-E4D(O#")W.'29A"#E/]=
M6SWBEV7_<[ZXOGG%)U:GNH+>&6I<PY,;6=TKLSC]%W/(G*XFBSM&27L3-0Z2
M;'/" ]GE2CN=^)N0EM%KX&0'% U8JET"NYQ2WY(E!,!U X(@P3"VO<0FWK@4
MIS'7*[[ZI)NU /:)56UT*^07E<N?+I=H7?V,\H:.M4^75Q99^KB\HWCE.P-L
M]L(G _ZOM.Y)V2>U[,DCJ7;52^G(/MSUBH1>$H1V8 /D8(B<@&Y$AS84 7OX
M3_VR)R3>K'6O4UTCU8JY1N7*I\TK6I<^PQRB8_'3YIA%5C\^!RE>_LXAF[W^
M2>'_*RV <@9*K8 SL%2\!!8WHQX!2)(DM&T' H0\ H(0#<VA P>E&C9^(M(-
M6P"9YCKI5L0O2I<_32[1N_J9Y TM:Y\FKRRS]/%X1_7*=P)L_L(G ?XOM>[)
MV">W[$DCR;7JG22WTJJ7IXTW5?TE?Z"#^BYKZ'>[N\V?JD/>;#P_38+ L]/8
M]VUD0S<=*U." ,9<+UGIUD%W?=MI%G?S]JT* :J^==*_>_RW[2K0FB# O3I]
MQ;$>&N(FP=JY_S$>$E@C#?&4W$JITV-\*Z8\?)?6S04<8L#JN825U;+#7*RJ
M\EP"3B'=D1('Q';H!U%(U^=QATHBA$4*)$4^5_.*)TZ,4N!,+T>Z<1%;8J28
M1TD5X#3SS$')C-H\*<VK^6-D3BWUQ9[==@I)G/K AZGO0^"E-AP:[P78@UBL
M.[ BH2*S0JHW<#\Y2HK_\P=4K(>\MI[RK%ZS<%:BS[UBX,V8:*J-FBQU5809
M[_2D(<!XO0)7)1W%A^+[OFL83M(X!6$4VP#$R'/2*$C&#74<0ZZW]53(T;QH
MM[?@'[)BU\;-VU:YYJPEM]A"/@M0OH5]*2S%%OJ35FUK@9->[:VL97EL J$)
M\E*!JQF,I<222OVH$WQ:8/?/8W-H17ZKX&Y7L)URMO],I^J'$F</Q2';DW\?
M"W9O]?ZA*G/6?>>E:A$ P U3+P(0."[]7^0Y(VW"A*O\?E&%-+/=F0W6H;).
M5EC,#!J%6+TA5U9GBC7:(C2O5_0H'XL:YTPQNEW*CWI>E%" _021+^I:,QA_
M69-?OE*Q/-YRV\\SF7B,\]KTF+.Q[2AU8S<B < N)DD4X:$-3@ B(+10J).Z
M;)'"U3DO#/]HQH/7.1=P9T'/Q^CKH#ZK#D$6\ 5V_Q/X<2< 5/C #'[58-=D
M&D =<ISE7=U#4]^RGWGS)<^VE*V;EL:KFQ?,O0DB._%B!P/$DA DQK$WG@X0
M)^1O+*E2J':>[!_B:G5E%^'/M&7QU,L82ZAH2"'V'"?5:\$N2I2_".)"U5GK
M("];E*7* [RE6-SH7*[ 4@^P 4?'6LRJ- _,>2UWAH/I[JQZDT#D>@2D,/&B
MP/.!SY["[H6&",UJJ",H:NF(_*R0H]-P7AL<46!E0F^MF,Z,M_GA7*0US7.@
MN -K:81-C*;EC7FG:<PLC&9=BWAY+;_X.9:I8M]VL>>Y* P])_$C'Z:C%G3,
M"+2]52][66X[+_-^W=>"J:VN G^.0[ABZE5],8L3?Q4W*+@&L9 [E%^"D'/+
MO!L0E[&Z''UK0]V((%R?=3QW'Y2AR%VO>9?57>WHQHL\-PRQ8\,41-@+'2\>
M7I<.DB#B>O59XF-U5VLR360RVR+(\,7/FD 16Q=X\-!3J3E:/U6H*0Z1&<&N
MC.(ORS1E;><*8ED!%&62Z[JX+=BQW?,Z\>J&_*11='F;=V6B)$9QXI$HB1%
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M5_S"2?6^*4[?:FS?WI6L3NK.KWV5=H/$AGH)Z)56R XMWEI5K6L.W!<KF[T
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M3*^+A5?HV+ VBPW<_OM8- 4;!6V6['-=;/,-\5R";9(&T/.C@#V4&_HC?Z;
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M?'']^(E*0$T_P4KM-_MAJQ 2%"#/#=,8.VGL1GZ2]BD@-[*YIF!F(58]!^N
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ML3H.]I>*C?P(%0?# <AR(5# 6_ICGAI'&1'D7G>]\2%M,$%3#!/O#;]>T)K
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M\SG5W E/Y$1I4S6!.T/,^,QM#I-FJ-)<(U[.U>9S(GZN\\R!TF&%^Z7.ZN:
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M3\P07>567MI!5<KJS!5_U8-[/#<A#K#G.B1VG!1'!'DAM--A#Q>EKM@M3A4
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MSWA/?_K/?^C_AOZ'U3__SW_X?U!+ P04    "  "@TA,(:ZWU4R5   #@ <
M%0   &AO;'@M,C Q-S$R,S!?<')E+GAM;.R]:7<;.9(N_/W^BGK[?JXN[,N<
MF7L/UAZ?XRIY;-?T_9:')E,2NRBFAHO+ZE__ B0S)4M<DD0N)-W3/6U; I#
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M$*$%E%@2:Q4J$0$2R@32H1^(=&V W0/];'X[GN8CG4_#7Q;Q$'=^VCI7HZ$
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M1.-9/EQ\OA_/1A\&L\732B4??V\2[E1[:M3-* R+J\-*6R440$)868;-4$(
M2J',U7NQFP>XLV#(*H9JA<@F &\U@'W1D+MK96%42D6_A)2*&Q*F1?5H(75
M)OE\?@"'=7/0]G-&&U3V7#U$+T'M4]GG*IEQ7",:\\Y8#34(<P97NAY6/BEG
M_MDGPTHG3T.X]L.<E][Q3XNH<>[5BXYO)(-:\F!!&L^)4H@XJ%BU5WNI4@YJ
MT0\0JMT:TB=K13>W ?!XC#(;#U?*VN; >.<"5*-6%I96K  0#@INA?:.58D&
MJ$ ZQ8)'5QR7W3RT_2Q#'_-1_O 8!;<:Q EKT,X6,JNEIQQ9YYW& H75&(GJ
MG$\EG5:@*W9'MPOSF='LYO6LB27SAWS?*7]JTUF 77.!+=**"F=E3)&R08P%
M)5.G$/.*7=L]X=]<:%S5L5=]_I0/B^GHR!BY.HUE+&8]A$@%F]=Q@L,V@,IH
M&R9)T@O/Z-K]XUT@WCZWUGZ29JCUHJT,<D(08DXK9Y0$V *'JSGDTU)C77&D
M>%> MT\L7RQGB_N&F/6RL8QCRSA@@&AHE(8LK-)E?!:+25I2J'7M_O0N$.^
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M6!Y2*.T%=-#J,-RXFFLJO/ H)2[Z[+?)$V2_.XRQ3=B[/,A)>Y87&P(T-XY
M9BVPR#E>1B-88Y+>0$E\(>>\"=4<IEUQY468RLH+\6'P%)?EP[397S%30&$<
MAL4DPM@YCRB4E0'#:-*][>M=D%H!]^0][B6+;[Y,QG<K2<S_/E[<%\O%ZS[N
MVM:.:R6C' >LB*9,TZ!,,^$IK\9F38I&=(9^Y$9WLE:1[F/S^JV8#H_:OYXK
M9%8&9=*Y8)=9X8&2VF%0+;<PZ3F4Q)?E>\P;T<1^=C+&?3"H)F^R>*') FD)
M0%AJ"K21E;]-*)SB<#S^6F&Q&$RN@RM'XGH&8:VOGLS\?1ID^'KEO)) 5X2T
M) P"[QWG3AC$J0[&2U KJ'0*]QSH^GQ-ODZ@ZZO2F4 $<PD#XS@@QEE" X<W
M8Y,2IZB?YQZ#EBKM+7Z6-'0O*>K5:QR6*V%-L.>A4=!QXZN1(=";'Z4CWIPL
MZ#I1K\=A>VE1K]A:0ZRE!CJLA2<& +X97;S<V-N195]1K[6E72_J]3AX>_:>
M[#SOK%4O0\!![0CTBF#JH.4 E[-.!8,MZ2F^LS==4N5?SY-R$M)='B\]K\1U
MCY>VU,@$]-XHJ[%V"#(#H=>H'!^7.NGUHC-?E)K<SIJ!MROZ?/\B>ZD.QM/6
M#[/\8;SU.?3:=;,P2@4! L&B(XAH!P3VU42$MM/%J5=*G4"#UZGJ&@8[(6KG
M^XZL1>#'T\%T&"SE74\[UJZ;>8\0L!Q9"JAV7MI@>U3CX"3IC;X?A#1M@7TR
M:?1@GK]*S>"+F1H.9WGLWNJF\R[2U*F;(<ICZF/N%%2<$P(,9>4XXL;=R1'2
M]^]9?[Y@[K2 >3\[VO=T5]-1N6KNTY#J-I&Q,/B +,1*8X,()YK+$@&9]@[V
M\>=/W7N"V]O?&L.\*]:]<@5'=-RWX6090T%>#FT/Z^HVD1'G+= (<LZ"V:RT
MYJC:Z*EC*0]()EVCN$#6M81YCZP[CF 9#-HBLE Q3X6T/&@"T#^OX33EYOXE
MG&6US*4CX6THP#"FQ(I;]3(?E7W:^\KHL4UD 1@$F(,&>L \HP&M."H7K ZH
MA$UQ?)]I#LW&%*OV8#Z#\]"5XV3^?;<N\*Q3&FJ]XH991!U%F'#K*;?!O'9*
M2%IK?VUGA)^&]_EH.<G7#H 5W)\#P'JR/:5<G6J9AT&=(I0)ZT'T:'(@Z6:T
M6H2M[<I]-"GR?YVKLCF83]X)GOM0)SCA((.2V\PH8QAJ*9V 5!I'K/2V&K>%
MU^Y5;H!>7<N@DXUD.0_[Z#PFAOL23+U8_[=!V$D6XZ_Y.F*FOVUD2]_F-3:3
M?=4RIE"\["4HC;.?6,OP.C[*Q,<<8*T8^;:WE'( ZOD%@;E^>O&O0[$UQS:5
M206X#T8\T-I#QB"-J>,WJ'"'>CL>:&<Y:(8@._><5C#O[FQ\&9>U .3B*=X6
M/!".LZUX)C41G@L-*>:42F[()AE"&!DCKK=48NVPJ3W!OSD43\:Z*Q:]>*.B
MO,#\NO<'(W9JMY$Y!86C$G@&! *<:J54B8%QXLJNT:71X.UC<*V ?++:;)ZF
M*R5ME6X^_"1(X4"*F]TU,J!"VX(X 9! 5BD;_E/V.9@ 5[80M2#+H@V<.UN$
MHCODP/Y5E<D DQP)HP!EG"L& **X'(.T]>*J+R>[0F>;UJD =TJ2@Y%_+TIE
M1""J@33&2@$--!Q368X#.'IEN\T)\MO&@).PZXH#OXZGXX?EPT$6?%<NXUA2
MX0W"EBONK30P.H4W8]'LVC:74Z18-(=?9UP8?*O'A9?E,N"\T 8S2XQB6AA#
M-Q>FPE@$Q[WYULZ8"PGX=<4%'_BZR-^/OZX.A<*@HUM/S>?Y(NR0OP[^4<S,
M9!!VSOTJQA&M9%@9PH%UTA&NK-,>T=+YH'A:)N8SO'_?F1+2G@C.@(K/_:]E
M5A_94J9MC+204CJ)%5'*>\1+/)S5O=W):X>2K3"E/AL;D$!7C+Q9W.>S-_T_
MM&WNJ94Q!&S83H(MJK&5%%E JG%Z:U,LL,MB6AH+BK80[RZ6ZL.LB"\M?0RR
M#!^]CU&'^==\4CSN34MY5/TLAHT1 6U0-3ECV@O'286G!KT%MU\VV]K OKL+
M7*M^QGCQX?TT'I0^?1S?W==8U0[4S!#T0##K+%&0>X:"$5WM% +!I/=J?URN
M-8OZZ2%_X_EB-OZRC((9U,N=NZ=*A@RQ,AC 3@NIN1."D=(44H#!;B/9+YXK
M#</=V2GL<KXH'O+9QWRR/IZ^'S\>7H;VU,J@8D! P#%4A&@"-7^>#%KP*\OX
MW]42U!SB73'K\VPPRN/(#]/I==%,6B\M#INU<I0;C' ,F=J,R"*=HC(='Z)^
M-1Q*A+DKXFQQT1QP?.VHD='X:+SPT)$81^VQ=*9T&2H%ZH5@7<X.UYF3JQFX
M^Z13_&O8G0^ZL [6S92RQFO!M*:2>$(U4JQ2_9B[LA?MDB5?@TDI^"8'@]0+
M *DT.@J41LY :21QC%LC*HT."7G]LC]15MN"/4["]&1Y_YJ/QL-BMOIC,/FT
M?'R</.V7_>X:F1)"<HFH =Y8PB1RVI1]-H1?V>-%+?&@,7Q/YH1[F!<'7KI\
M422#5BGHO)<.1IT;4*/*4V5%?5+(UQFZ6EJ2^NF ]J@^O*^1<6E?M0P[PZPP
MPEN'O%38(EL9;-@D'>*?H8G<IUYZ*N8]LFL5]?AA-A[NNW>QMU[F<-A @?-,
M82H8LE!R6CD$?%(ZG<M03$X0^V$NG0QP5V3Z,'A:W\DM-DMS.8A\_K=9,=^W
M7!VJFFE++$#,.6 ]E5!H*RH-GRI_97%'K5"J88Q[7*)BAI:;V\TH1FZZ&"^>
M/L\&T_E@6/[ZR+VQ3HN9YD1I )&#+J"N"!6RTC"4OK:8I:Z6M1:@[RQ6:3">
MK?)2O9L^+A?S,F'0Q^V/:-6HE6'-,8[C0DPQ 8E4J#RDT<K)E)OQ9^@Q;(5B
MS<';]0KWXI;FQWQ8W$W'_\Q'[T8!R/'M>%#YY,NIHJ:C]^''XTD +I^'WRT?
MWCKP5T$QG^\'T[\5Q>C/\6128UWLI!^9)L%00Y9B19'VCE!I2JM:4PQ3@J#.
MT AI=34]1X&=[ 8I7[C[,"O^D0]W)_9\72[C@ JEA% &>FZTUQB'_A& K>/.
M\I1X@C,\M&N44$T >K+ RP"JP7<!5-]3-F:>&"[RT<<\^GHV2?H612#^XR3?
M_61E TUGVA'E X(<6<<<LU!;5]+>XR0O^QEFGFJ>5MW+X Q"U0_9NX>J9MYI
MIX!'G&"L%%18B_*,70-,4E@GKIQU+6'<74:!K_ETN?6]PM=%,J@E]@89"4E8
MH+$R")86NT8Z*9!<_B L.1'+SBX?/.8Q1='T[MUT6#SD[_<O*UM*9V$3)P0(
MRS!$@FCFC2U/-+5A+NGA%_"#D"0=UZ[X4NZH>Q:_O^<Q=CB8 5_#H.[RW^?Y
M[7+R?GR[SV>1TFQF/),&"\4],""8#1;P9\,A3+D4!OXHYP$="J!'MX<IIG&6
MK?)Y3.?CT6K61?C6UNK3<<Z+0ZUE"E%$(&,<ZC"1XP4A4@I#<^]X"C%_E%.%
M]G$_V;#<TK4/^6Q<C&Z+V>8PI+@]@7+--9XY*CV5C-GHUI;:,N6"88.5%%AQ
ME?8JV[6?*?0FAE8(J0)T017=='CYL)RL,E.6ZJEOF;(-?CZCEB' #*4804()
MM,KY@*8C!@*A<%)<XK6?8IRQH+K2"VJ<5#S[I"7@ 56.E""8 XF)T94)[T12
M:IH?Y13A1# O\73LPZP(EMSBZ<-D,%V$$BZ47;DC.SH5V_G]C!MOF0VP:^F0
MEEA056&/!4Q:,Z_]].*<)=6O,?6\Z*\B*M84@$=;4=N;R1C5AB*'N3-$<\<X
MJ?)::0;2'J.^]J.1#@!_IEZG2=7#S E*R,/@W?0V_A%_=(WIU7$P737G$ECG
M@P(E'?.:<JT]8Q097,MWT,YH^TRO'NPG'S1'H+RG"@N+O6(E*LI>6\K(9@B2
MFE[].,PO\!:MDEY03IGEDA%C'-&T'%^TSZ^+4^V)O^XMVJ/@OHY;M#QF@Y(^
M:'1QP@ICM*KFJB'DRA)R)4O^Z%NTQ^';[2U:QE58F37D#EI#@Q:GC"W[!J%+
M>8[P0F1_HJSVW*(]#M-+ODK'*4(HZ-Y>:DV=)TR%";09*07HRN[>]KDYG8IY
MC^R:E[;0QCM[',E>U\X"?$)CX:7TR&//J92H'+=7[DK?+DJCP&%>)<)\#O3Z
M+5_4"@^JW49&K#","T$%PCI><J<6E!A8ZE,RUYSALM8YU5+ [I%P9??=8!:#
M=.<?\MGJ4JH>S,?#XWBWMZE,4T(0E@QQ1(65GC,MJBD(?,JN>FFGX@W2KTG,
MSY"%=CQ9+O)1,SS<-)8)KQVF3'@K$;8&>NJKS<!"G&(=7-I1=@=,/ WUOAS=
MFS>H5E?RU60E^RMU=G-A,)! "H"#^)F@5)%*C??U9D%-&WX'JKL\U0?K9!9;
M@6A8PW#89YUB ,+*!/%(7JE]GR;&HAUP+\_W+#D46%+OC5< !Y. X&K-DP2D
MZ,%G1)X&Y5S3R7P<KM?A9 9,*XZY<9 "8 WQ3FS<JYQ2 9)B/<^'2XU)_F@G
M\W'X=NMD%D@3P+ "RCLKJ9&"^[)O"J>%]UR&[$^4U1XG\W&8GL&ET):>TD+$
M8PV!5]8Y(1!6P5HK<9#2I)RYGY&OIKT]JCVLSX!S+;^990%D2"&NB&<&8(*1
MLR4>3+(KV]-:84KBFUG'2: K1K;WP@S7AC'OD.>>$$6Y0+(:+]7TQV%<&AN.
M?&'F.-2[8EDW[V<!'904KR%A04TQ%!'RC*FS'%S'_MHUX]K _F2=ON&7C1S&
MT IKL:"0<LR0D+#L-78P)8O;&1Y?M,V8AN'N:G%J_F4C(P04'B (E6;*<.E,
MI5( C:\L.6!7"U%SB'?%K)27C<+")X$$"E#H+;<$Q;]N1D2"EIK H3.\+]<5
MAQ)A/GG?VF$/5V=V1QZ8/)_U2>M!L*<=X5:$KRJ%)*]\*R0IL= 9[6#-^Q3:
M0/<2+UJ:P?Q^<VONZV 2LTX?=_38X(<S9)4C$!OIE3*:,D=5Y6NT"%W)G92&
MF=?BU<ID$5WDA%C.9E7:PU\'LS_R1:SY*1\N9ZMR7<V/0_W(#$1,&T4EA@!Y
MPX'VE3;->=)T.2-S]X*F2\,2N_C9$UK)P\H1:O8R:5Y\/F,<(<4T%H@)QQ2!
MRK%G^T"F7$V[$#7IC.?*Z8*ZQ"GR;OHU)GV9'9DC+?U[&8), "L-Y,913!ER
M")?8(N2NY)73RYD$ITKF$EE_O@E=K*-,6V.!Y=P90*T@%1,\23HU."-'R^7,
MBJ8D=8FSY+=B.ESOC"]^U]$,V?KMC O%"-32 428UH09)Y\Q9REYN\XHV]'E
MS(XFI'2),\.\&;0:KIX+FG\8/!U(CM)I/S)$G-1"((YBDC:""/6FE(4Q-F7&
MU,^U)-<S9IK?#18Q5N!?$Z=IP5W')+(;-M6_]]Q)/S+@O$4". $MP(1!J5WE
M9]2.I]P%J?^JQK\F4=N"N\A)-'@<+P:3]WD0ULV7R?ANU5QGIR;;/IY1:+FP
M 6BJ 8'0*$LKKXDT-B7@H/[S(O^:+JU(ZQ+GR.4\;D@DL0[B8$@"APC&# 8K
MLY0%Y4DYR\[HT97+F3--B^P2IT^YJ7X>?'OQRV?3KZ/9<Z@;&70(2<1-,#HE
M $@*H-3S0I9TY_Z(]V+^M>^T++BNIM Q^>0IY,%>(]HC3*/9Q@&I L \ "F)
M1\[I19AV.7<BFF>^I):CVNX_RUM8/0]],8MB@<!(XJ#UTDC@2.5:B+D<4]AZ
M_/ES$772RV/K>0CG''*8?)=X_!K3F!C"E9>08(&)< Y92*OU2$)?*[2IG='V
MF;,;.:,950H+Y#SQ0%G]'!LA!+Z.^,AF"9*:L_LXS"\O;XH->J!'#%*O&0<6
M 6RJ^'>&M+DN3K4G_IKI5(Z#^SK2J4"!"# ""L.D(8HYKJK]E5#_@^3LKBWY
MH].I'(=OM^E4@G8GC%2"46B(\9IP)LJ^"0NO)*2_!5GM2:=R'*8GR_O7?#0>
M%K/5'X/)I^7CX^1IO^QWU\@DI3(0W@)L)?5!\5>V<C@ ]^+5G8N.56^9!XWA
MV^.^4IF!QVTIS]:CUQA[&=90+ T.]AFASSNR@B;EJ.L,F=2GPG(JYB>O.-_E
M'8W.@]$_EO/%CB#1 S4RQP&P\05MR,-::83V\GF_M?KZ=YX3Q%>T 6V/WL*.
M7RGG$#/#B7'" DJ=H(P\7T)',D71/<.EJ5'*=0=[5W3</.X[_UQLMOYR:/G\
M;[/]V?\/5<V !!Y2+*0W%D&F!;.5]\/H>D_:G?]MIE:)UC#&_2YR[;X>*I%D
M7B/&-<!$,J<\JH*+"4(I;#O^VE!K9Q<]+&N-X-W3><1UG3= !A36@A,?W]/6
M5"NP,:D%<8#7,BHZ&ZT=SX>3E4/@<X!=A^_^<=RXMS2081RL44HP#4HYT0AX
MAU2)@+;PRMYN;(8,AR=Y.M)]3>_/WUW;OHI)[L,&CHS!P23VD@4A<T-*X#'7
MM2YFU+1D]Z6JV3=IZU?.0-@*6+#VO5:"":,AA-5HH(8_TFL)M05;][6$4U'N
MT:^VY3'O8W:'FBUEC*&@D!"NH!<66:>#?ESB(0!-28]^QB9N(ZSK!O(N]XM/
M^=W*AE+3T=_RXFXV>+P?#U^,H;?=8].QC_EC,8N^@QH[QZXJ&0?0>:5C6CED
M@&9*B'6T$G462M#G\_&ONGR<7EBC=F88<1Y  :WA%F'"E*3EV*GK+R'7XVQ<
MS,:+I]6BT9+C/9D/KR-/&L?[G*:Z&HU6*]E@\N*'Z\BTJU@%5##'E>5!0,@X
M"2$@3 3UW6 &$<+UDIFW'9#VNO,O)*&?-K^L'Y-6N[4L&$@4 ^<$-0X1ST#8
M%DML EQ7]MIM.D5VAJ2U!7EGB92#>E1,QJ-5CU<.LP-!:=LK!(TG)@UGAJ!@
M&U.+N#6H')VEQ%T9H=J4_^L4RDT WA^=#@:C[:J2:>>#EH[C\1"CPGJ+@"U'
M"#WN[7FX#C295)D?I-!)$'=%HG?3%=RKN>,FXX>-&5?CQ8D]]3)K'+0J^OX#
M:$Q@(54U_SSPO45B]T*G8^7_YGV)YI ^.?1DMW9>'?[L<M?5J)H%1<!+J83#
M!-BP=B-&GM=KQU.BK)/<)ET84AUL;RW)H:LUZK=EI/K-[<WCZCAP>E=:6WO6
MIYUU,NJHD$)B8:A'V.+X,/-FC!@!U9LZWB+7FI=_T0[:73-J#<8Z"W%M2KVM
ME&'B/51AG%R%!=@A3 PI1ZDEO9+(ILYHE(QP5SS:9/79QYJR2 8U1MQ!R9WG
M7 $JGO=_; 5(.1I("DJZY'7G1'"[HL?NH=_<KI]MV3S9LX] ]1O)F!54$$>E
MDQP;1+TGOD0!0-MM)-*54*PU^$_6Q=>K9'&[RLXW&^?S/\>+^[M9/@B0+^X'
M4PCB[THK)!_-=N:N2VDNL\1;R:*+7R(@&3!Q<2Y79")2O%#GEA>X#7YUB/TY
M'824*[9^*G_]=$7'( :$F6^)X(;&_/Q:8+^.?Z36AY^>=B]_AT5>V8W/. \F
M)?R[SC'J5LVD#*JZ<QJ!8&PB38G:/!@71B*L[RW>K<^CS=K2+5H%NS/M)4AN
M]3KERXX?.+'862<S1@L%L><&0(.M-M*+<HP<BI0;CN=*J.;E_UHW:0CMCO7A
ME[T]>&2QLTYFG7*8&HPHIC%+%^:;&^-AC+['D-PNEJATP6]7<Y-A/HY*\WSX
MU[OBZR]K_>=IS:3-/UZ3://C[/=/6]CR_,O,." P\<Q;BQ6C&FN'R_XJG99T
M[]QID2[$(A'/KI82MXS/8!P\IGI9+&,R3 &C88Q#9!@:8+2I1D)X;Y?L+XH9
M#2#;%4?4?#SX,!B.;\?#@T1Y4S9#7%J%G<54":4<0H'YU9AHO3LO%^:O:X\M
MJ?">?F=^,EEER#6EA;T_1<>.XAEW0%F.";- B6!F ^9(V5O,1<JC%>?J66N>
M# TB?/I!]EYU_/W!P^QZU3-B"92. <<]0-H:;D2U(!HD4A[-.M>MIC5KIT7@
M3Z;1AWPVC+*YR^-IU<Y#H)UE,Q)4="F95=1H3A6#'E=ZNE8T*3_OY1+D!#D6
MS2)]3K[2S>^O,V*<0,]QT !,W$24H]SC,I8?$^EJK9!7&S%.' [Z$";(<A3V
MU[!"5MC$$+(K7!R:XTL3X>-'X=^Y/_;-^E'3)[NM7J8!,@9@:(71#'GI 17E
M6"E&U^B7[80:NURU#0BA8W=M71=M&>?JM6&8,48D1IQQAZ@LQZ*LKW45Z%()
MU8R0M[MF3X+W9 77C@=WTV*^& \/6,QO"F8@*EB:0XV$0A9*9K0K>VB9N$;5
M-E%418-XGBQQ/<L'\\5_YH/)XGZ_R-^6S*QTUG$JM4 <,V44X&4?28S8NT)[
MMT&9)P-ZLM#_]C3]M)S=11MLO\S?%,R<DP[)L)Q1IX3F!DG#RAYJAE-<'!?B
M'TT1>2J>ISO _L@GP8J<U)GHV\IF'@""E#)1Z<962@JA*?OI0=)4OQ!7:(K<
M&X#T9-%O$B.K?+ZXS^,&LU.SVU<\\Z%=8(0&G##-M3!D\[9$Z"W&Z$H"_QJ4
M>3- =G>M=!:LH*#('CPS>U4RP\X"KQ1QU"KA%:>P2L] 0-C.$HC!KGIE: ;0
MOJ+:7QC+^\Y/CJF>&08X)MRC8"$AA; 5KK252/A[;UG,K\TKT;PLSO'J3=">
M/&!A*EFML$6>&E8MM 8DY<0_VB+]FL^^%'UZ5--DO.L"SG$0=T62ZC[BN^FP
M>,C?[\\KO:5T!E',6"(A5T:@8(&'_U9+, :VTYO)UT6==+2[8I'-@YR&X[7\
M'B(4_US_?3I2P^$LCW_?_VYFS18RPYWEV$DJG ];/J3N>19Y*E-<9Q=B4[?#
MM7;P[XI_;W*Q?Y@5H^5P,?ZZ><IS#_,.U@U6"(6666^ M90R  PFU9@M2<G5
M<2'V?#N<:QKY[J(F#U!JTWO,',6.06LQUD 2JXRL_%4FZ87I)#? I?/F)'C/
M*6REY]38C=[GTPAI$LRIH-X2J2!P6FV$H(&K]R[U602IU$EX>EJ+&5.4,<^M
MY('KD)KHK:@PPJJW%U)[O2E8ES=IP2HGRJ S1U$UFHV9Z ."+JP$L^E@4EV;
M5XO%;/QEN<A'GV.6YWQ\-ZUB@Y]O"8^':I8/CN-QXU^-Z<ZQ=,Y"@1!FEA!2
MWG-PFF)TU6ZI]KC>MYRZV#Q-\? P7I3[9O5FUW#<XTZYIT_/&0YJ;)]'M9,%
MP0A$'$..,@<XT2SHP:M\[8@:4"\TOD<\ZBQ!QS64<8>T=MIHRJ%'3 &#3(D(
M@RKE<LFY[Z M4>?-N4J+\NAY]3C'S.+]+"P:0V]P4'\DI@P+ZY38/#B!L.#D
MM!SD.VZ5/<0]*%IJX;^C=U,[>!C<[;X!LJ-X)B! 7@J/E!8,1L\G!66/B0/_
MFOA'B[9H'/6NE.7W81;?;:Y]+!:351CI9@1_#H),@_ZSNC?W83#;^S#K4>UD
M3&"LL!=$61.@0!A"5F*!:5*BWC-*7-@-Z;J00)]L=-\>\^E\WUV7/;4R@@E%
M/@A->>RHL8 97LTZ[WL[VK@VIIV&=S=*S',B,SV8#*;#_--]_L+7W+VKL(S7
MO[GUXVGHT'@P^5"LWYRJXS:L43W#0;( QY<1@;'.6._!.GT&T]@B=MJK>@TZ
M^FN,\_N"F> N&-(,>PV9)IY:3ETY(@Q^C L>C4A\J^/_1)B[/1TRRUF$JS9W
M7I7/B(/.*8XI(8A!PHP3OAQ;L/&N^>&L4Z6\E2QIN'8643J8W\==,/SA_F<Y
M_CJ8K/;%A1G,9D]A7_SOP61K>M*CZF=* 6:AAQA1Y[PA2)-J[ &6:S:F$LGP
MVEO2 MR=+4_#5>:J^<=\F(>>?YGDO^6+#3#[5JD]U3+HG03,0^2%DQI[Q#RJ
MIBA&UYC+HQUB-8AR5WQZ-_T:.E?,GO;'=[TLEF')/>;>66,D-,X Z6@Y$D-<
MBGYT[D%<S?(E =7.0K-F^>-@//H\^+8W$OEEL<QA2Q240!C L84TC(%7^J$U
M*?PX]X"K9OF1@&K'_-@8Y8<WHJWE,\=7[@"E$*9A=718; +%(D"P7EKI"PVU
M:H4Q2?#V8FG5M; RZX57P9((W794>44]?%;+I$EQLQU_!ZM8#":72I446+M;
M78K'?+9X^C 9A!%/1U%=?XSNB?W:RKYJ 2]/)-? $<>@0I(15NVS2J!K?HJM
M(=.\07B[4W,7@^G=.&CD:PQ"3]VWX60Y"N;>WXIB].=X,MFK_AZNGE'F&/$&
M8R$AIH (_+Q!>\>N7RU.)E8+,'=%L!HDJD8 PRJ-&2=.<B<LE\YQ6*W8&J2L
M0)>A'R<3Y40H.[N5%T\_-Q0NIL.#&L[6\ADE $$/D8(6,*:8%YL,D6%L3"9%
M35V&4IQ,DR9P/;=;*98I#CF@GCB @'%::%WV'D&>\BC$9>B_#9TL' ED=W$)
M@R_CR7@1 ]^FHT^+8OC'?3$)XIE'+6OQ5.-$JFX3&<) 8TZ%LIC&&X$,>5"I
M:D3U%AMSZ>><+0F@!PK6/P;=72E#VB 6HTP#F,$J\)"B:IX::Z_YO9+FF;";
M:FFP=T:N8GKW.9\]V/Q+C6.K+:4S#SQ 6#%E+((0$:9\Y<P*FF"G1^N=)RQH
M0MZO*92,<==GGQ\&3_%LK?ZIY_<5,N(9=Q9 ;0RQ'()X[O)" ;SF\\X6^-,(
MR!U2:+8,HGD#PWX6;:^362@)$DI*ATC0!R"13E5C%"SE5?1S]_BT0Z1&<.XN
M:\I:/)O;?8>)M+U"1I71P#)"B)4>(RHLK69*F#@I&]JYNX-:8%$C('<7./8X
MCB9T/ICG-U\FFUCG&FO2_HH9\P)+Z@0P6&,HC.:@BC6!@EU9!LL66-0HOOT9
M;D<9;!GDF"@GF>1>6<5 S'%6G0%BI:[8M=2&7IT*<!\F62UW]?8*&1"0<>4<
MC"_$NS C%*^,!F)QBK_Z@M3JENS\)B#O>5>KQ:V#=3/A@DV!@.3(&(L1)C%"
M=S-F 57*WG:&]ZQ:9U;3@'>M?7\>?'N!42V.':J:2<<<#VHA8R;,,,H9P\_!
M,-2E4.R"-/)V^-8P^#T9>T?Q[$V=3$C" </,Q.?+$>-&DLJ@->%75WRTVQG!
M4E'O-%C@V"5L=Z4,$AXF"@&($!R'R.AS )9UHML#XBOC5F.P=Z:*'<[*=%Q:
MDLPA)@ 0S!-'I,3<6R"K4W?"4^)O^8].K^9P[RP#WBD!"GN0L\H!BZ2$,$P>
M1Q'4Y-E"5C[%AA0_.KL:@[W#NR5K<:UZ?N@2[9;2&34><22X!9X2)RP4D#SK
MDC@EPN7<0P^:D/;;RR6)"'>Y[1736K1Y731C6#K.M0-0.BMI&!&N0DJ=K)?/
MXD+=6"UP)A'>SLZ%JR1S'P;CT;OIQBNR[U1X>XV,:\$4T_&L,BA^- Y35!')
MG*9D4#WW,^$6Z-,,REVQZ&/,2CC-1VXPFP;-;:Z&P^7#<A+S 06K=#P<[].*
M#E?.+#42>*ED0"RLN,!)C9X76YW"K7/W2[7 K<8![XIFG^-KJLO94ZW][6WA
M#%F!*!,!LU5D*_':5GX0PG'*B^CUO4]R3:-I?A<!_]S^,X?-$R@9V@ZCGDIF
MKSP885,.4KK/I_/QU_SY=:+?\L7-[>?!M_VQ4,>TE%$ME&$0,8,QEE!!92NO
M"!<LY:K3N3NCVM@-6T6_/Y_!4;Z"#'+J>%R205 !('(*BFJ.>0=2[ED>[X'J
M-DRA!4XE WPN-V/JQ;ILK9II1A4F %F N.3$&.QMI4X:21,H)<^<4EU>46@"
M_&>Z]9#(\\,*TM4;Q\_&X55F]:0Q[I]R"H-EA2F&PK*-YJN($Z;'AX'49%+\
M&47BBYDMEE\6M\O)V\1;-<*ZCVDG$S'\"T,9(Y%CR(VPW)1X:)5T5^[\/8E-
M\N6U2M.B%/KQ4X<UXF:VPFRTL@D^Y+-/]P'HVJ[K70UD-+ZZ;1SF3BAOF4#*
M5Z/'%*4$BI^_9[)%#K8"?S_D6_5TKI:+^R"1?^:CVJ1[73%C+ R7,Q)V=B -
M8UQ+7(Y6B*0D%>?OQ^R,;(FP]TFR=_/Y\FB"K2O%G%5!G:2 (VPP="[8*JP<
M)?$N)=+\_!V9'9/K),A[.*@[8=^L43MSABN# 8?:6H&(!<Q5XY9(7G,6E5:I
MUCSV/7#NB.UR3ZW,.*LM)\+ L'C3("DM284AIRGAG.?OY>R&8XF8]\:M@[OD
MCAJ9AT8%,R?>&*+0"!;?3"G'ATQ2-KESC[/KEE,GX=W+4=^ZOW7/^M:E,Z^I
MX]8JJ0QB0 7 GL>%<=)=AJ2(N@ND3CJ\73LO*SCF-[?QN0,_*?X\B]>(JLX<
MYZ]\4RV3$A'-C, <,XX,,KP\JU"$X7KIT-H9;4S]'[K[859\'0=\]=/OJT?Z
M;A[SV6#UOO!P,?ZZ=HL?QN#XQC*$&.300!/6- \Q5PA4+ <BZ3;O!7DL$QA3
M="R"KO:4,)#GL^+]G'LNET'EB)#&<X%HP ]K(BK'!-=):9///^U2F[)_2[.3
M4>\N6O(?R_GZGL+GXF,^+,(^NWKKY+GGGXOF%K\V/I=9:J$/2I^U6B%!N%)>
ME\A:+5.RTIV[,[U#-I^!Z+J[(1J$'O3-2(8]9'Y9+!/0F*" 8L<]4HA[PZTK
M1V*X2DD@=>Y[=+_,>'-G]&2A=+_F^F*F'HK98OS/0US;62>S"@LH)')(*N"<
M=1I50"DKKOH1A',B7E,2ZHR%+[I8F=C3.U/,5U<6X]._JZ/[?:2LV41FF"6"
MJ8BH1()Y2EUE6@N;=$G^W$\@SXNC[0BLLW#3Z*C1@P!/#)?-I_-#J^;V"ID%
M&@ ".(/.(F.DY )6JCB15_UJPSG1L1'Q=)TV9 W4Y\&WS<M<.I_FMWNO QVH
MF2F)X.H\5PJ#N(1>D"H:!5!\S2E$SHJ.S<JI*U[^;3">SB-0^?QFZKY%3);C
M^?W:9Q:3C.UAYL&Z&418,HD84UI;I[R%O#KW]9:DF#7UST._OV#4ZJG#61&R
M:?%TF@<G)E0).*UQV\RD/53<62=3G(1=P%M@$5,,86I%I8M8:E+B=>L?G^Z^
MX_:CK9)-":HK,H8^QL.^W.;K/U^@LKF"7,-O6;^1#&LGM$4.(Z/C%2UG617-
M(*5*">T]=UNG0V]D:P+ICY9O8^6/(N3;ZAD2 BM)K..,$Q_4:8!X!2Z&*8$G
M]7V2O:Z<;=#D(!.3)=$?!\MGS/<G%=M;+Z:W B"^8@N=1T1H+)_'&I22%)6Q
MOD/RQV/=Z2+HCVX?ZCU)O[]BYA'4F'.BE(0J#)ER6IVL.H-3TB36WW%_/,(E
MR*!WQI6F_D9U5=/1BP<F3V'BW@979_],<XBL\_$-;NTUJ,PT1U).J.L['']8
MAC8IF_[5P\WC3"?IAINZ&4'20^@9 DPXA0T1O-*Z+?(I6_2Y>QQ[U0A/P[]7
MSKUZQ^E8VKVJGCD-,9!(  )Q4$4XC5I*>1:*>+</D_P8S$L307_D>Y7]^RCF
MO:J;60T $)A 9CP-XX1>5(N\4?*:KV#T0KLT_#L,GZWIKVHDGCMS ")-(??A
M/\KK@(*K\%7&IWBRCS]W[C8W3;=AM^T(I&=:1@-_WM1U@SV-990SYQFQ3*JH
MHA -H'[V'H ?Y#'QUJ\;-">"SG('#)XVAU!J^#_+\2S7R_EXFL?SR56BNCC*
MS6_V9A,XHIF@K6@DE+!.(2\Y$! ]I^H 4*9DN&S"A]WI:MD(8U[G&6A/&+W1
M,N 6%OO%TX?)8+H(YG[,3O;XL#^'5/U&,N@YBQH,1!(H3PRRSU #Z+MY='IK
M3$1_&WDGU&Q*)#6(64R^K>@6,VVLR!9_\J)'OPZFR]LPN.4LKWKQ^S3(T"SG
MB^(AG_T^']SEZFZ6KR]M;F%>8HN9B+M0L-P(I A@B:0TXEE;-]VD];EB&G8K
MG^[R_Q3#/!_-?8#TTV"2W]RJKX/Q)+JE?#&+/_F4#Y>S0U;/,<UD3@$%@)44
M6P<PPEZZ"GDN;&_QMA=+S0ZDT&-X3AE@M'F]]_@SF:TM9()Q'!3UL!]H#;EU
M2%E?Q;13F)(9MHE<Z=>Q:+8KE/.SP!NQO+-X,TAR%+06:1RU!!-9H0P-3Z'F
MN3_7W2$G6Q-(S[2L[O$TX1C:TUA&"(W/4EL""92(40YTI=$HBU..L<\]M+%+
MQU!S(NB*F!_SQXV>?'/[\GWS/?3;525#RG#G.)?,80L,5@95MW\,="GQLZ<Z
M?'I?#1MAQ)LW<QH10!]VR\NNK]]QK<>YVFUDB,<(=@,L$1J H)&HY[Q27L(4
MKV.2"_SB6=>6"/I8Z=[&^9;6UL'K_,<TDU%D%,#,2"F-H@1+#JLL!HXFY:1L
M(K[QXCG9HC#Z6!U_*Q9YC2BQ754R[+&2(H GN9466TEI=2CJ#4LQ1B['6]/V
MVI> >!]+G2F"D31;C$-OC]#K7M7*&,7>Q#>ND0-4.(WM\]R1UG03=OB#+&1I
MV/>Q;KV/QXZAXT&">Z_3[ZR3(<* D51)''17H8*20)XO(#*>8I\F!1=>/+&:
M@KP7>[0FK7;6R:CPDG!IG*82<F>#2529]S18_)T$#W9X![XO(S0!]*Y##=;7
M[V.^Z?C@T2I_3HW8@BVULK#50X2HQB[8.Y@K*UUU5<L3FZ)MU4_J?)WD:@[V
M/K;#LK\WM^O\U*NSYG?A!], 4+S$LCU[3HR-F(=BD^4HH+G*;WWS&']1]S2W
M\>]FBB-JHL?>>4\-84PP6?GK'4K)6W[\DXQG<>+6]A[=MPS[]#MO@MK?QU/'
MFR^3\=W@$/N/:"4S4&#OG:',.V*4%U[92CK,I[Q! \&_;)@VA9$:]>6+V>?!
MM[^/%_?QT=,PZH_YZOWFS\5_Y_/P9YA6X2>QC^'/@,)XN-B\WO3[='PP BRQ
M]<RB@(840 >UB2I&(#7/5[X13$KJ?2')'CI@:7\2.[\SYD;.EC.H/%'< P@A
M$9Y*86QU&PTAD?0:Z_%'+6<1^]#&LMJ:1+KBI;N]S8>+FUOW;7@_F-[E'\-4
MNYFNHM.GH_A'#,K\.ICL"+8]I9G,2P4TL#B,W"*$-9+/-Y"833H%//<\H:W$
M.[0(?E<TW-[9#WF0R.AUS-L>&A[33":YP9)*ZAU07&(.C:]BY !.N@)S_&W]
M;E?(5FC8(OC]TE"%-7XV>PK+^>KQQJ/Y]ZI^IF#,>!IUE("R1U0A5NG7SJD4
MG?)H?_KC2CR!#[/%5=(O#?OKXAUPVL=L^9(H02W& H+GY[D9E)TXW+_CG9MV
M& 36(^N.0_Z9=3V\@5<\A#;O\^E\_#5?YR']OG/]O(:W[DD$^FW_CGL@KTY+
M6<SV"REV\05$X"0$W$D.@42&8<"MKS-36K,C3WB:S BJ  78"B(]U$J+F -@
M/1XO?3<9*_MZFJPUX>]]E^PXR+O::%;Q@%L&[XM9/KZ;FM4EDN'3Y]E@.@]8
M1%%/1ZM_3=:"KU(FKVXQ?QY\^Q"?O@B_6"QFXR_+10R\^5Q\6 EF#ST[[4?F
M%31*8<4A!PY"$Y]"WL@BOA:7DAWI@C(OM$K^<Q9HWY,KK@>[+Q"^'?D)\^;8
M3V1: QYT$,J8E9!3IXFD)8+4^11=\(+NG/0R)5J6U3FP_6,^G SF\_'M>/AJ
M=L=C5'5CWFW&?7/[//)$^B=],Z.:,@T$ 3*^92Z(E524& >S(.5Z3!.I1*]W
M)G0IMKZGALUOQ]-\M'GX9A46T+9"E?K)S(& )/,$!6W6"DR4A:Y"V(OK#"[N
M>V)T++6NYH7-9^.O@\5JF &YY<KG$%_CV2P$Q=UT_,]54KD=N*Q/.L(_-V,/
M4.R9$VU\+J-*.XDMBC@BSH56#I7($DLZ==ZV'PS=U40X U'UO3G4VPQOIL]0
MM:\Q;?U:9GW89[TSRL1'VS@,ZXRM%A>M:GG'6GPYZK)G0O\".X>)T(XR5+/E
MC' K!=;4*L:U"G]*!ZN%0^-N@L=[/QGNC>;-BZBS<[RW ZJQ1N^IE2$IF,8*
M<><\U])1QJL]S#O(.@WRODXJ-@?_F1W<K:?*?;X(V\7D^Y[^$*=X"%D/G;*$
M&^ZUB0?\>B,\@+6M=<&LVZWO]^DL'TRBION?Z]C74@6^F;[P$,[&\_ K&_XY
MO5N'UYRF R9\+8M/HE($&54N!O(XSIFKL)4T*;[T\LV@VLRKN2MV)ZF^E;\M
MGH\N?&('M W+G5<$ P$T<\Y)%#:#$D- :8K%T\3;>]=)^K;%U#?5X_Q]8:W]
MUS+,\-L8,Z3F_YF/[O+YZ9;]H68S!CG'1EL$E.= *XY1J3X# GC*\IUT_'>=
M3&Y!)'VJFCV'A:T_7W6HWC/3VVID5%$1=D6 L/;2!UX956Z-BC-4Z]"OK1N8
MJP=^ZB2<?%TT(Y8;*Y41C H '#26E>Q5$NE.@[VZ?Y0I3=!O;DTF8=O5#A./
M1^>;OOZM*$;S_><BVXJ'D6$NO9>02F>5]@B3:F00V908J7-GS>E2+AH'M@_*
M?,IG7\?#_ C6O*B1$8VX)%@(C@BUA'IA8 46-2G+S;D'U[5"G-.Q[2X]P'K8
M-3:EC'L'/9"<:BZ#1JXX@+X<@<$TY6+_\8IFM_[+QMAQ(IC=.;WG0;'>=+*&
MPK*U?(8!$L2:H'ASI55\9T:6WEO%J+OF&-VFM98F .Z6/*O-\E/Q#-).VE0E
MXY5M%E\GXCI ;@&&DN/->#0PZ)K5W$0!;Z7+J<#V1!3U$/U !Q,"[ZF5(>HU
M90!*J*&01@!2Q0YJ2D@W[XU=(8$20.Z63*6F=9 _9<&, 2<YD=3J, 1LL.:&
MEZ/1)BFKW+E'S;=!F1-Q[8HE?YL5\_F'67&[-\'EBU(9AH0C*"TC1CJ@%'15
MQ)E6($G;/?>7B)OEQ^F@=N;5+]\]=M]BHK=:KKJ==3*KD.,,$\"I8-#KZ LN
MQV@I2(FR/O>%I6GMMRF0N[.FYWGX5KQ%;L/LF12K)Q WG=]K8N^IEPGKM,/"
M26>(<2ILMMB48PWZ73?O^_9#J 8(\,8 ;P[JSAQ\^6023YBFHU\'LS_R%WCL
M\_'MK)0QX:R!88/6RDA)PW:MJU48,=G-$?BU$*HQG#M3A?)IP& 2.JQ&#^/I
M.(X_GF4>IM2!FIGA4IOX[K4ATGA%T?--%8TL[]9!>.F\:A;LKLCUTF",I\N+
MP?0N/K!P\(G2_16S&+1I)13>4"8MI0S*"D5/1$KL[+GGF6N>6HUBW:%NM9@M
MX^/2 0IS/YC='3BU>%L\HPXB")7'C%OBK9?6D')D7*%NT\1=.HL:0+@W ^\8
MPRX#8=,6B& H ^S<&>Q]-29B5<IQQKD_/=L\:U+A[9PRM5(T;2F=(8^<A!0S
MJ3GPV,/PO]54 +R;JW571YN3 >Z*..NWDJ-1N>YJV%[S(,7],6W;JV0"2>^P
MQE8#H*WF^L5.;+A*T7J.O[QVZ?M50RAWQZ-U]PZ;9:]*9A)R8KB6"&,KG=<(
M@^J<QNFD-^3JWS/KZWG@-GB3 F]G5OU@/)W'93&?WTS=MXC <CR_7T=*'WB0
M\&#=C  '%4+>, ,EXU 25QWJ<(M3]K(CWO3H+,B\!6N^88@[O?#P6S$MOM]_
M#R]*^RMFQGJ+ %=24H@MHI2S9Z5/HI2=[8BW.*YE:VL4[.XVN%*3BQD/3#$-
M'5^&OF_@*:9SG=\6L\V]B\^#;_G\U_%T)9QR25;3T?>MQ+R]BZ=?\\5]S%->
M[O?[-/<.>Y%A:I'S$A%%HK_.&HOLLQQPTD'.N3_DT<:^?*Z2ZW8&A9%M,-U<
MKSO(]C<U,O__M_=E36[D2)KO^V-V<1\O:X:S1[.JDDQ23=D\P5C,D,1I)D/-
M0R7UKU^ 9$1F*I-DD(B+E,9Z2JE4( +N_@%PAU\>:2&E O%_@$(K/*C*$IHH
MG)S^G?#GN[IOA\M]H>BR,M3>>TX-PQAXBF#\ [GJ3#$(H"S$C#T^IGW$Y/"V
M+YRXR7(1:4Y=0+:]$1L$R1P:$K VCAD&M 9.6P"((-75C2$.Y*!G[.Z<MF-D
M6N+Q4"C2D]5L>@:$ML^'E!M.M !0 P.@C&:XK7=2S[*J.HW=>LB7]PD 7<+A
MH=!C9_/-NCB6:G!@1#"(8Z*EDQ1(RV1<?%Q5]&&7=3L_]AB8SA%T&8_[PM"?
MQ>S3Y]1\\FL\Q3\5OV_N_RJ651O@-YOU:CU9I+HL#<ZW<U\5G 8<J]31T@!'
M@8#F8549J44&ZL;N@&[[W.N8]V-#XZES\JSW!"&,PP(H'Q56K8F-"[6R9TW\
M]6 EGWK 87>XN1"@ETAD8'3N-_AGI)R/ST-O"IX+RPTD#'OLF'#$HRK;P%BB
M<BR$L9_/0R.T)9GT4=;F426>IQ_OL8;-B_6NU>(NE0-ZTC;8SE;3>;G:-#*=
M,]X:+"*($VH4)]I3S(E3<->B#C-'6",'\&AX]2&*4L?9_+-=9M6O#5*GSEZ&
M*RB0  8:KTG%K<B]P6S);C:77G#5I")\-^+I>=-1=W>S-'XR?[7X6"[OMR^S
MQ7HRF__:D!Z  P5@A#MA792D1,H+6<D006\;.;Z>\:J<?]MR "(,MO2GW]31
M&JEQMIE\49^6Q:[6F?H4?TS!*&^7Q?UL<_]V\CT5''R!XHO>$RB,\,162\20
M0\XHX%1%HS(ZZT+\MK:1QF@H^Y-' X7Z9;R]7<X6T]F7R5S=EYL4S*'+Y;+\
M.UV''(+6D2&!1.6*8@EM%(D&0"A:]33&&!*7$Q>1I?;>"(K:8WVO 3A7W6)$
M8(D<U0@PZFTJNZXQJ?GJI,N ] CKD_8)Z?%(K:_5<*JWT!-2MP1.IYO[S3S%
MH$92/Y3[P*C5>G:??A?)W>T$'TI=;%N8[L!TKA[4P10"Q)(HKRE52!*IG<+1
MN-]+0$J>4Q0IRT=Z.^MFI*+L.\)\IU*M/OMY^?>VAO$V#U"M_62VW/:\;Q![
M?O(= 4NOM>4."A8Y8'0\7W'% XU%CL,MR_5Q.W#N2A9]AK#O&B'\T&GZ16;^
M7JYML8I/I96W*[Z]#7RM'S@1\-[BE]+%*.8P<M(PJSATR#A4\5,)=&.-!(?
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M;Y?%E\GLKJZQL[C;Q;ENW>+K7:WZDV=B\Y<$8ADUC"/KF.7,:NPAJ1G+W$^
MKW/A4/;$ZUYC[1L"Z]FSP1!(I!3,(LPCGSP4VN]I\D:BG)SZ$6I8'> GEZ5]
MP41-I\M-%,1L\M=LOO63GD3+H2&!0NF],Q B@%.W(*!8M1 \H"8'-"-4JCH
M34N<'32!X;CK??5ZMBA>K8O[<Z] &[\WH+@3FSACH(GFV!%E6*61>FA)SMW4
M"%,-1JC:]RF^OJ#^) 3])0)W6WVS/(/S7Q8$IG%/4=H H5/K8N1K,]];AG-Z
M0H]0G^L)03_V_NU:+#T'*SX*PJTFO"4M90.5GQ8I3O?5HBIW]BM@\<?@,$H
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M'?Y1EG=_1Q7IZ61Z3"RM)A#G\N/TSDHU/>L]P5K!F8"8$R>M!0C$_]_)1AC
M8*,KQ:X.P$.3;Y9,?G)TX 83BJ$7U"*N*&51>:UH]Q+=<CO<CD#RO.IGRT(8
M>'-0=W=;6RHIDQ_+Y?TNKF'@C/1A-@XH#.6<"\TA%L@R8YGGD!A,/5#07I:U
M_K(9&8^2N\UTG8ZM0]GG+SX7G!568X.%BNJ]L%)RRJHY&J!N+)>O(_F5[7&X
M][QSO5G%J:ZBAO)IIYXTS#]_:5QP@AE(/0,:<:N)M !$-8:A2*TDD.=4@QX1
MFC+E?"CWO 6.]A<BN)WBZ82^Q\\%H3$5D C%C3%*I<@VOZ.%2*?=C:"C9;D^
M"_&[G*,77U+^5MS-II.Y*E;KS\5Z-CW<M_+8XX$389B3'D3[Q@(95TA*#V&(
M*4.X13=6I>)"296M,[*W:K&SQ6Q=O)Y]+9X=KOK[;Y/_*9=F/EF=.F#.>$N*
M9L3"8>"9H1H0+)D0U9;K',NQ3D84T]3N<=,=?T> LX?Y_SZY/YUO?N:;@A4"
M6PBQUTCAU+2+I-S7'3^@43?6S+03I#1'8PL2R' B?RWFY9?D&II^7B3K]_O!
M=(?C X)P4@&GD_G K8->"RWK&4,R6%6^WC&3)\^R V9?# ^S6:W+^V+YKICO
MXH\_S[ZL3O=C;#PVI.-<<167E/1.0."%T14=5-L<T(SH8.L5-!WPO:\#KS(@
MU/1?F]DN4N&$$G5@1/#2842QDA2 N&,;R'&]32.=Y7D<471LNPI3.[P<$BOI
MQV5Q6ATZ.39PJ &W%E'EM/$N<DW:BF8O;N5^IS7)-T!2#G\O/[^^+[8WG2=.
MJB=/!:5)I!E8IYF%A$&)O*GFQI6^L9OB%F55ML73B^7]:"]\?225\N"S <2M
M4T&/",=*>>@T=>3137@_L>-7<FZTQ<6^3HS?-PF*;SZ^*[Z4RQ0N]D?4QHXI
M%R\/"$Q%NP_&C9%I31CPEGG$(8,L_9^0-W(VM"#=L@-V]@66)Y-\6RRG25J?
M'C< >;5PWZ9QXWSHE' P-RS_I4'MNJ]:+[%)O8F8QO7B= KG5*@8D:'4/NAZ
M8WE?P/PQ-NF(\SX ):)MARBP0$/BE?$,[BF \3C.*40Z8BLH'S07,G#@@)2'
MUBUUIY:(Y C^?V\_LX]TWD6H_&0!*H YJ"'RCD*MA/%"N'V.0Q2O50/V1SER
M)?2"\-X522._2Z>HCU1.YO]=3(Y5IFGA[7$;5$QX 2!$Z4?#M*\"OJ"Q6?GT
MMQ49UQADS5T#'0EI! ZL%RA+A'SXNVP-SOOW1?L5 L*L95$>\0QP'E4Y'9$W
M1N:4QQU[B[ Q O@RL8P8LO'S1YO!7O;&@+RV&FDDXA]2> Z\)C5_-,CI79RE
MO/W,L+U ,.,%KB\W[>D.U0L#EIP#BD5D"R-64(6K! \!H;0YL,VZ0?N)87N!
M7$:,VOALNZB-SP:E0 I/(U%S8@IH#+3%%7=8-/<S4)M5.^%G1NWY<AF- ?Z,
MD3^CT<V-DX!9(@050' HA:O\1AP8.& OPT?MG _#\E1SP^8O"=8 X+ 'BEAN
MD<(4I-3*'2>\TSE>I=LRH1M#YG!_[G9E,8)SL*.08DJ)(-@Z!Q%%UBMJ276U
MR0GSMUS$LPNT9 0?GR>)$2"RX^!C93T!QD:>$$$A9(K**NI$: )RO!9C1V8G
ML,F,1#Y/'&.(1'8I!E89CYWRFF/E*>75C"4Q/RF \H3;+"SY/,[W5S[G[;),
M+MYW4:;QHY^C,K*GX;YHT'6MT?C@!-=:>P@,EY!81H"L0IP$DB+GXF/LU\Q=
MHZY+08PW-IY8:*C "'F/.&/"*6QK.HP<+(;Y!@#5E1!ZJY>TG-P5B?[3S4E^
M?#00!)T5QEO,'2!$&(#K/=H;G',ZCOV"MJ]]*I/GE^M0J0/*[*_-MBS)IV51
M'#W>3@T)-NZD%!*GB32&* B4K,)G!&0NIU/-" O*]J,ZM<;NWJ)FRVVAQ51G
ML9KOZ4WG\*! I(364X84%YY"+TQMM@A(:4XXR0CKO_:UX[3&\(OWGBJ/X/5L
M>KQKUI&G P4(H6@W6,2PP]&J=<!5<U78Y11.:%XS]3;/IO;8?C%$]GDE=[.:
MOLF.OJ-0.3XJ,*+B66IL\@X99(!ZM&M:8'*B>T988[07E+3*\8O1$NDKEHO)
M?!-Q6GY<_STYE<9U<$"00B!(%'?<&T8(4<[7^-86YYCFS0M]WA9&VF+VY>;W
MY,ML/9G/_EW<-8/'P0%!*FF D\IP :01$F/Z &CALR)<P4^*C[:X/0)WQ^L&
M31F;# ^ 2N:L@8X@A$7</H%##Y2C''MJ[#>$P[K<+A7!",#WCV6YNA!XVZ%!
M:ZNPH$Y9*!BB3 !473U(3++:$%RQ,^0"1#2'VR6,'P'4'C5M>AR2=6&PW<LO
M"T (:#5R5DHJ.:& V*IPC=2&YB3/CGT/' J.[8ABX-BZ[=GPL]55EB3Y])GR
M#C)CK)&>[)LU"!75X4;5D8:.H&M2H/V"MX5H?'HNH214>&P]!T#!BC<>VEMV
M\G<$HHMCZBX52E]G7D5)>8P2OUDGKCV/13X;Q6U\)@!E(#;12B*>4.>DDU7_
M<J%8Y.P-GY/]PGL :?5QE/Y>K'?M7MX6R_>?(]\'.SKKSI_[B30X)0\-"0I'
M/!$@%2<Z2CE=)5C*M?8,08A%HRH8_5#99,,X."9H*;TBJ=B684 @[9QR%9U"
MTYR;@K$?;OFR_[&E9TM<'F35/NT\^N:CGJQFTQ3U-)MOHCZ_X]"V7,G0.29M
M+O-HDAB!&(NF2+2@$8QV--X)!AI+FOF(&UXC/T/'L:8B+SX<,&">N'3:2!%-
M*L>85-5LH3<YWH6K7:R-)5BVS-Z^=$JU6,_NTB*,:L/[8KI9;INONF_3^2:N
MM]2'SY3W7S;K_;K]D33]_>47G$CPZ/"K 4O*C8>$<LE3>WIK&:_XC,A-GCEM
MH*X<JX2&70F-,D-.#0T>8XZ8<<2EXUY)KKVM*!9YCMNQ8G)40&H$[HOEU9O]
MOX[:7N)6M-RV['H[GRQ.QK =&16@ 8@K1I@ S@//M(ULV].I.<L).KE.7%Z"
M@6?MH=KB=W\U(E,P9^JUOIW[MISEN_=_G$36T7$!<<.Y1A92CHDC1"&$]K1:
M8V_:2]P9MMKD^,41*S]NT:]/52@^." (*SB1CENH+,(\3A+0:L;(@<':)ER'
MKM8J<_O:;/XL9I\^)Q?>UV(Y^514Q72W<U^]V:Q7Z\GB+A*TO2$XLOF<]9X@
MI72(.D2LE5PXS+%B-2^0[+6369SP7^5@4+L 'V5_G.\OE7*ZW$:73^;QJ+XO
M%[O9J_4NJV%[*U[N%-#)JKA[._F>'E;+Y63Q:1>5?@2:^2\/"&K"+2# .V:8
MPW%3J+=R O4MUOKK"*V]"R,C4+C!3#]\+DRYB"MOM367;/'7^D'#.!Q1G/OF
M "1$T! K+>+24HP@-C7[!3(9@!Q;">;V,#@,\P<^R1]?Z3\^#LX_RP^]*3 <
MSQ.F$8E:-+0T)0359XJA),>I?'[J9QD%>[6[8[><'Z5.V<"A<]'[ O:..X0<
M<R0J/0(1YRM?@06 YNB88ZV]-P8-\T+^7XF#Y60OCE;>'T \4QQV/%J=FG/K
ME6*^XITFZI:K:'4,MG;]*A>):Q"/_\"!KFVZ\9G$F%"A,%4$,<2HK4U8SYQL
MI&YT';[ZS&_R-,#B@A#6L]X8K*720@TLL$3QJ I 4[EB/%5LL%;Q0P8/-,;-
MP8C5+F70SZ[PMYI.TY85J7B[+!?QQ^G3^Y/>=X9'$RKGLVGR)9[>&PX/"H("
MG]I\0:XI@Y +27;15U1!Y=2 P>VV6$V7LR^[D^2(*'XOU_]=K-5=^25BZ@@3
M+GI?8 (" *$GUD-$G=' FXH_PN/!VE#VX0=J 35E_S(8>&<X\D\5&V]G\Q &
MJ:2U0<$=P\03M(=!JA9N!@P$/B6%[[O_-M$ISGU54-9RP9SAW'$".+4$V8HK
M-)YK0VT9_>\23>'Q8QF=;CG>QP;Q9OVY6.K)?!(G_OYSD<R+C^7R_DDJ9^_+
M__%\MN7VBKN'5(XF6T&S%X2X4U,MO(/0>@DT(\*!G28'( .D45)80Z_#+MPZ
M=8TLEO&GQ>,9[C&T.K;(SW])B'2YJ!I+:1PP"D2"**RHP\C><B>VMN5?]B2$
MH5?\T7_[^&KQ-7XQRJX8.GN@KPT",29P5.*<-( Q+H@R<K=?>TVA:*14=^59
MW\GB^[O)W[_%Z2]GDWE4Z=:I7_*J6'Y]T4O9?'"0T<:U"G@4&< PHYXP6E$N
M+,QQ1(Y0-V@;#L^<XRWSN[_XC?W$_RR7_ZS+*9\-L\.C@P3(8JPD18ZAN$,*
MM;_@I=Y8EA6R/:)&U7WCK#6&]PZTE%V[^EQL"SF<#[3#HX.7V"$9U7Q%G4+2
M(D%81;=C685$1Q19T3?06F-X[T"+DVV"J/A8D-JE9N!J5Y4'VU35NZ9$->M,
M=65Q$'WCZ'PVCUM5CEOOEV@>?$])"6NUN'/_VLRV30=^$L59<P, ,IX[8X5!
MR$%%]K(DQIO+?'DO6]:_31:;C_&;F^5L\:GF<^3Y^WTAP4/6],F!P1)@$.#.
M.\FHDU2C??Y I )Z=LN-V-J6<]DAXR]/L:B^_4?JD%XU>/AC-?GTJ"[VP72+
M)H,#P99Y0(U6\>N8)H>AJ"B1UMUBZD4?$.J"^7VI('H3V9;<S:EBS?V79?EU
M-]U3M1N/C@O,>JP(]M!)85@T)HVJCN!45?>6V[]T!+0N^-X7QEX7DU415\I9
M #L\*$!+F8%**V*DE$I8JZKK"8)Y5N#:V+O =(RNUIC>&[0FBV/1"^F?@Z&0
M"D,I5- PC.,V#.J9&PMO,4:W+[B<S][>:L5NEHO9M@#:XL[/OJ6?3M<C/C0F
M0(*\E$D%]%!9ACF%M0JHA<Q1G+(:OUP_A-KB>5^X.FA+GP+7\8'QY!;&(86%
MUS"5!!-$NXK:J"WFN#C.[QXSRFN=2Q'6*N-[RR!XJ'MLBRB]Z:Z(6OQY7FS%
MNWA2#_D@C<<CE%KY1$!8.*T)]TPY;16(?ZT/ !=MYPSH-N]B(W?0712?$D$W
M ]Z!A#3X;GK\0OS8L*B/,">4 \A#;KV%45&M%S1E-B=1\/R&.3_'3GH^VX>^
M,!\X4Z6OF^^XY+7TDG(+%'+2.(OU7B@>"V#'D,52NUW,9IE ?D':RO%7!!MQ
M";4@")%MJA8FI-(DO5/FU\UY<YP<S%II502#'S]-X'=Z<*#8"">)\PA#H(DA
M0N]+/@$0-]\<X-W(??NEP&N=^7T<2''2=YOI^L])*C2R'C*EX1^;29I"T>BL
M>?YP2+?,!BEKC(U+&F@KU3ZW1%,!V(#9D4]Y_/T!<PV7](G!P4)DL**"0B1%
M1)AU#E:40]S,EWRE9TD.#IXOWW89/<CR_8$*-5W/OD81#!Q5D;NV+88>,"<M
MQ)3S%"6NY:X?!.?:-[LN[X:RW_8>B5>+]RD_?[*\2SO_GK,_"&-;@6>R*FRQ
M^_-=.9_[<OEW''2$'2U](4"I5<J_A=P3YK3S%/F*AY:!P7:)WC:&QB JQR"
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M(/3T/)X.'7KJ %7(1VJ] ,A:#P!2U6RU)(UZ$%^/A[0K!&0Q=>C04RH D9@
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M'Y1ZH;)BKN4OR+\<K="?O#("8KX=G^.6*9> -??% 3+/D,3>$PPHM8(B6W,
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M+3(P,3<Q,C,P+GAM;%!+ 0(4 Q0    (  *#2$S&:,VH618   O^   1
M          "  >R. 0!H;VQX+3(P,3<Q,C,P+GAS9%!+ 0(4 Q0    (  *#
M2$Q=? ;C:28  "^C 0 5              "  72E 0!H;VQX+3(P,3<Q,C,P
M7V-A;"YX;6Q02P$"% ,4    "  "@TA,HQBA\C1E  #,Z@0 %0
M    @ $0S $ :&]L>"TR,#$W,3(S,%]D968N>&UL4$L! A0#%     @  H-(
M3*XY'3NSZ@  -"<, !4              ( !=S$" &AO;'@M,C Q-S$R,S!?
M;&%B+GAM;%!+ 0(4 Q0    (  *#2$PAKK?53)4   . !P 5
M  "  5T< P!H;VQX+3(P,3<Q,C,P7W!R92YX;6Q02P4&      8 !@"* 0
&W+$#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
